Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes,database,module,overlap.n
regulation of cellular amine metabolic process (GO:0033238),14/51,6.14713645698082e-09,1.69169195296112e-05,0,0,9.41185543520174,177.952581141655,PSMD14;OAZ2;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,14
regulation of cellular amino acid metabolic process (GO:0006521),14/54,1.38329868540793e-08,1.90341899112132e-05,0,0,8.70460440985733,157.520347151378,PSMD14;OAZ2;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,14
regulation of primary metabolic process (GO:0080090),21/130,3.50301032141345e-08,2.71332004102681e-05,0,0,4.81802680244008,82.7113458198038,FDPS;SMARCD3;PSMD14;OAZ2;TM7SF2;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;CARM1;PMVK;PSMC2;DHCR7;FDFT1,GO_BP,turquoise,21
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),17/87,3.94377912939944e-08,2.71332004102681e-05,0,0,6.05403645833333,103.212490654889,PSMD14;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;DDIT3;PSME3;PSMC2;ANKRD2;ATF4;HSPA1A,GO_BP,turquoise,17
regulation of mRNA catabolic process (GO:0061013),20/122,5.74102756163606e-08,2.77657479340206e-05,0,0,4.89888504421376,81.6793187012414,SET;PSMD14;HSPB1;EXOSC7;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;FXR2;PSMB5;PSMA1;PSMB2;CSDC2;PSMC4;PSMD2;PSME3;APEX1;PSMC2;HSPA1A,GO_BP,turquoise,20
regulation of mRNA stability (GO:0043488),22/146,6.05357876468472e-08,2.77657479340206e-05,0,0,4.43920432926056,73.7797140801174,SET;PSMD14;HSPB1;TENT5B;EXOSC7;PSMA6;PSMD6;PSMA3;RIDA;PSMC5;PSMD7;FXR2;PSMB5;PSMA1;PSMB2;CSDC2;PSMC4;PSMD2;PSME3;APEX1;PSMC2;HSPA1A,GO_BP,turquoise,22
regulation of cellular ketone metabolic process (GO:0010565),14/64,1.41689166707882e-07,5.57040838257275e-05,0,0,6.96005188067445,109.757443951595,PSMD14;OAZ2;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,14
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),14/66,2.13108523783239e-07,7.19260964222429e-05,0,0,6.69165918387708,102.793683658613,PSMD14;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2;NABP2,GO_BP,turquoise,14
negative regulation of cell cycle G2/M phase transition (GO:1902750),13/57,2.35223425799486e-07,7.19260964222429e-05,0,0,7.33699364107395,111.982553149081,PSMD14;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,13
anaphase-promoting complex-dependent catabolic process (GO:0031145),15/84,8.39262035543046e-07,0.000230964912181446,0,0,5.40542066629023,75.6258505941281,PSMD14;ANAPC10;FBXO31;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,15
pre-replicative complex assembly (GO:0036388),13/64,9.79398917228839e-07,0.000245027801837615,0,0,6.32764401097226,87.5513504302766,PSMD14;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,13
regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),14/75,1.11256128784357e-06,0.000255147388678791,0,0,5.70168612191959,78.1635354703784,PSMD14;SIRT2;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,14
negative regulation of canonical Wnt signaling pathway (GO:0090090),21/165,2.09748607167839e-06,0.000444021666866072,0,0,3.64029777486911,47.5960599204368,MESP1;PSMD14;SIAH2;AMFR;FUZ;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;DDIT3;PSME3;DVL1;PSMC2;NKX2-5;EMD,GO_BP,turquoise,21
negative regulation of mitotic cell cycle phase transition (GO:1901991),15/92,2.77353053137475e-06,0.000545196858738809,0,0,4.8417945690673,61.9526473382197,PSMD14;MYO16;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2;CDK2AP2,GO_BP,turquoise,15
regulation of hematopoietic stem cell differentiation (GO:1902036),13/71,3.36265788330167e-06,0.000616935632989746,0,0,5.56193049848133,70.0957801070323,PSMD14;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,13
protein modification by small protein removal (GO:0070646),28/276,4.55818195311976e-06,0.000751857317594902,0,0,2.82884476072783,34.7907925744964,VCP;PSMD14;KEAP1;BABAM2;PSMD6;PSMD7;PSMB5;PSMB2;PSMD2;RUVBL1;UFD1;USP5;DESI1;SIAH2;USP2;ADRM1;COPS4;PSMA6;PSMA3;PSMC5;COPS5;PSMA1;TNIP1;PSMC4;PSME3;PSMC2;STAMBP;BAP1,GO_BP,turquoise,28
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",13/73,4.64446744153827e-06,0.000751857317594902,0,0,5.37597150259067,66.0160368032615,PSMD14;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,13
"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",14/85,5.24401643375714e-06,0.000787114863210719,0,0,4.89607424051442,59.5285409615437,PSMD14;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;DVL1;PSMC2,GO_BP,turquoise,14
NIK/NF-kappaB signaling (GO:0038061),13/74,5.43429593059726e-06,0.000787114863210719,0,0,5.28756476683938,64.0999875204822,PSMD14;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,13
regulation of hematopoietic progenitor cell differentiation (GO:1901532),13/75,6.34047264736307e-06,0.000872449036277158,0,0,5.20200986127361,62.2605527993324,PSMD14;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,13
regulation of establishment of planar polarity (GO:0090175),14/88,7.96206491923281e-06,0.00104340965036803,0,0,4.69684859957234,55.1448642129535,PSMD14;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;DVL1;PSMC2,GO_BP,turquoise,14
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),14/89,9.11191860640708e-06,0.00113981818203783,0,0,4.63398184176394,53.7816562002061,PSMD14;FBXO31;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,14
antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),13/78,9.90907208031046e-06,0.00118564201587019,0,0,4.96113989637306,57.1625508037215,PSMD14;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,13
regulation of cell cycle phase transition (GO:1901987),14/95,1.96340814921586e-05,0.00222016926683548,0,0,4.28937887303646,46.4893333337292,PSMD14;ANAPC10;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,14
protein deubiquitination (GO:0016579),26/267,2.03936507577776e-05,0.00222016926683548,0,0,2.69695329626775,29.1278694713519,VCP;PSMD14;KEAP1;BABAM2;PSMD6;PSMD7;PSMB5;PSMB2;PSMD2;RUVBL1;UFD1;USP5;SIAH2;USP2;ADRM1;PSMA6;PSMA3;PSMC5;COPS5;PSMA1;TNIP1;PSMC4;PSME3;PSMC2;STAMBP;BAP1,GO_BP,turquoise,26
negative regulation of Wnt signaling pathway (GO:0030178),21/191,2.09754363872538e-05,0.00222016926683548,0,0,3.07934246997228,33.1711651645216,PSMD14;SIAH2;AMFR;CTNNBIP1;FUZ;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;DDIT3;PSME3;DVL1;PSMC2;NKX2-5;EMD,GO_BP,turquoise,21
positive regulation of canonical Wnt signaling pathway (GO:0090263),16/130,5.08793621944124e-05,0.00518592610218603,0,0,3.48614057901581,34.4641711379261,VCP;PSMD14;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;RUVBL1;PSMC2;LGR6,GO_BP,turquoise,16
regulation of stem cell differentiation (GO:2000736),13/91,5.39235650579939e-05,0.00529991610855712,0,0,4.13147668393782,40.6039172564207,PSMD14;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,13
cellular response to hypoxia (GO:0071456),16/131,5.58876354183202e-05,0.00530354388521438,0,0,3.45564538926895,33.8382581037973,PSMD14;SUV39H1;MT3;SIRT2;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,16
ubiquitin-dependent protein catabolic process (GO:0006511),30/354,6.88260627754131e-05,0.0063136441585979,0,0,2.31677704194261,22.2038245134296,VCP;UBE2D4;PSMD14;FAF1;UBE2D2;KEAP1;ANAPC10;PSMD6;COP1;PSMD7;PSMB5;PSMB2;PSMD2;UFD1;SIAH2;AMFR;ADRM1;SIRT2;PSMA6;RNF167;PSMA3;PSMC5;PSMA1;UBE2R2;PSMC4;DDIT3;PSME3;PSMC2;UBAP1;SPSB4,GO_BP,turquoise,30
interleukin-1-mediated signaling pathway (GO:0070498),13/94,7.60484310891492e-05,0.00675113814055931,0,0,3.97783534830167,37.7263480143387,PSMD14;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,13
non-canonical Wnt signaling pathway (GO:0035567),15/124,0.000105603077142342,0.00908186463424139,0,0,3.41463124031931,31.2637594088672,PSMD14;CAMK2A;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;DVL1;PSMC2,GO_BP,turquoise,15
DNA-dependent DNA replication (GO:0006261),15/129,0.000165207252284078,0.0132926493194983,0,0,3.26401230348599,28.4240303226399,BLM;PSMD14;GINS3;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,15
muscle contraction (GO:0006936),15/129,0.000165207252284078,0.0132926493194983,0,0,3.26401230348599,28.4240303226399,MYLK2;CHRNB1;MYBPC1;SMPX;TPM2;TPM1;MYL4;SLC6A8;ACTC1;DES;TNNI1;ANKRD2;MYL9;EMD;SNTA1,GO_BP,turquoise,15
regulation of canonical Wnt signaling pathway (GO:0060828),23/253,0.000170006864973587,0.0132926493194983,0,0,2.49146981627297,21.6251401542009,VCP;PSMD14;SIAH2;AMFR;FUZ;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;DDIT3;PSME3;PSMC2;RUVBL1;DVL1;NKX2-5;LGR6;EMD,GO_BP,turquoise,23
proteasomal protein catabolic process (GO:0010498),20/205,0.000173886400981809,0.0132926493194983,0,0,2.68927751280692,23.2813667843765,VCP;PSMD14;SIAH2;FAF1;SIRT2;PSMA6;PSMD6;PSMA3;PSMC5;COP1;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;DDIT3;PSME3;PSMC2;SPSB4,GO_BP,turquoise,20
positive regulation of telomerase RNA localization to Cajal body (GO:1904874),5/15,0.000198837832886754,0.0147892355703877,0,0,12.3108974358974,104.926037074323,CCT3;RUVBL1;TCP1;CCT8;CCT5,GO_BP,turquoise,5
post-translational protein modification (GO:0043687),28/345,0.000244547327618219,0.017710374884351,0,0,2.20505148581692,18.3374324071231,PSMD14;KEAP1;ASB12;KNG1;KBTBD13;PSMD6;COP1;PSMD7;PSMB5;PSMB2;PSMD2;STC2;QSOX1;RBBP7;FN3K;FBXO31;COPS4;PSMA6;PTP4A2;PSMA3;PSMC5;COPS5;PSMA1;PSMC4;PSME3;PSMC2;PNPLA2;SPSB4,GO_BP,turquoise,28
protein polyubiquitination (GO:0000209),26/314,0.000295104152587128,0.0208237596902507,0,0,2.25123517786561,18.2984497104618,ANKRD39;LRSAM1;UBE2D4;PSMD14;UBE2D2;ANAPC10;PSMD6;PSMD7;PSMB5;PSMB2;PSMD2;SIAH2;UBE2E3;AMFR;MUL1;FBXO31;PSMA6;RNF167;PSMA3;PSMC5;PSMA1;UBE2R2;PSMC4;PSME3;UBE2T;PSMC2,GO_BP,turquoise,26
positive regulation of Wnt signaling pathway (GO:0030177),16/153,0.000347472217869308,0.0239060885894084,0,0,2.8973830835382,23.0771516658573,VCP;PSMD14;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;RUVBL1;PSMC2;LGR6,GO_BP,turquoise,16
tail-anchored membrane protein insertion into ER membrane (GO:0071816),5/17,0.000383779430265288,0.025327293605998,0,0,10.2580128205128,80.6838107298474,EMC3;EMC4;GET1;EMC7;EMC8,GO_BP,turquoise,5
positive regulation of establishment of protein localization to telomere (GO:1904851),4/10,0.000409192061902878,0.025327293605998,0,0,16.3969270166453,127.917771794778,CCT3;TCP1;CCT8;CCT5,GO_BP,turquoise,4
protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),4/10,0.000409192061902878,0.025327293605998,0,0,16.3969270166453,127.917771794778,EMC3;EMC4;EMC7;EMC8,GO_BP,turquoise,4
Fc-epsilon receptor signaling pathway (GO:0038095),13/111,0.000411878530717179,0.025327293605998,0,0,3.28488156920799,25.6049359920351,PSMD14;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,13
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),26/321,0.000414145425970171,0.025327293605998,0,0,2.1970031933186,17.1131024193627,VCP;PSMD14;FAF1;ANAPC10;PSMD6;COP1;PSMD7;PSMB5;PSMB2;PSMD2;UFD1;RNF175;HSPA5;SIAH2;AMFR;SIRT2;FBXO31;PSMA6;PSMA3;PSMC5;PSMA1;PSMC4;DDIT3;PSME3;PSMC2;SPSB4,GO_BP,turquoise,26
Fc receptor signaling pathway (GO:0038093),13/112,0.000449570572534157,0.0264935898505455,0,0,3.25153085256712,25.0602561847683,PSMD14;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,13
regulation of mitotic cell cycle phase transition (GO:1901990),18/188,0.000452470466197543,0.0264935898505455,0,0,2.62911266201396,20.246239409246,NPM2;PSMD14;TUBA4A;ANAPC10;SIRT2;PSMA6;PSMD6;ACTR1A;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,18
protein-DNA complex assembly (GO:0065004),15/143,0.000509118931824176,0.0284657111406882,0,0,2.90488027597403,22.0272101393581,PSMD14;H2BC5;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2;MNAT1,GO_BP,turquoise,15
regulation of telomerase RNA localization to Cajal body (GO:1904872),5/18,0.000514311435184018,0.0284657111406882,0,0,9.46844181459566,71.701494835173,CCT3;RUVBL1;TCP1;CCT8;CCT5,GO_BP,turquoise,5
positive regulation of proteasomal protein catabolic process (GO:1901800),11/86,0.000531083199886166,0.0284657111406882,0,0,3.62687338501292,27.3487719377403,SH3RF2;VCP;COP1;PSMC5;USP5;DVL1;PSMC2;KEAP1;SIRT2;HSPA1B;HSPA1A,GO_BP,turquoise,11
cellular response to lectin (GO:1990858),13/115,0.000580657554213609,0.0284657111406882,0,0,3.15540231636696,23.5120051013823,PSMD14;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,13
stimulatory C-type lectin receptor signaling pathway (GO:0002223),13/115,0.000580657554213609,0.0284657111406882,0,0,3.15540231636696,23.5120051013823,PSMD14;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,13
response to unfolded protein (GO:0006986),8/49,0.000588157693106972,0.0284657111406882,0,0,4.81501710770004,35.8165791980297,PACRG;HSP90AB1;HSPA5;DDIT3;HSPB1;BAK1;HSPA1B;HSPA1A,GO_BP,turquoise,8
actin-myosin filament sliding (GO:0033275),7/38,0.000608498360236044,0.0284657111406882,0,0,5.56795754208475,41.2280326024878,MYL4;MYBPC1;ACTC1;DES;TPM2;TPM1;TNNI1,GO_BP,turquoise,7
tRNA aminoacylation (GO:0043039),7/38,0.000608498360236044,0.0284657111406882,0,0,5.56795754208475,41.2280326024878,AARS1;MARS1;GATB;YARS1;YARS2;FARS2;FARSB,GO_BP,turquoise,7
muscle filament sliding (GO:0030049),7/38,0.000608498360236044,0.0284657111406882,0,0,5.56795754208475,41.2280326024878,MYL4;MYBPC1;ACTC1;DES;TPM2;TPM1;TNNI1,GO_BP,turquoise,7
regulation of establishment of protein localization to telomere (GO:0070203),4/11,0.00062308597316852,0.0284657111406882,0,0,14.0537772087068,103.728484923375,CCT3;TCP1;CCT8;CCT5,GO_BP,turquoise,4
regulation of protein localization to Cajal body (GO:1904869),4/11,0.00062308597316852,0.0284657111406882,0,0,14.0537772087068,103.728484923375,CCT3;TCP1;CCT8;CCT5,GO_BP,turquoise,4
positive regulation of protein localization to Cajal body (GO:1904871),4/11,0.00062308597316852,0.0284657111406882,0,0,14.0537772087068,103.728484923375,CCT3;TCP1;CCT8;CCT5,GO_BP,turquoise,4
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),4/11,0.00062308597316852,0.0284657111406882,0,0,14.0537772087068,103.728484923375,HSPA5;CREB3L1;DDIT3;ATF4,GO_BP,turquoise,4
tumor necrosis factor-mediated signaling pathway (GO:0033209),13/116,0.000630962347231824,0.0284657111406882,0,0,3.12460385331254,23.0229072389323,PSMD14;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,13
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),12/102,0.000651744854574223,0.0289290619320687,0,0,3.29883570504528,24.1997883181294,SH3RF2;VCP;COP1;HSP90AB1;USP5;DESI1;DVL1;GLMN;KEAP1;SIRT2;HSPA1B;HSPA1A,GO_BP,turquoise,12
positive regulation of establishment of protein localization (GO:1904951),5/19,0.000675587431465226,0.0295113747840048,0,0,8.79166666666667,64.1785334619856,CCT3;PTP4A3;TCP1;CCT8;CCT5,GO_BP,turquoise,5
regulation of G2/M transition of mitotic cell cycle (GO:0010389),15/149,0.000784113907927292,0.0337168980408736,0,0,2.77393874781935,19.836314646485,PSMD14;TUBA4A;PSMA6;PSMD6;ACTR1A;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,15
innate immune response activating cell surface receptor signaling pathway (GO:0002220),13/119,0.000804457476159179,0.0340594919136932,0,0,3.03569508260827,21.6303670385991,PSMD14;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,13
cholesterol metabolic process (GO:0008203),10/77,0.000833566117698102,0.0347571811500784,0,0,3.68762638420799,26.1445244434002,FDPS;NSDHL;PMVK;SCAP;CEL;DHCR7;CYP46A1;MT3;TM7SF2;FDFT1,GO_BP,turquoise,10
"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",4/12,0.000905699664957443,0.0372012757904908,0,0,12.2964148527529,86.1585540510954,CCT3;TCP1;CCT8;CCT5,GO_BP,turquoise,4
extracellular matrix disassembly (GO:0022617),9/66,0.00105310555845566,0.0426198014245584,0,0,3.89812805208899,26.7256119441125,MMP11;KIF9;CTSL;MMP15;CTRB2;CTRB1;HPN;TLL2;CAPN1,GO_BP,turquoise,9
cellular heat acclimation (GO:0070370),3/6,0.00110213833111652,0.0433297812461807,0,0,24.5677749360614,167.318906104287,RBBP7;HSPA1B;HSPA1A,GO_BP,turquoise,3
heat acclimation (GO:0010286),3/6,0.00110213833111652,0.0433297812461807,0,0,24.5677749360614,167.318906104287,RBBP7;HSPA1B;HSPA1A,GO_BP,turquoise,3
proteasomal ubiquitin-independent protein catabolic process (GO:0010499),5/22,0.00138762096571672,0.0537849703894704,0,0,7.23906485671192,47.634237826894,PSMA6;PSMA3;PSMB5;PSMA1;PSMB2,GO_BP,turquoise,5
T cell receptor signaling pathway (GO:0050852),15/158,0.00142680788798112,0.054535768162834,0,0,2.59812914358369,17.0237620561,STOML2;EIF2B2;PSMD14;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,15
protein ubiquitination (GO:0016567),35/525,0.00168285593501482,0.0629799383716561,0,0,1.78333333333333,11.3906189587929,RNF10;LRSAM1;VCP;UBE2D4;PSMD14;FBH1;UBE2D2;KEAP1;ASB12;PSMD6;PSMD7;TRIM7;PSMB5;PSMB2;PSMD2;USP5;H2BC5;UBE2E3;AMFR;SIAH2;MUL1;FBXO31;PSMA6;RNF167;SH3RF2;PSMA3;PSMC5;PSMA1;UBE2R2;PSMC4;PSME3;UBE2T;PSMC2;TRIM54;SPSB4,GO_BP,turquoise,35
respiratory chain complex IV assembly (GO:0008535),5/23,0.00171638640184383,0.0629799383716561,0,0,6.83653846153846,43.5318919668895,COX19;COX14;TIMM21;COA8;COA6,GO_BP,turquoise,5
positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),5/23,0.00171638640184383,0.0629799383716561,0,0,6.83653846153846,43.5318919668895,PSMC5;PSMC4;SUB1;PSMC2;NKX2-5,GO_BP,turquoise,5
positive regulation of microtubule nucleation (GO:0090063),3/7,0.00187251656137995,0.0664234912906973,0,0,18.4248721227622,115.716893435274,GIT1;HSPA1B;HSPA1A,GO_BP,turquoise,3
positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),3/7,0.00187251656137995,0.0664234912906973,0,0,18.4248721227622,115.716893435274,PSMC5;PSMC4;PSMC2,GO_BP,turquoise,3
secondary alcohol biosynthetic process (GO:1902653),6/34,0.00188264255838459,0.0664234912906973,0,0,5.27792041078306,33.1193668627209,FDPS;NSDHL;PMVK;DHCR7;TM7SF2;FDFT1,GO_BP,turquoise,6
positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),5/24,0.00209882694980924,0.073113566656646,0,0,6.47638326585695,39.9358187779412,HSPA5;CREB3L1;DDIT3;MT3;ATF4,GO_BP,turquoise,5
cholesterol biosynthetic process (GO:0006695),6/35,0.00219785670522507,0.0756062706597423,0,0,5.09565756274623,31.1868134539222,FDPS;NSDHL;PMVK;DHCR7;TM7SF2;FDFT1,GO_BP,turquoise,6
regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),3/8,0.00290886316968733,0.0976676665960559,0,0,14.7391304347826,86.0764176435092,ANKRD2;MT3;ATF4,GO_BP,turquoise,3
acyl-CoA metabolic process (GO:0006637),6/37,0.00294564546783163,0.0976676665960559,0,0,4.76640854693776,27.7758993454188,MCEE;ACOT2;ACOT1;DBI;MLYCD;ACSF2,GO_BP,turquoise,6
protein insertion into ER membrane (GO:0045048),6/37,0.00294564546783163,0.0976676665960559,0,0,4.76640854693776,27.7758993454188,EMC3;EMC4;GET1;EMC7;EMC8;EMD,GO_BP,turquoise,6
sterol biosynthetic process (GO:0016126),6/38,0.00338386191427926,0.110861761763054,0,0,4.61721758664955,26.2661394936056,FDPS;NSDHL;PMVK;DHCR7;TM7SF2;FDFT1,GO_BP,turquoise,6
cellular response to unfolded protein (GO:0034620),5/27,0.00361730334061859,0.117115515216263,0,0,5.59236596736597,31.4404294664484,PACRG;HSPA5;BAK1;HSPA1B;HSPA1A,GO_BP,turquoise,5
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),9/79,0.00373133737761692,0.118030350151744,0,0,3.17203608247423,17.7348174595225,SH3RF2;VCP;COP1;USP5;DVL1;KEAP1;SIRT2;HSPA1B;HSPA1A,GO_BP,turquoise,9
positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),9/79,0.00373133737761692,0.118030350151744,0,0,3.17203608247423,17.7348174595225,SH3RF2;VCP;COP1;USP5;DVL1;KEAP1;SIRT2;HSPA1B;HSPA1A,GO_BP,turquoise,9
cellular component disassembly (GO:0022411),8/66,0.0041790826465176,0.128122570367402,0,0,3.40070119380464,18.6278968686176,MMP11;KIF9;CTSL;MMP15;CTRB2;CTRB1;TLL2;CAPN1,GO_BP,turquoise,8
cholesterol catabolic process (GO:0006707),3/9,0.00423661115677091,0.128122570367402,0,0,12.2819693094629,67.1085769515763,CEL;CYP46A1;MT3,GO_BP,turquoise,3
sterol catabolic process (GO:0016127),3/9,0.00423661115677091,0.128122570367402,0,0,12.2819693094629,67.1085769515763,CEL;CYP46A1;MT3,GO_BP,turquoise,3
protein K6-linked ubiquitination (GO:0085020),3/9,0.00423661115677091,0.128122570367402,0,0,12.2819693094629,67.1085769515763,ANKRD39;UBE2D4;UBE2T,GO_BP,turquoise,3
cardiac muscle tissue development (GO:0048738),7/53,0.00447256770128921,0.133307744966237,0,0,3.74938526880519,20.2833967022018,MESP1;MYLK2;ACTC1;MSX2;GATA5;NKX2-5;CACNA1G,GO_BP,turquoise,7
regulation of mitotic cell cycle (GO:0007346),15/178,0.00450494923032705,0.133307744966237,0,0,2.27695004382121,12.3014017111996,PSMD14;USP2;ANAPC10;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,15
regulation of transcription by RNA polymerase I (GO:0006356),4/18,0.00464061345157952,0.134431244407861,0,0,7.02432778489117,37.7410719520227,RASL11A;ERBB2;POLR2K;ATF4,GO_BP,turquoise,4
tRNA metabolic process (GO:0006399),4/18,0.00464061345157952,0.134431244407861,0,0,7.02432778489117,37.7410719520227,AARS1;YARS2;FARS2;THG1L,GO_BP,turquoise,4
protein stabilization (GO:0050821),15/179,0.00474420634011553,0.136000581749979,0,0,2.26294741843522,12.1086494768805,CCT3;HSP90AB1;PEX19;USP2;MUL1;MT3;EFNA1;DVL1;TCP1;GET1;CCT8;COA8;CCT5;HSPA1B;HSPA1A,GO_BP,turquoise,15
regulation of proteasomal protein catabolic process (GO:0061136),7/54,0.00496857010311342,0.138721755394663,0,0,3.66941967948367,19.4648887105127,PSMC5;HSP90AB1;DESI1;PSMD14;PSME3;GLMN;PSMC2,GO_BP,turquoise,7
striated muscle contraction (GO:0006941),7/54,0.00496857010311342,0.138721755394663,0,0,3.66941967948367,19.4648887105127,KCNH2;MYL4;MYLK2;SMPX;TPM1;TNNI1;MYH14,GO_BP,turquoise,7
heart contraction (GO:0060047),6/41,0.00499035384595627,0.138721755394663,0,0,4.22079589216945,22.3712669304823,KCNH2;MYL4;MYLK2;ACTC1;TPM1;TNNI1,GO_BP,turquoise,6
regulation of cell growth (GO:0001558),17/217,0.00543647648292024,0.149611832809965,0,0,2.10452473958333,10.9743054961825,DCUN1D5;EI24;HPN;OSGIN1;MUL1;CGRRF1;MT3;AGT;SUPV3L1;ERBB2;TP53TG5;CHPT1;APBB1;RBBP7;BAP1;HSPA1B;HSPA1A,GO_BP,turquoise,17
regulation of mitochondrial membrane permeability (GO:0046902),4/19,0.0056979572202338,0.153733120294935,0,0,6.55569782330346,33.8775358003205,HEBP2;CAMK2A;MUL1;BAK1,GO_BP,turquoise,4
fatty acid transmembrane transport (GO:1902001),4/19,0.0056979572202338,0.153733120294935,0,0,6.55569782330346,33.8775358003205,CPT2;SLC25A20;CPT1B;ABCD1,GO_BP,turquoise,4
regulation of endoplasmic reticulum unfolded protein response (GO:1900101),3/10,0.00587694016652895,0.154031803221787,0,0,10.5268542199488,54.0734924224715,COPS5;HSPA5;BAK1,GO_BP,turquoise,3
regulation of microtubule nucleation (GO:0010968),3/10,0.00587694016652895,0.154031803221787,0,0,10.5268542199488,54.0734924224715,GIT1;HSPA1B;HSPA1A,GO_BP,turquoise,3
regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),3/10,0.00587694016652895,0.154031803221787,0,0,10.5268542199488,54.0734924224715,PSMC5;PSMC4;PSMC2,GO_BP,turquoise,3
tRNA aminoacylation for protein translation (GO:0006418),6/43,0.00633367987489812,0.164436669959619,0,0,3.99222842868543,20.2081567777777,AARS1;MARS1;YARS1;YARS2;FARS2;FARSB,GO_BP,turquoise,6
antigen receptor-mediated signaling pathway (GO:0050851),15/185,0.0064054344108136,0.164745378491206,0,0,2.18239113827349,11.0224032818055,STOML2;EIF2B2;PSMD14;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,15
purine nucleoside bisphosphate metabolic process (GO:0034032),5/31,0.0066915433204026,0.168946121263743,0,0,4.7310157790927,23.6877737192518,ACOT2;ACOT1;DBI;MLYCD;ACSF2,GO_BP,turquoise,5
ribonucleoside bisphosphate metabolic process (GO:0033875),5/31,0.0066915433204026,0.168946121263743,0,0,4.7310157790927,23.6877737192518,ACOT2;ACOT1;DBI;MLYCD;ACSF2,GO_BP,turquoise,5
regulation of protein modification by small protein conjugation or removal (GO:1903320),4/20,0.00690447622820643,0.171181248468685,0,0,6.14564660691421,30.5781892174132,HSP90AB1;DCUN1D5;HSPA1B;HSPA1A,GO_BP,turquoise,4
mitochondrial cytochrome c oxidase assembly (GO:0033617),4/20,0.00690447622820643,0.171181248468685,0,0,6.14564660691421,30.5781892174132,COX19;COX14;TIMM21;COA8,GO_BP,turquoise,4
muscle organ development (GO:0007517),7/58,0.00737444962806637,0.181200762289631,0,0,3.38091637683351,16.5994001076062,TEAD4;ITGA7;ZBTB42;ANKRD2;ITGB1BP2;EMD;MAPK12,GO_BP,turquoise,7
cellular response to topologically incorrect protein (GO:0035967),5/32,0.00767963797294727,0.184575522393405,0,0,4.55555555555556,22.181833082976,PACRG;HSPA5;BAK1;HSPA1B;HSPA1A,GO_BP,turquoise,5
alcohol catabolic process (GO:0046164),3/11,0.00784714248547543,0.184575522393405,0,0,9.2105179028133,44.6489602650028,CEL;CYP46A1;MT3,GO_BP,turquoise,3
regulation of cardiac muscle cell apoptotic process (GO:0010665),3/11,0.00784714248547543,0.184575522393405,0,0,9.2105179028133,44.6489602650028,HAND2;CAMK2A;NKX2-5,GO_BP,turquoise,3
carnitine shuttle (GO:0006853),3/11,0.00784714248547543,0.184575522393405,0,0,9.2105179028133,44.6489602650028,CPT2;SLC25A20;CPT1B,GO_BP,turquoise,3
PERK-mediated unfolded protein response (GO:0036499),3/11,0.00784714248547543,0.184575522393405,0,0,9.2105179028133,44.6489602650028,HSPA5;DDIT3;ATF4,GO_BP,turquoise,3
mitochondrial translational elongation (GO:0070125),9/89,0.00816470344271418,0.186514023255393,0,0,2.77408182989691,13.3376047726495,MRPS25;MRPS22;MRPL18;MRPS23;MRPS31;MRPS18A;MRPL9;MRPS6;MRPS18C,GO_BP,turquoise,9
mitochondrial translational termination (GO:0070126),9/89,0.00816470344271418,0.186514023255393,0,0,2.77408182989691,13.3376047726495,MRPS25;MRPS22;MRPL18;MRPS23;MRPS31;MRPS18A;MRPL9;MRPS6;MRPS18C,GO_BP,turquoise,9
cellular response to interleukin-1 (GO:0071347),13/155,0.00817359956300878,0.186514023255393,0,0,2.26181310661899,10.8721870222698,PSMD14;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,13
mitochondrial translation (GO:0032543),10/105,0.00825141856007224,0.186514023255393,0,0,2.59694397283531,12.4585014880398,MRPS25;MRPL18;MRPS22;MRPS23;MRPS31;MRPS18A;GATB;MRPL9;MRPS6;MRPS18C,GO_BP,turquoise,10
intracellular lipid transport (GO:0032365),4/21,0.00826842690303706,0.186514023255393,0,0,5.78383671010017,27.7352958289581,CPT2;SLC25A20;CPT1B;ABCD1,GO_BP,turquoise,4
mitochondrial respiratory chain complex assembly (GO:0033108),9/90,0.00876550377679306,0.196119238973451,0,0,2.73969072164948,12.9777266941678,CHCHD4;COX19;TIMMDC1;TMEM126A;NDUFC1;COX14;TIMM21;NDUFAF1;COA8,GO_BP,turquoise,9
chaperone-mediated protein complex assembly (GO:0051131),4/22,0.00979749899761561,0.217441268076114,0,0,5.46222791293214,25.2662350876264,HSP90AB1;NDUFAF1;HOPX;HSPA1A,GO_BP,turquoise,4
cardiac muscle contraction (GO:0060048),5/34,0.00995135607117607,0.219089055263012,0,0,4.24093722369584,19.5509175865702,KCNH2;MYL4;MYLK2;TPM1;TNNI1,GO_BP,turquoise,5
cellular response to oxidative stress (GO:0034599),11/125,0.0102190825540852,0.223197739593987,0,0,2.3812389500884,10.9144050794223,GPX3;TPM1;KEAP1;MPV17;ANKRD2;MT3;PRDX6;SIRT2;HSPA1B;ATF4;HSPA1A,GO_BP,turquoise,11
translation (GO:0006412),16/214,0.0105192679328809,0.223316978557733,0,0,1.99834495803286,9.101555358579,AARS1;MRPL18;MARS1;MRPS18A;GATB;RPS4Y1;YARS1;MRPS6;YARS2;RPL3L;MRPS18C;FARS2;COPS5;TNIP1;MRPL9;FARSB,GO_BP,turquoise,16
purine ribonucleotide metabolic process (GO:0009150),8/77,0.010528627796711,0.223316978557733,0,0,2.85691903083207,13.0094301289215,TPST2;HINT1;ACOT2;ACOT1;DBI;MLYCD;ACSF2;RAN,GO_BP,turquoise,8
phosphatidylcholine metabolic process (GO:0046470),8/77,0.010528627796711,0.223316978557733,0,0,2.85691903083207,13.0094301289215,ABHD4;SLC44A2;LPCAT4;PEMT;DBI;PLAAT3;CHPT1;PLA2G5,GO_BP,turquoise,8
glucose metabolic process (GO:0006006),7/62,0.0105491305277999,0.223316978557733,0,0,3.13437719093246,14.266781761223,TKTL1;KCNJ11;MDH2;ALDOC;ENO3;PGM1;ATF4,GO_BP,turquoise,7
myelination (GO:0042552),6/48,0.0108139268390293,0.227175012679456,0,0,3.51604621309371,15.9168615172914,EIF2B2;LGI4;GPC1;MAL;ABCD1;SIRT2,GO_BP,turquoise,6
negative regulation of reactive oxygen species metabolic process (GO:2000378),4/23,0.0114987901380577,0.237929853082216,0,0,5.17447267336074,23.1066773430093,COA8;MT3;ABCD1;SIRT2,GO_BP,turquoise,4
positive regulation of transcription by RNA polymerase I (GO:0045943),4/23,0.0114987901380577,0.237929853082216,0,0,5.17447267336074,23.1066773430093,MARS1;RASL11A;ERBB2;ATF4,GO_BP,turquoise,4
RNA catabolic process (GO:0006401),6/49,0.0119248307610858,0.244903986973941,0,0,3.43409857599188,15.2100773853406,SUPV3L1;EXOSC7;RIDA;LSM6;HSPA1B;HSPA1A,GO_BP,turquoise,6
cellular response to heat (GO:0034605),5/36,0.0126456039440691,0.257782978178356,0,0,3.96691480562448,17.3371855105765,VCP;HSP90AB1;RBBP7;HSPA1B;HSPA1A,GO_BP,turquoise,5
ribosomal subunit export from nucleus (GO:0000054),3/13,0.012828922520288,0.259597020410534,0,0,7.36764705882353,32.0938617009038,LTV1;RRS1;RAN,GO_BP,turquoise,3
translational termination (GO:0006415),9/96,0.0130994899066022,0.263137198707804,0,0,2.54994667614646,11.0544829006898,MRPS25;MRPS22;MRPL18;MRPS23;MRPS31;MRPS18A;MRPL9;MRPS6;MRPS18C,GO_BP,turquoise,9
regulation of IRE1-mediated unfolded protein response (GO:1903894),3/14,0.01585860217481,0.303075508229701,0,0,6.69751220646361,27.7547799289547,COPS5;HSPA5;BAK1,GO_BP,turquoise,3
negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),3/14,0.01585860217481,0.303075508229701,0,0,6.69751220646361,27.7547799289547,CREB3L1;GPC1;FUZ,GO_BP,turquoise,3
phosphatidylethanolamine acyl-chain remodeling (GO:0036152),4/26,0.0176977234283669,0.335264555551971,0,0,4.46816435804912,18.026001560217,ABHD4;LPCAT4;PLAAT3;PLA2G5,GO_BP,turquoise,4
regulation of cellular response to stress (GO:0080135),10/118,0.017786564357045,0.335264555551971,0,0,2.28279569892473,9.19809591626398,DNAJC2;HSP90AB1;AMFR;CAMK2A;FKBP4;ABCD1;HSPA1B;ATF4;MANF;HSPA1A,GO_BP,turquoise,10
acetyl-CoA metabolic process (GO:0006084),3/15,0.0192549296968238,0.355634674668854,0,0,6.13906649616368,24.2492399910204,PMVK;MLYCD;ACSS1,GO_BP,turquoise,3
integrated stress response signaling (GO:0140467),3/15,0.0192549296968238,0.355634674668854,0,0,6.13906649616368,24.2492399910204,HSPA5;DDIT3;ATF4,GO_BP,turquoise,3
nitric oxide biosynthetic process (GO:0006809),3/15,0.0192549296968238,0.355634674668854,0,0,6.13906649616368,24.2492399910204,CYB5B;CYB5R3;SPR,GO_BP,turquoise,3
cellular response to tumor necrosis factor (GO:0071356),14/194,0.0211125787279988,0.363314152233858,0,0,1.92023346303502,7.40804230816551,PSMD14;YBX3;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PSMC2,GO_BP,turquoise,14
translational elongation (GO:0006414),9/104,0.0211229158275499,0.363314152233858,0,0,2.33423765599566,9.00408079384919,MRPS25;MRPL18;MRPS22;MRPS23;MRPS31;MRPS18A;MRPL9;MRPS6;MRPS18C,GO_BP,turquoise,9
regulation of mitochondrial membrane potential (GO:0051881),5/41,0.0214306123661538,0.364055834763305,0,0,3.4150641025641,13.1238690074586,HEBP2;STOML2;VCP;BAK1;ABCD1,GO_BP,turquoise,5
gluconeogenesis (GO:0006094),5/41,0.0214306123661538,0.364055834763305,0,0,3.4150641025641,13.1238690074586,MDH2;ALDOC;ENO3;PGM1;ATF4,GO_BP,turquoise,5
glycerophospholipid biosynthetic process (GO:0046474),13/177,0.0225951631391737,0.381483981343595,0,0,1.95614021230886,7.41380938506908,ABHD4;SLC44A2;MTMR14;PLA2G5;AGPAT1;ETNPPL;PTDSS1;ETNK2;LPCAT4;INPP5J;PEMT;CHPT1;PI4KB,GO_BP,turquoise,13
regulation of muscle contraction (GO:0006937),4/28,0.0227936448862807,0.382488480042954,0,0,4.09539052496799,15.4857917253685,MYLK2;TPM1;TNNI1;MYL9,GO_BP,turquoise,4
nitric oxide metabolic process (GO:0046209),3/16,0.0230204293983664,0.383952858813966,0,0,5.66653551052528,21.3706202892414,CYB5B;CYB5R3;SPR,GO_BP,turquoise,3
protein K48-linked ubiquitination (GO:0070936),6/57,0.0238240383462831,0.394962370656452,0,0,2.89420826096806,10.8158304836946,UBE2D4;UBE2R2;UBE2D2;UBE2E3;AMFR;UBE2T,GO_BP,turquoise,6
lipid catabolic process (GO:0016042),4/29,0.0256425135654553,0.416988557370717,0,0,3.93137003841229,14.4025883624101,PLAAT3;CEL;MT3;SIRT2,GO_BP,turquoise,4
protein K11-linked ubiquitination (GO:0070979),4/29,0.0256425135654553,0.416988557370717,0,0,3.93137003841229,14.4025883624101,UBE2D4;UBE2E3;UBE2T;ANAPC10,GO_BP,turquoise,4
RNA modification (GO:0009451),6/58,0.0257220704383814,0.416988557370717,0,0,2.8384022909055,10.3897044459186,AARS1;TFB1M;MRM2;THG1L;FTSJ3;JMJD6,GO_BP,turquoise,6
substantia nigra development (GO:0021762),5/43,0.0258327916629244,0.416988557370717,0,0,3.23498650472335,11.8274684488271,HSPA5;MAPKAP1;CALM3;NDRG2;SIRT2,GO_BP,turquoise,5
negative regulation of cell growth (GO:0030308),10/126,0.0267090560409818,0.416988557370717,0,0,2.12447163515017,7.69643512609735,EI24;OSGIN1;MUL1;TP53TG5;APBB1;RBBP7;CGRRF1;MT3;HSPA1B;HSPA1A,GO_BP,turquoise,10
negative regulation of growth (GO:0045926),10/126,0.0267090560409818,0.416988557370717,0,0,2.12447163515017,7.69643512609735,EI24;OSGIN1;MUL1;TP53TG5;APBB1;RBBP7;CGRRF1;MT3;HSPA1B;HSPA1A,GO_BP,turquoise,10
copper ion homeostasis (GO:0055070),3/17,0.0271554606561044,0.416988557370717,0,0,5.26150895140665,18.9739332166405,COX19;ABCB6;CUTC,GO_BP,turquoise,3
muscle tissue morphogenesis (GO:0060415),3/17,0.0271554606561044,0.416988557370717,0,0,5.26150895140665,18.9739332166405,MYLK2;ACTC1;NKX2-5,GO_BP,turquoise,3
hexose biosynthetic process (GO:0019319),5/44,0.0282349759606915,0.416988557370717,0,0,3.15187376725838,11.2433445207879,MDH2;ALDOC;ENO3;PGM1;ATF4,GO_BP,turquoise,5
intracellular protein transmembrane transport (GO:0065002),5/44,0.0282349759606915,0.416988557370717,0,0,3.15187376725838,11.2433445207879,CHCHD4;HSPA5;TIMM21;DNAJC15;TOMM40L,GO_BP,turquoise,5
mRNA catabolic process (GO:0006402),5/44,0.0282349759606915,0.416988557370717,0,0,3.15187376725838,11.2433445207879,SUPV3L1;RIDA;LSM6;HSPA1B;HSPA1A,GO_BP,turquoise,5
phosphatidylcholine acyl-chain remodeling (GO:0036151),4/30,0.0286958339094802,0.420058164462178,0,0,3.77996651236088,13.4226736602146,LPCAT4;DBI;PLAAT3;PLA2G5,GO_BP,turquoise,4
MAPK cascade (GO:0000165),19/303,0.030778073311094,0.448154802921327,0,0,1.65340804618836,5.75543528196387,PSMD14;CAMK2A;MT3;MAPK12;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;PEA15;PSMC2;ERBB2;MARK3,GO_BP,turquoise,19
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),3/18,0.0316584382317505,0.453310202687427,0,0,4.91048593350384,16.954683032856,MUL1;BAK1;HSPA1A,GO_BP,turquoise,3
mitochondrial fusion (GO:0008053),3/18,0.0316584382317505,0.453310202687427,0,0,4.91048593350384,16.954683032856,STOML2;CHCHD3;THG1L,GO_BP,turquoise,3
'de novo' posttranslational protein folding (GO:0051084),4/31,0.0319557337650294,0.453310202687427,0,0,3.63977806231327,12.5332250784099,CHCHD4;HSPA5;HSPA1B;HSPA1A,GO_BP,turquoise,4
negative regulation of response to biotic stimulus (GO:0002832),4/31,0.0319557337650294,0.453310202687427,0,0,3.63977806231327,12.5332250784099,ILRUN;MUL1;TRAFD1;SIRT2,GO_BP,turquoise,4
phosphatidylethanolamine metabolic process (GO:0046337),4/31,0.0319557337650294,0.453310202687427,0,0,3.63977806231327,12.5332250784099,ABHD4;ETNK2;PLAAT3;ETNPPL,GO_BP,turquoise,4
regulation of cellular protein localization (GO:1903827),5/46,0.0334520086269845,0.472102193545955,0,0,2.99781113195747,10.1854933435564,VCP;HSP90AB1;GPC1;SUMO3;DVL1,GO_BP,turquoise,5
protein transmembrane import into intracellular organelle (GO:0044743),4/32,0.0354237524031052,0.489375847784108,0,0,3.50960307298335,11.7233823349598,CHCHD4;TIMM21;DNAJC15;TOMM40L,GO_BP,turquoise,4
cardiac muscle tissue morphogenesis (GO:0055008),4/32,0.0354237524031052,0.489375847784108,0,0,3.50960307298335,11.7233823349598,MYLK2;ACTC1;TPM1;NKX2-5,GO_BP,turquoise,4
long-chain fatty acid transport (GO:0015909),4/32,0.0354237524031052,0.489375847784108,0,0,3.50960307298335,11.7233823349598,CPT2;SLC25A20;ABCD1;CPT1B,GO_BP,turquoise,4
protein import into mitochondrial matrix (GO:0030150),3/19,0.0365260364803289,0.489375847784108,0,0,4.60334079283888,15.2358148666276,TIMM21;DNAJC15;TOMM40L,GO_BP,turquoise,3
cellular amide metabolic process (GO:0043603),9/115,0.0372152647364475,0.492386579589921,0,0,2.09080188679245,6.88090482084997,ABHD4;FPGS;ACOT2;ACOT1;DBI;PLAAT3;MLYCD;ACSF2;ATF4,GO_BP,turquoise,9
very long-chain fatty acid metabolic process (GO:0000038),4/33,0.0391008572374478,0.512407424368839,0,0,3.38840566912447,10.9838927099939,TECR;ACOT2;ACOT1;ABCD1,GO_BP,turquoise,4
positive regulation of telomere maintenance via telomerase (GO:0032212),4/33,0.0391008572374478,0.512407424368839,0,0,3.38840566912447,10.9838927099939,CCT3;TCP1;CCT8;CCT5,GO_BP,turquoise,4
cellular modified amino acid biosynthetic process (GO:0042398),3/20,0.0417533785762445,0.540537148725591,0,0,4.33233037460509,13.7593725584823,PTDSS1;FPGS;CHAC2,GO_BP,turquoise,3
positive regulation of cyclin-dependent protein kinase activity (GO:1904031),3/20,0.0417533785762445,0.540537148725591,0,0,4.33233037460509,13.7593725584823,CCND3;HSP90AB1;MAPRE3,GO_BP,turquoise,3
protein autoubiquitination (GO:0051865),6/65,0.0418366325140083,0.540537148725591,0,0,2.50072887883205,7.93727081726206,RNF10;SH3RF2;LRSAM1;UBE2D2;AMFR;UBE2T,GO_BP,turquoise,6
phosphatidylserine metabolic process (GO:0006658),4/34,0.0429874623056252,0.552810730210657,0,0,3.2752880921895,10.3068297867815,PTDSS1;LPCAT4;PLAAT3;PLA2G5,GO_BP,turquoise,4
mitochondrion organization (GO:0007005),12/175,0.0434866713280754,0.556629392999365,0,0,1.81449059119517,5.68897379144418,CHCHD4;SUPV3L1;STOML2;CHCHD3;TMEM11;MUL1;MYH14;MPV17;TFB1M;TMEM70;THG1L;RAB5IF,GO_BP,turquoise,12
cellular response to chemical stress (GO:0062197),8/101,0.0451054557286345,0.564056653776404,0,0,2.11699256860547,6.56003510455777,GPX3;KEAP1;MT3;PRDX6;SIRT2;HSPA1B;ATF4;HSPA1A,GO_BP,turquoise,8
regulation of trans-synaptic signaling (GO:0099177),4/35,0.0470834482610718,0.573334732807388,0,0,3.16946842344389,9.68536859910245,NTF4;PSMC5;GRIK5;CEL,GO_BP,turquoise,4
rRNA modification (GO:0000154),3/21,0.0473342116446029,0.573849120907256,0,0,4.09143222506394,12.4810038272896,TFB1M;MRM2;FTSJ3,GO_BP,turquoise,3
positive regulation of protein localization to nucleus (GO:1900182),6/68,0.0503275783581425,0.607462700182492,0,0,2.37935318232639,7.11236746888224,CCT3;TCP1;TESK1;CCT8;CCT5;RAN,GO_BP,turquoise,6
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),4/36,0.0513881836104079,0.614870788242793,0,0,3.07026248399488,9.11360450664505,HINT1;PPP1R13B;RPS27L;TMEM109,GO_BP,turquoise,4
positive regulation of telomere maintenance via telomere lengthening (GO:1904358),4/36,0.0513881836104079,0.614870788242793,0,0,3.07026248399488,9.11360450664505,CCT3;TCP1;CCT8;CCT5,GO_BP,turquoise,4
regulation of telomere maintenance via telomerase (GO:0032210),5/52,0.0525065451862663,0.618457640482456,0,0,2.61429350791053,7.70384572053442,CCT3;TCP1;CCT8;SMG5;CCT5,GO_BP,turquoise,5
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),3/22,0.0532610686025952,0.618457640482456,0,0,3.87589177547449,11.3662450111228,CREB3L1;DDIT3;HSPA1A,GO_BP,turquoise,3
rRNA methylation (GO:0031167),3/22,0.0532610686025952,0.618457640482456,0,0,3.87589177547449,11.3662450111228,TFB1M;MRM2;FTSJ3,GO_BP,turquoise,3
"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",3/22,0.0532610686025952,0.618457640482456,0,0,3.87589177547449,11.3662450111228,EXOSC7;RRS1;FTSJ3,GO_BP,turquoise,3
tetrapyrrole metabolic process (GO:0033013),3/22,0.0532610686025952,0.618457640482456,0,0,3.87589177547449,11.3662450111228,ABCB6;CTRB2;CTRB1,GO_BP,turquoise,3
phosphatidylserine acyl-chain remodeling (GO:0036150),3/22,0.0532610686025952,0.618457640482456,0,0,3.87589177547449,11.3662450111228,LPCAT4;PLAAT3;PLA2G5,GO_BP,turquoise,3
positive regulation of peptidase activity (GO:0010952),3/22,0.0532610686025952,0.618457640482456,0,0,3.87589177547449,11.3662450111228,VCP;PSME3;MAPK12,GO_BP,turquoise,3
modification-dependent protein catabolic process (GO:0019941),13/201,0.0539802111037772,0.619840266341133,0,0,1.70427047734539,4.97500030473268,UBE2D4;PSMD14;SIAH2;UBE2D2;AMFR;ADRM1;KEAP1;ANAPC10;RNF167;UBE2R2;PSMC2;UFD1;SPSB4,GO_BP,turquoise,13
peptide biosynthetic process (GO:0043043),11/162,0.0547658996240111,0.619840266341133,0,0,1.79427417560792,5.21180585621986,COPS5;TNIP1;MRPL18;MRPS18A;MRPL9;RPS4Y1;YARS2;MRPS6;RPL3L;MRPS18C;FARSB,GO_BP,turquoise,11
fatty acid metabolic process (GO:0006631),9/124,0.0554332982619263,0.619840266341133,0,0,1.92626624831914,5.57186923519428,CPT2;PON2;ACOT2;ACOT1;ECHDC3;MLYCD;CEL;CPT1B;ACSF2,GO_BP,turquoise,9
anterograde axonal transport (GO:0008089),4/37,0.0559005468958745,0.619840266341133,0,0,2.9770690257246,8.58640626323925,BLOC1S2;HSPB1;KIF1C;AP3S1,GO_BP,turquoise,4
snRNA transcription by RNA polymerase II (GO:0042795),6/70,0.0565333963850379,0.619840266341133,0,0,2.30475770218229,6.62139309217584,INTS12;SNAPC1;NABP2;INTS9;GTF2E2;POLR2K,GO_BP,turquoise,6
sterol metabolic process (GO:0016125),6/70,0.0565333963850379,0.619840266341133,0,0,2.30475770218229,6.62139309217584,NSDHL;PMVK;SCAP;DHCR7;CYP46A1;TM7SF2,GO_BP,turquoise,6
platelet degranulation (GO:0002576),9/125,0.0577597877282711,0.630773554873818,0,0,1.90956052257376,5.44504014420286,LGALS3BP;SCCPDH;ITGA2B;OLA1;QSOX1;TUBA4A;KNG1;VTI1B;MANF,GO_BP,turquoise,9
snRNA transcription (GO:0009301),6/71,0.0598011340987521,0.650213603975533,0,0,2.2691813962674,6.39167279686276,INTS12;SNAPC1;NABP2;INTS9;GTF2E2;POLR2K,GO_BP,turquoise,6
regulation of cyclin-dependent protein kinase activity (GO:1904029),5/54,0.0600124474599511,0.650213603975533,0,0,2.50732600732601,7.05361774936968,CCND3;BLM;HSP90AB1;MNAT1;CCNJL,GO_BP,turquoise,5
endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),12/185,0.0612820395049159,0.661365383205994,0,0,1.70870940484113,4.77117539957222,DCTN5;ACTR1A;LMAN2L;COL7A1;TRAPPC12;COG2;COPZ2;TMED1;CD59;ANK1;CNIH4;VTI1B,GO_BP,turquoise,12
positive regulation of apoptotic process (GO:0043065),18/310,0.0641518347170376,0.684586441288304,0,0,1.52084263542355,4.17699823399161,MTCH1;MTCH2;FAF1;PDCD5;ARHGEF16;TPD52L1;SIRT2;KNG1;GADD45G;ADAMTSL4;DDIT3;SAP18;APBB1;BAK1;ZNF622;CTSD;CTNNBL1;ATF4,GO_BP,turquoise,18
cellular protein metabolic process (GO:0044267),23/417,0.0644087359836759,0.684586441288304,0,0,1.44184752921113,3.95427550449038,STOML2;MRPL18;UBE2D2;SIAH2;SFTPC;MRPS18A;RPS4Y1;MRPS6;YARS2;RPL3L;KNG1;GNMT;MRPS18C;COPS5;TNIP1;MMP15;STC2;QSOX1;MRPL9;BAP1;FARSB;MSRB1;PNPLA2,GO_BP,turquoise,23
cellular protein modification process (GO:0006464),50/1025,0.0663182357770544,0.684586441288304,0,0,1.27263212977499,3.45302050250244,PIGS;PIGT;UBE2D2;KEAP1;DUSP13;KBTBD13;PSMD6;PSMD7;PSMD2;QSOX1;LMTK3;CEL;SIRT2;DDOST;CTDNEP1;PSMA6;PTP4A2;PSMA3;PSMA1;MMP15;PSME3;PSMD14;CAMK2A;PPM1J;ASB12;ART3;KNG1;PORCN;COP1;PSMB5;PSMB2;GRK4;STC2;ERBB2;RBBP7;MARK3;FN3K;CDK18;MT3;FBXO31;GNMT;COPS4;PSMC5;COPS5;STK24;PSMC4;PSMC2;BAP1;SPSB4;PNPLA2,GO_BP,turquoise,50
regulation of lipid metabolic process (GO:0019216),7/92,0.0697483074732232,0.710916082097445,0,0,2.02495085437774,5.39216493347261,FDPS;SMARCD3;CARM1;PMVK;DHCR7;TM7SF2;FDFT1,GO_BP,turquoise,7
negative regulation of ERBB signaling pathway (GO:1901185),4/40,0.0706653268628331,0.717605090503751,0,0,2.72855313700384,7.2301207917913,SH3KBP1;ERBB2;EPS15L1;EPN1,GO_BP,turquoise,4
regulation of reactive oxygen species metabolic process (GO:2000377),5/57,0.072352923466784,0.72553409450099,0,0,2.36230276134122,6.2038781403757,CBR1;MPV17;MT3;SIRT2;AGT,GO_BP,turquoise,5
regulation of heart contraction (GO:0008016),7/93,0.0730078535931822,0.72553409450099,0,0,2.00130029293956,5.23777963172054,DES;KCNJ11;FXYD3;TPM1;CALM3;NKX2-5;AGT,GO_BP,turquoise,7
cardiac conduction system development (GO:0003161),3/25,0.0730279593665604,0.72553409450099,0,0,3.34683794466403,8.75838341215062,MSX2;NKX2-5;CACNA1G,GO_BP,turquoise,3
regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),3/25,0.0730279593665604,0.72553409450099,0,0,3.34683794466403,8.75838341215062,EFNA1;PSMD14;PSME3,GO_BP,turquoise,3
peripheral nervous system development (GO:0007422),3/25,0.0730279593665604,0.72553409450099,0,0,3.34683794466403,8.75838341215062,NTF4;ADGRB2;GPC1,GO_BP,turquoise,3
peroxisome organization (GO:0007031),3/25,0.0730279593665604,0.72553409450099,0,0,3.34683794466403,8.75838341215062,PEX19;PLAAT3;ABCD1,GO_BP,turquoise,3
mitochondrial respiratory chain complex I assembly (GO:0032981),5/58,0.0767520636905682,0.737643651668781,0,0,2.31761006289308,5.94971062340471,TIMMDC1;TMEM126A;NDUFC1;TIMM21;NDUFAF1,GO_BP,turquoise,5
NADH dehydrogenase complex assembly (GO:0010257),5/58,0.0767520636905682,0.737643651668781,0,0,2.31761006289308,5.94971062340471,TIMMDC1;TMEM126A;NDUFC1;TIMM21;NDUFAF1,GO_BP,turquoise,5
regulation of cell division (GO:0051302),6/76,0.0777908523075761,0.737643651668781,0,0,2.10654685494223,5.37955492130222,BLM;KDF1;CDK2AP2;CALM3;GIT1;SIRT2,GO_BP,turquoise,6
mRNA metabolic process (GO:0016071),7/95,0.0797926942773702,0.743549196213847,0,0,1.95561170834307,4.94441870491625,LSM10;RIDA;LSM6;AKAP8L;SRSF4;HSPA1B;HSPA1A,GO_BP,turquoise,7
chaperone cofactor-dependent protein refolding (GO:0051085),3/26,0.0802449532251136,0.743549196213847,0,0,3.20115645502057,8.07546585876643,HSPA5;HSPA1B;HSPA1A,GO_BP,turquoise,3
regulation of myelination (GO:0031641),3/26,0.0802449532251136,0.743549196213847,0,0,3.20115645502057,8.07546585876643,RNF10;LGI4;SIRT2,GO_BP,turquoise,3
snRNA processing (GO:0016180),3/26,0.0802449532251136,0.743549196213847,0,0,3.20115645502057,8.07546585876643,TOE1;INTS12;INTS9,GO_BP,turquoise,3
negative regulation of macroautophagy (GO:0016242),3/26,0.0802449532251136,0.743549196213847,0,0,3.20115645502057,8.07546585876643,FEZ1;FEZ2;QSOX1,GO_BP,turquoise,3
response to reactive oxygen species (GO:0000302),5/59,0.0812922555763311,0.7507257964633,0,0,2.27457264957265,5.70850526954826,STK24;TPM1;MPV17;GLRX2;COA8,GO_BP,turquoise,5
regulation of protein-containing complex assembly (GO:0043254),8/116,0.0862488706598991,0.790238937637153,0,0,1.82153582153582,4.46370689566259,LGALS3;VCP;KIF9;HSPA5;FBLIM1;FAF1;BAK1;RHOC,GO_BP,turquoise,8
protein peptidyl-prolyl isomerization (GO:0000413),3/27,0.0877572665360351,0.790238937637153,0,0,3.06761508951407,7.46406155639701,PPIL1;CWC27;FKBP4,GO_BP,turquoise,3
cellular lipid catabolic process (GO:0044242),3/27,0.0877572665360351,0.790238937637153,0,0,3.06761508951407,7.46406155639701,CEL;MT3;SIRT2,GO_BP,turquoise,3
melanosome organization (GO:0032438),3/27,0.0877572665360351,0.790238937637153,0,0,3.06761508951407,7.46406155639701,ABCB6;BLOC1S2;ASIP,GO_BP,turquoise,3
regulation of cellular response to heat (GO:1900034),6/79,0.0898955321609295,0.790238937637153,0,0,2.01965990820687,4.86557689643188,DNAJC2;HSP90AB1;CAMK2A;FKBP4;HSPA1B;HSPA1A,GO_BP,turquoise,6
positive regulation of DNA biosynthetic process (GO:2000573),5/61,0.0907901546498945,0.793188906655587,0,0,2.19310897435897,5.26171676285032,CCT3;HSP90AB1;TCP1;CCT8;CCT5,GO_BP,turquoise,5
positive regulation of protein-containing complex assembly (GO:0031334),8/118,0.0929864561335964,0.794460425453736,0,0,1.78822978822979,4.24758477208945,LGALS3;VCP;PSMC5;PSMC4;FAF1;PSMC2;BAK1;RHOC,GO_BP,turquoise,8
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),6/80,0.0941454210753458,0.794460425453736,0,0,1.99226312320022,4.7075477392278,LGALS3;PSME3;SIAH2;PEA15;HSPA1B;HSPA1A,GO_BP,turquoise,6
calcium ion import (GO:0070509),3/28,0.0955529070838377,0.794460425453736,0,0,2.94475703324808,6.91451091273642,CACNB2;SLC25A23;CACNA1G,GO_BP,turquoise,3
transcription by RNA polymerase III (GO:0006383),3/28,0.0955529070838377,0.794460425453736,0,0,2.94475703324808,6.91451091273642,SNAPC1;GTF3C6;POLR2K,GO_BP,turquoise,3
phagosome acidification (GO:0090383),3/28,0.0955529070838377,0.794460425453736,0,0,2.94475703324808,6.91451091273642,RAB20;ATP6V0E2;ATP6V1F,GO_BP,turquoise,3
positive regulation of microtubule polymerization (GO:0031116),3/28,0.0955529070838377,0.794460425453736,0,0,2.94475703324808,6.91451091273642,GIT1;HSPA1B;HSPA1A,GO_BP,turquoise,3
positive regulation of Notch signaling pathway (GO:0045747),4/45,0.0991963819529555,0.794460425453736,0,0,2.39517816432966,5.5344273776379,ENHO;MESP1;GATA5;TM2D3,GO_BP,turquoise,4
cytoskeleton organization (GO:0007010),8/120,0.100017112896853,0.794460425453736,0,0,1.75611325611326,4.04329970899654,ARHGAP10;DES;SH3KBP1;TPM1;RND2;RHOC;ANK1;PACSIN1,GO_BP,turquoise,8
glycolytic process (GO:0006096),3/29,0.10361949656943,0.794460425453736,0,0,2.83134959669487,6.41875384207992,ALDOC;ENO3;PGM1,GO_BP,turquoise,3
response to zinc ion (GO:0010043),3/29,0.10361949656943,0.794460425453736,0,0,2.83134959669487,6.41875384207992,SLC30A3;HVCN1;MT3,GO_BP,turquoise,3
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),3/29,0.10361949656943,0.794460425453736,0,0,2.83134959669487,6.41875384207992,DDIT3;BAK1;ATF4,GO_BP,turquoise,3
negative regulation of epithelial to mesenchymal transition (GO:0010719),3/29,0.10361949656943,0.794460425453736,0,0,2.83134959669487,6.41875384207992,EFNA1;HPN;FUZ,GO_BP,turquoise,3
protein ADP-ribosylation (GO:0006471),3/29,0.10361949656943,0.794460425453736,0,0,2.83134959669487,6.41875384207992,ART5;ART3;SIRT2,GO_BP,turquoise,3
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),5/64,0.106054824905157,0.794460425453736,0,0,2.0812690134724,4.66994954447758,CREB3L1;HSPB1;YBX3;TPT1;HSPA1A,GO_BP,turquoise,5
regulation of cell death (GO:0010941),7/102,0.106301200762378,0.794460425453736,0,0,1.81085103504262,4.05898401979372,PACRG;FAF1;TMEM109;HPR;MT3;HSPA1B;HSPA1A,GO_BP,turquoise,7
intrinsic apoptotic signaling pathway (GO:0097193),7/102,0.106301200762378,0.794460425453736,0,0,1.81085103504262,4.05898401979372,HINT1;PPP1R13B;STK24;DDIT3;BAK1;ZNF622;ATF4,GO_BP,turquoise,7
positive regulation of cellular protein metabolic process (GO:0032270),7/102,0.106301200762378,0.794460425453736,0,0,1.81085103504262,4.05898401979372,FXR2;FAF1;ERBB2;RPS27L;BAK1;LARP6;AGT,GO_BP,turquoise,7
regulation of cellular catabolic process (GO:0031329),5/65,0.111406343489609,0.794460425453736,0,0,2.04647435897436,4.49113330041495,VPS29;DDIT3;HSPB1;KEAP1;ABCD1,GO_BP,turquoise,5
steroid biosynthetic process (GO:0006694),5/65,0.111406343489609,0.794460425453736,0,0,2.04647435897436,4.49113330041495,PMVK;DHCR7;CYP46A1;TM7SF2;FDFT1,GO_BP,turquoise,5
regulation of apoptotic process (GO:0042981),36/742,0.111804707853178,0.794460425453736,0,0,1.26008237612378,2.76084251425108,MTCH1;MTCH2;BEX2;VCP;PPP1R13B;GLO1;FAF1;HPN;PDCD5;HSPB1;KNG1;BABAM2;ADAMTSL4;SAP18;BAK1;ZNF622;APBB1;NKX2-5;CTSD;CTNNBL1;HSPA5;SIAH2;ARHGEF16;OSGIN1;MT3;AGT;GADD45G;SUPV3L1;SH3RF2;ARHGAP10;COPS5;APEX1;HSPA1B;TPT1;ATF4;HSPA1A,GO_BP,turquoise,36
polyol metabolic process (GO:0019751),4/47,0.111893799285356,0.794460425453736,0,0,2.28353631301551,5.00141282901867,ITPK1;ITPKA;INPP5J;PLCD3,GO_BP,turquoise,4
regulation of cation transmembrane transport (GO:1904062),3/30,0.111944353259652,0.794460425453736,0,0,2.72634271099744,5.97001815840728,KCNH2;KCNN2;SNTA1,GO_BP,turquoise,3
regulation of striated muscle contraction (GO:0006942),3/30,0.111944353259652,0.794460425453736,0,0,2.72634271099744,5.97001815840728,TNNI1;CALM3;NKX2-5,GO_BP,turquoise,3
snRNA 3'-end processing (GO:0034472),3/30,0.111944353259652,0.794460425453736,0,0,2.72634271099744,5.97001815840728,EXOSC7;TOE1;INTS12,GO_BP,turquoise,3
double-strand break repair (GO:0006302),10/164,0.112069828511874,0.794460425453736,0,0,1.59706744868035,3.49539473398845,BABAM2;BLM;VCP;XRCC6;PSMD14;FBH1;NABP2;APBB1;AP5S1;BAP1,GO_BP,turquoise,10
nuclear export (GO:0051168),6/84,0.1121945917492,0.794460425453736,0,0,1.88970079984201,4.13375921760949,DESI1;SARNP;RITA1;SRSF4;THOC5;RAN,GO_BP,turquoise,6
establishment of protein localization to mitochondrion (GO:0072655),4/48,0.118499569985397,0.794460425453736,0,0,2.23152135956233,4.75949128789691,CHCHD4;TIMM21;DNAJC15;TOMM40L,GO_BP,turquoise,4
inositol phosphate metabolic process (GO:0043647),4/48,0.118499569985397,0.794460425453736,0,0,2.23152135956233,4.75949128789691,ITPK1;ITPKA;INPP5J;PLCD3,GO_BP,turquoise,4
phosphatidic acid biosynthetic process (GO:0006654),4/48,0.118499569985397,0.794460425453736,0,0,2.23152135956233,4.75949128789691,ABHD4;LPCAT4;PLA2G5;AGPAT1,GO_BP,turquoise,4
protein palmitoylation (GO:0018345),3/31,0.120514567437838,0.794460425453736,0,0,2.62883631713555,5.56257727275427,PORCN;ZDHHC18;ZDHHC14,GO_BP,turquoise,3
activation of protein kinase B activity (GO:0032148),3/31,0.120514567437838,0.794460425453736,0,0,2.62883631713555,5.56257727275427,MAPKAP1;ADRA2C;MT3,GO_BP,turquoise,3
cardiac muscle cell action potential involved in contraction (GO:0086002),3/31,0.120514567437838,0.794460425453736,0,0,2.62883631713555,5.56257727275427,KCNH2;CACNA1G;SNTA1,GO_BP,turquoise,3
cellular nitrogen compound biosynthetic process (GO:0044271),3/31,0.120514567437838,0.794460425453736,0,0,2.62883631713555,5.56257727275427,CYB5B;CYB5R3;SPR,GO_BP,turquoise,3
negative regulation of DNA binding (GO:0043392),3/31,0.120514567437838,0.794460425453736,0,0,2.62883631713555,5.56257727275427,ILRUN;MSX2;SUMO3,GO_BP,turquoise,3
cellular protein-containing complex assembly (GO:0034622),10/168,0.125606101563062,0.794460425453736,0,0,1.55630869742752,3.22872494428324,CHCHD4;HSP90AB1;VBP1;TCP1;ADRM1;STXBP6;NDUFAF1;HOPX;RAB5IF;HSPA1A,GO_BP,turquoise,10
regulation of translational initiation (GO:0006446),5/68,0.128217449533769,0.794460425453736,0,0,1.94871794871795,4.00272051354372,EIF5B;EIF2B2;HSPB1;EIF1B;ATF4,GO_BP,turquoise,5
aortic valve morphogenesis (GO:0003180),3/32,0.129317070148873,0.794460425453736,0,0,2.53805450216068,5.19155998235174,EFNA1;GATA5;NKX2-5,GO_BP,turquoise,3
endodermal cell differentiation (GO:0035987),3/32,0.129317070148873,0.794460425453736,0,0,2.53805450216068,5.19155998235174,MMP15;COL7A1;ITGA7,GO_BP,turquoise,3
GPI anchor biosynthetic process (GO:0006506),3/32,0.129317070148873,0.794460425453736,0,0,2.53805450216068,5.19155998235174,PIGS;PYURF;PIGT,GO_BP,turquoise,3
intra-Golgi vesicle-mediated transport (GO:0006891),3/32,0.129317070148873,0.794460425453736,0,0,2.53805450216068,5.19155998235174,COG2;COPZ2;VTI1B,GO_BP,turquoise,3
mitochondrial membrane organization (GO:0007006),3/32,0.129317070148873,0.794460425453736,0,0,2.53805450216068,5.19155998235174,CHCHD3;TMEM11;BAK1,GO_BP,turquoise,3
peptidyl-proline modification (GO:0018208),3/32,0.129317070148873,0.794460425453736,0,0,2.53805450216068,5.19155998235174,PPIL1;CWC27;FKBP4,GO_BP,turquoise,3
protein K63-linked deubiquitination (GO:0070536),3/32,0.129317070148873,0.794460425453736,0,0,2.53805450216068,5.19155998235174,BABAM2;PSMD14;STAMBP,GO_BP,turquoise,3
ribosome assembly (GO:0042255),4/50,0.132199481838329,0.794460425453736,0,0,2.13427601180204,4.3185864347526,MTERF3;RRS1;RPS27L;RPL3L,GO_BP,turquoise,4
organic hydroxy compound biosynthetic process (GO:1901617),4/50,0.132199481838329,0.794460425453736,0,0,2.13427601180204,4.3185864347526,PMVK;DHCR7;CYP46A1;TM7SF2,GO_BP,turquoise,4
phosphatidic acid metabolic process (GO:0046473),4/50,0.132199481838329,0.794460425453736,0,0,2.13427601180204,4.3185864347526,ABHD4;LPCAT4;PLA2G5;AGPAT1,GO_BP,turquoise,4
extracellular matrix organization (GO:0030198),16/300,0.133652543502928,0.794460425453736,0,0,1.38691184820235,2.79117646770217,CTRB2;COL23A1;CTRB1;ITGA2B;MMP11;KIF9;ADAMTSL4;CTSL;MMP15;CREB3L1;COL7A1;ST7;ITGA7;TLL2;QSOX1;CAPN1,GO_BP,turquoise,16
neutrophil degranulation (GO:0043312),24/481,0.137058381959617,0.794460425453736,0,0,1.29448468415105,2.57259193414231,XRCC6;VCP;HSP90AB1;PSMD14;SLC44A2;HVCN1;PRDX6;DDOST;LGALS3;HEBP2;PSMD6;PSMD7;CYB5R3;PSMD2;PSMC2;QSOX1;ALDOC;CD59;CCT8;CAPN1;CTSD;HSPA1B;PGM1;HSPA1A,GO_BP,turquoise,24
phosphatidylcholine biosynthetic process (GO:0006656),3/33,0.13833869568875,0.794460425453736,0,0,2.45332480818414,4.85279983395511,SLC44A2;PEMT;CHPT1,GO_BP,turquoise,3
mitotic nuclear membrane organization (GO:0101024),4/51,0.139282772052968,0.794460425453736,0,0,2.08875691285041,4.11746014485742,RANGAP1;EMD;SIRT2;RAN,GO_BP,turquoise,4
mitotic nuclear membrane reassembly (GO:0007084),4/51,0.139282772052968,0.794460425453736,0,0,2.08875691285041,4.11746014485742,RANGAP1;EMD;SIRT2;RAN,GO_BP,turquoise,4
"regulation of mRNA splicing, via spliceosome (GO:0048024)",6/90,0.142272984089112,0.794460425453736,0,0,1.75417201540436,3.42064883841839,SMU1;FXR2;SAP18;SRSF4;PRDX6;JMJD6,GO_BP,turquoise,6
neutrophil activation involved in immune response (GO:0002283),24/485,0.145757973315745,0.794460425453736,0,0,1.28297906909792,2.47077103412878,XRCC6;VCP;HSP90AB1;PSMD14;SLC44A2;HVCN1;PRDX6;DDOST;LGALS3;HEBP2;PSMD6;PSMD7;CYB5R3;PSMD2;PSMC2;QSOX1;ALDOC;CD59;CCT8;CAPN1;CTSD;HSPA1B;PGM1;HSPA1A,GO_BP,turquoise,24
protein tetramerization (GO:0051262),5/71,0.146106223432652,0.794460425453736,0,0,1.85984848484848,3.57727230966802,AQP4;CUTC;THG1L;GNMT;FARSB,GO_BP,turquoise,5
regulation of G1/S transition of mitotic cell cycle (GO:2000045),5/71,0.146106223432652,0.794460425453736,0,0,1.85984848484848,3.57727230966802,LSM10;CCND3;PSME3;CDK2AP2;MYO16,GO_BP,turquoise,5
fatty acid biosynthetic process (GO:0006633),5/71,0.146106223432652,0.794460425453736,0,0,1.85984848484848,3.57727230966802,FADS3;GSTM4;TECR;MLYCD;ABCD1,GO_BP,turquoise,5
mitochondrial ATP synthesis coupled electron transport (GO:0042775),5/71,0.146106223432652,0.794460425453736,0,0,1.85984848484848,3.57727230966802,NDUFC1;SDHC;SDHD;NDUFAF1;COA6,GO_BP,turquoise,5
phosphatidylinositol-mediated signaling (GO:0048015),5/71,0.146106223432652,0.794460425453736,0,0,1.85984848484848,3.57727230966802,ERBB2;PI4KB;PLCD3;SIRT2;MYO16,GO_BP,turquoise,5
regulation of protein serine/threonine kinase activity (GO:0071900),7/111,0.146426023535074,0.794460425453736,0,0,1.65336414870477,3.176500965851,CCND3;BLM;TESK1;MTCP1;CALM3;MNAT1;CCNJL,GO_BP,turquoise,7
negative regulation of protein metabolic process (GO:0051248),4/52,0.14651412687977,0.794460425453736,0,0,2.04513444302177,3.92795357185085,HSP90AB1;VBP1;PFDN1;SIRT2,GO_BP,turquoise,4
phosphatidylinositol 3-kinase signaling (GO:0014065),3/34,0.14756623831158,0.794460425453736,0,0,2.37406154607706,4.54271484937006,ERBB2;MYO16;SIRT2,GO_BP,turquoise,3
neutrophil mediated immunity (GO:0002446),24/488,0.152487593568356,0.794460425453736,0,0,1.27448003987494,2.39687897639602,XRCC6;VCP;HSP90AB1;PSMD14;SLC44A2;HVCN1;PRDX6;DDOST;LGALS3;HEBP2;PSMD6;PSMD7;CYB5R3;PSMD2;PSMC2;QSOX1;ALDOC;CD59;CCT8;CAPN1;CTSD;HSPA1B;PGM1;HSPA1A,GO_BP,turquoise,24
organelle organization (GO:0006996),21/420,0.153782567377183,0.794460425453736,0,0,1.29622485533205,2.42681236206003,STOML2;PLEKHF1;PEX19;LMAN2L;SH3KBP1;TANGO2;TPM1;COG2;PLAAT3;TFB1M;ANK1;ARHGAP10;KIF9;DES;TMEM11;TRAPPC12;TMED1;REEP6;ABCD1;ROPN1;PACSIN1,GO_BP,turquoise,21
heart morphogenesis (GO:0003007),4/53,0.153887763708647,0.794460425453736,0,0,2.00329248216572,3.74922548363578,MESP1;MYLK2;ACTC1;NKX2-5,GO_BP,turquoise,4
positive regulation of programmed cell death (GO:0043068),15/286,0.156976578911565,0.794460425453736,0,0,1.36176738390761,2.52152837431485,MTCH1;MTCH2;FAF1;PDCD5;ARHGEF16;KNG1;GADD45G;ADAMTSL4;SAP18;APBB1;BAK1;ZNF622;CTSD;CTNNBL1;ATF4,GO_BP,turquoise,15
regulation of autophagosome assembly (GO:2000785),3/35,0.156986503449059,0.794460425453736,0,0,2.29975223785166,4.25821076276513,LRSAM1;FEZ1;FEZ2,GO_BP,turquoise,3
regulation of blood circulation (GO:1903522),3/35,0.156986503449059,0.794460425453736,0,0,2.29975223785166,4.25821076276513,DES;TPM1;AGT,GO_BP,turquoise,3
intracellular pH reduction (GO:0051452),3/35,0.156986503449059,0.794460425453736,0,0,2.29975223785166,4.25821076276513,RAB20;ATP6V0E2;ATP6V1F,GO_BP,turquoise,3
negative regulation of organelle assembly (GO:1902116),3/35,0.156986503449059,0.794460425453736,0,0,2.29975223785166,4.25821076276513,FEZ1;FEZ2;TESK1,GO_BP,turquoise,3
endoplasmic reticulum organization (GO:0007029),5/73,0.158590981123723,0.794460425453736,0,0,1.80495852187029,3.32369906175101,RTN3;LMAN2L;GET1;REEP6;EMD,GO_BP,turquoise,5
ubiquitin-dependent ERAD pathway (GO:0030433),5/73,0.158590981123723,0.794460425453736,0,0,1.80495852187029,3.32369906175101,VCP;HSPA5;AMFR;UFD1;RNF175,GO_BP,turquoise,5
proteolysis (GO:0006508),15/287,0.160038462089341,0.794460425453736,0,0,1.35668926661574,2.48591750936049,TMPRSS5;DESI1;CTRB2;CTRB1;HPN;PRSS56;PSMA6;PSMD6;PSMB5;CTSL;MMP15;PSMC4;CAPN1;CTSD;ATG4D,GO_BP,turquoise,15
nuclear membrane reassembly (GO:0031468),4/54,0.161397791229797,0.794460425453736,0,0,1.96312419974392,3.58050926373865,RANGAP1;EMD;SIRT2;RAN,GO_BP,turquoise,4
negative regulation of cell death (GO:0060548),6/94,0.164174342494752,0.794460425453736,0,0,1.6740868246003,3.02478418991904,PACRG;PSMC5;TMEM109;MT3;HSPA1B;HSPA1A,GO_BP,turquoise,6
aortic valve development (GO:0003176),3/36,0.166586353917232,0.794460425453736,0,0,2.22994652406417,3.99660261816833,EFNA1;GATA5;NKX2-5,GO_BP,turquoise,3
endoderm formation (GO:0001706),3/36,0.166586353917232,0.794460425453736,0,0,2.22994652406417,3.99660261816833,MMP15;COL7A1;ITGA7,GO_BP,turquoise,3
platelet aggregation (GO:0070527),3/36,0.166586353917232,0.794460425453736,0,0,2.22994652406417,3.99660261816833,GNAS;HSPB1;MYL9,GO_BP,turquoise,3
positive regulation of cytokine-mediated signaling pathway (GO:0001961),3/36,0.166586353917232,0.794460425453736,0,0,2.22994652406417,3.99660261816833,AGPAT1;HSPA1B;HSPA1A,GO_BP,turquoise,3
protein targeting to mitochondrion (GO:0006626),4/55,0.169038227250493,0.794460425453736,0,0,1.92453114408375,3.42110505378513,CHCHD4;TIMM21;DNAJC15;TOMM40L,GO_BP,turquoise,4
pyruvate metabolic process (GO:0006090),4/55,0.169038227250493,0.794460425453736,0,0,1.92453114408375,3.42110505378513,GLO1;ALDOC;ENO3;PGM1,GO_BP,turquoise,4
regulation of cardiac conduction (GO:1903779),4/55,0.169038227250493,0.794460425453736,0,0,1.92453114408375,3.42110505378513,KCNJ11;FXYD3;NKX2-5;AGT,GO_BP,turquoise,4
regulated exocytosis (GO:0045055),10/180,0.171188176810825,0.794460425453736,0,0,1.44554079696395,2.55136776645589,LGALS3BP;SCCPDH;RAB26;ITGA2B;OLA1;QSOX1;TUBA4A;KNG1;VTI1B;MANF,GO_BP,turquoise,10
positive regulation of cellular biosynthetic process (GO:0031328),10/180,0.171188176810825,0.794460425453736,0,0,1.44554079696395,2.55136776645589,CTDNEP1;FXR2;HSP90AB1;NPM2;FAF1;ASIP;ERBB2;RPS27L;PTH1R;LARP6,GO_BP,turquoise,10
negative regulation of cellular process (GO:0048523),27/566,0.172174720459864,0.794460425453736,0,0,1.23421169859165,2.17128137819448,BLM;PPP1R13B;EI24;PDCD5;KNG1;TMEM109;TP53TG5;RBBP7;APBB1;PACRG;GLMN;OSGIN1;MUL1;FUZ;CGRRF1;MT3;SIRT2;HOPX;MYO16;SSTR5;RNF167;FABP6;NUPR2;INHA;HSPA1B;BAP1;HSPA1A,GO_BP,turquoise,27
cellular macromolecule biosynthetic process (GO:0034645),16/314,0.174104526001172,0.794460425453736,0,0,1.32077744128608,2.30885030017451,BLM;DUT;SET;MRPL18;MRPS18A;RPS4Y1;MRPS6;YARS2;RPL3L;MRPS18C;COPS5;TNIP1;MRPL9;INHA;POLR2K;FARSB,GO_BP,turquoise,16
proton transmembrane transport (GO:1902600),3/37,0.176352751506544,0.794460425453736,0,0,2.16424702873477,3.75555082035167,HVCN1;ATP6V0E2;ATP6V1F,GO_BP,turquoise,3
regulation of p38MAPK cascade (GO:1900744),3/37,0.176352751506544,0.794460425453736,0,0,2.16424702873477,3.75555082035167,HAND2;ULK4;GADD45G,GO_BP,turquoise,3
phagosome maturation (GO:0090382),3/37,0.176352751506544,0.794460425453736,0,0,2.16424702873477,3.75555082035167,RAB20;ATP6V0E2;ATP6V1F,GO_BP,turquoise,3
positive regulation of calcium ion transport (GO:0051928),3/37,0.176352751506544,0.794460425453736,0,0,2.16424702873477,3.75555082035167,LGALS3;CACNB2;CAMK2A,GO_BP,turquoise,3
telomere maintenance (GO:0000723),4/56,0.176803015747004,0.794460425453736,0,0,1.88742243671821,3.27037285213813,BLM;XRCC6;APEX1;TPRKB,GO_BP,turquoise,4
water-soluble vitamin metabolic process (GO:0006767),5/76,0.178091415875046,0.794460425453736,0,0,1.72842181292886,2.98231974260902,CYB5R3;FLAD1;CTRB2;FPGS;CTRB1,GO_BP,turquoise,5
phospholipid metabolic process (GO:0006644),5/76,0.178091415875046,0.794460425453736,0,0,1.72842181292886,2.98231974260902,LPCAT4;PLAAT3;PLA2G5;AGPAT1;FDFT1,GO_BP,turquoise,5
ribosomal large subunit biogenesis (GO:0042273),4/57,0.184686043238691,0.794460425453736,0,0,1.8517140579325,3.12772643613151,NOP16;RRS1;ZNF622;RPL3L,GO_BP,turquoise,4
regulation of cell communication (GO:0010646),3/38,0.186272794193251,0.794460425453736,0,0,2.10230179028133,3.53300865063612,MTCH1;GRK4;GLRX2,GO_BP,turquoise,3
negative regulation of innate immune response (GO:0045824),3/38,0.186272794193251,0.794460425453736,0,0,2.10230179028133,3.53300865063612,SUSD4;MUL1;TRAFD1,GO_BP,turquoise,3
positive regulation of potassium ion transport (GO:0043268),3/38,0.186272794193251,0.794460425453736,0,0,2.10230179028133,3.53300865063612,KCNH2;KCNN1;KCNN2,GO_BP,turquoise,3
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),7/119,0.187228349542962,0.794460425453736,0,0,1.53462403598972,2.5711494498506,MTCH1;BEX3;VCP;PDCD5;MUL1;RPS27L;CTSD,GO_BP,turquoise,7
macroautophagy (GO:0016236),7/120,0.192630816200195,0.794460425453736,0,0,1.5209636690402,2.50499642632855,ILRUN;VCP;MTERF3;MTMR14;FUNDC1;EI24;VTI1B,GO_BP,turquoise,7
chromatin organization (GO:0006325),8/142,0.195371691541248,0.794460425453736,0,0,1.46610576461323,2.3939328858848,SUPV3L1;SMARCD3;NPM2;SOX15;SUV39H1;HDAC11;RUVBL1;HMGN3,GO_BP,turquoise,8
regulation of exit from mitosis (GO:0007096),3/39,0.196333749219494,0.794460425453736,0,0,2.04379795396419,3.32717894048764,NPM2;ANAPC10;SIRT2,GO_BP,turquoise,3
regulation of heart rate by cardiac conduction (GO:0086091),3/39,0.196333749219494,0.794460425453736,0,0,2.04379795396419,3.32717894048764,KCNH2;CACNB2;CACNA1G,GO_BP,turquoise,3
DNA recombination (GO:0006310),3/39,0.196333749219494,0.794460425453736,0,0,2.04379795396419,3.32717894048764,SUPV3L1;BLM;FBH1,GO_BP,turquoise,3
DNA replication-independent nucleosome assembly (GO:0006336),3/39,0.196333749219494,0.794460425453736,0,0,2.04379795396419,3.32717894048764,RUVBL1;RBBP7;CABIN1,GO_BP,turquoise,3
protein acylation (GO:0043543),3/39,0.196333749219494,0.794460425453736,0,0,2.04379795396419,3.32717894048764,PORCN;ZDHHC18;ZDHHC14,GO_BP,turquoise,3
recombinational repair (GO:0000725),5/79,0.198436723265275,0.794460425453736,0,0,1.65809078309078,2.68160535902286,BLM;PSMD14;FBH1;NABP2;AP5S1,GO_BP,turquoise,5
positive regulation of translation (GO:0045727),6/100,0.199476245063281,0.794460425453736,0,0,1.56673859011826,2.52567680289486,RPUSD4;FXR2;ERBB2;RPS27L;YBX3;LARP6,GO_BP,turquoise,6
mitotic DNA damage checkpoint signaling (GO:0044773),4/59,0.200782166414584,0.794460425453736,0,0,1.78419275986498,2.86458340134196,BABAM2;BLM;RPS27L;FBXO31,GO_BP,turquoise,4
mRNA processing (GO:0006397),15/300,0.202592203985738,0.794460425453736,0,0,1.29391660970608,2.06581571943572,RBM17;PPIL1;GPKOW;AKAP8L;CWC27;THOC5;SMU1;LSM6;SNRPD1;SARNP;SRSF4;RALY;MNAT1;CTNNBL1;POLR2K,GO_BP,turquoise,15
negative regulation of cellular component organization (GO:0051129),5/80,0.205389477577011,0.794460425453736,0,0,1.63589743589744,2.5893756950925,LGALS3;LRSAM1;HSPA5;HSPA1B;HSPA1A,GO_BP,turquoise,5
positive regulation of protein localization to membrane (GO:1905477),6/101,0.205616545464027,0.794460425453736,0,0,1.55016552935612,2.45196235039812,LGALS3;PPP1R13B;CD81;PDCD5;ARHGEF16;ERBB2,GO_BP,turquoise,6
glycolipid biosynthetic process (GO:0009247),3/40,0.206523082625055,0.794460425453736,0,0,1.98845648717771,3.13647810490865,PYURF;SCCPDH;A4GALT,GO_BP,turquoise,3
ribosomal small subunit biogenesis (GO:0042274),3/40,0.206523082625055,0.794460425453736,0,0,1.98845648717771,3.13647810490865,LTV1;LSM6;RPS27L,GO_BP,turquoise,3
ribonucleoprotein complex biogenesis (GO:0022613),4/60,0.208982883930396,0.794460425453736,0,0,1.75224071702945,2.74313796858607,LTV1;NOP16;RRS1;ZNF622,GO_BP,turquoise,4
peptidyl-threonine phosphorylation (GO:0018107),4/60,0.208982883930396,0.794460425453736,0,0,1.75224071702945,2.74313796858607,MYLK2;HIPK4;SBK1;CAMK2A,GO_BP,turquoise,4
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),5/81,0.212421591383598,0.794460425453736,0,0,1.61428812415655,2.50082665431309,MTCH1;BEX3;VCP;MUL1;RPS27L,GO_BP,turquoise,5
positive regulation of cellular amide metabolic process (GO:0034250),5/81,0.212421591383598,0.794460425453736,0,0,1.61428812415655,2.50082665431309,EFNA1;FXR2;ERBB2;RPS27L;LARP6,GO_BP,turquoise,5
phosphate-containing compound metabolic process (GO:0006796),11/212,0.212581518662882,0.794460425453736,0,0,1.34440202090324,2.08171208101666,LPCAT4;ITPK1;ITPKA;INPP5J;PLAAT3;ALDOC;DUSP28;PLA2G5;PLCD3;AGPAT1;DUSP13,GO_BP,turquoise,11
protein methylation (GO:0006479),3/41,0.216828485145943,0.794460425453736,0,0,1.93602772916947,2.95950613389679,METTL22;CARM1;METTL21A,GO_BP,turquoise,3
carbohydrate catabolic process (GO:0016052),3/41,0.216828485145943,0.794460425453736,0,0,1.93602772916947,2.95950613389679,ALDOC;ENO3;PGM1,GO_BP,turquoise,3
regulation of G0 to G1 transition (GO:0070316),3/41,0.216828485145943,0.794460425453736,0,0,1.93602772916947,2.95950613389679,MAX;SOX15;RBBP7,GO_BP,turquoise,3
hexose metabolic process (GO:0019318),3/41,0.216828485145943,0.794460425453736,0,0,1.93602772916947,2.95950613389679,KCNJ11;ALDOC;PGM1,GO_BP,turquoise,3
nucleobase-containing compound catabolic process (GO:0034655),3/41,0.216828485145943,0.794460425453736,0,0,1.93602772916947,2.95950613389679,EXOSC7;SUPV3L1;ENTPD6,GO_BP,turquoise,3
positive regulation of cation transmembrane transport (GO:1904064),3/41,0.216828485145943,0.794460425453736,0,0,1.93602772916947,2.95950613389679,KCNH2;KCNN1;KCNN2,GO_BP,turquoise,3
protein lipidation (GO:0006497),4/61,0.217277111451641,0.794460425453736,0,0,1.72140979850394,2.6278727462237,PYURF;PORCN;ZDHHC18;ZDHHC14,GO_BP,turquoise,4
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),5/82,0.219529337528344,0.794460425453736,0,0,1.59324009324009,2.41578119901033,CCND3;BLM;MAPRE3;MNAT1;CCNJL,GO_BP,turquoise,5
ribosome biogenesis (GO:0042254),10/192,0.223456235063568,0.794460425453736,0,0,1.34937965260546,2.02209898030536,LTV1;EXOSC7;NOP58;NOP16;RRS1;DDX10;RRP12;ZNF622;MRM2;RAN,GO_BP,turquoise,10
long-chain fatty acid metabolic process (GO:0001676),5/83,0.2267089663534,0.794460425453736,0,0,1.57273175542406,2.33407259379231,GSTM4;CPT2;ACOT2;ACOT1;ABCD1,GO_BP,turquoise,5
regulation of nervous system development (GO:0051960),3/42,0.227237895171147,0.794460425453736,0,0,1.88628762541806,2.79502142825791,HES6;LGI4;SIRT2,GO_BP,turquoise,3
mitochondrial gene expression (GO:0140053),3/42,0.227237895171147,0.794460425453736,0,0,1.88628762541806,2.79502142825791,GATB;MRPS18A;MRPS6,GO_BP,turquoise,3
phosphatidylinositol phosphate biosynthetic process (GO:0046854),3/42,0.227237895171147,0.794460425453736,0,0,1.88628762541806,2.79502142825791,TMEM150A;ITPKA;PI4KB,GO_BP,turquoise,3
positive regulation of ATPase activity (GO:0032781),3/42,0.227237895171147,0.794460425453736,0,0,1.88628762541806,2.79502142825791,MYL4;TPM1;AHSA1,GO_BP,turquoise,3
regulation of JNK cascade (GO:0046328),6/105,0.230821841476002,0.794460425453736,0,0,1.48722137939083,2.18042882041843,SH3RF2;COPS5;ULK4;ZNF622;TPD52L1;GADD45G,GO_BP,turquoise,6
negative regulation of endopeptidase activity (GO:0010951),4/63,0.234121390703794,0.794460425453736,0,0,1.66288330909959,2.41436610844996,SPINK2;MT3;KNG1;AGT,GO_BP,turquoise,4
gene expression (GO:0010467),17/356,0.236584494026328,0.794460425453736,0,0,1.23253134218289,1.77663213833244,RBPMS;MRPL18;MRPS18A;RPS4Y1;THOC5;MRPS6;YARS2;RPL3L;SMG5;MRPS18C;COPS5;TNIP1;SARNP;SRSF4;MRPL9;POLR2K;FARSB,GO_BP,turquoise,17
chromosome organization (GO:0051276),6/106,0.237271565575699,0.794460425453736,0,0,1.47227214377407,2.11793701515674,COPS4;COPS5;SOX15;SUV39H1;HDAC11;HMGN3,GO_BP,turquoise,6
positive regulation of protein serine/threonine kinase activity (GO:0071902),6/106,0.237271565575699,0.794460425453736,0,0,1.47227214377407,2.11793701515674,CCND3;ERBB2;MTCP1;CALM3;MAPRE3;TPD52L1,GO_BP,turquoise,6
glutathione metabolic process (GO:0006749),3/43,0.237739518332496,0.794460425453736,0,0,1.83903452685422,2.64191960535405,GSTM4;CHAC2;GLRX2,GO_BP,turquoise,3
regulation of extrinsic apoptotic signaling pathway (GO:2001236),4/64,0.242659162138855,0.794460425453736,0,0,1.63508322663252,2.31543717989708,LGALS3;PSME3;SIAH2;AGT,GO_BP,turquoise,4
tRNA processing (GO:0008033),4/64,0.242659162138855,0.794460425453736,0,0,1.63508322663252,2.31543717989708,AARS1;TSEN2;FARS2;THG1L,GO_BP,turquoise,4
protein catabolic process (GO:0030163),4/64,0.242659162138855,0.794460425453736,0,0,1.63508322663252,2.31543717989708,LRSAM1;VCP;SIAH2;CTSD,GO_BP,turquoise,4
homotypic cell-cell adhesion (GO:0034109),3/44,0.248321844845276,0.794460425453736,0,0,1.79408645748862,2.49921556304154,GNAS;HSPB1;MYL9,GO_BP,turquoise,3
metal ion homeostasis (GO:0055065),3/44,0.248321844845276,0.794460425453736,0,0,1.79408645748862,2.49921556304154,KCNH2;S100A14;MT3,GO_BP,turquoise,3
negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),3/44,0.248321844845276,0.794460425453736,0,0,1.79408645748862,2.49921556304154,SH3KBP1;EPS15L1;EPN1,GO_BP,turquoise,3
neurogenesis (GO:0022008),3/44,0.248321844845276,0.794460425453736,0,0,1.79408645748862,2.49921556304154,MESP1;RITA1;WDR62,GO_BP,turquoise,3
positive regulation of potassium ion transmembrane transport (GO:1901381),3/44,0.248321844845276,0.794460425453736,0,0,1.79408645748862,2.49921556304154,KCNH2;KCNN1;KCNN2,GO_BP,turquoise,3
positive regulation of stress fiber assembly (GO:0051496),3/44,0.248321844845276,0.794460425453736,0,0,1.79408645748862,2.49921556304154,TPM1;TESK1;RHOC,GO_BP,turquoise,3
protein K63-linked ubiquitination (GO:0070534),3/44,0.248321844845276,0.794460425453736,0,0,1.79408645748862,2.49921556304154,UBE2D4;UBE2E3;UBE2T,GO_BP,turquoise,3
ERAD pathway (GO:0036503),5/87,0.256070869403429,0.794460425453736,0,0,1.49570043777361,2.03759426072103,VCP;HSPA5;AMFR;UFD1;RNF175,GO_BP,turquoise,5
protein modification by small protein conjugation (GO:0032446),19/409,0.257042634800699,0.794460425453736,0,0,1.19727856999397,1.62651887752019,VCP;UBE2D4;USP5;DCUN1D5;H2BC5;FBH1;UBE2D2;UBE2E3;AMFR;MUL1;KEAP1;ASB12;RANGAP1;TRIM7;UBE2R2;SUMO3;UBE2T;TRIM54;SPSB4,GO_BP,turquoise,19
action potential (GO:0001508),3/45,0.25897366389114,0.794460425453736,0,0,1.75127877237852,2.36602824442172,KCNH2;MYH14;CACNA1G,GO_BP,turquoise,3
mitotic G2/M transition checkpoint (GO:0044818),3/45,0.25897366389114,0.794460425453736,0,0,1.75127877237852,2.36602824442172,BABAM2;BLM;NABP2,GO_BP,turquoise,3
zymogen activation (GO:0031638),3/45,0.25897366389114,0.794460425453736,0,0,1.75127877237852,2.36602824442172,CTSL;HPR;BAK1,GO_BP,turquoise,3
embryonic organ development (GO:0048568),4/66,0.2599355976287,0.794460425453736,0,0,1.58217339225972,2.13169603838166,TEAD4;PKDCC;NKX2-5;ATF4,GO_BP,turquoise,4
regulation of protein localization (GO:0032880),4/66,0.2599355976287,0.794460425453736,0,0,1.58217339225972,2.13169603838166,HSP90AB1;DVL1;TESK1;CTSD,GO_BP,turquoise,4
positive regulation of cell death (GO:0010942),4/66,0.2599355976287,0.794460425453736,0,0,1.58217339225972,2.13169603838166,HEBP2;FAF1;HPR;MT3,GO_BP,turquoise,4
negative regulation of binding (GO:0051100),5/88,0.263553301598013,0.794460425453736,0,0,1.47760271856657,1.97038270561363,ILRUN;PEX19;SUMO3;CTNNBIP1;DVL1,GO_BP,turquoise,5
response to endoplasmic reticulum stress (GO:0034976),6/110,0.263586860792954,0.794460425453736,0,0,1.41535005431026,1.88718858955144,VCP;HSPA5;CREB3L1;DDIT3;BAK1;ATF4,GO_BP,turquoise,6
regulation of translation (GO:0006417),9/178,0.265841908704536,0.794460425453736,0,0,1.3070670408101,1.73167231115611,EIF5B;RIDA;FXR2;EIF2B2;ERBB2;HSPB1;RPS27L;EIF1B;LARP6,GO_BP,turquoise,9
ncRNA processing (GO:0034470),10/201,0.2662470328148,0.794460425453736,0,0,1.285188312785,1.70072915778674,EXOSC7;INTS12;AARS1;NOP58;DDX10;RRP12;INTS9;MRM2;FARS2;THG1L,GO_BP,turquoise,10
regulation of epidermal growth factor receptor signaling pathway (GO:0042058),4/67,0.268662286116928,0.794460425453736,0,0,1.55697823303457,2.04633669416585,SH3KBP1;EPS15L1;EPN1;AGT,GO_BP,turquoise,4
peptidyl-threonine modification (GO:0018210),4/67,0.268662286116928,0.794460425453736,0,0,1.55697823303457,2.04633669416585,MYLK2;HIPK4;SBK1;GALNT16,GO_BP,turquoise,4
regulation of DNA metabolic process (GO:0051052),3/46,0.269684076188727,0.794460425453736,0,0,1.71046214238982,2.24156763897036,SUB1;MPV17;SMG5,GO_BP,turquoise,3
regulation of telomerase activity (GO:0051972),3/46,0.269684076188727,0.794460425453736,0,0,1.71046214238982,2.24156763897036,HSP90AB1;TCP1;NABP2,GO_BP,turquoise,3
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),5/89,0.271084978317536,0.794460425453736,0,0,1.4599358974359,1.90568780928095,BEX3;SIAH2;PDCD5;CTSD;MT3,GO_BP,turquoise,5
positive regulation of binding (GO:0051099),5/90,0.278662154050294,0.794460425453736,0,0,1.44268476621418,1.8433978873985,GPSM1;AMFR;MARK3;SIRT2;RAN,GO_BP,turquoise,5
regulation of DNA binding (GO:0051101),3/47,0.280442503869784,0.794460425453736,0,0,1.67150081376424,2.12512365681418,ILRUN;SUMO3;SIRT2,GO_BP,turquoise,3
regulation of protein localization to nucleus (GO:1900180),3/47,0.280442503869784,0.794460425453736,0,0,1.67150081376424,2.12512365681418,ILRUN;SUMO3;TESK1,GO_BP,turquoise,3
telomere organization (GO:0032200),3/47,0.280442503869784,0.794460425453736,0,0,1.67150081376424,2.12512365681418,BLM;XRCC6;APEX1,GO_BP,turquoise,3
negative regulation of cold-induced thermogenesis (GO:0120163),3/47,0.280442503869784,0.794460425453736,0,0,1.67150081376424,2.12512365681418,RHEB;DDIT3;ATF4,GO_BP,turquoise,3
cellular response to starvation (GO:0009267),8/158,0.281405013317509,0.794460425453736,0,0,1.30862290862291,1.65928192045005,HSPA5;STK24;RHEB;MARS1;NUPR2;ATP6V0E2;ATF4;ATP6V1F,GO_BP,turquoise,8
positive regulation of metabolic process (GO:0009893),6/113,0.283792581481969,0.794460425453736,0,0,1.37545139347114,1.73239706034205,PYURF;CPT2;GNAS;PEMT;AGPAT1;GADD45G,GO_BP,turquoise,6
RNA 3'-end processing (GO:0031123),4/69,0.286263202637403,0.794460425453736,0,0,1.50891362158968,1.88741495017974,SUPV3L1;SARNP;SRSF4;THOC5,GO_BP,turquoise,4
positive regulation of protein phosphorylation (GO:0001934),17/371,0.290479184988784,0.794460425453736,0,0,1.17936749646893,1.45796164635213,XRCC6;HSP90AB1;RBPMS;FBH1;CD81;TESK1;MT3;AGT;NTF4;EFNA1;CCND3;FXR2;ERBB2;MTCP1;CALM3;MAPRE3;INHA,GO_BP,turquoise,17
cellular response to ionizing radiation (GO:0071479),3/48,0.291238698906245,0.794460425453736,0,0,1.63427109974425,2.01605656556283,BLM;XRCC6;TMEM109,GO_BP,turquoise,3
Golgi to plasma membrane transport (GO:0006893),3/48,0.291238698906245,0.794460425453736,0,0,1.63427109974425,2.01605656556283,RAB26;ARL3;STXBP6,GO_BP,turquoise,3
positive regulation of cellular component biogenesis (GO:0044089),5/92,0.293938129936135,0.794460425453736,0,0,1.40937223695844,1.72561560215452,LGALS3;VCP;FAF1;BAK1;RHOC,GO_BP,turquoise,5
aerobic electron transport chain (GO:0019646),4/70,0.295125917358969,0.794460425453736,0,0,1.48597369340007,1.81341271501482,NDUFC1;SDHC;SDHD;NDUFAF1,GO_BP,turquoise,4
fatty acid catabolic process (GO:0009062),4/70,0.295125917358969,0.794460425453736,0,0,1.48597369340007,1.81341271501482,MCEE;CPT2;CEL;ABCD1,GO_BP,turquoise,4
cellular response to DNA damage stimulus (GO:0006974),16/350,0.301314497404833,0.794460425453736,0,0,1.17617560717317,1.41094110265213,BLM;VCP;DCUN1D5;FBH1;SUV39H1;MAPK12;FBXO31;BABAM2;DDIT3;APEX1;UBE2T;NABP2;NUPR2;APBB1;BAK1;MNAT1,GO_BP,turquoise,16
regulation of cellular localization (GO:0060341),3/49,0.302062749404355,0.794460425453736,0,0,1.59866006894251,1.91378874698683,HSP90AB1;DVL1;REEP6,GO_BP,turquoise,3
response to hydrogen peroxide (GO:0042542),3/49,0.302062749404355,0.794460425453736,0,0,1.59866006894251,1.91378874698683,OSER1;STK24;GLRX2,GO_BP,turquoise,3
mitotic cytokinesis (GO:0000281),3/49,0.302062749404355,0.794460425453736,0,0,1.59866006894251,1.91378874698683,ARL3;STAMBP;RHOC,GO_BP,turquoise,3
regulation of endopeptidase activity (GO:0052548),4/71,0.304022614669176,0.794460425453736,0,0,1.46371853918627,1.74278114792028,PSMA3;PSME3;KNG1;AGT,GO_BP,turquoise,4
response to metal ion (GO:0010038),4/71,0.304022614669176,0.794460425453736,0,0,1.46371853918627,1.74278114792028,SLC30A3;HVCN1;CALM3;MT3,GO_BP,turquoise,4
protein localization to cell periphery (GO:1990778),7/140,0.311244410761024,0.794460425453736,0,0,1.29089433094304,1.50670189981698,CACNB2;PLEKHF1;TMEM150A;CD81;ARL3;ANK1;PACSIN1,GO_BP,turquoise,7
regulation of complement activation (GO:0030449),3/50,0.31290508452792,0.794460425453736,0,0,1.56456440115362,1.81779756488045,CD81;SUSD4;CD59,GO_BP,turquoise,3
positive regulation of ion transport (GO:0043270),3/50,0.31290508452792,0.794460425453736,0,0,1.56456440115362,1.81779756488045,CACNB2;CAMK2A;NKX2-5,GO_BP,turquoise,3
response to ionizing radiation (GO:0010212),4/72,0.312947777884208,0.794460425453736,0,0,1.4421179483317,1.67533574320661,BABAM2;BLM;COP1;NABP2,GO_BP,turquoise,4
negative regulation of supramolecular fiber organization (GO:1902904),4/72,0.312947777884208,0.794460425453736,0,0,1.4421179483317,1.67533574320661,VBP1;CHADL;PFDN1;TRIM54,GO_BP,turquoise,4
insulin receptor signaling pathway (GO:0008286),4/73,0.321895996807004,0.794460425453736,0,0,1.42114346155987,1.61090416748487,GRB14;AP3S1;ATP6V0E2;ATP6V1F,GO_BP,turquoise,4
transcription-coupled nucleotide-excision repair (GO:0006283),4/73,0.321895996807004,0.794460425453736,0,0,1.42114346155987,1.61090416748487,COPS4;COPS5;MNAT1;POLR2K,GO_BP,turquoise,4
positive regulation of JNK cascade (GO:0046330),4/73,0.321895996807004,0.794460425453736,0,0,1.42114346155987,1.61090416748487,SH3RF2;ZNF622;TPD52L1;GADD45G,GO_BP,turquoise,4
regulation of protein modification process (GO:0031399),3/51,0.323756477701923,0.794460425453736,0,0,1.53188938618926,1.72760917754879,HSPB1;MT3;ROPN1,GO_BP,turquoise,3
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),3/51,0.323756477701923,0.794460425453736,0,0,1.53188938618926,1.72760917754879,TMEM109;RPS27L;BAK1,GO_BP,turquoise,3
negative regulation of protein ubiquitination (GO:0031397),3/51,0.323756477701923,0.794460425453736,0,0,1.53188938618926,1.72760917754879,SH3RF2;HSPA1B;HSPA1A,GO_BP,turquoise,3
positive regulation of actin filament bundle assembly (GO:0032233),3/51,0.323756477701923,0.794460425453736,0,0,1.53188938618926,1.72760917754879,TPM1;TESK1;RHOC,GO_BP,turquoise,3
protein localization to organelle (GO:0033365),7/142,0.323893284396453,0.794460425453736,0,0,1.27163667523565,1.43356839837214,CTDNEP1;MTCH2;ARL3;DVL1;GET1;EMD;ROPN1,GO_BP,turquoise,7
monocarboxylic acid metabolic process (GO:0032787),7/143,0.330249198811421,0.794460425453736,0,0,1.26222024799637,1.3984236095899,SLC6A8;GLO1;ACOT2;ACOT1;ECHDC3;CPT1B;ACSF2,GO_BP,turquoise,7
cellular response to amino acid starvation (GO:0034198),4/74,0.330861972537351,0.794460425453736,0,0,1.40076824583867,1.54932531013757,RHEB;ATP6V0E2;ATF4;ATP6V1F,GO_BP,turquoise,4
regulation of peptide hormone secretion (GO:0090276),4/74,0.330861972537351,0.794460425453736,0,0,1.40076824583867,1.54932531013757,KCNJ11;ENSA;ADRA2C;SSTR5,GO_BP,turquoise,4
calcium ion homeostasis (GO:0055074),5/97,0.332667224909776,0.794460425453736,0,0,1.33242753623188,1.46648655262468,STOML2;STC2;S100A14;PTH1R;TPT1,GO_BP,turquoise,5
double-strand break repair via homologous recombination (GO:0000724),5/97,0.332667224909776,0.794460425453736,0,0,1.33242753623188,1.46648655262468,BLM;PSMD14;FBH1;NABP2;AP5S1,GO_BP,turquoise,5
regulation of exocytosis (GO:0017157),3/52,0.334608048577941,0.794460425453736,0,0,1.50054804530508,1.64279315208594,RAB26;LGI3;STXBP6,GO_BP,turquoise,3
plasma membrane bounded cell projection morphogenesis (GO:0120039),3/52,0.334608048577941,0.794460425453736,0,0,1.50054804530508,1.64279315208594,NTF4;MYO16;PACSIN1,GO_BP,turquoise,3
protein homotetramerization (GO:0051289),3/52,0.334608048577941,0.794460425453736,0,0,1.50054804530508,1.64279315208594,AQP4;THG1L;GNMT,GO_BP,turquoise,3
response to amino acid starvation (GO:1990928),4/75,0.339840521986983,0.794460425453736,0,0,1.38096697985609,1.49044841854208,RHEB;ATP6V0E2;ATF4;ATP6V1F,GO_BP,turquoise,4
regulation of neuron apoptotic process (GO:0043523),5/98,0.340476958481489,0.794460425453736,0,0,1.31803143093466,1.42005737773328,NTF4;SET;DDIT3;MT3;ATF4,GO_BP,turquoise,5
regulation of DNA replication (GO:0006275),3/53,0.345451263808832,0.794460425453736,0,0,1.47046035805627,1.56295776353341,BLM;NPM2;FAF1,GO_BP,turquoise,3
cellular macromolecule catabolic process (GO:0044265),3/53,0.345451263808832,0.794460425453736,0,0,1.47046035805627,1.56295776353341,SUPV3L1;EXOSC7;SIAH2,GO_BP,turquoise,3
regulation of immune effector process (GO:0002697),3/53,0.345451263808832,0.794460425453736,0,0,1.47046035805627,1.56295776353341,CD81;SUSD4;CD59,GO_BP,turquoise,3
negative regulation of cysteine-type endopeptidase activity (GO:2000117),3/53,0.345451263808832,0.794460425453736,0,0,1.47046035805627,1.56295776353341,BEX3;SIAH2;MT3,GO_BP,turquoise,3
epithelium development (GO:0060429),6/122,0.346074551675842,0.794460425453736,0,0,1.26813775397282,1.34562231479276,FN3K;LGALS3;CBR1;DVL1;ALDOC;NKX2-5,GO_BP,turquoise,6
potassium ion transport (GO:0006813),6/122,0.346074551675842,0.794460425453736,0,0,1.26813775397282,1.34562231479276,KCNH2;KCNF1;KCNJ11;HPN;KCNN1;KCNN2,GO_BP,turquoise,6
positive regulation of stress-activated MAPK cascade (GO:0032874),5/99,0.348299917146575,0.794460425453736,0,0,1.30394162575014,1.37525593987878,SH3RF2;HAND2;ZNF622;TPD52L1;GADD45G,GO_BP,turquoise,5
establishment of protein localization to organelle (GO:0072594),4/76,0.348826581792522,0.794460425453736,0,0,1.36171574903969,1.43413231082022,IPO13;LRSAM1;PEX19;RAN,GO_BP,turquoise,4
"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",3/54,0.356277936580152,0.794460425453736,0,0,1.44155258011133,1.48774588127803,SMU1;FXR2;SAP18,GO_BP,turquoise,3
regulation of humoral immune response (GO:0002920),3/54,0.356277936580152,0.794460425453736,0,0,1.44155258011133,1.48774588127803,CD81;SUSD4;CD59,GO_BP,turquoise,3
regulation of potassium ion transmembrane transport (GO:1901379),3/54,0.356277936580152,0.794460425453736,0,0,1.44155258011133,1.48774588127803,KCNH2;KCNN1;KCNN2,GO_BP,turquoise,3
protein localization to membrane (GO:0072657),9/195,0.35798508328036,0.794460425453736,0,0,1.18654389757233,1.21889378324742,CACNB2;TMEM150A;PLEKHF1;CD81;ARL3;DVL1;CYP46A1;ANK1;PACSIN1,GO_BP,turquoise,9
positive regulation of intracellular protein transport (GO:0090316),7/148,0.362267338606874,0.794460425453736,0,0,1.21714160695728,1.23585252439068,PPP1R13B;CD81;ERBB2;EMD;OAZ2;BAP1;RAN,GO_BP,turquoise,7
epithelial cell differentiation (GO:0030855),5/101,0.363972123944303,0.794460425453736,0,0,1.27664262820513,1.29027461416588,FN3K;LGALS3;MESP1;CBR1;ALDOC,GO_BP,turquoise,5
protein modification process (GO:0036211),4/78,0.366801598258123,0.794460425453736,0,0,1.32477419801363,1.32866132570277,MMP15;UBE2D2;BAP1;GNMT,GO_BP,turquoise,4
negative regulation of apoptotic signaling pathway (GO:2001234),4/78,0.366801598258123,0.794460425453736,0,0,1.32477419801363,1.32866132570277,LGALS3;PSME3;SIAH2;HSPA1A,GO_BP,turquoise,4
triglyceride metabolic process (GO:0006641),3/55,0.367080225205359,0.794460425453736,0,0,1.41375663977966,1.41683135904856,FABP6;PLAAT3;PNPLA2,GO_BP,turquoise,3
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),3/55,0.367080225205359,0.794460425453736,0,0,1.41375663977966,1.41683135904856,BEX3;SIAH2;MT3,GO_BP,turquoise,3
negative regulation of protein modification by small protein conjugation or removal (GO:1903321),3/55,0.367080225205359,0.794460425453736,0,0,1.41375663977966,1.41683135904856,SH3RF2;HSPA1B;HSPA1A,GO_BP,turquoise,3
positive regulation of response to DNA damage stimulus (GO:2001022),3/55,0.367080225205359,0.794460425453736,0,0,1.41375663977966,1.41683135904856,BABAM2;FXR2;FBH1,GO_BP,turquoise,3
regulation of phosphorylation (GO:0042325),6/125,0.367161479857206,0.794460425453736,0,0,1.23597372196632,1.23838823134833,GLMN;TESK1;HSPB1;INHA;ROPN1;SIRT2,GO_BP,turquoise,6
regulation of protein catabolic process (GO:0042176),5/102,0.37181482163975,0.794460425453736,0,0,1.2634152788792,1.24997170638103,VCP;RAB26;FAF1;OAZ2;SIRT2,GO_BP,turquoise,5
mitotic sister chromatid segregation (GO:0000070),5/102,0.37181482163975,0.794460425453736,0,0,1.2634152788792,1.24997170638103,SET;AKAP8L;RRS1;TUBG2;RAN,GO_BP,turquoise,5
phosphatidylinositol biosynthetic process (GO:0006661),6/126,0.374205433342289,0.794460425453736,0,0,1.22560975609756,1.20471353303149,PYURF;TMEM150A;MTMR14;ITPKA;INPP5J;PI4KB,GO_BP,turquoise,6
protein-containing complex disassembly (GO:0032984),3/56,0.377850630744213,0.794460425453736,0,0,1.38700960285673,1.3499158594106,VCP;DVL1;VTI1B,GO_BP,turquoise,3
negative regulation of metabolic process (GO:0009892),3/56,0.377850630744213,0.794460425453736,0,0,1.38700960285673,1.3499158594106,RHEB;DDIT3;ATF4,GO_BP,turquoise,3
peptidyl-tyrosine modification (GO:0018212),3/56,0.377850630744213,0.794460425453736,0,0,1.38700960285673,1.3499158594106,TPST2;PKDCC;ERBB2,GO_BP,turquoise,3
regulation of cell cycle (GO:0051726),13/296,0.379173526587832,0.794460425453736,0,0,1.12651275197276,1.09244849885748,BEX2;HSP90AB1;PPP1R13B;YY1AP1;SIRT2;MAPK12;GADD45G;RNF167;TRNP1;NUPR2;APBB1;INHA;BAP1,GO_BP,turquoise,13
endomembrane system organization (GO:0010256),9/199,0.380338596700697,0.794460425453736,0,0,1.16131985892566,1.12264021859027,CTDNEP1;PLEKHF1;LMAN2L;TANGO2;COG2;TRAPPC12;TMED1;REEP6;A4GALT,GO_BP,turquoise,9
negative regulation of cell cycle (GO:0045786),4/80,0.384749031779368,0.794460425453736,0,0,1.28977693914684,1.23194852965753,RNF167;PPP1R13B;NUPR2;INHA,GO_BP,turquoise,4
cellular metal ion homeostasis (GO:0006875),5/104,0.387497480350166,0.794460425453736,0,0,1.23776223776224,1.17345545495223,STOML2;STC2;PTH1R;MT3;TPT1,GO_BP,turquoise,5
negative regulation of DNA recombination (GO:0045910),3/57,0.388581993975384,0.794460425453736,0,0,1.36125319693095,1.28672605283621,BLM;FBH1;POLR2K,GO_BP,turquoise,3
positive regulation of proteolysis (GO:0045862),3/57,0.388581993975384,0.794460425453736,0,0,1.36125319693095,1.28672605283621,TNIP1;BAK1;MAPK12,GO_BP,turquoise,3
inorganic cation transmembrane transport (GO:0098662),12/274,0.390603056867044,0.794460425453736,0,0,1.12299655352893,1.05568799703048,KCNH2;KCNF1;SLC6A8;SLC30A3;KCNJ11;HVCN1;HPN;KCNN1;KCNN2;ATP6V0E2;CACNA1G;ATP6V1F,GO_BP,turquoise,12
"mRNA splicing, via spliceosome (GO:0000398)",12/274,0.390603056867044,0.794460425453736,0,0,1.12299655352893,1.05568799703048,SMU1;RBM17;PPIL1;LSM6;GPKOW;SNRPD1;STRAP;SRSF4;RALY;CWC27;CTNNBL1;POLR2K,GO_BP,turquoise,12
positive regulation of cellular metabolic process (GO:0031325),5/105,0.395331260237839,0.794460425453736,0,0,1.22532051282051,1.13713570513723,CBR1;HPN;AGPAT1;MT3;AGT,GO_BP,turquoise,5
positive regulation of macromolecule biosynthetic process (GO:0010557),6/129,0.395349476048456,0.794460425453736,0,0,1.19552897711262,1.10943314403115,FXR2;NPM2;FAF1;ERBB2;RPS27L;LARP6,GO_BP,turquoise,6
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",11/251,0.397873392047045,0.794460425453736,0,0,1.12362726098191,1.03555896837926,SMU1;RBM17;PPIL1;LSM6;GPKOW;SNRPD1;SRSF4;RALY;CWC27;CTNNBL1;POLR2K,GO_BP,turquoise,11
regulation of neurotransmitter receptor activity (GO:0099601),3/58,0.39926749132461,0.794460425453736,0,0,1.33643338758428,1.22701114307854,LYNX1;CAMK2A;CAPN1,GO_BP,turquoise,3
negative regulation of hydrolase activity (GO:0051346),3/58,0.39926749132461,0.794460425453736,0,0,1.33643338758428,1.22701114307854,GPSM1;SH3RF2;CAMK2A,GO_BP,turquoise,3
negative regulation of neuron projection development (GO:0010977),3/58,0.39926749132461,0.794460425453736,0,0,1.33643338758428,1.22701114307854,EFNA1;FKBP4;MT3,GO_BP,turquoise,3
positive regulation of mitochondrion organization (GO:0010822),3/58,0.39926749132461,0.794460425453736,0,0,1.33643338758428,1.22701114307854,PDCD5;MUL1;BAK1,GO_BP,turquoise,3
positive regulation of protein binding (GO:0032092),3/58,0.39926749132461,0.794460425453736,0,0,1.33643338758428,1.22701114307854,AMFR;MARK3;RAN,GO_BP,turquoise,3
positive regulation of protein kinase activity (GO:0045860),7/154,0.400969019757238,0.794460425453736,0,0,1.16709511568123,1.06657451132131,EFNA1;XRCC6;HSP90AB1;MTCP1;CALM3;MAPRE3;AGT,GO_BP,turquoise,7
Golgi organization (GO:0007030),6/130,0.40239398285485,0.794460425453736,0,0,1.1858255000207,1.07948495410287,LMAN2L;TANGO2;TRAPPC12;COG2;TMED1;VTI1B,GO_BP,turquoise,6
regulation of G protein-coupled receptor signaling pathway (GO:0008277),4/82,0.402632987174188,0.794460425453736,0,0,1.25657441150399,1.14314323050634,GRK4;CAMK2A;GIT1;RGS6,GO_BP,turquoise,4
RNA export from nucleus (GO:0006405),5/106,0.403155995450204,0.794460425453736,0,0,1.21312515866971,1.10204135802695,SARNP;SRSF4;THOC5;SMG5;RAN,GO_BP,turquoise,5
protein localization to nucleus (GO:0034504),5/106,0.403155995450204,0.794460425453736,0,0,1.21312515866971,1.10204135802695,IPO13;CTDNEP1;DVL1;RRS1;RAN,GO_BP,turquoise,5
cell cycle G2/M phase transition (GO:0044839),6/131,0.409433044127701,0.798749353843603,0,0,1.17627727856226,1.05039431379859,ACTR1A;AKAP8L;ENSA;MNAT1;TPD52L1;TUBA4A,GO_BP,turquoise,6
regulation of secretion by cell (GO:1903530),3/59,0.409900630586425,0.798749353843603,0,0,1.3125,1.17054067342031,RAB26;LGI3;CAMK2A,GO_BP,turquoise,3
negative regulation of autophagy (GO:0010507),3/59,0.409900630586425,0.798749353843603,0,0,1.3125,1.17054067342031,QSOX1;MT3;SIRT2,GO_BP,turquoise,3
positive regulation of apoptotic signaling pathway (GO:2001235),3/59,0.409900630586425,0.798749353843603,0,0,1.3125,1.17054067342031,DDIT3;TPD52L1;AGT,GO_BP,turquoise,3
regulation of Notch signaling pathway (GO:0008593),4/83,0.411540529884678,0.798749353843603,0,0,1.24060357542262,1.10146711873443,ENHO;MESP1;RITA1;TM2D3,GO_BP,turquoise,4
regulation of cell differentiation (GO:0045595),7/156,0.413875311430566,0.798749353843603,0,0,1.15130863856731,1.01567357878819,NTF4;LGALS3;HSP90AB1;PLEKHB1;ST7;HOPX;ATF4,GO_BP,turquoise,7
negative regulation of cell population proliferation (GO:0008285),16/379,0.418745030811026,0.798749353843603,0,0,1.08054895807585,0.940610371840573,HPN;PDCD5;CTNNBIP1;GLMN;KDF1;FUZ;CGRRF1;SIRT2;MYO16;SSTR5;FABP6;NUPR2;EMD;BAP1;HSPA1B;HSPA1A,GO_BP,turquoise,16
cellular protein catabolic process (GO:0044257),3/60,0.420475245469176,0.798749353843603,0,0,1.28940638040113,1.11710258103011,PSMA6;CTSL;SIAH2,GO_BP,turquoise,3
RNA methylation (GO:0001510),3/60,0.420475245469176,0.798749353843603,0,0,1.28940638040113,1.11710258103011,TFB1M;MRM2;FTSJ3,GO_BP,turquoise,3
regulation of autophagy (GO:0010506),10/231,0.421564642145301,0.798749353843603,0,0,1.10897679170924,0.957914358719352,VPS29;PLEKHF1;RHEB;DDIT3;KEAP1;HSPB1;CAPN1;ATP6V0E2;MT3;SIRT2,GO_BP,turquoise,10
modulation of chemical synaptic transmission (GO:0050804),5/109,0.426547032687736,0.798749353843603,0,0,1.17794625246548,1.00364865784825,NTF4;PSMC5;GRIK5;CAMK2A;CEL,GO_BP,turquoise,5
negative regulation of programmed cell death (GO:0043069),16/381,0.427024969528137,0.798749353843603,0,0,1.07451413506244,0.91431782143777,HSPA5;SIAH2;GLO1;HPN;HSPB1;MT3;SUPV3L1;BABAM2;SH3RF2;ARHGAP10;PSMC5;COPS5;NKX2-5;HSPA1B;TPT1;HSPA1A,GO_BP,turquoise,16
G1/S transition of mitotic cell cycle (GO:0000082),4/85,0.429266674137541,0.798749353843603,0,0,1.20984492815479,1.02313795083946,CDK18;MAX;CAMK2A;MNAT1,GO_BP,turquoise,4
negative regulation of defense response (GO:0031348),4/85,0.429266674137541,0.798749353843603,0,0,1.20984492815479,1.02313795083946,ILRUN;MUL1;TRAFD1;SIRT2,GO_BP,turquoise,4
regulation of endocytosis (GO:0030100),3/61,0.430985490204976,0.800858925755633,0,0,1.26710909251257,1.06650146419037,LGALS3;LRSAM1;PACSIN1,GO_BP,turquoise,3
positive regulation of interleukin-8 production (GO:0032757),3/61,0.430985490204976,0.800858925755633,0,0,1.26710909251257,1.06650146419037,DDIT3;HSPA1B;HSPA1A,GO_BP,turquoise,3
positive regulation of cell differentiation (GO:0045597),11/258,0.433154980262596,0.804347169826358,0,0,1.09138080741508,0.913114331205918,PKDCC;HSP90AB1;GPC1;CARM1;CTNNBIP1;GATA5;PLA2G5;NKX2-5;ADRA2C;AGT;MAPK12,GO_BP,turquoise,11
mitotic cell cycle phase transition (GO:0044772),9/209,0.436473600002137,0.805786762275157,0,0,1.10267396907217,0.914146918880743,ACTR1A;CCND3;MAX;ENSA;CAMK2A;MNAT1;TPD52L1;TUBA4A;CCNJL,GO_BP,turquoise,9
double-strand break repair via nonhomologous end joining (GO:0006303),3/62,0.441425833439311,0.805786762275157,0,0,1.24556764489141,1.01855703852803,BABAM2;XRCC6;PSMD14,GO_BP,turquoise,3
positive regulation of cysteine-type endopeptidase activity (GO:2001056),3/62,0.441425833439311,0.805786762275157,0,0,1.24556764489141,1.01855703852803,PDCD5;BAK1;CTSD,GO_BP,turquoise,3
cellular divalent inorganic cation homeostasis (GO:0072503),5/111,0.442044076829331,0.805786762275157,0,0,1.15559990324141,0.943368989446981,STOML2;STC2;PTH1R;MT3;TPT1,GO_BP,turquoise,5
protein localization to plasma membrane (GO:0072659),6/136,0.44447258748818,0.805786762275157,0,0,1.13073960699121,0.916879315726614,CACNB2;PLEKHF1;TMEM150A;CD81;ANK1;PACSIN1,GO_BP,turquoise,6
cellular calcium ion homeostasis (GO:0006874),6/136,0.44447258748818,0.805786762275157,0,0,1.13073960699121,0.916879315726614,STOML2;TMEM178A;STC2;PTH1R;BAK1;TPT1,GO_BP,turquoise,6
ribonucleoprotein complex assembly (GO:0022618),6/136,0.44447258748818,0.805786762275157,0,0,1.13073960699121,0.916879315726614,HSP90AB1;SNRPD1;RRS1;STRAP;RPS27L;RPL3L,GO_BP,turquoise,6
protein targeting to membrane (GO:0006612),4/87,0.446849066285568,0.805786762275157,0,0,1.1805686253336,0.95098864009889,ZDHHC18;PEX19;ABCD1;ZDHHC14,GO_BP,turquoise,4
regulation of macroautophagy (GO:0016241),5/112,0.449755578762077,0.805786762275157,0,0,1.14473999520729,0.914705640300796,GPSM1;RHEB;QSOX1;CAPN1;ATP6V0E2,GO_BP,turquoise,5
phosphatidylinositol metabolic process (GO:0046488),5/112,0.449755578762077,0.805786762275157,0,0,1.14473999520729,0.914705640300796,MTMR14;INPP5J;PLAAT3;PLA2G5;PI4KB,GO_BP,turquoise,5
cell cycle G1/S phase transition (GO:0044843),3/63,0.451791051668084,0.805786762275157,0,0,1.2247442455243,0.97310275834526,MAX;CAMK2A;MNAT1,GO_BP,turquoise,3
cellular response to reactive oxygen species (GO:0034614),3/63,0.451791051668084,0.805786762275157,0,0,1.2247442455243,0.97310275834526,OSER1;TPM1;MPV17,GO_BP,turquoise,3
organonitrogen compound catabolic process (GO:1901565),3/63,0.451791051668084,0.805786762275157,0,0,1.2247442455243,0.97310275834526,LRSAM1;RIDA;PLA2G5,GO_BP,turquoise,3
regulation of cilium assembly (GO:1902017),3/64,0.462076222514366,0.810064585773609,0,0,1.20460358056266,0.929984582460535,TESK1;FUZ;TBC1D10B,GO_BP,turquoise,3
regulation of innate immune response (GO:0045088),3/64,0.462076222514366,0.810064585773609,0,0,1.20460358056266,0.929984582460535,HSP90AB1;MUL1;TRAFD1,GO_BP,turquoise,3
lipid homeostasis (GO:0055088),3/64,0.462076222514366,0.810064585773609,0,0,1.20460358056266,0.929984582460535,ABHD4;ABCD1;PNPLA2,GO_BP,turquoise,3
plasma membrane organization (GO:0007009),3/64,0.462076222514366,0.810064585773609,0,0,1.20460358056266,0.929984582460535,A4GALT;ABCD1;PACSIN1,GO_BP,turquoise,3
regulation of type I interferon production (GO:0032479),4/89,0.464259427187498,0.810064585773609,0,0,1.15267003088047,0.884457284712235,ILRUN;XRCC6;UFD1;POLR2K,GO_BP,turquoise,4
protein import (GO:0017038),4/89,0.464259427187498,0.810064585773609,0,0,1.15267003088047,0.884457284712235,IPO13;PEX19;ABCD1;RAN,GO_BP,turquoise,4
histone modification (GO:0016570),5/114,0.465092062443622,0.810064585773609,0,0,1.12361797224183,0.860151928132403,CARM1;HDAC11;RUVBL1;MT3;SIRT2,GO_BP,turquoise,5
positive regulation of cellular component organization (GO:0051130),5/114,0.465092062443622,0.810064585773609,0,0,1.12361797224183,0.860151928132403,LGALS3;VCP;FAF1;BAK1;RHOC,GO_BP,turquoise,5
potassium ion transmembrane transport (GO:0071805),6/139,0.465299280865545,0.810064585773609,0,0,1.10506046888724,0.845453547757355,KCNH2;KCNF1;KCNJ11;HPN;KCNN1;KCNN2,GO_BP,turquoise,6
chemical homeostasis (GO:0048878),3/65,0.472276717485275,0.810064585773609,0,0,1.18511261447075,0.889059868471959,ABHD4;AQP4;PNPLA2,GO_BP,turquoise,3
tRNA modification (GO:0006400),3/65,0.472276717485275,0.810064585773609,0,0,1.18511261447075,0.889059868471959,AARS1;TPRKB;THG1L,GO_BP,turquoise,3
mitotic G1 DNA damage checkpoint signaling (GO:0031571),3/65,0.472276717485275,0.810064585773609,0,0,1.18511261447075,0.889059868471959,CARM1;RPS27L;FBXO31,GO_BP,turquoise,3
protein complex oligomerization (GO:0051259),4/90,0.472891854980336,0.810064585773609,0,0,1.13920733704553,0.85313933424882,BLM;STOML2;CUTC;JMJD6,GO_BP,turquoise,4
regulation of protein phosphorylation (GO:0001932),11/266,0.47332262133865,0.810064585773609,0,0,1.05669554643563,0.790385072455122,EFNA1;CCND3;FXR2;FBH1;AKAP8L;ERBB2;TESK1;HSPB1;MT3;ROPN1;ATF4,GO_BP,turquoise,11
membrane organization (GO:0061024),10/242,0.479641516121276,0.819464390492697,0,0,1.05578420467186,0.775701859724183,CTDNEP1;MTCH1;CHRNB1;SH3KBP1;ARPC1A;EPS15L1;A4GALT;EMD;EPN1;VTI1B,GO_BP,turquoise,10
toll-like receptor signaling pathway (GO:0002224),4/91,0.481471655983728,0.819464390492697,0,0,1.12605413042518,0.823041877270088,TNIP1;CTSL;UBE2D2;S100A14,GO_BP,turquoise,4
cellular response to nutrient levels (GO:0031669),3/66,0.4823881949848,0.819464390492697,0,0,1.16624040920716,0.850196378551586,STK24;MARS1;NUPR2,GO_BP,turquoise,3
positive regulation of cell cycle (GO:0045787),3/66,0.4823881949848,0.819464390492697,0,0,1.16624040920716,0.850196378551586,CCND3;USP2;MAPRE3,GO_BP,turquoise,3
transcription by RNA polymerase II (GO:0006366),13/320,0.489554968918122,0.819499068187438,0,0,1.03713017501814,0.740779071388411,BTF3;TEAD4;INTS12;ADRM1;GTF2E2;LSM10;SNAPC1;NABP2;PIR;INTS9;MNAT1;POLR2K;ATF4,GO_BP,turquoise,13
Wnt signaling pathway (GO:0016055),4/92,0.489995903450472,0.819499068187438,0,0,1.11319986031894,0.794110302273164,VPS29;WNT6;PORCN;DVL1,GO_BP,turquoise,4
transcription elongation from RNA polymerase II promoter (GO:0006368),3/67,0.492406592335056,0.819499068187438,0,0,1.14795796035806,0.813271387081438,ADRM1;MNAT1;POLR2K,GO_BP,turquoise,3
regulation of programmed cell death (GO:0043067),8/194,0.494265365731843,0.819499068187438,0,0,1.05334827915473,0.7422763393393,BEX2;PSMC5;VCP;PPP1R13B;APEX1;OSGIN1;AGT;TPT1,GO_BP,turquoise,8
regulation of protein binding (GO:0043393),5/118,0.495353731038211,0.819731489968224,0,0,1.0836169729975,0.761222679177039,AMFR;CTNNBIP1;DVL1;MARK3;RAN,GO_BP,turquoise,5
canonical Wnt signaling pathway (GO:0060070),3/68,0.502328118595436,0.82105914647605,0,0,1.13023804839662,0.77817087436042,WNT6;PORCN;DVL1,GO_BP,turquoise,3
regulation of myeloid cell differentiation (GO:0045637),3/68,0.502328118595436,0.82105914647605,0,0,1.13023804839662,0.77817087436042,LGALS3;ITGA2B;MYL9,GO_BP,turquoise,3
cellular response to decreased oxygen levels (GO:0036294),3/69,0.5121492462391,0.82105914647605,0,0,1.11305510346431,0.744788801330813,SUV39H1;MT3;SIRT2,GO_BP,turquoise,3
"DNA-templated transcription, elongation (GO:0006354)",3/69,0.5121492462391,0.82105914647605,0,0,1.11305510346431,0.744788801330813,ADRM1;MNAT1;POLR2K,GO_BP,turquoise,3
protein homooligomerization (GO:0051260),5/121,0.517622593506306,0.821991524459267,0,0,1.05542661361627,0.69500780383375,BLM;AQP4;THG1L;JMJD6;GNMT,GO_BP,turquoise,5
rRNA processing (GO:0006364),7/173,0.521525769937874,0.821991524459267,0,0,1.03248211354415,0.672142335909748,EXOSC7;NOP58;LSM6;DDX10;RRP12;TFB1M;MRM2,GO_BP,turquoise,7
COPII-coated vesicle budding (GO:0090114),3/70,0.521866703715383,0.821991524459267,0,0,1.09638508226133,0.713026451895072,COL7A1;SCAP;CD59,GO_BP,turquoise,3
"DNA-templated transcription, termination (GO:0006353)",3/70,0.521866703715383,0.821991524459267,0,0,1.09638508226133,0.713026451895072,LSM10;MNAT1;POLR2K,GO_BP,turquoise,3
positive regulation of gene expression (GO:0010628),19/482,0.52576124261918,0.821991524459267,0,0,1.00459597696936,0.645862871395905,MYLK2;HPN;PDCD5;GLMN;GATA5;RPS27L;AGPAT1;MT3;LARP6;AGT;WNT6;FXR2;ACTC1;HAND2;ERBB2;HSPA1B;POLR2K;ATF4;HSPA1A,GO_BP,turquoise,19
positive regulation of transferase activity (GO:0051347),6/148,0.526338420953221,0.821991524459267,0,0,1.03453325860167,0.663974708629748,HSP90AB1;DCUN1D5;TCP1;ERBB2;DBI;ZNF622,GO_BP,turquoise,6
myeloid leukocyte differentiation (GO:0002573),3/71,0.531477467195071,0.821991524459267,0,0,1.08020535579961,0.682791839253901,GLO1;PIR;THOC5,GO_BP,turquoise,3
negative regulation of neuron apoptotic process (GO:0043524),3/71,0.531477467195071,0.821991524459267,0,0,1.08020535579961,0.682791839253901,NTF4;SET;MT3,GO_BP,turquoise,3
positive regulation of cellular protein localization (GO:1903829),3/71,0.531477467195071,0.821991524459267,0,0,1.08020535579961,0.682791839253901,HSP90AB1;TESK1;TRAPPC12,GO_BP,turquoise,3
positive regulation of cold-induced thermogenesis (GO:0120162),4/97,0.5316905541789,0.821991524459267,0,0,1.05307504853166,0.665220793698821,CPT2;GNAS;PEMT;GADD45G,GO_BP,turquoise,4
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),4/98,0.539827298558969,0.827571872142462,0,0,1.04181763696298,0.642286832490261,DCTN5;ACTR1A;CTSL;CTSD,GO_BP,turquoise,4
regulation of peptidyl-serine phosphorylation (GO:0033135),4/98,0.539827298558969,0.827571872142462,0,0,1.04181763696298,0.642286832490261,NTF4;HSP90AB1;INPP5J;MTCP1,GO_BP,turquoise,4
RNA splicing (GO:0008380),4/98,0.539827298558969,0.827571872142462,0,0,1.04181763696298,0.642286832490261,SMU1;LSM6;SNRPD1;SRSF4,GO_BP,turquoise,4
negative regulation of neuron death (GO:1901215),4/98,0.539827298558969,0.827571872142462,0,0,1.04181763696298,0.642286832490261,NTF4;SET;MT3;ATF4,GO_BP,turquoise,4
cell junction organization (GO:0034330),3/72,0.54097875270608,0.827571872142462,0,0,1.06449460691649,0.653999166879137,FBLIM1;DVL1;LIMS2,GO_BP,turquoise,3
cell morphogenesis involved in differentiation (GO:0000904),3/72,0.54097875270608,0.827571872142462,0,0,1.06449460691649,0.653999166879137,EFNA1;PARVB;ATF4,GO_BP,turquoise,3
cytoskeleton-dependent cytokinesis (GO:0061640),3/72,0.54097875270608,0.827571872142462,0,0,1.06449460691649,0.653999166879137,ARL3;STAMBP;RHOC,GO_BP,turquoise,3
extrinsic apoptotic signaling pathway (GO:0097191),3/72,0.54097875270608,0.827571872142462,0,0,1.06449460691649,0.653999166879137,BLOC1S2;BAK1;DEDD,GO_BP,turquoise,3
regulation of protein secretion (GO:0050708),5/125,0.546646932102456,0.827571872142462,0,0,1.02003205128205,0.616050547682741,KCNJ11;ENSA;APBB1;ADRA2C;SSTR5,GO_BP,turquoise,5
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),4/99,0.547891604906466,0.827571872142462,0,0,1.03079722353258,0.620207818962342,SARNP;SRSF4;THOC5;SMG5,GO_BP,turquoise,4
regulation of actin filament-based process (GO:0032970),3/73,0.550368008239844,0.827571872142462,0,0,1.04923273657289,0.626568339290115,TESK1;RND2;RHOC,GO_BP,turquoise,3
actin filament organization (GO:0007015),6/152,0.552555684086453,0.828682965997776,0,0,1.00597886296094,0.596747732867799,ACTC1;TPM2;TPM1;CORO6;RND2;RHOC,GO_BP,turquoise,6
negative regulation of protein phosphorylation (GO:0001933),6/152,0.552555684086453,0.828682965997776,0,0,1.00597886296094,0.596747732867799,DVL1;TESK1;INPP5J;HSPB1;CALM3;SIRT2,GO_BP,turquoise,6
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),4/100,0.5558815530428,0.830502732884791,0,0,1.02000640204866,0.598947801635906,DCTN5;ACTR1A;CTSL;CTSD,GO_BP,turquoise,4
RNA processing (GO:0006396),7/179,0.557845180681863,0.832984230730595,0,0,0.996151431816823,0.581427500622504,SMU1;LSM6;RBPMS;SNRPD1;AKAP8L;SRSF4;TSEN2,GO_BP,turquoise,7
proteolysis involved in cellular protein catabolic process (GO:0051603),3/74,0.559642905600121,0.834762751334165,0,0,1.03440077806995,0.600424517889298,PSMA6;VCP;CTSL,GO_BP,turquoise,3
regulation of stress fiber assembly (GO:0051492),3/74,0.559642905600121,0.834762751334165,0,0,1.03440077806995,0.600424517889298,TPM1;TESK1;RHOC,GO_BP,turquoise,3
positive regulation of cell cycle process (GO:0090068),4/101,0.563795339269926,0.834914011054547,0,0,1.00943807172935,0.578472585799329,NPM2;SOX15;SIRT2;SSTR5,GO_BP,turquoise,4
microtubule cytoskeleton organization involved in mitosis (GO:1902850),5/128,0.567856956484031,0.834914011054547,0,0,0.994996873045654,0.563054531008687,WDR62;TUBG2;RANGAP1;RAN;SPC24,GO_BP,turquoise,5
positive regulation of cell growth (GO:0030307),4/102,0.571631274057902,0.838555045952744,0,0,0.999085421620633,0.558749633105861,SUPV3L1;CPNE5;HPN;ERBB2,GO_BP,turquoise,4
cellular response to insulin stimulus (GO:0032869),5/129,0.574812899164912,0.840144794304392,0,0,0.986921009098429,0.54646870689643,GRB14;MARS1;AP3S1;ATP6V0E2;ATP6V1F,GO_BP,turquoise,5
actomyosin structure organization (GO:0031032),3/76,0.577841385048702,0.840144794304392,0,0,1.00595592614652,0.551722430947098,ACTC1;TPM1;MYH14,GO_BP,turquoise,3
regulation of RNA splicing (GO:0043484),3/76,0.577841385048702,0.840144794304392,0,0,1.00595592614652,0.551722430947098,RBM38;JMJD6;HSPA1A,GO_BP,turquoise,3
RNA transport (GO:0050658),3/76,0.577841385048702,0.840144794304392,0,0,1.00595592614652,0.551722430947098,SARNP;SRSF4;THOC5,GO_BP,turquoise,3
positive regulation of growth (GO:0045927),3/76,0.577841385048702,0.840144794304392,0,0,1.00595592614652,0.551722430947098,SUPV3L1;HPN;ERBB2,GO_BP,turquoise,3
regulation of signal transduction by p53 class mediator (GO:1901796),6/156,0.578091324092097,0.840144794304392,0,0,0.978947368421053,0.536486087417846,BLM;PPP1R13B;MAPKAP1;USP2;RRS1;RBBP7,GO_BP,turquoise,6
antigen processing and presentation of exogenous peptide antigen (GO:0002478),4/103,0.579387779401733,0.840144794304392,0,0,0.988941915958561,0.539747968243933,DCTN5;ACTR1A;CTSL;CTSD,GO_BP,turquoise,4
G2/M transition of mitotic cell cycle (GO:0000086),5/130,0.581709651633835,0.840144794304392,0,0,0.978974358974359,0.530392483636078,ACTR1A;ENSA;MNAT1;TPD52L1;TUBA4A,GO_BP,turquoise,5
mitotic spindle organization (GO:0007052),6/157,0.58436030792917,0.840144794304392,0,0,0.972413265436245,0.522416891883735,VCP;WDR62;TUBG2;RANGAP1;RAN;SPC24,GO_BP,turquoise,6
regulation of organelle assembly (GO:1902115),3/77,0.586761359140688,0.840144794304392,0,0,0.992310085021082,0.529037306160799,KIF9;TRAPPC12;TBC1D10B,GO_BP,turquoise,3
import into nucleus (GO:0051170),3/77,0.586761359140688,0.840144794304392,0,0,0.992310085021082,0.529037306160799,IPO13;SNRPD1;RAN,GO_BP,turquoise,3
negative regulation of developmental process (GO:0051093),3/77,0.586761359140688,0.840144794304392,0,0,0.992310085021082,0.529037306160799,MUL1;FUZ;HOPX,GO_BP,turquoise,3
positive regulation of protein modification by small protein conjugation or removal (GO:1903322),3/77,0.586761359140688,0.840144794304392,0,0,0.992310085021082,0.529037306160799,DCUN1D5;TNIP1;MUL1,GO_BP,turquoise,3
regulation of insulin secretion (GO:0050796),4/104,0.587063386427088,0.840144794304392,0,0,0.979001280409731,0.521438091159932,KCNJ11;ENSA;ADRA2C;SSTR5,GO_BP,turquoise,4
mRNA transport (GO:0051028),4/104,0.587063386427088,0.840144794304392,0,0,0.979001280409731,0.521438091159932,SARNP;SRSF4;THOC5;SMG5,GO_BP,turquoise,4
cellular response to growth factor stimulus (GO:0071363),6/158,0.590581303711995,0.842987421066084,0,0,0.96596513749071,0.508723575469978,PDCD5;MARS1;ERBB2;HSPB1;EMD;SIRT2,GO_BP,turquoise,6
skeletal system development (GO:0001501),6/158,0.590581303711995,0.842987421066084,0,0,0.96596513749071,0.508723575469978,TEAD4;PKDCC;GNAS;UFD1;PTH1R;INHA,GO_BP,turquoise,6
organonitrogen compound biosynthetic process (GO:1901566),6/158,0.590581303711995,0.842987421066084,0,0,0.96596513749071,0.508723575469978,GSTM4;TNIP1;SLC44A2;PEMT;CHPT1;INHA,GO_BP,turquoise,6
nucleotide-excision repair (GO:0006289),4/105,0.594656733013818,0.843769030217144,0,0,0.969257489129195,0.503791894858749,COPS4;COPS5;MNAT1;POLR2K,GO_BP,turquoise,4
negative regulation of protein serine/threonine kinase activity (GO:0071901),3/78,0.595559743543668,0.843769030217144,0,0,0.979028132992327,0.507384825257974,TESK1;PKIG;AGT,GO_BP,turquoise,3
small GTPase mediated signal transduction (GO:0007264),4/106,0.602166560809037,0.843769030217144,0,0,0.959704752579649,0.486782589394112,RRAD;RHEB;ARL3;SIAH2,GO_BP,turquoise,4
peptidyl-lysine modification (GO:0018205),4/106,0.602166560809037,0.843769030217144,0,0,0.959704752579649,0.486782589394112,SUMO3;RANGAP1;METTL21A;SIRT2,GO_BP,turquoise,4
axonogenesis (GO:0007409),9/240,0.602877131575456,0.844334791906185,0,0,0.953139643861293,0.482328562904285,EFNA1;HSP90AB1;SH3KBP1;FEZ1;GPC1;SEMA4B;FEZ2;APBB1;LGR6,GO_BP,turquoise,9
regulation of neuron differentiation (GO:0045664),3/79,0.604235211988207,0.845376361663215,0,0,0.966095706016961,0.486711030008638,NTF4;ADRA2C;NKX2-5,GO_BP,turquoise,3
mRNA 3'-end processing (GO:0031124),3/79,0.604235211988207,0.845376361663215,0,0,0.966095706016961,0.486711030008638,SARNP;SRSF4;THOC5,GO_BP,turquoise,3
negative regulation of signal transduction (GO:0009968),10/267,0.605154046669054,0.846231675016889,0,0,0.951826283419104,0.478075910677145,TMEM25;VCP;GRB14;CREB3L1;SIAH2;GPC1;CTNNBIP1;ERBB2;RITA1;AGT,GO_BP,turquoise,10
positive regulation of protein modification process (GO:0031401),8/214,0.605963853623389,0.846933735485814,0,0,0.950081843285727,0.475929193230666,EFNA1;CCND3;FXR2;FBH1;ERBB2;TESK1;CALM3;MT3,GO_BP,turquoise,8
mRNA export from nucleus (GO:0006406),4/107,0.609591712882573,0.85123083634993,0,0,0.950337506060192,0.470384629582492,SARNP;SRSF4;THOC5;SMG5,GO_BP,turquoise,4
regulation of protein localization to plasma membrane (GO:1903076),3/80,0.61278661535609,0.85123083634993,0,0,0.953499186235759,0.466965263674658,LGALS3;ARHGEF16;VTI1B,GO_BP,turquoise,3
negative regulation of cellular response to growth factor stimulus (GO:0090288),3/80,0.61278661535609,0.85123083634993,0,0,0.953499186235759,0.466965263674658,CREB3L1;GPC1;AGT,GO_BP,turquoise,3
extracellular structure organization (GO:0043062),8/216,0.616439260510367,0.85123083634993,0,0,0.940847440847441,0.455177743324484,MMP11;ADAMTSL4;MMP15;COL7A1;COL23A1;ITGA2B;ST7;ITGA7,GO_BP,turquoise,8
regulation of interleukin-8 production (GO:0032677),3/81,0.621212974808029,0.853973549391821,0,0,0.941225654141255,0.448099934185775,DDIT3;HSPA1B;HSPA1A,GO_BP,turquoise,3
negative regulation of protein modification process (GO:0031400),3/81,0.621212974808029,0.853973549391821,0,0,0.941225654141255,0.448099934185775,ENSA;DBI;SNTA1,GO_BP,turquoise,3
external encapsulating structure organization (GO:0045229),8/217,0.621621684610683,0.853973549391821,0,0,0.936296515243884,0.445137455623554,MMP11;ADAMTSL4;MMP15;COL7A1;COL23A1;ITGA2B;ST7;ITGA7,GO_BP,turquoise,8
regulation of nucleic acid-templated transcription (GO:1903506),16/430,0.622707521209587,0.853973549391821,0,0,0.944874766777859,0.447566709894649,HES6;IGSF1;GLRX2;YY1AP1;PTP4A3;HINT1;SOX15;DDIT3;CARM1;GPBP1;ZNF219;DVL1;RALY;APBB1;SLC2A4RG;ATF4,GO_BP,turquoise,16
regulation of protein ubiquitination (GO:0031396),4/109,0.624183853458613,0.853973549391821,0,0,0.93213828425096,0.439326390291052,SH3RF2;HSP90AB1;HSPA1B;HSPA1A,GO_BP,turquoise,4
"regulation of gene expression, epigenetic (GO:0040029)",3/82,0.629513474272291,0.853973549391821,0,0,0.929262844378258,0.430070298000312,GLMN;RBBP7;POLR2K,GO_BP,turquoise,3
ephrin receptor signaling pathway (GO:0048013),3/82,0.629513474272291,0.853973549391821,0,0,0.929262844378258,0.430070298000312,EFNA1;ARPC1A;GIT1,GO_BP,turquoise,3
negative regulation of apoptotic process (GO:0043066),18/485,0.6304334127557,0.853973549391821,0,0,0.942139485020478,0.43465392159036,BEX3;SET;HSPA5;GLO1;SIAH2;HPN;HSPB1;MT3;NTF4;SUPV3L1;BABAM2;SH3RF2;ARHGAP10;COPS5;NKX2-5;HSPA1B;TPT1;HSPA1A,GO_BP,turquoise,18
regulation of protein kinase activity (GO:0045859),4/110,0.631349010927073,0.853973549391821,0,0,0.923296209504023,0.424620659850723,XRCC6;DVL1;HSPB1;MAPRE3,GO_BP,turquoise,4
glycoprotein biosynthetic process (GO:0009101),3/83,0.63768745316023,0.860252877988702,0,0,0.917599104859335,0.412834261386779,TNIP1;GAL3ST3;DDOST,GO_BP,turquoise,3
regulation of cellular component organization (GO:0051128),5/139,0.640941311839718,0.86333973396933,0,0,0.91279181017987,0.406025664634609,DCUN1D5;CHPT1;BAP1;AGT;PACSIN1,GO_BP,turquoise,5
regulation of cytoskeleton organization (GO:0051493),4/112,0.645413606871168,0.86333973396933,0,0,0.906103286384976,0.396749933944666,TESK1;CDK2AP2;RND2;RHOC,GO_BP,turquoise,4
regulation of cytokinesis (GO:0032465),3/84,0.64573439968706,0.86333973396933,0,0,0.906223358908781,0.396352197016207,CALM3;GIT1;SSTR5,GO_BP,turquoise,3
neuron projection morphogenesis (GO:0048812),5/140,0.647191086910875,0.86333973396933,0,0,0.905982905982906,0.394205560861677,NTF4;DVL1;APBB1;MYO16;PACSIN1,GO_BP,turquoise,5
negative regulation of nucleic acid-templated transcription (GO:1903507),17/464,0.649540150203868,0.866053533605158,0,0,0.929390380313199,0.401023238566724,MESP1;TSC22D4;XRCC6;SET;MTERF3;MSX2;SUV39H1;PBXIP1;MT3;SIRT2;CREB3L1;DDIT3;ZNF219;NACC1;SAP18;NKX2-5;BAP1,GO_BP,turquoise,17
DNA metabolic process (GO:0006259),10/277,0.651083114201994,0.866576850263799,0,0,0.915694092062341,0.392940792983049,SUPV3L1;XRCC6;BLM;VCP;APEX1;UBE2T;NABP2;GLRX2;MNAT1;RAN,GO_BP,turquoise,10
positive regulation of cellular catabolic process (GO:0031331),5/141,0.653371999830081,0.868413652194653,0,0,0.899274132730015,0.382738835010135,SUPV3L1;PLEKHF1;FAF1;ABCD1;PNPLA2,GO_BP,turquoise,5
positive regulation of protein catabolic process (GO:0045732),3/85,0.653653943971174,0.868413652194653,0,0,0.895125070176533,0.380586775665768,VCP;FAF1;OAZ2,GO_BP,turquoise,3
peptidyl-serine modification (GO:0018209),6/169,0.655609793772574,0.868413652194653,0,0,0.9002575269537,0.380079269399544,HIPK4;SBK1;GALNT16;CAMK2A;MARK3;MAPK12,GO_BP,turquoise,6
positive regulation of kinase activity (GO:0033674),4/114,0.659119733310181,0.868413652194653,0,0,0.88953556047026,0.370802962063749,XRCC6;ERBB2;MAPRE3;ZNF622,GO_BP,turquoise,4
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),20/547,0.660219016383648,0.868413652194653,0,0,0.92708759658196,0.384911617784721,MESP1;TSC22D4;XRCC6;SET;MTERF3;MSX2;SUV39H1;PBXIP1;DBI;MT3;SIRT2;RIDA;FXR2;CREB3L1;DDIT3;ZNF219;NACC1;SAP18;NKX2-5;BAP1,GO_BP,turquoise,20
positive regulation of signal transduction (GO:0009967),9/252,0.660513770008088,0.868413652194653,0,0,0.905498281786942,0.375543919227599,ENHO;MESP1;TM2D3;BAK1;LGR6;AGPAT1;TPD52L1;MT3;LIMS2,GO_BP,turquoise,9
negative regulation of cellular amide metabolic process (GO:0034249),3/86,0.661445851162534,0.868413652194653,0,0,0.884294210088436,0.365502811303947,RTN3;RIDA;FXR2,GO_BP,turquoise,3
negative regulation of phosphorylation (GO:0042326),3/86,0.661445851162534,0.868413652194653,0,0,0.884294210088436,0.365502811303947,TESK1;INHA;GIT1,GO_BP,turquoise,3
regulation of signal transduction (GO:0009966),7/198,0.663642983922937,0.868413652194653,0,0,0.896162801652781,0.367436560692009,MTCH1;GRK4;AMFR;FUZ;GLRX2;GIT1;RGS6,GO_BP,turquoise,7
positive regulation of phosphorylation (GO:0042327),9/253,0.66509198782596,0.868413652194653,0,0,0.90173969072165,0.367756426229758,EFNA1;CCND3;FXR2;FBH1;GLMN;ERBB2;TESK1;ZNF622;MT3,GO_BP,turquoise,9
receptor-mediated endocytosis (GO:0006898),5/143,0.665525177890399,0.868413652194653,0,0,0.886148272017837,0.360820797837414,CD81;GRK4;CTSL;HPR;PI4KB,GO_BP,turquoise,5
nitrogen compound transport (GO:0071705),5/143,0.665525177890399,0.868413652194653,0,0,0.886148272017837,0.360820797837414,SLC6A8;ABCB6;LMAN2L;SLC44A2;SLC16A10,GO_BP,turquoise,5
calcium ion transport (GO:0006816),4/115,0.665837113552973,0.868413652194653,0,0,0.881475585700938,0.358505122861866,CACNB2;CAMK2A;TPT1;CACNA1G,GO_BP,turquoise,4
calcium ion transmembrane transport (GO:0070588),3/87,0.669110015176704,0.868413652194653,0,0,0.873721227621483,0.351067117608878,STOML2;SLC25A23;CACNA1G,GO_BP,turquoise,3
"retrograde transport, endosome to Golgi (GO:0042147)",3/88,0.676646452348117,0.870561494559148,0,0,0.863397021212577,0.337248375839255,VPS29;TBC1D10B;VTI1B,GO_BP,turquoise,3
metal ion transport (GO:0030001),3/88,0.676646452348117,0.870561494559148,0,0,0.863397021212577,0.337248375839255,CAMK2A;MT3;TPT1,GO_BP,turquoise,3
regulation of cation channel activity (GO:2001257),3/89,0.684055295017436,0.87385628246533,0,0,0.853312912627134,0.324017013031467,CACNB2;CAMK2A;CAPN1,GO_BP,turquoise,3
collagen fibril organization (GO:0030199),3/89,0.684055295017436,0.87385628246533,0,0,0.853312912627134,0.324017013031467,COL7A1;COL23A1;TLL2,GO_BP,turquoise,3
positive regulation of inflammatory response (GO:0050729),3/89,0.684055295017436,0.87385628246533,0,0,0.853312912627134,0.324017013031467,TNIP1;CD81;AGT,GO_BP,turquoise,3
adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),4/118,0.685442356032536,0.87385628246533,0,0,0.858144079789743,0.324113187439082,ADGRB2;GNAS;PTH1R;ADRA2C,GO_BP,turquoise,4
negative regulation of response to external stimulus (GO:0032102),4/118,0.685442356032536,0.87385628246533,0,0,0.858144079789743,0.324113187439082,ILRUN;MUL1;TRAFD1;SIRT2,GO_BP,turquoise,4
axon guidance (GO:0007411),7/203,0.688758002269446,0.875097886539943,0,0,0.873071979434447,0.325538245570504,EFNA1;SH3KBP1;FEZ1;GPC1;SEMA4B;FEZ2;LGR6,GO_BP,turquoise,7
negative regulation of protein kinase activity (GO:0006469),3/90,0.691336785853081,0.876533327804817,0,0,0.843460622629862,0.311345088642098,DVL1;TESK1;HSPB1,GO_BP,turquoise,3
regulation of actin cytoskeleton organization (GO:0032956),3/91,0.698491271781368,0.876533327804817,0,0,0.833832248314346,0.299206190310637,TESK1;RND2;RHOC,GO_BP,turquoise,3
sensory perception of sound (GO:0007605),3/91,0.698491271781368,0.876533327804817,0,0,0.833832248314346,0.299206190310637,HPN;MYH14;CRYM,GO_BP,turquoise,3
positive regulation of hydrolase activity (GO:0051345),5/149,0.70028762975691,0.876918895799445,0,0,0.848958333333333,0.302453400912449,ERBB2;CALM3;RHOC;RGS6;MAPK12,GO_BP,turquoise,5
cellular component assembly (GO:0022607),9/261,0.700387984363074,0.876918895799445,0,0,0.872744845360825,0.310802622295207,RTN3;FBLIM1;DVL1;QSOX1;PARVB;NDUFAF1;MNAT1;SH3BGR;LIMS2,GO_BP,turquoise,9
negative regulation of immune response (GO:0050777),6/178,0.703798503170743,0.88078830410454,0,0,0.852748007284234,0.299538977526919,ILRUN;LGALS3;MUL1;TRAFD1;PTH1R;SIRT2,GO_BP,turquoise,6
regulation of peptidyl-tyrosine phosphorylation (GO:0050730),3/92,0.705519198338098,0.881738798286306,0,0,0.824420241960976,0.287575336980566,EFNA1;CD81;AGT,GO_BP,turquoise,3
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),3/92,0.705519198338098,0.881738798286306,0,0,0.824420241960976,0.287575336980566,HSP90AB1;RBPMS;INHA,GO_BP,turquoise,3
visual perception (GO:0007601),3/93,0.712421104193008,0.883904215760709,0,0,0.815217391304348,0.276428889071444,ROM1;KIFC3;REEP6,GO_BP,turquoise,3
positive regulation of peptidyl-serine phosphorylation (GO:0033138),3/93,0.712421104193008,0.883904215760709,0,0,0.815217391304348,0.276428889071444,NTF4;HSP90AB1;MTCP1,GO_BP,turquoise,3
positive regulation of nucleic acid-templated transcription (GO:1903508),18/511,0.714869750197811,0.8849849539111,0,0,0.891214949316507,0.299140682906134,KCNH2;MESP1;RNF10;BLM;XRCC6;SMARCD3;MT3;AGT;JMJD6;BICRA;DNAJC2;PSMC5;DDIT3;HAND2;MAPRE3;APBB1;NKX2-5;ATF4,GO_BP,turquoise,18
hemopoiesis (GO:0030097),3/94,0.71919761600853,0.885404204015011,0,0,0.806216801101712,0.265744464940062,GLRX5;NKX2-5;ATF4,GO_BP,turquoise,3
negative regulation of cellular protein metabolic process (GO:0032269),3/94,0.71919761600853,0.885404204015011,0,0,0.806216801101712,0.265744464940062,RIDA;FXR2;KNG1,GO_BP,turquoise,3
nucleosome organization (GO:0034728),3/94,0.71919761600853,0.885404204015011,0,0,0.806216801101712,0.265744464940062,SET;SMARCD3;H2BC5,GO_BP,turquoise,3
supramolecular fiber organization (GO:0097435),12/351,0.727767897835754,0.891329441408098,0,0,0.864394555175217,0.274681340251232,HSP90AB1;ACTC1;DES;SIAH2;TPM2;COL7A1;COL23A1;TPM1;CORO6;TLL2;RHOC;RND2,GO_BP,turquoise,12
cellular transition metal ion homeostasis (GO:0046916),3/96,0.732377371979357,0.891620342427635,0,0,0.788796303935319,0.245677993865611,COX19;ABCB6;MT3,GO_BP,turquoise,3
regulation of vesicle-mediated transport (GO:0060627),3/96,0.732377371979357,0.891620342427635,0,0,0.788796303935319,0.245677993865611,RAB26;LGI3;PACSIN1,GO_BP,turquoise,3
positive regulation of NF-kappaB transcription factor activity (GO:0051092),5/155,0.732468948848191,0.891620342427635,0,0,0.81474358974359,0.253657649341599,PSMA6;CAMK2A;AGT;HSPA1B;HSPA1A,GO_BP,turquoise,5
DNA repair (GO:0006281),10/298,0.737062378756341,0.895538925535298,0,0,0.847983870967742,0.258705252690769,BABAM2;BLM;VCP;FBH1;APEX1;UBE2T;NABP2;APBB1;MNAT1;BAP1,GO_BP,turquoise,10
peptidyl-serine phosphorylation (GO:0018105),5/156,0.737580785264559,0.895773310259517,0,0,0.809305484802174,0.246336126216569,HIPK4;SBK1;CAMK2A;MARK3;MAPK12,GO_BP,turquoise,5
regulation of MAP kinase activity (GO:0043405),3/97,0.738782262958908,0.896836695043191,0,0,0.780364042009033,0.236256804764582,ERBB2;TPD52L1;AGT,GO_BP,turquoise,3
plasma membrane bounded cell projection organization (GO:0120036),4/128,0.744846160497894,0.896946194327454,0,0,0.78852587666763,0.232282042861635,BLOC1S2;TPM1;ROPN1;MANF,GO_BP,turquoise,4
positive regulation of defense response (GO:0031349),3/98,0.745065043689157,0.896946194327454,0,0,0.772109301386459,0.227219226372787,LRSAM1;TNIP1;AGT,GO_BP,turquoise,3
protein autophosphorylation (GO:0046777),5/159,0.752486808876566,0.901459950527869,0,0,0.793414918414918,0.225624838211783,MYLK2;STK24;CAMK2A;ERBB2;MARK3,GO_BP,turquoise,5
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),3/100,0.757268301048911,0.904766748378015,0,0,0.756110422654046,0.210227173818648,HSP90AB1;STRAP;HSPA1A,GO_BP,turquoise,3
negative regulation of cell differentiation (GO:0045596),6/191,0.76497541141878,0.905204737033795,0,0,0.7922839399091,0.212262048177685,EFNA1;CHADL;HPN;ANKRD2;HOPX;SIRT2,GO_BP,turquoise,6
rRNA metabolic process (GO:0016072),5/162,0.766753008287935,0.905204737033795,0,0,0.778131634819533,0.206664410862442,EXOSC7;NOP58;DDX10;RRP12;MRM2,GO_BP,turquoise,5
"transcription, DNA-templated (GO:0006351)",7/221,0.768819186822382,0.905204737033795,0,0,0.798879225428249,0.210024920798966,BTF3;GTF3C6;PIR;MNAT1;GTF2E2;POLR2K;ATF4,GO_BP,turquoise,7
protein O-linked glycosylation (GO:0006493),3/102,0.768995765436396,0.905204737033795,0,0,0.740757963264357,0.194574757967714,C1GALT1C1;GALNT16;ST6GALNAC4,GO_BP,turquoise,3
regulation of cell adhesion (GO:0030155),4/133,0.771162627933779,0.905204737033795,0,0,0.757764345055534,0.196909608988576,EFNA1;TPM1;ERBB2;KNG1,GO_BP,turquoise,4
RNA metabolic process (GO:0016070),4/133,0.771162627933779,0.905204737033795,0,0,0.757764345055534,0.196909608988576,SUPV3L1;EXOSC7;RBPMS;POLR2K,GO_BP,turquoise,4
chromatin remodeling (GO:0006338),3/103,0.774683997219452,0.906432976338406,0,0,0.733312020460358,0.187214616243978,SMARCD3;NPM2;RUVBL1,GO_BP,turquoise,3
heart development (GO:0007507),5/164,0.775912036841203,0.907484031188692,0,0,0.768263183357523,0.194920753874436,MESP1;HAND2;GATA5;CACYBP;NKX2-5,GO_BP,turquoise,5
negative regulation of macromolecule metabolic process (GO:0010605),6/194,0.777675244830448,0.909159844423702,0,0,0.779518203916642,0.196006940910306,HSP90AB1;CREB3L1;SUB1;STC2;HAND2;GATA5,GO_BP,turquoise,6
activation of GTPase activity (GO:0090630),3/105,0.785715698714874,0.912160185312889,0,0,0.718858131487889,0.173360012781465,ARHGEF16;RANGAP1;TBC1D10B,GO_BP,turquoise,3
organic substance transport (GO:0071702),4/136,0.785901836935222,0.912160185312889,0,0,0.740426027237807,0.178385943896964,PEX19;ABCB6;LMAN2L;ABCD1,GO_BP,turquoise,4
protein processing (GO:0016485),3/106,0.7910617822012,0.912394726241232,0,0,0.71184168053038,0.166840889172822,STOML2;CTSL;HPR,GO_BP,turquoise,3
"DNA-templated transcription, initiation (GO:0006352)",5/168,0.793398677921518,0.912806505702348,0,0,0.749252792197578,0.173399152055339,TEAD4;MNAT1;TFB1M;GTF2E2;POLR2K,GO_BP,turquoise,5
DNA replication (GO:0006260),3/108,0.801421204211748,0.917052454881801,0,0,0.698209718670077,0.154561723406736,BLM;DUT;SET,GO_BP,turquoise,3
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),3/108,0.801421204211748,0.917052454881801,0,0,0.698209718670077,0.154561723406736,IGSF1;STRAP;HSPA1A,GO_BP,turquoise,3
transcription initiation from RNA polymerase II promoter (GO:0006367),4/140,0.804365225000386,0.918475261146927,0,0,0.718498154703623,0.156418379654089,TEAD4;MNAT1;GTF2E2;POLR2K,GO_BP,turquoise,4
neuron projection development (GO:0031175),5/171,0.805799605127486,0.918475261146927,0,0,0.735596231078159,0.15883008258463,NTF4;BLOC1S2;MYO16;PACSIN1;MANF,GO_BP,turquoise,5
regulation of Wnt signaling pathway (GO:0030111),3/111,0.816149698434949,0.925409187888798,0,0,0.678708439897698,0.137884700973355,CTNNBIP1;LGR6;EMD,GO_BP,turquoise,3
negative regulation of gene expression (GO:0010629),10/322,0.816458396872821,0.925409187888798,0,0,0.781761786600496,0.158525124171349,RIDA;FXR2;LSM6;CREB3L1;STC2;HAND2;GATA5;RBBP7;HSPA1B;HSPA1A,GO_BP,turquoise,10
negative regulation of DNA-binding transcription factor activity (GO:0043433),4/143,0.817347806768237,0.925654800093082,0,0,0.702880461315966,0.141764355706691,HES6;DDIT3;CTNNBIP1;KEAP1,GO_BP,turquoise,4
neuron development (GO:0048666),4/143,0.817347806768237,0.925654800093082,0,0,0.702880461315966,0.141764355706691,LGI4;ARL3;BLOC1S2;MANF,GO_BP,turquoise,4
protein-containing complex subunit organization (GO:0043933),3/112,0.820848848783503,0.926502024361766,0,0,0.672446561392806,0.132751907196678,NDUFAF1;MNAT1;SH3BGR,GO_BP,turquoise,3
regulation of cellular macromolecule biosynthetic process (GO:2000112),15/468,0.823433783535127,0.9279646897169,0,0,0.806828932656747,0.156744384310348,HES6;IGSF1;GLRX2;YY1AP1;PTP4A3;HINT1;SOX15;DDIT3;CARM1;GPBP1;ZNF219;DVL1;APBB1;SLC2A4RG;ATF4,GO_BP,turquoise,15
protein-containing complex assembly (GO:0065003),8/267,0.827087875404994,0.930257539827561,0,0,0.753556645448537,0.143058457644971,BLM;STOML2;COL7A1;RUVBL1;CD59;NDUFAF1;MNAT1;SH3BGR,GO_BP,turquoise,8
activation of protein kinase activity (GO:0032147),3/114,0.829940584664796,0.931483070553637,0,0,0.660261284302205,0.123073472925165,MAPKAP1;ADRA2C;MT3,GO_BP,turquoise,3
negative regulation of cell motility (GO:2000146),3/114,0.829940584664796,0.931483070553637,0,0,0.660261284302205,0.123073472925165,STK24;TPM1;FUZ,GO_BP,turquoise,3
positive regulation of protein metabolic process (GO:0051247),3/115,0.834336205205877,0.935253218981417,0,0,0.654331841432225,0.11851182023987,VCP;OAZ2;AGT,GO_BP,turquoise,3
cytosolic transport (GO:0016482),3/116,0.838633701797832,0.937032649525483,0,0,0.648507344453749,0.114125137576009,VPS29;TBC1D10B;VTI1B,GO_BP,turquoise,3
ion transport (GO:0006811),3/116,0.838633701797832,0.937032649525483,0,0,0.648507344453749,0.114125137576009,CHRNB1;KCNN1;KCNN2,GO_BP,turquoise,3
negative regulation of cytokine production (GO:0001818),5/182,0.846273395969108,0.940987630588681,0,0,0.68948283355063,0.11508351615896,ILRUN;DDIT3;UFD1;INHA;ABCD1,GO_BP,turquoise,5
positive regulation of cytokine production (GO:0001819),10/335,0.851180652161643,0.943499253157821,0,0,0.749975186104218,0.12084416975963,XRCC6;STOML2;DDIT3;GLMN;AGPAT1;AGT;HSPA1B;POLR2K;ATF4;HSPA1A,GO_BP,turquoise,10
positive regulation of DNA-binding transcription factor activity (GO:0051091),7/246,0.8534481223888,0.943499253157821,0,0,0.714373299200826,0.113207108769294,PSMA6;COPS5;DDIT3;CAMK2A;AGT;HSPA1B;HSPA1A,GO_BP,turquoise,7
dephosphorylation (GO:0016311),4/153,0.855586070091389,0.944579364991348,0,0,0.655363541836744,0.102216122820732,CTDNEP1;DUSP28;PPM1J;DUSP13,GO_BP,turquoise,4
protein transport (GO:0015031),11/369,0.861661668195137,0.947380307979631,0,0,0.748585307406926,0.111458799011529,VPS29;LRSAM1;RAB20;LMAN2L;RAB26;TANGO2;COPZ2;TMED1;ATP6V0E2;TBC1D10B;ATP6V1F,GO_BP,turquoise,11
protein targeting (GO:0006605),3/125,0.873150900351922,0.951757956954854,0,0,0.600383631713555,0.0814401697129225,ZDHHC18;PEX19;ZDHHC14,GO_BP,turquoise,3
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),12/404,0.873286684177238,0.951757956954854,0,0,0.74542598410645,0.100998800780136,NTF4;EFNA1;GRB14;HPN;ARPC1A;ERBB2;AP3S1;ATP6V0E2;SIRT2;POLR2K;GIT1;ATP6V1F,GO_BP,turquoise,12
positive regulation of multicellular organismal process (GO:0051240),10/345,0.874203986880969,0.951757956954854,0,0,0.727202696196437,0.0977662474296178,MESP1;CPT2;GLMN;GNAS;GATA5;PEMT;SMTNL2;AGPAT1;AGT;GADD45G,GO_BP,turquoise,10
regulation of response to external stimulus (GO:0032101),3/130,0.889361557915333,0.960052618126906,0,0,0.576595444750992,0.0676066371603837,PSMA6;STK24;GRK4,GO_BP,turquoise,3
positive regulation of macromolecule metabolic process (GO:0010604),11/384,0.892051170910041,0.960052618126906,0,0,0.71790981704318,0.0820081173977036,MYLK2;WNT6;ACTC1;HAND2;HPN;PDCD5;GATA5;MT3;HSPA1B;ATF4;HSPA1A,GO_BP,turquoise,11
regulation of neuron projection development (GO:0010975),4/165,0.892281613192219,0.960052618126906,0,0,0.606134832711685,0.0690833000952051,ULK4;FKBP4;MT3;LZTS3,GO_BP,turquoise,4
cellular response to metal ion (GO:0071248),3/131,0.892372328964674,0.960052618126906,0,0,0.572060821611253,0.0651416093902398,CPNE5;HVCN1;MT3,GO_BP,turquoise,3
negative regulation of intracellular signal transduction (GO:1902532),5/198,0.892477266759828,0.960052618126906,0,0,0.631792214693769,0.0718690413694479,TNIP1;DDIT3;MUL1;STAMBP;MARK3,GO_BP,turquoise,5
regulation of MAPK cascade (GO:0043408),4/166,0.894935649457879,0.960554956048394,0,0,0.602361644615166,0.0668642287350262,ULK4;ERBB2;ZNF622;ADRA2C,GO_BP,turquoise,4
nervous system development (GO:0007399),13/447,0.897572515632485,0.961900248836256,0,0,0.728710513120508,0.0787454523889892,MESP1;EIF2B2;RITA1;WDR62;CYP46A1;HPCAL4;NTF4;ADGRB2;FEZ1;FEZ2;DVL1;ADORA1;MAL,GO_BP,turquoise,13
positive regulation of cellular process (GO:0048522),19/625,0.900442769699192,0.963562885394855,0,0,0.761684719385777,0.0798768637106921,RNF10;HSP90AB1;CD81;FAF1;HPN;TPM1;HPR;PLA2G5;AGPAT1;MT3;SIRT2;SUPV3L1;FXR2;NACC1;ERBB2;ECHDC3;STAMBP;CAPN1;NKX2-5,GO_BP,turquoise,19
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),3/134,0.900968529448135,0.963562885394855,0,0,0.558872337517815,0.0582819740282966,EFNA1;CD81;AGT,GO_BP,turquoise,3
positive regulation of response to external stimulus (GO:0032103),3/139,0.913927652461934,0.971730459444002,0,0,0.53818451933203,0.048438687101049,LRSAM1;TNIP1;AGT,GO_BP,turquoise,3
protein dephosphorylation (GO:0006470),3/139,0.913927652461934,0.971730459444002,0,0,0.53818451933203,0.048438687101049,CTDNEP1;PPM1J;DUSP13,GO_BP,turquoise,3
cation transport (GO:0006812),4/174,0.914175203306876,0.971730459444002,0,0,0.573774195978007,0.0514865013744137,CHRNB1;KCNF1;KCNN1;KCNN2,GO_BP,turquoise,4
neuron differentiation (GO:0030182),4/174,0.914175203306876,0.971730459444002,0,0,0.573774195978007,0.0514865013744137,WNT6;HAND2;ERBB2;MANF,GO_BP,turquoise,4
positive regulation of MAPK cascade (GO:0043410),7/274,0.916488373730328,0.973007479156594,0,0,0.638514196585887,0.055682203447319,HAND2;ERBB2;PLA2G5;ZNF622;ADRA2C;TPD52L1;MT3,GO_BP,turquoise,7
regulation of small GTPase mediated signal transduction (GO:0051056),3/141,0.918664922958287,0.97385540461738,0,0,0.53032914489047,0.0449898544332779,ARHGAP10;ARHGEF16;RHOC,GO_BP,turquoise,3
positive regulation of developmental process (GO:0051094),4/177,0.920538724041957,0.973980226283531,0,0,0.563735539881433,0.0466751665431677,HSP90AB1;DVL1;MUL1;PACSIN1,GO_BP,turquoise,4
negative regulation of cell migration (GO:0030336),3/144,0.925325886278777,0.977652029781419,0,0,0.518963922294172,0.0402764236339851,STK24;TPM1;FUZ,GO_BP,turquoise,3
negative regulation of multicellular organismal process (GO:0051241),5/214,0.926183803480654,0.977652029781419,0,0,0.582934609250399,0.0447009252343878,EFNA1;RHEB;DDIT3;HPN;ATF4,GO_BP,turquoise,5
positive regulation of GTPase activity (GO:0043547),5/214,0.926183803480654,0.977652029781419,0,0,0.582934609250399,0.0447009252343878,ARHGEF16;ERBB2;RANGAP1;RGS6;TBC1D10B,GO_BP,turquoise,5
regulation of cell population proliferation (GO:0042127),23/764,0.927158167349896,0.977975958814455,0,0,0.752515753344597,0.0569135980722079,XRCC6;CD81;PDCD5;GLMN;OSGIN1;FUZ;CGRRF1;SIRT2;AGT;MYO16;SSTR5;FABP6;NACC1;TRNP1;ERBB2;NUPR2;STAMBP;CAPN1;NKX2-5;INHA;HSPA1B;BAP1;HSPA1A,GO_BP,turquoise,23
regulation of cell migration (GO:0030334),11/408,0.929135689022982,0.978942950159675,0,0,0.673650570493169,0.0495136481017255,SH3RF2;STK24;HSPA5;SEMA4B;TPM1;ULK4;CAMK2A;OSGIN1;FUZ;LGR6;RHOC,GO_BP,turquoise,11
"negative regulation of transcription, DNA-templated (GO:0045892)",29/948,0.936538923235092,0.983279263852253,0,0,0.763689540620988,0.0500706903509618,MESP1;SET;MAX;SUV39H1;PBXIP1;SOX15;CREB3L1;NACC1;SAP18;ANKRD2;APBB1;CRYM;NKX2-5;ZNF764;TSC22D4;XRCC6;MTERF3;MSX2;USP2;RITA1;MT3;SIRT2;EFNA1;DDIT3;ZNF219;HDGF;NUPR2;BAP1;ATF4,GO_BP,turquoise,29
regulation of cytokine production (GO:0001817),3/150,0.937170802469151,0.983279263852253,0,0,0.497625137011326,0.0322907592073817,GLMN;AGPAT1;AGT,GO_BP,turquoise,3
positive regulation of cell motility (GO:2000147),5/221,0.937716842630167,0.983459127636517,0,0,0.56383547008547,0.0362587080135181,SH3RF2;HSPA5;SEMA4B;RHOC;LGR6,GO_BP,turquoise,5
regulation of GTPase activity (GO:0043087),4/189,0.941964929374375,0.984351462748627,0,0,0.52683669585078,0.0314981093742946,GPSM1;ERBB2;RGS6;TBC1D10B,GO_BP,turquoise,4
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),5/224,0.942144532296469,0.984351462748627,0,0,0.556023884791008,0.0331371246355543,TNIP1;SLC44A2;MUL1;HSPB1;RHOC,GO_BP,turquoise,5
cellular protein localization (GO:0034613),8/329,0.948257353917793,0.986991012852407,0,0,0.60602124153526,0.0321975105226309,VPS29;RAB20;ATG9A;COPZ2;TMED1;MESD;TBC1D10B;PACSIN1,GO_BP,turquoise,8
intracellular protein transport (GO:0006886),8/336,0.95545351935357,0.988363237585845,0,0,0.592868129453495,0.0270165037469,IPO13;VPS29;RAB20;DESI1;COPZ2;TMED1;RAN;TBC1D10B,GO_BP,turquoise,8
negative regulation of transcription by RNA polymerase II (GO:0000122),19/684,0.958584439590255,0.988363237585845,0,0,0.691906005221932,0.0292659806201368,MSX2;MAX;SUV39H1;USP2;RITA1;SIRT2;EFNA1;SOX15;DDIT3;ZNF219;HDGF;NUPR2;ANKRD2;APBB1;NKX2-5;ZNF764;CRYM;ATF4;HSPA1A,GO_BP,turquoise,19
regulation of intracellular signal transduction (GO:1902531),11/437,0.958913156393141,0.988363237585845,0,0,0.62682425301161,0.0262982639927462,ARHGAP10;BLM;PPP1R13B;MAPKAP1;USP2;ULK4;ARHGEF16;RRS1;HSPB1;RBBP7;RHOC,GO_BP,turquoise,11
generation of neurons (GO:0048699),4/202,0.959125882562275,0.988363237585845,0,0,0.491910138517053,0.0205288603840584,HES6;WNT6;ERBB2;ASTN2,GO_BP,turquoise,4
regulation of ERK1 and ERK2 cascade (GO:0070372),5/238,0.959276901975945,0.988363237585845,0,0,0.522229558710246,0.0217119578625921,TNIP1;HAND2;ERBB2;PLA2G5;MT3,GO_BP,turquoise,5
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),3/165,0.959599878718162,0.988363237585845,0,0,0.451193520886616,0.0186067129399739,ADGRB2;GNAS;PTH1R,GO_BP,turquoise,3
regulation of protein kinase B signaling (GO:0051896),4/207,0.964373828301336,0.990373838719688,0,0,0.479667976511104,0.017400565432963,HSP90AB1;DDIT3;ERBB2;MUL1,GO_BP,turquoise,4
nuclear-transcribed mRNA catabolic process (GO:0000956),3/171,0.966262266338067,0.990373838719688,0,0,0.434942455242967,0.0149272182675063,EXOSC7;RPS4Y1;SMG5,GO_BP,turquoise,3
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),3/171,0.966262266338067,0.990373838719688,0,0,0.434942455242967,0.0149272182675063,SLC44A2;MUL1;RHOC,GO_BP,turquoise,3
positive regulation of ERK1 and ERK2 cascade (GO:0070374),3/172,0.967266603899001,0.991034137725261,0,0,0.432346131146053,0.0143889632389371,HAND2;PLA2G5;MT3,GO_BP,turquoise,3
cellular response to oxygen-containing compound (GO:1901701),7/323,0.972043376980074,0.993582043088261,0,0,0.538108912824184,0.0152579969658435,H2AZ1;WNT6;VCP;TPM1;MPV17;MT3;GIT1,GO_BP,turquoise,7
cytokine-mediated signaling pathway (GO:0019221),16/621,0.974727664765068,0.99458618599613,0,0,0.640006878096487,0.0163823617817273,PSMD14;CAMK2A;MT3;PSMA6;PSMD6;PSMA3;PSMC5;PSMD7;PSMB5;PSMA1;PSMB2;PSMC4;PSMD2;PSME3;TCP1;PSMC2,GO_BP,turquoise,16
protein phosphorylation (GO:0006468),12/496,0.975793133063064,0.99458618599613,0,0,0.600782611484717,0.0147219789532377,CDK18;HIPK4;MYLK2;PKDCC;SBK1;STK24;GRK4;CAMK2A;ERBB2;LMTK3;MARK3;MAPK12,GO_BP,turquoise,12
apoptotic process (GO:0006915),4/231,0.981907583404497,0.996999459564359,0,0,0.428412686773424,0.00782199552540078,MAL;GLRX2;BAK1;YARS1,GO_BP,turquoise,4
positive regulation of cell migration (GO:0030335),5/269,0.981967594752716,0.996999459564359,0,0,0.460154428904429,0.00837341652480014,SH3RF2;HSPA5;SEMA4B;RHOC;LGR6,GO_BP,turquoise,5
chemical synaptic transmission (GO:0007268),6/306,0.982145906569395,0.996999459564359,0,0,0.485622593068036,0.00874868557242237,CHRNB1;CACNB2;GRIK5;DVL1;KCNN1;CEL,GO_BP,turquoise,6
regulation of gene expression (GO:0010468),30/1079,0.984496741297725,0.998281146665932,0,0,0.688110404737404,0.0107515123899849,MYLK2;IGSF1;HPN;PDCD5;GATA5;YBX3;WNT6;HINT1;SOX15;CREB3L1;STC2;GPBP1;DVL1;APBB1;RBM38;HES6;GLMN;GLRX2;MT3;YY1AP1;PTP4A3;ACTC1;DDIT3;HAND2;CARM1;ZNF219;SLC2A4RG;HSPA1B;ATF4;HSPA1A,GO_BP,turquoise,30
"positive regulation of transcription, DNA-templated (GO:0045893)",33/1183,0.987442676944534,0.999467387979893,0,0,0.689344357076781,0.00871112921346675,MESP1;RNF10;BLM;SMARCD3;MAX;CD81;RASL11A;AKAP8L;GATA5;BICRA;SOX15;DVL1;ERBB2;APBB1;NKX2-5;KCNH2;H2AZ1;XRCC6;SPAG8;THOC5;MT3;SIRT2;AGT;JMJD6;DNAJC2;PSMC5;COPS5;TNIP1;DDIT3;APEX1;HAND2;MAPRE3;ATF4,GO_BP,turquoise,33
regulation of angiogenesis (GO:0045765),3/203,0.987469803148415,0.999467387979893,0,0,0.364737851662404,0.00459911152086236,HSPB6;ERBB2;HSPB1,GO_BP,turquoise,3
anterograde trans-synaptic signaling (GO:0098916),4/244,0.987605564834068,0.999467387979893,0,0,0.404929577464789,0.00505023586125783,CHRNB1;CACNB2;KCNN1;CEL,GO_BP,turquoise,4
regulation of inflammatory response (GO:0050727),3/206,0.988606512750727,0.999502249481999,0,0,0.359290942763912,0.00411707549127507,PSMA6;TNIP1;AGT,GO_BP,turquoise,3
positive regulation of intracellular signal transduction (GO:1902533),12/546,0.991462089071182,0.999995813021028,0,0,0.543076006221202,0.00465664197483228,PTP4A3;HSP90AB1;RHEB;SLC44A2;DDIT3;ERBB2;MUL1;GPR62;ZNF622;ADRA2C;RHOC;AGT,GO_BP,turquoise,12
positive regulation of transcription by RNA polymerase II (GO:0045944),23/908,0.99236587122359,0.999995813021028,0,0,0.625161261621958,0.00479087200103181,H2AZ1;MESP1;RNF10;XRCC6;SMARCD3;SPAG8;MAX;CD81;AKAP8L;GATA5;SIRT2;JMJD6;COPS5;TNIP1;DDIT3;APEX1;HAND2;SUB1;SOX15;DVL1;APBB1;NKX2-5;ATF4,GO_BP,turquoise,23
cellular response to lipid (GO:0071396),3/219,0.99248372467448,0.999995813021028,0,0,0.337436061381074,0.00254584199753595,H2AZ1;WNT6;GIT1,GO_BP,turquoise,3
central nervous system development (GO:0007417),4/268,0.993944285287971,0.999995813021028,0,0,0.367652194156676,0.00223316535244096,EIF2B2;ABCB6;MAL;HPCAL4,GO_BP,turquoise,4
cilium organization (GO:0044782),3/228,0.994383856766087,0.999995813021028,0,0,0.323785166240409,0.00182354933431488,ARL3;FUZ;ROPN1,GO_BP,turquoise,3
phosphorylation (GO:0016310),7/400,0.995982046675086,0.999995813021028,0,0,0.430915049353402,0.00173488423593827,CDK18;STK24;GRK4;CAMK2A;ERBB2;LMTK3;MARK3,GO_BP,turquoise,7
"regulation of transcription, DNA-templated (GO:0006355)",65/2244,0.997601880365163,0.999995813021028,0,0,0.705815613686197,0.0016946630973188,MESP1;RNF10;SUV39H1;HINT1;SOX15;CREB3L1;GPBP1;RUVBL1;ZNF768;ANKRD2;ZNF764;ZNF563;KCNH2;TEAD4;HES6;TSC22D4;ZSCAN5A;MSX2;GLRX2;SIRT2;JMJD6;DNAJC2;PTP4A3;DDIT3;HAND2;SUB1;MAPRE3;NUPR2;ATF4;ZNF672;BLM;SET;SMARCD3;MAX;IGSF1;GATA5;ZBTB42;PBXIP1;BICRA;DVL1;NACC1;ERBB2;SAP18;BRD9;ZNF787;APBB1;NKX2-5;POLR2K;ZNF584;CDK18;XRCC6;MTERF3;MT3;YY1AP1;AGT;HOPX;PSMC5;CARM1;ZNF219;HDGF;MNAT1;ZNF576;SLC2A4RG;BAP1;ZNF530,GO_BP,turquoise,65
positive regulation of cell population proliferation (GO:0008284),8/474,0.99846522063777,0.999995813021028,0,0,0.4142487060942,0.000636268756014365,CD81;SOX15;NACC1;ERBB2;STAMBP;CAPN1;NKX2-5;AGT,GO_BP,turquoise,8
cilium assembly (GO:0060271),4/314,0.998546174475394,0.999995813021028,0,0,0.312337367312379,0.000454414436636551,ACTR1A;ARL3;FUZ;TUBA4A,GO_BP,turquoise,4
plasma membrane bounded cell projection assembly (GO:0120031),3/278,0.998933505530284,0.999995813021028,0,0,0.264217623808417,0.000281937003458101,ARL3;FUZ;PARVB,GO_BP,turquoise,3
organelle assembly (GO:0070925),5/425,0.999822298911909,0.999995813021028,0,0,0.286858974358974,5.0979681578804e-05,ABCB6;ARL3;ATG9A;FUZ;MAPRE3,GO_BP,turquoise,5
regulation of transcription by RNA polymerase II (GO:0006357),55/2206,0.999954254565445,0.999995813021028,0,0,0.59769587894767,2.7342483115742e-05,MESP1;RNF10;CD81;SUV39H1;AKAP8L;SOX15;CREB3L1;RUVBL1;ZNF768;ANKRD2;ZNF764;ZNF563;TEAD4;HES6;ZSCAN5A;MSX2;USP2;SIRT2;JMJD6;DDIT3;HAND2;SUB1;NUPR2;ATF4;ZNF672;SMARCD3;MAX;GATA5;ZBTB42;DVL1;NACC1;ERBB2;SAP18;BRD9;ZNF787;APBB1;CRYM;NKX2-5;H2AZ1;ZNF584;XRCC6;SPAG8;RITA1;HOPX;EFNA1;PSMC5;COPS5;TNIP1;APEX1;ZNF219;HDGF;MNAT1;ZNF576;SLC2A4RG;ZNF530,GO_BP,turquoise,55
Cardiomyocytes,23/174,3.51060651843852e-07,5.40633403839532e-05,0,0,3.81074551111575,56.6364690415625,PNMT;RASL12;MYH7B;ADPRHL1;HSPB6;SMPX;RRAD;TPM1;PYGM;PTH1R;ENO3;ART3;MYL4;KBTBD13;ACTC1;DES;HAND2;CORO6;TNNI1;ITGA7;NKX2-5;SMTNL2;TRIM54,PanglaoDB,turquoise,23
Myocytes,16/163,0.000701498929352339,0.0540154175601301,0,0,2.69886680289801,19.5999565912283,RASL12;HSPB6;SMPX;TPM2;TPM1;GATA5;PYGM;ENO3;KBTBD13;ACTC1;DES;TNNI1;MYH14;ITGA7;ANKRD2;TRIM54,PanglaoDB,turquoise,16
Basal Cells,14/141,0.00132358747853296,0.0679441572313584,0,0,2.72916858155376,18.0873176265294,LAD1;MT1L;HSPB1;RHOC;LGALS3;HEBP2;SH3RF2;S100A16;FXYD3;SRSF4;CD59;CAPN1;S100A14;A4GALT,PanglaoDB,turquoise,14
Schwann Cells,13/138,0.00308783397595031,0.118881608074087,0,0,2.57170984455959,14.8652168997669,RASL12;CD82;TMEM178A;LGI4;LGI3;CAMK2A;AQP4;GPR62;MT3;ART3;AGT;ITGA7;ALDOC,PanglaoDB,turquoise,13
Sertoli Cells,13/158,0.00952802315876192,0.25621345245741,0,0,2.21466857244953,10.3060001020972,RASL12;LYNX1;HSPB6;GPX3;MRO;PTH1R;AGT;WNT6;DES;S100A16;ERBB2;KIF1C;INHA,PanglaoDB,turquoise,13
Undefined Placental Cells,10/108,0.00998234230353546,0.25621345245741,0,0,2.51705069124424,11.5958952602829,CCT3;TEAD4;AHCY;MMP15;ARHGEF16;TMEM52;HDGF;DHCR7;REEP6;FKBP4,PanglaoDB,turquoise,10
Airway Smooth Muscle Cells,9/99,0.0157838655825676,0.313150398570097,0,0,2.4645618556701,10.2248929612149,DES;HSPB6;TPM2;HAND2;TPM1;GATA5;PTH1R;MYL9;LIMS2,PanglaoDB,turquoise,9
Olfactory Epithelial Cells,16/226,0.0169345517598894,0.313150398570097,0,0,1.88296488946684,7.6794826143123,PACRG;LMAN2L;LRRC10B;TMEM178A;MAPKAP1;SIAH2;ARL3;AK1;LARP6;KIF9;ADGRB2;CLDN9;FAM131C;GPC1;MAPRE3;KLHDC9,PanglaoDB,turquoise,16
Principal Cells,11/136,0.0183009973190317,0.313150398570097,0,0,2.17043927648579,8.6834928546594,EFNA1;EPN3;LGALS3;LAD1;TMEM178A;FXYD3;ARHGEF16;ERBB2;MYH14;AQP4;S100A14,PanglaoDB,turquoise,11
Adrenergic Neurons,9/106,0.0235848976615692,0.363207423988166,0,0,2.28586991178659,8.56549447149172,PNMT;KCNH2;ENHO;KLC4;MMP15;GRIK5;OGDHL;REEP6;GADD45G,PanglaoDB,turquoise,9
Oxyphil Cells,8/94,0.0313949265507541,0.439528971710558,0,0,2.29014396456257,7.92643782736042,KBTBD13;CACNB2;MYH7B;GALNT16;KCNJ11;PPP1R1A;PYGM;ART3,PanglaoDB,turquoise,8
Oligodendrocytes,12/178,0.0483932798559829,0.588104653078714,0,0,1.78141803955797,5.39483627405766,TMEM178A;LGI4;LGI3;HDAC11;CAMK2A;FAM181B;AQP4;GPR62;PTGDS;NDRG2;MT3;PNPLA2,PanglaoDB,turquoise,12
Juxtaglomerular Cells,8/103,0.0496451979871642,0.588104653078714,0,0,2.07220754589176,6.22253591077457,RASL12;DES;RBPMS;HSPB6;FBLIM1;CREB3L1;TPM1;MYL9,PanglaoDB,turquoise,8
Myoblasts,9/126,0.0601483071216223,0.661631378337845,0,0,1.89314036478985,5.32150772776105,PKDCC;ACTC1;DES;HSPB6;TPM2;GPC1;TPM1;CAPN1;ENO3,PanglaoDB,turquoise,9
Gastric Chief Cells,8/109,0.0649944704976711,0.66727656377609,0,0,1.94849446334595,5.32611819603776,EFNA1;LAD1;ALDH2;ARHGEF16;ERBB2;KDF1;MYH14;S100A14,PanglaoDB,turquoise,8
Smooth Muscle Cells,11/169,0.0696766305803542,0.670637569335909,0,0,1.71415137539659,4.5663112271834,RASL12;ACTC1;DES;HSPB6;RRAD;TPM2;TPM1;KIF1C;LGR6;MYL9;SH3BGR,PanglaoDB,turquoise,11
Ductal Cells,9/132,0.0757972131715606,0.686633578142372,0,0,1.80022630123208,4.64403254247608,EFNA1;LAD1;AKR1B10;MLPH;S100A16;FXYD3;ARHGEF16;MYH14;S100A14,PanglaoDB,turquoise,9
Astrocytes,10/154,0.082057465187863,0.702047202162828,0,0,1.70887096774194,4.27275071512283,SLC25A28;HSPB6;TMEM178A;LGI4;LGI3;CAMK2A;AQP4;ALDOC;MT3;AGT,PanglaoDB,turquoise,10
Trophoblast Stem Cells,7/99,0.0944193015022347,0.73486356615888,0,0,1.87019391974964,4.41367590681524,EPN3;NTF4;MLPH;MSX2;FXYD3;ARHGEF16;S100A14,PanglaoDB,turquoise,7
Transient Cells,8/120,0.100017112896853,0.73486356615888,0,0,1.75611325611326,4.04329970899654,LAD1;MMP15;GPC1;HDAC11;ARHGEF16;ERBB2;INPP5J;MYH14,PanglaoDB,turquoise,8
Luminal Epithelial Cells,9/140,0.100208668112575,0.73486356615888,0,0,1.68958054615566,3.88688103646356,EPN3;LAD1;MLPH;FXYD3;STC2;ARHGEF16;ERBB2;S100A14;PTH1R,PanglaoDB,turquoise,9
Pulmonary Alveolar Type I Cells,8/131,0.143762982425443,0.984825971564583,0,0,1.59814169570267,3.09973851825821,MMP11;FBLIM1;S100A16;GPC1;ERBB2;S100A14;A4GALT;HOPX,PanglaoDB,turquoise,8
Cholangiocytes,8/134,0.157110087202319,0.984825971564583,0,0,1.55984555984556,2.88697546293855,EFNA1;LAD1;FXYD3;ARHGEF16;MYH14;AQP4;KCNN2;S100A14,PanglaoDB,turquoise,8
Mammary Epithelial Cells,8/134,0.157110087202319,0.984825971564583,0,0,1.55984555984556,2.88697546293855,EPN3;LAD1;SH3RF2;S100A16;FXYD3;ARHGEF16;ERBB2;S100A14,PanglaoDB,turquoise,8
Satellite Glial Cells,7/114,0.161200179269512,0.984825971564583,0,0,1.60675588016241,2.93250355211332,LYNX1;ALDH2;TMEM176B;AQP4;PTGDS;NDRG2;MT3,PanglaoDB,turquoise,7
Myoepithelial Cells,7/115,0.16626931987454,0.984825971564583,0,0,1.59179520137104,2.85591362438858,NTF4;SH3RF2;FBLIM1;S100A16;ERBB2;S100A14;MYL9,PanglaoDB,turquoise,7
Hemangioblasts,6/97,0.181481167960338,0.999664443639718,0,0,1.61864323096672,2.76238202266712,LSM10;MYL4;CCND3;SMIM1;ITGA2B;MSRB1,PanglaoDB,turquoise,6
Myofibroblasts,6/100,0.199476245063281,0.999664443639718,0,0,1.56673859011826,2.52567680289486,RASL12;DES;HSPB6;TPM2;TPM1;MYL9,PanglaoDB,turquoise,6
Trichocytes,6/103,0.21809538761469,0.999664443639718,0,0,1.51804454561095,2.31171277568448,EPN3;NTF4;LAD1;S100A16;ARHGEF16;S100A14,PanglaoDB,turquoise,6
Loop Of Henle Cells,8/147,0.221054638364155,0.999664443639718,0,0,1.41299778709851,2.13270167569623,RASL12;SH3RF2;SMARCD3;ALDH2;GPX3;TNNI1;PARVB;MYL9,PanglaoDB,turquoise,8
M?ller Cells,8/147,0.221054638364155,0.999664443639718,0,0,1.41299778709851,2.13270167569623,RASL12;TMEM178A;S100A16;AQP4;DBI;CRYM;PRDX6;AGT,PanglaoDB,turquoise,8
Enteric Glia Cells,6/111,0.270281765508929,0.999664443639718,0,0,1.4017971758665,1.83395763117254,RASL12;LGI4;LGI3;TSPAN7;AQP4;NDRG2,PanglaoDB,turquoise,6
Cardiac Stem And Precursor Cells,6/113,0.283792581481969,0.999664443639718,0,0,1.37545139347114,1.73239706034205,TEAD4;MESP1;PKDCC;STC2;NKX2-5;LARP6,PanglaoDB,turquoise,6
Oligodendrocyte Progenitor Cells,6/125,0.367161479857206,0.999664443639718,0,0,1.23597372196632,1.23838823134833,LAD1;TMEM178A;LGI3;AQP4;ALDOC;GPR62,PanglaoDB,turquoise,6
Cholinergic Neurons,5/102,0.37181482163975,0.999664443639718,0,0,1.2634152788792,1.24997170638103,OGDHL;RHBDL3;RND2;GAL3ST3;SPSB4,PanglaoDB,turquoise,5
Reticulocytes,5/103,0.37965764804698,0.999664443639718,0,0,1.25045787545788,1.21105014384171,STIP1;RUVBL1;HDGF;CCT8;FTSJ3,PanglaoDB,turquoise,5
Crypt Cells,5/110,0.434307038315084,0.999664443639718,0,0,1.16666666666667,0.973004122369067,RASL12;LRRC10B;MYH14;NDRG2;HOPX,PanglaoDB,turquoise,5
Parietal Cells,5/111,0.442044076829331,0.999664443639718,0,0,1.15559990324141,0.943368989446981,PPP1R13B;CHDH;MYH14;AQP4;NDRG2,PanglaoDB,turquoise,5
Mast Cells,10/235,0.442766064694929,0.999664443639718,0,0,1.08903225806452,0.88724952116746,RASL12;MLPH;ALDH2;SMPX;GPX3;CREB3L1;TMEM176B;COPZ2;PTGDS;A4GALT,PanglaoDB,turquoise,10
Granulosa Cells,5/112,0.449755578762077,0.999664443639718,0,0,1.14473999520729,0.914705640300796,TEAD4;STC2;GPC1;INHA;LARP6,PanglaoDB,turquoise,5
GABAergic Neurons,5/113,0.457439048027649,0.999664443639718,0,0,1.1340811965812,0.886978094908318,MYBPC1;LGI3;CAMK2A;AQP4;MT3,PanglaoDB,turquoise,5
Foveolar Cells,5/114,0.465092062443622,0.999664443639718,0,0,1.12361797224183,0.860151928132403,LAD1;AKR1B10;MLPH;FXYD3;S100A14,PanglaoDB,turquoise,5
Pancreatic Progenitor Cells,5/114,0.465092062443622,0.999664443639718,0,0,1.12361797224183,0.860151928132403,LRRC10B;MMP15;ARHGEF16;INPP5J;MYH14,PanglaoDB,turquoise,5
Choroid Plexus Cells,5/117,0.487845269906069,0.999664443639718,0,0,1.09334935897436,0.784759148492081,TMEM178A;GPX3;MMP15;MYH14;AGT,PanglaoDB,turquoise,5
Airway Goblet Cells,5/118,0.495353731038211,0.999664443639718,0,0,1.0836169729975,0.761222679177039,EPN3;LAD1;FXYD3;QSOX1;S100A14,PanglaoDB,turquoise,5
Peritubular Myoid Cells,5/120,0.510244331107796,0.999664443639718,0,0,1.06465997770346,0.716373061260305,RASL12;HSPB6;TPM2;TPM1;MYL9,PanglaoDB,turquoise,5
Tanycytes,5/121,0.517622593506306,0.999664443639718,0,0,1.05542661361627,0.69500780383375,RASL12;TMEM178A;COL23A1;CRYM;PRDX6,PanglaoDB,turquoise,5
Goblet Cells,5/122,0.524953702847149,0.999664443639718,0,0,1.04635108481262,0.674315939701529,LAD1;FXYD3;CREB3L1;S100A14;MANF,PanglaoDB,turquoise,5
Erythroblasts,5/124,0.539467517659281,0.999664443639718,0,0,1.02865761689291,0.634859403245097,RPIA;CCND3;C11ORF21;ITGA2B;BPGM,PanglaoDB,turquoise,5
Embryonic Stem Cells,7/176,0.539831160313739,0.999664443639718,0,0,1.01399431100835,0.625126331104478,TEAD4;RBPMS;FBLIM1;SOX15;NACC1;ERBB2;CD59,PanglaoDB,turquoise,7
Luteal Cells,5/125,0.546646932102456,0.999664443639718,0,0,1.02003205128205,0.616050547682741,PKDCC;S100A16;MMP15;GPC1;DHCR7,PanglaoDB,turquoise,5
Microfold Cells,5/126,0.553772609937668,0.999664443639718,0,0,1.0115490570036,0.59782663358408,LGALS3;LAD1;RAB20;TNIP1;CTSD,PanglaoDB,turquoise,5
Glomus Cells,5/127,0.560843083930061,0.999664443639718,0,0,1.00320512820513,0.58016769127315,PKDCC;KCNJ11;GPC1;PTH1R;LARP6,PanglaoDB,turquoise,5
Trophoblast Cells,5/130,0.581709651633835,0.999664443639718,0,0,0.978974358974359,0.530392483636078,LGALS3;LAD1;TMEM40;S100A14;HOPX,PanglaoDB,turquoise,5
Adipocytes,8/210,0.584587444922705,0.999664443639718,0,0,0.969099226524969,0.520259856552339,HSPB6;GPX3;CREB3L1;COPZ2;CPT1B;MYL9;AGT;PNPLA2,PanglaoDB,turquoise,8
Bergmann Glia,5/132,0.595320879364852,0.999664443639718,0,0,0.963456491015546,0.499701262122203,CAMK2A;FAM181B;AQP4;MT3;HOPX,PanglaoDB,turquoise,5
Hepatic Stellate Cells,5/132,0.595320879364852,0.999664443639718,0,0,0.963456491015546,0.499701262122203,RASL12;DES;HSPB6;TPM2;MYL9,PanglaoDB,turquoise,5
Parathyroid Chief Cells,4/106,0.602166560809037,0.999664443639718,0,0,0.959704752579649,0.486782589394112,USP2;INPP5J;ITGA7;OGDHL,PanglaoDB,turquoise,4
Ependymal Cells,5/136,0.621784923221558,0.999664443639718,0,0,0.933842239185751,0.443725438960424,PACRG;C1ORF194;LRRC10B;AQP4;MYO16,PanglaoDB,turquoise,5
Motor Neurons,4/111,0.638425825474685,0.999664443639718,0,0,0.914619407182261,0.410435257964357,ADGRB2;FAM131C;STC2;SPSB4,PanglaoDB,turquoise,4
Satellite Cells,5/139,0.640941311839718,0.999664443639718,0,0,0.91279181017987,0.406025664634609,MESP1;S100A16;GPC1;ERBB2;ITGA7,PanglaoDB,turquoise,5
Clara Cells,4/113,0.652311750297937,0.999664443639718,0,0,0.89774342468489,0.383545335296699,FXYD3;SFTPC;CARM1;S100A14,PanglaoDB,turquoise,4
Endothelial Cells (Blood Brain Barrier),4/113,0.652311750297937,0.999664443639718,0,0,0.89774342468489,0.383545335296699,ADGRB2;GPC1;LGI3;LARP6,PanglaoDB,turquoise,4
Interneurons,11/305,0.655510676382172,0.999664443639718,0,0,0.914636397194537,0.386288165740279,ISCA1;LYNX1;CPNE5;CLDN9;TCEAL3;RAB26;AKAP8L;CAMK2A;AQP4;HPCAL4;PACSIN1,PanglaoDB,turquoise,11
Hepatoblasts,4/114,0.659119733310181,0.999664443639718,0,0,0.88953556047026,0.370802962063749,EFNA1;LAD1;ARHGEF16;S100A14,PanglaoDB,turquoise,4
Meningeal Cells,4/115,0.665837113552973,0.999664443639718,0,0,0.881475585700938,0.358505122861866,RASL12;PKDCC;PTH1R;PTGDS,PanglaoDB,turquoise,4
Neuroblasts,5/146,0.68322695789688,0.999664443639718,0,0,0.867157665030005,0.330324790251199,ADGRB2;RHBDL3;RND2;GAL3ST3;SPSB4,PanglaoDB,turquoise,5
Mesangial Cells,5/148,0.694672358078532,0.999664443639718,0,0,0.854939931863009,0.311467417166707,ADAMTSL4;TPM2;TPM1;MYL9;HOPX,PanglaoDB,turquoise,5
Neural Stem/Precursor Cells,5/152,0.71670215787509,0.999664443639718,0,0,0.831501831501832,0.276969040316494,ALDOC;RHBDL3;RND2;PRSS56;HOPX,PanglaoDB,turquoise,5
Erythroid-like And Erythroid Precursor Cells,5/153,0.722029711221081,0.999664443639718,0,0,0.825840263340263,0.268967080988058,MYL4;RBM38;C11ORF21;TMCC2;BPGM,PanglaoDB,turquoise,5
Sebocytes,4/124,0.722179576664185,0.999664443639718,0,0,0.814980793854033,0.265261130402875,LGALS3;LAD1;RAB20;S100A14,PanglaoDB,turquoise,4
Melanocytes,4/133,0.771162627933779,0.999664443639718,0,0,0.757764345055534,0.196909608988576,S100A16;GPC1;HSPB1;PTGDS,PanglaoDB,turquoise,4
Airway Epithelial Cells,3/103,0.774683997219452,0.999664443639718,0,0,0.733312020460358,0.187214616243978,FXYD3;MYH14;S100A14,PanglaoDB,turquoise,3
Salivary Mucous Cells,3/105,0.785715698714874,0.999664443639718,0,0,0.718858131487889,0.173360012781465,GSDMC;FXYD3;S100A14,PanglaoDB,turquoise,3
Alpha Cells,4/136,0.785901836935222,0.999664443639718,0,0,0.740426027237807,0.178385943896964,PKDCC;TSPAN7;PEMT;AGT,PanglaoDB,turquoise,4
Epiblast Cells,3/109,0.806437347638521,0.999664443639718,0,0,0.69158664286059,0.148780390405086,RND2;GAL3ST3;SPSB4,PanglaoDB,turquoise,3
Pancreatic Stellate Cells,3/111,0.816149698434949,0.999664443639718,0,0,0.678708439897698,0.137884700973355,MMP11;HSPB6;MYL9,PanglaoDB,turquoise,3
Retinal Progenitor Cells,3/112,0.820848848783503,0.999664443639718,0,0,0.672446561392806,0.132751907196678,RHBDL3;RND2;GAL3ST3,PanglaoDB,turquoise,3
Leydig Cells,4/145,0.82560341837195,0.999664443639718,0,0,0.692837878333833,0.132775966332213,RASL12;DHCR7;PTGDS;INHA,PanglaoDB,turquoise,4
Taste Receptor Cells,3/115,0.834336205205877,0.999664443639718,0,0,0.654331841432225,0.11851182023987,KCNH2;CACNB2;CYP46A1,PanglaoDB,turquoise,3
Platelets,6/214,0.849397063688365,0.999664443639718,0,0,0.70382393601264,0.114884138031778,ARHGAP10;C11ORF21;ALDH2;ITGA2B;AGPAT1;MYL9,PanglaoDB,turquoise,6
Podocytes,5/184,0.852829816178365,0.999664443639718,0,0,0.681707491763358,0.108524603778491,DES;S100A16;TPM1;PTH1R;EMC7,PanglaoDB,turquoise,5
Endothelial Cells,7/246,0.8534481223888,0.999664443639718,0,0,0.714373299200826,0.113207108769294,RASL12;FAM167B;FCN3;CD82;HSPB6;PALMD;PTGDS,PanglaoDB,turquoise,7
Pericytes,4/155,0.862359422753785,0.999664443639718,0,0,0.646615393747191,0.0957528323642017,RASL12;DES;HSPB6;PTH1R,PanglaoDB,turquoise,4
Acinar Cells,3/124,0.869666862046316,0.999664443639718,0,0,0.605377185009829,0.084537932023679,CTRB2;CTRB1;CEL,PanglaoDB,turquoise,3
Germ Cells,6/222,0.872243131225108,0.999664443639718,0,0,0.677471116816431,0.0926015444901745,SPINK2;SPATA24;NUPR2;TMEM53;ROPN1;FAM71E1,PanglaoDB,turquoise,6
Keratinocytes,3/127,0.879872519996092,0.999664443639718,0,0,0.590638148667602,0.0755888340771596,LAD1;FXYD3;S100A14,PanglaoDB,turquoise,3
Gamma (PP) Cells,3/128,0.883113144342569,0.999664443639718,0,0,0.585882352941177,0.0728263191161387,APOBEC2;AQP4;AGT,PanglaoDB,turquoise,3
Proximal Tubule Cells,4/164,0.889569024137779,0.999664443639718,0,0,0.609955185659411,0.0713758433170466,HPN;OSGIN1;FAH;KNG1,PanglaoDB,turquoise,4
Retinal Ganglion Cells,4/164,0.889569024137779,0.999664443639718,0,0,0.609955185659411,0.0713758433170466,CPNE5;RBPMS;CSDC2;GAL3ST3,PanglaoDB,turquoise,4
Delta Cells,3/131,0.892372328964674,0.999664443639718,0,0,0.572060821611253,0.0651416093902398,PPP1R1A;TSPAN7;AGT,PanglaoDB,turquoise,3
Pulmonary Alveolar Type II Cells,3/135,0.90369337695721,0.999664443639718,0,0,0.55460939316438,0.0561626094398665,SFTPC;TMEM176B;S100A14,PanglaoDB,turquoise,3
Enterocytes,5/203,0.904218965548747,0.999664443639718,0,0,0.615675990675991,0.0619885548388387,CBR1;FAHD1;FABP6;CTRB1;ART3,PanglaoDB,turquoise,5
Mesothelial Cells,3/144,0.925325886278777,0.999664443639718,0,0,0.518963922294172,0.0402764236339851,DES;S100A16;RASL11A,PanglaoDB,turquoise,3
Osteoclasts,3/144,0.925325886278777,0.999664443639718,0,0,0.518963922294172,0.0402764236339851,TMEM176B;PTH1R;CTSD,PanglaoDB,turquoise,3
Gamma Delta T Cells,3/146,0.929484822814415,0.999664443639718,0,0,0.511652030833617,0.037414452571153,H2AZ1;PTGDS;HOPX,PanglaoDB,turquoise,3
Photoreceptor Cells,3/149,0.93532531959004,0.999664443639718,0,0,0.501059804505483,0.0335012968656301,ROM1;TRNP1;CACNA2D3,PanglaoDB,turquoise,3
Endothelial Cells (Aorta),4/185,0.935489105666118,0.999664443639718,0,0,0.538592681149681,0.0359164723996695,HSPB6;S100A16;STXBP6;MYL9,PanglaoDB,turquoise,4
Hepatocytes,5/221,0.937716842630167,0.999664443639718,0,0,0.56383547008547,0.0362587080135181,GRB14;HPR;KNG1;MRPS18C;TM7SF2,PanglaoDB,turquoise,5
Fibroblasts,5/232,0.952597737784445,0.999664443639718,0,0,0.536202417259686,0.026039364954916,HSPB6;COL7A1;COPZ2;ENO3;MYL9,PanglaoDB,turquoise,5
Neurons,6/289,0.972586665110626,0.999664443639718,0,0,0.515256943530938,0.0143221292334779,BEX2;TCEAL3;HDAC11;AKAP8L;FAM181B;PACSIN1,PanglaoDB,turquoise,6
Hematopoietic Stem Cells,3/178,0.972724104081011,0.999664443639718,0,0,0.417391304347826,0.0115428683781399,TMEM176B;ITGA2B;CD59,PanglaoDB,turquoise,3
Epithelial Cells,4/218,0.973791898980265,0.999664443639718,0,0,0.454748884128903,0.0120770636330267,EPN3;LAD1;FXYD3;S100A14,PanglaoDB,turquoise,4
extracellular structure organization (GO:0043062),13/216,5.74539919959193e-09,3.53824748135253e-06,0,0,9.60737788139736,182.298712153697,COL15A1;ECM2;LAMA4;BGN;FGF2;HAPLN1;COMP;COL1A1;ADAMTS5;ACAN;SMOC2;COL3A1;LOX,GO_BP,pink,13
external encapsulating structure organization (GO:0045229),13/217,6.07424460318031e-09,3.53824748135253e-06,0,0,9.55979643765903,180.863779159491,COL15A1;ECM2;LAMA4;BGN;FGF2;HAPLN1;COMP;COL1A1;ADAMTS5;ACAN;SMOC2;COL3A1;LOX,GO_BP,pink,13
extracellular matrix organization (GO:0030198),14/300,3.70173383476782e-08,1.43750663916817e-05,0,0,7.36901559978483,126.097706461834,COL15A1;ECM2;LAMA4;BGN;FGF2;HAPLN1;COMP;COL1A1;ADAMTS5;ACAN;SMOC2;COL3A1;LOX;CAPN2,GO_BP,pink,14
skeletal system development (GO:0001501),9/158,2.1848698657088e-06,0.000636343348387688,0,0,8.81744966442953,114.926235873658,COMP;COL1A1;EXT1;ACAN;UCMA;FRZB;BMP6;HAPLN1;PAPSS1,GO_BP,pink,9
positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),5/47,2.17012483878239e-05,0.00505639087436298,0,0,16.9698526892772,182.224667018187,BMP4;INHBA;LEFTY2;BMP6;GDF7,GO_BP,pink,5
regulation of endothelial cell migration (GO:0010594),6/89,4.46259620200058e-05,0.00696422513546761,0,0,10.3577789418544,103.755888943918,BMP4;SMOC2;ABL1;VASH1;PTN;FGF2,GO_BP,pink,6
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),7/133,5.06222730757121e-05,0.00696422513546761,0,0,8.00081103000811,79.1369731875168,BMP4;COL3A1;LTBP2;INHBA;LEFTY2;BMP6;GDF7,GO_BP,pink,7
glycosaminoglycan catabolic process (GO:0006027),5/56,5.13036894541011e-05,0.00696422513546761,0,0,13.968824940048,137.980531066028,ACAN;OMD;BGN;FGF2;SLC9A1,GO_BP,pink,5
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),6/92,5.38008808748571e-05,0.00696422513546761,0,0,9.99494438827098,98.2525093987599,BMP4;SLC2A10;INHBA;LEFTY2;BMP6;GDF7,GO_BP,pink,6
regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),5/58,6.08359371927248e-05,0.00708738668295244,0,0,13.4403420659699,130.469834018256,BMP4;INHBA;LEFTY2;BMP6;GDF7,GO_BP,pink,5
negative regulation of blood vessel endothelial cell migration (GO:0043537),4/34,0.000101045926483043,0.0107016822138859,0,0,18.8819047619048,173.712304544924,VASH1;AGTR2;MEOX2;FGF2,GO_BP,pink,4
embryonic skeletal system development (GO:0048706),4/35,0.000113449017123224,0.011014008745713,0,0,18.2718894009217,165.984712192804,COL1A1;PDGFRA;UCMA;SLC2A10,GO_BP,pink,4
positive regulation of bone mineralization (GO:0030501),4/36,0.000126919781385289,0.0113739650241432,0,0,17.7,158.803609052693,BMP4;TMEM119;PTN;BMP6,GO_BP,pink,4
regulation of extracellular matrix organization (GO:1903053),3/15,0.000156088890341459,0.01212290381652,0,0,35.1843971631206,308.394228399621,FAP;SLC2A10;AEBP1,GO_BP,pink,3
regulation of phospholipase C activity (GO:1900274),3/15,0.000156088890341459,0.01212290381652,0,0,35.1843971631206,308.394228399621,PDGFRA;ABL1;FGF2,GO_BP,pink,3
platelet-derived growth factor receptor signaling pathway (GO:0048008),3/16,0.000191097650379186,0.0130112136741911,0,0,32.4762684124386,278.085387984288,PDGFRA;PDGFD;ABL1,GO_BP,pink,3
positive regulation of ossification (GO:0045778),4/40,0.000192568335367784,0.0130112136741911,0,0,15.7301587301587,134.572443539711,BMP4;TMEM119;PTN;BMP6,GO_BP,pink,4
integrin-mediated signaling pathway (GO:0007229),5/75,0.000207764858511098,0.0130112136741911,0,0,10.1675231243577,86.2114819845132,COL3A1;PTPRA;ABL1;ITGBL1;PTN,GO_BP,pink,5
positive regulation of biomineral tissue development (GO:0070169),4/41,0.000212200051338739,0.0130112136741911,0,0,15.3042471042471,129.443032602095,BMP4;TMEM119;PTN;BMP6,GO_BP,pink,4
proteolysis (GO:0006508),9/287,0.000239039527067411,0.0139240524516767,0,0,4.69496402877698,39.1507493141506,ACAN;CAPN14;FAP;CPXM2;CAPN2;TASP1;CPE;VASH1;AEBP1,GO_BP,pink,9
regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),3/20,0.000380895574190246,0.021130635425316,0,0,24.8297872340426,195.484549992469,SMOC2;SPRY4;FGF2,GO_BP,pink,3
regulation of SMAD protein signal transduction (GO:0060390),3/23,0.000582441559503213,0.0308429280373292,0,0,21.1021276595745,157.174591374744,BMP4;SLC2A10;BMP6,GO_BP,pink,3
positive regulation of phospholipase activity (GO:0010518),3/24,0.000662150402419533,0.0335393573399459,0,0,20.096251266464,147.104917663941,ARF4;PDGFRA;FGF2,GO_BP,pink,3
regulation of bone mineralization (GO:0030500),4/57,0.000757174306620278,0.036754502800526,0,0,10.6754716981132,76.7130543196129,BMP4;TMEM119;PTN;BMP6,GO_BP,pink,4
BMP signaling pathway (GO:0030509),4/65,0.00124140154027051,0.0498700963591431,0,0,9.27166276346604,62.0414636256165,BMP4;LEFTY2;BMP6;GDF7,GO_BP,pink,4
positive regulation of protein phosphorylation (GO:0001934),9/371,0.00149317500668972,0.0527136025088945,0,0,3.59005524861878,23.3599529659544,BMP4;PDGFD;ABL1;TMEM119;INHBA;FGF2;LEFTY2;BMP6;GDF7,GO_BP,pink,9
wound healing (GO:0042060),4/70,0.00163522762833964,0.0560305937357553,0,0,8.56709956709957,54.9662817562367,PDGFRA;COL3A1;NRG1;FGF2,GO_BP,pink,4
cellular response to BMP stimulus (GO:0071773),4/71,0.00172327845806515,0.0564517450948604,0,0,8.43880597014925,53.700567294103,BMP4;LEFTY2;BMP6;GDF7,GO_BP,pink,4
negative regulation of protein serine/threonine kinase activity (GO:0071901),4/78,0.00243372695053627,0.0746129446677567,0,0,7.63783783783784,45.9670398381286,BMP4;SLC8A3;SPRY4;ABL1,GO_BP,pink,4
negative regulation of endothelial cell migration (GO:0010596),3/38,0.00256408797651035,0.0765233909555727,0,0,12.0492401215805,71.8876032105477,VASH1;AGTR2;FGF2,GO_BP,pink,3
negative regulation of cellular component organization (GO:0051129),4/80,0.00266876562670927,0.0765233909555727,0,0,7.43609022556391,44.0673059705404,FAP;CRACD;SNX33;BMP6,GO_BP,pink,4
positive regulation of cell differentiation (GO:0045597),7/258,0.00269309787912316,0.0765233909555727,0,0,3.99089772297671,23.6143937325423,COL1A1;BMP4;FRZB;ABL1;TMEM119;PTN;BMP6,GO_BP,pink,7
sulfur compound catabolic process (GO:0044273),3/40,0.00297167308546756,0.0824285510611835,0,0,11.3967797584819,66.3136463878358,ACAN;OMD;BGN,GO_BP,pink,3
positive regulation of endothelial cell migration (GO:0010595),4/86,0.00346644789911615,0.0917820864197799,0,0,6.88989547038328,39.0286732299151,BMP4;SMOC2;ABL1;FGF2,GO_BP,pink,4
sodium ion transmembrane transport (GO:0035725),4/87,0.00361349976234772,0.0935494938474464,0,0,6.8065404475043,38.273711338289,SLC8A3;SLC6A1;SLC6A4;SLC9A1,GO_BP,pink,4
positive regulation of osteoblast differentiation (GO:0045669),3/44,0.00390092733584558,0.0951465815636666,0,0,10.2828230409964,57.0340993426495,BMP4;TMEM119;BMP6,GO_BP,pink,3
collagen fibril organization (GO:0030199),4/89,0.00392020250219399,0.0951465815636666,0,0,6.64571428571429,36.8279698202344,COL1A1;COL15A1;COL3A1;LOX,GO_BP,pink,4
neural crest cell development (GO:0014032),3/45,0.00415775740448224,0.0968757475244362,0,0,10.0374873353597,55.0333291466906,SEMA3D;SEMA3A;NRG1,GO_BP,pink,3
positive regulation of chemotaxis (GO:0050921),3/45,0.00415775740448224,0.0968757475244362,0,0,10.0374873353597,55.0333291466906,SMOC2;PTN;FGF2,GO_BP,pink,3
positive regulation of epithelial cell migration (GO:0010634),4/94,0.00476302247239386,0.104696626044129,0,0,6.27492063492064,33.5512027100955,BMP4;SMOC2;ABL1;FGF2,GO_BP,pink,4
protein maturation (GO:0051604),4/97,0.00532302205855977,0.10691932238314,0,0,6.0715821812596,31.7890683191014,CPXM2;TASP1;CPE;AEBP1,GO_BP,pink,4
regulation of MAP kinase activity (GO:0043405),4/97,0.00532302205855977,0.10691932238314,0,0,6.0715821812596,31.7890683191014,BMP4;PDGFD;SPRY4;FGF2,GO_BP,pink,4
glycosaminoglycan biosynthetic process (GO:0006024),4/97,0.00532302205855977,0.10691932238314,0,0,6.0715821812596,31.7890683191014,EXT1;ACAN;OMD;BGN,GO_BP,pink,4
regulation of cellular component movement (GO:0051270),3/50,0.00559480130854784,0.110473619058614,0,0,8.96740606609326,46.5042276009377,ABL1;NRG1;ZSWIM4,GO_BP,pink,3
cell-matrix adhesion (GO:0007160),4/100,0.00592547278929398,0.115052929992125,0,0,5.88095238095238,30.1604337017216,SGCE;COL3A1;ECM2;ITGBL1,GO_BP,pink,4
regulation of focal adhesion assembly (GO:0051893),3/54,0.00693403009509246,0.130895800540272,0,0,8.26241134751773,41.0750419617482,PTPRA;ABL1;SLC9A1,GO_BP,pink,3
regulation of blood vessel endothelial cell migration (GO:0043535),3/55,0.00729593345301826,0.130895800540272,0,0,8.10310965630115,39.8708498644119,VASH1;AGTR2;FGF2,GO_BP,pink,3
peptidyl-tyrosine modification (GO:0018212),3/56,0.00766883860767798,0.135366620877952,0,0,7.94981934965877,38.7203113829849,PDGFRA;EFEMP1;ABL1,GO_BP,pink,3
sulfur compound biosynthetic process (GO:0044272),4/113,0.0090588508622211,0.146577239645661,0,0,5.17614678899083,24.3486618027704,ACAN;OMD;BGN;PAPSS1,GO_BP,pink,4
cellular protein catabolic process (GO:0044257),3/60,0.00927193792081152,0.147969968188293,0,0,7.39044419559537,34.5929167710354,FAP;CAPN2;SPATA18,GO_BP,pink,3
positive regulation of epithelial cell proliferation (GO:0050679),4/123,0.0120917358678296,0.169721352843633,0,0,4.73877551020408,20.9227982295202,BMP4;PTN;FGF2;BMP6,GO_BP,pink,4
negative regulation of signal transduction (GO:0009968),6/267,0.0129253298653939,0.173611160777642,0,0,3.26420123271698,14.1945955991345,SLC2A10;FRZB;SPRY4;AGTR2;APCDD1;FGF2,GO_BP,pink,6
negative regulation of cell growth (GO:0030308),4/126,0.0131139760930751,0.173611160777642,0,0,4.62154566744731,20.0301335808254,FRZB;AGTR2;INHBA;RERG,GO_BP,pink,4
negative regulation of growth (GO:0045926),4/126,0.0131139760930751,0.173611160777642,0,0,4.62154566744731,20.0301335808254,FRZB;AGTR2;INHBA;RERG,GO_BP,pink,4
peptidyl-tyrosine phosphorylation (GO:0018108),3/69,0.0135476830795762,0.177337649300071,0,0,6.37975499677627,27.4427696291337,PDGFRA;EFEMP1;ABL1,GO_BP,pink,3
cell junction organization (GO:0034330),3/72,0.0151833083867556,0.192266894245329,0,0,6.10144927536232,25.5501763060018,SLC8A3;PPFIBP2;SLC6A1,GO_BP,pink,3
cytoskeleton-dependent cytokinesis (GO:0061640),3/72,0.0151833083867556,0.192266894245329,0,0,6.10144927536232,25.5501763060018,SNX33;MYH10;SEPTIN8,GO_BP,pink,3
regulation of angiogenesis (GO:0045765),5/203,0.0158642960356592,0.196967843395113,0,0,3.57132475837512,14.7984420711052,SMOC2;PTGIS;VASH1;THBS2;FGF2,GO_BP,pink,5
inorganic cation import across plasma membrane (GO:0098659),3/77,0.018146853312935,0.198861610474807,0,0,5.6877515813686,22.8036641239276,SLC8A3;SLC6A1;SLC9A1,GO_BP,pink,3
positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),3/77,0.018146853312935,0.198861610474807,0,0,5.6877515813686,22.8036641239276,PDGFRA;PDGFD;FGF2,GO_BP,pink,3
protein modification process (GO:0036211),3/78,0.0187753797298161,0.198861610474807,0,0,5.61163120567376,22.3074060667844,LOX;ABL1;CPE,GO_BP,pink,3
negative regulation of cellular response to growth factor stimulus (GO:0090288),3/80,0.0200683672325324,0.198861610474807,0,0,5.46532191213042,21.3618144647194,SPRY4;AGTR2;FGF2,GO_BP,pink,3
skin development (GO:0043588),3/80,0.0200683672325324,0.198861610474807,0,0,5.46532191213042,21.3618144647194,COL1A1;COL3A1;SLC2A10,GO_BP,pink,3
positive regulation of cell population proliferation (GO:0008284),8/474,0.0215871860553152,0.198861610474807,0,0,2.44761423882858,9.38820471967379,BMP4;PDGFRA;PDGFD;TMEM119;NRG1;PTN;FGF2;BMP6,GO_BP,pink,8
positive regulation of cell motility (GO:2000147),5/221,0.0220116689365729,0.198861610474807,0,0,3.27071675992539,12.4816522580304,COL1A1;PDGFRA;SEMA3D;PDGFD;SEMA3A,GO_BP,pink,5
peptide metabolic process (GO:0006518),3/83,0.022097809787392,0.198861610474807,0,0,5.25957446808511,20.0509536174275,CPXM2;CPE;AEBP1,GO_BP,pink,3
regulation of osteoblast differentiation (GO:0045667),3/83,0.022097809787392,0.198861610474807,0,0,5.25957446808511,20.0509536174275,BMP4;TMEM119;BMP6,GO_BP,pink,3
vascular transport (GO:0010232),3/84,0.0227982981125629,0.198861610474807,0,0,5.19437877593906,19.6403065897356,SLC2A10;SLC6A1;SLC16A2,GO_BP,pink,3
transport across blood-brain barrier (GO:0150104),3/86,0.0242352870814882,0.198861610474807,0,0,5.06870033324789,18.8552893199909,SLC2A10;SLC6A1;SLC16A2,GO_BP,pink,3
transforming growth factor beta receptor signaling pathway (GO:0007179),3/89,0.0264807350672574,0.198861610474807,0,0,4.89114299851559,17.7613924017221,COL3A1;LTBP2;LEFTY2,GO_BP,pink,3
sodium ion transport (GO:0006814),3/90,0.0272531768304724,0.198861610474807,0,0,4.83467840547811,17.41734079169,SLC8A3;SLC6A1;SLC6A4,GO_BP,pink,3
protein complex oligomerization (GO:0051259),3/90,0.0272531768304724,0.198861610474807,0,0,4.83467840547811,17.41734079169,EHD3;LRRC8D;SLC9A1,GO_BP,pink,3
regulation of actin cytoskeleton organization (GO:0032956),3/91,0.0280375794899794,0.198861610474807,0,0,4.77949709864604,17.0829241455442,PDGFRA;ABL1;CORO2B,GO_BP,pink,3
regulation of stem cell differentiation (GO:2000736),3/91,0.0280375794899794,0.198861610474807,0,0,4.77949709864604,17.0829241455442,PDGFRA;ABL1;PTN,GO_BP,pink,3
regulation of endothelial cell proliferation (GO:0001936),3/92,0.0288339290746898,0.198861610474807,0,0,4.72555582118097,16.7577778309335,BMP4;VASH1;FGF2,GO_BP,pink,3
regulation of epithelial cell proliferation (GO:0050678),3/93,0.0296422098222019,0.198861610474807,0,0,4.67281323877069,16.4415547120335,BMP4;FGF2;BMP6,GO_BP,pink,3
visual perception (GO:0007601),3/93,0.0296422098222019,0.198861610474807,0,0,4.67281323877069,16.4415547120335,COL1A1;EFEMP1;OAT,GO_BP,pink,3
sensory perception of light stimulus (GO:0050953),3/95,0.0312944929918231,0.198861610474807,0,0,4.57076780758557,15.8345709741949,COL1A1;EFEMP1;OAT,GO_BP,pink,3
cellular protein modification process (GO:0006464),13/1025,0.0338514436193005,0.198861610474807,0,0,1.84784117309839,6.25637192183192,ARF4;GOLM1;PPM1H;PRSS23;DCLK1;PRKAG3;BMP4;B3GNT9;COL3A1;LOX;PTPRA;ABL1;CPE,GO_BP,pink,13
organic anion transport (GO:0015711),3/99,0.034741348624502,0.198861610474807,0,0,4.37943262411348,14.7141258955326,SLC2A10;LRRC8D;SLC16A2,GO_BP,pink,3
positive regulation of phosphorylation (GO:0042327),5/253,0.0363851710841268,0.198861610474807,0,0,2.84404734277094,9.42401814002757,BMP4;PDGFRA;ABL1;TMEM119;FGF2,GO_BP,pink,5
cellular response to chemical stress (GO:0062197),3/101,0.0365355213088305,0.198861610474807,0,0,4.28962223187147,14.19637739643,ABL1;LRRC8D;ETV5,GO_BP,pink,3
positive regulation of vasculature development (GO:1904018),3/102,0.037450194158868,0.198861610474807,0,0,4.24607779926929,13.947275961434,SMOC2;PTGIS;FGF2,GO_BP,pink,3
positive regulation of multicellular organismal process (GO:0051240),6/345,0.0389386689154669,0.198861610474807,0,0,2.50314223419264,8.12461761796266,COL1A1;BMP4;TMEM119;INHBA;PTN;FGF2,GO_BP,pink,6
protein processing (GO:0016485),3/106,0.0412253697255301,0.198861610474807,0,0,4.08035529849205,13.0110348245742,CPXM2;CPE;AEBP1,GO_BP,pink,3
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),3/106,0.0412253697255301,0.198861610474807,0,0,4.08035529849205,13.0110348245742,PDGFRA;PDGFD;FGF2,GO_BP,pink,3
protein localization to nucleus (GO:0034504),3/106,0.0412253697255301,0.198861610474807,0,0,4.08035529849205,13.0110348245742,BMP4;COL1A1;NXT2,GO_BP,pink,3
supramolecular fiber organization (GO:0097435),6/351,0.0417606089355898,0.198861610474807,0,0,2.4588531821046,7.80883024787547,COL1A1;MYO1D;COL15A1;COL3A1;LOX;LTBP2,GO_BP,pink,6
nervous system development (GO:0007399),7/447,0.0432034382988967,0.198861610474807,0,0,2.25467816854678,7.08382722705181,ACAN;NRG1;INHBA;PTN;FGF2;DCLK1;HAPLN1,GO_BP,pink,7
central nervous system development (GO:0007417),5/268,0.0447326010471229,0.198861610474807,0,0,2.67978772875236,8.32624173363759,SLC8A3;ACAN;AGTR2;DCLK1;HAPLN1,GO_BP,pink,5
positive regulation of cell migration (GO:0030335),5/269,0.0453266330772381,0.198861610474807,0,0,2.66950076302594,8.25906294570344,COL1A1;PDGFRA;SEMA3D;PDGFD;SEMA3A,GO_BP,pink,5
regulation of cytoskeleton organization (GO:0051493),3/112,0.0472335172490944,0.198861610474807,0,0,3.854577396057,11.766681574748,CAPN2;ABL1;CORO2B,GO_BP,pink,3
inorganic cation transmembrane transport (GO:0098662),5/274,0.0483676384101535,0.198861610474807,0,0,2.61921317964216,7.93339849064948,SLC8A3;SCARA5;SLC6A1;SLC9A1;SLC6A4,GO_BP,pink,5
cellular response to transforming growth factor beta stimulus (GO:0071560),3/114,0.0493270189263678,0.198861610474807,0,0,3.78474218899751,11.3893614520973,COL3A1;LTBP2;LEFTY2,GO_BP,pink,3
regulation of cell population proliferation (GO:0042127),10/764,0.0496702899379057,0.199537544060897,0,0,1.89061324676353,5.67627949119161,BMP4;PDGFRA;FRZB;PDGFD;NRG1;INHBA;PTN;FGF2;BMP6;RERG,GO_BP,pink,10
cellular amide metabolic process (GO:0043603),3/115,0.0503905894058029,0.20104464608822,0,0,3.75075987841945,11.2070861274025,CPXM2;CPE;AEBP1,GO_BP,pink,3
positive regulation of angiogenesis (GO:0045766),3/116,0.0514653091698146,0.20393566388719,0,0,3.71737902466579,11.0288959470957,SMOC2;PTGIS;FGF2,GO_BP,pink,3
ion transport (GO:0006811),3/116,0.0514653091698146,0.20393566388719,0,0,3.71737902466579,11.0288959470957,SLC8A3;ANO1;SLC9A1,GO_BP,pink,3
regulation of cellular response to stress (GO:0080135),3/118,0.0536479987705361,0.204524960729641,0,0,3.65235892691952,10.6842861545711,ABL1;VASH1;CORO2B,GO_BP,pink,3
negative regulation of cell population proliferation (GO:0008285),6/379,0.0566164469562854,0.205477136149759,0,0,2.27101060729689,6.52110647507572,BMP4;FAP;FRZB;INHBA;SLC16A2;RERG,GO_BP,pink,6
positive regulation of macromolecule metabolic process (GO:0010604),6/384,0.0595656564918393,0.214526060180147,0,0,2.24039567517828,6.31943054527675,BMP4;SLC2A10;TMEM119;INHBA;FGF2;BMP6,GO_BP,pink,6
cellular response to oxidative stress (GO:0034599),3/125,0.0616310590346347,0.214526060180147,0,0,3.44157656086502,9.59026052427371,PDGFRA;ABL1;ETV5,GO_BP,pink,3
synapse organization (GO:0050808),3/126,0.0628144037824247,0.214526060180147,0,0,3.413423283169,9.44689085303603,SLC8A3;PPFIBP2;SLC6A1,GO_BP,pink,3
protein phosphorylation (GO:0006468),7/496,0.0677397082495214,0.2177779782825,0,0,2.02362933440807,5.44777760031787,BMP4;PDGFRA;EFEMP1;ABL1;DCLK1;PRKAG3;GDF7,GO_BP,pink,7
negative regulation of multicellular organismal process (GO:0051241),4/214,0.0691501242770506,0.2177779782825,0,0,2.67292517006803,7.14065390112775,BMP4;ADAMTS5;LAMA4;SLC6A4,GO_BP,pink,4
positive regulation of protein modification process (GO:0031401),4/214,0.0691501242770506,0.2177779782825,0,0,2.67292517006803,7.14065390112775,BMP4;ABL1;TMEM119;FGF2,GO_BP,pink,4
regulation of cell motility (GO:2000145),3/133,0.0713899966737564,0.221066278324876,0,0,3.22847790507365,8.52188227825896,ABL1;NRG1;FGF2,GO_BP,pink,3
regulation of cell growth (GO:0001558),4/217,0.0719754949242435,0.221488083629018,0,0,2.63487592219987,6.93349040487169,FRZB;AGTR2;INHBA;RERG,GO_BP,pink,4
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),6/404,0.0722682384498657,0.221488083629018,0,0,2.12562814070352,5.58481277406152,COL1A1;PDGFRA;PDGFD;NRG1;FGF2;ANGPTL1,GO_BP,pink,6
positive regulation of apoptotic process (GO:0043065),5/310,0.0737573883379729,0.221488083629018,0,0,2.30581436490152,6.01119834698234,BMP4;PTGIS;FAP;FRZB;ABL1,GO_BP,pink,5
regulation of cell migration (GO:0030334),6/408,0.0749825563240007,0.221488083629018,0,0,2.10404499242916,5.45052807914928,COL1A1;PDGFRA;SEMA3D;PDGFD;SEMA3A;FGF2,GO_BP,pink,6
positive regulation of nucleic acid-templated transcription (GO:1903508),7/511,0.0766463135934808,0.221570608775199,0,0,1.96188158961882,5.03919835103201,COL1A1;BMP4;LBH;TASP1;INHBA;FGF2;GDF7,GO_BP,pink,7
enzyme linked receptor protein signaling pathway (GO:0007167),3/140,0.0804615931204272,0.225669769402534,0,0,3.06243205466687,7.71725317397549,PDGFRA;PTN;ANGPTL1,GO_BP,pink,3
cellular protein metabolic process (GO:0044267),6/417,0.0813006358971205,0.225669769402534,0,0,2.05701893578758,5.16229768510035,BMP4;LOX;GOLM1;ABL1;CPE;PRSS23,GO_BP,pink,6
nitrogen compound transport (GO:0071705),3/143,0.0844956993593704,0.225669769402534,0,0,2.99635258358663,7.40415095795259,TMEM30B;LRRC8D;SLC6A4,GO_BP,pink,3
"positive regulation of transcription, DNA-templated (GO:0045893)",13/1183,0.0847710540675336,0.225669769402534,0,0,1.58490245971162,3.91122409369293,ARF4;INHBA;MEOX2;FGF2;BMP6;ETV5;SLC9A1;GDF7;COL1A1;BMP4;LBH;ABL1;TASP1,GO_BP,pink,13
positive regulation of signal transduction (GO:0009967),4/252,0.109106153567889,0.239629882038014,0,0,2.25898617511521,5.00463474338162,SMOC2;PTGIS;ARMC9;BMP6,GO_BP,pink,4
positive regulation of protein kinase B signaling (GO:0051897),3/161,0.110420187073529,0.241803605151619,0,0,2.65257204416914,5.84484251839019,PDGFRA;NRG1;FGF2,GO_BP,pink,3
heart development (GO:0007507),3/164,0.115009213610293,0.243179214161902,0,0,2.60274877758689,5.62907679182444,BMP4;COL3A1;MICAL2,GO_BP,pink,3
regulation of MAPK cascade (GO:0043408),3/166,0.118108283761996,0.245501883220751,0,0,2.57055214723926,5.49109375112331,LBH;TRIM5;FGF2,GO_BP,pink,3
positive regulation of transcription by RNA polymerase II (GO:0045944),10/908,0.120070401310705,0.245501883220751,0,0,1.5754745204933,3.33949715344648,BMP4;ARF4;ABL1;MICAL2;INHBA;MEOX2;FGF2;BMP6;ETV5;SLC9A1,GO_BP,pink,10
regulation of protein phosphorylation (GO:0001932),4/266,0.12596327913754,0.247544312576206,0,0,2.13675027262814,4.42684410789342,BMP4;ABL1;TMEM119;FGF2,GO_BP,pink,4
positive regulation of ERK1 and ERK2 cascade (GO:0070374),3/172,0.127589441454073,0.247544312576206,0,0,2.47853455873096,5.10314814141092,PDGFRA;PDGFD;FGF2,GO_BP,pink,3
positive regulation of gene expression (GO:0010628),6/482,0.135315264014186,0.254672508201173,0,0,1.77018633540373,3.54063454172854,BMP4;SLC2A10;TMEM119;INHBA;FGF2;BMP6,GO_BP,pink,6
positive regulation of developmental process (GO:0051094),3/177,0.135692044078945,0.254815570210069,0,0,2.40670090486672,4.80706579080515,BMP4;TMEM119;PTN,GO_BP,pink,3
positive regulation of MAPK cascade (GO:0043410),4/274,0.136062709086047,0.254815570210069,0,0,2.07259259259259,4.13407485216739,PDGFRA;TRIM5;PDGFD;FGF2,GO_BP,pink,4
positive regulation of cellular biosynthetic process (GO:0031328),3/180,0.140637283250615,0.254815570210069,0,0,2.3655487438394,4.64019219887856,SMOC2;AGTR2;FGF2,GO_BP,pink,3
negative regulation of macromolecule metabolic process (GO:0010605),3/194,0.164477606931764,0.278504500893345,0,0,2.19059819538821,3.95398778421498,BMP4;SLC2A10;FGF2,GO_BP,pink,3
positive regulation of cellular process (GO:0048522),7/625,0.165156910495144,0.278504500893345,0,0,1.59055583114828,2.864367235676,BMP4;PDGFRA;PDGFD;NRG1;PTN;FGF2;BMP6,GO_BP,pink,7
regulation of cell cycle (GO:0051726),4/296,0.165429282934073,0.278504500893345,0,0,1.91428571428571,3.44420481195284,BMP4;FAP;ABL1;INHBA,GO_BP,pink,4
protein localization to membrane (GO:0072657),3/195,0.166225087448942,0.279440442825422,0,0,2.1790780141844,3.910164741285,EHD3;CPE;PTN,GO_BP,pink,3
regulation of signal transduction (GO:0009966),3/198,0.171500456913143,0.284207727316945,0,0,2.14522640480087,3.78239744181505,RGS4;SLC8A3;TRIM5,GO_BP,pink,3
MAPK cascade (GO:0000165),4/303,0.175220290611902,0.287212820502653,0,0,1.86880076445294,3.25491139617146,PDGFRA;PTPRA;NRG1;FGF2,GO_BP,pink,4
axon guidance (GO:0007411),3/203,0.180397952414586,0.289333133425001,0,0,2.09106382978723,3.58113504956819,PTPRA;SEMA3D;SEMA3A,GO_BP,pink,3
regulation of protein kinase B signaling (GO:0051896),3/207,0.187605220665862,0.293850728479331,0,0,2.04964539007092,3.42990818915897,PDGFRA;NRG1;FGF2,GO_BP,pink,3
positive regulation of intracellular signal transduction (GO:1902533),6/546,0.201301327589567,0.304171266720941,0,0,1.55523349436393,2.49296518657746,PDGFRA;TRIM5;PDGFD;TRAF5;NRG1;FGF2,GO_BP,pink,6
cellular protein localization (GO:0034613),4/329,0.213196120999692,0.314795286393716,0,0,1.71701098901099,2.65371393903447,ARF4;CPE;TBC1D2B;SEPTIN8,GO_BP,pink,4
intracellular protein transport (GO:0006886),4/336,0.223797639596631,0.322624147352939,0,0,1.6802065404475,2.5152910842955,ARF4;TBC1D2B;LTBP2;NXT2,GO_BP,pink,4
negative regulation of cellular process (GO:0048523),6/566,0.224036854256247,0.322624147352939,0,0,1.49813664596273,2.24112959447599,BMP4;FRZB;AGTR2;INHBA;FGF2;RERG,GO_BP,pink,6
cilium organization (GO:0044782),3/228,0.226551839370775,0.324093918212315,0,0,1.85635933806147,2.75628798181114,ARF4;EHD3;ARMC9,GO_BP,pink,3
regulation of autophagy (GO:0010506),3/231,0.232243536313582,0.327558982815161,0,0,1.83165360209033,2.67415698764481,TRIM5;ABL1;PRKAG3,GO_BP,pink,3
regulation of ERK1 and ERK2 cascade (GO:0070372),3/238,0.245623370538108,0.337671139309038,0,0,1.77645993662291,2.49407146300146,PDGFRA;PDGFD;FGF2,GO_BP,pink,3
axonogenesis (GO:0007409),3/240,0.249469275141197,0.340726184325248,0,0,1.76128916419786,2.44540825082957,PTPRA;SEMA3D;SEMA3A,GO_BP,pink,3
regulation of canonical Wnt signaling pathway (GO:0060828),3/253,0.274671278265573,0.36116482977358,0,0,1.66859574468085,2.15612646330673,COL1A1;FRZB;LGR5,GO_BP,pink,3
protein transport (GO:0015031),4/369,0.275405116154207,0.361721488522718,0,0,1.52571428571429,1.96742705650129,ARF4;TBC1D2B;LTBP2;SNX33,GO_BP,pink,4
negative regulation of programmed cell death (GO:0043069),4/381,0.294671773250348,0.376830533300391,0,0,1.47624100037893,1.80380880320663,COMP;BMP4;ARF4;TXNDC5,GO_BP,pink,4
plasma membrane bounded cell projection assembly (GO:0120031),3/278,0.323741121718035,0.396591384649328,0,0,1.51497098646035,1.70860107896613,ARF4;EHD3;ARMC9,GO_BP,pink,3
phosphorylation (GO:0016310),4/400,0.325508511483244,0.398337621720566,0,0,1.4040404040404,1.5758481510386,ABL1;DGKI;DCLK1;PRKAG3,GO_BP,pink,4
positive regulation of programmed cell death (GO:0043068),3/286,0.33949609984785,0.409010296093842,0,0,1.47154349297045,1.58969786974298,BMP4;FRZB;ABL1,GO_BP,pink,3
regulation of gene expression (GO:0010468),9/1079,0.37412613243733,0.442045582443702,0,0,1.17046728971963,1.15075929615325,BMP4;EFEMP1;TRIM5;SLC2A10;ABL1;TMEM119;INHBA;FGF2;BMP6,GO_BP,pink,9
cilium assembly (GO:0060271),3/314,0.394323731537338,0.460769455607822,0,0,1.33714168434015,1.24432139145332,ARF4;EHD3;ARMC9,GO_BP,pink,3
negative regulation of gene expression (GO:0010629),3/322,0.40980569954629,0.470221538562269,0,0,1.30307476822517,1.16243669076009,BMP4;SLC2A10;FGF2,GO_BP,pink,3
regulation of apoptotic process (GO:0042981),6/742,0.445200499317046,0.500635696625829,0,0,1.12948960302457,0.914017479148846,COMP;BMP4;ARF4;FRZB;ABL1;TXNDC5,GO_BP,pink,6
post-translational protein modification (GO:0043687),3/345,0.453595301654979,0.507138700986612,0,0,1.21401020281199,0.959735625646074,BMP4;GOLM1;PRSS23,GO_BP,pink,3
negative regulation of apoptotic process (GO:0043066),4/485,0.463311003425715,0.513333582376306,0,0,1.15087615087615,0.885434319820875,COMP;BMP4;ARF4;TXNDC5,GO_BP,pink,4
organelle assembly (GO:0070925),3/425,0.593449009826311,0.63138638944991,0,0,0.979832610668549,0.511280558905439,ARF4;EHD3;ARMC9,GO_BP,pink,3
regulation of intracellular signal transduction (GO:1902531),3/437,0.612367663287417,0.647963967057076,0,0,0.952152171781547,0.466956772147185,LBH;TRAF5;PRKAG3,GO_BP,pink,3
negative regulation of nucleic acid-templated transcription (GO:1903507),3/464,0.652760364522882,0.680810944197993,0,0,0.89514007476808,0.381817696210281,BMP4;LBH;NRG1,GO_BP,pink,3
cytokine-mediated signaling pathway (GO:0019221),4/621,0.657673792020374,0.68460524064904,0,0,0.890900671451725,0.373328565353557,TRIM5;TRAF5;IL13RA2;FGF2,GO_BP,pink,4
cellular response to cytokine stimulus (GO:0071345),3/482,0.677988996225208,0.700795235352868,0,0,0.860702705103718,0.334489918223083,PTGIS;IL13RA2;FGF2,GO_BP,pink,3
"negative regulation of transcription, DNA-templated (GO:0045892)",6/948,0.683293591453796,0.704457552251037,0,0,0.87298070709868,0.332457815409658,BMP4;LBH;NRG1;AEBP1;BMP6;ETV5,GO_BP,pink,6
negative regulation of transcription by RNA polymerase II (GO:0000122),4/684,0.730094588762733,0.74610543500753,0,0,0.805714285714286,0.25346255040934,BMP4;AEBP1;BMP6;ETV5,GO_BP,pink,4
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),3/547,0.757831686657418,0.771742932653752,0,0,0.75531914893617,0.209445443356692,BMP4;LBH;NRG1,GO_BP,pink,3
"regulation of transcription, DNA-templated (GO:0006355)",13/2244,0.833554278445268,0.841499769834261,0,0,0.783973913727798,0.142727513742043,NRG1;INHBA;MEOX2;FGF2;ETV5;GDF7;COL1A1;BMP4;EFEMP1;LBH;SALL3;ABL1;TASP1,GO_BP,pink,13
regulation of transcription by RNA polymerase II (GO:0006357),11/2206,0.930976378757941,0.935795928604833,0,0,0.665459777005155,0.0475945975467831,BMP4;ARF4;SALL3;ABL1;AEBP1;INHBA;MEOX2;FGF2;BMP6;ETV5;SLC9A1,GO_BP,pink,11
Fibroblasts,21/232,2.30177386583796e-17,2.53195125242176e-15,0,0,15.8958501907294,608.974257197233,ITIH5;PDGFRA;COL15A1;SCARA5;LAMA4;BGN;LTBP2;FMO2;THBS2;FGF2;ASPN;COL1A1;ADAMTS5;COL3A1;EFEMP1;LOX;FAP;FRZB;ITGBL1;SVEP1;CTHRC1,PanglaoDB,pink,21
Peritubular Myoid Cells,16/120,3.6519906578899e-16,1.4060434652013e-14,0,0,23.7403846153846,843.877826409218,PDGFRA;COL15A1;FAM114A1;CPXM2;LAMA4;BGN;THBS2;ASPN;COL1A1;ADAMTS5;SMOC2;COL3A1;EFEMP1;FRZB;SVEP1;MATN2,PanglaoDB,pink,16
Leydig Cells,17/145,3.83466399600355e-16,1.4060434652013e-14,0,0,20.630905511811,732.341022840329,PDGFRA;FAM114A1;CPXM2;BGN;PRICKLE2;FMO2;INHBA;THBS2;COL1A1;ANO1;SMOC2;COL3A1;EFEMP1;FRZB;CPE;SVEP1;MATN2,PanglaoDB,pink,17
Juxtaglomerular Cells,15/103,8.1827502093914e-16,2.25025630758264e-14,0,0,26.1205073995772,907.409009446718,PDGFRA;COL15A1;FAM114A1;CPXM2;SLC2A10;BGN;THBS2;ASPN;COL1A1;ANO1;SMOC2;COL3A1;FRZB;SVEP1;MATN2,PanglaoDB,pink,15
Chondrocytes,16/146,8.72652533163135e-15,1.9198355729589e-13,0,0,18.9673076923077,614.017444501196,CHODL;PDGFRA;COL15A1;LAMA4;BGN;LTBP2;AEBP1;THBS2;HAPLN1;COMP;COL1A1;ADAMTS5;ACAN;COL3A1;FAP;FRZB,PanglaoDB,pink,16
Endothelial Cells (Aorta),17/185,2.3548329872538e-14,4.3171938099653e-13,0,0,15.686914135733,492.250996700405,PTGIS;FAM114A1;PCOLCE2;LAMA4;BGN;MICAL2;LTBP2;GNG12;BMP6;COL1A1;BMP4;EHD3;COL3A1;EFEMP1;LOX;ITGBL1;SVEP1,PanglaoDB,pink,17
Stromal Cells,14/124,2.926432315528e-13,4.59867935297258e-12,0,0,19.3317482517483,557.910816733702,PDGFRA;COL15A1;CFH;LAMA4;BGN;LTBP2;AEBP1;THBS2;BMP4;COL1A1;ADAMTS5;COL3A1;FAP;SVEP1,PanglaoDB,pink,14
Vascular Smooth Muscle Cells,13/103,4.95756056233746e-13,6.816645773214e-12,0,0,21.7945716709075,617.498895387405,PDGFRA;COL15A1;ECM2;SEMA3D;LAMA4;BGN;THBS2;ASPN;COL1A1;ADAMTS5;COL3A1;FAP;SVEP1,PanglaoDB,pink,13
Adipocytes,16/210,2.59311448222309e-12,3.16936214493933e-11,0,0,12.6688144329897,337.980676948249,PDGFRA;COL15A1;ECM2;CFH;FAM114A1;BGN;LTBP2;FMO2;THBS2;ASPN;COL1A1;ADAMTS5;COL3A1;LOX;FAP;SVEP1,PanglaoDB,pink,16
Mesangial Cells,14/148,3.41922299806061e-12,3.76114529786667e-11,0,0,15.8500574052813,418.466998971544,PDGFRA;COL15A1;FAM114A1;LAMA4;BGN;LTBP2;PTN;THBS2;COL1A1;ADAMTS5;COL3A1;EFEMP1;FAP;SVEP1,PanglaoDB,pink,14
Pulmonary Vascular Smooth Muscle Cells,12/99,6.59835663266497e-12,6.59835663266497e-11,0,0,20.6572622779519,531.804701719075,COL1A1;PDGFRA;ADAMTS5;COL15A1;COL3A1;FAP;LAMA4;BGN;SVEP1;AEBP1;PTN;THBS2,PanglaoDB,pink,12
Pancreatic Stellate Cells,12/111,2.61584835160924e-11,2.39786098897513e-10,0,0,18.1423324150597,442.071448351277,COL1A1;PDGFRA;ADAMTS5;COL15A1;COL3A1;LOX;FAP;LAMA4;BGN;LTBP2;INHBA;THBS2,PanglaoDB,pink,12
Pericytes,13/155,9.61733390089818e-11,8.13774406999077e-10,0,0,13.7771207397054,317.767484203569,PDGFRA;COL15A1;ECM2;LAMA4;BGN;THBS2;ASPN;COL1A1;ADAMTS5;COL3A1;FAP;FRZB;SVEP1,PanglaoDB,pink,13
Mesothelial Cells,12/144,5.61653426403579e-10,4.41299120745669e-09,0,0,13.5840220385675,289.341518685816,COL1A1;ANO1;COL3A1;EFEMP1;LOX;FAM114A1;BGN;PRICKLE2;SVEP1;FMO2;GNG12;MATN2,PanglaoDB,pink,12
Myofibroblasts,10/100,2.72190900463152e-09,1.99606660339645e-08,0,0,16.3897180762852,323.236911347086,COL1A1;PDGFRA;ADAMTS5;COL3A1;FAP;LAMA4;BGN;SVEP1;PTN;THBS2,PanglaoDB,pink,10
M?ller Cells,11/147,9.40091173854474e-09,6.46312682024951e-08,0,0,11.9924812030075,221.650544048604,COL1A1;PDGFRA;COL3A1;FRZB;BGN;PRICKLE2;CPE;PTN;SLC6A1;THBS2;DCLK1,PanglaoDB,pink,11
Osteoblasts,11/154,1.52953794519773e-08,9.8970102336324e-08,0,0,11.4013880855986,205.176131171574,COL1A1;PDGFRA;COL3A1;EFEMP1;LOX;FAM114A1;FAP;BGN;SVEP1;LTBP2;THBS2,PanglaoDB,pink,11
Smooth Muscle Cells,11/169,4.0099068214354e-08,2.3366208461447e-07,0,0,10.311125916056,175.618196847784,COL1A1;PDGFRA;ADAMTS5;COL15A1;COL3A1;LOX;PDGFD;LAMA4;BGN;SVEP1;THBS2,PanglaoDB,pink,11
Hepatic Stellate Cells,10/132,4.03598146152267e-08,2.3366208461447e-07,0,0,12.0712013701982,205.517408849146,COL1A1;PDGFRA;ADAMTS5;COL3A1;FAP;FRZB;LAMA4;BGN;SVEP1;THBS2,PanglaoDB,pink,10
Melanocytes,9/133,5.16182370425217e-07,2.83900303733869e-06,0,0,10.6086021505376,153.578672112173,COL1A1;LOX;FAM114A1;FAP;LAMA4;PRICKLE2;PTN;GNG12;THBS2,PanglaoDB,pink,9
Loop Of Henle Cells,9/147,1.19868838586493e-06,6.27884392595914e-06,0,0,9.5256038647343,129.874775129578,PDGFRA;ADAMTS5;ANO1;COL3A1;FAM114A1;FRZB;BGN;PRICKLE2;FMO2,PanglaoDB,pink,9
Endothelial Cells,11/246,1.72982210609259e-06,8.64911053046294e-06,0,0,6.90548712206047,91.6184950347216,PDGFRA;EHD3;COL15A1;COL3A1;LOX;CFH;SEMA3D;LAMA4;BGN;FMO2;MEOX2,PanglaoDB,pink,11
Meningeal Cells,8/115,1.83606772880723e-06,8.78119348559979e-06,0,0,10.8570643210555,143.398850227432,PDGFRA;COL3A1;FRZB;LAMA4;BGN;CPE;SVEP1;PTN,PanglaoDB,pink,8
Enterochromaffin Cells,7/109,1.39945618786833e-05,6.4141741943965e-05,0,0,9.89537712895377,110.599064138294,ITIH5;PDGFRA;FGF14;FRZB;LAMA4;BGN;MASP1,PanglaoDB,pink,7
Adipocyte Progenitor Cells,7/115,1.9853012722442e-05,8.73532559787446e-05,0,0,9.34279535009462,101.155891407309,COL1A1;COL3A1;EFEMP1;SCARA5;LOX;SVEP1;GNG12,PanglaoDB,pink,7
Schwann Cells,7/138,6.3994400762552e-05,0.00027074554168772,0,0,7.69348637655318,74.2938050371561,CPE;PTN;SLC6A1;CORO2B;DCLK1;MATN2;CTHRC1,PanglaoDB,pink,7
Airway Smooth Muscle Cells,6/99,8.11307636343069e-05,0.000330532740732361,0,0,9.2393641888733,87.0297136634445,COL1A1;PDGFRA;COL3A1;LOX;LAMA4;BGN,PanglaoDB,pink,6
Peri-islet Schwann Cells,6/114,0.000176793238558434,0.000670595042807854,0,0,7.95008051529791,68.6929064277404,FRZB;PRICKLE2;CPE;PTN;OLFML2A;DCLK1,PanglaoDB,pink,6
Radial Glia Cells,6/114,0.000176793238558434,0.000670595042807854,0,0,7.95008051529791,68.6929064277404,PDGFD;CPE;PTN;SLC6A1;CORO2B;DCLK1,PanglaoDB,pink,6
Myoepithelial Cells,6/115,0.000185432198984912,0.000679918062944677,0,0,7.87674511368169,67.6834627688987,COL1A1;ANO1;EFEMP1;FAM114A1;LTBP2;GNG12,PanglaoDB,pink,6
Tanycytes,6/121,0.000244514166562892,0.000867630913610261,0,0,7.46351606805293,62.0683707872495,FRZB;PRICKLE2;CPE;PTN;SLC16A2;DCLK1,PanglaoDB,pink,6
Oligodendrocyte Progenitor Cells,6/125,0.000291493679865437,0.00100200952453744,0,0,7.2111801242236,58.7025557979983,PDGFRA;PTN;SLC6A1;CORO2B;DCLK1;ETV5,PanglaoDB,pink,6
Mast Cells,8/235,0.000308082973716702,0.00102694324572234,0,0,5.08655091992744,41.1254835077406,EXT1;SGCE;PDGFRA;COL15A1;CFH;FMO2;DGKI;SLC6A4,PanglaoDB,pink,8
Glomus Cells,6/127,0.00031749653457138,0.00102719467067211,0,0,7.09126841537909,57.1204766511373,FRZB;BGN;PRICKLE2;CPE;PTN;DCLK1,PanglaoDB,pink,6
Pulmonary Alveolar Type I Cells,6/131,0.000374942084337709,0.00117838940791851,0,0,6.86295652173913,54.1400726701206,COL1A1;ANO1;EFEMP1;FAM114A1;OLFML2A;GNG12,PanglaoDB,pink,6
Osteocytes,5/98,0.000716280371535938,0.00218863446858203,0,0,7.64407828575849,55.3541257560093,COL1A1;PTN;SLC16A2;GNG12;CNN3,PanglaoDB,pink,5
Enteric Glia Cells,5/111,0.00125473586134517,0.00373029580399916,0,0,6.70218542147414,44.7761627536841,SMOC2;FRZB;PTN;SLC6A1;DCLK1,PanglaoDB,pink,5
Podocytes,6/184,0.00218412556935505,0.00618925559489928,0,0,4.80654616511969,29.4474960332757,MYO1D;EFEMP1;PRICKLE2;CPE;GNG12;CORO2B,PanglaoDB,pink,6
Myoblasts,5/126,0.00219437243819156,0.00618925559489928,0,0,5.86687674653666,35.916193259829,COL1A1;COL3A1;FAM114A1;BGN;GNG12,PanglaoDB,pink,5
Alpha Cells,5/136,0.00305460195915804,0.00840015538768462,0,0,5.41627766489099,31.3662380094178,RGS4;FGF14;FAP;FRZB;CPE,PanglaoDB,pink,5
Epsilon Cells,5/138,0.00325218378657088,0.00872537113470237,0,0,5.3342889598096,30.5570932991208,BMP4;FRZB;NPY1R;MASP1;MATN2,PanglaoDB,pink,5
His Bundle Cells,4/98,0.00551905421098629,0.0144546657906784,0,0,6.00668693009119,31.2320616509201,LAMA4;SLC16A2;FGF2;MYH10,PanglaoDB,pink,4
Crypt Cells,4/110,0.00825733441381861,0.0211234136167453,0,0,5.32345013477089,25.5347454746701,SMOC2;FRZB;APCDD1;LGR5,PanglaoDB,pink,4
Choroid Plexus Cells,4/117,0.0102042047967596,0.0255105119918991,0,0,4.99190897597977,22.8876800589617,FRZB;PRICKLE2;CPE;SLC16A2,PanglaoDB,pink,4
Gamma (PP) Cells,4/128,0.0138251794835416,0.0337948831819907,0,0,4.54654377880184,19.4649530639866,FGF14;FRZB;CPE;SLC6A1,PanglaoDB,pink,4
Satellite Cells,4/139,0.018173706502087,0.0434588633745559,0,0,4.17375661375661,16.7274958906235,COL1A1;COL3A1;EFEMP1;GNG12,PanglaoDB,pink,4
Astrocytes,4/154,0.0253434082609566,0.0593143597596856,0,0,3.75352380952381,13.7950881284452,LUZP2;PTN;SLC16A2;SLC6A1,PanglaoDB,pink,4
Sertoli Cells,4/158,0.0275050610716798,0.0630324316225995,0,0,3.65528756957328,13.1348564453197,FAM114A1;SLC2A10;BGN;MATN2,PanglaoDB,pink,4
Cardiomyocytes,4/174,0.0372293612258335,0.0835761170375854,0,0,3.30857142857143,10.8873755470289,BMP4;LOX;CACNA1S;FGF2,PanglaoDB,pink,4
Granulosa Cells,3/112,0.0472335172490944,0.101876213674517,0,0,3.854577396057,11.766681574748,GPR176;LOX;GNG12,PanglaoDB,pink,3
Retinal Progenitor Cells,3/112,0.0472335172490944,0.101876213674517,0,0,3.854577396057,11.766681574748,SALL3;CPE;LGR5,PanglaoDB,pink,3
Chromaffin Cells,3/122,0.0581449372374831,0.122998905694676,0,0,3.52887537993921,10.0390027931411,RGS4;CPE;DCLK1,PanglaoDB,pink,3
Luteal Cells,3/125,0.0616310590346347,0.127913518751129,0,0,3.44157656086502,9.59026052427371,CPE;SLC16A2;GNG12,PanglaoDB,pink,3
Delta Cells,3/131,0.0688882616918325,0.140327940483363,0,0,3.27925531914894,8.77289168160926,FRZB;CPE;SLC6A1,PanglaoDB,pink,3
Anterior Pituitary Gland Cells,3/133,0.0713899966737564,0.142779993347513,0,0,3.22847790507365,8.52188227825896,PDGFRA;FGF14;FRZB,PanglaoDB,pink,3
Neural Stem/Precursor Cells,3/152,0.0971010499693814,0.190734205296999,0,0,2.81407968013708,6.5624425108928,SALL3;PTN;DCLK1,PanglaoDB,pink,3
Myocytes,3/163,0.113471518433482,0.218980123292684,0,0,2.61914893617021,5.6998008526429,CHODL;COL3A1;CACNA1S,PanglaoDB,pink,3
Cajal-Retzius Cells,3/174,0.130809100675825,0.248086225419668,0,0,2.44929700136867,4.98190993944977,SMOC2;NRG1;DCLK1,PanglaoDB,pink,3
Olfactory Epithelial Cells,3/226,0.222772910556634,0.371288184261057,0,0,1.87319912222116,2.81280023146592,PCOLCE2;CPE;NRG1,PanglaoDB,pink,3
Neurons,3/289,0.345400381789269,0.513432999957021,0,0,1.45588454099092,1.54767952870998,CHODL;LUZP2;MATN2,PanglaoDB,pink,3
protein phosphorylation (GO:0006468),28/496,0.000106333557378975,0.096771239589828,0,0,2.32161172161172,21.2402622850827,APP;ROCK2;IGF1R;EEF2K;ERBB4;NEK1;STK38L;MAPK1;JAK2;MAPK6;ROS1;PDK1;CSNK1A1;PRKCE;DYRK1A;VRK2;BAZ1B;HIPK2;SRPK1;LATS2;WNK1;PEAK1;SIK3;ULK2;TNIK;TOP1;TEK;BMPR1A,GO_BP,brown,28
establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),6/32,0.000149794507157508,0.096771239589828,0,0,8.76923076923077,77.2240047472998,DLG1;DLG2;OPHN1;ERBIN;LIN7A;MYO9A,GO_BP,brown,6
regulation of cell-substrate junction assembly (GO:0090109),5/21,0.000164943100461245,0.096771239589828,0,0,11.8579434697856,103.281620279163,MACF1;ROCK2;PEAK1;CLASP1;VCL,GO_BP,brown,5
microtubule anchoring (GO:0034453),4/12,0.000186594870928915,0.096771239589828,0,0,18.943579766537,162.660388054578,PCM1;DAG1;BICD2;CLASP1,GO_BP,brown,4
cell-substrate junction assembly (GO:0007044),6/34,0.000212776497397534,0.096771239589828,0,0,8.14202008928571,68.8429639612175,DST;PEAK1;ITGA6;PTPRK;FERMT2;PLEC,GO_BP,brown,6
regulation of cellular component organization (GO:0051128),12/139,0.0002719841042655,0.096771239589828,0,0,3.61426659612213,29.6722863899729,RPTOR;ARHGEF11;TJP1;OPHN1;ROCK2;RAPGEF1;STK38L;RAPGEF2;PTPN11;ANKRA2;ROS1;PICALM,GO_BP,brown,12
phosphorylation (GO:0016310),23/400,0.000332874116694098,0.096771239589828,0,0,2.35466066500549,18.8555249157254,APP;CSNK1A1;ROCK2;PRKCE;STAT3;DYRK1A;VRK2;HIPK2;SRPK1;LATS2;WNK1;PEAK1;SIK3;NEK1;STK38L;MAPK1;TNIK;TOP1;JAK2;MAPK6;ROS1;PDK1;BMPR1A,GO_BP,brown,23
regulation of cellular component biogenesis (GO:0044087),6/39,0.000462671862239261,0.096771239589828,0,0,6.90660511363636,53.032315399794,TJP1;ROCK2;RAPGEF1;RAPGEF2;PTPN11;ANKRA2,GO_BP,brown,6
regulation of focal adhesion assembly (GO:0051893),7/54,0.000463535278783791,0.096771239589828,0,0,5.66452929175168,43.4844845189346,MACF1;PEAK1;ROCK2;TEK;VCL;CLASP1;FERMT2,GO_BP,brown,7
cytoplasmic microtubule organization (GO:0031122),7/54,0.000463535278783791,0.096771239589828,0,0,5.66452929175168,43.4844845189346,PCM1;CLIP1;DLG1;DST;HOOK1;SLAIN2;CLASP1,GO_BP,brown,7
regulation of intracellular signal transduction (GO:1902531),24/437,0.000483444939828967,0.096771239589828,0,0,2.24316985423141,17.125644290391,ARHGEF11;STARD13;RALBP1;ITSN1;OCRL;CHD4;VRK2;BRCA1;ARHGAP26;MYO9A;HIPK2;SYDE2;CYLD;DLG1;OPHN1;PRKAR1A;GNA12;CAPN3;MAPK1;TNIK;TEK;RFFL;ROS1;TAF3,GO_BP,brown,24
steroid hormone mediated signaling pathway (GO:0043401),4/15,0.000483690473876247,0.096771239589828,0,0,13.7750265298903,105.159453038625,AR;ABHD2;PGR;ESR2,GO_BP,brown,4
post-Golgi vesicle-mediated transport (GO:0006892),9/89,0.000495285871916443,0.096771239589828,0,0,4.28826129666012,32.63527846558,RAB10;APP;EXOC8;DNAJC6;SORT1;GOLGB1;AP4E1;VPS13A;EXOC6B,GO_BP,brown,9
regulation of cardiac muscle cell contraction (GO:0086004),5/27,0.000575642901577302,0.0974755313337566,0,0,8.62130072656388,64.3151021589429,DLG1;PDE4D;CACNA1C;SCN5A;DSC2,GO_BP,brown,5
regulation of cell junction assembly (GO:1901888),5/27,0.000575642901577302,0.0974755313337566,0,0,8.62130072656388,64.3151021589429,TJP1;MEF2C;ROCK2;RAPGEF1;RAPGEF2,GO_BP,brown,5
peptidyl-serine phosphorylation (GO:0018105),12/156,0.000772961396820142,0.122707621745197,0,0,3.18478260869565,22.8198637485431,LATS2;WNK1;ROCK2;CSNK1A1;PRKCE;DYRK1A;ULK2;STK38L;MAPK1;VRK2;TOP1;HIPK2,GO_BP,brown,12
regulation of NMDA receptor activity (GO:2000310),5/32,0.00129091718334372,0.187385159986778,0,0,7.02295863114577,46.7195462799004,APP;GRIN2A;MEF2C;DLG1;DLG2,GO_BP,brown,5
Golgi to plasma membrane transport (GO:0006893),6/48,0.00143008120532747,0.187385159986778,0,0,5.42410714285714,35.52803223213,RAB10;MACF1;EXOC8;KIF13A;EXOC6B;ANK3,GO_BP,brown,6
peptidyl-serine modification (GO:0018209),12/169,0.00154675430528207,0.187385159986778,0,0,2.91911079781476,18.8913073393634,LATS2;WNK1;ROCK2;CSNK1A1;PRKCE;DYRK1A;ULK2;STK38L;MAPK1;VRK2;TOP1;HIPK2,GO_BP,brown,12
establishment of epithelial cell polarity (GO:0090162),4/20,0.00154924738571745,0.187385159986778,0,0,9.46789883268482,61.2571731200824,OPHN1;MYO18A;MYO9A;CLASP1,GO_BP,brown,4
maintenance of protein location in nucleus (GO:0051457),4/20,0.00154924738571745,0.187385159986778,0,0,9.46789883268482,61.2571731200824,SUN1;TAF3;TOPORS;SYNE1,GO_BP,brown,4
regulation of Ras protein signal transduction (GO:0046578),8/86,0.00173601479154157,0.200430798659799,0,0,3.90226244343891,24.8034167145954,KANK2;STARD13;OPHN1;RAPGEF1;ERBIN;SHOC2;JAK2;OGT,GO_BP,brown,8
endomembrane system organization (GO:0010256),13/199,0.00212022595298486,0.217599605396616,0,0,2.67058447780262,16.4407392617081,SUN1;EXOC8;CSNK1A1;COG3;MIA3;ANK3;SYNE1;ALS2;HOOK1;GOLGB1;MYO18A;CLASP1;SEC31A,GO_BP,brown,13
regulation of cation channel activity (GO:2001257),8/89,0.00216054442373614,0.217599605396616,0,0,3.75715323166304,23.0591336123566,APP;MEF2C;GRIN2A;DLG1;DLG2;PDE4D;DMD;ANK3,GO_BP,brown,8
regulation of embryonic development (GO:0045995),5/36,0.00221999856753018,0.217599605396616,0,0,6.11551279632774,37.3673042869993,DAG1;PLCB1;CCSAP;CLASP1;B4GALT5,GO_BP,brown,5
protein localization to cell junction (GO:1902414),4/22,0.00224519818914805,0.217599605396616,0,0,8.41504539559014,51.3230377322756,TJP1;PCLO;HEG1;FERMT2,GO_BP,brown,4
cellular protein modification process (GO:0006464),42/1025,0.00231306667153883,0.217599605396616,0,0,1.6604930883849,10.0778332212907,APP;ROCK2;EPAS1;MIA3;PTPRK;DCAF5;PPM1E;PTPRG;MAN2A2;NEK1;STK38L;MAPK1;FEM1C;CHML;JAK2;SBF1;MAPK6;ROS1;PDK1;CSNK1A1;FEM1B;PRKCE;RHBDD1;COG3;DYRK1A;VRK2;SSH2;HIPK2;SRPK1;PPM1A;LATS2;WNK1;GAN;PEAK1;PIGK;SIK3;TNIK;PTPN4;FBXL4;KBTBD8;BMPR1A;B4GALT5,GO_BP,brown,42
regulation of ventricular cardiac muscle cell action potential (GO:0098911),3/12,0.00319169134333967,0.248637246007664,0,0,12.6038834951456,72.4370934328402,DLG1;CACNA1C;DSC2,GO_BP,brown,3
hemidesmosome assembly (GO:0031581),3/12,0.00319169134333967,0.248637246007664,0,0,12.6038834951456,72.4370934328402,DST;ITGA6;PLEC,GO_BP,brown,3
microtubule anchoring at microtubule organizing center (GO:0072393),3/12,0.00319169134333967,0.248637246007664,0,0,12.6038834951456,72.4370934328402,NIN;PCM1;BICD2,GO_BP,brown,3
positive regulation of sodium ion transmembrane transport (GO:1902307),3/12,0.00319169134333967,0.248637246007664,0,0,12.6038834951456,72.4370934328402,WNK1;DMD;ANK3,GO_BP,brown,3
cell morphogenesis involved in neuron differentiation (GO:0048667),7/76,0.00351596517596366,0.248637246007664,0,0,3.85407980941036,21.7772513572689,RAB10;APP;MEF2C;OPHN1;MAP1B;ANK3;CELSR2,GO_BP,brown,7
protein import into nucleus (GO:0006606),7/76,0.00351596517596366,0.248637246007664,0,0,3.85407980941036,21.7772513572689,RANBP2;IPO11;IPO8;STAT3;FAM53C;KPNA6;KPNA3,GO_BP,brown,7
neuron projection morphogenesis (GO:0048812),10/140,0.00355598755753055,0.248637246007664,0,0,2.93034524530588,16.5245756893659,RAB10;APP;ANKRD27;SLC9A6;ALS2;MAP1B;ANK3;TNIK;CELSR2;ZNF365,GO_BP,brown,10
regulation of sodium ion transmembrane transporter activity (GO:2000649),5/40,0.00356027277839266,0.248637246007664,0,0,5.41548315232526,30.5320505600668,WNK1;PRKCE;HECW2;DMD;ANK3,GO_BP,brown,5
heart development (GO:0007507),11/164,0.00371142036241097,0.248637246007664,0,0,2.74095989480605,15.3393452207183,MEF2C;SGCD;ERBB4;HEG1;CHD7;RBM20;PTPN11;CACNA1C;UTY;TEK;KDM6A,GO_BP,brown,11
regulation of GTPase activity (GO:0043087),12/189,0.00389614197400893,0.248637246007664,0,0,2.58658806190125,14.3497916504594,RALBP1;FGD6;ALS2;WNK1;RAPGEF1;PLXNA1;RAPGEF2;OCRL;PKP4;ITGA6;FERMT2;PICALM,GO_BP,brown,12
axonogenesis (GO:0007409),14/240,0.00409177121459982,0.248637246007664,0,0,2.36676499508358,13.0143137308549,APP;PTPN11;ANK3;ENAH;RAB10;OPHN1;SLC9A6;PALLD;MAP1B;DOK6;DAG1;ULK2;MAPK1;B4GALT5,GO_BP,brown,14
clathrin-dependent endocytosis (GO:0072583),4/26,0.00422870232093209,0.248637246007664,0,0,6.88362221436151,37.6249160938338,DNAJC6;ITSN1;FNBP1L;PICALM,GO_BP,brown,4
hippo signaling (GO:0035329),4/26,0.00422870232093209,0.248637246007664,0,0,6.88362221436151,37.6249160938338,TJP1;LATS2;AMOTL1;TEAD1,GO_BP,brown,4
histone lysine demethylation (GO:0070076),4/26,0.00422870232093209,0.248637246007664,0,0,6.88362221436151,37.6249160938338,KDM5D;RIOX2;UTY;KDM6A,GO_BP,brown,4
histone H3-K4 trimethylation (GO:0080182),3/14,0.0050812474866899,0.248637246007664,0,0,10.3112091791703,54.465853445882,WDR82;BEND3;OGT,GO_BP,brown,3
nuclear migration (GO:0007097),3/14,0.0050812474866899,0.248637246007664,0,0,10.3112091791703,54.465853445882,PCM1;SYNE2;PAFAH1B1,GO_BP,brown,3
polarized epithelial cell differentiation (GO:0030859),3/14,0.0050812474866899,0.248637246007664,0,0,10.3112091791703,54.465853445882,RAB10;OPHN1;MYO9A,GO_BP,brown,3
positive regulation of cardiac muscle cell proliferation (GO:0060045),3/14,0.0050812474866899,0.248637246007664,0,0,10.3112091791703,54.465853445882,MEF2C;ERBB4;BMPR1A,GO_BP,brown,3
positive regulation of sodium ion transmembrane transporter activity (GO:2000651),3/14,0.0050812474866899,0.248637246007664,0,0,10.3112091791703,54.465853445882,WNK1;DMD;ANK3,GO_BP,brown,3
chromatin remodeling (GO:0006338),8/103,0.00532109688124627,0.248637246007664,0,0,3.20115583075335,16.7614946292809,TADA2B;HDAC4;KDM5D;CHD4;INO80;TOP1;BAZ1B;KDM6A,GO_BP,brown,8
circulatory system development (GO:0072359),9/126,0.005554587649536,0.248637246007664,0,0,2.92655281849781,15.1979724257874,MEF2C;ERBB4;HEG1;RBM20;PTPN11;CACNA1C;UTY;TEK;KDM6A,GO_BP,brown,9
positive regulation of microtubule polymerization (GO:0031116),4/28,0.00556035747625222,0.248637246007664,0,0,6.30933852140078,32.7586716049884,CLIP1;SLAIN2;CKAP5;CLASP1,GO_BP,brown,4
protein localization to Golgi apparatus (GO:0034067),4/28,0.00556035747625222,0.248637246007664,0,0,6.30933852140078,32.7586716049884,VPS13D;VPS13A;ARL5A;BICD2,GO_BP,brown,4
response to cytokine (GO:0034097),10/150,0.00577664175025175,0.248637246007664,0,0,2.71962879640045,14.0167839956341,HDAC4;APP;IL1RAPL1;STAT3;BCL2;IFNLR1;PTPN11;AFF3;JAK2;PTPN4,GO_BP,brown,10
plasma membrane bounded cell projection assembly (GO:0120031),15/278,0.00617113532480471,0.248637246007664,0,0,2.17920613202912,11.0875228436137,EXOC8;OCRL;FNBP1L;DYNLL2;PCM1;ABLIM1;FGD6;OPHN1;FAM161A;S1PR1;RAPGEF2;NEK1;TNIK;SSX2IP;VCL,GO_BP,brown,15
establishment of endothelial barrier (GO:0061028),4/29,0.00632018531607748,0.248637246007664,0,0,6.05665369649806,30.6709351959616,TJP1;PDE4D;RAPGEF1;RAPGEF2,GO_BP,brown,4
vesicle organization (GO:0016050),5/46,0.00653512486383427,0.248637246007664,0,0,4.62154709266391,23.2489876205884,EXOC8;ALS2;SORT1;HOOK1;FNBP1L,GO_BP,brown,5
regulation of cell-matrix adhesion (GO:0001952),6/65,0.00666102143013187,0.248637246007664,0,0,3.85785222457627,19.3335586730276,MACF1;PEAK1;ROCK2;PLEKHA2;VCL;CLASP1,GO_BP,brown,6
cellular response to metal ion (GO:0071248),9/131,0.00712700329059363,0.248637246007664,0,0,2.80588746819543,13.8719272450992,SLC12A2;CPNE8;MEF2C;DLG2;CAPN3;MAPK1;ANK3;SCN5A;ADCY1,GO_BP,brown,9
cardiac muscle cell action potential (GO:0086001),4/30,0.00714587360573206,0.248637246007664,0,0,5.82340616581862,28.7747322198341,KCND3;DMD;CACNA1C;SCN5A,GO_BP,brown,4
Golgi to plasma membrane protein transport (GO:0043001),4/30,0.00714587360573206,0.248637246007664,0,0,5.82340616581862,28.7747322198341,RAB10;MACF1;KIF13A;ANK3,GO_BP,brown,4
histone H3-K4 methylation (GO:0051568),4/30,0.00714587360573206,0.248637246007664,0,0,5.82340616581862,28.7747322198341,WDR82;BEND3;OGT;KDM6A,GO_BP,brown,4
maintenance of blood-brain barrier (GO:0035633),4/30,0.00714587360573206,0.248637246007664,0,0,5.82340616581862,28.7747322198341,SLC12A2;TJP1;DMD;VCL,GO_BP,brown,4
peptidyl-lysine trimethylation (GO:0018023),4/30,0.00714587360573206,0.248637246007664,0,0,5.82340616581862,28.7747322198341,WDR82;BEND3;KMT5B;OGT,GO_BP,brown,4
positive regulation of small GTPase mediated signal transduction (GO:0051057),4/30,0.00714587360573206,0.248637246007664,0,0,5.82340616581862,28.7747322198341,ERBIN;RAPGEF1;SHOC2;JAK2,GO_BP,brown,4
retrograde axonal transport (GO:0008090),3/16,0.00752268915871189,0.258211222474705,0,0,8.72397311426438,42.6587594470283,DLG2;DST;PAFAH1B1,GO_BP,brown,3
response to endoplasmic reticulum stress (GO:0034976),8/110,0.00784753031016187,0.265769693170815,0,0,2.98039215686275,14.4476190949507,NIBAN1;RNF139;RHBDD1;CREB3L2;SEL1L;BCL2;HYOU1;ATF6,GO_BP,brown,8
cellular component assembly (GO:0022607),14/261,0.00839733226480797,0.272988270299524,0,0,2.1631803868646,10.3396587601729,MYO7B;LIN7A;ANK3;MYO9A;PCLO;OPHN1;CALD1;CAPN3;TEAD1;KPNA3;FERMT2;MDN1;PLS1;PICALM,GO_BP,brown,14
protein autophosphorylation (GO:0046777),10/159,0.00858785448800667,0.272988270299524,0,0,2.55416688685726,12.1512097479785,EEF2K;PEAK1;ERBB4;DYRK1A;ULK2;VRK2;TNIK;TEK;JAK2;IGF1R,GO_BP,brown,10
positive regulation of cardiac muscle tissue growth (GO:0055023),3/17,0.00896126306160308,0.272988270299524,0,0,8.1004160887656,38.1921989650501,MEF2C;ERBB4;BMPR1A,GO_BP,brown,3
regulation of dendrite morphogenesis (GO:0048814),4/32,0.00900380529475909,0.272988270299524,0,0,5.40689271817677,25.4670485414637,HECW2;IL1RAPL1;RAPGEF2;TNIK,GO_BP,brown,4
chondrocyte differentiation (GO:0002062),4/32,0.00900380529475909,0.272988270299524,0,0,5.40689271817677,25.4670485414637,MEF2C;SNX19;CREB3L2;SOX5,GO_BP,brown,4
neuron migration (GO:0001764),5/50,0.00928689487786331,0.272988270299524,0,0,4.20987654320988,19.6986481445174,MEF2C;MAP1B;RAPGEF2;PEX13;PAFAH1B1,GO_BP,brown,5
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),19/404,0.00945786133321186,0.272988270299524,0,0,1.88867605340551,8.80294720820718,ROCK2;SORT1;ITSN1;STAT3;PTPN11;PTPRG;IGF1R;ERBB4;POLR2D;RAPGEF1;COL4A6;RAPGEF2;MAPK1;SHOC2;TEK;JAK2;PLCB1;ROS1;ATP6V1E2,GO_BP,brown,19
Wnt signaling pathway (GO:0016055),7/92,0.00991676925636344,0.276248033405076,0,0,3.12602739726027,14.4220152090348,AMER1;CSNK1A1;USP34;DIXDC1;STRN;CELSR2;FERMT2,GO_BP,brown,7
regulation of epithelial cell migration (GO:0010632),5/51,0.0100826193375886,0.276248033405076,0,0,4.11814560555979,18.9308773000758,MACF1;CAPN7;PRKCE;CLASP1;PTPRG,GO_BP,brown,5
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),5/51,0.0100826193375886,0.276248033405076,0,0,4.11814560555979,18.9308773000758,BCL2;BRCA1;USP28;TOPORS;HIPK2,GO_BP,brown,5
regulation of G1/S transition of mitotic cell cycle (GO:2000045),6/71,0.0101508157722292,0.276248033405076,0,0,3.50066105769231,16.0687386055811,RPTOR;KANK2;DLG1;CCND1;INO80;PLCB1,GO_BP,brown,6
regulation of cell migration (GO:0030334),19/408,0.010426659026707,0.276248033405076,0,0,1.86886369139307,8.52835273076581,MACF1;ROCK2;STAT3;MIA3;PTPRK;SYNE2;CCAR1;IGF1R;TJP1;ERBB4;RUFY3;GNA12;DAG1;PLXNA1;ITGA6;AMOTL1;RFFL;FERMT2;VCL,GO_BP,brown,19
supramolecular fiber organization (GO:0097435),17/351,0.0104383692252179,0.276248033405076,0,0,1.9453069908088,8.87500972020286,APP;DST;MYO7B;SHROOM3;SLAIN2;CKAP5;COL19A1;PCM1;CLIP1;DLG1;HOOK1;RUFY3;FAT1;COL4A6;CAPN3;ITGA6;PLEC,GO_BP,brown,17
regulation of establishment or maintenance of cell polarity (GO:0032878),3/18,0.0105496296221624,0.276248033405076,0,0,7.56,34.4105838209476,ROCK2;RUFY3;TEK,GO_BP,brown,3
interleukin-6-mediated signaling pathway (GO:0070102),3/18,0.0105496296221624,0.276248033405076,0,0,7.56,34.4105838209476,STAT3;PTPN11;JAK2,GO_BP,brown,3
sodium ion import across plasma membrane (GO:0098719),3/18,0.0105496296221624,0.276248033405076,0,0,7.56,34.4105838209476,SLC12A2;SLC9A6;SLC9A7,GO_BP,brown,3
positive regulation of cell migration (GO:0030335),14/269,0.010764774240842,0.279005373181007,0,0,2.09444444444444,9.49092498461419,ROCK2;PRKCE;STAT3;MIA3;SYNE2;CCAR1;IGF1R;TJP1;CAPN7;RUFY3;RAPGEF2;ITGA6;FERMT2;CLASP1,GO_BP,brown,14
response to steroid hormone (GO:0048545),4/34,0.0111510324608423,0.286097196470096,0,0,5.04591439688716,22.6875573158357,AR;ABHD2;UBE3A;SOX30,GO_BP,brown,4
regulation of small GTPase mediated signal transduction (GO:0051056),9/141,0.0112696289995415,0.286248576588354,0,0,2.59198071084122,11.6267023887329,SYDE2;ARHGEF11;RALBP1;STARD13;OPHN1;ITSN1;OCRL;ARHGAP26;MYO9A,GO_BP,brown,9
establishment or maintenance of apical/basal cell polarity (GO:0035088),3/19,0.0122904884454393,0.292014956295003,0,0,7.0871359223301,31.1758120791794,DLG1;DLG2;ERBIN,GO_BP,brown,3
heart trabecula morphogenesis (GO:0061384),3/19,0.0122904884454393,0.292014956295003,0,0,7.0871359223301,31.1758120791794,S1PR1;TEK;BMPR1A,GO_BP,brown,3
NLS-bearing protein import into nucleus (GO:0006607),3/19,0.0122904884454393,0.292014956295003,0,0,7.0871359223301,31.1758120791794,RANBP2;KPNA6;KPNA3,GO_BP,brown,3
protein localization to membrane (GO:0072657),11/195,0.0129912165595809,0.292014956295003,0,0,2.27551239173313,9.88364665720454,RAB10;DLG1;DLG2;ROCK2;RAPGEF2;CAPN3;LIN7A;ANK3;TNIK;ARL5A;FERMT2,GO_BP,brown,11
regulation of microtubule-based process (GO:0032886),4/36,0.0136026696673363,0.295305820128497,0,0,4.73005836575875,20.3273747726578,MACF1;CYLD;BICD2;CLASP1,GO_BP,brown,4
regulation of ossification (GO:0030278),4/36,0.0136026696673363,0.295305820128497,0,0,4.73005836575875,20.3273747726578,MEF2C;S1PR1;TXLNG;PTPN11,GO_BP,brown,4
establishment of protein localization to plasma membrane (GO:0061951),4/36,0.0136026696673363,0.295305820128497,0,0,4.73005836575875,20.3273747726578,RAB10;MACF1;KIF13A;ANK3,GO_BP,brown,4
regulation of sodium ion transport (GO:0002028),4/36,0.0136026696673363,0.295305820128497,0,0,4.73005836575875,20.3273747726578,DLG1;WNK1;SCN5A;ANK3,GO_BP,brown,4
positive regulation of nucleic acid-templated transcription (GO:1903508),22/511,0.0144109429174383,0.308231693800255,0,0,1.72276370472986,7.30411745553745,HDAC4;NCOA1;ARHGEF11;EHF;MEF2C;ATMIN;STAT3;DYRK1A;RORB;BRCA1;RGMB;ESR2;HIPK2;AR;PPM1A;ERBB4;CREB3L2;CAPN3;PLCB1;TEAD1;PICALM;CREB5,GO_BP,brown,22
positive regulation of protein modification by small protein conjugation or removal (GO:1903322),6/77,0.0147759195934547,0.308231693800255,0,0,3.20384022887324,13.5034063584767,AMER1;HDAC4;DCUN1D4;UBE3A;BRCA1;TSPYL5,GO_BP,brown,6
glutamate receptor signaling pathway (GO:0007215),4/37,0.0149468677945612,0.308231693800255,0,0,4.58648744251857,19.2781694558563,APP;GRIN2A;PLCB1;CPEB4,GO_BP,brown,4
negative regulation of stress-activated MAPK cascade (GO:0032873),4/37,0.0149468677945612,0.308231693800255,0,0,4.58648744251857,19.2781694558563,CYLD;DLG1;DUSP19;AIDA,GO_BP,brown,4
"positive regulation of transcription, DNA-templated (GO:0045893)",43/1183,0.0158150270650867,0.308231693800255,0,0,1.45652077562327,6.0398926486276,HDAC4;APP;EHF;EPAS1;RORB;BRCA1;WDR43;YY1;RPTOR;SERTAD2;ERBB4;CREB3L2;NRIP1;CAPN3;TEAD1;NCOA1;ARHGEF11;UTP15;MEF2C;ATMIN;STAT3;DYRK1A;VEZF1;INO80;RGMB;SREBF2;ESR2;SOX30;HIPK2;AR;PPM1A;NFIC;ASXL3;RARB;PGR;ITGA6;PLCB1;LPIN1;ATF6;OGT;PICALM;BMPR1A;CREB5,GO_BP,brown,43
actin filament-based transport (GO:0099515),3/21,0.01623785139184,0.308231693800255,0,0,6.29902912621359,25.9545842173883,MYO7B;FNBP1L;SYNE2,GO_BP,brown,3
regulation of cardiac muscle cell proliferation (GO:0060043),3/21,0.01623785139184,0.308231693800255,0,0,6.29902912621359,25.9545842173883,MEF2C;ERBB4;BMPR1A,GO_BP,brown,3
regulation of fibroblast migration (GO:0010762),3/21,0.01623785139184,0.308231693800255,0,0,6.29902912621359,25.9545842173883,PRKCE;GNA12;RFFL,GO_BP,brown,3
focal adhesion assembly (GO:0048041),3/21,0.01623785139184,0.308231693800255,0,0,6.29902912621359,25.9545842173883,PEAK1;PTPRK;FERMT2,GO_BP,brown,3
neurotrophin signaling pathway (GO:0038179),3/21,0.01623785139184,0.308231693800255,0,0,6.29902912621359,25.9545842173883,SORT1;RAPGEF1;RAPGEF2,GO_BP,brown,3
synaptic vesicle endocytosis (GO:0048488),4/38,0.0163720082988694,0.308231693800255,0,0,4.45136186770428,18.304811098039,OPHN1;DNAJC6;ITSN1;PICALM,GO_BP,brown,4
cell junction assembly (GO:0034329),7/102,0.0168077484745711,0.308231693800255,0,0,2.79552992069214,11.4222984191483,TJP1;OPHN1;PKP4;ITGA6;TLN2;MYO9A;FERMT2,GO_BP,brown,7
regulation of neurotransmitter receptor activity (GO:0099601),5/58,0.0169891484771794,0.308231693800255,0,0,3.57295229688477,14.5604253976888,APP;MEF2C;GRIN2A;DLG1;DLG2,GO_BP,brown,5
regulation of heart rate by cardiac conduction (GO:0086091),4/39,0.0178794629152579,0.322083941877696,0,0,4.32395775430795,17.4000494164878,KCND3;CACNA1C;SCN5A;DSC2,GO_BP,brown,4
regulation of JNK cascade (GO:0046328),7/105,0.019407827029733,0.343437758535036,0,0,2.70953312831982,10.6811932090933,APP;CYLD;DUSP19;AIDA;PLCB1;IGF1R;HIPK2,GO_BP,brown,7
peptidyl-threonine phosphorylation (GO:0018107),5/60,0.0194230498409301,0.343437758535036,0,0,3.44267233740918,13.5685865197648,ROCK2;WNK1;DYRK1A;MAPK1;HIPK2,GO_BP,brown,5
regulation of microtubule polymerization (GO:0031113),4/40,0.0194704870980493,0.343437758535036,0,0,4.20363164721141,16.5574973899283,CLIP1;DYRK1A;SLAIN2;CLASP1,GO_BP,brown,4
positive regulation of protein ubiquitination (GO:0031398),6/82,0.0196112482268545,0.343534968939382,0,0,2.99229029605263,11.7646440918421,AMER1;DCUN1D4;UBE3A;BRCA1;TOPORS;TSPYL5,GO_BP,brown,6
regulation of osteoblast differentiation (GO:0045667),6/83,0.0206933339527386,0.347845319331153,0,0,2.95327719155844,11.4526425666686,MEF2C;NOCT;SUCO;RORB;FERMT2;BMPR1A,GO_BP,brown,6
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),3/23,0.0208148827854341,0.347845319331153,0,0,5.66854368932039,21.9490944961708,PDE4D;DMD;CACNA1C,GO_BP,brown,3
vascular transport (GO:0010232),6/84,0.0218151843579598,0.352933555854891,0,0,2.91526442307692,11.151320855259,SLC12A2;SLC22A5;SLC16A7;ABCC9;SLC7A1;ABCG2,GO_BP,brown,6
protein deubiquitination (GO:0016579),13/267,0.022400561065568,0.360110285484447,0,0,1.94873314103064,7.40259270384645,USP38;DESI2;USP9Y;USP34;INO80;BRCA1;USP28;TADA2B;YY1;AR;CYLD;OTULIN;OGT,GO_BP,brown,13
regulation of ubiquitin-dependent protein catabolic process (GO:2000058),4/42,0.0229076870109034,0.365946698161602,0,0,3.98197829203359,15.0370759247952,RNF139;GNA12;UBE3A;HIPK2,GO_BP,brown,4
purine ribonucleotide catabolic process (GO:0009154),3/24,0.0233411844553756,0.366464976880604,0,0,5.39833564493759,20.284440015996,PDE4D;NT5C1A;NT5C2,GO_BP,brown,3
axon extension (GO:0048675),3/24,0.0233411844553756,0.366464976880604,0,0,5.39833564493759,20.284440015996,SLC9A6;MAP1B;ULK2,GO_BP,brown,3
positive regulation of Ras protein signal transduction (GO:0046579),5/63,0.0234849974422892,0.366464976880604,0,0,3.26409894467971,12.2449194613202,ALS2;RAPGEF1;ERBIN;SHOC2;JAK2,GO_BP,brown,5
positive regulation of GTPase activity (GO:0043547),11/214,0.0241077885008503,0.366464976880604,0,0,2.06050271567513,7.67582657840142,SYDE2;RAP1GAP2;RALBP1;ALS2;RAPGEF1;RAPGEF2;PKP4;ITGA6;SIPA1L2;FERMT2;PICALM,GO_BP,brown,11
transport across blood-brain barrier (GO:0150104),6/86,0.024180450696463,0.366464976880604,0,0,2.84208984375,10.5788574960388,SLC12A2;SLC22A5;SLC16A7;ABCC9;SLC7A1;ABCG2,GO_BP,brown,6
cellular protein localization (GO:0034613),15/329,0.0251574485245776,0.366464976880604,0,0,1.82041508908333,6.70386290494128,ITSN1;COG3;PTPRK;DNAJC27;BICD2;HERC2;SNX27;KIF13A;PIGK;CAPN3;DMD;ARL5A;FERMT2;VCL;SEC31A,GO_BP,brown,15
regulation of cAMP-mediated signaling (GO:0043949),3/25,0.0260260993013987,0.366464976880604,0,0,5.15269196822595,18.8003975040756,PRKAR1A;PDE4D;RAPGEF2,GO_BP,brown,3
regulation of cardiac muscle cell action potential (GO:0098901),3/25,0.0260260993013987,0.366464976880604,0,0,5.15269196822595,18.8003975040756,DLG1;CACNA1C;DSC2,GO_BP,brown,3
cAMP-mediated signaling (GO:0019933),3/25,0.0260260993013987,0.366464976880604,0,0,5.15269196822595,18.8003975040756,PDE4D;RAPGEF2;ADCY1,GO_BP,brown,3
positive regulation of peptidyl-threonine phosphorylation (GO:0010800),3/25,0.0260260993013987,0.366464976880604,0,0,5.15269196822595,18.8003975040756,RPTOR;APP;MAPK1,GO_BP,brown,3
organelle organization (GO:0006996),18/420,0.0262594465895421,0.366464976880604,0,0,1.70865671641791,6.21904822981363,DST;CSNK1A1;SORT1;VPS13D;COG3;MIA3;FNBP1L;SYNE1;ARMC2;FGD6;PCLO;FAM161A;PALLD;GOLGB1;MYO18A;TNIK;CLASP1;SEC31A,GO_BP,brown,18
cation transmembrane transport (GO:0098655),4/44,0.0266913467413038,0.366464976880604,0,0,3.78249027237354,13.7055352363719,SLC22A5;TRPM7;ABCC9;SLC7A1,GO_BP,brown,4
intracellular steroid hormone receptor signaling pathway (GO:0030518),4/44,0.0266913467413038,0.366464976880604,0,0,3.78249027237354,13.7055352363719,AR;UBE3A;PGR;ESR2,GO_BP,brown,4
positive regulation of osteoblast differentiation (GO:0045669),4/44,0.0266913467413038,0.366464976880604,0,0,3.78249027237354,13.7055352363719,MEF2C;SUCO;FERMT2;BMPR1A,GO_BP,brown,4
ERBB signaling pathway (GO:0038127),5/66,0.0280583047764729,0.374121825899448,0,0,3.10309014795641,11.0888014760854,ERBB4;ERBIN;MAPK1;PTPN11;FAM83B,GO_BP,brown,5
protein dephosphorylation (GO:0006470),8/139,0.0284321933367094,0.374121825899448,0,0,2.31713815297111,8.24955219886096,PPM1A;PTPN11;PTPRK;SBF1;SSH2;PTPN4;PPM1E;PTPRG,GO_BP,brown,8
positive regulation of RNA metabolic process (GO:0051254),4/45,0.0287150214576573,0.374121825899448,0,0,3.6900446047262,13.1008941331336,UTP15;DYRK1A;RBM20;WDR43,GO_BP,brown,4
positive regulation of kinase activity (GO:0033674),7/114,0.0288685921564467,0.374121825899448,0,0,2.48047625144028,8.79329091939593,ALS2;ERBB4;DUSP19;RAPGEF2;TEK;ROS1;IGF1R,GO_BP,brown,7
regulation of biomineral tissue development (GO:0070167),3/26,0.0288692432583826,0.374121825899448,0,0,4.92840861122837,17.4711025546428,ROCK2;S1PR1;TXLNG,GO_BP,brown,3
regulation of chondrocyte differentiation (GO:0032330),3/26,0.0288692432583826,0.374121825899448,0,0,4.92840861122837,17.4711025546428,MBOAT2;PTPN11;SOX5,GO_BP,brown,3
endothelial cell development (GO:0001885),3/26,0.0288692432583826,0.374121825899448,0,0,4.92840861122837,17.4711025546428,PDE4D;RAPGEF1;RAPGEF2,GO_BP,brown,3
lamellipodium assembly (GO:0030032),3/26,0.0288692432583826,0.374121825899448,0,0,4.92840861122837,17.4711025546428,ABLIM1;S1PR1;VCL,GO_BP,brown,3
positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),3/26,0.0288692432583826,0.374121825899448,0,0,4.92840861122837,17.4711025546428,RPTOR;CCND1;PLCB1,GO_BP,brown,3
positive regulation of ion transmembrane transporter activity (GO:0032414),3/26,0.0288692432583826,0.374121825899448,0,0,4.92840861122837,17.4711025546428,WNK1;DMD;ANK3,GO_BP,brown,3
positive regulation of microtubule polymerization or depolymerization (GO:0031112),3/26,0.0288692432583826,0.374121825899448,0,0,4.92840861122837,17.4711025546428,CLIP1;SLAIN2;CLASP1,GO_BP,brown,3
regulation of MAPK cascade (GO:0043408),9/166,0.0292018255283244,0.376510846913421,0,0,2.17642936693654,7.69046551896374,ROCK2;DAG1;DUSP19;MAPK1;VRK2;TNIK;TEK;ROS1;IGF1R,GO_BP,brown,9
transcription initiation from RNA polymerase II promoter (GO:0006367),8/140,0.0295014728399823,0.378453237442197,0,0,2.29946524064171,8.10174058152165,AR;POLR2D;RARB;PGR;RORB;TEAD1;TAF3;ESR2,GO_BP,brown,8
peptidyl-threonine modification (GO:0018210),5/67,0.0296994233459001,0.379078066827067,0,0,3.05288310381689,10.7358531330394,ROCK2;WNK1;DYRK1A;MAPK1;HIPK2,GO_BP,brown,5
positive regulation of supramolecular fiber organization (GO:1902905),6/91,0.030827103078701,0.381530320659754,0,0,2.67421875,9.30457243989397,APP;CLIP1;PRKCE;SYNPO2;SLAIN2;CLASP1,GO_BP,brown,6
cytosolic transport (GO:0016482),7/116,0.0313302834493333,0.381530320659754,0,0,2.43471157471409,8.43182039302427,ANKRD27;HOOK1;HEATR5B;SORT1;VTI1A;VPS13A;WASHC2C,GO_BP,brown,7
Ras protein signal transduction (GO:0007265),8/142,0.0317224332789519,0.381871945632881,0,0,2.26491074041557,7.81559809820578,ARHGEF11;ROCK2;GNA12;RAPGEF1;RAPGEF2;SHOC2;PLD1;USP28,GO_BP,brown,8
positive regulation of phosphorylation (GO:0042327),12/253,0.0327413776657338,0.389937004019349,0,0,1.89339543732472,6.47373793153317,NIBAN1;APP;AR;RALBP1;CCND1;ROCK2;ERBB4;ITGA6;TNIK;TEK;ROS1;IGF1R,GO_BP,brown,12
nitrogen compound transport (GO:0071705),8/143,0.0328746657378682,0.389937004019349,0,0,2.2480174291939,7.67709856716968,SLC12A2;SNX4;RALBP1;SLC7A6;SLC22A5;MIA3;SLC7A1;ABCG2,GO_BP,brown,8
positive regulation of protein phosphorylation (GO:0001934),16/371,0.0331079741074695,0.389937004019349,0,0,1.71725492396611,5.85237235227221,NIBAN1;APP;RALBP1;ROCK2;DUSP19;PTPN11;RPTOR;CCND1;ALS2;ERBB4;RAPGEF2;MAPK1;TNIK;TEK;JAK2;BMPR1A,GO_BP,brown,16
cellular response to calcium ion (GO:0071277),5/69,0.0331599971921966,0.389937004019349,0,0,2.95717592592593,10.0733567017478,CPNE8;MEF2C;CAPN3;SCN5A;ADCY1,GO_BP,brown,5
peptidyl-tyrosine phosphorylation (GO:0018108),5/69,0.0331599971921966,0.389937004019349,0,0,2.95717592592593,10.0733567017478,ERBB4;DYRK1A;TEK;JAK2;IGF1R,GO_BP,brown,5
cellular response to light stimulus (GO:0071482),5/70,0.034980397982225,0.399192286644858,0,0,2.91153096416254,9.76226850019644,YY1;RHBDD1;PTPRK;INO80;USP28,GO_BP,brown,5
wound healing (GO:0042060),5/70,0.034980397982225,0.399192286644858,0,0,2.91153096416254,9.76226850019644,MACF1;DST;MIA3;PLEC;DCBLD2,GO_BP,brown,5
cellular response to interleukin-6 (GO:0071354),3/28,0.0350270519521505,0.399192286644858,0,0,4.53366990291262,15.1952049257143,STAT3;PTPN11;JAK2,GO_BP,brown,3
nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),3/28,0.0350270519521505,0.399192286644858,0,0,4.53366990291262,15.1952049257143,CYLD;OTULIN;TAB3,GO_BP,brown,3
protein localization to cell surface (GO:0034394),3/28,0.0350270519521505,0.399192286644858,0,0,4.53366990291262,15.1952049257143,PIGK;PTPRK;VCL,GO_BP,brown,3
protein polyubiquitination (GO:0000209),14/314,0.0350471968196076,0.399192286644858,0,0,1.77611111111111,5.9518542700416,UBE3C;ZFP91;LNPEP;UBE3A;BRCA1;TOPORS;HECW2;RNF19A;TTC3;MARCHF8;BCL2;ARIH1;RFFL;FBXL4,GO_BP,brown,14
cilium assembly (GO:0060271),14/314,0.0350471968196076,0.399192286644858,0,0,1.77611111111111,5.9518542700416,EXOC8;GORAB;OCRL;HAUS6;FNBP1L;DYNLL2;CKAP5;PCM1;ABLIM1;FAM161A;NEK1;SSX2IP;CLASP1;PAFAH1B1,GO_BP,brown,14
regulation of macromolecule metabolic process (GO:0060255),10/200,0.0359907479625136,0.405683651619556,0,0,1.99875673435557,6.64485352079773,APP;MKLN1;SORT1;ROCK2;FUBP1;ADNP2;UTY;ANKRA2;AFF3;KDM6A,GO_BP,brown,10
modification-dependent protein catabolic process (GO:0019941),10/201,0.037039396678301,0.405683651619556,0,0,1.98818897637795,6.5526198608205,UBE3C;RNF19A;TTC3;FBXO45;FEM1C;ARIH1;RNF150;RFFL;FBXL4;TOPORS,GO_BP,brown,10
adherens junction organization (GO:0034332),4/49,0.0377008490384462,0.40923143828057,0,0,3.36134889753567,11.0187459347348,TJP1;CADM1;VCL;FERMT2,GO_BP,brown,4
regulation of ubiquitin-protein transferase activity (GO:0051438),3/29,0.0383393878677598,0.409816998392941,0,0,4.35907393577297,14.2161497797539,FEM1B;DCUN1D4;TOPORS,GO_BP,brown,3
lamellipodium organization (GO:0097581),3/29,0.0383393878677598,0.409816998392941,0,0,4.35907393577297,14.2161497797539,ABLIM1;S1PR1;VCL,GO_BP,brown,3
regulation of vesicle-mediated transport (GO:0060627),6/96,0.0385667563072408,0.409816998392941,0,0,2.525,8.21979563810749,RAB10;OPHN1;RNF139;MAPK1;PLD1;PICALM,GO_BP,brown,6
cell junction organization (GO:0034330),5/72,0.0388034499645759,0.409816998392941,0,0,2.8243286491519,9.17693890399452,TJP1;APP;OPHN1;MYO9A;FERMT2,GO_BP,brown,5
cell morphogenesis involved in differentiation (GO:0000904),5/72,0.0388034499645759,0.409816998392941,0,0,2.8243286491519,9.17693890399452,MEF2C;OPHN1;PEAK1;TEK;FERMT2,GO_BP,brown,5
positive regulation of transferase activity (GO:0051347),8/148,0.0390636650160268,0.409816998392941,0,0,2.16717086834734,7.02718704843599,ERBB4;DCUN1D4;MAPK1;SERINC1;TEK;ROS1;TOPORS;IGF1R,GO_BP,brown,8
positive regulation of ion transport (GO:0043270),4/50,0.0401716308472296,0.409816998392941,0,0,3.28810691930299,10.5699295396163,SNX4;DLG1;SCN5A;ANK3,GO_BP,brown,4
positive regulation of hydrolase activity (GO:0051345),8/149,0.0403887068597208,0.409816998392941,0,0,2.15168961201502,6.90521320391255,RALBP1;ALS2;RAPGEF1;RAPGEF2;PKP4;ITGA6;FERMT2;PICALM,GO_BP,brown,8
regulation of hydrolase activity (GO:0051336),5/73,0.0408067738997191,0.409816998392941,0,0,2.78265107212476,8.90144250629566,RALBP1;FGD6;PLXNA1;OCRL;PAFAH1B1,GO_BP,brown,5
regulation of Rho protein signal transduction (GO:0035023),5/73,0.0408067738997191,0.409816998392941,0,0,2.78265107212476,8.90144250629566,KANK2;RALBP1;STARD13;OPHN1;HEG1,GO_BP,brown,5
regulation of anatomical structure morphogenesis (GO:0022603),7/123,0.0410409943090728,0.409816998392941,0,0,2.28696268304204,7.30269230643571,MEF2C;HECW2;RUFY3;DAG1;TNIK;FERMT2;CLASP1,GO_BP,brown,7
positive regulation of developmental process (GO:0051094),9/177,0.041361000980843,0.409816998392941,0,0,2.03276733090093,6.47521130271715,AR;RALBP1;DAG1;KMT5B;PLCB1;CLASP1;SOX5;BMPR1A;B4GALT5,GO_BP,brown,9
proteasomal protein catabolic process (GO:0010498),10/205,0.0414455077429372,0.409816998392941,0,0,1.94700181708056,6.19803843007252,RNF139;FEM1B;HECW2;RHBDD1;DDI2;SEL1L;FBXO45;FEM1C;RFFL;TOPORS,GO_BP,brown,10
cellular response to organic cyclic compound (GO:0071407),8/150,0.0417433474586088,0.409816998392941,0,0,2.13642640154653,6.78574997329267,AR;MEF2C;ROCK2;NRIP1;RAPGEF1;RAPGEF2;BRCA1;ADCY1,GO_BP,brown,8
regulation of cation transmembrane transport (GO:1904062),3/30,0.0418053389906161,0.409816998392941,0,0,4.19741100323625,13.3256517574945,DLG1;WNK1;SCN5A,GO_BP,brown,3
microtubule polymerization (GO:0046785),3/30,0.0418053389906161,0.409816998392941,0,0,4.19741100323625,13.3256517574945,SLAIN2;CKAP5;CLASP1,GO_BP,brown,3
negative regulation of cytoskeleton organization (GO:0051494),3/30,0.0418053389906161,0.409816998392941,0,0,4.19741100323625,13.3256517574945,TJP1;SSH2;CLASP1,GO_BP,brown,3
positive regulation of endopeptidase activity (GO:0010950),3/30,0.0418053389906161,0.409816998392941,0,0,4.19741100323625,13.3256517574945,ROCK2;STAT3;PICALM,GO_BP,brown,3
positive regulation of phosphate metabolic process (GO:0045937),3/30,0.0418053389906161,0.409816998392941,0,0,4.19741100323625,13.3256517574945,APP;AR;ITGA6,GO_BP,brown,3
positive regulation of actin filament bundle assembly (GO:0032233),4/51,0.0427324009670243,0.409816998392941,0,0,3.21798162099512,10.1456455091301,ROCK2;SYNPO2;PPM1E;FERMT2,GO_BP,brown,4
regulation of cytokine-mediated signaling pathway (GO:0001959),5/74,0.0428716695218454,0.409816998392941,0,0,2.74218154080854,8.63662157041781,CYLD;OTULIN;PTPN11;VRK2;JAK2,GO_BP,brown,5
regulation of stress fiber assembly (GO:0051492),5/74,0.0428716695218454,0.409816998392941,0,0,2.74218154080854,8.63662157041781,TJP1;ROCK2;PPM1E;CLASP1;FERMT2,GO_BP,brown,5
response to UV (GO:0009411),6/99,0.0437542529053989,0.413144246764733,0,0,2.44317036290323,7.6450867596617,YY1;CCND1;RHBDD1;INO80;PTPRK;USP28,GO_BP,brown,6
cartilage development (GO:0051216),4/52,0.0453831157699382,0.415016739165196,0,0,3.15077821011673,9.74414440309942,MEF2C;SNX19;CREB3L2;SOX5,GO_BP,brown,4
regulation of exocytosis (GO:0017157),4/52,0.0453831157699382,0.415016739165196,0,0,3.15077821011673,9.74414440309942,RAB10;RAB2B;IL1RAPL1;CLASP1,GO_BP,brown,4
endocytic recycling (GO:0032456),4/52,0.0453831157699382,0.415016739165196,0,0,3.15077821011673,9.74414440309942,SNX4;ANKRD27;SNX27;WASHC2C,GO_BP,brown,4
response to peptide hormone (GO:0043434),4/52,0.0453831157699382,0.415016739165196,0,0,3.15077821011673,9.74414440309942,ROCK2;SORT1;STAT3;OGT,GO_BP,brown,4
plasma membrane bounded cell projection morphogenesis (GO:0120039),4/52,0.0453831157699382,0.415016739165196,0,0,3.15077821011673,9.74414440309942,ANKRD27;ALS2;SLC9A6;TNIK,GO_BP,brown,4
regulation of cellular component size (GO:0032535),3/31,0.0454230919243798,0.415016739165196,0,0,4.04729542302358,12.5131635813163,RPTOR;RAP1GAP2;PICALM,GO_BP,brown,3
regulation of cellular pH (GO:0030641),3/31,0.0454230919243798,0.415016739165196,0,0,4.04729542302358,12.5131635813163,SLC4A7;SLC9A6;SLC9A7,GO_BP,brown,3
regulation of developmental growth (GO:0048638),3/31,0.0454230919243798,0.415016739165196,0,0,4.04729542302358,12.5131635813163,APP;LATS2;PLCB1,GO_BP,brown,3
positive regulation of RNA splicing (GO:0033120),3/31,0.0454230919243798,0.415016739165196,0,0,4.04729542302358,12.5131635813163,RBMXL1;DYRK1A;RBM20,GO_BP,brown,3
positive regulation of growth (GO:0045927),5/76,0.0471870252598374,0.424192190053499,0,0,2.66466243856904,8.13690998361454,RPTOR;BCL2;ADNP2;INO80;PLCB1,GO_BP,brown,5
microtubule cytoskeleton organization involved in mitosis (GO:1902850),7/128,0.0490582057739135,0.424192190053499,0,0,2.19189403373712,6.60800774431172,RANBP2;CLIP1;EML1;CKAP5;DYNLL2;CLASP1;PAFAH1B1,GO_BP,brown,7
regulation of cell morphogenesis (GO:0022604),3/32,0.049190609300699,0.424192190053499,0,0,3.90753264144627,11.7696936239494,MACF1;MYO9A;FERMT2,GO_BP,brown,3
intra-Golgi vesicle-mediated transport (GO:0006891),3/32,0.049190609300699,0.424192190053499,0,0,3.90753264144627,11.7696936239494,COG5;COG3;VTI1A,GO_BP,brown,3
positive regulation of cell growth (GO:0030307),6/102,0.0493585239002602,0.424192190053499,0,0,2.366455078125,7.11982277613921,RPTOR;MACF1;RUFY3;BCL2;ADNP2;INO80,GO_BP,brown,6
cellular response to UV (GO:0034644),5/77,0.0494377987493801,0.424192190053499,0,0,2.62751786874594,7.9010513070763,YY1;RHBDD1;PTPRK;INO80;USP28,GO_BP,brown,5
striated muscle contraction (GO:0006941),4/54,0.0509537340623912,0.434303639323737,0,0,3.02443579766537,9.00325309202673,ARHGEF11;DMD;SCN5A;RCSD1,GO_BP,brown,4
cellular response to organonitrogen compound (GO:0071417),6/103,0.0513201672495786,0.435963962588393,0,0,2.34193782216495,6.95478595908368,RPTOR;MEF2C;RAPGEF1;RAPGEF2;BRCA1;CPEB4,GO_BP,brown,6
mitotic spindle organization (GO:0007052),8/157,0.0520706047694866,0.439593993623211,0,0,2.03532043689959,6.0146867496701,RANBP2;CLIP1;EML1;CKAP5;DYNLL2;MAP9;CLASP1;PAFAH1B1,GO_BP,brown,8
endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),9/185,0.0520936189293648,0.439593993623211,0,0,1.93956510091088,5.73085785935731,COG5;GOLGB1;COG3;VTI1A;HYOU1;MIA3;ANK3;DYNLL2;SEC31A,GO_BP,brown,9
G2/M transition of mitotic cell cycle (GO:0000086),7/130,0.0525244386536492,0.439802132971978,0,0,2.15603073838958,6.35269437725698,PCM1;HAUS6;PLCB1;PPP1R12B;CKAP5;CLASP1;PAFAH1B1,GO_BP,brown,7
Golgi organization (GO:0007030),7/130,0.0525244386536492,0.439802132971978,0,0,2.15603073838958,6.35269437725698,CSNK1A1;GOLGB1;COG3;VTI1A;MYO18A;CLASP1;SYNE1,GO_BP,brown,7
positive regulation of protein modification process (GO:0031401),10/214,0.0526377355997958,0.439802132971978,0,0,1.86023622047244,5.47713444701357,NIBAN1;APP;RALBP1;CCND1;FAM161A;ROCK2;ERBB4;DYRK1A;TNIK;TEK,GO_BP,brown,10
negative regulation of JNK cascade (GO:0046329),3/33,0.0531056481186826,0.440811588958999,0,0,3.77708737864078,11.087534199278,CYLD;DUSP19;AIDA,GO_BP,brown,3
neuron projection extension (GO:1990138),3/33,0.0531056481186826,0.440811588958999,0,0,3.77708737864078,11.087534199278,SLC9A6;MAP1B;ULK2,GO_BP,brown,3
axon development (GO:0061564),5/79,0.054125990339029,0.441830208029075,0,0,2.55624045097729,7.45512393451641,RAB10;APP;MAP1B;MTR;ANK3,GO_BP,brown,5
cell cycle G2/M phase transition (GO:0044839),7/131,0.0543137847664321,0.441830208029075,0,0,2.13853292090146,6.22949768528276,PCM1;HAUS6;PLCB1;PPP1R12B;CKAP5;CLASP1;PAFAH1B1,GO_BP,brown,7
protein ubiquitination (GO:0016567),20/525,0.0562875333692874,0.441830208029075,0,0,1.50916537436876,4.34229466930943,UBE3C;EPAS1;LNPEP;FBXO45;UBE3A;BRCA1;PEX13;TOPORS;RNFT1;HERC2;RNF139;GAN;HECW2;RNF19A;OTULIN;BCL2;MARCHF8;ARIH1;FBXL4;KBTBD8,GO_BP,brown,20
regulation of protein localization to plasma membrane (GO:1903076),5/80,0.0565634596917968,0.441830208029075,0,0,2.52202729044834,7.24425124171207,AR;DLG1;PRKCE;PLS1;PICALM,GO_BP,brown,5
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),5/80,0.0565634596917968,0.441830208029075,0,0,2.52202729044834,7.24425124171207,AR;BCL2;ITGA6;BRCA1;RFFL,GO_BP,brown,5
protein modification by small protein removal (GO:0070646),12/276,0.0565814847911733,0.441830208029075,0,0,1.72637441609774,4.95827416169551,TADA2B;YY1;AR;CYLD;USP38;DESI2;USP9Y;USP34;INO80;BRCA1;USP28;OGT,GO_BP,brown,12
sensory organ development (GO:0007423),4/56,0.0568812905612235,0.441830208029075,0,0,2.90781203232565,8.33608298001526,CHD7;MYO7B;ATF6;HIPK2,GO_BP,brown,4
peptidyl-tyrosine modification (GO:0018212),4/56,0.0568812905612235,0.441830208029075,0,0,2.90781203232565,8.33608298001526,ERBB4;DYRK1A;TEK;JAK2,GO_BP,brown,4
protein localization to nucleus (GO:0034504),6/106,0.0574877218203049,0.445179309218214,0,0,2.271328125,6.48733079394209,IPO11;IPO8;STAT3;FAM53C;TAF3;TOPORS,GO_BP,brown,6
positive regulation of protein kinase B signaling (GO:0051897),8/161,0.058649728995044,0.452797299840158,0,0,1.98169934640523,5.62044084196964,ERBB4;STRN;PTPN11;TEK;FERMT2;IGF1R;TSPYL5;MTDH,GO_BP,brown,8
response to calcium ion (GO:0051592),6/107,0.0596380890697041,0.457488731924188,0,0,2.24872370049505,6.34018839257589,CPNE8;MEF2C;CAPN3;SCN5A;ADCY1;SEC31A,GO_BP,brown,6
regulation of bone mineralization (GO:0030500),4/57,0.059977853437305,0.457488731924188,0,0,2.85280082225975,8.02715359604829,MEF2C;S1PR1;TXLNG;BMPR1A,GO_BP,brown,4
monocarboxylic acid transport (GO:0015718),4/57,0.059977853437305,0.457488731924188,0,0,2.85280082225975,8.02715359604829,NCOA1;SLC16A7;ABCC11;ABCG2,GO_BP,brown,4
protein K48-linked ubiquitination (GO:0070936),4/57,0.059977853437305,0.457488731924188,0,0,2.85280082225975,8.02715359604829,TTC3;UBE3A;RFFL;TOPORS,GO_BP,brown,4
blood vessel diameter maintenance (GO:0097746),3/35,0.0613683927666142,0.460234961625804,0,0,3.54065533980583,9.88147460852635,EDNRA;ROCK2;GCLM,GO_BP,brown,3
cellular response to amyloid-beta (GO:1904646),3/35,0.0613683927666142,0.460234961625804,0,0,3.54065533980583,9.88147460852635,APP;GRIN2A;IGF1R,GO_BP,brown,3
muscle cell differentiation (GO:0042692),3/35,0.0613683927666142,0.460234961625804,0,0,3.54065533980583,9.88147460852635,MEF2C;DMD;SYNE1,GO_BP,brown,3
negative regulation of neurogenesis (GO:0050768),3/35,0.0613683927666142,0.460234961625804,0,0,3.54065533980583,9.88147460852635,PCM1;RUFY3;RAPGEF2,GO_BP,brown,3
positive regulation of cell cycle G1/S phase transition (GO:1902808),3/35,0.0613683927666142,0.460234961625804,0,0,3.54065533980583,9.88147460852635,RPTOR;CCND1;PLCB1,GO_BP,brown,3
chordate embryonic development (GO:0043009),4/58,0.0631622049361524,0.460234961625804,0,0,2.7998270644185,7.73326004707916,KIAA1217;MBNL1;CHD7;BRCA1,GO_BP,brown,4
muscle organ development (GO:0007517),4/58,0.0631622049361524,0.460234961625804,0,0,2.7998270644185,7.73326004707916,MEF2C;SGCD;CAPN3;DMD,GO_BP,brown,4
activation of adenylate cyclase activity (GO:0007190),3/36,0.0657107358333348,0.471483810781555,0,0,3.43318623124448,9.34682534472932,EDNRA;ADCY1;LGR4,GO_BP,brown,3
cyclic-nucleotide-mediated signaling (GO:0019935),3/36,0.0657107358333348,0.471483810781555,0,0,3.43318623124448,9.34682534472932,PDE4D;RAPGEF2;ADCY1,GO_BP,brown,3
embryonic limb morphogenesis (GO:0030326),3/36,0.0657107358333348,0.471483810781555,0,0,3.43318623124448,9.34682534472932,MBNL1;CACNA1C;AFF3,GO_BP,brown,3
membrane assembly (GO:0071709),3/36,0.0657107358333348,0.471483810781555,0,0,3.43318623124448,9.34682534472932,IL1RAPL1;ANK3;PICALM,GO_BP,brown,3
negative regulation of cellular protein localization (GO:1903828),3/36,0.0657107358333348,0.471483810781555,0,0,3.43318623124448,9.34682534472932,LATS2;ROCK2;PICALM,GO_BP,brown,3
positive regulation of multicellular organismal process (GO:0051240),14/345,0.0663391379345349,0.47465186015132,0,0,1.60716683450822,4.36020382889697,CADM1;EPAS1;PTPN11;IGF1R;SNX4;KMT5B;JAK2;PLCB1;LPIN1;OGT;FERMT2;SOX5;BMPR1A;B4GALT5,GO_BP,brown,14
regulation of Wnt signaling pathway (GO:0030111),6/111,0.0687131654548101,0.489080357477532,0,0,2.16261160714286,5.79107263560296,AMER1;APP;MACF1;HMGXB4;OTULIN;SOX30,GO_BP,brown,6
regulation of cell cycle G2/M phase transition (GO:1902749),5/85,0.0696817707585861,0.489080357477532,0,0,2.36379142300195,6.29670667560769,PCM1;HAUS6;CKAP5;CLASP1;PAFAH1B1,GO_BP,brown,5
regulation of intracellular pH (GO:0051453),3/37,0.0701899051582786,0.489080357477532,0,0,3.33203883495146,8.8517303641642,SLC4A7;SLC9A6;SLC9A7,GO_BP,brown,3
regulation of microtubule cytoskeleton organization (GO:0070507),3/37,0.0701899051582786,0.489080357477532,0,0,3.33203883495146,8.8517303641642,CYLD;BICD2;CLASP1,GO_BP,brown,3
protein-containing complex subunit organization (GO:0043933),6/112,0.0711002638092366,0.490746386074622,0,0,2.14209905660377,5.66299065687883,CAPN3;LIN7A;KPNA3;TEAD1;MDN1;PICALM,GO_BP,brown,6
regulation of cytoskeleton organization (GO:0051493),6/112,0.0711002638092366,0.490746386074622,0,0,2.14209905660377,5.66299065687883,TJP1;CYLD;ROCK2;MAPK1;BICD2;CLASP1,GO_BP,brown,6
"DNA-templated transcription, initiation (GO:0006352)",8/168,0.0713757153552704,0.49131251220159,0,0,1.8943137254902,5.00060480453561,AR;POLR2D;RARB;PGR;RORB;TEAD1;TAF3;ESR2,GO_BP,brown,8
enzyme linked receptor protein signaling pathway (GO:0007167),7/140,0.0721229475153697,0.493779748487976,0,0,1.99289319188382,5.24007950323997,ERBB4;RAPGEF1;TEK;JAK2;ROS1;IGF1R;PTPRG,GO_BP,brown,7
protein localization to cell periphery (GO:1990778),7/140,0.0721229475153697,0.493779748487976,0,0,1.99289319188382,5.24007950323997,RAB10;DLG1;ROCK2;RAPGEF2;LIN7A;ANK3;TNIK,GO_BP,brown,7
positive regulation of metabolic process (GO:0009893),6/113,0.0735345834418078,0.501340131603809,0,0,2.1219699182243,5.53834034156488,EPAS1;BEND3;JAK2;LPIN1;OGT;IGF1R,GO_BP,brown,6
cilium organization (GO:0044782),10/228,0.0737374928315774,0.501340131603809,0,0,1.73950733222567,4.5353198581081,ARMC2;PCM1;ABLIM1;EXOC8;FAM161A;NEK1;OCRL;FNBP1L;DYNLL2;SSX2IP,GO_BP,brown,10
transcription by RNA polymerase II (GO:0006366),13/320,0.0743481946839931,0.501340131603809,0,0,1.60786274067146,4.17882865097342,MLLT1;RORB;TAF5L;ESR2;AR;NFIC;NOCT;POLR2D;RARB;PGR;TEAD1;TAF3;SOX5,GO_BP,brown,13
cellular response to transforming growth factor beta stimulus (GO:0071560),6/114,0.0760160290148075,0.501340131603809,0,0,2.10221354166667,5.41700708960546,MEF2C;USP9Y;PTPRK;FERMT2;SOX5;BMPR1A,GO_BP,brown,6
chromatin organization (GO:0006325),7/142,0.0764994762118477,0.501340131603809,0,0,1.96316590563166,5.04626178458503,TADA2B;HDAC4;KDM5D;INO80;TOP1;BAZ1B;KDM6A,GO_BP,brown,7
neuron projection development (GO:0031175),8/171,0.0773064333819868,0.501340131603809,0,0,1.85916035125707,4.75940978489705,APP;ANKRD27;OPHN1;SLC9A6;ALS2;RAPGEF2;TNIK;ZNF365,GO_BP,brown,8
cellular response to ketone (GO:1901655),3/39,0.0795464938206142,0.507658528402915,0,0,3.14660194174757,7.96535095017971,AR;ROCK2;ADCY1,GO_BP,brown,3
regulation of peptidyl-threonine phosphorylation (GO:0010799),3/39,0.0795464938206142,0.507658528402915,0,0,3.14660194174757,7.96535095017971,RPTOR;APP;MAPK1,GO_BP,brown,3
vesicle cytoskeletal trafficking (GO:0099518),3/39,0.0795464938206142,0.507658528402915,0,0,3.14660194174757,7.96535095017971,MYO7B;FNBP1L;PAFAH1B1,GO_BP,brown,3
generation of neurons (GO:0048699),9/202,0.0805363444052109,0.512687505737433,0,0,1.76716512108472,4.45157148986355,MEF2C;OPHN1;MAP1B;IL1RAPL1;ADNP2;RAPGEF2;EML1;PEX13;PAFAH1B1,GO_BP,brown,9
negative regulation of cell migration (GO:0030336),7/144,0.0810282931320155,0.513335511003167,0,0,1.93430656934307,4.86082901572324,DAG1;MIA3;PTPRK;VCL;CLASP1;BMPR1A;PTPRG,GO_BP,brown,7
collagen fibril organization (GO:0030199),5/89,0.0812821295996629,0.513335511003167,0,0,2.25076580339738,5.64903749874946,DST;COL4A6;ITGA6;COL19A1;PLEC,GO_BP,brown,5
protein import (GO:0017038),5/89,0.0812821295996629,0.513335511003167,0,0,2.25076580339738,5.64903749874946,IPO11;IPO8;STAT3;FAM53C;PEX13,GO_BP,brown,5
cation transport (GO:0006812),8/174,0.0835239188452075,0.513335511003167,0,0,1.82527758091188,4.53147470725312,SLC12A2;SLC7A6;KCND3;TRPM7;ABCC9;SCN5A;KCNA6;SLC7A1,GO_BP,brown,8
protein secretion (GO:0009306),4/64,0.0840704256047763,0.513335511003167,0,0,2.51906614785992,6.23746077529743,RAB10;SNX19;SEL1L;MIA3,GO_BP,brown,4
regulation of extrinsic apoptotic signaling pathway (GO:2001236),4/64,0.0840704256047763,0.513335511003167,0,0,2.51906614785992,6.23746077529743,AR;CYLD;FEM1B;ITGA6,GO_BP,brown,4
negative regulation of translation (GO:0017148),5/90,0.0843333153045923,0.513335511003167,0,0,2.22417153996101,5.50032793756981,SYNCRIP;RNF139;ROCK2;EIF4EBP2;CPEB4,GO_BP,brown,5
response to organonitrogen compound (GO:0010243),3/40,0.0844175255266857,0.513335511003167,0,0,3.06140120703228,7.5677233226888,RNF139;RHBDD1;SEL1L,GO_BP,brown,3
intraciliary transport involved in cilium assembly (GO:0035735),3/40,0.0844175255266857,0.513335511003167,0,0,3.06140120703228,7.5677233226888,PCM1;DYNLL2;SSX2IP,GO_BP,brown,3
organic hydroxy compound transport (GO:0015850),3/40,0.0844175255266857,0.513335511003167,0,0,3.06140120703228,7.5677233226888,NCOA1;RALBP1;ABCC11,GO_BP,brown,3
positive regulation of ossification (GO:0045778),3/40,0.0844175255266857,0.513335511003167,0,0,3.06140120703228,7.5677233226888,MEF2C;PTPN11;BMPR1A,GO_BP,brown,3
protein-containing complex assembly (GO:0065003),11/267,0.0884335926738713,0.528520765627372,0,0,1.62942246055227,3.95216967557825,AMER1;CSNK1A1;CAPN3;DMD;LIN7A;TEAD1;KPNA3;FERMT2;MDN1;SEC31A;PICALM,GO_BP,brown,11
endosome organization (GO:0007032),3/41,0.0894126325725343,0.531869055583694,0,0,2.98068472151252,7.19684329797483,EXOC8;ALS2;HOOK1,GO_BP,brown,3
heart contraction (GO:0060047),3/41,0.0894126325725343,0.531869055583694,0,0,2.98068472151252,7.19684329797483,SGCD;DMD;SCN5A,GO_BP,brown,3
regulation of protein kinase B signaling (GO:0051896),9/207,0.0903980462974273,0.532190009816546,0,0,1.7220932309341,4.13910726138203,ERBB4;DAG1;STRN;PTPN11;TEK;FERMT2;TSPYL5;MTDH;IGF1R,GO_BP,brown,9
cell-cell junction assembly (GO:0007043),4/66,0.0917044620346478,0.532190009816546,0,0,2.43755491402033,5.82376778923633,TJP1;PKP4;TLN2;VCL,GO_BP,brown,4
positive regulation of cell cycle (GO:0045787),4/66,0.0917044620346478,0.532190009816546,0,0,2.43755491402033,5.82376778923633,APP;ZBED9;CCND1;CCPG1,GO_BP,brown,4
regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),3/42,0.0945284014877581,0.532190009816546,0,0,2.90410754294249,6.85036843788053,FEM1B;BRCA1;RFFL,GO_BP,brown,3
mitotic cell cycle phase transition (GO:0044772),9/209,0.0945337487914626,0.532190009816546,0,0,1.70469548133595,4.02103293664866,PCM1;LATS2;CCND1;HAUS6;PLCB1;PPP1R12B;CKAP5;CLASP1;PAFAH1B1,GO_BP,brown,9
regulation of gene silencing by miRNA (GO:0060964),4/67,0.0956412923890524,0.532190009816546,0,0,2.39874004076339,5.6302041821084,RANBP2;IPO8;POLR2D;STAT3,GO_BP,brown,4
positive regulation of epithelial cell migration (GO:0010634),5/94,0.097129731932494,0.532190009816546,0,0,2.12377072519,4.95201266223965,CAPN7;ROCK2;PRKCE;TEK;CLASP1,GO_BP,brown,5
anion transport (GO:0006820),3/43,0.0997613505732586,0.532190009816546,0,0,2.83135922330097,6.52621063868809,LRRC8B;ABCC11;ABCG2,GO_BP,brown,3
positive regulation of axonogenesis (GO:0050772),3/43,0.0997613505732586,0.532190009816546,0,0,2.83135922330097,6.52621063868809,MACF1;RUFY3;PLXNA1,GO_BP,brown,3
cellular response to organic substance (GO:0071310),6/123,0.100443036535413,0.532190009816546,0,0,1.93960336538462,4.45752762326904,NCOA1;IL1RAPL1;STAT3;PTPN11;PTPN4;BMPR1A,GO_BP,brown,6
ciliary basal body-plasma membrane docking (GO:0097711),5/95,0.100474216260851,0.532190009816546,0,0,2.10006497725796,4.8256430001972,PCM1;HAUS6;CKAP5;CLASP1;PAFAH1B1,GO_BP,brown,5
actin filament organization (GO:0007015),7/152,0.100653755898147,0.532190009816546,0,0,1.82683042040624,4.19452835158745,ENAH;DLG1;RUFY3;MYO7B;FAT1;SHROOM3;PLS1,GO_BP,brown,7
dephosphorylation (GO:0016311),7/153,0.103274772619464,0.532190009816546,0,0,1.81422405704635,4.11894562602309,PPM1A;PTPRK;SBF1;SSH2;PTPN4;PPM1E;PTPRG,GO_BP,brown,7
cellular response to decreased oxygen levels (GO:0036294),4/69,0.103748474613955,0.532190009816546,0,0,2.32469320562706,5.26725690696142,EPAS1;HYOU1;HIPK2;CPEB4,GO_BP,brown,4
positive regulation of protein polymerization (GO:0032273),4/69,0.103748474613955,0.532190009816546,0,0,2.32469320562706,5.26725690696142,CLIP1;PRKCE;SLAIN2;CLASP1,GO_BP,brown,4
response to amyloid-beta (GO:1904645),3/44,0.105107939819832,0.532190009816546,0,0,2.76215960217855,6.22250326716142,APP;GRIN2A;IGF1R,GO_BP,brown,3
mRNA stabilization (GO:0048255),3/44,0.105107939819832,0.532190009816546,0,0,2.76215960217855,6.22250326716142,SYNCRIP;NOCT;TENT5A,GO_BP,brown,3
positive regulation of cell-matrix adhesion (GO:0001954),3/44,0.105107939819832,0.532190009816546,0,0,2.76215960217855,6.22250326716142,PLEKHA2;TEK;FERMT2,GO_BP,brown,3
positive regulation of stress fiber assembly (GO:0051496),3/44,0.105107939819832,0.532190009816546,0,0,2.76215960217855,6.22250326716142,ROCK2;PPM1E;FERMT2,GO_BP,brown,3
regulation of protein secretion (GO:0050708),6/125,0.106372975598802,0.532190009816546,0,0,1.90680803571429,4.27278254560505,SLC12A2;MYO18A;CACNA2D2;CACNA1C;HMGCR;RAPGEF4,GO_BP,brown,6
positive regulation of cold-induced thermogenesis (GO:0120162),5/97,0.107333648010325,0.532190009816546,0,0,2.05419950843292,4.58458935308425,EPAS1;JAK2;LPIN1;OGT;IGF1R,GO_BP,brown,5
positive regulation of DNA-binding transcription factor activity (GO:0051091),10/246,0.107704374727648,0.532190009816546,0,0,1.60533164286668,3.57726496848241,HDAC4;APP;AR;STAT3;CAPN3;TAB3;ADCY1;ESR2;MTDH;HIPK2,GO_BP,brown,10
action potential (GO:0001508),3/45,0.110564580309317,0.532190009816546,0,0,2.69625520110957,5.93757319775135,DMD;SCN5A;ANK3,GO_BP,brown,3
RNA splicing (GO:0008380),5/98,0.110847335771133,0.532190009816546,0,0,2.03200653964661,4.46960438420293,SYNCRIP;MBNL1;DHX15;SRRM1;SRPK1,GO_BP,brown,5
regulation of glycolytic process (GO:0006110),4/71,0.112158319582063,0.532190009816546,0,0,2.25506707706603,4.93373460914306,HDAC4;RANBP2;APP;OGT,GO_BP,brown,4
regulation of TOR signaling (GO:0032006),4/71,0.112158319582063,0.532190009816546,0,0,2.25506707706603,4.93373460914306,RPTOR;GNA12;RFFL;ROS1,GO_BP,brown,4
regulation of cell growth (GO:0001558),9/217,0.11215866424793,0.532190009816546,0,0,1.63845020401995,3.58466814795959,RPTOR;ARHGEF11;SERTAD2;BCL2;ADNP2;INO80;ROS1;ESR2;DCBLD2,GO_BP,brown,9
establishment of protein localization to extracellular region (GO:0035592),3/46,0.11612764300771,0.532190009816546,0,0,2.63341612102055,5.66991692878579,RAB10;SEL1L;MIA3,GO_BP,brown,3
interleukin-12-mediated signaling pathway (GO:0035722),3/46,0.11612764300771,0.532190009816546,0,0,2.63341612102055,5.66991692878579,MTAP;JAK2;PLCB1,GO_BP,brown,3
positive regulation of secretion by cell (GO:1903532),4/72,0.116473314096042,0.532190009816546,0,0,2.22178988326848,4.77705508826439,SLC12A2;RAB2B;MYO18A;CLASP1,GO_BP,brown,4
cell-matrix adhesion (GO:0007160),5/100,0.118039297626063,0.532190009816546,0,0,1.98902226326049,4.25001881473512,MKLN1;PEAK1;PTPRK;VCL;FERMT2,GO_BP,brown,5
organic acid transport (GO:0015849),5/100,0.118039297626063,0.532190009816546,0,0,1.98902226326049,4.25001881473512,NCOA1;SLC7A6;ABCC11;SLC7A1;ABCG2,GO_BP,brown,5
muscle contraction (GO:0006936),6/129,0.118761517989001,0.532190009816546,0,0,1.84441692073171,3.92978449728901,ARHGEF11;EDNRA;CALD1;ROCK2;DMD;VCL,GO_BP,brown,6
endoplasmic reticulum organization (GO:0007029),4/73,0.120859782291706,0.532190009816546,0,0,2.18947724581289,4.62663741779603,RAB10;APP;MIA3;SEC31A,GO_BP,brown,4
positive regulation of JNK cascade (GO:0046330),4/73,0.120859782291706,0.532190009816546,0,0,2.18947724581289,4.62663741779603,APP;DUSP19;PLCB1;HIPK2,GO_BP,brown,4
positive regulation of cell motility (GO:2000147),9/221,0.121611327280925,0.532190009816546,0,0,1.60720243170108,3.38625524346865,TJP1;ROCK2;RUFY3;STAT3;ITGA6;FERMT2;SYNE2;CCAR1;IGF1R,GO_BP,brown,9
positive regulation of protein localization to membrane (GO:1905477),5/101,0.121716149534632,0.532190009816546,0,0,1.96820175438597,4.14515804923697,DLG1;PRKCE;BCL2;ANK3;PLS1,GO_BP,brown,5
epidermal growth factor receptor signaling pathway (GO:0007173),3/47,0.121793467123777,0.532190009816546,0,0,2.57343336275375,5.41818010238603,ERBIN;PTPN11;FAM83B,GO_BP,brown,3
regulation of synapse assembly (GO:0051963),3/47,0.121793467123777,0.532190009816546,0,0,2.57343336275375,5.41818010238603,APP;MEF2C;IL1RAPL1,GO_BP,brown,3
regulation of peptide hormone secretion (GO:0090276),4/74,0.125316247906971,0.532190009816546,0,0,2.15808782657032,4.48216444623166,CHD7;CACNA2D2;CACNA1C;RAPGEF4,GO_BP,brown,4
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),5/102,0.125445925550658,0.532190009816546,0,0,1.94781053435421,4.04342187746142,CSNK1A1;RNF19A;GNA12;ARIH1;OGT,GO_BP,brown,5
intrinsic apoptotic signaling pathway (GO:0097193),5/102,0.125445925550658,0.532190009816546,0,0,1.94781053435421,4.04342187746142,BCL2;BRCA1;TOPORS;PDK1;HIPK2,GO_BP,brown,5
positive regulation of cellular protein metabolic process (GO:0032270),5/102,0.125445925550658,0.532190009816546,0,0,1.94781053435421,4.04342187746142,NIBAN1;AMER1;CAPN3;PLD1;OGT,GO_BP,brown,5
cellular response to interleukin-12 (GO:0071349),3/48,0.127558367817805,0.532190009816546,0,0,2.51611650485437,5.18113988515126,MTAP;JAK2;PLCB1,GO_BP,brown,3
histone H4 acetylation (GO:0043967),3/48,0.127558367817805,0.532190009816546,0,0,2.51611650485437,5.18113988515126,BEND3;JADE3;OGT,GO_BP,brown,3
substrate adhesion-dependent cell spreading (GO:0034446),3/48,0.127558367817805,0.532190009816546,0,0,2.51611650485437,5.18113988515126,PEAK1;TEK;FERMT2,GO_BP,brown,3
fibroblast growth factor receptor signaling pathway (GO:0008543),4/75,0.129841201271088,0.532190009816546,0,0,2.12758261632049,4.3433388600326,POLR2D;MAPK1;SHOC2;PTPN11,GO_BP,brown,4
regulation of cell adhesion (GO:0030155),6/133,0.13183365962052,0.532190009816546,0,0,1.78595595472441,3.6187295043626,ROCK2;PLXNA1;PKP4;MIA3;PTPN11;CELSR2,GO_BP,brown,6
negative regulation of macromolecule metabolic process (GO:0010605),8/194,0.13217666067395,0.532190009816546,0,0,1.62732447817837,3.2930797092223,YY1;APP;MEF2C;ROCK2;NOCT;PGR;BMPR1A;PICALM,GO_BP,brown,8
actomyosin structure organization (GO:0031032),4/76,0.134433101828419,0.532190009816546,0,0,2.09792477302205,4.20988170019557,TJP1;ROCK2;MYO18A;CAPN3,GO_BP,brown,4
cellular response to hormone stimulus (GO:0032870),4/76,0.134433101828419,0.532190009816546,0,0,2.09792477302205,4.20988170019557,NCOA1;AR;MEF2C;STAT3,GO_BP,brown,4
establishment of protein localization to organelle (GO:0072594),4/76,0.134433101828419,0.532190009816546,0,0,2.09792477302205,4.20988170019557,IPO11;IPO8;STAT3;FAM53C,GO_BP,brown,4
regulation of RNA splicing (GO:0043484),4/76,0.134433101828419,0.532190009816546,0,0,2.09792477302205,4.20988170019557,MBNL1;DYRK1A;RBM20;SRPK1,GO_BP,brown,4
cellular response to oxygen-containing compound (GO:1901701),12/323,0.135495097503046,0.532190009816546,0,0,1.46189138695779,2.92205747909385,RPTOR;MEF2C;ROCK2;NRIP1;RAPGEF1;ADNP2;RAPGEF2;MAPK1;MTR;PTPRK;RORB;CPEB4,GO_BP,brown,12
import into nucleus (GO:0051170),4/77,0.139090380518622,0.532190009816546,0,0,2.06907947337562,4.08153100915357,IPO11;IPO8;STAT3;FAM53C,GO_BP,brown,4
inorganic cation import across plasma membrane (GO:0098659),4/77,0.139090380518622,0.532190009816546,0,0,2.06907947337562,4.08153100915357,SLC12A2;SLC9A6;SLC9A7;ABCC9,GO_BP,brown,4
positive regulation of tumor necrosis factor production (GO:0032760),4/77,0.139090380518622,0.532190009816546,0,0,2.06907947337562,4.08153100915357,APP;STAT3;PTPN11;JAK2,GO_BP,brown,4
small GTPase mediated signal transduction (GO:0007264),5/106,0.140878491623164,0.532190009816546,0,0,1.87028351958003,3.66548922350763,RALBP1;RAPGEF2;SHOC2;PLD1;USP28,GO_BP,brown,5
protein localization to plasma membrane (GO:0072659),6/136,0.142068920660011,0.532190009816546,0,0,1.74447115384615,3.40423599111601,RAB10;DLG1;ROCK2;RAPGEF2;ANK3;TNIK,GO_BP,brown,6
blood circulation (GO:0008015),3/51,0.145410472392748,0.532190009816546,0,0,2.35849514563107,4.54763782036399,SGCD;ROCK2;GCLM,GO_BP,brown,3
inositol lipid-mediated signaling (GO:0048017),3/51,0.145410472392748,0.532190009816546,0,0,2.35849514563107,4.54763782036399,PLCB1;OGT;IGF1R,GO_BP,brown,3
regulation of autophagy (GO:0010506),9/231,0.147047773546004,0.532190009816546,0,0,1.53400945149472,2.94069267449905,RPTOR;EXOC8;STAT3;BCL2;TAB3;ATP6V1E2;ATF6;SREBF2;MTDH,GO_BP,brown,9
recombinational repair (GO:0000725),4/79,0.148594667938725,0.532190009816546,0,0,2.01369649805448,3.83917888455849,YY1;RAD51AP2;BRCA1;INO80,GO_BP,brown,4
positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),4/79,0.148594667938725,0.532190009816546,0,0,2.01369649805448,3.83917888455849,RNF139;CSNK1A1;RNF19A;ARIH1,GO_BP,brown,4
regulation of release of sequestered calcium ion into cytosol (GO:0051279),3/52,0.151534598693818,0.532190009816546,0,0,2.31024370913414,4.3592942814366,PDE4D;CAPN3;DMD,GO_BP,brown,3
sprouting angiogenesis (GO:0002040),3/52,0.151534598693818,0.532190009816546,0,0,2.31024370913414,4.3592942814366,OTULIN;MIA3;TEK,GO_BP,brown,3
negative regulation of cellular biosynthetic process (GO:0031327),3/52,0.151534598693818,0.532190009816546,0,0,2.31024370913414,4.3592942814366,ROCK2;RAPGEF2;BRCA1,GO_BP,brown,3
negative regulation of protein-containing complex assembly (GO:0031333),3/52,0.151534598693818,0.532190009816546,0,0,2.31024370913414,4.3592942814366,PPM1A;ANKRD27;AIDA,GO_BP,brown,3
positive regulation of developmental growth (GO:0048639),3/52,0.151534598693818,0.532190009816546,0,0,2.31024370913414,4.3592942814366,MACF1;RUFY3;PLCB1,GO_BP,brown,3
positive regulation of protein localization to cell periphery (GO:1904377),3/52,0.151534598693818,0.532190009816546,0,0,2.31024370913414,4.3592942814366,DLG1;PRKCE;PLS1,GO_BP,brown,3
positive regulation of protein localization to plasma membrane (GO:1903078),3/52,0.151534598693818,0.532190009816546,0,0,2.31024370913414,4.3592942814366,DLG1;PRKCE;PLS1,GO_BP,brown,3
potassium ion transmembrane transport (GO:0071805),6/139,0.152658534512977,0.532190009816546,0,0,1.70485784774436,3.20436838472772,SLC12A2;SLC9A6;SLC9A7;KCND3;ABCC9;KCNA6,GO_BP,brown,6
regulation of protein ubiquitination (GO:0031396),5/109,0.152968629270857,0.532190009816546,0,0,1.81605188184136,3.4096781168817,AMER1;UBE3A;BRCA1;OGT;TSPYL5,GO_BP,brown,5
modulation of chemical synaptic transmission (GO:0050804),5/109,0.152968629270857,0.532190009816546,0,0,1.81605188184136,3.4096781168817,SLC12A2;APP;MEF2C;OPHN1;EIF4EBP2,GO_BP,brown,5
regulation of NIK/NF-kappaB signaling (GO:1901222),4/80,0.153438417328375,0.532190009816546,0,0,1.98709809543314,3.72472791279165,APP;PPM1A;CYLD;DLG1,GO_BP,brown,4
negative regulation of cellular component organization (GO:0051129),4/80,0.153438417328375,0.532190009816546,0,0,1.98709809543314,3.72472791279165,AR;SACS;WASHC2C;AIDA,GO_BP,brown,4
cardiac muscle tissue development (GO:0048738),3/53,0.157739258701389,0.532190009816546,0,0,2.26392233009709,4.18103863315869,SGCD;SCN5A;BMPR1A,GO_BP,brown,3
IRE1-mediated unfolded protein response (GO:0036498),3/53,0.157739258701389,0.532190009816546,0,0,2.26392233009709,4.18103863315869,GFPT1;HYOU1;SEC31A,GO_BP,brown,3
positive regulation of B cell activation (GO:0050871),3/53,0.157739258701389,0.532190009816546,0,0,2.26392233009709,4.18103863315869,MEF2C;BCL2;KMT5B,GO_BP,brown,3
axon guidance (GO:0007411),8/203,0.157955211587041,0.532190009816546,0,0,1.55149321266968,2.86319346351788,ENAH;OPHN1;PALLD;DOK6;DAG1;PLXNA1;MAPK1;PTPN11,GO_BP,brown,8
positive regulation of cellular amide metabolic process (GO:0034250),4/81,0.158341030578326,0.532190009816546,0,0,1.96119056041235,3.61448234299346,NIBAN1;ROCK2;PLD1;PICALM,GO_BP,brown,4
positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),4/81,0.158341030578326,0.532190009816546,0,0,1.96119056041235,3.61448234299346,APP;STAT3;PTPN11;JAK2,GO_BP,brown,4
cell-cell junction organization (GO:0045216),4/82,0.163300830764298,0.532190009816546,0,0,1.93594732116133,3.50824860452295,TJP1;CADM1;PKP4;TLN2,GO_BP,brown,4
protein localization to organelle (GO:0033365),6/142,0.163587608355588,0.532190009816546,0,0,1.6669921875,3.01793366044872,TUB;APP;COG3;WASHC2C;BICD2;TOPORS,GO_BP,brown,6
protein transport (GO:0015031),13/369,0.163686083052128,0.532190009816546,0,0,1.38301257092001,2.50298280752901,MACF1;SEL1L;MIA3;ANK3;DNAJC27;RAB10;SNX4;HERC2;SNX27;KIF13A;ATP6V1E2;ARL5A;SEC31A,GO_BP,brown,13
regulation of proteolysis (GO:0030162),3/54,0.164020762297189,0.532190009816546,0,0,2.21941747572816,4.01217915135719,RNF139;CAPN3;OGT,GO_BP,brown,3
MAPK cascade (GO:0000165),11/303,0.1649863955605,0.532190009816546,0,0,1.42585987949529,2.56924588017855,MEF2C;DLG1;DLG2;ERBB4;RAPGEF2;MAPK1;SHOC2;TNIK;RASAL2;TEK;JAK2,GO_BP,brown,11
phosphatidylinositol metabolic process (GO:0046488),5/112,0.165474160111157,0.532190009816546,0,0,1.76486127051794,3.17487993745718,PLEKHA2;OCRL;SBF1;PLCB1;LCLAT1,GO_BP,brown,5
neuron development (GO:0048666),6/143,0.167303349423845,0.532190009816546,0,0,1.6547388229927,2.95858473639354,APP;MEF2C;OPHN1;WNK1;RAPGEF2;B4GALT5,GO_BP,brown,6
regulation of gene silencing by RNA (GO:0060966),3/55,0.170375437845289,0.53316256280176,0,0,2.17662434652726,3.85208272008977,RANBP2;IPO8;POLR2D,GO_BP,brown,3
regulation of posttranscriptional gene silencing (GO:0060147),3/55,0.170375437845289,0.53316256280176,0,0,2.17662434652726,3.85208272008977,RANBP2;IPO8;POLR2D,GO_BP,brown,3
regulation of cytokinesis (GO:0032465),4/84,0.173385210893724,0.53316256280176,0,0,1.88735408560311,3.30709639293806,PRKCE;KIF13A;PKP4;MAP9,GO_BP,brown,4
response to insulin (GO:0032868),4/84,0.173385210893724,0.53316256280176,0,0,1.88735408560311,3.30709639293806,RAB10;SORT1;LPIN1;OGT,GO_BP,brown,4
spindle assembly (GO:0051225),4/84,0.173385210893724,0.53316256280176,0,0,1.88735408560311,3.30709639293806,HAUS6;INO80;CLASP1;MAP9,GO_BP,brown,4
activation of protein kinase activity (GO:0032147),5/114,0.174029458455383,0.53316256280176,0,0,1.7322996584223,3.02897912158346,PRKAR1A;ZFP91;TNIK;ADCY1;JAK2,GO_BP,brown,5
negative regulation of transcription by RNA polymerase II (GO:0000122),22/684,0.175297188610385,0.53316256280176,0,0,1.26096384367995,2.19568169573339,KANK2;HDAC4;MEF2C;STAT3;SREBF2;ESR2;MTDH;SOX30;YY1;AR;PPM1A;DLG1;ZNF608;CCND1;NFIC;NRIP1;BEND3;RARB;ZNF555;TAF3;GZF1;MCPH1,GO_BP,brown,22
inorganic cation transmembrane transport (GO:0098662),10/274,0.175419537469912,0.53316256280176,0,0,1.43298138869005,2.4942113186177,SLC12A2;SLC30A6;SLC9A6;KCND3;SLC9A7;TRPM7;ABCC9;KCNA6;CACNA1C;SCN5A,GO_BP,brown,10
glycerophospholipid biosynthetic process (GO:0046474),7/177,0.176584452237692,0.53316256280176,0,0,1.55616438356164,2.69832062294711,PLEKHA2;OCRL;SBF1;PLD1;LPIN1;LCLAT1;SELENOI,GO_BP,brown,7
regulation of ATP metabolic process (GO:1903578),3/56,0.17679963671248,0.53316256280176,0,0,2.13544605239055,3.70016891394026,RANBP2;BEND3;OGT,GO_BP,brown,3
Rho protein signal transduction (GO:0007266),3/56,0.17679963671248,0.53316256280176,0,0,2.13544605239055,3.70016891394026,ARHGEF11;ROCK2;GNA12,GO_BP,brown,3
positive regulation of interleukin-1 beta production (GO:0032731),3/56,0.17679963671248,0.53316256280176,0,0,2.13544605239055,3.70016891394026,APP;STAT3;JAK2,GO_BP,brown,3
membrane organization (GO:0061024),9/242,0.17783829175281,0.53316256280176,0,0,1.4607536446959,2.5225471521711,SUN1;DNAJC6;ITSN1;OCRL;ANK3;FNBP1L;AGFG1;PICALM;EPN2,GO_BP,brown,9
positive regulation of angiogenesis (GO:0045766),5/116,0.182750311585747,0.53316256280176,0,0,1.70091143775354,2.89092771915731,TJP1;BRCA1;TEK;MTDH;HIPK2,GO_BP,brown,5
regulation of gene expression (GO:0010468),33/1079,0.183139496177247,0.53316256280176,0,0,1.19924306636968,2.03572367055408,HDAC4;APP;ROCK2;CHD7;RORB;BRCA1;AFF3;CELSR2;TAF5L;CCAR1;YY1;NOCT;ATXN1L;ADNP2;MAPK1;UTY;ZNF664;FADS1;KDM6A;MEF2C;MBNL1;SORT1;STAT3;ANK3;ESR2;AR;FUBP1;RBM20;PGR;ANKRA2;GZF1;PICALM;BMPR1A,GO_BP,brown,33
carboxylic acid transport (GO:0046942),3/57,0.183289737505517,0.53316256280176,0,0,2.0957928802589,3.5559047717165,SLC7A6;SLC16A7;SLC7A1,GO_BP,brown,3
cellular response to peptide (GO:1901653),3/57,0.183289737505517,0.53316256280176,0,0,2.0957928802589,3.5559047717165,APP;GRIN2A;IGF1R,GO_BP,brown,3
negative regulation of DNA recombination (GO:0045910),3/57,0.183289737505517,0.53316256280176,0,0,2.0957928802589,3.5559047717165,RADX;MSH3;POLR2D,GO_BP,brown,3
positive regulation of cell junction assembly (GO:1901890),3/57,0.183289737505517,0.53316256280176,0,0,2.0957928802589,3.5559047717165,IL1RAPL1;TEK;FERMT2,GO_BP,brown,3
positive regulation of proteolysis (GO:0045862),3/57,0.183289737505517,0.53316256280176,0,0,2.0957928802589,3.5559047717165,RHBDD1;CAPN3;OGT,GO_BP,brown,3
positive regulation of proteasomal protein catabolic process (GO:1901800),4/86,0.183677876733255,0.53316256280176,0,0,1.84113125177944,3.1199289622267,CSNK1A1;RNF19A;ARIH1;RNFT1,GO_BP,brown,4
nervous system development (GO:0007399),15/447,0.18614263502113,0.53316256280176,0,0,1.31502650762094,2.21087785384936,HDAC4;MBNL1;MEF2C;STAT3;CHD7;DYRK1A;MTR;HMGCR;ARHGAP26;SREBF2;NFASC;OPHN1;ERBB4;APBA1;TEAD1,GO_BP,brown,15
positive regulation of cell projection organization (GO:0031346),5/117,0.187170333814289,0.53316256280176,0,0,1.68563770537455,2.82468412417976,IL1RAPL1;RAPGEF1;PLXNA1;RAPGEF2;ITGA6,GO_BP,brown,5
sodium ion transmembrane transport (GO:0035725),4/87,0.18889799959113,0.53316256280176,0,0,1.81885518728611,3.03120964619337,SLC12A2;SLC9A6;SLC9A7;SCN5A,GO_BP,brown,4
negative regulation of angiogenesis (GO:0016525),4/87,0.18889799959113,0.53316256280176,0,0,1.81885518728611,3.03120964619337,SLC12A2;ROCK2;TEK;EPN2,GO_BP,brown,4
eye development (GO:0001654),3/58,0.189842149934268,0.53316256280176,0,0,2.05758164165931,3.41880017124494,CACNA1C;ATF6;HIPK2,GO_BP,brown,3
regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),3/58,0.189842149934268,0.53316256280176,0,0,2.05758164165931,3.41880017124494,CYLD;OTULIN;RFFL,GO_BP,brown,3
positive regulation of mitotic cell cycle phase transition (GO:1901992),3/58,0.189842149934268,0.53316256280176,0,0,2.05758164165931,3.41880017124494,RPTOR;CCND1;PLCB1,GO_BP,brown,3
positive regulation of protein binding (GO:0032092),3/58,0.189842149934268,0.53316256280176,0,0,2.05758164165931,3.41880017124494,APP;RAPGEF2;HIPK2,GO_BP,brown,3
regulation of G2/M transition of mitotic cell cycle (GO:0010389),6/149,0.190318043882255,0.53316256280176,0,0,1.58481752622378,2.62930529066763,PCM1;CCND1;HAUS6;CKAP5;CLASP1;PAFAH1B1,GO_BP,brown,6
brain development (GO:0007420),6/150,0.194267850577934,0.534030123045204,0,0,1.57373046875,2.57858475452392,GRIN2A;RAPGEF2;UBE3A;PTPN11;EML1;PAFAH1B1,GO_BP,brown,6
positive regulation of transcription by RNA polymerase II (GO:0045944),28/908,0.194674452165789,0.534030123045204,0,0,1.20792207792208,1.97667580891587,HDAC4;APP;EHF;EPAS1;RORB;BRCA1;YY1;NRIP1;TEAD1;NCOA1;MEF2C;ATMIN;STAT3;VEZF1;INO80;SREBF2;SOX30;HIPK2;AR;NFIC;ASXL3;RARB;PGR;ITGA6;LPIN1;ATF6;OGT;BMPR1A,GO_BP,brown,28
negative regulation of autophagy (GO:0010507),3/59,0.196453318535979,0.534030123045204,0,0,2.02073509015257,3.28840372459018,STAT3;BCL2;TAB3,GO_BP,brown,3
positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),3/59,0.196453318535979,0.534030123045204,0,0,2.02073509015257,3.28840372459018,ERBB4;STAT3;JAK2,GO_BP,brown,3
cellular response to DNA damage stimulus (GO:0006974),12/350,0.199106920930548,0.534030123045204,0,0,1.34321865425544,2.16783846090256,YY1;HERC2;CCND1;MSH3;BCL2;KMT5B;FBXO45;INO80;BRCA1;BAZ1B;USP28;TOPORS,GO_BP,brown,12
transforming growth factor beta receptor signaling pathway (GO:0007179),4/89,0.199477135950396,0.534030123045204,0,0,1.77587548638132,2.86281012214614,USP9Y;PTPRK;FERMT2;BMPR1A,GO_BP,brown,4
cytoskeleton organization (GO:0007010),5/120,0.200656608281753,0.534030123045204,0,0,1.64141028900754,2.63636795758347,PCLO;FGD6;DST;PALLD;TNIK,GO_BP,brown,5
"negative regulation of transcription, DNA-templated (GO:0045892)",29/948,0.201328346827934,0.534030123045204,0,0,1.19790338480299,1.9200212720547,KANK2;HDAC4;ARID4A;RORB;BRCA1;PTPRK;MTDH;YY1;ZNF608;CCND1;NRIP1;BEND3;CAPN3;MEF2C;RBM15;STAT3;SREBF2;ESR2;SOX30;AR;PPM1A;DLG1;NFIC;RARB;PLCB1;ZNF555;TAF3;GZF1;MCPH1,GO_BP,brown,29
negative regulation of protein phosphorylation (GO:0001933),6/152,0.202259207299568,0.534030123045204,0,0,1.55201198630137,2.48043362655141,NIBAN1;IBTK;PDE4D;DUSP19;DMD;PPM1E,GO_BP,brown,6
apical junction assembly (GO:0043297),3/60,0.203119725961131,0.534030123045204,0,0,1.9851814001022,3.16429913055832,DLG1;STRN;VCL,GO_BP,brown,3
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),3/60,0.203119725961131,0.534030123045204,0,0,1.9851814001022,3.16429913055832,CADM1;PALLD;CELSR2,GO_BP,brown,3
"regulation of mRNA splicing, via spliceosome (GO:0048024)",4/90,0.204832663282018,0.534030123045204,0,0,1.75513528187494,2.7828756495783,MBNL1;RBM15;RBMXL1;SRPK1,GO_BP,brown,4
positive regulation of Wnt signaling pathway (GO:0030177),6/153,0.206299388720617,0.534030123045204,0,0,1.5413743622449,2.43294663606399,AMER1;MACF1;PPM1A;WNK1;USP34;LGR4,GO_BP,brown,6
ubiquitin-dependent protein catabolic process (GO:0006511),12/354,0.209529292051554,0.534030123045204,0,0,1.32723112128146,2.07431854395532,UBE3C;FEM1B;HECW2;RNF19A;TTC3;FBXO45;FEM1C;ARIH1;RNF150;RFFL;FBXL4;TOPORS,GO_BP,brown,12
epithelium development (GO:0060429),5/122,0.209825657135198,0.534030123045204,0,0,1.61318538511521,2.51895396820644,KANK2;EHF;DAG1;JAK2;VCL,GO_BP,brown,5
potassium ion transport (GO:0006813),5/122,0.209825657135198,0.534030123045204,0,0,1.61318538511521,2.51895396820644,SLC9A6;SLC9A7;KCND3;ABCC9;KCNA6,GO_BP,brown,5
regulation of canonical Wnt signaling pathway (GO:0060828),9/253,0.211283522211056,0.534030123045204,0,0,1.39410286965764,2.16720866686663,AMER1;CYLD;PPM1A;LATS2;WNK1;CSNK1A1;OTULIN;USP34;LGR4,GO_BP,brown,9
proteolysis (GO:0006508),10/287,0.212357618579673,0.534030123045204,0,0,1.36480570795077,2.1147439871398,NLN;CAPN7;DESI2;DDI2;CAPN3;LNPEP;UBE3A;OGT;ZMPSTE24;RSPRY1,GO_BP,brown,10
positive regulation of NF-kappaB transcription factor activity (GO:0051092),6/155,0.214465288569616,0.534030123045204,0,0,1.52052747483221,2.34101531955396,APP;AR;STAT3;CAPN3;TAB3;MTDH,GO_BP,brown,6
negative regulation of gene expression (GO:0010629),11/322,0.215377124762443,0.534030123045204,0,0,1.33742397432726,2.05343358422432,YY1;APP;SYNCRIP;MEF2C;RNF139;ROCK2;NOCT;PGR;LGR4;BMPR1A;PICALM,GO_BP,brown,11
cellular response to fibroblast growth factor stimulus (GO:0044344),4/92,0.215666914356576,0.534030123045204,0,0,1.71506897771489,2.63095032700346,POLR2D;MAPK1;SHOC2;PTPN11,GO_BP,brown,4
regulation of lipid metabolic process (GO:0019216),4/92,0.215666914356576,0.534030123045204,0,0,1.71506897771489,2.63095032700346,NCOA1;HMGCS1;HMGCR;SREBF2,GO_BP,brown,4
"transcription, DNA-templated (GO:0006351)",8/221,0.215801987758829,0.534030123045204,0,0,1.41905550952775,2.1759712253826,NFIC;NOCT;POLR2D;MLLT1;TAF3;TOPORS;TAF5L;SOX5,GO_BP,brown,8
regulation of mitotic cell cycle phase transition (GO:1901990),7/188,0.216036033267309,0.534030123045204,0,0,1.4607583440551,2.23833471244036,PCM1;HECW2;HAUS6;INO80;CKAP5;CLASP1;PAFAH1B1,GO_BP,brown,7
positive regulation of interleukin-1 production (GO:0032732),3/62,0.216604396608307,0.534030123045204,0,0,1.91768964949811,2.93345657789789,APP;STAT3;JAK2,GO_BP,brown,3
negative regulation of cellular process (GO:0048523),18/566,0.217699750220174,0.534030123045204,0,0,1.24383941605839,1.89640540942358,KANK2;APP;IFNLR1;MIA3;PTPRK;ESR2;DCBLD2;AR;RNF139;SERTAD2;ERBB4;BCL2;ADNP2;RAPGEF2;PLXNA1;STRN;JAK2;FERMT2,GO_BP,brown,18
regulation of cell differentiation (GO:0045595),6/156,0.218589602171704,0.534030123045204,0,0,1.5103125,2.29651967234607,AR;PLEKHB2;DAG1;MBOAT2;FADS1;CLASP1,GO_BP,brown,6
actin cytoskeleton reorganization (GO:0031532),3/63,0.22341584216962,0.534030123045204,0,0,1.88563106796117,2.82603390105354,MKLN1;S1PR1;TNIK,GO_BP,brown,3
positive regulation of viral process (GO:0048524),3/63,0.22341584216962,0.534030123045204,0,0,1.88563106796117,2.82603390105354,POLR2D;KPNA6;SRPK1,GO_BP,brown,3
regulation of phosphorylation (GO:0042325),5/125,0.223825631244445,0.534030123045204,0,0,1.57261208576998,2.35402410041034,RANBP2;APP;AR;ITGA6;OGT,GO_BP,brown,5
regulation of kinase activity (GO:0043549),4/94,0.226653816963387,0.534030123045204,0,0,1.67678339818418,2.48890235113086,ERBB4;TEK;ROS1;IGF1R,GO_BP,brown,4
cellular response to growth factor stimulus (GO:0071363),6/158,0.226917406961999,0.534030123045204,0,0,1.49028577302632,2.21034591854309,MEF2C;RAPGEF1;RAPGEF2;PTPN11;SOX5;BMPR1A,GO_BP,brown,6
cellular response to starvation (GO:0009267),6/158,0.226917406961999,0.534030123045204,0,0,1.49028577302632,2.21034591854309,RPTOR;MAPK1;ATP6V1E2;FADS1;SREBF2;CPEB4,GO_BP,brown,6
skeletal system development (GO:0001501),6/158,0.226917406961999,0.534030123045204,0,0,1.49028577302632,2.21034591854309,KIAA1217;CREB3L2;CHD7;BPNT2;COL19A1;SOX5,GO_BP,brown,6
positive regulation of cell differentiation (GO:0045597),9/258,0.227266814349078,0.534030123045204,0,0,1.36575378133359,2.02354253730096,AR;MEF2C;NOCT;SUCO;RAPGEF2;PLCB1;FERMT2;SOX5;BMPR1A,GO_BP,brown,9
BMP signaling pathway (GO:0030509),3/65,0.237160273197904,0.540738081144666,0,0,1.82461634826182,2.62565779026016,USP9Y;RGMB;BMPR1A,GO_BP,brown,3
chemical homeostasis (GO:0048878),3/65,0.237160273197904,0.540738081144666,0,0,1.82461634826182,2.62565779026016,SLC4A7;WNK1;EIF5A2,GO_BP,brown,3
protein autoubiquitination (GO:0051865),3/65,0.237160273197904,0.540738081144666,0,0,1.82461634826182,2.62565779026016,UBE3A;BRCA1;RNFT1,GO_BP,brown,3
plasma membrane bounded cell projection organization (GO:0120036),5/128,0.238095917423592,0.540738081144666,0,0,1.53401797175867,2.20144107596482,APP;ARMC2;OPHN1;FAM161A;RAPGEF2,GO_BP,brown,5
double-strand break repair via homologous recombination (GO:0000724),4/97,0.243390071918528,0.540738081144666,0,0,1.62244257562445,2.29265719815753,YY1;RAD51AP2;INO80;BRCA1,GO_BP,brown,4
cellular response to nutrient levels (GO:0031669),3/66,0.244086740878623,0.540738081144666,0,0,1.79556171983356,2.53215791558927,RPTOR;FADS1;SREBF2,GO_BP,brown,3
embryonic organ development (GO:0048568),3/66,0.244086740878623,0.540738081144666,0,0,1.79556171983356,2.53215791558927,RARB;TEAD1;BMPR1A,GO_BP,brown,3
regulation of primary metabolic process (GO:0080090),5/130,0.247745438560448,0.540738081144666,0,0,1.50931773879142,2.10603181570119,NCOA1;HMGCS1;ROCK2;HMGCR;SREBF2,GO_BP,brown,5
positive regulation of canonical Wnt signaling pathway (GO:0090263),5/130,0.247745438560448,0.540738081144666,0,0,1.50931773879142,2.10603181570119,AMER1;PPM1A;WNK1;USP34;LGR4,GO_BP,brown,5
regulation of peptidyl-serine phosphorylation (GO:0033135),4/98,0.249030188519562,0.540738081144666,0,0,1.6050997599139,2.23137943143711,RPTOR;APP;PDE4D;DMD,GO_BP,brown,4
anion transmembrane transport (GO:0098656),3/67,0.251045121610823,0.540843603809576,0,0,1.76741504854369,2.44278426208173,SLC16A7;LRRC8B;SLC7A1,GO_BP,brown,3
positive regulation of intracellular signal transduction (GO:1902533),17/546,0.251933008530917,0.542296475990279,0,0,1.21571978915515,1.67598165577838,APP;ROCK2;DUSP19;PTPN11;MTDH;IGF1R;RPTOR;PPM1A;ERBB4;BCL2;RAPGEF2;TAB3;STRN;TEK;JAK2;FERMT2;TSPYL5,GO_BP,brown,17
extracellular matrix organization (GO:0030198),10/300,0.252165445203216,0.542337197981514,0,0,1.30274232962259,1.7947488667167,APP;SH3PXD2A;EXOC8;DST;DAG1;COL4A6;ITGA6;NID1;COL19A1;PLEC,GO_BP,brown,10
double-strand break repair (GO:0006302),6/164,0.252482329928841,0.542559321505292,0,0,1.43324762658228,1.97274211760677,YY1;HERC2;RAD51AP2;INO80;BRCA1;BAZ1B,GO_BP,brown,6
regulation of protein phosphorylation (GO:0001932),9/266,0.253729727440885,0.54477895832616,0,0,1.32268964093783,1.81404985358552,NIBAN1;APP;RALBP1;IBTK;CCND1;ROCK2;ERBB4;TNIK;TEK,GO_BP,brown,9
positive regulation of stress-activated MAPK cascade (GO:0032874),4/99,0.254698149445378,0.546396367898024,0,0,1.58812205611305,2.17203667952112,APP;DUSP19;PLCB1;HIPK2,GO_BP,brown,4
intracellular protein transport (GO:0006886),11/336,0.256103389500877,0.547679797623831,0,0,1.27887725686542,1.74205341345574,IPO11;IPO8;HERC2;SNX27;KIF13A;STAT3;FAM53C;AP4E1;DNAJC27;ARL5A;SEC31A,GO_BP,brown,11
regulation of neuron projection development (GO:0010975),6/165,0.256820303722723,0.547679797623831,0,0,1.42415978773585,1.93597240387012,RUFY3;IL1RAPL1;RAPGEF1;RAPGEF2;ITGA6;ZNF365,GO_BP,brown,6
canonical Wnt signaling pathway (GO:0060070),3/68,0.258032294206188,0.547679797623831,0,0,1.74013442867812,2.35730882972916,AMER1;CSNK1A1;DIXDC1,GO_BP,brown,3
regulation of tyrosine phosphorylation of STAT protein (GO:0042509),3/68,0.258032294206188,0.547679797623831,0,0,1.74013442867812,2.35730882972916,ERBB4;STAT3;JAK2,GO_BP,brown,3
positive regulation of translation (GO:0045727),4/100,0.260392268278987,0.547729037614418,0,0,1.57149805447471,2.11455444671046,NIBAN1;EIF5A2;POLR2D;PLD1,GO_BP,brown,4
regulation of cell motility (GO:2000145),5/133,0.262402415196783,0.547729037614418,0,0,1.47371466861598,1.97164751207186,MACF1;ROCK2;ERBB4;PLXNA1;AMOTL1,GO_BP,brown,5
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),5/133,0.262402415196783,0.547729037614418,0,0,1.47371466861598,1.97164751207186,USP9Y;PTPRK;RGMB;FERMT2;BMPR1A,GO_BP,brown,5
protein modification by small protein conjugation (GO:0032446),13/409,0.264188477454802,0.547729037614418,0,0,1.24071407140714,1.65150519609874,RANBP2;EPAS1;DCUN1D4;FBXO45;BRCA1;PEX13;TOPORS;HERC2;RNF139;GAN;HECW2;OTULIN;ARIH1,GO_BP,brown,13
"regulation of transcription, DNA-templated (GO:0006355)",63/2244,0.264832190851691,0.547729037614418,0,0,1.09835996190879,1.45934573401311,EHF;CHD7;ARID4A;ZNF44;CHD4;RORB;BRCA1;PTPRK;IKZF2;CELSR2;CCAR1;YY1;ZNF608;CREB3L2;CAPN3;ZNF644;TEAD1;FADS1;SOX5;NCOA1;ARHGEF11;MEF2C;RBM15;ATMIN;DYRK1A;ZFP91;VEZF1;BAZ1B;ZFY;RGMB;SREBF2;AR;PPM1A;PRKAR1A;PGR;PLCB1;ZNF555;ATF6;CREB5;HDAC4;EPAS1;ZNF518B;ZBTB43;MED12L;TAF5L;MTDH;ERBB4;ATXN1L;HIVEP2;ZNF664;HDX;ZNF382;STAT3;ESR2;SOX30;HIPK2;TADA2B;ZNF71;NFIC;OGT;ZNF774;GZF1;PICALM,GO_BP,brown,63
negative regulation of cellular catabolic process (GO:0031330),3/69,0.265045195203306,0.547729037614418,0,0,1.71368049426302,2.27551907493066,STAT3;BCL2;TAB3,GO_BP,brown,3
positive regulation of protein transport (GO:0051222),3/69,0.265045195203306,0.547729037614418,0,0,1.71368049426302,2.27551907493066,PCM1;RUFY3;MYO18A,GO_BP,brown,3
cellular response to cytokine stimulus (GO:0071345),15/482,0.269590917414317,0.547729037614418,0,0,1.21423493301433,1.59167936365323,SLC12A2;STAT3;ERBIN;PTPN11;IFNLR1;BRCA1;SYNCRIP;CCND1;WNK1;IL1RAPL1;RAPGEF1;BCL2;S1PR1;JAK2;PTPN4,GO_BP,brown,15
positive regulation of gene expression (GO:0010628),15/482,0.269590917414317,0.547729037614418,0,0,1.21423493301433,1.59167936365323,NIBAN1;APP;MEF2C;CADM1;ROCK2;STAT3;DYRK1A;ANK3;BRCA1;BAZ1B;PLD1;AR;FUBP1;RBM20;MAPK1,GO_BP,brown,15
protein O-linked glycosylation (GO:0006493),4/102,0.271852297266922,0.549789405641929,0,0,1.53926784721671,2.00489080644097,CRPPA;TMTC1;OGT;B4GALT5,GO_BP,brown,4
positive regulation of vasculature development (GO:1904018),4/102,0.271852297266922,0.549789405641929,0,0,1.53926784721671,2.00489080644097,BRCA1;TEK;MTDH;HIPK2,GO_BP,brown,4
fatty acid catabolic process (GO:0009062),3/70,0.272080820036183,0.549789405641929,0,0,1.68801622953195,2.19721666314763,ABHD2;LPIN1;PEX13,GO_BP,brown,3
positive regulation of cell-substrate adhesion (GO:0010811),3/70,0.272080820036183,0.549789405641929,0,0,1.68801622953195,2.19721666314763,PLEKHA2;JAK2;FERMT2,GO_BP,brown,3
regulation of ERK1 and ERK2 cascade (GO:0070372),8/238,0.276612613037698,0.555900038133165,0,0,1.31300937766411,1.68739727463551,APP;DLG1;ERBB4;RAPGEF2;PTPN11;TEK;ROS1;FERMT2,GO_BP,brown,8
organic substance transport (GO:0071702),5/136,0.277253143111478,0.555900038133165,0,0,1.43974227341041,1.84693639721168,SNX4;SLC22A5;MIA3;ABCC11;ABCG2,GO_BP,brown,5
cellular response to BMP stimulus (GO:0071773),3/71,0.279136224320189,0.555900038133165,0,0,1.66310679611651,2.1222163366278,USP9Y;RGMB;BMPR1A,GO_BP,brown,3
histone acetylation (GO:0016573),3/71,0.279136224320189,0.555900038133165,0,0,1.66310679611651,2.1222163366278,BEND3;JADE3;TAF5L,GO_BP,brown,3
response to metal ion (GO:0010038),3/71,0.279136224320189,0.555900038133165,0,0,1.66310679611651,2.1222163366278,BCL2;CAPN3;SEC31A,GO_BP,brown,3
negative regulation of neuron apoptotic process (GO:0043524),3/71,0.279136224320189,0.555900038133165,0,0,1.66310679611651,2.1222163366278,MEF2C;BCL2;CPEB4,GO_BP,brown,3
phosphatidylinositol-mediated signaling (GO:0048015),3/71,0.279136224320189,0.555900038133165,0,0,1.66310679611651,2.1222163366278,PLCB1;OGT;IGF1R,GO_BP,brown,3
positive regulation of MAPK cascade (GO:0043410),9/274,0.281142292658774,0.555900038133165,0,0,1.28222559958483,1.62700882931265,APP;ROCK2;ERBB4;DUSP19;RAPGEF2;PTPN11;TEK;FERMT2;IGF1R,GO_BP,brown,9
post-translational protein modification (GO:0043687),11/345,0.28359334718637,0.555900038133165,0,0,1.24383186290142,1.56749425642514,APP;EPAS1;GAN;FEM1B;RHBDD1;MIA3;FEM1C;CHML;DCAF5;FBXL4;KBTBD8,GO_BP,brown,11
extrinsic apoptotic signaling pathway (GO:0097191),3/72,0.286208524506337,0.555900038133165,0,0,1.63891937526382,2.05034488958816,SORT1;BCL2;JAK2,GO_BP,brown,3
response to ionizing radiation (GO:0010212),3/72,0.286208524506337,0.555900038133165,0,0,1.63891937526382,2.05034488958816,BRCA1;INO80;USP28,GO_BP,brown,3
negative regulation of supramolecular fiber organization (GO:1902904),3/72,0.286208524506337,0.555900038133165,0,0,1.63891937526382,2.05034488958816,DYRK1A;SSH2;CLASP1,GO_BP,brown,3
positive regulation of ERK1 and ERK2 cascade (GO:0070374),6/172,0.287707257958319,0.555900038133165,0,0,1.36361069277108,1.6988022660518,APP;ERBB4;RAPGEF2;PTPN11;TEK;FERMT2,GO_BP,brown,6
response to molecule of bacterial origin (GO:0002237),3/73,0.293294898754466,0.562665440208718,0,0,1.61542302357836,1.98144023447692,NOCT;ERBIN;JAK2,GO_BP,brown,3
neurotransmitter transport (GO:0006836),3/73,0.293294898754466,0.562665440208718,0,0,1.61542302357836,1.98144023447692,LIN7A;APBA1;GLS,GO_BP,brown,3
positive regulation of synaptic transmission (GO:0050806),3/73,0.293294898754466,0.562665440208718,0,0,1.61542302357836,1.98144023447692,APP;GRIN2A;ADCY1,GO_BP,brown,3
cellular response to peptide hormone stimulus (GO:0071375),4/106,0.295013550247716,0.563187302599749,0,0,1.47859922178988,1.80497632859362,RAB10;PRKAR1A;ADCY1;LPIN1,GO_BP,brown,4
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),4/106,0.295013550247716,0.563187302599749,0,0,1.47859922178988,1.80497632859362,MAPK1;TEK;JAK2;IGF1R,GO_BP,brown,4
positive regulation of protein serine/threonine kinase activity (GO:0071902),4/106,0.295013550247716,0.563187302599749,0,0,1.47859922178988,1.80497632859362,RPTOR;CCND1;RAPGEF2;FERMT2,GO_BP,brown,4
neuron differentiation (GO:0030182),6/174,0.296677505952391,0.563187302599749,0,0,1.34723772321429,1.63704144875537,MEF2C;OPHN1;WNK1;IL1RAPL1;ADNP2;RORB,GO_BP,brown,6
anterograde trans-synaptic signaling (GO:0098916),8/244,0.299131197945423,0.563187302599749,0,0,1.27922897972748,1.54386693271747,GRIN2A;DLG1;DLG2;PRKAR1A;HRH2;MAPK1;APBA1;PAFAH1B1,GO_BP,brown,8
proteolysis involved in cellular protein catabolic process (GO:0051603),3/74,0.300392587724862,0.563187302599749,0,0,1.59258854095446,1.91535055188369,DDI2;RHBDD1;RSPRY1,GO_BP,brown,3
cellular response to amino acid starvation (GO:0034198),3/74,0.300392587724862,0.563187302599749,0,0,1.59258854095446,1.91535055188369,RPTOR;MAPK1;ATP6V1E2,GO_BP,brown,3
mitotic nuclear division (GO:0140014),3/74,0.300392587724862,0.563187302599749,0,0,1.59258854095446,1.91535055188369,INO80;CLASP1;MAP9,GO_BP,brown,3
mRNA export from nucleus (GO:0006406),4/107,0.30084472197726,0.563187302599749,0,0,1.46416833515923,1.75870193262705,RANBP2;POLR2D;AGFG1;SRRM1,GO_BP,brown,4
response to amino acid starvation (GO:1990928),3/75,0.307498894864225,0.563187302599749,0,0,1.57038834951456,1.85193351780252,RPTOR;MAPK1;ATP6V1E2,GO_BP,brown,3
integrin-mediated signaling pathway (GO:0007229),3/75,0.307498894864225,0.563187302599749,0,0,1.57038834951456,1.85193351780252,DST;ERBIN;FERMT2,GO_BP,brown,3
positive regulation of lymphocyte proliferation (GO:0050671),3/75,0.307498894864225,0.563187302599749,0,0,1.57038834951456,1.85193351780252,MEF2C;BCL2;SLC7A1,GO_BP,brown,3
organelle assembly (GO:0070925),13/425,0.309460240770356,0.566303322447194,0,0,1.19153128905124,1.39757762110344,EXOC8;HAUS6;OCRL;INO80;FNBP1L;DYNLL2;ABLIM1;PCM1;FAM161A;NEK1;ULK2;CAPN3;SSX2IP,GO_BP,brown,13
phosphate-containing compound metabolic process (GO:0006796),7/212,0.31099714229821,0.568706077348778,0,0,1.28813899097895,1.50450970111865,PPM1A;GPD2;STAT3;GFPT1;OCRL;TOP1;PLCB1,GO_BP,brown,7
regulation of transcription by RNA polymerase II (GO:0006357),61/2206,0.311514619271696,0.569242541690724,0,0,1.07884806659424,1.25827022049484,APP;EHF;ARID4A;ZNF44;CHD4;RORB;BRCA1;IKZF2;YY1;ZNF608;CCND1;CREB3L2;ZNF644;TEAD1;SOX5;NCOA1;MEF2C;ATMIN;ZFP91;VEZF1;BAZ1B;ZFY;SREBF2;AR;PPM1A;PRKAR1A;RARB;PGR;ITGA6;ZNF555;ATF6;CREB5;MCPH1;KANK2;HDAC4;EPAS1;ZNF518B;ZBTB43;MED12L;MTDH;NRIP1;BEND3;HIVEP2;HDX;ZNF382;STAT3;INO80;ESR2;SOX30;HIPK2;TADA2B;DLG1;ZNF71;NFIC;ASXL3;LPIN1;OGT;ZNF774;TAF3;GZF1;BMPR1A,GO_BP,brown,61
receptor-mediated endocytosis (GO:0006898),5/143,0.312499171157474,0.570221188749989,0,0,1.36621747605729,1.58912058726478,DNAJC6;AP4E1;HYOU1;FNBP1L;PICALM,GO_BP,brown,5
negative regulation of DNA-binding transcription factor activity (GO:0043433),5/143,0.312499171157474,0.570221188749989,0,0,1.36621747605729,1.58912058726478,HDAC4;CYLD;OTULIN;ERBIN;TAF3,GO_BP,brown,5
regulation of epithelial to mesenchymal transition (GO:0010717),3/76,0.314611187003412,0.571723411899526,0,0,1.54879638249767,1.79105559616583,DAG1;CLASP1;FERMT2,GO_BP,brown,3
chloride transport (GO:0006821),3/76,0.314611187003412,0.571723411899526,0,0,1.54879638249767,1.79105559616583,SLC12A2;CLIC5;CLCN4,GO_BP,brown,3
positive regulation of interleukin-6 production (GO:0032755),3/76,0.314611187003412,0.571723411899526,0,0,1.54879638249767,1.79105559616583,APP;STAT3;PTPN11,GO_BP,brown,3
regulation of protein kinase activity (GO:0045859),4/110,0.318411250150507,0.571723411899526,0,0,1.42250936054622,1.62793606004065,ALS2;DUSP19;RAPGEF2;PPM1E,GO_BP,brown,4
response to tumor necrosis factor (GO:0034612),4/110,0.318411250150507,0.571723411899526,0,0,1.42250936054622,1.62793606004065,ERBIN;BRCA1;AFF3;JAK2,GO_BP,brown,4
purine ribonucleotide metabolic process (GO:0009150),3/77,0.321726894548994,0.571723411899526,0,0,1.52778798215691,1.73259139394886,ACSL6;BPNT2;NT5C2,GO_BP,brown,3
positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),3/77,0.321726894548994,0.571723411899526,0,0,1.52778798215691,1.73259139394886,TEK;JAK2;IGF1R,GO_BP,brown,3
extracellular structure organization (GO:0043062),7/216,0.327618355181745,0.574689656188972,0,0,1.26322343842171,1.40963848709976,APP;SH3PXD2A;DAG1;COL4A6;ITGA6;NID1;COL19A1,GO_BP,brown,7
negative regulation of apoptotic signaling pathway (GO:2001234),3/78,0.328843511663261,0.57604311698254,0,0,1.50733980582524,1.67642307071121,AR;BCL2;ITGA6,GO_BP,brown,3
negative regulation of protein serine/threonine kinase activity (GO:0071901),3/78,0.328843511663261,0.57604311698254,0,0,1.50733980582524,1.67642307071121,LATS2;PRKAR1A;HEG1,GO_BP,brown,3
external encapsulating structure organization (GO:0045229),7/217,0.331795907936956,0.580544449614957,0,0,1.25714285714286,1.38692429445103,APP;SH3PXD2A;DAG1;COL4A6;ITGA6;NID1;COL19A1,GO_BP,brown,7
regulation of cellular response to heat (GO:1900034),3/79,0.335958596539262,0.580544449614957,0,0,1.48742973939704,1.6224397969341,RPTOR;RANBP2;MAPK1,GO_BP,brown,3
mRNA 3'-end processing (GO:0031124),3/79,0.335958596539262,0.580544449614957,0,0,1.48742973939704,1.6224397969341,APP;POLR2D;SRRM1,GO_BP,brown,3
negative regulation of NF-kappaB transcription factor activity (GO:0032088),3/79,0.335958596539262,0.580544449614957,0,0,1.48742973939704,1.6224397969341,CYLD;OTULIN;ERBIN,GO_BP,brown,3
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),3/79,0.335958596539262,0.580544449614957,0,0,1.48742973939704,1.6224397969341,CSNK1A1;RNF19A;ARIH1,GO_BP,brown,3
positive regulation of intracellular protein transport (GO:0090316),5/148,0.338030600827109,0.580544449614957,0,0,1.31810684442263,1.42964353320942,PCM1;RUFY3;BCL2;ANK3;SREBF2,GO_BP,brown,5
cellular response to lipid (GO:0071396),7/219,0.340173927456872,0.580544449614957,0,0,1.24515378650814,1.34264713754953,AR;MEF2C;ROCK2;NRIP1;ADNP2;ADCY1;RORB,GO_BP,brown,7
response to lipid (GO:0033993),4/114,0.341947407737493,0.580544449614957,0,0,1.37049876193845,1.47067993584167,NOCT;STAT3;ERBIN;JAK2,GO_BP,brown,4
negative regulation of cell motility (GO:2000146),4/114,0.341947407737493,0.580544449614957,0,0,1.37049876193845,1.47067993584167,DAG1;MIA3;PTPRK;VCL,GO_BP,brown,4
glycerophospholipid metabolic process (GO:0006650),3/80,0.343069771209469,0.580544449614957,0,0,1.46803681755138,1.57053725903896,SERINC1;PLCB1;PAFAH1B1,GO_BP,brown,3
lipid biosynthetic process (GO:0008610),3/80,0.343069771209469,0.580544449614957,0,0,1.46803681755138,1.57053725903896,ACSL6;HMGCR;FADS1,GO_BP,brown,3
negative regulation of cellular response to growth factor stimulus (GO:0090288),3/80,0.343069771209469,0.580544449614957,0,0,1.46803681755138,1.57053725903896,EPN2;HIPK2;BMPR1A,GO_BP,brown,3
negative regulation of protein modification process (GO:0031400),3/81,0.350174721508407,0.589550126285173,0,0,1.44914115011202,1.52061720390801,NIBAN1;IBTK;DMD,GO_BP,brown,3
ion transport (GO:0006811),4/116,0.35373823354935,0.589550126285173,0,0,1.34588660366871,1.3986427914277,SLC12A2;SLC9A6;SLC9A7;WNK1,GO_BP,brown,4
ephrin receptor signaling pathway (GO:0048013),3/82,0.357271197001867,0.589550126285173,0,0,1.43072385400025,1.47258702014446,ROCK2;ITSN1;PTPN11,GO_BP,brown,3
positive regulation of cytoskeleton organization (GO:0051495),3/82,0.357271197001867,0.589550126285173,0,0,1.43072385400025,1.47258702014446,PRKCE;SYNPO2;TEK,GO_BP,brown,3
regulation of cell cycle (GO:0051726),9/296,0.359996306561506,0.589550126285173,0,0,1.18258113538194,1.2081976250849,ZBED9;CYLD;CCND1;CCPG1;STAT3;TXLNG;BRCA1;PTPRK;HIPK2,GO_BP,brown,9
regulation of defense response (GO:0031347),3/83,0.364357010724708,0.592488352907015,0,0,1.41276699029126,1.42635935334415,CYLD;JAK2;ZMPSTE24,GO_BP,brown,3
regulation of interleukin-1 beta production (GO:0032651),3/83,0.364357010724708,0.592488352907015,0,0,1.41276699029126,1.42635935334415,APP;STAT3;JAK2,GO_BP,brown,3
regulation of Notch signaling pathway (GO:0008593),3/83,0.364357010724708,0.592488352907015,0,0,1.41276699029126,1.42635935334415,STAT3;SREBF2;EPN2,GO_BP,brown,3
glycoprotein biosynthetic process (GO:0009101),3/83,0.364357010724708,0.592488352907015,0,0,1.41276699029126,1.42635935334415,CSGALNACT1;COG3;B4GALT5,GO_BP,brown,3
peptide metabolic process (GO:0006518),3/83,0.364357010724708,0.592488352907015,0,0,1.41276699029126,1.42635935334415,NLN;DMD;LNPEP,GO_BP,brown,3
adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),4/118,0.365529376881272,0.59325534650379,0,0,1.32213802989965,1.33061112138279,S1PR1;RAPGEF2;ADCY1;LGR4,GO_BP,brown,4
regulation of cellular response to stress (GO:0080135),4/118,0.365529376881272,0.59325534650379,0,0,1.32213802989965,1.33061112138279,RPTOR;RANBP2;ROCK2;MAPK1,GO_BP,brown,4
regulation of protein binding (GO:0043393),4/118,0.365529376881272,0.59325534650379,0,0,1.32213802989965,1.33061112138279,HDAC4;APP;RAPGEF2;HIPK2,GO_BP,brown,4
positive regulation of protein kinase activity (GO:0045860),5/154,0.368864574457426,0.595969615442189,0,0,1.26463623637767,1.26125423131977,RPTOR;ALS2;DUSP19;RAPGEF2;TNIK,GO_BP,brown,5
negative regulation of Wnt signaling pathway (GO:0030178),6/191,0.374519660381035,0.595969615442189,0,0,1.22236064189189,1.20049380758347,AMER1;CYLD;HMGXB4;LATS2;CSNK1A1;SOX30,GO_BP,brown,6
B cell activation (GO:0042113),3/85,0.3784882201586,0.598605279702893,0,0,1.37816717973005,1.33898634025943,HDAC4;MEF2C;BCL2,GO_BP,brown,3
regulation of signal transduction by p53 class mediator (GO:1901796),5/156,0.379157626023597,0.599290833914086,0,0,1.24775699366149,1.21007880084401,CHD4;BRCA1;RFFL;TAF3;HIPK2,GO_BP,brown,5
negative regulation of phosphorylation (GO:0042326),3/86,0.385529556135982,0.604960549008219,0,0,1.36149257223067,1.29768951669788,HDAC4;NIBAN1;IBTK,GO_BP,brown,3
apoptotic process (GO:0006915),7/231,0.390861236004485,0.604960549008219,0,0,1.17771526418787,1.10634887205863,APP;FEM1B;PRKCE;BCL2;CAPN3;JAK2;OGT,GO_BP,brown,7
calcium ion transmembrane transport (GO:0070588),3/87,0.392552109883547,0.604960549008219,0,0,1.34521497919556,1.25789167592614,GRIN2A;TRPM7;CACNA1C,GO_BP,brown,3
ERAD pathway (GO:0036503),3/87,0.392552109883547,0.604960549008219,0,0,1.34521497919556,1.25789167592614,RNF139;RHBDD1;SEL1L,GO_BP,brown,3
chemical synaptic transmission (GO:0007268),9/306,0.396781070353864,0.610802374968978,0,0,1.14216824432934,1.05578675727109,GRIN2A;DLG1;DLG2;PRKAR1A;HRH2;MAPK1;APBA1;LIN7A;PAFAH1B1,GO_BP,brown,9
"retrograde transport, endosome to Golgi (GO:0042147)",3/88,0.399554005950776,0.613944697668063,0,0,1.32932038834951,1.21952695090764,HEATR5B;VTI1A;WASHC2C,GO_BP,brown,3
sensory perception of mechanical stimulus (GO:0050954),3/88,0.399554005950776,0.613944697668063,0,0,1.32932038834951,1.21952695090764,CLIC5;USP53;MYO7B,GO_BP,brown,3
positive regulation of neuron projection development (GO:0010976),3/88,0.399554005950776,0.613944697668063,0,0,1.32932038834951,1.21952695090764,RAPGEF1;RAPGEF2;ITGA6,GO_BP,brown,3
regulation of tumor necrosis factor production (GO:0032680),4/124,0.400799964497151,0.613944697668063,0,0,1.2556420233463,1.14802448366265,APP;STAT3;PTPN11;JAK2,GO_BP,brown,4
cellular response to oxidative stress (GO:0034599),4/125,0.406650354020055,0.613944697668063,0,0,1.24520050165611,1.1204333337219,ADNP2;MAPK1;VRK2;PTPRK,GO_BP,brown,4
negative regulation of intracellular signal transduction (GO:1902532),6/198,0.406896826977577,0.613944697668063,0,0,1.1773681640625,1.05868429865989,CYLD;PPM1A;PDE4D;DAG1;BCL2;RFFL,GO_BP,brown,6
negative regulation of cell growth (GO:0030308),4/126,0.412489584434183,0.617761523857797,0,0,1.23493015245264,1.09358538627858,SERTAD2;ULK2;ESR2;DCBLD2,GO_BP,brown,4
phosphatidylinositol biosynthetic process (GO:0006661),4/126,0.412489584434183,0.617761523857797,0,0,1.23493015245264,1.09358538627858,PLEKHA2;OCRL;SBF1;SOCS4,GO_BP,brown,4
positive regulation of binding (GO:0051099),3/90,0.413488626398271,0.618892817355103,0,0,1.29862738533646,1.14685066106312,APP;RAPGEF2;HIPK2,GO_BP,brown,3
sensory perception of sound (GO:0007605),3/91,0.420417901098874,0.62298521079727,0,0,1.28380406001765,1.11242399756949,CLIC5;USP53;MYO7B,GO_BP,brown,3
regulation of peptidyl-tyrosine phosphorylation (GO:0050730),3/92,0.427319617479139,0.62570882509067,0,0,1.26931384313298,1.07919985800708,APP;PTPN11;JAK2,GO_BP,brown,3
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),3/92,0.427319617479139,0.62570882509067,0,0,1.26931384313298,1.07919985800708,JAK2;HIPK2;BMPR1A,GO_BP,brown,3
cellular response to insulin stimulus (GO:0032869),4/129,0.429929210406034,0.628320019810889,0,0,1.20510505836576,1.01727100993894,RAB10;LPIN1;ATP6V1E2;IGF1R,GO_BP,brown,4
positive regulation of macromolecule biosynthetic process (GO:0010557),4/129,0.429929210406034,0.628320019810889,0,0,1.20510505836576,1.01727100993894,NIBAN1;AR;PLD1;JAK2,GO_BP,brown,4
regulation of heart contraction (GO:0008016),3/93,0.434192197277769,0.63249851524787,0,0,1.25514563106796,1.04712782534985,PDE4D;ABCC9;CORIN,GO_BP,brown,3
visual perception (GO:0007601),3/93,0.434192197277769,0.63249851524787,0,0,1.25514563106796,1.04712782534985,ABLIM1;ATF6;MYO9A,GO_BP,brown,3
protein glycosylation (GO:0006486),4/130,0.435712820267532,0.63249851524787,0,0,1.19547896979804,0.993170361165251,COG3;GFPT1;OGT;B4GALT5,GO_BP,brown,4
regulation of nucleic acid-templated transcription (GO:1903506),12/430,0.437433024452726,0.63249851524787,0,0,1.08160447831761,0.894304839107988,MEF2C;STAT3;ATXN1L;CHD7;RORB;ZNF664;CELSR2;FADS1;TAF5L;ESR2;GZF1;CCAR1,GO_BP,brown,12
regulation of cellular macromolecule biosynthetic process (GO:2000112),13/468,0.438194412529779,0.63249851524787,0,0,1.07649222065064,0.888205768296291,APP;MEF2C;STAT3;CHD7;RORB;CELSR2;TAF5L;ESR2;CCAR1;ATXN1L;ZNF664;FADS1;GZF1,GO_BP,brown,13
negative regulation of cell death (GO:0060548),3/94,0.441034119498919,0.635409338359191,0,0,1.2412888082791,1.01616002821874,KANK2;ADNP2;FERMT2,GO_BP,brown,3
sensory perception of light stimulus (GO:0050953),3/95,0.447843919588636,0.642899179279077,0,0,1.22773322076826,0.986250988725835,ABLIM1;ATF6;MYO9A,GO_BP,brown,3
positive regulation of cell population proliferation (GO:0008284),13/474,0.456388282616197,0.645808489050217,0,0,1.0621464315629,0.833159700156857,HDAC4;ZBED9;MEF2C;CCAR1;IGF1R;TJP1;AR;CCPG1;ERBB4;BCL2;SCN5A;TSPYL5;BMPR1A,GO_BP,brown,13
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),4/134,0.45867216656378,0.64867889926058,0,0,1.15845555222987,0.902922914683336,ERBB4;STAT3;PTPN11;JAK2,GO_BP,brown,4
regulation of neuron apoptotic process (GO:0043523),3/98,0.468066771643998,0.65002165116225,0,0,1.18877874297394,0.902454629025242,MEF2C;BCL2;CPEB4,GO_BP,brown,3
negative regulation of neuron death (GO:1901215),3/98,0.468066771643998,0.65002165116225,0,0,1.18877874297394,0.902454629025242,MEF2C;BCL2;CPEB4,GO_BP,brown,3
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),3/99,0.47473453829982,0.654530910918403,0,0,1.17633495145631,0.87636894820769,RANBP2;AGFG1;SRRM1,GO_BP,brown,3
organic anion transport (GO:0015711),3/99,0.47473453829982,0.654530910918403,0,0,1.17633495145631,0.87636894820769,SLC4A7;ABCC11;ABCG2,GO_BP,brown,3
negative regulation of multicellular organismal process (GO:0051241),6/214,0.480061663629319,0.654530910918403,0,0,1.08589993990385,0.796877590963642,MEF2C;ROCK2;LNPEP;HMGCR;LGR4;PTPRG,GO_BP,brown,6
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),3/100,0.481363677793534,0.654530910918403,0,0,1.16414773295966,0.851145902061239,MARCHF8;DYNLL2;SEC31A,GO_BP,brown,3
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),3/100,0.481363677793534,0.654530910918403,0,0,1.16414773295966,0.851145902061239,PPM1A;LATS2;HIPK2,GO_BP,brown,3
epithelial cell differentiation (GO:0030855),3/101,0.487953046532576,0.661703338862853,0,0,1.15220923320785,0.826751712528229,RAB10;EHF;ERBB4,GO_BP,brown,3
positive regulation of cell cycle process (GO:0090068),3/101,0.487953046532576,0.661703338862853,0,0,1.15220923320785,0.826751712528229,PRKCE;PKP4;INO80,GO_BP,brown,3
regulation of translation (GO:0006417),5/178,0.490670699839623,0.663500107707868,0,0,1.08784324330415,0.774524860937899,NIBAN1;APP;SYNCRIP;RNF139;PLD1,GO_BP,brown,5
RNA processing (GO:0006396),5/179,0.495594395565833,0.664279559228082,0,0,1.08153525576393,0.759234978299494,SYNCRIP;MBNL1;DHX15;SRRM1;SRPK1,GO_BP,brown,5
positive regulation of cellular catabolic process (GO:0031331),4/141,0.49803492325092,0.66614465774478,0,0,1.0988667670198,0.766003625347301,AMER1;APP;ATF6;MTDH,GO_BP,brown,4
regulation of insulin secretion (GO:0050796),3/104,0.507471840308254,0.668022092446894,0,0,1.11781216956647,0.75822770734825,CACNA2D2;CACNA1C;RAPGEF4,GO_BP,brown,3
mRNA transport (GO:0051028),3/104,0.507471840308254,0.668022092446894,0,0,1.11781216956647,0.75822770734825,RANBP2;AGFG1;SRRM1,GO_BP,brown,3
activation of GTPase activity (GO:0090630),3/105,0.513891681454037,0.672962151484235,0,0,1.10679611650485,0.736841514868519,SYDE2;RAP1GAP2;SIPA1L2,GO_BP,brown,3
protein processing (GO:0016485),3/106,0.520266769407099,0.672962151484235,0,0,1.09599396738618,0.716137342836111,DDI2;OGT;ZMPSTE24,GO_BP,brown,3
regulation of cell cycle process (GO:0010564),3/106,0.520266769407099,0.672962151484235,0,0,1.09599396738618,0.716137342836111,KIF13A;TXLNG;MAP9,GO_BP,brown,3
RNA export from nucleus (GO:0006405),3/106,0.520266769407099,0.672962151484235,0,0,1.09599396738618,0.716137342836111,RANBP2;AGFG1;SRRM1,GO_BP,brown,3
peptidyl-lysine modification (GO:0018205),3/106,0.520266769407099,0.672962151484235,0,0,1.09599396738618,0.716137342836111,HDAC4;RANBP2;TOPORS,GO_BP,brown,3
negative regulation of cell population proliferation (GO:0008285),10/379,0.521199143800413,0.673027872523157,0,0,1.01962102298188,0.664408587838639,KANK2;APP;AR;RNF139;ERBB4;RAPGEF2;IFNLR1;STRN;PTPRK;JAK2,GO_BP,brown,10
negative regulation of programmed cell death (GO:0043069),10/381,0.527921026529559,0.680377569435063,0,0,1.01401829488295,0.647763584441638,KANK2;TJP1;RHBDD1;BCL2;MYO18A;CAPN3;TEK;TOPORS;MTDH;IGF1R,GO_BP,brown,10
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),3/108,0.532879306619565,0.680377569435063,0,0,1.07500693481276,0.676674211417294,PPM1A;BMPR1A;HIPK2,GO_BP,brown,3
regulation of interleukin-6 production (GO:0032675),3/110,0.545303133945459,0.68908953244849,0,0,1.0548044642047,0.639647592982237,APP;STAT3;PTPN11,GO_BP,brown,3
regulation of protein serine/threonine kinase activity (GO:0071900),3/111,0.551442494570419,0.696501211441504,0,0,1.04498381877023,0.62199288257216,RPTOR;CCND1;DUSP19,GO_BP,brown,3
regulation of macroautophagy (GO:0016241),3/112,0.557532616246358,0.699670378095726,0,0,1.03534336866483,0.604883080174485,RPTOR;EXOC8;ATP6V1E2,GO_BP,brown,3
sulfur compound biosynthetic process (GO:0044272),3/113,0.563572896202192,0.702272487178652,0,0,1.02587819947043,0.588298666395392,CSGALNACT1;GCLM;B4GALT5,GO_BP,brown,3
"mRNA splicing, via spliceosome (GO:0000398)",7/274,0.567796215060808,0.702272487178652,0,0,0.985839618285362,0.557978028245015,SYNCRIP;RBM15;POLR2D;DHX15;CCAR1;SRRM1;SRPK1,GO_BP,brown,7
positive regulation of protein metabolic process (GO:0051247),3/115,0.575501713354794,0.710288800739153,0,0,1.00745492371706,0.556632016482855,APP;ROCK2;HECW2,GO_BP,brown,3
regulation of protein-containing complex assembly (GO:0043254),3/116,0.581389235567392,0.712363076865015,0,0,0.998487842598161,0.541514710114008,PTPN11;AIDA;ANKRA2,GO_BP,brown,3
regulation of signal transduction (GO:0009966),5/198,0.585185794194072,0.715651821848579,0,0,0.974103364340615,0.521949797533101,APP;FRRS1L;PLCB1;OGT;SREBF2,GO_BP,brown,5
organonitrogen compound biosynthetic process (GO:1901566),4/158,0.587884818900412,0.715651821848579,0,0,0.976704229622518,0.518848958663159,CERS6;DMD;LPIN1;B4GALT5,GO_BP,brown,4
response to lipopolysaccharide (GO:0032496),4/159,0.592873153746435,0.718120081314232,0,0,0.970352704907745,0.50727594983307,MEF2C;NOCT;ERBIN;JAK2,GO_BP,brown,4
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),8/321,0.593647147060878,0.718714849158547,0,0,0.960671552966234,0.500961552891587,FEM1B;HECW2;SEL1L;FBXO45;FEM1C;RFFL;FBXL4;TOPORS,GO_BP,brown,8
cellular response to lipopolysaccharide (GO:0071222),3/120,0.604416579717234,0.723476961584248,0,0,0.964152352501867,0.485442627249584,MEF2C;PRKCE;MTDH,GO_BP,brown,3
negative regulation of apoptotic process (GO:0043066),12/485,0.605175538459251,0.724044214642722,0,0,0.953078909324888,0.478671222291557,TJP1;MEF2C;RHBDD1;BCL2;MYO18A;CAPN3;MAPK1;TEK;TOPORS;MTDH;CPEB4;IGF1R,GO_BP,brown,12
regulation of cell population proliferation (GO:0042127),19/764,0.605495754268399,0.724086259812492,0,0,0.957628007693239,0.480449371967537,KANK2;HDAC4;APP;STAT3;IFNLR1;PTPRK;CCAR1;IGF1R;TJP1;AR;RNF139;CCPG1;ERBB4;BCL2;RAPGEF2;STRN;JAK2;TSPYL5;BMPR1A,GO_BP,brown,19
regulation of angiogenesis (GO:0045765),5/203,0.607297719778648,0.724811372019486,0,0,0.949258668556914,0.473429595458381,ROCK2;BRCA1;TEK;MTDH;HIPK2,GO_BP,brown,5
protein homooligomerization (GO:0051260),3/121,0.610040892397044,0.724811372019486,0,0,0.95593220338983,0.472449691631658,ALS2;BEND3;GLS,GO_BP,brown,3
regulation of inflammatory response (GO:0050727),5/206,0.620235190820122,0.730121391383964,0,0,0.934945157254662,0.446582662211479,APP;CYLD;OTULIN;TEK;JAK2,GO_BP,brown,5
positive regulation of epithelial cell proliferation (GO:0050679),3/123,0.621128370937218,0.730121391383964,0,0,0.939902912621359,0.447598217101998,ZBED9;SCN5A;TEK,GO_BP,brown,3
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),4/165,0.622040429509802,0.730121391383964,0,0,0.933900476109916,0.443369427674307,GNA12;S1PR1;ADCY1;LGR4,GO_BP,brown,4
negative regulation of canonical Wnt signaling pathway (GO:0090090),4/165,0.622040429509802,0.730121391383964,0,0,0.933900476109916,0.443369427674307,AMER1;CYLD;LATS2;CSNK1A1,GO_BP,brown,4
defense response to symbiont (GO:0140546),3/124,0.6265910545577,0.735122992414115,0,0,0.932086977453262,0.435714475291897,BCL2;IFNLR1;ABCC9,GO_BP,brown,3
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",6/251,0.63532546016994,0.741261676082521,0,0,0.920137117346939,0.417390644514726,SYNCRIP;RBM15;POLR2D;DHX15;CCAR1;SRRM1,GO_BP,brown,6
negative regulation of growth (GO:0045926),3/126,0.63735332263613,0.742962064129322,0,0,0.916836372247218,0.412971625354872,SERTAD2;ESR2;DCBLD2,GO_BP,brown,3
positive regulation of signal transduction (GO:0009967),6/252,0.639131416767031,0.7430879192036,0,0,0.916349085365854,0.41019925649143,MACF1;STAT3;PTPN11;TEK;JAK2;EPN2,GO_BP,brown,6
positive regulation of cytokine production (GO:0001819),8/335,0.641409441666391,0.743239042806859,0,0,0.918870300413744,0.408058604507491,APP;CADM1;ROCK2;PDE4D;STAT3;PTPN11;BRCA1;PLCB1,GO_BP,brown,8
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),4/170,0.645317106605685,0.746731353376369,0,0,0.905536543059397,0.39663718066523,CADM1;PALLD;IL1RAPL1;CELSR2,GO_BP,brown,4
negative regulation of inflammatory response (GO:0050728),5/212,0.645337891239224,0.746731353376369,0,0,0.907562787806876,0.397495472429753,PRKAR1A;HRH2;OTULIN;ADCY1;TEK,GO_BP,brown,5
positive regulation of cellular process (GO:0048522),15/625,0.655474059816885,0.751377717471811,0,0,0.922595574096405,0.389701187253828,HDAC4;TUB;ZBED9;INO80;CCAR1;IGF1R;RPTOR;TJP1;AR;CCND1;CCPG1;ERBB4;BCL2;ADNP2;TSPYL5,GO_BP,brown,15
DNA repair (GO:0006281),7/298,0.655635836429646,0.751377717471811,0,0,0.903403474085581,0.381371570222705,HERC2;RAD51AP2;MSH3;KMT5B;INO80;BRCA1;BAZ1B,GO_BP,brown,7
regulation of response to external stimulus (GO:0032101),3/130,0.658221654111245,0.751377717471811,0,0,0.887776163901842,0.371280015810831,CYLD;JAK2;ZMPSTE24,GO_BP,brown,3
cellular response to hypoxia (GO:0071456),3/131,0.663301534455271,0.755170729500846,0,0,0.880794902912621,0.361588846383825,EPAS1;HYOU1;HIPK2,GO_BP,brown,3
positive regulation of macromolecule metabolic process (GO:0010604),9/384,0.666074036742784,0.75798747908901,0,0,0.900919449901768,0.366092626063434,APP;AR;MEF2C;ROCK2;FUBP1;STAT3;MAPK1;ANK3;BRCA1,GO_BP,brown,9
defense response to virus (GO:0051607),3/133,0.673296440065218,0.76169580558371,0,0,0.867154592979836,0.343019970108936,BCL2;IFNLR1;ABCC9,GO_BP,brown,3
ribonucleoprotein complex assembly (GO:0022618),3/136,0.687877043048791,0.769695017332127,0,0,0.847463318490401,0.317074310347867,POLR2D;MDN1;SRPK1,GO_BP,brown,3
negative regulation of inflammatory response to antigenic stimulus (GO:0002862),3/136,0.687877043048791,0.769695017332127,0,0,0.847463318490401,0.317074310347867,PRKAR1A;HRH2;ADCY1,GO_BP,brown,3
regulated exocytosis (GO:0045055),4/180,0.688964832598674,0.770572732188741,0,0,0.853643438273788,0.318037710682817,RAB10;APP;PCLO;VCL,GO_BP,brown,4
regulation of inflammatory response to antigenic stimulus (GO:0002861),3/137,0.69262768901819,0.772459237707659,0,0,0.841095493406753,0.308902976166041,PRKAR1A;HRH2;ADCY1,GO_BP,brown,3
negative regulation of signal transduction (GO:0009968),6/267,0.693308912986577,0.772459237707659,0,0,0.863011853448276,0.316103651345259,KANK2;HMGXB4;BCL2;LGR4;SOX30;EPN2,GO_BP,brown,6
central nervous system development (GO:0007417),6/268,0.696721600957544,0.775832032631373,0,0,0.859673187022901,0.310659560365338,GRIN2A;STAT3;CHD7;UBE3A;PTPN11;EML1,GO_BP,brown,6
cellular macromolecule biosynthetic process (GO:0034645),7/314,0.707842494953238,0.781968445480878,0,0,0.855606621748249,0.295640900189628,EEF2K;POLR2D;EIF4EBP2;BRCA1;TOP1;TOPORS;B4GALT5,GO_BP,brown,7
antigen receptor-mediated signaling pathway (GO:0050851),4/185,0.709313109601552,0.781968445480878,0,0,0.829847152653868,0.285017832972302,MEF2C;WNK1;PDE4D;BCL2,GO_BP,brown,4
DNA metabolic process (GO:0006259),6/277,0.726289564936177,0.795504741241004,0,0,0.830733971402214,0.265674118759776,MSH3;KMT5B;INO80;BRCA1;TOP1;ZNF365,GO_BP,brown,6
regulation of apoptotic process (GO:0042981),17/742,0.732191723352315,0.800160758870684,0,0,0.877882854979696,0.273647394930858,ARHGEF11;MEF2C;RHBDD1;ITSN1;TOPORS;MTDH;CCAR1;IGF1R;TJP1;LATS2;BCL2;MYO18A;CAPN3;ITGA6;TEK;JAK2;ATF6,GO_BP,brown,17
negative regulation of cell differentiation (GO:0045596),4/191,0.732430615895409,0.800160758870684,0,0,0.80297134771843,0.250034569979868,NOCT;PTPN11;RORB;FERMT2,GO_BP,brown,4
regulation of mRNA stability (GO:0043488),3/146,0.732944021555764,0.800377392412571,0,0,0.787792789734537,0.24475615046807,ROCK2;NOCT;TENT5A,GO_BP,brown,3
ribosome biogenesis (GO:0042254),4/192,0.736146348132606,0.803528888808259,0,0,0.798658829373292,0.244650234072707,UTP15;URB2;MDN1;WDR43,GO_BP,brown,4
positive regulation of programmed cell death (GO:0043068),6/286,0.753783630512184,0.816813319752964,0,0,0.803655133928572,0.227153054764728,ARHGEF11;LATS2;ITSN1;ITGA6;ATF6;CCAR1,GO_BP,brown,6
mRNA processing (GO:0006397),6/300,0.792462562262114,0.844931983666802,0,0,0.764827806122449,0.177906606991344,SYNCRIP;RBM15;POLR2D;DHX15;CCAR1;SRRM1,GO_BP,brown,6
rRNA metabolic process (GO:0016072),3/162,0.794185359859226,0.845444599347206,0,0,0.707931855651218,0.16313468007314,UTP15;MDN1;WDR43,GO_BP,brown,3
positive regulation of apoptotic process (GO:0043065),6/310,0.81712332834161,0.860486423709656,0,0,0.739283511513158,0.149309573924327,ARHGEF11;LATS2;ITSN1;ITGA6;ATF6;CCAR1,GO_BP,brown,6
gene expression (GO:0010467),7/356,0.818549478621257,0.860524745965259,0,0,0.750991090002748,0.150364512688246,RANBP2;SYNCRIP;POLR2D;EIF4EBP2;TOPORS;AGFG1;SRRM1,GO_BP,brown,7
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),3/171,0.823184349826654,0.863684538511513,0,0,0.669694868238558,0.130305949994923,PPM1A;TAB3;MTDH,GO_BP,brown,3
rRNA processing (GO:0006364),3/173,0.829134636241095,0.86738137399192,0,0,0.661747572815534,0.123993448642544,UTP15;MDN1;WDR43,GO_BP,brown,3
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),4/224,0.835330896344944,0.871709316645915,0,0,0.681358330385568,0.12259499850246,PPM1A;CAPN3;TAB3;MTDH,GO_BP,brown,4
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),11/547,0.842201101148776,0.87528265013007,0,0,0.7668977597221,0.131704303206494,HDAC4;SYNCRIP;RBM15;RNF139;ARID4A;CAPN3;RORB;BRCA1;PTPRK;PLCB1;GZF1,GO_BP,brown,11
negative regulation of immune response (GO:0050777),3/178,0.843264236817188,0.87602910491438,0,0,0.642674063800277,0.10955981084198,PRKAR1A;HRH2;ADCY1,GO_BP,brown,3
negative regulation of nucleic acid-templated transcription (GO:1903507),9/464,0.852580633694207,0.882445667062948,0,0,0.73940715473132,0.117926190692456,HDAC4;RBM15;ARID4A;CAPN3;RORB;BRCA1;PTPRK;PLCB1;GZF1,GO_BP,brown,9
cellular response to tumor necrosis factor (GO:0071356),3/194,0.881877841953011,0.903942582147154,0,0,0.588349514563107,0.0739565540342498,ERBIN;BRCA1;JAK2,GO_BP,brown,3
innate immune response (GO:0045087),5/302,0.894598736311882,0.915503944493224,0,0,0.62959024947329,0.0701237623374801,APP;CYLD;OTULIN;IFNLR1;SRPK1,GO_BP,brown,5
ncRNA processing (GO:0034470),3/201,0.895934379966909,0.916132578549094,0,0,0.567343336275375,0.0623442842967264,UTP15;WDR43;MDN1,GO_BP,brown,3
cytokine-mediated signaling pathway (GO:0019221),11/621,0.931107770671242,0.942987933614416,0,0,0.671232256604262,0.0479127265752861,MTAP;CCND1;STAT3;RAPGEF1;BCL2;S1PR1;TAB3;PTPN11;IFNLR1;JAK2;PLCB1,GO_BP,brown,11
inflammatory response (GO:0006954),3/230,0.939461216472338,0.948045883925204,0,0,0.494119156580129,0.0308571197318062,HDAC4;STAT3;ADCY1,GO_BP,brown,3
cellular protein metabolic process (GO:0044267),4/417,0.995033368705219,0.995867964418873,0,0,0.359314496754317,0.00178902903476734,APP;MSRB3;EIF4EBP2;MIA3,GO_BP,brown,4
neutrophil degranulation (GO:0043312),5/481,0.995275824356,0.995867964418873,0,0,0.389167362851573,0.00184285138933902,RAB10;NFASC;MAPK1;PLD1;VCL,GO_BP,brown,5
neutrophil activation involved in immune response (GO:0002283),5/485,0.995623472777293,0.995867964418873,0,0,0.385843079922027,0.00169235877731446,RAB10;NFASC;MAPK1;PLD1;VCL,GO_BP,brown,5
neutrophil mediated immunity (GO:0002446),5/488,0.995867964418873,0.995867964418873,0,0,0.383386001234971,0.00158744655454522,RAB10;NFASC;MAPK1;PLD1;VCL,GO_BP,brown,5
His Bundle Cells,17/98,5.39429249045031e-10,7.82172411115295e-08,0,0,8.12737487986989,173.442320683931,GUCY1A2;ITSN1;DIXDC1;RASSF8;EML1;PTPRG;ENAH;TJP1;EDNRA;LRCH2;NFASC;CALD1;MAP1B;AMOTL1;RNF150;FERMT2;BMPR1A,PanglaoDB,brown,17
Podocytes,19/184,3.32948155218073e-07,2.41387412533103e-05,0,0,4.45767899435234,66.487526112178,CLIC5;STARD13;DST;RASSF8;ZFP91;RASAL2;ADCY1;PTPRG;KIAA1217;ENAH;TJP1;EDNRA;CALD1;PALLD;PRRG1;FAT1;TEAD1;FERMT2;LGR4,PanglaoDB,brown,19
Chromaffin Cells,13/122,1.70255410636324e-05,0.000822901151408899,0,0,4.57532927604687,50.240757074054,SLC12A2;GUCY1A2;DST;ITSN1;PLD1;TTLL7;LRCH2;NFASC;PCLO;MAP1B;ASXL3;RAPGEF2;RAPGEF4,PanglaoDB,brown,13
Peri-islet Schwann Cells,11/114,0.000184036984034805,0.0059567251007922,0,0,4.08205511192815,35.1071999179098,ENAH;TJP1;EDNRA;NFASC;MAP1B;ITSN1;FAT1;EML1;TEAD1;FERMT2;PTPRG,PanglaoDB,brown,11
Embryonic Stem Cells,14/176,0.000205404313820421,0.0059567251007922,0,0,3.31275720164609,28.1270652601154,STAT3;SHROOM3;FNBP1L;PTPRG;DCBLD2;ENAH;TJP1;COL4A6;FAT1;ITGA6;TEAD1;FERMT2;LGR4;ABCG2,PanglaoDB,brown,14
Cardiac Stem And Precursor Cells,10/113,0.000712879697658561,0.0172279260267486,0,0,3.70365415488113,26.8374108808068,ENAH;TJP1;EDNRA;CCND1;PRRG1;FAT1;TEAD1;FERMT2;ABCG2;PTPRG,PanglaoDB,brown,10
Distal Tubule Cells,11/137,0.00089010579887567,0.0184379058338532,0,0,3.33295764064995,23.4112618278454,EHF;CLIP1;WNK1;TSC22D2;ADGRF5;SLC16A7;TRPM7;PLD1;LPP;LARP1B;CPEB4,PanglaoDB,brown,11
Mesangial Cells,11/148,0.00166754738529542,0.0268008824724652,0,0,3.06360586821002,19.5960527529806,EDNRA;MEF2C;LATS2;CALD1;PALLD;NOCT;DYRK1A;TEK;FILIP1L;OGT;TNS1,PanglaoDB,brown,11
Glomus Cells,10/127,0.00174327387861401,0.0268008824724652,0,0,3.25812638804765,20.6955875199697,GUCY1A2;EDNRA;LRCH2;NFASC;EPAS1;CALD1;MAP1B;TLN2;TEAD1;FERMT2,PanglaoDB,brown,10
Gamma (PP) Cells,10/128,0.00184833672223898,0.0268008824724652,0,0,3.23034832510343,20.3300974094227,GUCY1A2;STOX2;NFASC;PCLO;ERBB4;ASXL3;CNTN3;ABCC9;SORBS2;RAPGEF4,PanglaoDB,brown,10
Melanocytes,10/133,0.0024530668350807,0.032335881007882,0,0,3.09823314768581,18.6216709123343,STARD13;CCND1;DST;EPAS1;CALD1;PALLD;RASSF8;RASAL2;FILIP1L;TEAD1,PanglaoDB,brown,10
Kidney Progenitor Cells,8/105,0.0059682651574916,0.0721165373196901,0,0,3.13482918940772,16.054397552737,ENAH;LRCH2;IGDCC4;MAP1B;FAT1;TEAD1;FERMT2;PTPRG,PanglaoDB,brown,8
Granulosa Cells,8/112,0.00871213555375478,0.0971738196380341,0,0,2.92277526395173,13.8628351187141,ENAH;TJP1;PRRG1;DAG1;FAT1;AMOTL1;TEAD1;FERMT2,PanglaoDB,brown,8
Satellite Cells,9/139,0.0103241143469044,0.106928327164367,0,0,2.63212936376001,12.0374459447835,KIAA1217;ENAH;TJP1;EDNRA;PALLD;DAG1;DMD;TEAD1;FERMT2,PanglaoDB,brown,9
Tanycytes,8/121,0.0135065871339224,0.130563675627917,0,0,2.68873850425126,11.5738840127405,GUCY1A2;STOX2;EDNRA;LRCH2;NFASC;MAP1B;ASXL3;CACNA2D2,PanglaoDB,brown,8
Vascular Smooth Muscle Cells,7/103,0.0176453180897226,0.159910695188111,0,0,2.76626712328767,11.1682081952873,EDNRA;SGCD;CALD1;SYNPO2;MSRB3;TEK;VSTM4,PanglaoDB,brown,7
Pulmonary Alveolar Type I Cells,8/131,0.0208274755811435,0.174714447987306,0,0,2.46886657101865,9.55817303954494,KIAA1217;TJP1;CLIC5;EDNRA;EPAS1;PALLD;SHROOM3;TEAD1,PanglaoDB,brown,8
Bergmann Glia,8/132,0.0216886900949759,0.174714447987306,0,0,2.44882985452245,9.38137986720004,GRIN2A;NFASC;DLG2;CHL1;KCND3;RUFY3;BICD2;RAPGEF4,PanglaoDB,brown,8
Endothelial Cells (Blood Brain Barrier),7/113,0.0276882594994407,0.207712386655285,0,0,2.50400620315327,8.98123623739675,TJP1;APP;MAP1B;FAT1;TEAD1;ABCG2;EPN2,PanglaoDB,brown,7
Enteric Neurons,9/166,0.0292018255283244,0.207712386655285,0,0,2.17642936693654,7.69046551896374,TUB;GUCY1A2;LRCH2;NFASC;PCLO;MAP1B;ASXL3;ARHGAP26;RGMB,PanglaoDB,brown,9
Meningeal Cells,7/115,0.0300824835845585,0.207712386655285,0,0,2.45738203957382,8.61020521291311,TJP1;GUCY1A2;EDNRA;CALD1;MAP1B;EML1;FERMT2,PanglaoDB,brown,7
Loop Of Henle Cells,8/147,0.0377680086336657,0.24892551144916,0,0,2.18287487656933,7.15173738796496,EDNRA;EPAS1;CALD1;ADGRF5;TRPM7;SORBS2;TEK;TNS1,PanglaoDB,brown,8
Pulmonary Vascular Smooth Muscle Cells,6/99,0.0437542529053989,0.275842029186211,0,0,2.44317036290323,7.6450867596617,SGCD;CALD1;MSRB3;TEK;VSTM4;TNS1,PanglaoDB,brown,6
Anterior Pituitary Gland Cells,7/133,0.0580055708735503,0.3504503240277,0,0,2.10437051532942,5.99159787150984,LRCH2;NFASC;SGCD;ASXL3;CACNA1C;RNF150;CPEB4,PanglaoDB,brown,7
Alpha Cells,7/136,0.0638274423907327,0.37019916586625,0,0,2.05511309334183,5.65479174639661,NFASC;ASXL3;PGR;CNTN3;SORBS2;GLS;RAPGEF4,PanglaoDB,brown,7
Parietal Cells,6/111,0.0687131654548101,0.37767820978494,0,0,2.16261160714286,5.79107263560296,ABLIM1;USP54;HOOK1;SORBS2;ANK3;PLEKHH1,PanglaoDB,brown,6
Smooth Muscle Cells,8/169,0.0733207560176505,0.37767820978494,0,0,1.88245037145293,4.91867630819052,EDNRA;SGCD;CALD1;SYNPO2;MSRB3;ZBTB44;TEK;TNS1,PanglaoDB,brown,8
Pancreatic Progenitor Cells,6/114,0.0760160290148075,0.37767820978494,0,0,2.10221354166667,5.41700708960546,KIAA1217;ENAH;PCLO;EPAS1;SHROOM3;TEAD1,PanglaoDB,brown,6
Satellite Glial Cells,6/114,0.0760160290148075,0.37767820978494,0,0,2.10221354166667,5.41700708960546,GRIN2A;CHL1;KCND3;MAPK1;JAK2;TNS1,PanglaoDB,brown,6
Adipocyte Progenitor Cells,6/115,0.0785444826561353,0.37767820978494,0,0,2.08281966743119,5.29888101397597,ENAH;KANK2;EDNRA;CALD1;TEAD1;FERMT2,PanglaoDB,brown,6
Mesothelial Cells,7/144,0.0810282931320155,0.37767820978494,0,0,1.93430656934307,4.86082901572324,KIAA1217;TJP1;AR;EDNRA;EPAS1;PALLD;ADGRF5,PanglaoDB,brown,7
Leydig Cells,7/145,0.0833496738835729,0.37767820978494,0,0,1.92019058963669,4.77111787830975,KIAA1217;TJP1;EDNRA;EPAS1;CALD1;ADGRF5;TEK,PanglaoDB,brown,7
Mast Cells,10/235,0.0860271177602255,0.377997941673718,0,0,1.68477690288714,4.13291393784077,ENAH;EDNRA;STARD13;SGCD;SYNPO2;ADGRF5;RAPGEF2;TEK;CCDC141;TNS1,PanglaoDB,brown,10
Peritubular Myoid Cells,6/120,0.0918862017951294,0.391867625302758,0,0,1.99095394736842,4.75281403247497,EDNRA;CALD1;SYNPO2;ADGRF5;TEK;TNS1,PanglaoDB,brown,6
Astrocytes,7/154,0.105932532082739,0.434401721265251,0,0,1.80178920883422,4.04493186866258,GRIN2A;NFASC;ACSL6;S1PR1;TEAD1;SYNE1;RAPGEF4,PanglaoDB,brown,7
Pericytes,7/155,0.108626831676471,0.434401721265251,0,0,1.78952239911144,3.97244773530289,EDNRA;SGCD;SYNPO2;ADGRF5;ABCC9;TEK;TNS1,PanglaoDB,brown,7
Osteocytes,5/98,0.110847335771133,0.434401721265251,0,0,2.03200653964661,4.46960438420293,ENAH;EDNRA;CALD1;COL4A6;FERMT2,PanglaoDB,brown,5
Myofibroblasts,5/100,0.118039297626063,0.450413109362611,0,0,1.98902226326049,4.25001881473512,EDNRA;CALD1;PALLD;TEK;TNS1,PanglaoDB,brown,5
Purkinje Fiber Cells,5/102,0.125445925550658,0.464948540426774,0,0,1.94781053435421,4.04342187746142,GUCY1A2;LRCH2;NFASC;MAP1B;ASXL3,PanglaoDB,brown,5
Juxtaglomerular Cells,5/103,0.129227853450372,0.464948540426774,0,0,1.92783546167005,3.94469475390696,EDNRA;CALD1;SYNPO2;TEK;TNS1,PanglaoDB,brown,5
Myocytes,7/163,0.131468207982743,0.464948540426774,0,0,1.69704952581665,3.44329689240722,EDNRA;SGCD;SYNPO2;DMD;NID1;PLD1;ARHGAP26,PanglaoDB,brown,7
Spermatozoa,5/108,0.148891209378056,0.514029175233765,0,0,1.83377808058442,3.49250256520605,CCPG1;CHL1;ABHD2;PLD1;CPEB4,PanglaoDB,brown,5
Enterochromaffin Cells,5/109,0.152968629270857,0.515824447541261,0,0,1.81605188184136,3.4096781168817,GRIN2A;NFASC;SGCD;CNTN3;SORBS2,PanglaoDB,brown,5
Cardiomyocytes,7/174,0.166403066869644,0.548373743093145,0,0,1.58436551554425,2.84130972946583,EDNRA;PDE4D;SYNPO2;RBM20;STRN;DMD;SORBS2,PanglaoDB,brown,7
Trigeminal Neurons,6/144,0.171054439568772,0.548571119044143,0,0,1.64266304347826,2.90057072884596,NFASC;DLG2;MAP1B;RUFY3;ASXL3;TLN2,PanglaoDB,brown,6
Radial Glia Cells,5/114,0.174029458455383,0.548571119044143,0,0,1.7322996584223,3.02897912158346,GUCY1A2;LRCH2;NFASC;MAP1B;ASXL3,PanglaoDB,brown,5
Choroid Plexus Cells,5/117,0.187170333814289,0.57744039155472,0,0,1.68563770537455,2.82468412417976,KIAA1217;TJP1;SHROOM3;TEAD1;LGR4,PanglaoDB,brown,5
Transient Cells,5/120,0.200656608281753,0.606150170851129,0,0,1.64141028900754,2.63636795758347,KIAA1217;SUN1;EPAS1;DAG1;LGR4,PanglaoDB,brown,5
Endothelial Cells (Aorta),7/185,0.204966903438581,0.606534714257025,0,0,1.48560874249654,2.35455133798285,EDNRA;EPAS1;CALD1;PALLD;ADGRF5;TMTC1;TEK,PanglaoDB,brown,7
Luteal Cells,5/125,0.223825631244445,0.64909433060889,0,0,1.57261208576998,2.35402410041034,KIAA1217;DAG1;TEAD1;FERMT2;LGR4,PanglaoDB,brown,5
Myoblasts,5/126,0.228553774123931,0.649809749960195,0,0,1.55953474135292,2.30184795295288,EDNRA;CALD1;PALLD;TEAD1;FERMT2,PanglaoDB,brown,5
Delta Cells,5/131,0.252607802319361,0.683911697584811,0,0,1.49726167270027,2.06010806067117,EHF;NFASC;ASXL3;SORBS2;RAPGEF4,PanglaoDB,brown,5
Airway Smooth Muscle Cells,4/99,0.254698149445378,0.683911697584811,0,0,1.58812205611305,2.17203667952112,EDNRA;CALD1;MSRB3;NID1,PanglaoDB,brown,4
Trophoblast Stem Cells,4/99,0.254698149445378,0.683911697584811,0,0,1.58812205611305,2.17203667952112,ENAH;CCND1;SHROOM3;FAM83B,PanglaoDB,brown,4
Reticulocytes,4/103,0.27761490083889,0.727041411445045,0,0,1.52364108006131,1.9525770873966,DHX15;CHD4;URB2;TAF5L,PanglaoDB,brown,4
Epsilon Cells,5/138,0.287247203025987,0.727041411445045,0,0,1.41794544841636,1.76876230860539,ACSS3;HRH2;SORBS2;AFF3;CORIN,PanglaoDB,brown,5
Cajal-Retzius Cells,6/174,0.296677505952391,0.727041411445045,0,0,1.34723772321429,1.63704144875537,LRCH2;MAP1B;CACNA2D2;RGMB;MAP9;RALGPS2,PanglaoDB,brown,6
Luminal Epithelial Cells,5/140,0.297306373411206,0.727041411445045,0,0,1.39679445527399,1.69430065572517,SLC12A2;AR;EHF;PGR;FAM83B,PanglaoDB,brown,5
Glutaminergic Neurons,4/107,0.30084472197726,0.727041411445045,0,0,1.46416833515923,1.75870193262705,GRIN2A;DLG2;FRRS1L;GLS,PanglaoDB,brown,4
Pinealocytes,4/107,0.30084472197726,0.727041411445045,0,0,1.46416833515923,1.75870193262705,ZNF382;SV2B;FRRS1L;ZNF774,PanglaoDB,brown,4
Crypt Cells,4/110,0.318411250150507,0.756879201177435,0,0,1.42250936054622,1.62793606004065,SLC12A2;CLIC5;ASXL3;ANK3,PanglaoDB,brown,4
Chondrocytes,5/146,0.327792481879048,0.759910346490663,0,0,1.33694164489237,1.49119068290187,EDNRA;SGCD;CALD1;CREB3L2;NID1,PanglaoDB,brown,5
Retinal Progenitor Cells,4/112,0.330167943647667,0.759910346490663,0,0,1.39602248162559,1.5470076651306,STOX2;PCLO;IGDCC4;MAP1B,PanglaoDB,brown,4
Photoreceptor Cells,5/149,0.343159508209303,0.777470760786702,0,0,1.30888564002599,1.3999315960927,SV2B;FRRS1L;LIN7A;GLS;SYNE1,PanglaoDB,brown,5
Intercalated Cells,4/118,0.365529376881272,0.815411686888992,0,0,1.32213802989965,1.33061112138279,OPHN1;ERBB4;ADGRF5;WDR31,PanglaoDB,brown,4
Fibroblasts,7/232,0.395100797099887,0.867402908240103,0,0,1.1724200913242,1.08872613756681,EDNRA;SGCD;PALLD;SYNPO2;STAT3;TEK;TNS1,PanglaoDB,brown,7
Stromal Cells,4/124,0.400799964497151,0.867402908240103,0,0,1.2556420233463,1.14802448366265,EDNRA;SGCD;TEK;TNS1,PanglaoDB,brown,4
Hepatic Stellate Cells,4/132,0.447229468692711,0.953651072947692,0,0,1.1766780155642,0.946853340763665,EDNRA;CALD1;TEK;VCL,PanglaoDB,brown,4
Mammary Epithelial Cells,4/134,0.45867216656378,0.959927445854034,0,0,1.15845555222987,0.902922914683336,EHF;STAT3;FAM83B;ABCG2,PanglaoDB,brown,4
Immature Neurons,4/136,0.470033439004389,0.959927445854034,0,0,1.14078528475416,0.861237493445692,PCLO;BCL2;HIVEP2;SOX5,PanglaoDB,brown,4
Principal Cells,4/136,0.470033439004389,0.959927445854034,0,0,1.14078528475416,0.861237493445692,KIAA1217;EHF;CELSR2;FAM83B,PanglaoDB,brown,4
Oligodendrocytes,5/178,0.490670699839623,0.982229108325903,0,0,1.08784324330415,0.774524860937899,DLG2;EML1;PLEKHH1;CREB5;RAPGEF4,PanglaoDB,brown,5
Cholinergic Neurons,3/102,0.494501551088213,0.982229108325903,0,0,1.1405119152692,0.803154183306261,LRCH2;BRCA1;PPM1E,PanglaoDB,brown,3
Germ Cells,6/222,0.515666566858975,0.996466380865508,0,0,1.04524739583333,0.692262030607579,LRRC57;HOOK1;RSBN1L;BRCA1;MDN1;CREB5,PanglaoDB,brown,6
Neuroblasts,4/146,0.525384508592378,0.996466380865508,0,0,1.05990025757659,0.682178183666344,ERBB4;MAP1B;ITGA6;PPM1E,PanglaoDB,brown,4
Ionocytes,3/107,0.526596248239888,0.996466380865508,0,0,1.08539955190441,0.696089695829279,SLC12A2;SLC9A7;SHROOM3,PanglaoDB,brown,3
Enteric Glia Cells,3/111,0.551442494570419,0.996466380865508,0,0,1.04498381877023,0.62199288257216,NFASC;CHL1;RAPGEF4,PanglaoDB,brown,3
Motor Neurons,3/111,0.551442494570419,0.996466380865508,0,0,1.04498381877023,0.62199288257216,ENAH;IGDCC4;TEAD1,PanglaoDB,brown,3
Osteoblasts,4/154,0.567581131711941,0.996466380865508,0,0,1.00295719844358,0.568046449620252,EDNRA;CALD1;PALLD;TEK,PanglaoDB,brown,4
Purkinje Neurons,4/155,0.572708808494471,0.996466380865508,0,0,0.996263560697812,0.555295270443735,CACNA2D2;PKP4;HIVEP2;PPM1E,PanglaoDB,brown,4
Taste Receptor Cells,3/115,0.575501713354794,0.996466380865508,0,0,1.00745492371706,0.556632016482855,SV2B;FRRS1L;ACSL6,PanglaoDB,brown,3
Endothelial Cells,6/246,0.615947316579282,0.996466380865508,0,0,0.93955078125,0.455300524850419,EPAS1;ADGRF5;TEK;TNS1;ABCG2;PLEC,PanglaoDB,brown,6
Neurons,7/289,0.623955314872218,0.996466380865508,0,0,0.932672690177791,0.439919812494164,PCLO;FRRS1L;SACS;CACNA2D2;ARID4A;PTPN11;SYNE1,PanglaoDB,brown,7
Adipocytes,5/210,0.637086675552215,0.996466380865508,0,0,0.916512147577616,0.413209102407003,AR;EPAS1;ADGRF5;LPIN1;TNS1,PanglaoDB,brown,5
Keratinocytes,3/127,0.642652595527711,0.996466380865508,0,0,0.909395552771688,0.402090141818168,EHF;FAM83B;PLEC,PanglaoDB,brown,3
Interneurons,7/305,0.67914151519986,0.996466380865508,0,0,0.88186080720787,0.341214659564639,SV2B;FRRS1L;DNAJC6;HIVEP2;ADCY1;RORB;PTPN4,PanglaoDB,brown,7
Hematopoietic Stem Cells,4/178,0.680549200723715,0.996466380865508,0,0,0.86354488125587,0.332339702286725,ITGA6;TEK;TNS1;ABCG2,PanglaoDB,brown,4
Pulmonary Alveolar Type II Cells,3/135,0.683071673923945,0.996466380865508,0,0,0.853927625772286,0.325479198405478,DDX3Y;EHF;ADGRF5,PanglaoDB,brown,3
Olfactory Epithelial Cells,5/226,0.699726983910121,0.996466380865508,0,0,0.849452691557955,0.303309861840173,PCLO;KIAA0895;ACSL6;CELSR2;EPN2,PanglaoDB,brown,5
Basal Cells,3/141,0.711085415960215,0.996466380865508,0,0,0.816547066272689,0.278412109891515,EHF;EPAS1;BCL2,PanglaoDB,brown,3
Beta Cells,3/145,0.72867910480864,0.996466380865508,0,0,0.793381649118009,0.251122610936648,NFASC;ASXL3;RAPGEF4,PanglaoDB,brown,3
Enterocytes,4/203,0.774474329149904,0.996466380865508,0,0,0.754081692509239,0.192721234827986,EHF;RGMB;GLS;ABCG2,PanglaoDB,brown,4
Sertoli Cells,3/158,0.780076271090173,0.996466380865508,0,0,0.726351393673661,0.180399232928417,AR;EPAS1;TNS1,PanglaoDB,brown,3
Epithelial Cells,4/218,0.819510582470336,0.996466380865508,0,0,0.700680024728172,0.139468934829245,EHF;PGR;BRCA1;FAM83B,PanglaoDB,brown,4
melanosome localization (GO:0032400),3/21,0.000729285749659987,0.217084058148789,0,0,19.6537698412698,141.967924074338,VPS33A;VPS33B;BLOC1S3,GO_BP,red,3
positive regulation of double-strand break repair (GO:2000781),3/40,0.00481065430952672,0.480297568879028,0,0,9.55212355212355,50.9789399848428,FUS;KMT5C;PNKP,GO_BP,red,3
DNA replication (GO:0006260),4/108,0.0138974976872174,0.480297568879028,0,0,4.54283740211884,19.4253838714301,ING4;ORC6;MCM7;PNKP,GO_BP,red,4
cellular response to DNA damage stimulus (GO:0006974),7/350,0.0311803085055277,0.480297568879028,0,0,2.42483822797412,8.40926264328017,UBA7;MCM7;KMT5C;PNKP;BRAT1;TP73;HINFP,GO_BP,red,7
regulation of neuron death (GO:1901214),3/86,0.0375200008900232,0.480297568879028,0,0,4.24827882960413,13.9465944094559,CTSZ;TRAF2;HLA-F,GO_BP,red,3
protein transport (GO:0015031),7/369,0.0396929682635079,0.480297568879028,0,0,2.29532744913085,7.40606046132166,VPS33A;VPS33B;SGSM2;TBC1D13;IFT27;TSNARE1;ATP6V0A1,GO_BP,red,7
negative regulation of binding (GO:0051100),3/88,0.0397434266364761,0.480297568879028,0,0,4.14789915966387,13.3782640365827,SMO;CTSZ;ZFPM1,GO_BP,red,3
peptidyl-lysine modification (GO:0018205),3/106,0.0626328204451139,0.480297568879028,0,0,3.41990291262136,9.47472422975541,HDAC10;VPS33B;P3H4,GO_BP,red,3
small GTPase mediated signal transduction (GO:0007264),3/106,0.0626328204451139,0.480297568879028,0,0,3.41990291262136,9.47472422975541,ARHGAP33;TNK2;RGL2,GO_BP,red,3
cellular protein localization (GO:0034613),6/329,0.0638233794333224,0.480297568879028,0,0,2.19600337742753,6.04260130593258,VPS33A;VPS33B;SGSM2;TBC1D13;IFT27;TSNARE1,GO_BP,red,6
modulation of chemical synaptic transmission (GO:0050804),3/109,0.0669315926783218,0.480297568879028,0,0,3.32260781671159,8.98461125335941,KCTD13;CPLX1;BEGAIN,GO_BP,red,3
intracellular protein transport (GO:0006886),6/336,0.0691383702040727,0.480297568879028,0,0,2.14865013774105,5.74043129359597,VPS33A;VPS33B;SGSM2;TBC1D13;IFT27;TSNARE1,GO_BP,red,6
regulation of protein binding (GO:0043393),3/118,0.0806049448033453,0.480297568879028,0,0,3.0611801242236,7.70864934443926,STING1;CTSZ;ZFPM1,GO_BP,red,3
macroautophagy (GO:0016236),3/120,0.0837961537274635,0.480297568879028,0,0,3.00854700854701,7.45929569331015,HDAC10;VPS33A;VPS33B,GO_BP,red,3
protein localization to membrane (GO:0072657),4/195,0.0865585387060558,0.480297568879028,0,0,2.46267674075932,6.02600829978378,GAK;ZFYVE27;DLG3;MADCAM1,GO_BP,red,4
DNA metabolic process (GO:0006259),5/277,0.0896769746424862,0.480297568879028,0,0,2.16568479801559,5.22263819419776,ORC6;MCM7;KMT5C;PNKP;HINFP,GO_BP,red,5
endomembrane system organization (GO:0010256),4/199,0.0915907883015721,0.480297568879028,0,0,2.4116689697528,5.76491277628802,GAK;REEP4;VPS33B;VPS11,GO_BP,red,4
DNA-dependent DNA replication (GO:0006261),3/129,0.0988056035588684,0.480297568879028,0,0,2.79237528344671,6.46323451077914,ORC6;MCM7;PNKP,GO_BP,red,3
muscle contraction (GO:0006936),3/129,0.0988056035588684,0.480297568879028,0,0,2.79237528344671,6.46323451077914,PABPN1;CHRNE;SORBS3,GO_BP,red,3
positive regulation of intracellular protein transport (GO:0090316),3/148,0.133653011274339,0.480297568879028,0,0,2.42413793103448,4.87859772013835,VPS11;TP73;RBM22,GO_BP,red,3
positive regulation of transferase activity (GO:0051347),3/148,0.133653011274339,0.480297568879028,0,0,2.42413793103448,4.87859772013835,PABPN1;PNKP;CHTF18,GO_BP,red,3
organelle organization (GO:0006996),6/420,0.151734194674753,0.482201551048235,0,0,1.70531400966184,3.21558274341003,NCKIPSD;ABCD4;GAK;SPRYD3;MTX1;VPS11,GO_BP,red,6
positive regulation of cytokine production (GO:0001819),5/335,0.16012647798365,0.483314874365398,0,0,1.77975538517707,3.26014041044387,SETD4;ZNF580;STING1;TRAF2;ZFPM1,GO_BP,red,5
positive regulation of DNA-binding transcription factor activity (GO:0051091),4/246,0.16018214092666,0.483314874365398,0,0,1.93863512644133,3.55050114789446,TRIM8;SMO;STING1;TRAF2,GO_BP,red,4
regulation of nucleic acid-templated transcription (GO:1903506),6/430,0.163693325183529,0.483314874365398,0,0,1.66423670668954,3.01186997112081,RHOXF1;TGIF2;HDAC10;FUS;SNAI3;HINFP,GO_BP,red,6
regulation of cellular macromolecule biosynthetic process (GO:2000112),6/468,0.212528487686266,0.512145041965864,0,0,1.52436048799685,2.36074544188881,RHOXF1;TGIF2;HDAC10;FUS;SNAI3;HINFP,GO_BP,red,6
DNA repair (GO:0006281),4/298,0.251532821858935,0.512145041965864,0,0,1.59151085583934,2.19657430746349,KMT5C;PNKP;TP73;HINFP,GO_BP,red,4
axon guidance (GO:0007411),3/203,0.251536753863174,0.512145041965864,0,0,1.75258928571429,2.41886442714783,EFNA3;SMO;EVL,GO_BP,red,3
extracellular matrix organization (GO:0030198),4/300,0.255262236626293,0.512145041965864,0,0,1.58059556562551,2.15824615899174,LAMB3;APLP1;P3H4;MADCAM1,GO_BP,red,4
mitotic cell cycle phase transition (GO:0044772),3/209,0.265323284867024,0.512145041965864,0,0,1.70102288488211,2.25692780122451,HAUS5;FBXL6;HINFP,GO_BP,red,3
phosphate-containing compound metabolic process (GO:0006796),3/212,0.272251933374769,0.515660347534407,0,0,1.67634996582365,2.18097726388773,ISYNA1;TNK2;PNKP,GO_BP,red,3
protein modification by small protein conjugation (GO:0032446),5/409,0.272555077308219,0.515660347534407,0,0,1.44824346892521,1.88259278144161,UBA7;KCTD13;VPS11;FBXO24;UBE2Z,GO_BP,red,5
extracellular structure organization (GO:0043062),3/216,0.281520505302516,0.52117354017763,0,0,1.64453386988598,2.08452889207573,LAMB3;APLP1;MADCAM1,GO_BP,red,3
cilium assembly (GO:0060271),4/314,0.281663321097498,0.52117354017763,0,0,1.50813212285107,1.91086797504051,MKS1;IFT122;IFT27;HAUS5,GO_BP,red,4
external encapsulating structure organization (GO:0045229),3/217,0.283842393680563,0.52117354017763,0,0,1.63676568758344,2.06123819404015,LAMB3;APLP1;MADCAM1,GO_BP,red,3
transcription by RNA polymerase II (GO:0006366),4/320,0.293110660415218,0.530928640468132,0,0,1.47904191616766,1.81508772446464,RXRB;HDAC10;PABPN1;NELFCD,GO_BP,red,4
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),3/224,0.300137655784583,0.537120093418101,0,0,1.58435681965094,1.9067957036766,TRIM8;TRAF2;LIME1,GO_BP,red,3
apoptotic process (GO:0006915),3/231,0.316483025599031,0.546652498761963,0,0,1.53516604010025,1.76618653087343,ING4;BRAT1;BNIPL,GO_BP,red,3
regulation of autophagy (GO:0010506),3/231,0.316483025599031,0.546652498761963,0,0,1.53516604010025,1.76618653087343,TRIM8;OSBPL7;ATP6V0A1,GO_BP,red,3
regulation of intracellular signal transduction (GO:1902531),5/437,0.31899060541598,0.548791459017435,0,0,1.35242358322178,1.54527056683883,ARHGAP33;PRKAR1B;TRAF2;LIME1;TP73,GO_BP,red,5
membrane organization (GO:0061024),3/242,0.342194674748477,0.554142695507898,0,0,1.46368798565451,1.56962310538958,GAK;REEP4;VPS33B,GO_BP,red,3
anterograde trans-synaptic signaling (GO:0098916),3/244,0.346865470274068,0.556105682144959,0,0,1.45139300533491,1.53676142801272,PRKAR1B;CHRNE;CPLX1,GO_BP,red,3
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",3/251,0.363186363999828,0.562530570231292,0,0,1.40992223502304,1.42802447617325,PABPN1;FUS;RBM22,GO_BP,red,3
cellular component assembly (GO:0022607),3/261,0.386388505722255,0.57859176547816,0,0,1.35458194905869,1.28808812764139,ZFYVE27;P3H4;TRAF2,GO_BP,red,3
neutrophil degranulation (GO:0043312),5/481,0.393472532898494,0.580618213128896,0,0,1.22462539232561,1.14226200604084,STING1;NPC2;CTSZ;CKAP4;ATP6V0A1,GO_BP,red,5
positive regulation of gene expression (GO:0010628),5/482,0.395168276649613,0.580618213128896,0,0,1.22199489783032,1.13455332741767,RHOXF1;SMO;ZNF580;RBM22;HINFP,GO_BP,red,5
protein-containing complex assembly (GO:0065003),3/267,0.400219455631019,0.582127315979769,0,0,1.32339015151515,1.21188426603551,STING1;CTSZ;TRAF2,GO_BP,red,3
neutrophil activation involved in immune response (GO:0002283),5/485,0.400253272129427,0.582127315979769,0,0,1.21416917670683,1.1117634187996,STING1;NPC2;CTSZ;CKAP4;ATP6V0A1,GO_BP,red,5
neutrophil mediated immunity (GO:0002446),5/488,0.405334287725577,0.585701486956214,0,0,1.20644066951034,1.08946798313514,STING1;NPC2;CTSZ;CKAP4;ATP6V0A1,GO_BP,red,5
negative regulation of cell population proliferation (GO:0008285),4/379,0.4071910767269,0.586989111273243,0,0,1.24257085828343,1.11641602842909,ING4;DLG3;TP73;BNIPL,GO_BP,red,4
"mRNA splicing, via spliceosome (GO:0000398)",3/274,0.416246861370763,0.589189633237639,0,0,1.28874538745387,1.12955540481454,PABPN1;FUS;RBM22,GO_BP,red,3
positive regulation of macromolecule metabolic process (GO:0010604),4/384,0.416803045793978,0.589189633237639,0,0,1.2259060825717,1.07284126467184,RHOXF1;SMO;ZNF580;HINFP,GO_BP,red,4
protein modification by small protein removal (GO:0070646),3/276,0.420801836879402,0.591551772966311,0,0,1.27917320774464,1.10724369722404,INO80E;COPS7B;TRAF2,GO_BP,red,3
plasma membrane bounded cell projection assembly (GO:0120031),3/278,0.42534515559169,0.591979793160131,0,0,1.26974025974026,1.08544293216375,ABLIM2;MKS1;IFT122,GO_BP,red,3
regulation of gene expression (GO:0010468),10/1079,0.443165791094051,0.60635512477968,0,0,1.09000691422296,0.887059979502597,RHOXF1;TGIF2;HDAC10;SMO;PABPN1;ZNF580;FUS;SNAI3;TP73;HINFP,GO_BP,red,10
positive regulation of programmed cell death (GO:0043068),3/286,0.443392941188277,0.60635512477968,0,0,1.23334174659263,1.00307548788065,ING4;PNMA3;UBE2Z,GO_BP,red,3
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),4/404,0.454864759945973,0.607924412212646,0,0,1.16341317365269,0.916484701789077,EFNA3;ZFYVE27;TNK2;ATP6V0A1,GO_BP,red,4
regulation of cell cycle (GO:0051726),3/296,0.465639015441693,0.607924412212646,0,0,1.19063871282301,0.910058258819238,ING4;TP73;FBXL6,GO_BP,red,3
protein ubiquitination (GO:0016567),5/525,0.4673738109611,0.608403517767146,0,0,1.11845458758109,0.850725515842906,KCTD13;VPS11;TRAF2;FBXO24;UBE2Z,GO_BP,red,5
mRNA processing (GO:0006397),3/300,0.474429931299341,0.612658795731622,0,0,1.17436267436267,0.875653358546201,PABPN1;FUS;RBM22,GO_BP,red,3
innate immune response (GO:0045087),3/302,0.478800921584254,0.613151168394308,0,0,1.16638795986622,0.859010184637822,TRIM8;STING1;TNK2,GO_BP,red,3
MAPK cascade (GO:0000165),3/303,0.480980152436749,0.613586505839227,0,0,1.16244047619048,0.850824212472972,DLG3;PABPN1;RGL2,GO_BP,red,3
chemical synaptic transmission (GO:0007268),3/306,0.487492300804673,0.61396666115484,0,0,1.1507543611504,0.826794893162821,PRKAR1B;CHRNE;CPLX1,GO_BP,red,3
organelle assembly (GO:0070925),4/425,0.493932440233713,0.617987531790265,0,0,1.10418592743255,0.778844756244254,STING1;MKS1;IFT122;HAUS5,GO_BP,red,4
positive regulation of apoptotic process (GO:0043065),3/310,0.496114099462242,0.617987531790265,0,0,1.13552815262913,0.795947708539278,ING4;PNMA3;UBE2Z,GO_BP,red,3
cellular macromolecule biosynthetic process (GO:0034645),3/314,0.504663911033247,0.62160672076233,0,0,1.12069361506661,0.766400442647041,ING4;ORC6;MCM7,GO_BP,red,3
nervous system development (GO:0007399),4/447,0.53357391822581,0.638818599739228,0,0,1.04816101431449,0.65841037473243,IGSF8;SMO;APLP1;EVL,GO_BP,red,4
negative regulation of cellular process (GO:0048523),5/566,0.533689616880975,0.638818599739228,0,0,1.0345123810751,0.649612584739951,ING4;ORC6;DLG3;CCDC85B;BNIPL,GO_BP,red,5
negative regulation of nucleic acid-templated transcription (GO:1903507),4/464,0.563140319129958,0.659088210986962,0,0,1.00853944285342,0.579130021138012,ING4;HDAC10;CCDC85B;HINFP,GO_BP,red,4
post-translational protein modification (GO:0043687),3/345,0.568259950150296,0.66161164991423,0,0,1.01749164578112,0.575062169992106,ASB13;COPS7B;CKAP4,GO_BP,red,3
supramolecular fiber organization (GO:0097435),3/351,0.57998399179876,0.670888218492607,0,0,0.999640804597701,0.544559102758553,LAMB3;P3H4;EVL,GO_BP,red,3
positive regulation of transcription by RNA polymerase II (GO:0045944),7/908,0.663161517343655,0.735656192531533,0,0,0.896673073279013,0.368296541395529,RXRB;STING1;ZGLP1;ABHD14B;ZFPM1;TP73;HINFP,GO_BP,red,7
phosphorylation (GO:0016310),3/400,0.668004341569788,0.738772765409575,0,0,0.874055415617129,0.352646927759175,PRKAR1B;TNK2;PNKP,GO_BP,red,3
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),4/547,0.691482321797886,0.756732491869501,0,0,0.850718452597567,0.313845089104144,ING4;HDAC10;CCDC85B;HINFP,GO_BP,red,4
"negative regulation of transcription, DNA-templated (GO:0045892)",7/948,0.706483394612914,0.765794185820777,0,0,0.856742956377492,0.29768012156132,ING4;TGIF2;HDAC10;CCDC85B;ZGLP1;ZFPM1;HINFP,GO_BP,red,7
regulation of apoptotic process (GO:0042981),5/742,0.764798430166908,0.810494230327063,0,0,0.780271697372938,0.209224370225885,ING4;TRAF2;PNMA3;UBE2Z;TP73,GO_BP,red,5
positive regulation of nucleic acid-templated transcription (GO:1903508),3/511,0.816055975919373,0.847369751739535,0,0,0.679169010123735,0.13805626608559,RXRB;TP73;HINFP,GO_BP,red,3
negative regulation of transcription by RNA polymerase II (GO:0000122),4/684,0.840625708108279,0.865626796592633,0,0,0.674498062698133,0.117098781617755,TGIF2;HDAC10;ZGLP1;ZFPM1,GO_BP,red,4
cellular protein modification process (GO:0006464),6/1025,0.876843832891849,0.89590565534602,0,0,0.671246319921492,0.0882194686428719,METAP1D;PRKAR1B;UBA7;ASB13;COPS7B;CKAP4,GO_BP,red,6
"positive regulation of transcription, DNA-templated (GO:0045893)",7/1183,0.885403766932547,0.903617787280873,0,0,0.677010743321719,0.0823999959259473,RXRB;STING1;ZGLP1;ABHD14B;ZFPM1;TP73;HINFP,GO_BP,red,7
regulation of cell population proliferation (GO:0042127),4/764,0.895947382293781,0.911254000442308,0,0,0.600976993381658,0.0660315014831188,SETD4;ING4;DLG3;BNIPL,GO_BP,red,4
cytokine-mediated signaling pathway (GO:0019221),3/621,0.903681344771934,0.915990284768827,0,0,0.555102866389274,0.0562199720270189,TRIM8;TRAF2;HLA-F,GO_BP,red,3
regulation of transcription by RNA polymerase II (GO:0006357),14/2206,0.91029890277465,0.920608063621476,0,0,0.717484541354782,0.0674308250372139,RHOXF1;TGIF2;HDAC10;ZNF580;FUS;ABHD14B;LIME1;HINFP;RXRB;STING1;ZGLP1;CCNL2;ZFPM1;TP73,GO_BP,red,14
"regulation of transcription, DNA-templated (GO:0006355)",14/2244,0.921977913747401,0.931364566715418,0,0,0.703738824940733,0.0571675270475434,RHOXF1;TGIF2;HDAC10;ZNF580;FUS;SNAI3;LIME1;HINFP;ING4;RXRB;CCDC85B;ZGLP1;CCNL2;TP73,GO_BP,red,14
Urothelial Cells,3/106,0.0626328204451139,0.805862086071905,0,0,3.41990291262136,9.47472422975541,GDPD3;NADSYN1;BNIPL,PanglaoDB,red,3
Parietal Cells,3/111,0.0698706279610373,0.805862086071905,0,0,3.26074735449735,8.67720712806359,ABLIM2;DLG3;ZDHHC11B,PanglaoDB,red,3
Microfold Cells,3/126,0.0936873160744462,0.805862086071905,0,0,2.86091753774681,6.7740589925899,LAMB3;CTSZ;ODF3B,PanglaoDB,red,3
Neurons,4/289,0.234905341344412,0.805862086071905,0,0,1.64252547536506,2.37931747852924,PABPN1;CPLX1;DTD1;ATP6V0A1,PanglaoDB,red,4
Olfactory Epithelial Cells,3/226,0.304804058446319,0.805862086071905,0,0,1.56998718770019,1.86528001791292,EFNA3;APLP1;SPA17,PanglaoDB,red,3
regulation of immune response (GO:0050776),53/179,1.5972891489871e-33,4.32705630460605e-30,0,0,11.8764222503161,896.871780957864,ITGB2;CD3G;PTPN22;TREM2;CXCL13;SLA2;CD3E;ITGAL;CD3D;IL4I1;CASP8;DHX58;FCER1A;ITGB7;CD34;CD96;LAG3;ITGA4;RIPK3;SYK;CD300A;HLA-B;FOXP3;NCR1;CD200R1;NCR3;CD8B;JAML;CD8A;CD226;HCST;KLRB1;CD1C;CD1B;CD1A;KLRK1;CD19;CD300LB;SLAMF7;SLAMF6;KLRC1;CD300LF;VCAM1;CRTAM;SH2D1A;SH2D1B;LILRB1;TREML1;CD40LG;HLA-DRA;CD247;CD22;HLA-DRB1,GO_BP,blue,53
antigen receptor-mediated signaling pathway (GO:0050851),45/185,1.18585990068378e-24,1.60624723547618e-21,0,0,8.96298417326114,493.784906432208,BLK;ITK;TXK;PIK3CD;CD3G;PTPN22;SLA2;CD3E;CD3D;IKBKB;CD19;INPP5D;BLNK;CTLA4;FYN;HLA-DQA2;ERMAP;HLA-DQA1;HLA-DPA1;FYB1;BTN3A1;SYK;PRKCB;TRAT1;THEMIS;BTN3A3;LAX1;PSMB9;LAT2;ZAP70;CD4;PTPRC;LCK;BTK;HLA-DPB1;HLA-DRA;PRKCQ;LCP2;CD247;MS4A1;CARD11;SKAP1;HLA-DRB1;LAT;HLA-DQB2,GO_BP,blue,45
T cell receptor signaling pathway (GO:0050852),35/158,4.78228128306005e-18,4.31839999860322e-15,0,0,7.82765629380432,312.179566719652,ITK;TXK;PIK3CD;CD3G;PTPN22;CD3E;CD3D;IKBKB;INPP5D;CTLA4;FYN;HLA-DQA2;ERMAP;HLA-DQA1;HLA-DPA1;FYB1;BTN3A1;TRAT1;THEMIS;BTN3A3;PSMB9;ZAP70;CD4;PTPRC;LCK;HLA-DPB1;HLA-DRA;PRKCQ;LCP2;CD247;CARD11;SKAP1;HLA-DRB1;LAT;HLA-DQB2,GO_BP,blue,35
T cell activation (GO:0042110),27/92,1.44355662866925e-17,9.77648726766253e-15,0,0,11.3310314685315,439.381556120878,ITK;PIK3CD;CD3G;PTPN22;NLRC3;CD3E;SLA2;CD1C;PIK3CG;LFNG;CASP8;CD74;CRTAM;RHOH;FOXP3;CD2;ZAP70;CD4;PTPRC;CD8B;JAML;CD8A;LCK;CD7;LCP1;CD44;LAT,GO_BP,blue,27
cytokine-mediated signaling pathway (GO:0019221),69/621,1.45546403994438e-16,7.88570416841863e-14,0,0,3.53417673716012,128.877418638079,CIITA;CXCL9;TNFRSF13B;FLT3;ITGB2;PIK3CD;FASLG;SLA2;CXCL13;TNFSF13B;IKBKB;ITGAX;CASP1;CCR5;JAK3;HLA-DPA1;IL13RA1;CCR2;SYK;TNFRSF18;HLA-B;TYK2;AIM2;IFNG;LCK;XCL2;LCP1;LTB;HLA-DQB2;CD44;CSF1R;RNASEL;SP100;CSF2RB;IL2RG;INPP5D;IL21R;TNFRSF14;FYN;IL12RB1;CD300LF;HLA-DQA2;CCL17;HLA-DQA1;CCL24;CCL22;TGFB1;VCAM1;STAT1;TNFSF15;IL10RA;STAT2;TNFRSF9;ST18;PSMB9;CXCL10;CXCL11;CD4;CXCL12;CD40LG;IL2RB;HLA-DPB1;PDCD4;HLA-DRA;CD27;TNFSF8;PTPN6;IL7R;HLA-DRB1,GO_BP,blue,69
regulation of T cell activation (GO:0050863),18/47,1.8640465160149e-14,8.41617001980727e-12,0,0,16.7490448324225,529.494951185142,SIRPG;CRTAM;PTPN22;LAX1;CD2;IL4I1;CD4;SIT1;LCK;TBX21;HLA-DPB1;PRKCQ;TNFSF8;TIGIT;JAK3;LAT;CCR2;HLA-DPA1,GO_BP,blue,18
inflammatory response (GO:0006954),37/230,2.89451114283154e-14,1.12017581227581e-11,0,0,5.26953457466665,164.269177728456,CSF1R;CIITA;CXCL9;GPR68;ITGB2;LOXL3;LY75;CXCR4;PIK3CD;FPR3;CXCL13;ITGAL;PIK3CG;IKBKB;ADGRE5;BLNK;CCR5;CCL17;PTGDR;CCR2;CCL24;CD96;PLA2G2D;XCR1;CCL22;TGFB1;LYZ;CXCL10;NCR3;CXCL11;CD40LG;IFNG;XCL2;TLR10;ADAM8;CD44;LAT,GO_BP,blue,37
regulation of B cell receptor signaling pathway (GO:0050855),12/23,4.85663728960158e-12,1.64457880219134e-09,0,0,29.2193703375901,761.184315495997,BLK;PRKCH;CD300A;PRKCB;FCRL3;CD19;LPXN;STAP1;PTPN22;GCSAM;PAX5;CD22,GO_BP,blue,12
positive regulation of cytokine production (GO:0001819),41/335,1.2401358561712e-11,3.73280892707532e-09,0,0,3.83503401360544,96.3100340530498,FCN1;ITK;CSF1R;TXK;PIK3CD;PTPN22;CLEC9A;LY9;PIK3CG;DHX58;SLAMF6;TNFRSF14;IL12RB1;TIGIT;CD34;CCR2;HLA-DPA1;ZBP1;GBP5;CD74;TGFB1;BTN3A1;SYK;CRTAM;LILRB1;POU2F2;CD2;CD4;CD40LG;PTPRC;TMIGD2;IFNG;CD6;HLA-DPB1;TLR8;CD226;PRKCQ;TLR7;LTB;CARD11;CD244,GO_BP,blue,41
B cell receptor signaling pathway (GO:0050853),13/34,8.53217944941743e-11,2.31136741284718e-08,0,0,16.5953044170314,384.755348583,BLK;ITK;SYK;PRKCB;PIK3CD;LAT2;PTPRC;LCK;CD19;BLNK;BTK;CTLA4;MS4A1,GO_BP,blue,13
regulation of T cell mediated cytotoxicity (GO:0001914),12/29,1.52302611511065e-10,3.75079795075887e-08,0,0,18.9007608606725,427.254566671478,PTPRC;RIPK3;HLA-B;HLA-DRA;CD1E;LILRB1;KLRC1;CD1C;IL12RB1;CD1B;CD1A;HLA-DRB1,GO_BP,blue,12
positive regulation of leukocyte mediated cytotoxicity (GO:0001912),14/43,1.96723899753673e-10,4.44104203693917e-08,0,0,12.9543596402636,289.519832190576,CRTAM;HLA-B;CD1E;CD1C;CD1B;CD1A;NCR3;KLRK1;STAP1;HLA-DRA;SLAMF6;CD226;IL12RB1;HLA-DRB1,GO_BP,blue,14
regulation of interferon-gamma production (GO:0032649),19/86,2.15159890446001e-10,4.4836011016786e-08,0,0,7.64795404997485,170.240701500512,BTN3A1;RIPK3;TXK;CRTAM;PTPN22;LILRB1;FOXP3;CD2;AXL;HLA-DPB1;TLR8;CD226;TLR7;SLAMF6;IL12RB1;CD244;HLA-DRB1;CCR2;HLA-DPA1,GO_BP,blue,19
cellular response to cytokine stimulus (GO:0071345),48/482,3.3567808489921e-10,6.49537094279972e-08,0,0,3.04997604766178,66.5348263953106,CSF1R;RIPOR2;SELPLG;FLT3;DOCK8;ITGB2;PIK3CD;CXCR4;FASLG;CSF2RB;SLA2;IL2RG;IKBKB;TCL1A;INPP5D;ITGAX;CASP1;FYN;LDLRAP1;IL12RB1;CCR5;JAK3;CCL17;HLA-DPA1;IL13RA1;CCR2;GBP5;CCL24;CCL22;TGFB1;VCAM1;SYK;STAT1;IL10RA;STAT2;PYHIN1;TYK2;CXCL10;CD4;CXCL12;AIM2;RUFY4;LCK;AXL;IL2RB;XCL2;PTPN6;PTPN7,GO_BP,blue,48
regulation of lymphocyte differentiation (GO:0045619),10/20,5.30729654087569e-10,9.5849775528215e-08,0,0,26.7115117891817,570.471569569126,ZNF683;CD2;IL4I1;FCRL3;TBX21;CRTAM;SLAMF8;PRDM1;IKZF3;CCR2,GO_BP,blue,10
positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),10/21,9.80081547207569e-10,1.65940056961582e-07,0,0,24.2819316605724,503.689465144702,PRKCH;PTPRC;TESPA1;PRKCB;TRAT1;LCK;STAP1;CD226;KCNN4;CARD11,GO_BP,blue,10
positive regulation of interferon-gamma production (GO:0032729),15/57,1.2715913655376e-09,2.02631824073021e-07,0,0,9.59048284118117,196.441828168174,BTN3A1;TXK;CRTAM;PTPN22;LILRB1;CD2;HLA-DPB1;TLR8;CD226;TLR7;SLAMF6;IL12RB1;CD244;CCR2;HLA-DPA1,GO_BP,blue,15
regulation of T cell receptor signaling pathway (GO:0050856),12/35,2.00122765587425e-09,3.01184762209075e-07,0,0,13.965773719538,279.727534778486,TESPA1;CD300A;PVRIG;TRAT1;LCK;SH2D1A;PTPN22;CD226;UBASH3A;SLA2;KCNN4;CARD11,GO_BP,blue,12
cellular response to interferon-gamma (GO:0071346),21/121,2.70827071267655e-09,3.86142387402146e-07,0,0,5.66970422535211,111.846003060197,GBP5;CCL24;CIITA;SP100;VCAM1;CCL22;STAT1;HLA-B;IFNG;CASP1;XCL2;HLA-DPB1;HLA-DRA;IL12RB1;HLA-DQA2;CCL17;HLA-DQA1;HLA-DRB1;CD44;HLA-DQB2;HLA-DPA1,GO_BP,blue,21
positive regulation of cytosolic calcium ion concentration (GO:0007204),23/147,3.87750569478603e-09,5.25208146358767e-07,0,0,5.01566201931839,97.1437119062883,CX3CR1;CD52;EDN1;P2RY10;XCR1;GPR65;GPR55;CXCR5;CXCR4;FPR3;CXCR6;CXCL13;GPR174;P2RX7;CYSLTR1;P2RX4;CXCR3;CCR6;CCR5;CCR4;GPR18;PTGDR;CCR2,GO_BP,blue,23
calcium-mediated signaling (GO:0019722),19/102,4.55926518866225e-09,5.8814520933743e-07,0,0,6.16850548260458,118.472960101146,CX3CR1;EDN1;VCAM1;XCR1;CXCR5;CXCR4;CXCR6;CAMKK2;LAT2;P2RX7;PTPRC;P2RX4;CXCR3;BTK;CCR6;CCR5;CCR4;LAT;CCR2,GO_BP,blue,19
regulation of T cell differentiation (GO:0045580),12/39,8.19893556811892e-09,1.00958711154701e-06,0,0,11.894297635605,221.463038034592,ZNF683;CD2;ZAP70;IFNG;TBX21;TNFRSF18;CRTAM;CTLA4;RHOH;PRDM1;FOXP3;CCR2,GO_BP,blue,12
B cell activation (GO:0042113),17/85,9.62651432544456e-09,1.06710588565236e-06,0,0,6.72303921568627,124.098864064431,FCRL1;VCAM1;ITGA4;FLT3;PRKCB;PIK3CD;LAX1;LAT2;ZAP70;CASP8;CD40LG;PTPRC;BLNK;BTK;JAK3;MS4A1;CD22,GO_BP,blue,17
positive regulation of immune response (GO:0050778),16/75,9.84778410531892e-09,1.06710588565236e-06,0,0,7.28600213345976,134.324876469594,GBP5;CD74;ITGB2;SH2D1B;LILRB1;HLA-DMB;PTPRC;IFNG;MYB;TLR8;HLA-DRA;ADAM8;CD226;IL12RB1;SKAP1;HLA-DRB1,GO_BP,blue,16
positive regulation of T cell activation (GO:0050870),16/75,9.84778410531892e-09,1.06710588565236e-06,0,0,7.28600213345976,134.324876469594,VCAM1;DOCK8;SIRPG;RHOH;CD3E;ZAP70;HLA-DMB;CD40LG;PTPRC;CD6;LCK;HLA-DPB1;PRKCQ;JAK3;CCR2;HLA-DPA1,GO_BP,blue,16
regulation of T cell proliferation (GO:0042129),16/76,1.20560373292276e-08,1.25614635095683e-06,0,0,7.1641958041958,130.629799035979,PLA2G2D;VCAM1;RIPK3;LILRB1;CD3E;FOXP3;IL4I1;HLA-DMB;CD40LG;PTPRC;CD6;HLA-DPB1;TNFSF8;JAK3;HLA-DRB1;HLA-DPA1,GO_BP,blue,16
regulation of lymphocyte activation (GO:0051249),8/15,1.57136530080349e-08,1.5766031851395e-06,0,0,30.4477376012646,547.107355226872,CD4;LCK;SIT1;FCRL3;CD19;CRTAM;IKZF3;LAT,GO_BP,blue,8
neutrophil chemotaxis (GO:0030593),15/70,2.67367756061266e-08,2.58678303989275e-06,0,0,7.31868969019807,127.617645095839,CCL24;CXCL9;EDN1;CCL22;SYK;ITGB2;PIK3CD;CXCL13;PIK3CG;CXCL10;CXCL11;JAML;XCL2;S100A12;CCL17,GO_BP,blue,15
granulocyte chemotaxis (GO:0071621),15/73,4.86731877445752e-08,4.54674708965704e-06,0,0,6.93905316894625,116.840731504341,CCL24;CXCL9;EDN1;CCL22;SYK;ITGB2;PIK3CD;CXCL13;PIK3CG;CXCL10;CXCL11;JAML;XCL2;S100A12;CCL17,GO_BP,blue,15
lymphocyte differentiation (GO:0030098),16/84,5.41459498468432e-08,4.88937927116994e-06,0,0,6.31871657754011,105.722128730874,VCAM1;ITGA4;FLT3;PIK3CD;RHOH;PTPN22;IKZF1;LFNG;ZAP70;CD4;PTPRC;LCK;AXL;BLNK;JAK3;MS4A1,GO_BP,blue,16
T cell migration (GO:0072678),8/18,9.69078679184435e-08,8.46849723196979e-06,0,0,21.3100968188105,344.147517791271,CXCL10;ZAP70;CXCL11;PIK3CD;CCR6;PIK3CG;CXCL16;MYO1G,GO_BP,blue,8
neutrophil migration (GO:1990266),15/77,1.03085717138855e-07,8.72685024153623e-06,0,0,6.49002072445486,104.409538791264,CCL24;CXCL9;EDN1;CCL22;SYK;ITGB2;PIK3CD;CXCL13;PIK3CG;CXCL10;CXCL11;JAML;XCL2;S100A12;CCL17,GO_BP,blue,15
regulation of antigen receptor-mediated signaling pathway (GO:0050854),7/13,1.19899449956908e-07,9.53770100512832e-06,0,0,31.0407458563536,494.684334153687,BLK;PTPRC;CD300A;CD19;PTPN22;GCSAM;PAX5,GO_BP,blue,7
positive regulation of immune effector process (GO:0002699),10/32,1.24420193520306e-07,9.53770100512832e-06,0,0,12.1340310175262,192.926255855969,HLA-DMB;PTPRC;IFNG;DHX58;MYB;HLA-DRA;LILRB1;IL12RB1;HLA-DRB1;CCR2,GO_BP,blue,10
second-messenger-mediated signaling (GO:0019932),16/89,1.26217683195794e-07,9.53770100512832e-06,0,0,5.8843950569978,93.4751323376709,CX3CR1;EDN1;XCR1;CXCR5;CXCR4;CXCR6;CAMKK2;LAT2;P2RX4;CXCR3;BTK;CCR6;CCR5;CCR4;LAT;CCR2,GO_BP,blue,16
regulation of cytokine production (GO:0001817),21/150,1.3244377128015e-07,9.53770100512832e-06,0,0,4.38847035702588,69.5006774599219,ZBP1;ITK;BTN3A1;RIPK3;TXK;CRTAM;HLA-B;PLD4;PIK3CD;TREM2;BTN3A3;CLEC9A;FOXP3;PIK3CG;PTPRC;CASP8;TMIGD2;IFNG;ERMAP;HLA-DRB1;CCR2,GO_BP,blue,21
interferon-gamma-mediated signaling pathway (GO:0060333),14/68,1.32601461766687e-07,9.53770100512832e-06,0,0,6.94793119479312,110.026866831782,CIITA;SP100;VCAM1;STAT1;HLA-B;IFNG;HLA-DPB1;HLA-DRA;HLA-DQA2;CD44;HLA-DQB2;HLA-DQA1;HLA-DRB1;HLA-DPA1,GO_BP,blue,14
negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),9/25,1.33788349278286e-07,9.53770100512832e-06,0,0,14.9997403047091,237.400991331249,CD300A;PVRIG;FCRL3;SH2D1A;LPXN;PTPN22;UBASH3A;SLA2;CD22,GO_BP,blue,9
pyroptosis (GO:0070269),8/19,1.62027214492304e-07,1.12546595912731e-05,0,0,19.3718093801081,302.887955107202,ZBP1;AIM2;CASP8;GZMA;CASP1;GZMB;TREM2;NLRP1,GO_BP,blue,8
response to interferon-gamma (GO:0034341),15/80,1.75135051145264e-07,1.1861021338813e-05,0,0,6.18951439621831,96.2946603604096,GBP5;CCL24;CD74;CIITA;SP100;CCL22;STAT1;CXCL16;UBD;CASP1;XCL2;IL12RB1;CCL17;SHFL;HLA-DPA1,GO_BP,blue,15
natural killer cell activation (GO:0030101),11/43,2.8495806758738e-07,1.88280830510783e-05,0,0,9.18433159722222,138.416361644417,CD2;NCR1;NCR3;CASP8;KLRK1;PTPRC;AXL;IL21R;PIK3CD;SLAMF7;CD244,GO_BP,blue,11
lymphocyte chemotaxis (GO:0048247),11/44,3.67485060433965e-07,2.37027863979907e-05,0,0,8.90555555555556,131.949904572852,CCL24;CXCL10;CXCL11;CCL22;XCL2;PIK3CD;ADAM8;CXCL13;CCL17;PIK3CG;CXCL16,GO_BP,blue,11
defense response to virus (GO:0051607),19/133,3.7845061497794e-07,2.38423887436102e-05,0,0,4.48384831460674,66.3034732336835,ZBP1;APOBEC3D;RNASEL;APOBEC3G;RIPK3;APOBEC3H;STAT1;STAT2;PRF1;LILRB1;SLFN13;CXCL10;PTPRC;TLR8;TLR7;NLRP1;SKP2;ATG7;SHFL,GO_BP,blue,19
defense response to symbiont (GO:0140546),18/124,5.99856497627498e-07,3.69320739107475e-05,0,0,4.56394718039641,65.3857333146551,ZBP1;APOBEC3D;RNASEL;APOBEC3G;RIPK3;APOBEC3H;STAT1;STAT2;PRF1;LILRB1;SLFN13;PTPRC;TLR8;TLR7;NLRP1;SKP2;ATG7;SHFL,GO_BP,blue,18
positive regulation of T cell proliferation (GO:0042102),13/66,6.38725799739036e-07,3.84512931442899e-05,0,0,6.56456614284963,93.6355967301996,VCAM1;SYK;CD3E;TMIGD2;HLA-DMB;CD40LG;PTPRC;CD6;HLA-DPB1;IL12RB1;JAK3;CCR2;HLA-DPA1,GO_BP,blue,13
innate immune response (GO:0045087),30/302,7.57859980355285e-07,4.46313627561406e-05,0,0,2.98895485440967,42.1226449071677,FCN1;BLK;CX3CR1;SP100;CIITA;PIK3CD;TREM2;PIK3CG;CXCL16;IKBKB;UBD;DHX58;CLEC5A;CD300LB;S100A12;FYN;NLRP1;SKP2;CD74;APOBEC3G;SYK;STYK1;TREML1;CXCL10;ZAP70;LCK;BTK;TLR8;TRIM59;SHFL,GO_BP,blue,30
enzyme linked receptor protein signaling pathway (GO:0007167),19/140,8.47321057119449e-07,4.88381434837572e-05,0,0,4.22290834803603,59.0412677590712,BLK;CSF1R;SYK;FLT3;STYK1;CD3E;ZAP70;CD4;CD8B;CD8A;LCK;AXL;CD7;BLNK;STAP1;CLNK;LCP2;FYN;JAK3,GO_BP,blue,19
T cell chemotaxis (GO:0010818),6/11,9.22237247089161e-07,5.20487646325945e-05,0,0,31.8852413793103,443.092087551345,CXCL10;CXCL11;PIK3CD;PIK3CG;CCR2;CXCL16,GO_BP,blue,6
negative regulation of lymphocyte proliferation (GO:0050672),10/39,9.72406809280671e-07,5.37602050273742e-05,0,0,9.20177913817017,127.384752130496,BLK;IL4I1;PLA2G2D;TNFRSF13B;CD300A;LST1;CTLA4;LILRB1;FOXP3;HLA-DRB1,GO_BP,blue,10
positive regulation of leukocyte cell-cell adhesion (GO:1903039),9/31,1.08406582318167e-06,5.79711202180461e-05,0,0,10.9055023923445,149.784806297841,LCK;ITGB2;SIRPG;HLA-DPB1;PRKCQ;CD44;SKAP1;CCR2;HLA-DPA1,GO_BP,blue,9
cell chemotaxis (GO:0060326),13/69,1.09137214142501e-06,5.79711202180461e-05,0,0,6.21192300039793,85.2777436513753,CX3CR1;XCR1;CXCR5;CXCR4;CXCR6;CXCL12;BIN2;CXCR3;PRKCQ;CCR6;CCR5;CCR4;CCR2,GO_BP,blue,13
lymphocyte migration (GO:0072676),10/40,1.25435127651853e-06,6.53468770786288e-05,0,0,8.89459084604716,120.867634659436,CCL24;ZAP70;CCL22;TBX21;CRTAM;XCL2;ADAM8;CCR6;CCL17;MYO1G,GO_BP,blue,10
cellular response to chemokine (GO:1990869),12/60,1.45051372849496e-06,7.41404092545819e-05,0,0,6.68324061196106,89.846765162882,RIPOR2;CCL24;CXCL10;CXCL9;CXCL11;CCL22;CXCL12;DOCK8;XCL2;CXCL13;CCL17;CCR2,GO_BP,blue,12
T cell differentiation (GO:0030217),10/41,1.60501038232226e-06,8.05180208465002e-05,0,0,8.60722115341596,114.840818236249,LFNG;ZAP70;CD4;PTPRC;RIPK3;CD8A;LCK;PIK3CD;RHOH;PTPN22,GO_BP,blue,10
cellular response to lipopolysaccharide (GO:0071222),17/120,1.73610404447625e-06,8.55110155724758e-05,0,0,4.43042071197411,58.7645111222753,CX3CR1;CXCL9;TGFB1;GFI1;PTPN22;LILRB1;CXCL13;NUGGC;CXCL10;CXCL11;CD6;AXL;CASP1;PDCD4;STAP1;CARD16;CCR5,GO_BP,blue,17
regulation of B cell differentiation (GO:0045577),7/18,1.89421048668448e-06,9.16324322933617e-05,0,0,16.9269211451532,223.041104648206,IL4I1;SYK;FCRL3;BTK;SLAMF8;CD27;IKZF3,GO_BP,blue,7
positive regulation of T cell mediated cytotoxicity (GO:0001916),8/26,2.66782347603745e-06,0.000126791820992727,0,0,11.8340248962656,151.880805570031,HLA-B;HLA-DRA;CD1E;CD1C;IL12RB1;CD1B;CD1A;HLA-DRB1,GO_BP,blue,8
negative regulation of T cell activation (GO:0050868),10/45,4.00163151383901e-06,0.000186903789154998,0,0,7.62195363582326,94.7318013851023,RIPOR2;IL4I1;PLA2G2D;PTPN22;LILRB1;TIGIT;JAK3;FOXP3;LAX1;HLA-DRB1,GO_BP,blue,10
positive regulation of cytokine-mediated signaling pathway (GO:0001961),9/36,4.29691429007452e-06,0.000195407936813709,0,0,8.88365650969529,109.780792723673,ZBP1;CD74;EDN1;AXL;GFI1;TXK;CASP1;CXCR4;CD300LF,GO_BP,blue,9
regulation of T cell migration (GO:2000404),7/20,4.32797202245203e-06,0.000195407936813709,0,0,14.3212919677008,176.873848737126,RIPOR2;CXCL10;CD200R1;CXCL12;DOCK8;TNFRSF14;CCR6,GO_BP,blue,7
regulation of B cell proliferation (GO:0030888),10/46,4.94708822960288e-06,0.000219699377278593,0,0,7.40984743411928,90.5239675532841,BLK;CD74;PTPRC;TNFRSF13B;CD300A;FCRL3;CTLA4;IKZF3;CD22;TNFSF13B,GO_BP,blue,10
positive regulation of T cell receptor signaling pathway (GO:0050862),6/14,5.45490795395501e-06,0.000238344284633292,0,0,19.9251724137931,241.473061121399,TESPA1;TRAT1;LCK;CD226;KCNN4;CARD11,GO_BP,blue,6
peptidyl-tyrosine phosphorylation (GO:0018108),12/69,6.76268925787495e-06,0.000290795638088623,0,0,5.62535685528146,66.9647538812716,BLK;ITK;ZAP70;CSF1R;SYK;FLT3;LCK;TXK;BTK;FYN;PTPN6;JAK3,GO_BP,blue,12
regulation of cytosolic calcium ion concentration (GO:0051480),18/148,7.96322233252353e-06,0.0003349727884209,0,0,3.71671161937642,43.6367099725168,CX3CR1;CD52;EDN1;XCR1;TRPC6;CXCR5;CXCR4;FPR3;CXCR6;CXCL13;SLC8B1;CYSLTR1;CXCR3;CCR6;CCR5;CCR4;PTGDR;CCR2,GO_BP,blue,18
antigen processing and presentation of lipid antigen via MHC class Ib (GO:0048003),4/5,8.59472294403807e-06,0.0003349727884209,0,0,106.013755158184,1236.5828334917,CD1E;CD1C;CD1B;CD1A,GO_BP,blue,4
"antigen processing and presentation, endogenous lipid antigen via MHC class Ib (GO:0048006)",4/5,8.59472294403807e-06,0.0003349727884209,0,0,106.013755158184,1236.5828334917,CD1E;CD1C;CD1B;CD1A,GO_BP,blue,4
"antigen processing and presentation, exogenous lipid antigen via MHC class Ib (GO:0048007)",4/5,8.59472294403807e-06,0.0003349727884209,0,0,106.013755158184,1236.5828334917,CD1E;CD1C;CD1B;CD1A,GO_BP,blue,4
"positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032831)",4/5,8.59472294403807e-06,0.0003349727884209,0,0,106.013755158184,1236.5828334917,IFNG;HLA-DRA;FOXP3;HLA-DRB1,GO_BP,blue,4
positive thymic T cell selection (GO:0045059),4/5,8.59472294403807e-06,0.0003349727884209,0,0,106.013755158184,1236.5828334917,ZAP70;CD3G;CD3E;CD3D,GO_BP,blue,4
regulation of natural killer cell mediated cytotoxicity (GO:0042269),8/30,8.77927943074342e-06,0.0003349727884209,0,0,9.68037218659625,112.709698451178,NCR1;NCR3;KLRK1;CRTAM;SLAMF6;LILRB1;CD226;KLRC1,GO_BP,blue,8
heterotypic cell-cell adhesion (GO:0034113),8/30,8.77927943074342e-06,0.0003349727884209,0,0,9.68037218659625,112.709698451178,CD2;CD200R1;VCAM1;ITGA4;ITGAD;ITGB2;ITGAX;ITGB7,GO_BP,blue,8
cellular defense response (GO:0006968),10/49,9.03300144247231e-06,0.000339866679273021,0,0,6.83879227568548,79.4300136170794,NCR1;CX3CR1;ITK;CXCL9;FCMR;TRAT1;CLEC5A;PRF1;CCR6;CCR5,GO_BP,blue,10
immunoglobulin mediated immune response (GO:0016064),5/10,1.39146551384501e-05,0.000516367133836458,0,0,26.534435261708,296.723125242218,CD74;CD19;CD27;TLR8;GAPT,GO_BP,blue,5
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),14/100,1.61533439546642e-05,0.000591343361799803,0,0,4.35538905646914,48.0546776372344,CD74;LAG3;MARCHF1;HLA-DMA;HLA-DMB;HLA-DPB1;HLA-DRA;HLA-DOA;HLA-DOB;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB2;HLA-DPA1,GO_BP,blue,14
positive regulation of lymphocyte proliferation (GO:0050671),12/75,1.64036851889033e-05,0.000592501109023186,0,0,5.08801907411087,56.0598172669952,CD74;HLA-DMB;VCAM1;CD40LG;PTPRC;CD6;FCRL3;HLA-DPB1;CD3E;JAK3;TNFSF13B;HLA-DPA1,GO_BP,blue,12
regulation of innate immune response (GO:0045088),11/64,1.83212952038764e-05,0.000653057746148698,0,0,5.53920335429769,60.4185642524503,GBP5;RNASEL;CASP8;DHX58;SH2D1B;TLR8;PTPN22;TREM2;ADAM8;NLRC3;PTPN6,GO_BP,blue,11
tumor necrosis factor-mediated signaling pathway (GO:0033209),15/116,2.14903351116321e-05,0.000756069062563784,0,0,3.97588362188174,42.7324284190562,TNFRSF13B;TNFSF15;STAT1;TNFRSF9;TNFRSF18;ST18;TNFSF13B;PSMB9;IKBKB;AIM2;CD40LG;CD27;TNFRSF14;TNFSF8;LTB,GO_BP,blue,15
positive regulation of T cell migration (GO:2000406),7/25,2.28751093133398e-05,0.000794470142690224,0,0,10.3404696132597,110.492686512289,CXCL10;CXCL12;DOCK8;XCL2;TNFRSF14;CXCL13;CCR2,GO_BP,blue,7
B cell mediated immunity (GO:0019724),5/11,2.47417888674873e-05,0.000827083989830461,0,0,22.1108815426997,234.530493908212,CD74;CD19;CD27;TLR8;SLA2,GO_BP,blue,5
negative regulation of B cell receptor signaling pathway (GO:0050859),4/6,2.50353957792904e-05,0.000827083989830461,0,0,53.0041265474553,561.590376550954,CD300A;FCRL3;LPXN;CD22,GO_BP,blue,4
negative regulation of myeloid leukocyte mediated immunity (GO:0002887),4/6,2.50353957792904e-05,0.000827083989830461,0,0,53.0041265474553,561.590376550954,CX3CR1;CD84;CD300A;CCR2,GO_BP,blue,4
peptide antigen assembly with MHC protein complex (GO:0002501),4/6,2.50353957792904e-05,0.000827083989830461,0,0,53.0041265474553,561.590376550954,HLA-DMA;HLA-DMB;HLA-DRA;HLA-DRB1,GO_BP,blue,4
mononuclear cell differentiation (GO:1903131),7/26,3.03199590492303e-05,0.000978890636008972,0,0,9.7957255015993,101.911831990943,BLK;CSF1R;FLT3;AXL;TREM2;LILRB1;IKZF1,GO_BP,blue,7
cellular response to tumor necrosis factor (GO:0071356),20/194,3.04333743138007e-05,0.000978890636008972,0,0,3.08695863038945,32.104279346648,CCL24;CCL22;TNFRSF13B;TNFSF15;STAT1;TNFRSF9;TNFRSF18;ST18;PSMB9;TNFSF13B;IKBKB;TCL1A;CD40LG;AIM2;XCL2;CD27;TNFSF8;TNFRSF14;LTB;CCL17,GO_BP,blue,20
chemokine-mediated signaling pathway (GO:0070098),10/56,3.1075893206634e-05,0.000978890636008972,0,0,5.79599589941506,60.1570945559435,CCL24;CXCL10;CXCL9;CXCL11;CCL22;CXCL12;XCL2;CXCL13;CCL17;CCR2,GO_BP,blue,10
peptidyl-tyrosine modification (GO:0018212),10/56,3.1075893206634e-05,0.000978890636008972,0,0,5.79599589941506,60.1570945559435,BLK;ZAP70;CSF1R;SYK;FLT3;LCK;BTK;FYN;PTPN6;JAK3,GO_BP,blue,10
response to cytokine (GO:0034097),17/150,3.56367579592526e-05,0.00110965491162776,0,0,3.42570712495525,35.0865477388241,CSF1R;CD74;CIITA;SP100;FLT3;STAT1;CXCR4;CXCL16;CASP8;LAMP3;UBD;CASP1;PTPN6;PTPN7;LDLRAP1;JAK3;SHFL,GO_BP,blue,17
positive regulation of T cell mediated immunity (GO:0002711),8/36,3.73826185427326e-05,0.00115078992763935,0,0,7.60363564512942,77.5137786430295,HLA-B;HLA-DRA;CD1E;CD1C;IL12RB1;CD1B;CD1A;HLA-DRB1,GO_BP,blue,8
negative regulation of cytokine production (GO:0001818),19/182,4.01425360349843e-05,0.00122186663054801,0,0,3.12792100365341,31.6641759013902,CD84;PTPN22;TREM2;NLRC3;LILRB1;FOXP3;CD200R1;PTPRC;IFNG;AXL;TBX21;DHX58;PDCD4;TLR8;PTPN6;TIGIT;CD34;JAK3;HLA-DRB1,GO_BP,blue,19
leukocyte cell-cell adhesion (GO:0007159),7/28,5.12053064158181e-05,0.00154127972311612,0,0,8.86187845303867,87.5524115697777,VCAM1;CD40LG;ITGA4;SYK;ITGB2;CERCAM;ITGAL,GO_BP,blue,7
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),13/98,5.73718146189965e-05,0.00170791478904244,0,0,4.08638374569884,39.9074496203811,CD74;LAG3;HLA-DMA;HLA-DMB;HLA-DPB1;HLA-DRA;HLA-DOA;HLA-DOB;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB2;HLA-DPA1,GO_BP,blue,13
positive regulation of lymphocyte differentiation (GO:0045621),6/20,5.83334936839691e-05,0.00171766776510731,0,0,11.3822660098522,110.969514416529,ZAP70;SYK;AXL;BTK;RHOH;CD27,GO_BP,blue,6
regulation of cytokine-mediated signaling pathway (GO:0001959),11/74,7.39449259005624e-05,0.00215394413187767,0,0,4.65753968253968,44.3034023296757,IKBKB;ZBP1;CD74;RNASEL;CASP8;PTPRC;SYK;IFNG;STAT1;AXL;PTPN6,GO_BP,blue,11
cellular response to molecule of bacterial origin (GO:0071219),14/115,7.86123310296528e-05,0.00226554047616308,0,0,3.70564922601047,35.0220240870371,CX3CR1;CXCL9;GFI1;LILRB1;CXCL13;NUGGC;CXCL10;CXCL11;AXL;CASP1;PDCD4;STAP1;CARD16;CCR5,GO_BP,blue,14
regulation of interleukin-12 production (GO:0032655),9/51,8.50630210732436e-05,0.00242563920092018,0,0,5.70647012267511,53.48171221944,CD40LG;SYK;IFNG;HLA-B;TLR8;LILRB1;LTB;TIGIT;JAK3,GO_BP,blue,9
antigen processing and presentation of exogenous peptide antigen (GO:0002478),13/103,9.66908220444558e-05,0.00272849413456699,0,0,3.858356545961,35.6666173204584,CD74;LAG3;HLA-DMA;HLA-DMB;HLA-DPB1;HLA-DRA;HLA-DOA;HLA-DOB;HLA-DQA2;HLA-DQA1;HLA-DRB1;HLA-DQB2;HLA-DPA1,GO_BP,blue,13
negative regulation of T cell mediated immunity (GO:0002710),5/14,9.78305325782491e-05,0.00273219497685028,0,0,14.7382920110193,136.067947714682,IL4I1;PTPRC;LILRB1;KLRC1;FOXP3,GO_BP,blue,5
negative regulation of lymphocyte activation (GO:0051250),6/22,0.000105484822407876,0.00291590187656056,0,0,9.95844827586207,91.1889479989205,IL4I1;LST1;PTPN22;TIGIT;LAX1;JAK3,GO_BP,blue,6
cellular response to interleukin-21 (GO:0098757),4/8,0.000110155886471615,0.00292561074952555,0,0,26.4993122420908,241.50450424929,STAT1;IL21R;IL2RG;JAK3,GO_BP,blue,4
regulation of lymphocyte apoptotic process (GO:0070228),4/8,0.000110155886471615,0.00292561074952555,0,0,26.4993122420908,241.50450424929,BLK;BTK;CD3G;JAK3,GO_BP,blue,4
interleukin-21-mediated signaling pathway (GO:0038114),4/8,0.000110155886471615,0.00292561074952555,0,0,26.4993122420908,241.50450424929,STAT1;IL21R;IL2RG;JAK3,GO_BP,blue,4
"positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",4/8,0.000110155886471615,0.00292561074952555,0,0,26.4993122420908,241.50450424929,MYB;HLA-DRA;FOXP3;HLA-DRB1,GO_BP,blue,4
positive regulation of phagocytosis (GO:0050766),9/53,0.000116094508903246,0.00305339829727081,0,0,5.44651850919164,49.3514813610912,PTPRC;IFNG;SIRPG;IL2RB;STAP1;TREM2;DOCK2;IL2RG;CD300LF,GO_BP,blue,9
positive regulation of natural killer cell mediated immunity (GO:0002717),6/23,0.000138325972402722,0.00360312556960551,0,0,9.37217038539554,83.2801457660869,NCR3;KLRK1;CRTAM;SH2D1B;CD226;SLAMF6,GO_BP,blue,6
macrophage differentiation (GO:0030225),5/15,0.000142340922050948,0.00361877290962293,0,0,13.2637741046832,117.481034295517,CSF1R;CD4;CASP8;IFNG;HLA-DRB1,GO_BP,blue,5
T cell proliferation (GO:0042098),5/15,0.000142340922050948,0.00361877290962293,0,0,13.2637741046832,117.481034295517,BTN3A1;DOCK8;CRTAM;LILRB1;PIK3CG,GO_BP,blue,5
positive regulation of T cell differentiation (GO:0045582),8/43,0.000142934182845941,0.00361877290962293,0,0,6.08069551472041,53.8331653439869,IL4I1;ZAP70;TESPA1;RHOH;HLA-DRA;ADAM8;IL12RB1;HLA-DRB1,GO_BP,blue,8
dendritic cell differentiation (GO:0097028),6/24,0.000178766807062225,0.00443317569501394,0,0,8.85103448275862,76.3793679391433,BLK;FLT3;AXL;UBD;LILRB1;TREM2,GO_BP,blue,6
immune response-activating cell surface receptor signaling pathway (GO:0002429),6/24,0.000178766807062225,0.00443317569501394,0,0,8.85103448275862,76.3793679391433,BLK;NCR3;CD19;FPR3;SLA2;LAX1,GO_BP,blue,6
positive regulation of interleukin-1 beta production (GO:0032731),9/56,0.000180010825563504,0.00443317569501394,0,0,5.09807272941593,43.9580993127888,P2RX7;GBP5;CASP8;AIM2;IFNG;PYHIN1;CASP1;TLR8;NLRP1,GO_BP,blue,9
dendritic cell chemotaxis (GO:0002407),5/16,0.000200832141750849,0.00490138983786532,0,0,12.0573503631355,102.644719373014,CXCR4;CCR6;CCR5;PIK3CG;CCR2,GO_BP,blue,5
regulation of defense response (GO:0031347),11/83,0.000212113521600648,0.00508509318598368,0,0,4.0734375,34.454718727769,ZBP1;CASP8;AKNA;CASP5;DHX58;CASP1;PTPN22;TREM2;NLRP1;CCR2;PTGES,GO_BP,blue,11
regulation of interleukin-1 beta production (GO:0032651),11/83,0.000212113521600648,0.00508509318598368,0,0,4.0734375,34.454718727769,CX3CR1;P2RX7;GBP5;CASP8;AIM2;IFNG;PYHIN1;CASP1;TLR8;CARD16;NLRP1,GO_BP,blue,11
negative regulation of T cell proliferation (GO:0042130),7/35,0.00023278244915687,0.00553164609443824,0,0,6.64399171270718,55.5796896998892,IL4I1;PLA2G2D;CRTAM;TNFRSF14;LILRB1;FOXP3;HLA-DRB1,GO_BP,blue,7
response to lipopolysaccharide (GO:0032496),16/159,0.000244117113254492,0.00575055008527322,0,0,2.99296787128955,24.8950951468761,CX3CR1;CXCL9;GFI1;PTPN22;LILRB1;CXCL13;NUGGC;CXCL10;CXCL11;CD6;AXL;CASP1;PDCD4;STAP1;CARD16;CCR5,GO_BP,blue,16
positive regulation of intracellular signal transduction (GO:1902533),37/546,0.00024900525978318,0.00581513145476408,0,0,1.96497624884641,16.3054447094173,CX3CR1;FLT3;PIK3CD;FASLG;TREM2;PIK3CG;IKBKB;CASP8;CD19;UBD;DHX58;RAC2;CASP1;S100A12;BMF;FYN;ICOS;CD74;TGFB1;PRKCB;TRAT1;FCRL3;WNT16;CD4;PTPRC;P2RX4;LCK;AXL;PDCD4;CD27;ADAM8;PTPN6;TLR7;CARD16;HCST;HLA-DRB1;CARD11,GO_BP,blue,37
cell-matrix adhesion (GO:0007160),12/100,0.000287177761121636,0.00659570884043449,0,0,3.63781767606524,29.6678915876386,CD96;OTOA;VCAM1;PARVG;ITGA4;CTTN;ITGB2;ITGB7;ITGAL;CD34;LYVE1;CD44,GO_BP,blue,12
regulation of regulatory T cell differentiation (GO:0045589),6/26,0.00028729924074244,0.00659570884043449,0,0,7.96510344827586,64.955308978785,IL4I1;LAG3;IFNG;TNFRSF18;CTLA4;FOXP3,GO_BP,blue,6
regulation of response to external stimulus (GO:0032101),14/130,0.000292094889154483,0.0066494542413403,0,0,3.22394555860145,26.2378612026903,ZBP1;AKNA;PDE6G;CXCR4;PTPN22;TREM2;CASP8;P2RX4;CASP5;DHX58;CASP1;NLRP1;PTGES;CCR2,GO_BP,blue,14
negative regulation of immune response (GO:0050777),17/178,0.000295463513961639,0.006670088827684,0,0,2.82579118603963,22.9651066341023,SYK;CD300A;CD3G;TREM2;NLRC3;LILRB1;FOXP3;CYSLTR1;HTR7;ADM2;DHX58;FYN;CD247;INSL3;HLA-DRB1;PTGDR;CCR2,GO_BP,blue,17
regulation of interleukin-10 production (GO:0032653),8/48,0.000316696479388526,0.00709033688151666,0,0,5.31922544951591,42.8600139636845,CD40LG;SYK;LILRB1;TIGIT;CD34;JAK3;FOXP3;HLA-DRB1,GO_BP,blue,8
"phagocytosis, engulfment (GO:0006911)",7/37,0.000334494543457033,0.0074274239198779,0,0,6.20041436464088,49.6212340592344,MSR1;SH3BP1;BIN2;ITGB2;RAC2;RHOH;ARHGAP25,GO_BP,blue,7
protein phosphorylation (GO:0006468),34/496,0.000356228290342527,0.007845710882422,0,0,1.98574596135572,15.7667013412284,BLK;CSF1R;RNASEL;FLT3;TXK;PIK3CD;CAMKK2;IKBKB;STK10;RPS6KA1;FYN;JAK3;MAP3K5;MAP4K1;PRKCH;TGFB1;RIPK3;SYK;PRKCB;CAD;MATK;TYK2;PASK;RUNX3;CLK2;ZAP70;LCK;ADM2;BTK;PRKCQ;PTPN6;TLR7;HCST;CAMK1G,GO_BP,blue,34
dendritic cell migration (GO:0036336),5/18,0.000370696869400714,0.00796998269211536,0,0,10.2013138376775,80.5916635910958,CXCR4;CCR6;CCR5;PIK3CG;CCR2,GO_BP,blue,5
leukocyte tethering or rolling (GO:0050901),5/18,0.000370696869400714,0.00796998269211536,0,0,10.2013138376775,80.5916635910958,CX3CR1;SELPLG;VCAM1;ITGA4;ITGB7,GO_BP,blue,5
negative regulation of leukocyte cell-cell adhesion (GO:1903038),5/18,0.000370696869400714,0.00796998269211536,0,0,10.2013138376775,80.5916635910958,IL4I1;PTPN22;TIGIT;LAX1;JAK3,GO_BP,blue,5
positive regulation of interleukin-1 production (GO:0032732),9/62,0.000396683032462013,0.00846153019637475,0,0,4.51952124601474,35.3985761940886,P2RX7;GBP5;CASP8;AIM2;IFNG;PYHIN1;CASP1;TLR8;NLRP1,GO_BP,blue,9
regulation of B cell activation (GO:0050864),6/28,0.000441744623448865,0.00927663709242616,0,0,7.24025078369906,55.929334441902,IL4I1;CD19;FCRL3;SLAMF8;IKZF3;CD22,GO_BP,blue,6
positive regulation of defense response to virus by host (GO:0002230),6/28,0.000441744623448865,0.00927663709242616,0,0,7.24025078369906,55.929334441902,AIM2;APOBEC3G;STAT1;PTPN22;LILRB1;IL12RB1,GO_BP,blue,6
chemokine (C-X-C motif) ligand 12 signaling pathway (GO:0038146),3/5,0.000460157856261007,0.00951578345504631,0,0,39.698489010989,305.040845823747,CXCL12;CXCR4;TREM2,GO_BP,blue,3
regulation of natural killer cell differentiation (GO:0032823),3/5,0.000460157856261007,0.00951578345504631,0,0,39.698489010989,305.040845823747,ZNF683;AXL;PRDM1,GO_BP,blue,3
regulation of dendritic cell apoptotic process (GO:2000668),4/11,0.000475564964699849,0.00954300362497697,0,0,15.1401061112203,115.837058766332,BLK;CXCL12;AXL;LILRB1,GO_BP,blue,4
cellular response to interleukin-2 (GO:0071352),4/11,0.000475564964699849,0.00954300362497697,0,0,15.1401061112203,115.837058766332,SYK;IL2RB;IL2RG;JAK3,GO_BP,blue,4
regulation of lymphocyte migration (GO:2000401),4/11,0.000475564964699849,0.00954300362497697,0,0,15.1401061112203,115.837058766332,STK10;CCR6;GCSAM;SLC8B1,GO_BP,blue,4
interleukin-2-mediated signaling pathway (GO:0038110),4/11,0.000475564964699849,0.00954300362497697,0,0,15.1401061112203,115.837058766332,SYK;IL2RB;IL2RG;JAK3,GO_BP,blue,4
regulation of lymphocyte proliferation (GO:0050670),5/19,0.000488042235346549,0.009580481272129,0,0,9.47215663124754,72.2262230653909,LST1;PTPN22;TNFSF8;IKZF3;CD22,GO_BP,blue,5
leukocyte adhesion to vascular endothelial cell (GO:0061756),5/19,0.000488042235346549,0.009580481272129,0,0,9.47215663124754,72.2262230653909,CX3CR1;SELPLG;VCAM1;ITGA4;ITGB7,GO_BP,blue,5
negative regulation of T cell receptor signaling pathway (GO:0050860),5/19,0.000488042235346549,0.009580481272129,0,0,9.47215663124754,72.2262230653909,PVRIG;SH2D1A;PTPN22;UBASH3A;SLA2,GO_BP,blue,5
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),7/40,0.000550824214399758,0.0107351280345967,0,0,5.63586137619287,42.2920382147826,CASP8;STAT1;PPM1N;RHOH;NLRC3;TREM2;TRIM59,GO_BP,blue,7
positive regulation of response to external stimulus (GO:0032103),14/139,0.000579448296783929,0.011212324542769,0,0,2.99041562064156,22.2888658185399,ZBP1;GBP5;TGFB1;SH2D1B;TREM2;PLA2G7;IFNG;DHX58;PDCD4;S100A12;TLR8;ADAM8;TLR7;CCR2,GO_BP,blue,14
regulation of tumor necrosis factor production (GO:0032680),13/124,0.000615565214172109,0.0118267103914343,0,0,3.12497176842581,23.1028214872939,CX3CR1;SYK;PTPN22;NLRC3;LILRB1;CLU;LILRA4;CD2;PTPRC;IFNG;PTPN6;CD34;CCR2,GO_BP,blue,13
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),5/20,0.000631279261520335,0.0118800354021254,0,0,8.84022038567493,65.1326418055681,CD8A;BTN3A3;SLA2;HLA-DRB1;MYO1G,GO_BP,blue,5
positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),5/20,0.000631279261520335,0.0118800354021254,0,0,8.84022038567493,65.1326418055681,NCR3;KLRK1;CRTAM;CD226;SLAMF6,GO_BP,blue,5
hemopoiesis (GO:0030097),11/94,0.000631496898451846,0.0118800354021254,0,0,3.53155957161981,26.0184738876599,CSF1R;SELPLG;TGFB1;PTPRC;TNFRSF13B;FLT3;LCK;PLD4;CD34;RUNX3;RUNX2,GO_BP,blue,11
regulation of small GTPase mediated signal transduction (GO:0051056),14/141,0.000668645586542432,0.0124921440961617,0,0,2.94301496831725,21.5141940198475,ARHGAP9;ARAP2;RHOH;ARAP1;ARHGAP25;ARHGAP45;SYDE1;ARHGAP30;SH3BP1;CHN2;ARHGDIB;TAGAP;RAC2;ARHGEF1,GO_BP,blue,14
regulation of interleukin-6 production (GO:0032675),12/110,0.000690569724382882,0.0127669421871598,0,0,3.26490874513922,23.7619849959597,CD74;CD200R1;SYK;IFNG;HLA-B;TLR8;PTPN22;TREM2;TLR7;NLRC3;PTPN6;POU2F2,GO_BP,blue,12
negative regulation of B cell proliferation (GO:0030889),4/12,0.000692779808605568,0.0127669421871598,0,0,13.2469050894085,96.3685632309114,BLK;TNFRSF13B;CD300A;CTLA4,GO_BP,blue,4
Fc-epsilon receptor signaling pathway (GO:0038095),12/111,0.000749097084833594,0.0137115135325284,0,0,3.23176128461247,23.2578288771037,IKBKB;LAT2;ITK;SYK;BTK;FCER1A;PRKCQ;LCP2;CARD11;LAT;LILRA4;PSMB9,GO_BP,blue,12
sensory perception of pain (GO:0019233),5/21,0.00080381991165382,0.0146144170514778,0,0,8.2872761707989,59.056251297672,P2RX7;P2RX4;TRPA1;CCR2;PTGES,GO_BP,blue,5
Fc receptor signaling pathway (GO:0038093),12/112,0.000811713946425764,0.0146595538724493,0,0,3.19927677329624,22.7672134568671,IKBKB;LAT2;ITK;SYK;BTK;FCER1A;PRKCQ;LCP2;CARD11;LAT;LILRA4;PSMB9,GO_BP,blue,12
regulation of T-helper 17 cell lineage commitment (GO:2000328),3/6,0.000895283661239056,0.0155049592966075,0,0,26.4642857142857,185.736147604626,TBX21;LOXL3;IL12RB1,GO_BP,blue,3
regulation of T-helper cell differentiation (GO:0045622),3/6,0.000895283661239056,0.0155049592966075,0,0,26.4642857142857,185.736147604626,MYB;HLA-DRA;HLA-DRB1,GO_BP,blue,3
negative regulation of mast cell activation (GO:0033004),3/6,0.000895283661239056,0.0155049592966075,0,0,26.4642857142857,185.736147604626,CD84;CD300A;CD300LF,GO_BP,blue,3
neutrophil extravasation (GO:0072672),3/6,0.000895283661239056,0.0155049592966075,0,0,26.4642857142857,185.736147604626,JAML;PIK3CD;PIK3CG,GO_BP,blue,3
positive regulation of cell-cell adhesion mediated by integrin (GO:0033634),3/6,0.000895283661239056,0.0155049592966075,0,0,26.4642857142857,185.736147604626,CD3E;CXCL13;SKAP1,GO_BP,blue,3
positive regulation of killing of cells of other organism (GO:0051712),3/6,0.000895283661239056,0.0155049592966075,0,0,26.4642857142857,185.736147604626,IFNG;SYK;PRF1,GO_BP,blue,3
positive regulation of defense response (GO:0031349),11/98,0.000898589372302464,0.0155049592966075,0,0,3.36848659003831,23.6288702955029,ZBP1;GBP5;IFNG;SH2D1B;PDCD4;S100A12;TLR8;ADAM8;TLR7;PLA2G7;CCR2,GO_BP,blue,11
hematopoietic progenitor cell differentiation (GO:0002244),6/32,0.00093838990252097,0.0160892294046159,0,0,6.12509283819629,42.7001354607059,CSF1R;TGFB1;PTPRC;TNFRSF13B;FLT3;PLD4,GO_BP,blue,6
cellular response to interleukin-15 (GO:0071350),4/13,0.000971866170038195,0.0162517620656387,0,0,11.7744154057772,81.6707886602282,CD4;IL2RB;IL2RG;JAK3,GO_BP,blue,4
interleukin-15-mediated signaling pathway (GO:0035723),4/13,0.000971866170038195,0.0162517620656387,0,0,11.7744154057772,81.6707886602282,CD4;IL2RB;IL2RG;JAK3,GO_BP,blue,4
lymphocyte mediated immunity (GO:0002449),4/13,0.000971866170038195,0.0162517620656387,0,0,11.7744154057772,81.6707886602282,CD8A;BTN3A3;SLA2;MYO1G,GO_BP,blue,4
macrophage activation involved in immune response (GO:0002281),4/13,0.000971866170038195,0.0162517620656387,0,0,11.7744154057772,81.6707886602282,CX3CR1;SYK;IFNG;TREM2,GO_BP,blue,4
microglial cell activation (GO:0001774),5/22,0.0010092135770954,0.0167727581616652,0,0,7.79938421649652,53.8047062919562,CX3CR1;IFNG;ITGB2;TREM2;CLU,GO_BP,blue,5
regulation of interleukin-17 production (GO:0032660),6/33,0.00111190378717013,0.018366752191731,0,0,5.89793103448276,40.1158490497249,TGFB1;IFNG;SLAMF6;PRKCQ;LY9;FOXP3,GO_BP,blue,6
regulation of phagocytosis (GO:0050764),8/58,0.00116762439918891,0.0191702696812289,0,0,4.2531673582296,28.7207205809469,PTPRC;SYK;IFNG;SIRPG;IL2RB;TREM2;DOCK2;IL2RG,GO_BP,blue,8
regulation of interleukin-4 production (GO:0032673),5/23,0.0012511279045923,0.0204175029731357,0,0,7.36570247933884,49.2302179249104,CD40LG;SYK;PRKCQ;FOXP3;HLA-DRB1,GO_BP,blue,5
positive regulation of calcium ion transport into cytosol (GO:0010524),6/34,0.00130897715043595,0.0209350608500911,0,0,5.68699507389163,37.7531693910587,P2RX7;CXCL10;CXCL9;CXCL11;P2RX4;CD19,GO_BP,blue,6
negative regulation of interleukin-12 production (GO:0032695),4/14,0.00132148224635126,0.0209350608500911,0,0,10.5964236588721,70.2437057700251,TLR8;LILRB1;TIGIT;JAK3,GO_BP,blue,4
negative regulation of neuroinflammatory response (GO:0150079),4/14,0.00132148224635126,0.0209350608500911,0,0,10.5964236588721,70.2437057700251,CD200R1;PTPRC;TREM2;CST7,GO_BP,blue,4
positive regulation of lymphocyte migration (GO:2000403),4/14,0.00132148224635126,0.0209350608500911,0,0,10.5964236588721,70.2437057700251,CXCL10;CXCL12;DOCK8;TNFRSF14,GO_BP,blue,4
positive regulation of regulatory T cell differentiation (GO:0045591),4/14,0.00132148224635126,0.0209350608500911,0,0,10.5964236588721,70.2437057700251,IL4I1;HLA-DRA;FOXP3;HLA-DRB1,GO_BP,blue,4
regulation of microglial cell migration (GO:1904139),3/7,0.00152420937628581,0.0236001435809114,0,0,19.8471840659341,128.734382050778,CX3CR1;P2RX4;TREM2,GO_BP,blue,3
negative regulation of dendritic cell apoptotic process (GO:2000669),3/7,0.00152420937628581,0.0236001435809114,0,0,19.8471840659341,128.734382050778,CXCL12;AXL;LILRB1,GO_BP,blue,3
positive regulation of B cell receptor signaling pathway (GO:0050861),3/7,0.00152420937628581,0.0236001435809114,0,0,19.8471840659341,128.734382050778,PRKCH;PRKCB;STAP1,GO_BP,blue,3
positive regulation of lymphocyte activation (GO:0051251),6/35,0.00153163898872727,0.0236001435809114,0,0,5.49060642092747,35.5869091516399,LCK;SIRPG;HLA-DPB1;PRKCQ;CCR2;HLA-DPA1,GO_BP,blue,6
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),18/224,0.00153326883360665,0.0236001435809114,0,0,2.33618377156552,15.1392962837413,CD74;PRKCB;STAT1;PPM1N;RHOH;FASLG;TREM2;NLRC3;IKBKB;CD4;CASP8;UBD;CASP1;S100A12;TRIM59;CARD16;HLA-DRB1;CARD11,GO_BP,blue,18
positive regulation of NF-kappaB transcription factor activity (GO:0051092),14/155,0.00167949335575461,0.0257047881397697,0,0,2.64886198403513,16.9242761448464,CX3CR1;PRKCH;RIPK3;PRKCB;CLU;IKBKB;AIM2;CD40LG;BTK;S100A12;ADAM8;PRKCQ;CARD16;CARD11,GO_BP,blue,14
regulation of interleukin-2 production (GO:0032663),7/48,0.00168996054086822,0.0257196803663595,0,0,4.53429456946503,28.9426294001491,CD4;PTPRC;TBX21;CD34;FOXP3;CARD11;CCR2,GO_BP,blue,7
phosphorylation (GO:0016310),27/400,0.00173353589401611,0.0260519911055657,0,0,1.94290762856447,12.3522141650524,CERKL;RNASEL;DGKA;TXK;PIK3CD;PIK3CG;CAMKK2;IKBKB;STK10;FYN;JAK3;MAP3K5;MAP4K1;PRKCH;TGFB1;SYK;PRKCB;MATK;TYK2;PASK;RUNX3;CLK2;ZAP70;LCK;ADM2;BTK;HCST,GO_BP,blue,27
regulation of microglial cell activation (GO:1903978),4/15,0.00175026296833258,0.0260519911055657,0,0,9.63261222958609,61.1477187356173,PTPRC;STAP1;TREM2;CST7,GO_BP,blue,4
regulation of T cell chemotaxis (GO:0010819),4/15,0.00175026296833258,0.0260519911055657,0,0,9.63261222958609,61.1477187356173,CXCL10;XCL2;CXCL13;CCR2,GO_BP,blue,4
negative regulation of leukocyte mediated cytotoxicity (GO:0001911),4/15,0.00175026296833258,0.0260519911055657,0,0,9.63261222958609,61.1477187356173,CX3CR1;PTPRC;LILRB1;KLRC1,GO_BP,blue,4
regulation of defense response to virus by host (GO:0050691),6/36,0.00178197808482816,0.0262357534336929,0,0,5.30731034482759,33.5954403260454,AIM2;APOBEC3G;STAT1;PTPN22;LILRB1;IL12RB1,GO_BP,blue,6
positive regulation of myeloid leukocyte differentiation (GO:0002763),6/36,0.00178197808482816,0.0262357534336929,0,0,5.30731034482759,33.5954403260454,CD74;CD4;CASP8;IFNG;EVI2B;HLA-DRB1,GO_BP,blue,6
regulation of interferon-alpha production (GO:0032647),5/25,0.00185966408367485,0.0272315135279738,0,0,6.6284435261708,41.6754067629566,STAT1;TLR8;NLRC3;TLR7;LILRA4,GO_BP,blue,5
regulation of peptidyl-tyrosine phosphorylation (GO:0050730),10/92,0.00193781718672292,0.0282233696711419,0,0,3.24532322993133,20.2709155688556,CD74;RAP2B;TGFB1;PTPRC;ITGB2;TREM2;FYN;TNFRSF14;PTPN6;CD44,GO_BP,blue,10
regulation of monocyte chemotaxis (GO:0090025),5/26,0.0022340381179707,0.032149762469229,0,0,6.31247540338449,38.530999619775,CXCL10;CXCL12;SLAMF8;PLA2G7;CCR2,GO_BP,blue,5
regulation of mast cell degranulation (GO:0043304),4/16,0.00226674220436425,0.032149762469229,0,0,8.82943603851444,53.7660705042919,BLK;CD84;SYK;CD300A,GO_BP,blue,4
T cell mediated immunity (GO:0002456),4/16,0.00226674220436425,0.032149762469229,0,0,8.82943603851444,53.7660705042919,CD8A;CRTAM;BTN3A3;MYO1G,GO_BP,blue,4
positive regulation of alpha-beta T cell proliferation (GO:0046641),4/16,0.00226674220436425,0.032149762469229,0,0,8.82943603851444,53.7660705042919,SYK;PTPN22;RASAL3;CCR2,GO_BP,blue,4
positive regulation of endothelial cell apoptotic process (GO:2000353),4/16,0.00226674220436425,0.032149762469229,0,0,8.82943603851444,53.7660705042919,CD40LG;ITGA4;PDCD4;FASLG,GO_BP,blue,4
regulation of alpha-beta T cell proliferation (GO:0046640),3/8,0.00237264611768895,0.0322989865970823,0,0,15.8769230769231,95.9561449758703,SYK;TNFRSF14;CCR2,GO_BP,blue,3
fusion of virus membrane with host plasma membrane (GO:0019064),3/8,0.00237264611768895,0.0322989865970823,0,0,15.8769230769231,95.9561449758703,CD4;CXCR4;CCR5,GO_BP,blue,3
membrane fusion involved in viral entry into host cell (GO:0039663),3/8,0.00237264611768895,0.0322989865970823,0,0,15.8769230769231,95.9561449758703,CD4;CXCR4;CCR5,GO_BP,blue,3
natural killer cell differentiation (GO:0001779),3/8,0.00237264611768895,0.0322989865970823,0,0,15.8769230769231,95.9561449758703,PTPRC;AXL;PIK3CD,GO_BP,blue,3
negative regulation of macrophage migration (GO:1905522),3/8,0.00237264611768895,0.0322989865970823,0,0,15.8769230769231,95.9561449758703,CD200R1;SLAMF8;STAP1,GO_BP,blue,3
negative regulation of T cell mediated cytotoxicity (GO:0001915),3/8,0.00237264611768895,0.0322989865970823,0,0,15.8769230769231,95.9561449758703,PTPRC;LILRB1;KLRC1,GO_BP,blue,3
negative regulation of T-helper 17 cell differentiation (GO:2000320),3/8,0.00237264611768895,0.0322989865970823,0,0,15.8769230769231,95.9561449758703,TBX21;LOXL3;FOXP3,GO_BP,blue,3
positive regulation of glial cell migration (GO:1903977),3/8,0.00237264611768895,0.0322989865970823,0,0,15.8769230769231,95.9561449758703,P2RX4;TREM2;CCR2,GO_BP,blue,3
positive regulation of protein kinase B signaling (GO:0051897),14/161,0.00239646611644411,0.0324601335472355,0,0,2.53994819685196,15.3254380309424,CX3CR1;TGFB1;FLT3;TRAT1;PIK3CD;PIK3CG;P2RX4;LCK;AXL;CD19;RAC2;ADAM8;FYN;ICOS,GO_BP,blue,14
release of sequestered calcium ion into cytosol (GO:0051209),5/27,0.00266039897042583,0.035855824929769,0,0,6.02523165539694,35.7252806003086,PTPRC;LCK;FASLG;SLC8B1;RYR3,GO_BP,blue,5
positive regulation of MAPK cascade (GO:0043410),20/274,0.00271815628746588,0.0364528979343815,0,0,2.10582854358395,12.4408169527163,CCL24;CD74;CSF1R;EDN1;CCL22;TGFB1;FLT3;FCRL3;GPR55;PTPN22;TREM2;PIK3CG;CD4;PTPRC;XCL2;S100A12;ADAM8;CCL17;HLA-DRB1;CD44,GO_BP,blue,20
regulation of interleukin-8 production (GO:0032677),9/81,0.00276139332407345,0.036850317807463,0,0,3.32358033240997,19.5826014547265,FCN1;CD2;CD74;PTPRC;SYK;TLR8;PTPN22;TLR7;CD244,GO_BP,blue,9
negative regulation of cytokine production involved in immune response (GO:0002719),4/17,0.00287928467974669,0.0382352068501656,0,0,8.14982541529997,47.6782177770454,TGFB1;LILRB1;FOXP3;JAK3,GO_BP,blue,4
positive regulation of B cell activation (GO:0050871),7/53,0.00302339812966306,0.0399531001622304,0,0,4.04038553927456,23.4397870990218,CD74;PTPRC;SYK;FCRL3;BTK;CD27;TNFSF13B,GO_BP,blue,7
regulation of nitric oxide biosynthetic process (GO:0045428),6/40,0.00310364398450285,0.0407350232895003,0,0,4.68194726166329,27.0390805969584,CX3CR1;EDN1;P2RX4;IFNG;CLU;CD34,GO_BP,blue,6
regulation of calcium-mediated signaling (GO:0050848),5/28,0.00314271682078463,0.0407350232895003,0,0,5.7629656246257,33.2100554209967,P2RX4;TRAT1;TREM2;SLA2;CD22,GO_BP,blue,5
T cell activation involved in immune response (GO:0002286),5/28,0.00314271682078463,0.0407350232895003,0,0,5.7629656246257,33.2100554209967,CD74;LILRB1;LCP1;CD1C;ITGAL,GO_BP,blue,5
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),5/28,0.00314271682078463,0.0407350232895003,0,0,5.7629656246257,33.2100554209967,GPR174;P2RY10;GPR65;GPR55;GPR18,GO_BP,blue,5
calcium ion transport (GO:0006816),11/115,0.0032703368017986,0.0421873447432019,0,0,2.81537126068376,16.1119820535773,CATSPER1;P2RX7;CACNA1I;TRPC6;P2RX4;TRPA1;FYN;KCNN4;CCR5;MS4A1;RYR3,GO_BP,blue,11
negative regulation of viral genome replication (GO:0045071),7/54,0.00336640710969911,0.0426384677217333,0,0,3.95421417656048,22.51493664834,APOBEC3D;FAM111A;RNASEL;APOBEC3G;APOBEC3H;ZC3HAV1;SHFL,GO_BP,blue,7
cellular response to interleukin-9 (GO:0071355),3/9,0.00346270317415331,0.0426384677217333,0,0,13.2300824175824,74.9577537713847,STAT1;IL2RG;JAK3,GO_BP,blue,3
DNA cytosine deamination (GO:0070383),3/9,0.00346270317415331,0.0426384677217333,0,0,13.2300824175824,74.9577537713847,APOBEC3D;APOBEC3G;APOBEC3H,GO_BP,blue,3
interleukin-9-mediated signaling pathway (GO:0038113),3/9,0.00346270317415331,0.0426384677217333,0,0,13.2300824175824,74.9577537713847,STAT1;IL2RG;JAK3,GO_BP,blue,3
negative regulation of alpha-beta T cell activation (GO:0046636),3/9,0.00346270317415331,0.0426384677217333,0,0,13.2300824175824,74.9577537713847,CD300A;LILRB1;TNFRSF14,GO_BP,blue,3
negative regulation of leukocyte degranulation (GO:0043301),3/9,0.00346270317415331,0.0426384677217333,0,0,13.2300824175824,74.9577537713847,CD84;CD300A;CCR2,GO_BP,blue,3
negative regulation of production of molecular mediator of immune response (GO:0002701),3/9,0.00346270317415331,0.0426384677217333,0,0,13.2300824175824,74.9577537713847,FCRL3;LILRB1;CD22,GO_BP,blue,3
positive regulation of B cell differentiation (GO:0045579),3/9,0.00346270317415331,0.0426384677217333,0,0,13.2300824175824,74.9577537713847,SYK;BTK;CD27,GO_BP,blue,3
positive regulation of memory T cell differentiation (GO:0043382),3/9,0.00346270317415331,0.0426384677217333,0,0,13.2300824175824,74.9577537713847,HLA-DRA;IL12RB1;HLA-DRB1,GO_BP,blue,3
positive regulation of smooth muscle cell apoptotic process (GO:0034393),3/9,0.00346270317415331,0.0426384677217333,0,0,13.2300824175824,74.9577537713847,IFNG;CDKN2A;PDCD4,GO_BP,blue,3
regulation of cell adhesion (GO:0030155),12/133,0.00352963436769571,0.0432659705976818,0,0,2.6411338061357,14.9133231242675,RIPOR2;ADAMDEC1;CXCL12;TNFRSF18;CXCR3;ARHGDIB;RAC2;LPXN;CXCR4;ADAM8;PIK3CG;PLXNA3,GO_BP,blue,12
positive regulation of cell adhesion mediated by integrin (GO:0033630),4/18,0.00359602680323616,0.0438812459908412,0,0,7.56730202397328,42.588213606787,SYK;CD3E;CXCL13;SKAP1,GO_BP,blue,4
positive regulation of protein-containing complex assembly (GO:0031334),11/118,0.00398772383439202,0.0480183499652604,0,0,2.73600726895119,15.1151670377569,GBP5;TCL1A;TGFB1;SYK;IFNG;BMF;CAPG;LCP1;CXCL13;CLU;SKAP1,GO_BP,blue,11
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),6/42,0.00398823504694854,0.0480183499652604,0,0,4.42137931034483,24.425496557115,ALCAM;VCAM1;CD6;JAML;CRTAM;ITGAL,GO_BP,blue,6
monocyte chemotaxis (GO:0002548),6/42,0.00398823504694854,0.0480183499652604,0,0,4.42137931034483,24.425496557115,CCL24;CCL22;PTPRO;XCL2;S100A12;CCL17,GO_BP,blue,6
myeloid leukocyte differentiation (GO:0002573),8/71,0.00428340756281552,0.0512097723540013,0,0,3.37324639399328,18.3943342650147,CSF1R;CD4;CASP8;IFNG;UBD;PIK3CD;TREM2;HLA-DRB1,GO_BP,blue,8
plasma membrane invagination (GO:0099024),5/30,0.00429111049256489,0.0512097723540013,0,0,5.30137741046832,28.8989200876969,MSR1;SH3BP1;BIN2;ITGB2;ARHGAP25,GO_BP,blue,5
positive regulation of ERK1 and ERK2 cascade (GO:0070374),14/172,0.00436089803459536,0.0518143542794686,0,0,2.36175696908709,12.8363316237114,CSF1R;CCL24;CD74;TGFB1;CCL22;GPR55;PTPN22;TREM2;CD4;PTPRC;XCL2;CCL17;HLA-DRB1;CD44,GO_BP,blue,14
positive regulation of monocyte chemotaxis (GO:0090026),4/19,0.00442482565457611,0.0523443349268414,0,0,7.06244841815681,38.2821739842072,CXCL10;CXCL12;PLA2G7;CCR2,GO_BP,blue,4
regulation of inflammatory response to antigenic stimulus (GO:0002861),12/137,0.00448570393360722,0.0527088947025138,0,0,2.55608344923505,13.8203849568226,CYSLTR1;PLA2G2D;HTR7;SYK;ADM2;CD3G;TREM2;FYN;CD247;INSL3;HLA-DRB1;PTGDR,GO_BP,blue,12
regulation of cytokine production involved in inflammatory response (GO:1900015),6/43,0.00449455691261745,0.0527088947025138,0,0,4.30165890027959,23.2499853845442,GBP5;CD6;PDCD4;PLD4;NLRC3;TREM2,GO_BP,blue,6
B cell homeostasis (GO:0001782),3/10,0.00481316945545304,0.0534380166181241,0,0,11.3394819466248,60.512005579497,DOCK10;TNFRSF13B;GAPT,GO_BP,blue,3
regulation of cell activation (GO:0050865),3/10,0.00481316945545304,0.0534380166181241,0,0,11.3394819466248,60.512005579497,SYK;TXK;TREM2,GO_BP,blue,3
regulation of cell-cell adhesion mediated by integrin (GO:0033632),3/10,0.00481316945545304,0.0534380166181241,0,0,11.3394819466248,60.512005579497,CD3E;CXCL13;SKAP1,GO_BP,blue,3
regulation of mast cell activation (GO:0033003),3/10,0.00481316945545304,0.0534380166181241,0,0,11.3394819466248,60.512005579497,CD84;CD226;CD300LF,GO_BP,blue,3
regulation of memory T cell differentiation (GO:0043380),3/10,0.00481316945545304,0.0534380166181241,0,0,11.3394819466248,60.512005579497,HLA-DRA;IL12RB1;HLA-DRB1,GO_BP,blue,3
regulation of neutrophil migration (GO:1902622),3/10,0.00481316945545304,0.0534380166181241,0,0,11.3394819466248,60.512005579497,RAC2;SLAMF8;RHOH,GO_BP,blue,3
"regulation of phagocytosis, engulfment (GO:0060099)",3/10,0.00481316945545304,0.0534380166181241,0,0,11.3394819466248,60.512005579497,CD300A;STAP1;TREM2,GO_BP,blue,3
regulation of tau-protein kinase activity (GO:1902947),3/10,0.00481316945545304,0.0534380166181241,0,0,11.3394819466248,60.512005579497,IFNG;NAB2;CLU,GO_BP,blue,3
indolalkylamine catabolic process (GO:0046218),3/10,0.00481316945545304,0.0534380166181241,0,0,11.3394819466248,60.512005579497,IL4I1;HAAO;IDO2,GO_BP,blue,3
negative regulation of leukocyte migration (GO:0002686),3/10,0.00481316945545304,0.0534380166181241,0,0,11.3394819466248,60.512005579497,CD200R1;CD300A;SLAMF8,GO_BP,blue,3
positive regulation by symbiont of entry into host (GO:0075294),3/10,0.00481316945545304,0.0534380166181241,0,0,11.3394819466248,60.512005579497,CD74;CD4;HLA-DRB1,GO_BP,blue,3
positive regulation of monocyte differentiation (GO:0045657),3/10,0.00481316945545304,0.0534380166181241,0,0,11.3394819466248,60.512005579497,CD74;CD4;HLA-DRB1,GO_BP,blue,3
positive regulation of viral entry into host cell (GO:0046598),3/10,0.00481316945545304,0.0534380166181241,0,0,11.3394819466248,60.512005579497,CD74;CD4;HLA-DRB1,GO_BP,blue,3
receptor signaling pathway via JAK-STAT (GO:0007259),5/31,0.00496508149615115,0.054455084101512,0,0,5.09721339266794,27.0423765350766,IFNG;STAT1;STAT2;JAK3;CCR2,GO_BP,blue,5
positive regulation of mononuclear cell migration (GO:0071677),5/31,0.00496508149615115,0.054455084101512,0,0,5.09721339266794,27.0423765350766,CXCL10;CXCL12;CCR6;PLA2G7;CCR2,GO_BP,blue,5
positive regulation of Rho protein signal transduction (GO:0035025),5/31,0.00496508149615115,0.054455084101512,0,0,5.09721339266794,27.0423765350766,GPR174;P2RY10;GPR65;GPR55;GPR18,GO_BP,blue,5
regulation of calcium ion transport (GO:0051924),7/58,0.00504237021593837,0.0550797617539397,0,0,3.64332141696458,19.2727295504215,CD84;CD4;TRPC6;P2RX4;FCRL3;LILRB1;SLC8B1,GO_BP,blue,7
negative regulation of cell adhesion (GO:0007162),8/73,0.00507922350027097,0.0552595038643939,0,0,3.26911373550378,17.2694100304972,RIPOR2;ADAMDEC1;TGFB1;PTPRC;PTPRO;ARHGDIB;LPXN;PLXNA3,GO_BP,blue,8
positive regulation of alpha-beta T cell activation (GO:0046635),4/20,0.00537321542445262,0.0582241623393686,0,0,6.6207015130674,34.6019628228199,SYK;HLA-DRA;HLA-DRB1;CCR2,GO_BP,blue,4
positive regulation of GTPase activity (GO:0043547),16/214,0.00550354565982679,0.0593988254680111,0,0,2.15537190082645,11.2130264440541,CCL24;CCL22;GPR65;DOCK8;ARAP1;CXCL13;ARHGAP25;ARHGAP45;DOCK10;SYDE1;SIPA1L1;SH3BP1;TBC1D10C;XCL2;RGS10;CCL17,GO_BP,blue,16
B cell proliferation (GO:0042100),5/32,0.00571076726840495,0.0613907481353532,0,0,4.90817263544536,25.3526842153847,CD40LG;PTPRC;CD19;MS4A1;GAPT,GO_BP,blue,5
negative regulation of tumor necrosis factor production (GO:0032720),6/46,0.00629775705773812,0.0663321548434394,0,0,3.97841379310345,20.1608574902295,NLRC3;PTPN22;LILRB1;PTPN6;CD34;LILRA4,GO_BP,blue,6
cytidine to uridine editing (GO:0016554),3/11,0.0064397773066905,0.0663321548434394,0,0,9.92153159340659,50.0567195751395,APOBEC3D;APOBEC3G;APOBEC3H,GO_BP,blue,3
regulation of T cell apoptotic process (GO:0070232),3/11,0.0064397773066905,0.0663321548434394,0,0,9.92153159340659,50.0567195751395,RIPK3;PRKCQ;JAK3,GO_BP,blue,3
regulation of toll-like receptor 9 signaling pathway (GO:0034163),3/11,0.0064397773066905,0.0663321548434394,0,0,9.92153159340659,50.0567195751395,FCRL3;PTPN22;LILRA4,GO_BP,blue,3
T cell homeostasis (GO:0043029),3/11,0.0064397773066905,0.0663321548434394,0,0,9.92153159340659,50.0567195751395,RIPK3;FOXP3;JAK3,GO_BP,blue,3
tryptophan catabolic process (GO:0006569),3/11,0.0064397773066905,0.0663321548434394,0,0,9.92153159340659,50.0567195751395,IL4I1;HAAO;IDO2,GO_BP,blue,3
tryptophan metabolic process (GO:0006568),3/11,0.0064397773066905,0.0663321548434394,0,0,9.92153159340659,50.0567195751395,IL4I1;HAAO;IDO2,GO_BP,blue,3
negative regulation of lymphocyte migration (GO:2000402),3/11,0.0064397773066905,0.0663321548434394,0,0,9.92153159340659,50.0567195751395,RIPOR2;CD200R1;GCSAM,GO_BP,blue,3
negative regulation of T-helper cell differentiation (GO:0045623),3/11,0.0064397773066905,0.0663321548434394,0,0,9.92153159340659,50.0567195751395,TBX21;FOXP3;JAK3,GO_BP,blue,3
positive regulation of cellular extravasation (GO:0002693),3/11,0.0064397773066905,0.0663321548434394,0,0,9.92153159340659,50.0567195751395,RIPOR2;ADAM8;CCR2,GO_BP,blue,3
positive regulation of leukocyte apoptotic process (GO:2000108),3/11,0.0064397773066905,0.0663321548434394,0,0,9.92153159340659,50.0567195751395,BLK;CDKN2A;PIK3CD,GO_BP,blue,3
B cell differentiation (GO:0030183),7/61,0.00666170544075626,0.0681002265622971,0,0,3.44037753222836,17.2410383146524,VCAM1;PTPRC;ITGA4;FLT3;BLNK;JAK3;MS4A1,GO_BP,blue,7
positive regulation of interleukin-8 production (GO:0032757),7/61,0.00666170544075626,0.0681002265622971,0,0,3.44037753222836,17.2410383146524,FCN1;CD2;CD74;SYK;TLR8;TLR7;CD244,GO_BP,blue,7
regulation of ERK1 and ERK2 cascade (GO:0070372),17/238,0.00673546216137748,0.0685953646435022,0,0,2.05214393449688,10.2614766070698,CCL24;CD74;CSF1R;CCL22;TGFB1;SYK;RGS14;GPR55;PTPN22;TREM2;CD4;PTPRC;XCL2;PTPN6;CCL17;HLA-DRB1;CD44,GO_BP,blue,17
positive regulation of cell-cell adhesion (GO:0022409),6/47,0.00700137800038889,0.071036453194957,0,0,3.88117746005046,19.2570375160051,LCK;SIRPG;CD3E;CXCL13;CD44;SKAP1,GO_BP,blue,6
regulation of kinase activity (GO:0043549),9/94,0.00742068919830573,0.0748501517821062,0,0,2.81336157731791,13.7952716300978,CSF1R;CD74;CD4;FLT3;AXL;SLAMF8;TREM2;HLA-DRB1;CAMKK2,GO_BP,blue,9
regulation of activated T cell proliferation (GO:0046006),5/34,0.00743251784030512,0.0748501517821062,0,0,4.56920300180488,22.3977332567633,TMIGD2;RIPK3;CRTAM;IL12RB1;FOXP3,GO_BP,blue,5
cell projection assembly (GO:0030031),4/22,0.00765707580458755,0.075704446549736,0,0,5.88445667125172,28.6698091470952,PARVG;RAC2;RHOH;CAPG,GO_BP,blue,4
regulation of platelet activation (GO:0010543),4/22,0.00765707580458755,0.075704446549736,0,0,5.88445667125172,28.6698091470952,BLK;SYK;TXK;PRKCQ,GO_BP,blue,4
negative regulation of B cell activation (GO:0050869),4/22,0.00765707580458755,0.075704446549736,0,0,5.88445667125172,28.6698091470952,BLK;TNFRSF13B;CD300A;CTLA4,GO_BP,blue,4
negative regulation of interleukin-2 production (GO:0032703),4/22,0.00765707580458755,0.075704446549736,0,0,5.88445667125172,28.6698091470952,PTPRC;TBX21;FOXP3;CD34,GO_BP,blue,4
positive regulation of neutrophil migration (GO:1902624),4/22,0.00765707580458755,0.075704446549736,0,0,5.88445667125172,28.6698091470952,CD74;RIPOR2;RAC2;ADAM8,GO_BP,blue,4
negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),6/48,0.00776015369395195,0.076444568570603,0,0,3.78857142857143,18.4077333211301,NLRC3;PTPN22;LILRB1;PTPN6;CD34;LILRA4,GO_BP,blue,6
protein mono-ADP-ribosylation (GO:0140289),3/12,0.00835544968364587,0.0811287211218519,0,0,8.81868131868132,42.1959905523866,PARP15;PARP12;PARP8,GO_BP,blue,3
"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",3/12,0.00835544968364587,0.0811287211218519,0,0,8.81868131868132,42.1959905523866,HLA-DRA;RUNX3;HLA-DRB1,GO_BP,blue,3
regulation of natural killer cell activation (GO:0032814),3/12,0.00835544968364587,0.0811287211218519,0,0,8.81868131868132,42.1959905523866,ZNF683;PTPN22;PRDM1,GO_BP,blue,3
negative regulation of leukocyte apoptotic process (GO:2000107),3/12,0.00835544968364587,0.0811287211218519,0,0,8.81868131868132,42.1959905523866,CXCL12;AXL;LILRB1,GO_BP,blue,3
regulation of inflammatory response (GO:0050727),15/206,0.00890437148319655,0.0861497940999266,0,0,2.09255901020796,9.87941668705547,ZBP1;AKNA;NLRC3;AOAH;PLA2G7;CD200R1;CASP5;IFNG;CASP1;PDCD4;S100A12;TLR7;NLRP1;PTGES;CCR2,GO_BP,blue,15
positive regulation of kinase activity (GO:0033674),10/114,0.008975829620152,0.0862065076445977,0,0,2.55587858743199,12.0464178511793,CSF1R;CD74;CD4;PTPRC;FLT3;AXL;TREM2;LCP2;HLA-DRB1;LAT,GO_BP,blue,10
positive regulation of epithelial cell apoptotic process (GO:1904037),4/23,0.00900570013415324,0.0862065076445977,0,0,5.5744588431188,26.2551300694491,CD40LG;ITGA4;PDCD4;FASLG,GO_BP,blue,4
positive regulation of interleukin-17 production (GO:0032740),4/23,0.00900570013415324,0.0862065076445977,0,0,5.5744588431188,26.2551300694491,TGFB1;PRKCQ;SLAMF6;LY9,GO_BP,blue,4
macrophage activation (GO:0042116),5/36,0.00948600620431057,0.0901669852893941,0,0,4.27397138540834,19.9078920066377,SYK;IFNG;ITGB2;TREM2;CLU,GO_BP,blue,5
positive regulation of innate immune response (GO:0045089),5/36,0.00948600620431057,0.0901669852893941,0,0,4.27397138540834,19.9078920066377,ZBP1;GBP5;SH2D1B;TLR8;ADAM8,GO_BP,blue,5
regulation of GTPase activity (GO:0043087),14/189,0.00978317636172755,0.0926665201535662,0,0,2.13043235704324,9.85770452663701,ARHGAP9;CCL24;CCL22;DOCK8;ARAP1;DOCK10;KLRK1;SIPA1L1;SH3BP1;CHN2;XCL2;RGS10;CCL17;PLXNA3,GO_BP,blue,14
sensory perception (GO:0007600),6/51,0.0103902398178135,0.0964160608870903,0,0,3.53544827586207,16.1459976934544,P2RX7;P2RX4;TRPA1;PNOC;CCR2;PTGES,GO_BP,blue,6
regulation of cytokine production involved in immune response (GO:0002718),4/24,0.0105001781525566,0.0964160608870903,0,0,5.29546079779918,24.1280419385707,BTK;LILRB1;TNFRSF14;CCR2,GO_BP,blue,4
lymphocyte activation involved in immune response (GO:0002285),4/24,0.0105001781525566,0.0964160608870903,0,0,5.29546079779918,24.1280419385707,CD74;LCP1;CD1C;CD244,GO_BP,blue,4
positive regulation of viral life cycle (GO:1903902),4/24,0.0105001781525566,0.0964160608870903,0,0,5.29546079779918,24.1280419385707,CD74;CD4;AXL;HLA-DRB1,GO_BP,blue,4
regulation of homotypic cell-cell adhesion (GO:0034110),3/13,0.0105705315922724,0.0964160608870903,0,0,7.9364010989011,36.1081265242118,BLK;SYK;PRKCQ,GO_BP,blue,3
DNA deamination (GO:0045006),3/13,0.0105705315922724,0.0964160608870903,0,0,7.9364010989011,36.1081265242118,APOBEC3D;APOBEC3G;APOBEC3H,GO_BP,blue,3
entry into host (GO:0044409),3/13,0.0105705315922724,0.0964160608870903,0,0,7.9364010989011,36.1081265242118,CD4;CXCR4;CCR5,GO_BP,blue,3
regulation of receptor signaling pathway via STAT (GO:1904892),3/13,0.0105705315922724,0.0964160608870903,0,0,7.9364010989011,36.1081265242118,PTPRC;IL7R;JAK3,GO_BP,blue,3
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),3/13,0.0105705315922724,0.0964160608870903,0,0,7.9364010989011,36.1081265242118,PRKCQ;IL12RB1;CCR2,GO_BP,blue,3
positive regulation of calcium-mediated signaling (GO:0050850),3/13,0.0105705315922724,0.0964160608870903,0,0,7.9364010989011,36.1081265242118,P2RX4;TRAT1;TREM2,GO_BP,blue,3
"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",3/13,0.0105705315922724,0.0964160608870903,0,0,7.9364010989011,36.1081265242118,HLA-DRA;PRKCQ;HLA-DRB1,GO_BP,blue,3
apoptotic process (GO:0006915),16/231,0.0110936629467364,0.10084809705607,0,0,1.98317775248008,8.92703912939339,GZMA;ITGB2;PRF1;CXCR4;GZMB;FASLG;HK2;GZMH;CD2;CASP8;CASP5;IFNG;CASP1;PDCD4;BMF;NLRP1,GO_BP,blue,16
negative regulation of inflammatory response to antigenic stimulus (GO:0002862),11/136,0.0113046003695463,0.102421947829769,0,0,2.33982222222222,10.4883596286219,CYSLTR1;HTR7;SYK;ADM2;CD3G;TREM2;FYN;CD247;INSL3;HLA-DRB1;PTGDR,GO_BP,blue,11
negative regulation of inflammatory response (GO:0050728),15/212,0.0114020964683058,0.102960931108801,0,0,2.02818818591725,9.07402884053231,SYK;CD3G;TREM2;NLRC3;AOAH;CD200R1;CYSLTR1;HTR7;ADM2;SLAMF8;FYN;CD247;INSL3;HLA-DRB1;PTGDR,GO_BP,blue,15
positive regulation of protein localization to membrane (GO:1905477),9/101,0.0116529503297036,0.104278886435473,0,0,2.59835300493797,11.5683765533669,PRKCH;CASP8;IFNG;ITGB2;GZMB;TREM2;FYN;AKAP5;SLC5A3,GO_BP,blue,9
lymphocyte proliferation (GO:0046651),5/38,0.0118992761542225,0.104278886435473,0,0,4.0145254194841,17.7894769999245,CD40LG;PTPRC;FLT3;MS4A1;PIK3CG,GO_BP,blue,5
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),10/119,0.0119472794858661,0.104278886435473,0,0,2.43800022903969,10.7936406210935,CASP8;CASP5;SYK;TNFSF15;LCK;CASP1;FASLG;NLRP1;ST18;MAP3K5,GO_BP,blue,10
receptor signaling pathway via STAT (GO:0097696),4/25,0.0121459943684023,0.104278886435473,0,0,5.04303399489094,22.2435916703335,IFNG;STAT1;STAT2;CCR2,GO_BP,blue,4
positive regulation of MAP kinase activity (GO:0043406),7/69,0.012843049127984,0.107714613274639,0,0,2.99521030119408,13.0439987026854,EDN1;TGFB1;FLT3;S100A12;ADAM8;PIK3CG;MAP3K5,GO_BP,blue,7
regulation of macrophage cytokine production (GO:0010935),3/14,0.0130930067006232,0.107808374322153,0,0,7.21453546453547,31.2798957026705,CD74;TGFB1;LILRB1,GO_BP,blue,3
response to chemokine (GO:1990868),3/14,0.0130930067006232,0.107808374322153,0,0,7.21453546453547,31.2798957026705,RIPOR2;CXCL12;DOCK8,GO_BP,blue,3
immune response-regulating cell surface receptor signaling pathway (GO:0002768),3/14,0.0130930067006232,0.107808374322153,0,0,7.21453546453547,31.2798957026705,NCR3;BTLA;LILRB1,GO_BP,blue,3
T cell differentiation in thymus (GO:0033077),3/14,0.0130930067006232,0.107808374322153,0,0,7.21453546453547,31.2798957026705,PTPRC;RIPK3;CCR6,GO_BP,blue,3
positive regulation of superoxide anion generation (GO:0032930),3/14,0.0130930067006232,0.107808374322153,0,0,7.21453546453547,31.2798957026705,TGFB1;SYK;ITGB2,GO_BP,blue,3
positive regulation of T cell chemotaxis (GO:0010820),3/14,0.0130930067006232,0.107808374322153,0,0,7.21453546453547,31.2798957026705,XCL2;CXCL13;CCR2,GO_BP,blue,3
regulation of viral entry into host cell (GO:0046596),5/39,0.0132490666297755,0.10876279242443,0,0,3.89624858207746,16.8467093845624,FCN1;CD74;CIITA;CD4;HLA-DRB1,GO_BP,blue,5
positive regulation of leukocyte chemotaxis (GO:0002690),6/54,0.0135974627254069,0.11128557861972,0,0,3.31396551724138,14.2429998307136,CSF1R;CXCL10;CXCL12;CCR6;PLA2G7;CCR2,GO_BP,blue,6
negative regulation of viral process (GO:0048525),7/70,0.013834125206614,0.112881461399751,0,0,2.9475138121547,12.6171774319883,FAM111A;RNASEL;APOBEC3G;APOBEC3H;STAT1;ZC3HAV1;SHFL,GO_BP,blue,7
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),4/26,0.0139481723712956,0.113130535789939,0,0,4.81355508315618,20.5654654314627,CD74;CXCL12;CLU;CD44,GO_BP,blue,4
positive regulation of interleukin-2 production (GO:0032743),4/26,0.0139481723712956,0.113130535789939,0,0,4.81355508315618,20.5654654314627,CD4;PTPRC;CARD11;CCR2,GO_BP,blue,4
cellular response to lipid (GO:0071396),15/219,0.0149761433828314,0.121105589325643,0,0,1.95787463029905,8.2256123899407,MAP4K1;CX3CR1;CXCL9;GFI1;LILRB1;CXCL13;NUGGC;CXCL10;CXCL11;AXL;CASP1;PDCD4;STAP1;CARD16;CCR5,GO_BP,blue,15
positive regulation of protein serine/threonine kinase activity (GO:0071902),9/106,0.0156300829208979,0.125074922040467,0,0,2.46377473798441,10.2457497263334,CSF1R;TCL1A;EDN1;TGFB1;IFNG;FLT3;S100A12;ADAM8;PIK3CG,GO_BP,blue,9
positive regulation of calcium ion transmembrane transport (GO:1904427),4/27,0.0159112676468298,0.125074922040467,0,0,4.60403085939836,19.0640384044491,CXCL10;CXCL9;CXCL11;CD19,GO_BP,blue,4
positive regulation of nitric oxide biosynthetic process (GO:0045429),4/27,0.0159112676468298,0.125074922040467,0,0,4.60403085939836,19.0640384044491,EDN1;P2RX4;IFNG;CLU,GO_BP,blue,4
cellular response to ATP (GO:0071318),3/15,0.0159286999276342,0.125074922040467,0,0,6.61298076923077,27.37531189945,P2RX7;P2RX4;RYR3,GO_BP,blue,3
regulation of superoxide anion generation (GO:0032928),3/15,0.0159286999276342,0.125074922040467,0,0,6.61298076923077,27.37531189945,TGFB1;SYK;ITGB2,GO_BP,blue,3
negative regulation of leukocyte activation (GO:0002695),3/15,0.0159286999276342,0.125074922040467,0,0,6.61298076923077,27.37531189945,CD84;CD300A;CD300LF,GO_BP,blue,3
negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),3/15,0.0159286999276342,0.125074922040467,0,0,6.61298076923077,27.37531189945,APOBEC3D;APOBEC3G;APOBEC3H,GO_BP,blue,3
positive regulation of cell killing (GO:0031343),3/15,0.0159286999276342,0.125074922040467,0,0,6.61298076923077,27.37531189945,SYK;IFNG;PRF1,GO_BP,blue,3
positive regulation of heterotypic cell-cell adhesion (GO:0034116),3/15,0.0159286999276342,0.125074922040467,0,0,6.61298076923077,27.37531189945,LCK;CD44;SKAP1,GO_BP,blue,3
prostanoid biosynthetic process (GO:0046457),3/15,0.0159286999276342,0.125074922040467,0,0,6.61298076923077,27.37531189945,CD74;EDN1;PTGES,GO_BP,blue,3
positive regulation of inflammatory response (GO:0050729),8/89,0.016107286319429,0.126111672368015,0,0,2.6211771937913,10.8214869077098,ZBP1;IFNG;PDCD4;S100A12;ADAM8;TLR7;PLA2G7;CCR2,GO_BP,blue,8
regulation of Rho protein signal transduction (GO:0035023),7/73,0.0171342881212356,0.13320892019766,0,0,2.81309643395279,11.4399451986244,GPR174;RIPOR2;P2RY10;GPR65;ARHGDIB;GPR55;GPR18,GO_BP,blue,7
regulation of chemokine production (GO:0032642),5/42,0.0179072589098399,0.13320892019766,0,0,3.57977812523267,14.3998333569341,CSF1R;CD74;IFNG;TREM2;TLR7,GO_BP,blue,5
receptor clustering (GO:0043113),4/28,0.0180393637912908,0.13320892019766,0,0,4.41196698762036,17.7149255758254,ITGA4;ITGB2;ITGB7;ITGAL,GO_BP,blue,4
response to interferon-beta (GO:0035456),4/28,0.0180393637912908,0.13320892019766,0,0,4.41196698762036,17.7149255758254,AIM2;STAT1;PYHIN1;SHFL,GO_BP,blue,4
positive regulation of nitric oxide metabolic process (GO:1904407),4/28,0.0180393637912908,0.13320892019766,0,0,4.41196698762036,17.7149255758254,EDN1;P2RX4;IFNG;CLU,GO_BP,blue,4
positive regulation of programmed cell death (GO:0043068),18/286,0.0182455281533786,0.133586853425683,0,0,1.78988298339997,7.16639660320104,ZBP1;RARG;TNFAIP8;SYK;GZMA;PRF1;LILRB1;FASLG;CLU;CASP8;IFNG;UBD;CTLA4;ARHGEF1;BMF;PLEKHN1;ATG7;MAP3K5,GO_BP,blue,18
aromatic amino acid family catabolic process (GO:0009074),3/16,0.0190814668313055,0.136750512291023,0,0,6.1039729501268,24.1658592610752,IL4I1;HAAO;IDO2,GO_BP,blue,3
regulation of amyloid-beta clearance (GO:1900221),3/16,0.0190814668313055,0.136750512291023,0,0,6.1039729501268,24.1658592610752,IFNG;TREM2;CLU,GO_BP,blue,3
B cell activation involved in immune response (GO:0002312),3/16,0.0190814668313055,0.136750512291023,0,0,6.1039729501268,24.1658592610752,CD40LG;CD19;GAPT,GO_BP,blue,3
regulation of monocyte differentiation (GO:0045655),3/16,0.0190814668313055,0.136750512291023,0,0,6.1039729501268,24.1658592610752,CD74;CD4;HLA-DRB1,GO_BP,blue,3
epiboly involved in wound healing (GO:0090505),3/16,0.0190814668313055,0.136750512291023,0,0,6.1039729501268,24.1658592610752,CARMIL2;LCP1;CD44,GO_BP,blue,3
response to organophosphorus (GO:0046683),3/16,0.0190814668313055,0.136750512291023,0,0,6.1039729501268,24.1658592610752,P2RX7;P2RX4;STAT1,GO_BP,blue,3
negative regulation of immune effector process (GO:0002698),3/16,0.0190814668313055,0.136750512291023,0,0,6.1039729501268,24.1658592610752,CD300A;SLAMF8;LILRB1,GO_BP,blue,3
negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),3/16,0.0190814668313055,0.136750512291023,0,0,6.1039729501268,24.1658592610752,HLA-B;LILRB1;KLRC1,GO_BP,blue,3
response to tumor necrosis factor (GO:0034612),9/110,0.0194666196584682,0.139142671912375,0,0,2.36570582265983,9.31864320269191,IKBKB;CCL24;TCL1A;CASP8;CCL22;UBD;XCL2;CCL17;CXCL16,GO_BP,blue,9
integrin-mediated signaling pathway (GO:0007229),7/75,0.0196208425847651,0.139873215246422,0,0,2.73007393565161,10.7323653170454,FYB1;CD40LG;SYK;TXK;ITGB2;ITGB7;LAT,GO_BP,blue,7
lipid modification (GO:0030258),5/43,0.0196720911808367,0.139873215246422,0,0,3.48539219950703,13.6925526485676,PLPP5;DGKA;PLPPR4;MBOAT1;PLA2G7,GO_BP,blue,5
regulation of protein kinase B signaling (GO:0051896),14/207,0.0202169916272608,0.142640229175297,0,0,1.92991812459803,7.52905807196594,CX3CR1;TGFB1;FLT3;TRAT1;PIK3CD;PIK3CG;P2RX4;AXL;LCK;CD19;RAC2;ADAM8;FYN;ICOS,GO_BP,blue,14
regulation of actin polymerization or depolymerization (GO:0008064),4/29,0.0203360717681732,0.142640229175297,0,0,4.23526822558459,16.4978903499659,FCHSD1;CXCL12;SH3BP1;CTTN,GO_BP,blue,4
regulation of response to biotic stimulus (GO:0002831),4/29,0.0203360717681732,0.142640229175297,0,0,4.23526822558459,16.4978903499659,CASP8;DHX58;PTPN22;TREM2,GO_BP,blue,4
negative regulation of interferon-gamma production (GO:0032689),4/29,0.0203360717681732,0.142640229175297,0,0,4.23526822558459,16.4978903499659,AXL;LILRB1;FOXP3;HLA-DRB1,GO_BP,blue,4
protein ADP-ribosylation (GO:0006471),4/29,0.0203360717681732,0.142640229175297,0,0,4.23526822558459,16.4978903499659,ZC3HAV1;PARP15;PARP12;PARP8,GO_BP,blue,4
negative regulation of autophagy (GO:0010507),6/59,0.0203771755964709,0.142640229175297,0,0,3.00054651919323,11.6821473283965,DAPL1;IL10RA;PTPN22;TREM2;BMF;ATG7,GO_BP,blue,6
neutrophil activation involved in immune response (GO:0002283),27/485,0.0204920218252955,0.143074451352385,0,0,1.57520655518063,6.12396147398453,ARHGAP9;FCN1;ITGB2;ITGAL;STK10;ADGRE5;CLEC5A;ITGAX;TBC1D10C;S100A12;ATG7;SYK;CD300A;ATP6AP2;HLA-B;IRAG2;LYZ;ARHGAP45;CHIT1;PFKL;PTPRC;RAP2B;BIN2;ADAM8;PTPN6;DOCK2;CD44,GO_BP,blue,27
positive regulation of cell migration (GO:0030335),17/269,0.0206186138175269,0.143588238641852,0,0,1.79676870748299,6.97426739093157,LRRC15;CCL24;CSF1R;CARMIL2;EDN1;TGFB1;TNFRSF18;PIK3CD;CXCL16;SHTN1;SYDE1;CXCL12;PTPRC;IFNG;ITGAX;INSL3;CCR2,GO_BP,blue,17
positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),7/77,0.022348996337535,0.155068732813341,0,0,2.6517955801105,10.079405696725,FLT3;PIK3CD;TREM2;PTPN6;WNT16;HCST;PIK3CG,GO_BP,blue,7
regulation of leukocyte migration (GO:0002685),3/17,0.022553370516226,0.155068732813341,0,0,5.66768053375196,21.4911120682101,TNFRSF18;RAC2;RHOH,GO_BP,blue,3
regulation of NLRP3 inflammasome complex assembly (GO:1900225),3/17,0.022553370516226,0.155068732813341,0,0,5.66768053375196,21.4911120682101,GBP5;NLRC3;TREM2,GO_BP,blue,3
response to purine-containing compound (GO:0014074),3/17,0.022553370516226,0.155068732813341,0,0,5.66768053375196,21.4911120682101,P2RX7;P2RX4;STAT1,GO_BP,blue,3
negative regulation of interleukin-10 production (GO:0032693),3/17,0.022553370516226,0.155068732813341,0,0,5.66768053375196,21.4911120682101,LILRB1;FOXP3;JAK3,GO_BP,blue,3
cell projection organization (GO:0030030),4/30,0.0228045318345672,0.15561077264444,0,0,4.07216167601312,15.3960125682818,PARVG;RAC2;RHOH;CAPG,GO_BP,blue,4
regulation of type I interferon-mediated signaling pathway (GO:0060338),4/30,0.0228045318345672,0.15561077264444,0,0,4.07216167601312,15.3960125682818,ZBP1;RNASEL;STAT2;PTPN6,GO_BP,blue,4
positive regulation of B cell proliferation (GO:0030890),4/30,0.0228045318345672,0.15561077264444,0,0,4.07216167601312,15.3960125682818,CD74;PTPRC;FCRL3;TNFSF13B,GO_BP,blue,4
regulation of apoptotic process (GO:0042981),38/742,0.0232676071780445,0.158371728254579,0,0,1.44601452840089,5.43801691089721,RARG;FCMR;TNFAIP8;FLT3;FASLG;CD3E;CLU;IKZF3;NUGGC;IKBKB;TCL1A;CASP8;UBD;CLEC5A;RPS6KA1;CASP1;CTLA4;BMF;PLEKHN1;SKP2;ATG7;JAK3;MAP3K5;ZBP1;CD74;RIPK3;STAT1;GZMA;LILRB1;CXCL10;CD40LG;AXL;IL2RB;CD27;PTPN6;ARHGEF1;EVI2B;CD44,GO_BP,blue,38
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),12/171,0.0234252563618517,0.159045161614677,0,0,2.00593066890598,7.53014439218979,IKBKB;CD74;CD4;CASP8;PRKCB;UBD;CASP1;S100A12;FASLG;CARD16;CARD11;HLA-DRB1,GO_BP,blue,12
positive regulation of response to biotic stimulus (GO:0002833),5/45,0.023534671159851,0.159388560430091,0,0,3.3107782369146,12.413036537142,GBP5;DHX58;SH2D1B;TLR8;ADAM8,GO_BP,blue,5
phosphate-containing compound metabolic process (GO:0006796),14/212,0.0242342313193434,0.159534784553285,0,0,1.88068974261443,6.99614539562632,CERKL;PLA2G2D;TGFB1;PLPPR4;PLD4;PIK3CD;PLB1;HK2;PIK3CG;PFKL;PTPRC;INPP5D;HKDC1;PLCH2,GO_BP,blue,14
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),10/134,0.0253316566860656,0.161824072990464,0,0,2.14140306921391,7.8711561459067,CSF1R;CD74;TGFB1;PTPRC;IFNG;FLT3;TNFRSF18;TNFRSF14;TREM2;CD44,GO_BP,blue,10
positive regulation of cysteine-type endopeptidase activity (GO:2001056),6/62,0.0253871796539737,0.161824072990464,0,0,2.83935960591133,10.4304186612636,CASP8;AIM2;SYK;CASP1;FYN;MAP3K5,GO_BP,blue,6
negative regulation of interleukin-6 production (GO:0032715),4/31,0.0254474179010475,0.161824072990464,0,0,3.92113709307657,14.3950471445125,CD200R1;NLRC3;PTPN22;PTPN6,GO_BP,blue,4
negative regulation of response to DNA damage stimulus (GO:2001021),4/31,0.0254474179010475,0.161824072990464,0,0,3.92113709307657,14.3950471445125,CD74;CXCL12;CLU;CD44,GO_BP,blue,4
prostaglandin metabolic process (GO:0006693),4/31,0.0254474179010475,0.161824072990464,0,0,3.92113709307657,14.3950471445125,CD74;EDN1;CYP2S1;PTGES,GO_BP,blue,4
interleukin-12-mediated signaling pathway (GO:0035722),5/46,0.0256367370421259,0.162383144769982,0,0,3.22985957132299,11.8333299043812,IFNG;PDCD4;TYK2;LCP1;IL12RB1,GO_BP,blue,5
regulation of MAP kinase activity (GO:0043405),8/97,0.0256552181474908,0.162383144769982,0,0,2.38457115327832,8.73470390614551,EDN1;TGFB1;RGS14;CD300A;FLT3;S100A12;ADAM8;PIK3CG,GO_BP,blue,8
regulation of adaptive immune response (GO:0002819),3/18,0.0263448468039502,0.16331393590824,0,0,5.28956043956044,19.2353944489759,IL4I1;RIPK3;SKAP1,GO_BP,blue,3
base conversion or substitution editing (GO:0016553),3/18,0.0263448468039502,0.16331393590824,0,0,5.28956043956044,19.2353944489759,APOBEC3D;APOBEC3G;APOBEC3H,GO_BP,blue,3
regulation of platelet aggregation (GO:0090330),3/18,0.0263448468039502,0.16331393590824,0,0,5.28956043956044,19.2353944489759,BLK;SYK;PRKCQ,GO_BP,blue,3
regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),3/18,0.0263448468039502,0.16331393590824,0,0,5.28956043956044,19.2353944489759,APOBEC3D;APOBEC3G;APOBEC3H,GO_BP,blue,3
response to interferon-alpha (GO:0035455),3/18,0.0263448468039502,0.16331393590824,0,0,5.28956043956044,19.2353944489759,AXL;PYHIN1;LAMP3,GO_BP,blue,3
hyaluronan catabolic process (GO:0030214),3/18,0.0263448468039502,0.16331393590824,0,0,5.28956043956044,19.2353944489759,TGFB1;LYVE1;CD44,GO_BP,blue,3
positive regulation of interleukin-4 production (GO:0032753),3/18,0.0263448468039502,0.16331393590824,0,0,5.28956043956044,19.2353944489759,CD40LG;SYK;PRKCQ,GO_BP,blue,3
positive regulation of lymphocyte chemotaxis (GO:0140131),3/18,0.0263448468039502,0.16331393590824,0,0,5.28956043956044,19.2353944489759,XCL2;CXCL13;CCR2,GO_BP,blue,3
positive regulation of phosphoprotein phosphatase activity (GO:0032516),3/18,0.0263448468039502,0.16331393590824,0,0,5.28956043956044,19.2353944489759,PTPRC;CD300A;FCRL3,GO_BP,blue,3
regulation of protein localization to plasma membrane (GO:1903076),7/80,0.0269158730024408,0.166472830967151,0,0,2.542420343601,9.19094893031105,LRRC15;PRKCH;TGFB1;IFNG;TREM2;AKAP5;LDLRAP1,GO_BP,blue,7
positive regulation of Ras protein signal transduction (GO:0046579),6/63,0.0272240089151553,0.16799508007097,0,0,2.78940108892922,10.0520420104412,GPR174;P2RY10;GPR65;GPR55;PIK3CG;GPR18,GO_BP,blue,6
positive regulation of neuron death (GO:1901216),5/47,0.0278552353831761,0.171499619665964,0,0,3.15279417552145,11.2893183877704,IFNG;ITGB2;FYN;CLU;MAP3K5,GO_BP,blue,5
regulation of chemotaxis (GO:0050920),4/32,0.0282669439893149,0.173246948567995,0,0,3.78089998034977,13.482924554679,TGFB1;P2RX4;CXCR4;TREM2,GO_BP,blue,4
positive regulation of interleukin-10 production (GO:0032733),4/32,0.0282669439893149,0.173246948567995,0,0,3.78089998034977,13.482924554679,CD40LG;SYK;TIGIT;CD34,GO_BP,blue,4
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),7/81,0.0285693412054007,0.173919877135799,0,0,2.50793265641332,8.91675673908834,CASP8;CASP5;LCK;TNFSF15;CASP1;FASLG;NLRP1,GO_BP,blue,7
phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),7/81,0.0285693412054007,0.173919877135799,0,0,2.50793265641332,8.91675673908834,GPR174;CX3CR1;P2RY10;GPR65;GPR55;FPR3;GPR18,GO_BP,blue,7
positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),7/81,0.0285693412054007,0.173919877135799,0,0,2.50793265641332,8.91675673908834,CD2;PTPRC;SYK;IFNG;ADAM8;CLU;CCR2,GO_BP,blue,7
positive regulation of multicellular organismal process (GO:0051240),20/345,0.0291850854093826,0.177269947026945,0,0,1.63964080926106,5.7946504420284,ITK;PRKCH;TGFB1;BTN3A1;SYK;TXK;TGFB1I1;CRTAM;CXCR4;PIK3CD;TREM2;CLEC9A;ETV4;PIK3CG;SYDE1;TMIGD2;IFNG;UCP2;ITGAX;CCR2,GO_BP,blue,20
cellular response to interleukin-12 (GO:0071349),5/48,0.0301918760256475,0.1802262685361,0,0,3.07931321673394,10.7781579147163,IFNG;PDCD4;TYK2;LCP1;IL12RB1,GO_BP,blue,5
substrate adhesion-dependent cell spreading (GO:0034446),5/48,0.0301918760256475,0.1802262685361,0,0,3.07931321673394,10.7781579147163,ITGA4;PARVG;LAMB4;LPXN;ITGB7,GO_BP,blue,5
positive regulation of endocytosis (GO:0045807),5/48,0.0301918760256475,0.1802262685361,0,0,3.07931321673394,10.7781579147163,AXL;STAP1;TREM2;LDLRAP1;CLU,GO_BP,blue,5
cellular response to interleukin-7 (GO:0098761),3/19,0.0304548583076216,0.1802262685361,0,0,4.95870535714286,17.3133680880594,IL2RG;IL7R;JAK3,GO_BP,blue,3
response to ATP (GO:0033198),3/19,0.0304548583076216,0.1802262685361,0,0,4.95870535714286,17.3133680880594,P2RX7;P2RX4;RYR3,GO_BP,blue,3
interleukin-7-mediated signaling pathway (GO:0038111),3/19,0.0304548583076216,0.1802262685361,0,0,4.95870535714286,17.3133680880594,IL2RG;IL7R;JAK3,GO_BP,blue,3
myeloid cell activation involved in immune response (GO:0002275),3/19,0.0304548583076216,0.1802262685361,0,0,4.95870535714286,17.3133680880594,SYK;IFNG;DOCK2,GO_BP,blue,3
negative regulation of cytokine production involved in inflammatory response (GO:1900016),3/19,0.0304548583076216,0.1802262685361,0,0,4.95870535714286,17.3133680880594,PDCD4;NLRC3;TREM2,GO_BP,blue,3
positive regulation of macrophage migration (GO:1905523),3/19,0.0304548583076216,0.1802262685361,0,0,4.95870535714286,17.3133680880594,CSF1R;P2RX4;TREM2,GO_BP,blue,3
positive regulation of neutrophil chemotaxis (GO:0090023),3/19,0.0304548583076216,0.1802262685361,0,0,4.95870535714286,17.3133680880594,CD74;RIPOR2;RAC2,GO_BP,blue,3
prostaglandin biosynthetic process (GO:0001516),3/19,0.0304548583076216,0.1802262685361,0,0,4.95870535714286,17.3133680880594,CD74;EDN1;PTGES,GO_BP,blue,3
neutrophil degranulation (GO:0043312),26/481,0.0310637539909918,0.1802262685361,0,0,1.52494427558257,5.29416978994527,ARHGAP9;FCN1;ITGB2;ITGAL;STK10;ADGRE5;CLEC5A;ITGAX;TBC1D10C;S100A12;ATG7;CD300A;ATP6AP2;HLA-B;IRAG2;LYZ;ARHGAP45;CHIT1;PFKL;PTPRC;RAP2B;BIN2;ADAM8;PTPN6;DOCK2;CD44,GO_BP,blue,26
cellular response to type I interferon (GO:0071357),6/65,0.0311563458416257,0.1802262685361,0,0,2.69456458211572,9.34673676934335,RNASEL;SP100;STAT1;STAT2;HLA-B;TYK2,GO_BP,blue,6
type I interferon signaling pathway (GO:0060337),6/65,0.0311563458416257,0.1802262685361,0,0,2.69456458211572,9.34673676934335,RNASEL;SP100;STAT1;STAT2;HLA-B;TYK2,GO_BP,blue,6
apoptotic cell clearance (GO:0043277),4/33,0.031264872558452,0.1802262685361,0,0,3.65033439263862,12.6493581010926,FCN1;RAC2;RHOH;TREM2,GO_BP,blue,4
protein autophosphorylation (GO:0046777),11/159,0.0319513178036103,0.1802262685361,0,0,1.97382695195195,6.7969557200203,MAP4K1;STK10;CSF1R;ITK;RIPK3;FLT3;TXK;CAD;PASK;CLK2;CAMKK2,GO_BP,blue,11
cellular response to mechanical stimulus (GO:0071260),5/49,0.0326481854610494,0.181609721589287,0,0,3.00917230152767,10.2972853047808,CASP8;CASP5;CASP1;TLR8;TLR7,GO_BP,blue,5
regulation of interferon-beta production (GO:0032648),5/49,0.0326481854610494,0.181609721589287,0,0,3.00917230152767,10.2972853047808,DHX58;TLR8;TLR7;NLRC3;LILRB1,GO_BP,blue,5
positive regulation of cell death (GO:0010942),6/66,0.0332543555193457,0.184602559635057,0,0,2.64951724137931,9.01781614506916,RARG;IFNG;ITGB2;FYN;CLU;MAP3K5,GO_BP,blue,6
positive regulation of interleukin-12 production (GO:0032735),4/34,0.0344425244484222,0.19041795659342,0,0,3.52847317744154,11.885532411054,CD40LG;SYK;IFNG;LTB,GO_BP,blue,4
positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),4/34,0.0344425244484222,0.19041795659342,0,0,3.52847317744154,11.885532411054,CXCL10;CXCL9;CXCL11;CD19,GO_BP,blue,4
regulation of acute inflammatory response (GO:0002673),3/20,0.034881038065384,0.190509540562752,0,0,4.66677440206852,15.6608171633107,PLA2G2D;ADAM8;PTGES,GO_BP,blue,3
cellular response to interferon-beta (GO:0035458),3/20,0.034881038065384,0.190509540562752,0,0,4.66677440206852,15.6608171633107,AIM2;STAT1;PYHIN1,GO_BP,blue,3
lipopolysaccharide-mediated signaling pathway (GO:0031663),3/20,0.034881038065384,0.190509540562752,0,0,4.66677440206852,15.6608171633107,TGFB1;CD6;PTPN22,GO_BP,blue,3
mesoderm development (GO:0007498),3/20,0.034881038065384,0.190509540562752,0,0,4.66677440206852,15.6608171633107,BTK;IKZF1;IKZF3,GO_BP,blue,3
natural killer cell mediated immunity (GO:0002228),3/20,0.034881038065384,0.190509540562752,0,0,4.66677440206852,15.6608171633107,KLRK1;GZMB;SLAMF7,GO_BP,blue,3
positive regulation of interferon-alpha production (GO:0032727),3/20,0.034881038065384,0.190509540562752,0,0,4.66677440206852,15.6608171633107,STAT1;TLR8;TLR7,GO_BP,blue,3
neutrophil mediated immunity (GO:0002446),26/488,0.0360823616594421,0.196304969089438,0,0,1.50128028000368,4.98717972220999,ARHGAP9;FCN1;ITGB2;ITGAL;STK10;ADGRE5;CLEC5A;ITGAX;TBC1D10C;S100A12;ATG7;CD300A;ATP6AP2;HLA-B;IRAG2;LYZ;ARHGAP45;CHIT1;PFKL;PTPRC;RAP2B;BIN2;ADAM8;PTPN6;DOCK2;CD44,GO_BP,blue,26
regulation of angiogenesis (GO:0045765),13/203,0.0360870707296198,0.196304969089438,0,0,1.81811317988565,6.03944586739901,SP100;PRKCB;STAT1;PIK3CD;FASLG;CXCL13;HK2;CXCL10;TMIGD2;ADM2;ITGAX;CD34;CCR2,GO_BP,blue,13
positive regulation of DNA-binding transcription factor activity (GO:0051091),15/246,0.0372628434132928,0.202294674963147,0,0,1.72658347239353,5.68004283376908,CX3CR1;EDN1;PRKCH;RIPK3;PRKCB;CLU;IKBKB;CD40LG;AIM2;BTK;S100A12;PRKCQ;ADAM8;CARD16;CARD11,GO_BP,blue,15
cellular response to amyloid-beta (GO:1904646),4/35,0.0378007902425537,0.20425210775852,0,0,3.41447397612814,11.1838543475148,VCAM1;ITGA4;TREM2;FYN,GO_BP,blue,4
regulation of JUN kinase activity (GO:0043506),4/35,0.0378007902425537,0.20425210775852,0,0,3.41447397612814,11.1838543475148,EDN1;PDCD4;PTPN22;MAP3K5,GO_BP,blue,4
regulation of neuron death (GO:1901214),7/86,0.037866389992638,0.20425210775852,0,0,2.34859081054619,7.68856146326679,CD200R1;IFNG;ITGB2;FYN;CLU;CD34;MAP3K5,GO_BP,blue,7
blood circulation (GO:0008015),5/51,0.0379249945376653,0.20425210775852,0,0,2.87803928614205,9.41736156575283,CXCL10;HTR7;CXCL12;STAT1;XCL2,GO_BP,blue,5
purinergic nucleotide receptor signaling pathway (GO:0035590),3/21,0.0396198233642033,0.208959741603799,0,0,4.40728021978022,14.2285767108785,P2RX7;P2RX4;CASP1,GO_BP,blue,3
regulation of transposition (GO:0010528),3/21,0.0396198233642033,0.208959741603799,0,0,4.40728021978022,14.2285767108785,APOBEC3D;APOBEC3G;APOBEC3H,GO_BP,blue,3
negative regulation of small GTPase mediated signal transduction (GO:0051058),3/21,0.0396198233642033,0.208959741603799,0,0,4.40728021978022,14.2285767108785,SH3BP1;RASAL3;ARHGAP25,GO_BP,blue,3
positive regulation of phosphatase activity (GO:0010922),3/21,0.0396198233642033,0.208959741603799,0,0,4.40728021978022,14.2285767108785,RIPK3;IFNG;CD300A,GO_BP,blue,3
calcium ion transmembrane transport (GO:0070588),7/87,0.0399379798175213,0.208959741603799,0,0,2.31911256906077,7.4685339688486,P2RX7;TRPC6;P2RX4;TRPA1;SLC8B1;RYR3;GRIN2D,GO_BP,blue,7
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),11/165,0.0401545891815394,0.208959741603799,0,0,1.89632936507937,6.09673407466231,CXCL10;CXCL11;CXCL9;ADGRE5;CNR2;GPR65;ADGRG5;OXER1;AKAP5;INSL3;S1PR5,GO_BP,blue,11
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),8/106,0.0404508080274908,0.208959741603799,0,0,2.16456375081153,6.94320330544283,FLT3;PIK3CD;TREM2;NLRC3;PTPN6;WNT16;HCST;PIK3CG,GO_BP,blue,8
negative regulation of toll-like receptor signaling pathway (GO:0034122),4/36,0.0413401428131297,0.212909594830358,0,0,3.30759972489684,10.5377523166425,CD300A;TREM2;CD300LF;LILRA4,GO_BP,blue,4
regulation of immune effector process (GO:0002697),5/53,0.0436941847649565,0.223757176802017,0,0,2.75783402203857,8.63351042942744,ZNF683;CD19;HLA-DRA;CLU;HLA-DRB1,GO_BP,blue,5
negative regulation of cysteine-type endopeptidase activity (GO:2000117),5/53,0.0436941847649565,0.223757176802017,0,0,2.75783402203857,8.63351042942744,LAMP3;RPS6KA1;CARD16;CST7;CD44,GO_BP,blue,5
positive regulation of chemokine production (GO:0032722),5/53,0.0436941847649565,0.223757176802017,0,0,2.75783402203857,8.63351042942744,CSF1R;CD74;SYK;IFNG;TLR7,GO_BP,blue,5
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),7/89,0.0442994887589177,0.226428896316808,0,0,2.26231303058887,7.05113685432244,SYK;LAMP3;RPS6KA1;CASP1;CARD16;CD44;MAP3K5,GO_BP,blue,7
regulation of macrophage chemotaxis (GO:0010758),3/22,0.0446665802586457,0.227020198725462,0,0,4.1751012145749,12.9784261352355,CSF1R;SLAMF8;STAP1,GO_BP,blue,3
natural killer cell mediated cytotoxicity (GO:0042267),3/22,0.0446665802586457,0.227020198725462,0,0,4.1751012145749,12.9784261352355,KLRK1;GZMB;SLAMF7,GO_BP,blue,3
positive regulation of granulocyte chemotaxis (GO:0071624),3/22,0.0446665802586457,0.227020198725462,0,0,4.1751012145749,12.9784261352355,CD74;RIPOR2;RAC2,GO_BP,blue,3
positive regulation of calcium ion transport (GO:0051928),4/37,0.0450606509178093,0.22838892228561,0,0,3.20720270101288,9.94151341813223,P2RX7;TRPC6;CXCL12;P2RX4,GO_BP,blue,4
protein tetramerization (GO:0051262),6/71,0.0451044936961246,0.22838892228561,0,0,2.44507161803714,7.57672288848176,GBP5;TRPA1;AQP10;MS4A1;RYR3;HLA-DRB1,GO_BP,blue,6
positive regulation of hydrolase activity (GO:0051345),10/149,0.0470869700542758,0.237982466188495,0,0,1.90881968489009,5.83289285611174,DOCK10;CCL24;CCL22;RIPK3;SH3BP1;DOCK8;XCL2;RGS10;ARAP1;CCL17,GO_BP,blue,10
extrinsic apoptotic signaling pathway (GO:0097191),6/72,0.0477523300535622,0.240895832616574,0,0,2.40789968652038,7.32417449221976,P2RX7;CASP8;TGFB1;IFNG;CD27;FASLG,GO_BP,blue,6
toll-like receptor signaling pathway (GO:0002224),7/91,0.0489562827034227,0.242079843872057,0,0,2.2082182320442,6.66181364043661,IKBKB;CASP8;ITGB2;BTK;TLR8;TLR10;TLR7,GO_BP,blue,7
negative regulation of innate immune response (GO:0045824),4/38,0.0489619936112256,0.242079843872057,0,0,3.11271138441622,9.39015043172049,STAT2;DHX58;SLAMF8;NLRC3,GO_BP,blue,4
positive regulation of production of molecular mediator of immune response (GO:0002702),4/38,0.0489619936112256,0.242079843872057,0,0,3.11271138441622,9.39015043172049,PTPRC;PTPN22;TNFRSF14;CD244,GO_BP,blue,4
negative regulation of cytokine-mediated signaling pathway (GO:0001960),5/55,0.0499613424192373,0.242383870980003,0,0,2.64724517906336,7.93248533243771,PTPRC;STAT2;STAP1;TREM2;CARD16,GO_BP,blue,5
extracellular matrix organization (GO:0030198),17/300,0.0499668162713423,0.242383870980003,0,0,1.59734141006226,4.78626768082762,TGFB1;VCAM1;ITGA4;ITGB2;LOXL3;TNC;CAPG;ITGAL;ITGAD;COL8A2;ITGAX;COL10A1;ADAM8;ITGB7;COL9A2;LCP1;CD44,GO_BP,blue,17
regulation of cysteine-type endopeptidase activity (GO:2000116),3/23,0.050015719408572,0.242383870980003,0,0,3.96614010989011,11.8802472170634,AIM2;FYN;PSMB9,GO_BP,blue,3
regulation of interferon-gamma-mediated signaling pathway (GO:0060334),3/23,0.050015719408572,0.242383870980003,0,0,3.96614010989011,11.8802472170634,IFNG;STAT1;TXK,GO_BP,blue,3
regulation of necroptotic process (GO:0060544),3/23,0.050015719408572,0.242383870980003,0,0,3.96614010989011,11.8802472170634,ZBP1;CASP8;RIPK3,GO_BP,blue,3
hyaluronan metabolic process (GO:0030212),3/23,0.050015719408572,0.242383870980003,0,0,3.96614010989011,11.8802472170634,TGFB1;LYVE1;CD44,GO_BP,blue,3
cellular response to oxygen-containing compound (GO:1901701),18/323,0.050991498905996,0.246671375957756,0,0,1.56968707608121,4.67153997505118,CX3CR1;CXCL9;GFI1;LILRB1;CXCL13;NUGGC;RYR3;CAMKK2;P2RX7;CXCL10;CXCL11;P2RX4;AXL;CASP1;PDCD4;STAP1;CARD16;CCR5,GO_BP,blue,18
response to peptide (GO:1901652),4/39,0.0530434754192936,0.256140418735947,0,0,3.02361957162507,8.87929249164166,STAT1;STAT2;FYN;NLRP1,GO_BP,blue,4
regulation of programmed cell death (GO:0043067),12/194,0.0532350434733923,0.256608065426014,0,0,1.75032477953201,5.13376976910712,CXCL10;RARG;RIPK3;STAT1;FLT3;CASP1;PTPN6;SKP2;CD3E;IKZF3;JAK3;CLU,GO_BP,blue,12
Fc receptor mediated stimulatory signaling pathway (GO:0002431),6/74,0.0533306815398726,0.256612462329512,0,0,2.33683569979716,6.84983439666325,BLK;SYK;CD3G;FYN;CD247;MYO1G,GO_BP,blue,6
regulation of ruffle assembly (GO:1900027),3/24,0.055660803692467,0.266876313633439,0,0,3.77708006279435,10.910016758729,CARMIL2;P2RX4;STAP1,GO_BP,blue,3
"wound healing, spreading of cells (GO:0044319)",3/24,0.055660803692467,0.266876313633439,0,0,3.77708006279435,10.910016758729,CARMIL2;LCP1;CD44,GO_BP,blue,3
positive regulation of protein kinase activity (GO:0045860),10/154,0.0565045504869319,0.270443157719256,0,0,1.84205963938974,5.29303699031074,CSF1R;TCL1A;CD4;PTPRC;RIPK3;IFNG;NAB2;LCP2;CLU;LAT,GO_BP,blue,10
cellular response to peptide (GO:1901653),5/57,0.0567291661481617,0.27103934937455,0,0,2.54516317016317,7.30326123354373,VCAM1;ITGA4;PTPN22;TREM2;FYN,GO_BP,blue,5
positive regulation of interleukin-6 production (GO:0032755),6/76,0.0592883677048098,0.27549260396626,0,0,2.26983251231527,6.41305347579982,CD74;SYK;IFNG;TLR8;TLR7;POU2F2,GO_BP,blue,6
negative regulation of intracellular signal transduction (GO:1902532),12/198,0.0602584898762408,0.278763034386377,0,0,1.71232446498273,4.81011086982224,P2RX7;CASP8;SH3BP1;STAT1;PPM1N;RHOH;TREM2;TRIM59;NLRC3;SLA2;ARHGAP25;CD22,GO_BP,blue,12
receptor metabolic process (GO:0043112),5/58,0.0603009000186108,0.278763034386377,0,0,2.49701127917251,7.01262707596863,TGFB1;SYK;ITGB2;LILRB1;LDLRAP1,GO_BP,blue,5
regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),5/58,0.0603009000186108,0.278763034386377,0,0,2.49701127917251,7.01262707596863,IKBKB;CASP8;SYK;CASP1;CARD16,GO_BP,blue,5
regulation of calcium ion import (GO:0090279),3/25,0.0615946480836521,0.282533582080771,0,0,3.60520729270729,10.0483627219323,CXCL12;FCRL3;FYN,GO_BP,blue,3
regulation of heterotypic cell-cell adhesion (GO:0034114),3/25,0.0615946480836521,0.282533582080771,0,0,3.60520729270729,10.0483627219323,LCK;CD44;SKAP1,GO_BP,blue,3
regulation of neutrophil chemotaxis (GO:0090022),3/25,0.0615946480836521,0.282533582080771,0,0,3.60520729270729,10.0483627219323,RIPOR2;CD74;RAC2,GO_BP,blue,3
negative regulation of sequestering of calcium ion (GO:0051283),3/25,0.0615946480836521,0.282533582080771,0,0,3.60520729270729,10.0483627219323,PTPRC;LCK;RYR3,GO_BP,blue,3
cortical cytoskeleton organization (GO:0030865),4/41,0.061742296268666,0.282533582080771,0,0,2.85988326703595,7.96416307826118,IKBKB;RAC2;RHOH;LCP1,GO_BP,blue,4
import into cell (GO:0098657),4/41,0.061742296268666,0.282533582080771,0,0,2.85988326703595,7.96416307826118,SLC46A1;IL10RA;TREM2;SLC5A3,GO_BP,blue,4
positive regulation of tumor necrosis factor production (GO:0032760),6/77,0.0624100071497002,0.28462745684939,0,0,2.23774647887324,6.20757507145395,CD2;PTPRC;SYK;IFNG;CLU;CCR2,GO_BP,blue,6
positive regulation of type I interferon production (GO:0032481),6/77,0.0624100071497002,0.28462745684939,0,0,2.23774647887324,6.20757507145395,ZBP1;STAT1;DHX58;TLR8;PTPN22;TLR7,GO_BP,blue,6
calcium ion transmembrane import into cytosol (GO:0097553),4/42,0.0663565149414871,0.301610400967263,0,0,2.78447838992254,7.5534916523926,PTPRC;LCK;RYR3;GRIN2D,GO_BP,blue,4
regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),4/42,0.0663565149414871,0.301610400967263,0,0,2.78447838992254,7.5534916523926,SP100;CASP8;TMC8;FASLG,GO_BP,blue,4
adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),8/118,0.0677123128293763,0.303345054143091,0,0,1.92722243178675,5.18902181046357,CXCL10;CXCL11;CXCL9;ADGRE5;CNR2;GPR65;ADGRG5;S1PR5,GO_BP,blue,8
negative regulation of transposition (GO:0010529),3/26,0.0678094123325838,0.303345054143091,0,0,3.44827998088868,9.27950856226639,APOBEC3D;APOBEC3G;APOBEC3H,GO_BP,blue,3
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),21/404,0.067815858269707,0.303345054143091,0,0,1.45848563968668,3.92472537002156,BLK;CSF1R;SYK;RGS14;FLT3;STYK1;CD3E;ZAP70;CD4;SIPA1L1;CD8B;LCK;AXL;CD8A;CD7;BLNK;STAP1;CLNK;LCP2;FYN;ATP6V0D2,GO_BP,blue,21
negative regulation of type I interferon production (GO:0032480),4/43,0.0711446650826439,0.311862294027318,0,0,2.71294042958417,7.17040990623678,DHX58;NLRC3;LILRB1;LILRA4,GO_BP,blue,4
dendritic spine organization (GO:0097061),3/27,0.0742966867361629,0.324105836341812,0,0,3.30442994505495,8.59048991939019,DOCK10;TREM2;FYN,GO_BP,blue,3
regulation of toll-like receptor signaling pathway (GO:0034121),3/27,0.0742966867361629,0.324105836341812,0,0,3.30442994505495,8.59048991939019,GFI1;FCRL3;TREM2,GO_BP,blue,3
stress-activated protein kinase signaling cascade (GO:0031098),3/27,0.0742966867361629,0.324105836341812,0,0,3.30442994505495,8.59048991939019,IKBKB;CCDC88C;MAP3K5,GO_BP,blue,3
I-kappaB kinase/NF-kappaB signaling (GO:0007249),5/62,0.0758317718808138,0.330270530587017,0,0,2.32129911555749,5.98718270263347,IKBKB;TLR8;TLR7;NLRC3;CARD11,GO_BP,blue,5
regulation of endothelial cell apoptotic process (GO:2000351),4/44,0.0761044209869648,0.330395635342448,0,0,2.64497936726272,6.81253825431194,CD40LG;ITGA4;PDCD4;FASLG,GO_BP,blue,4
response to amyloid-beta (GO:1904645),4/44,0.0761044209869648,0.330395635342448,0,0,2.64497936726272,6.81253825431194,VCAM1;ITGA4;TREM2;FYN,GO_BP,blue,4
positive regulation of gene expression (GO:0010628),24/482,0.0787815311692948,0.339069489427121,0,0,1.39424223145958,3.54287642845875,ITK;CD74;TGFB1;BTN3A1;TXK;CRTAM;PIK3CD;PTPN22;TREM2;LILRB1;CLEC9A;PASK;CD3E;WNT16;CLU;PIK3CG;P2RX7;TMIGD2;IFNG;ADM2;LAMP3;ITGAX;STAP1;CD34,GO_BP,blue,24
receptor-mediated endocytosis (GO:0006898),9/143,0.0793319758479453,0.339069489427121,0,0,1.78003679662629,4.51081617625425,MSR1;SYK;CTTN;FCHO1;ITGB2;LILRB1;CLEC9A;LDLRAP1;CXCL16,GO_BP,blue,9
negative regulation of DNA-binding transcription factor activity (GO:0043433),9/143,0.0793319758479453,0.339069489427121,0,0,1.78003679662629,4.51081617625425,EOMES;SP100;FOXS1;AIM2;CDKN2A;GFI1;NLRC3;WWP2;FOXP3,GO_BP,blue,9
positive regulation of cytoskeleton organization (GO:0051495),6/82,0.0794453065258335,0.339069489427121,0,0,2.08998185117967,5.29326874095447,FCHSD1;P2RX7;CCL24;EDN1;CTTN;STAP1,GO_BP,blue,6
positive regulation of vasculature development (GO:1904018),7/102,0.0799862384229205,0.339248617531091,0,0,1.95141029369003,4.9290685854857,TMIGD2;PRKCB;ADM2;ITGAX;PIK3CD;CD34;HK2,GO_BP,blue,7
actin cytoskeleton reorganization (GO:0031532),5/63,0.0800220991518521,0.339248617531091,0,0,2.28115797473164,5.7609559802854,SYDE1;SIPA1L1;CTTN;PARVG;GPR65,GO_BP,blue,5
cellular response to interleukin-6 (GO:0071354),3/28,0.08104757154283,0.341990453753157,0,0,3.17208791208791,7.97056554641075,SELPLG;STAT1;ST18,GO_BP,blue,3
regulation of immunoglobulin production (GO:0002637),3/28,0.08104757154283,0.341990453753157,0,0,3.17208791208791,7.97056554641075,PTPRC;FCRL3;CD22,GO_BP,blue,3
positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),3/28,0.08104757154283,0.341990453753157,0,0,3.17208791208791,7.97056554641075,TGFB1;FLT3;CD19,GO_BP,blue,3
positive regulation of chemotaxis (GO:0050921),4/45,0.0812331809684804,0.342240571140923,0,0,2.58033347871305,6.47775040073658,TGFB1;P2RX4;TREM2;CCR2,GO_BP,blue,4
cellular response to organic substance (GO:0071310),8/123,0.0817587349141431,0.343919895780146,0,0,1.84294906488664,4.61471243872906,CSF1R;TGFB1;FLT3;CASP1;CXCR4;PTPN6;PTPN7;LDLRAP1,GO_BP,blue,8
regulation of MAPK cascade (GO:0043408),10/166,0.0838822796087209,0.352305574356628,0,0,1.69929584978129,4.21143439941619,P2RX7;CD74;CD4;PTPRC;SYK;FLT3;FCRL3;ATP6AP2;PTPN6;HLA-DRB1,GO_BP,blue,10
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),5/64,0.0843335822079433,0.35365274644167,0,0,2.24237755054396,5.54534390973265,CXCL10;CXCL9;CXCL11;S100A12;CXCL13,GO_BP,blue,5
positive regulation of nucleic acid-templated transcription (GO:1903508),25/511,0.086304582698425,0.361358755069603,0,0,1.36856048683244,3.3527988112426,CIITA;SP100;DLX5;TGFB1I1;XPC;CREBL2;CAMKK2;IKBKB;TBX21;MYB;RPS6KA1;TNNI2;MAP3K5;EOMES;CD74;TGFB1;STAT1;PYHIN1;PBX4;FOXP3;RUNX3;RUNX2;CD4;SKAP1;HLA-DRB1,GO_BP,blue,25
glycolytic process (GO:0006096),3/29,0.0880527503953825,0.368109414847363,0,0,3.04992603550296,7.41076886338238,PFKL;HKDC1;HK2,GO_BP,blue,3
activation of GTPase activity (GO:0090630),7/105,0.0900535652531241,0.368373773730677,0,0,1.8913772691397,4.55320823436006,SYDE1;SIPA1L1;GPR65;TBC1D10C;CXCL13;ARHGAP25;ARHGAP45,GO_BP,blue,7
MAPK cascade (GO:0000165),16/303,0.091005470350717,0.368510940478464,0,0,1.4800419093102,3.5474172273105,TGFB1;FLT3;CSF2RB;RASAL3;IL2RG;CAMKK2;PSMB9;IKBKB;IL2RB;PRKCQ;FYN;PTPN7;CCR5;JAK3;LAT;MAP3K5,GO_BP,blue,16
regulation of DNA binding (GO:0051101),4/47,0.0919860272751596,0.370818672452987,0,0,2.46006205815553,5.86999981176107,SP100;TGFB1;GZMA;PYHIN1,GO_BP,blue,4
epithelial to mesenchymal transition (GO:0001837),4/47,0.0919860272751596,0.370818672452987,0,0,2.46006205815553,5.86999981176107,EOMES;AKNA;TGFB1;LOXL3,GO_BP,blue,4
polyol metabolic process (GO:0019751),4/47,0.0919860272751596,0.370818672452987,0,0,2.46006205815553,5.86999981176107,INPP5D;PLD4;PLCH2;SLC5A3,GO_BP,blue,4
positive regulation of transferase activity (GO:0051347),9/148,0.0933953914474786,0.375940736153372,0,0,1.71555830128141,4.06743995409367,CSF1R;CD74;CD4;TGFB1;FLT3;AXL;PRKCQ;TREM2;HLA-DRB1,GO_BP,blue,9
alpha-amino acid catabolic process (GO:1901606),3/30,0.095302557987547,0.381351003823139,0,0,2.93681318681319,6.90356272676049,IL4I1;HAAO;IDO2,GO_BP,blue,3
regulation of protein localization to membrane (GO:1905475),3/30,0.095302557987547,0.381351003823139,0,0,2.93681318681319,6.90356272676049,FYN;LDLRAP1;SLC5A3,GO_BP,blue,3
TRIF-dependent toll-like receptor signaling pathway (GO:0035666),3/30,0.095302557987547,0.381351003823139,0,0,2.93681318681319,6.90356272676049,IKBKB;CASP8;CD300LF,GO_BP,blue,3
positive regulation of lipid kinase activity (GO:0090218),3/30,0.095302557987547,0.381351003823139,0,0,2.93681318681319,6.90356272676049,TGFB1;FLT3;CD19,GO_BP,blue,3
negative regulation of MAP kinase activity (GO:0043407),4/48,0.0976036809275542,0.389982849015847,0,0,2.40402650994123,5.5937852171272,RGS14;CD300A;PDCD4;PTPN22,GO_BP,blue,4
regulation of viral genome replication (GO:0045069),5/67,0.0979822831036687,0.39091900578474,0,0,2.13354216653337,4.95615146243118,FAM111A;RNASEL;APOBEC3G;ZC3HAV1;SHFL,GO_BP,blue,5
extracellular structure organization (GO:0043062),12/216,0.0992953917556287,0.395575318038233,0,0,1.55976437863045,3.6025193370948,VCAM1;ITGA4;ITGAD;ITGB2;COL8A2;TNC;ITGAX;COL10A1;ITGB7;COL9A2;ITGAL;CD44,GO_BP,blue,12
external encapsulating structure organization (GO:0045229),12/217,0.101827144598014,0.398354933032248,0,0,1.55207435801757,3.54568060072394,VCAM1;ITGA4;ITGAD;ITGB2;COL8A2;TNC;ITGAX;COL10A1;ITGB7;COL9A2;ITGAL;CD44,GO_BP,blue,12
regulation of calcium ion-dependent exocytosis (GO:0017158),3/31,0.102787042521056,0.398354933032248,0,0,2.83177982731554,6.44257089972965,CACNA1I;SYT12;SYT6,GO_BP,blue,3
MyD88-independent toll-like receptor signaling pathway (GO:0002756),3/31,0.102787042521056,0.398354933032248,0,0,2.83177982731554,6.44257089972965,IKBKB;CASP8;CD300LF,GO_BP,blue,3
negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),3/31,0.102787042521056,0.398354933032248,0,0,2.83177982731554,6.44257089972965,PTPRC;CD300A;PTPN6,GO_BP,blue,3
negative regulation of response to biotic stimulus (GO:0002832),3/31,0.102787042521056,0.398354933032248,0,0,2.83177982731554,6.44257089972965,DHX58;NLRC3;CARD16,GO_BP,blue,3
positive regulation of locomotion (GO:0040017),3/31,0.102787042521056,0.398354933032248,0,0,2.83177982731554,6.44257089972965,CSF1R;TGFB1;TREM2,GO_BP,blue,3
positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),3/31,0.102787042521056,0.398354933032248,0,0,2.83177982731554,6.44257089972965,PYHIN1;TREM2;CLU,GO_BP,blue,3
receptor internalization (GO:0031623),4/49,0.103377506153555,0.398931145541281,0,0,2.35048143053645,5.33410706712772,SYK;ITGB2;LILRB1;LDLRAP1,GO_BP,blue,4
positive regulation of actin filament polymerization (GO:0030838),4/49,0.103377506153555,0.398931145541281,0,0,2.35048143053645,5.33410706712772,FCHSD1;CCL24;CARMIL2;CTTN,GO_BP,blue,4
positive regulation of reactive oxygen species metabolic process (GO:2000379),4/49,0.103377506153555,0.398931145541281,0,0,2.35048143053645,5.33410706712772,TGFB1;SYK;ITGB2;SLC5A3,GO_BP,blue,4
negative regulation of cellular catabolic process (GO:0031330),5/69,0.107661618237606,0.414872437845909,0,0,2.06665375344353,4.60607963174983,DAPL1;IL10RA;PTPN22;TREM2;BMF,GO_BP,blue,5
activation of phospholipase C activity (GO:0007202),3/32,0.110496023188864,0.423385752218717,0,0,2.73399014778325,6.02236719257004,ITK;TXK;GPR55,GO_BP,blue,3
chondrocyte differentiation (GO:0002062),3/32,0.110496023188864,0.423385752218717,0,0,2.73399014778325,6.02236719257004,TGFB1;RUNX3;RUNX2,GO_BP,blue,3
regulation of NMDA receptor activity (GO:2000310),3/32,0.110496023188864,0.423385752218717,0,0,2.73399014778325,6.02236719257004,GRIA2;IFNG;CCR2,GO_BP,blue,3
membrane depolarization (GO:0051899),3/32,0.110496023188864,0.423385752218717,0,0,2.73399014778325,6.02236719257004,P2RX7;CACNA1I;P2RX4,GO_BP,blue,3
regulation of protein modification process (GO:0031399),4/51,0.115378562884543,0.434111842853094,0,0,2.25022681377857,4.85944740057226,IFNG;STAT2;CCDC88C;ATG7,GO_BP,blue,4
inositol lipid-mediated signaling (GO:0048017),4/51,0.115378562884543,0.434111842853094,0,0,2.25022681377857,4.85944740057226,CSF1R;PIK3CD;PLCH2;PIK3CG,GO_BP,blue,4
positive regulation of transport (GO:0051050),6/91,0.115973555057422,0.435745299099248,0,0,1.86781338742394,4.02400425062219,IFNG;SIRPG;IL2RB;TREM2;DOCK2;IL2RG,GO_BP,blue,6
protein-containing complex subunit organization (GO:0043933),7/112,0.116164783612114,0.435859278123567,0,0,1.7646408839779,3.79882280595486,CD74;IL2RB;LPXN;CD3G;CAPG;CD247;CD3E,GO_BP,blue,7
Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),5/71,0.117788806762708,0.440731875027866,0,0,2.00381918357125,4.28589276927408,SYK;CD3G;FYN;CD247;MYO1G,GO_BP,blue,5
phosphatidylinositol-mediated signaling (GO:0048015),5/71,0.117788806762708,0.440731875027866,0,0,2.00381918357125,4.28589276927408,CSF1R;EDN1;PIK3CD;PLCH2;PIK3CG,GO_BP,blue,5
positive regulation of ATP metabolic process (GO:1903580),3/33,0.118419142926915,0.4424792526745,0,0,2.64271978021978,5.63830842700703,P2RX7;IFNG;TREM2,GO_BP,blue,3
positive regulation of cellular component biogenesis (GO:0044089),6/92,0.120478914626868,0.448785380484302,0,0,1.84599839615076,3.90665045257795,TCL1A;TGFB1;SYK;IFNG;BMF;CLU,GO_BP,blue,6
cartilage development (GO:0051216),4/52,0.121597810732919,0.448785380484302,0,0,2.20323246217332,4.64229080477823,TGFB1;RUNX3;RUNX2;CD44,GO_BP,blue,4
regulation of release of sequestered calcium ion into cytosol (GO:0051279),4/52,0.121597810732919,0.448785380484302,0,0,2.20323246217332,4.64229080477823,CXCL10;CXCL9;CXCL11;CD19,GO_BP,blue,4
negative regulation of cellular biosynthetic process (GO:0031327),4/52,0.121597810732919,0.448785380484302,0,0,2.20323246217332,4.64229080477823,GFI1;FYN;CD34;CLK2,GO_BP,blue,4
negative regulation of protein metabolic process (GO:0051248),4/52,0.121597810732919,0.448785380484302,0,0,2.20323246217332,4.64229080477823,CD84;EDN1;TREM2;CLU,GO_BP,blue,4
negative regulation of protein-containing complex assembly (GO:0031333),4/52,0.121597810732919,0.448785380484302,0,0,2.20323246217332,4.64229080477823,TMC8;TREM2;NLRC3;CLU,GO_BP,blue,4
positive regulation of protein localization to cell periphery (GO:1904377),4/52,0.121597810732919,0.448785380484302,0,0,2.20323246217332,4.64229080477823,PRKCH;IFNG;TREM2;AKAP5,GO_BP,blue,4
positive regulation of protein localization to plasma membrane (GO:1903078),4/52,0.121597810732919,0.448785380484302,0,0,2.20323246217332,4.64229080477823,PRKCH;IFNG;TREM2;AKAP5,GO_BP,blue,4
protein homotetramerization (GO:0051289),4/52,0.121597810732919,0.448785380484302,0,0,2.20323246217332,4.64229080477823,GBP5;TRPA1;AQP10;RYR3,GO_BP,blue,4
cell morphogenesis involved in differentiation (GO:0000904),5/72,0.123015411664713,0.452169267570837,0,0,1.97380864273673,4.13600870153415,ITGA4;PARVG;LAMB4;LPXN;ITGB7,GO_BP,blue,5
Fc-gamma receptor signaling pathway (GO:0038094),5/72,0.123015411664713,0.452169267570837,0,0,1.97380864273673,4.13600870153415,SYK;CD3G;FYN;CD247;MYO1G,GO_BP,blue,5
positive regulation of secretion by cell (GO:1903532),5/72,0.123015411664713,0.452169267570837,0,0,1.97380864273673,4.13600870153415,EDN1;TGFB1;P2RX4;TREM2;ADAM8,GO_BP,blue,5
positive regulation of cellular component organization (GO:0051130),7/114,0.12427960704817,0.456197094164623,0,0,1.73147622244023,3.61051119693907,TCL1A;TGFB1;SYK;IFNG;BMF;TREM2;CLU,GO_BP,blue,7
response to steroid hormone (GO:0048545),3/34,0.126545916825729,0.457694110388384,0,0,2.55733782346686,5.28640102963438,CATSPER1;PAQR7;TGFB1,GO_BP,blue,3
phosphatidylinositol 3-kinase signaling (GO:0014065),3/34,0.126545916825729,0.457694110388384,0,0,2.55733782346686,5.28640102963438,EDN1;PIK3CD;PIK3CG,GO_BP,blue,3
regulation of protein-containing complex assembly (GO:0043254),7/116,0.132674752323318,0.478583094599025,0,0,1.69952861270211,3.43280071519589,TCL1A;TGFB1;SYK;IFNG;TMC8;BMF;CLU,GO_BP,blue,7
positive regulation of angiogenesis (GO:0045766),7/116,0.132674752323318,0.478583094599025,0,0,1.69952861270211,3.43280071519589,TMIGD2;PRKCB;ADM2;ITGAX;PIK3CD;CD34;HK2,GO_BP,blue,7
regulation of phosphatidylinositol 3-kinase activity (GO:0043551),3/35,0.134865776515361,0.485194407144904,0,0,2.47729223901099,4.96319367095695,TGFB1;FLT3;CD19,GO_BP,blue,3
peptidyl-tyrosine dephosphorylation (GO:0035335),3/35,0.134865776515361,0.485194407144904,0,0,2.47729223901099,4.96319367095695,PTPRO;PTPN22;PTPN6,GO_BP,blue,3
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),4/55,0.141079429090363,0.496988521984125,0,0,2.0733069018529,4.06043103922334,LAMP3;RPS6KA1;CARD16;CD44,GO_BP,blue,4
endoderm formation (GO:0001706),3/36,0.143368110623196,0.503740871177999,0,0,2.4020979020979,4.66569025338099,EOMES;ITGA4;ITGB2,GO_BP,blue,3
positive regulation of interferon-beta production (GO:0032728),3/36,0.143368110623196,0.503740871177999,0,0,2.4020979020979,4.66569025338099,DHX58;TLR8;TLR7,GO_BP,blue,3
Ras protein signal transduction (GO:0007265),8/142,0.149413772382045,0.515364517171413,0,0,1.58006647261617,3.00376297176794,SHTN1;RAP2B;CDKN2A;ARHGDIB;RAC2;RHOH;ARHGEF1;LAT,GO_BP,blue,8
cellular protein modification process (GO:0006464),44/1025,0.151284685129621,0.515364517171413,0,0,1.19396925871025,2.25492065316732,CUL9;RNASEL;TXK;PTPRO;TNC;PIK3CD;DAPP1;PTPN22;CD3G;ZC3HAV1;FBXO41;CAMKK2;IKBKB;STK10;UBD;ST8SIA4;FYN;SKP2;ATG7;JAK3;MAP3K5;MAP4K1;PRKCH;TGFB1;RIPK3;SYK;PRKCB;MATK;WWP2;TYK2;PASK;RUNX3;PSMB9;PARP8;CLK2;ZAP70;PTPRC;LCK;ADM2;BTK;PTPN6;PTPN7;CD247;HCST,GO_BP,blue,44
regulation of actin cytoskeleton reorganization (GO:2000249),3/37,0.152042301713153,0.515364517171413,0,0,2.33132676147382,4.39127891919933,CSF1R;ARHGDIB;STAP1,GO_BP,blue,3
positive regulation of signaling receptor activity (GO:2000273),3/37,0.152042301713153,0.515364517171413,0,0,2.33132676147382,4.39127891919933,EDN1;IFNG;CCR2,GO_BP,blue,3
regulation of axon extension (GO:0030516),3/38,0.160877759853066,0.515364517171413,0,0,2.26459968602826,4.13767376941067,SHTN1;CTTN;TRIM46,GO_BP,blue,3
positive regulation of cell development (GO:0010720),3/38,0.160877759853066,0.515364517171413,0,0,2.26459968602826,4.13767376941067,CX3CR1;RGS14;IFNG,GO_BP,blue,3
cellular component assembly (GO:0022607),13/261,0.161585046473488,0.515364517171413,0,0,1.38867485847785,2.53117053639148,CD74;TGFB1;RHOH;CD3G;CAPG;CD3E;PARVG;SH3BP1;IL2RB;RAC2;LPXN;LCP1;CD247,GO_BP,blue,13
regulation of ion transport (GO:0043269),5/79,0.162433301223218,0.515364517171413,0,0,1.78644553644554,3.24684299551306,P2RX7;P2RX4;SYT12;WWP2;SYT6,GO_BP,blue,5
negative regulation of NF-kappaB transcription factor activity (GO:0032088),5/79,0.162433301223218,0.515364517171413,0,0,1.78644553644554,3.24684299551306,AIM2;CDKN2A;GFI1;NLRC3;FOXP3,GO_BP,blue,5
positive regulation of apoptotic process (GO:0043065),15/310,0.165423244224742,0.515364517171413,0,0,1.34745762711864,2.42441040411353,ZBP1;RARG;TNFAIP8;GZMA;LILRB1;FASLG;CLU;CASP8;UBD;CTLA4;ARHGEF1;BMF;PLEKHN1;ATG7;MAP3K5,GO_BP,blue,15
regulation of NIK/NF-kappaB signaling (GO:1901222),5/80,0.168439094749505,0.515364517171413,0,0,1.76253443526171,3.13939293610125,PDCD4;CD27;PTPN22;TLR7;NLRC3,GO_BP,blue,5
negative regulation of cell cycle (GO:0045786),5/80,0.168439094749505,0.515364517171413,0,0,1.76253443526171,3.13939293610125,TGFB1;CDKN2A;PDCD4;LILRB1;RUNX3,GO_BP,blue,5
positive regulation of cell adhesion (GO:0045785),5/80,0.168439094749505,0.515364517171413,0,0,1.76253443526171,3.13939293610125,CXCL12;SYK;TNFRSF18;SIRPG;ADAM8,GO_BP,blue,5
positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),4/59,0.168807757033524,0.515364517171413,0,0,1.92212079529824,3.41944279194965,CSF1R;IFNG;FLT3;TNFRSF18,GO_BP,blue,4
regulation of protein tyrosine kinase activity (GO:0061097),3/39,0.169863953098508,0.515364517171413,0,0,2.20157967032967,3.9028667363992,CSF1R;PTPRC;RAP2B,GO_BP,blue,3
negative regulation of cellular metabolic process (GO:0031324),3/39,0.169863953098508,0.515364517171413,0,0,2.20157967032967,3.9028667363992,EDN1;ANKRD13D;TRAT1,GO_BP,blue,3
regulation of phosphorylation (GO:0042325),7/125,0.173718441406329,0.526401854328574,0,0,1.56916612042326,2.74654197023172,IKBKB;NUP210;CDKN2A;STAT2;CCDC88C;SLAMF8;STAP1,GO_BP,blue,7
negative regulation of macromolecule metabolic process (GO:0010605),10/194,0.174095079352444,0.526953709458962,0,0,1.43859675571368,2.51488823547934,MSR1;ANKRD13D;TGFB1;IFNG;TRAT1;WWP2;PTPN22;CD3E;PARP15;CD34,GO_BP,blue,10
positive regulation of intracellular protein transport (GO:0090316),8/148,0.175136591337514,0.529514537872016,0,0,1.51187512349338,2.63397234193202,TGFB1;CASP8;IFNG;ITGB2;RAC2;GZMB;FYN;AKAP5,GO_BP,blue,8
cellular protein catabolic process (GO:0044257),4/60,0.176021265525786,0.529689011049821,0,0,1.88769895853802,3.27921712245645,CASP8;GZMA;GZMB;CTSW,GO_BP,blue,4
"regulation of DNA-templated transcription, initiation (GO:2000142)",4/61,0.183337590494185,0.542433843949146,0,0,1.85448490552378,3.14599653795624,CSF1R;CDKN2A;RUNX2;VENTX,GO_BP,blue,4
pattern recognition receptor signaling pathway (GO:0002221),4/61,0.183337590494185,0.542433843949146,0,0,1.85448490552378,3.14599653795624,FCN1;TLR8;TLR10;TLR7,GO_BP,blue,4
positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),5/83,0.186959356601781,0.542433843949146,0,0,1.69447976266158,2.84141216378325,P2RX7;RIPOR2;CARMIL2;RAC2;ARAP1,GO_BP,blue,5
carbohydrate catabolic process (GO:0016052),3/41,0.188246869222938,0.542433843949146,0,0,2.08549016772701,3.48277075609262,PFKL;HKDC1;HK2,GO_BP,blue,3
actin filament organization (GO:0007015),8/152,0.193305363873975,0.542433843949146,0,0,1.46957123098202,2.41521701688086,CARMIL2;SH3BP1;RAC2;RHOH;CAPG;LCP1;ARHGAP25;MYO1G,GO_BP,blue,8
phosphatidylinositol phosphate biosynthetic process (GO:0046854),3/42,0.197623052327056,0.542433843949146,0,0,2.03191039729501,3.29452699936821,PIK3CD;SLA2;PIK3CG,GO_BP,blue,3
positive regulation of protein tyrosine kinase activity (GO:0061098),3/42,0.197623052327056,0.542433843949146,0,0,2.03191039729501,3.29452699936821,CSF1R;STAP1;FYN,GO_BP,blue,3
dephosphorylation (GO:0016311),8/153,0.197966447892603,0.542433843949146,0,0,1.45935994658273,2.36366360043547,PLPP5;PTPRC;PLPPR4;PTPRO;DAPP1;PTPN22;PTPN6;PTPN7,GO_BP,blue,8
anterior/posterior pattern specification (GO:0009952),4/63,0.198258884982935,0.542433843949146,0,0,1.79143449980183,2.89886634949732,TIFAB;ATP6AP2;HOXD9;HOXB5,GO_BP,blue,4
regulation of extrinsic apoptotic signaling pathway (GO:2001236),4/64,0.205853906241965,0.552684075331499,0,0,1.76148555708391,2.78418391095302,SP100;CASP8;TMC8;FASLG,GO_BP,blue,4
regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),4/64,0.205853906241965,0.552684075331499,0,0,1.76148555708391,2.78418391095302,CSF1R;CDKN2A;RUNX2;VENTX,GO_BP,blue,4
plasma membrane organization (GO:0007009),4/64,0.205853906241965,0.552684075331499,0,0,1.76148555708391,2.78418391095302,P2RX7;BIN2;CXCR4;OTOF,GO_BP,blue,4
positive regulation of endothelial cell migration (GO:0010595),5/86,0.206173798960929,0.552994872658571,0,0,1.63146617692072,2.5761434698569,EDN1;TGFB1;P2RX4;PIK3CD;PIK3CG,GO_BP,blue,5
regulation of cell-cell adhesion (GO:0022407),3/43,0.207108933077431,0.554405236864388,0,0,1.98100961538462,3.11912019712285,TGFB1;SIRPG;ADAM8,GO_BP,blue,3
positive regulation of phospholipase C activity (GO:0010863),3/43,0.207108933077431,0.554405236864388,0,0,1.98100961538462,3.11912019712285,ITK;TXK;GPR55,GO_BP,blue,3
axon guidance (GO:0007411),10/203,0.210182378569891,0.555040616771208,0,0,1.37086516280641,2.1382475917706,ALCAM;CXCL12;PTPRO;RAC2;RHOH;CXCR4;PIK3CD;PRKCQ;FYN;PLXNA3,GO_BP,blue,10
positive regulation of cellular process (GO:0048522),27/625,0.210697851966429,0.555040616771208,0,0,1.19745030784433,1.86482547109248,CSF1R;FLT3;SIRPG;TREM2;IL2RG;CST7;CXCL16;POFUT2;TCL1A;ESM1;RPS6KA1;ITGAX;IL13RA1;EDN1;TGFB1;TNFRSF18;CLEC11A;MATK;P2RX7;CXCL12;P2RX4;IFNG;IL2RB;ADAM8;PTPN6;IL7R;DOCK2,GO_BP,blue,27
BMP signaling pathway (GO:0030509),4/65,0.213531866865059,0.555040616771208,0,0,1.73251854691411,2.67495527162503,TGFB1;DLX5;PDCD4;RUNX2,GO_BP,blue,4
regulation of protein kinase activity (GO:0045859),6/110,0.214725950633779,0.555040616771208,0,0,1.52506631299735,2.34615090142165,CD4;PTPRC;RAP2B;LCP2;LAT;CAMKK2,GO_BP,blue,6
positive regulation of biosynthetic process (GO:0009891),3/44,0.216694630521162,0.555040616771208,0,0,1.93259179844546,2.95544721747746,TGFB1;CREBL2;SLC5A3,GO_BP,blue,3
metal ion transport (GO:0030001),5/88,0.219329867974686,0.555040616771208,0,0,1.59198778585416,2.41532953900526,CATSPER1;FYN;CCR5;KCNN4;RYR3,GO_BP,blue,5
negative regulation of binding (GO:0051100),5/88,0.219329867974686,0.555040616771208,0,0,1.59198778585416,2.41532953900526,SP100;GZMA;TMC8;MITD1;CARD16,GO_BP,blue,5
cellular component disassembly (GO:0022411),4/66,0.221287789454696,0.555040616771208,0,0,1.70448595642721,2.57086118544901,ADAM8;CAPG;LCP1;CD44,GO_BP,blue,4
extracellular matrix disassembly (GO:0022617),4/66,0.221287789454696,0.555040616771208,0,0,1.70448595642721,2.57086118544901,ADAM8;CAPG;LCP1;CD44,GO_BP,blue,4
regulation of endothelial cell migration (GO:0010594),5/89,0.22600284343131,0.555040616771208,0,0,1.57295356158993,2.33930864576196,EDN1;SP100;SH3BP1;PIK3CD;PIK3CG,GO_BP,blue,5
regulation of receptor signaling pathway via JAK-STAT (GO:0046425),3/45,0.226370449487301,0.555040616771208,0,0,1.88647959183673,2.80252100153015,PTPRC;IL10RA;JAK3,GO_BP,blue,3
positive regulation of nervous system development (GO:0051962),3/45,0.226370449487301,0.555040616771208,0,0,1.88647959183673,2.80252100153015,CX3CR1;RGS14;IFNG,GO_BP,blue,3
regulation of fibroblast proliferation (GO:0048145),3/46,0.236126894468966,0.568088594241943,0,0,1.84251213902377,2.65945609737884,CD74;CD300A;NLRC3,GO_BP,blue,3
positive regulation of smooth muscle cell proliferation (GO:0048661),3/46,0.236126894468966,0.568088594241943,0,0,1.84251213902377,2.65945609737884,EDN1;STAT1;LDLRAP1,GO_BP,blue,3
regulation of tyrosine phosphorylation of STAT protein (GO:0042509),4/68,0.23701369121301,0.569716139748044,0,0,1.65104883081155,2.37691159766092,CSF1R;IFNG;FLT3;TNFRSF18,GO_BP,blue,4
regulation of actin cytoskeleton organization (GO:0032956),5/91,0.239523540682165,0.574729204347196,0,0,1.53621308219617,2.19540760928436,CSF1R;SH3BP1;ARHGDIB;RAC2;RHOH,GO_BP,blue,5
positive regulation of supramolecular fiber organization (GO:1902905),5/91,0.239523540682165,0.574729204347196,0,0,1.53621308219617,2.19540760928436,FCHSD1;CCL24;EDN1;CTTN;CLU,GO_BP,blue,5
cellular response to calcium ion (GO:0071277),4/69,0.244973819072502,0.579223985428958,0,0,1.62556343244101,2.28652392078719,SYT12;CPNE7;RYR3;SYT6,GO_BP,blue,4
retinoid metabolic process (GO:0001523),5/92,0.246365185993806,0.579223985428958,0,0,1.51847629904056,2.12729471467824,DHRS13;CYP26B1;CYP2S1;ABCA4;PLB1,GO_BP,blue,5
regulation of intracellular signal transduction (GO:1902531),19/437,0.250283166346448,0.579223985428958,0,0,1.20346016343207,1.66698769212367,ARHGAP9;ATP6AP2;ARAP2;RHOH;PTPN22;TREM2;AKAP5;PRDM1;ARAP1;ITFG2;ARHGAP25;ARHGAP45;SYDE1;ARHGAP30;CHN2;TAGAP;ARHGDIB;RAC2;ARHGEF1,GO_BP,blue,19
positive regulation of peptidyl-serine phosphorylation (GO:0033138),5/93,0.253256975001692,0.579223985428958,0,0,1.50114262459304,2.0615951155709,TCL1A;TGFB1;IFNG;CREBL2;CD44,GO_BP,blue,5
negative regulation of cellular process (GO:0048523),24/566,0.255008926270271,0.579223985428958,0,0,1.17289936690032,1.60271623287435,APOBEC3D;RIPOR2;ADAMDEC1;RARG;SP100;TGFB1;APOBEC3G;CDKN2A;APOBEC3H;TGFB1I1;SIRPG;TREM2;LILRB1;WNT16;CLU;FOXP3;RUNX3;ST18;ARHGDIB;PDCD4;LPXN;PTPN6;CD34;PLXNA3,GO_BP,blue,24
cognition (GO:0050890),3/48,0.255844748516539,0.579223985428958,0,0,1.76043956043956,2.39980386841788,HLA-DRA;SLC1A4;JAKMIP1,GO_BP,blue,3
inositol phosphate metabolic process (GO:0043647),3/48,0.255844748516539,0.579223985428958,0,0,1.76043956043956,2.39980386841788,INPP5D;PLD4;PLCH2,GO_BP,blue,3
negative regulation of cell death (GO:0060548),5/94,0.260195870579588,0.581096960758536,0,0,1.48419847091962,1.99820695096497,CD200R1;FYN;WNT16;CLU;CD34,GO_BP,blue,5
positive regulation of epithelial cell migration (GO:0010634),5/94,0.260195870579588,0.581096960758536,0,0,1.48419847091962,1.99820695096497,EDN1;IFNG;PIK3CD;INSL3;PIK3CG,GO_BP,blue,5
cellular response to BMP stimulus (GO:0071773),4/71,0.261064066505891,0.582076177913135,0,0,1.57687491018087,2.11772634664696,TGFB1;DLX5;PDCD4;RUNX2,GO_BP,blue,4
positive regulation of cellular protein localization (GO:1903829),4/71,0.261064066505891,0.582076177913135,0,0,1.57687491018087,2.11772634664696,TGFB1;PYHIN1;FYN;SLC5A3,GO_BP,blue,4
regulation of smooth muscle cell proliferation (GO:0048660),3/49,0.26578826442978,0.591149760542096,0,0,1.7220795508839,2.28185061105291,EDN1;IFNG;STAT1,GO_BP,blue,3
response to hydrogen peroxide (GO:0042542),3/49,0.26578826442978,0.591149760542096,0,0,1.7220795508839,2.28185061105291,RIPK3;FYN;MAP3K5,GO_BP,blue,3
negative regulation of cell projection organization (GO:0031345),3/49,0.26578826442978,0.591149760542096,0,0,1.7220795508839,2.28185061105291,GFI1;PTPRO;FYN,GO_BP,blue,3
regulation of protein phosphorylation (GO:0001932),12/266,0.268474686010489,0.591444942724711,0,0,1.24943874366191,1.64301025963421,CD74;CSF1R;CD4;TGFB1;IFNG;STAT2;CCDC88C;ITGB2;TREM2;FYN;HLA-DRB1;CAMKK2,GO_BP,blue,12
innate immune response activating cell surface receptor signaling pathway (GO:0002220),6/119,0.269170090249702,0.591444942724711,0,0,1.40294171498322,1.84123725225345,FCN1;IKBKB;SYK;FYN;CARD11;PSMB9,GO_BP,blue,6
negative regulation of epithelial cell proliferation (GO:0050680),4/72,0.269184575439025,0.591444942724711,0,0,1.55360466057124,2.03888547504143,TGFB1;STAT1;NLRC3;RUNX3,GO_BP,blue,4
positive regulation of neurogenesis (GO:0050769),4/72,0.269184575439025,0.591444942724711,0,0,1.55360466057124,2.03888547504143,CX3CR1;IFNG;RGS14;PLXNA3,GO_BP,blue,4
positive regulation of protein secretion (GO:0050714),4/72,0.269184575439025,0.591444942724711,0,0,1.55360466057124,2.03888547504143,BLK;TGFB1;TREM2;ADAM8,GO_BP,blue,4
protein-containing complex assembly (GO:0065003),12/267,0.272592098484804,0.591444942724711,0,0,1.24447353350241,1.61754024866766,P2RX7;CD74;CXCL12;CASP8;AIM2;BIN2;IL2RB;LPXN;CD3G;CAPG;CD247;CD3E,GO_BP,blue,12
positive regulation of ion transport (GO:0043270),3/50,0.27577663625821,0.591444942724711,0,0,1.68535188216039,2.17100967221472,P2RX7;TRPC6;P2RX4,GO_BP,blue,3
regulation of hydrolase activity (GO:0051336),4/73,0.277349022868177,0.591444942724711,0,0,1.5310089109503,1.96348609670673,ARHGAP9;SIPA1L1;CHN2;PLXNA3,GO_BP,blue,4
positive regulation of synaptic transmission (GO:0050806),4/73,0.277349022868177,0.591444942724711,0,0,1.5310089109503,1.96348609670673,RGS14;AKAP5;CCR2;GRIN2D,GO_BP,blue,4
peptidyl-serine modification (GO:0018209),8/169,0.27799039698511,0.591444942724711,0,0,1.31323075865742,1.68115692507029,IKBKB;MAP4K1;GALNT13;PRKCH;PRKCB;RPS6KA1;PRKCQ;CAMK1G,GO_BP,blue,8
protein homooligomerization (GO:0051260),6/121,0.281719057232988,0.591444942724711,0,0,1.3783988005997,1.74621756731545,GBP5;TRPA1;AQP10;PRF1;CARD11;RYR3,GO_BP,blue,6
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),8/170,0.283273708192432,0.591444942724711,0,0,1.30505609343784,1.64612164798245,CD84;ALCAM;VCAM1;JAML;CD6;CRTAM;ITGB2;ITGAL,GO_BP,blue,8
positive regulation of protein phosphorylation (GO:0001934),16/371,0.283975241862228,0.591444942724711,0,0,1.19225450605732,1.50089130921333,CX3CR1;CD74;CSF1R;TGFB1;CREBL2;TREM2;CAMKK2;TCL1A;CD4;PTPRC;IFNG;TNFRSF14;LCP2;HLA-DRB1;CD44;LAT,GO_BP,blue,16
proteolysis involved in cellular protein catabolic process (GO:0051603),4/74,0.285552744772456,0.591444942724711,0,0,1.50905875417567,1.89134637750957,CASP8;GZMA;GZMB;CTSW,GO_BP,blue,4
cellular response to amino acid starvation (GO:0034198),4/74,0.285552744772456,0.591444942724711,0,0,1.50905875417567,1.89134637750957,DAPL1;ITFG2;ATP6V0D2;MAP3K5,GO_BP,blue,4
negative regulation of protein binding (GO:0032091),4/74,0.285552744772456,0.591444942724711,0,0,1.50905875417567,1.89134637750957,ITGA4;TMC8;MITD1;CARD16,GO_BP,blue,4
regulation of axonogenesis (GO:0050770),3/51,0.28580151543115,0.591444942724711,0,0,1.65015453296703,2.06674876929169,SIPA1L1;OMG;PLXNA3,GO_BP,blue,3
cholesterol transport (GO:0030301),3/51,0.28580151543115,0.591444942724711,0,0,1.65015453296703,2.06674876929169,MSR1;LDLRAP1;CLU,GO_BP,blue,3
mesenchymal cell differentiation (GO:0048762),3/51,0.28580151543115,0.591444942724711,0,0,1.65015453296703,2.06674876929169,AKNA;TGFB1;LOXL3,GO_BP,blue,3
negative regulation of transport (GO:0051051),3/51,0.28580151543115,0.591444942724711,0,0,1.65015453296703,2.06674876929169,TRAT1;LILRB1;WWP2,GO_BP,blue,3
positive regulation of cell motility (GO:2000147),10/221,0.290176495395454,0.59824058297282,0,0,1.25273612873116,1.54996773926957,LRRC15;CCL24;CSF1R;CARMIL2;EDN1;TGFB1;CXCL12;ITGAX;PIK3CD;CXCL16,GO_BP,blue,10
response to amino acid starvation (GO:1990928),4/75,0.293791143211371,0.605232096547227,0,0,1.48772691167639,1.82229610595862,DAPL1;ITFG2;ATP6V0D2;MAP3K5,GO_BP,blue,4
regulation of anatomical structure morphogenesis (GO:0022603),6/123,0.294395387996177,0.606016038055959,0,0,1.3546949602122,1.65656374884352,LFNG;SP100;TGFB1;SIPA1L1;STAT2;CXCL13,GO_BP,blue,6
myeloid cell differentiation (GO:0030099),3/52,0.29585480284806,0.607314370480769,0,0,1.61639381027136,1.9685841613007,IKZF1;EVI2B;JAK3,GO_BP,blue,3
regulation of signal transduction (GO:0009966),9/198,0.299788720423899,0.607314370480769,0,0,1.25840918084685,1.51597699654016,LFNG;SP100;TGFB1;RGS14;TREM2;FYN;CD3E;CLU;FOXP3,GO_BP,blue,9
establishment of protein localization to organelle (GO:0072594),4/76,0.302059690611225,0.607314370480769,0,0,1.46698762035763,1.75617581431807,SYK;LAMP3;IL10RA;HK2,GO_BP,blue,4
phospholipid metabolic process (GO:0006644),4/76,0.302059690611225,0.607314370480769,0,0,1.46698762035763,1.75617581431807,PLA2G2D;PLPPR4;MBOAT1;PLB1,GO_BP,blue,4
positive regulation of NIK/NF-kappaB signaling (GO:1901224),3/53,0.305928652546334,0.607314370480769,0,0,1.58398351648352,1.87607540834143,PDCD4;CD27;TLR7,GO_BP,blue,3
phosphatidylcholine metabolic process (GO:0046470),4/77,0.310353934287301,0.607314370480769,0,0,1.44681652880104,1.69283597371618,PLA2G2D;MBOAT1;PLA2G7;PLB1,GO_BP,blue,4
defense response to bacterium (GO:0042742),8/176,0.315476520180697,0.61351463974839,0,0,1.25805176842521,1.45137786783622,SYK;SLAMF8;S100A12;TNFRSF14;TREM2;NLRP1;CXCL13;LYZ,GO_BP,blue,8
regulation of humoral immune response (GO:0002920),3/54,0.316015474751643,0.613681663872546,0,0,1.55284421460892,1.78882078169527,CD19;CXCL13;CLU,GO_BP,blue,3
inorganic anion transport (GO:0015698),3/54,0.316015474751643,0.613681663872546,0,0,1.55284421460892,1.78882078169527,PACC1;SLC4A10;SLC26A11,GO_BP,blue,3
positive regulation of signal transduction (GO:0009967),11/252,0.316796933304129,0.614758518854502,0,0,1.20624711848778,1.38657418626756,CD74;ESM1;PTPRC;PRKCB;AXL;PDE6G;ATP6AP2;LOXL3;CD226;TREM2;IL7R,GO_BP,blue,11
negative regulation of blood vessel morphogenesis (GO:2000181),4/78,0.318669500131797,0.617949660599168,0,0,1.42719060188111,1.63213626127393,CXCL10;STAT1;FASLG;CCR2,GO_BP,blue,4
negative regulation of programmed cell death (GO:0043069),16/381,0.320220848292133,0.620513789716301,0,0,1.15897691349746,1.31977843557617,CD74;FCMR;TNFAIP8;RIPK3;TREM2;NUGGC;IKBKB;TCL1A;CD40LG;AXL;RPS6KA1;CLEC5A;IL2RB;CD27;EVI2B;CD44,GO_BP,blue,16
positive regulation of phosphorylation (GO:0042327),11/253,0.321330394288287,0.62214816096128,0,0,1.20119949494949,1.36370427251164,P2RX7;CD74;CSF1R;CD4;TGFB1;IFNG;AXL;FLT3;TREM2;HLA-DRB1;CAMKK2,GO_BP,blue,11
negative regulation of apoptotic process (GO:0043066),20/485,0.32152359739601,0.62214816096128,0,0,1.1375164466222,1.29072209868812,CX3CR1;CD74;FCMR;TNFAIP8;PRKCH;TREM2;NUGGC;IKBKB;TCL1A;CD40LG;AXL;LAMP3;CLEC5A;IL2RB;RPS6KA1;CD27;ADAM8;CARD16;EVI2B;CD44,GO_BP,blue,20
pyruvate metabolic process (GO:0006090),3/55,0.326107937597494,0.625524042217269,0,0,1.52290257819104,1.70645323715968,PFKL;HKDC1;HK2,GO_BP,blue,3
regulation of blood vessel endothelial cell migration (GO:0043535),3/55,0.326107937597494,0.625524042217269,0,0,1.52290257819104,1.70645323715968,TGFB1;P2RX4;SH3BP1,GO_BP,blue,3
positive regulation of macromolecule metabolic process (GO:0010604),16/384,0.331329756107129,0.625524042217269,0,0,1.14934630586805,1.26961523369313,CD74;TGFB1;PIK3CD;LILRB1;PTPN22;TREM2;CD3E;WNT16;CLU;P2RX7;IFNG;ADM2;LAMP3;ITGAX;STAP1;CD34,GO_BP,blue,16
glycerophospholipid metabolic process (GO:0006650),4/80,0.335347516064375,0.625524042217269,0,0,1.3894881633244,1.51813798703661,CSF1R;PLA2G2D;CPNE7;PLA2G7,GO_BP,blue,4
negative regulation of cellular component organization (GO:0051129),4/80,0.335347516064375,0.625524042217269,0,0,1.3894881633244,1.51813798703661,CARMIL2;TMC8;LILRB1;CLU,GO_BP,blue,4
autophagosome organization (GO:1905037),3/56,0.336198968426852,0.625524042217269,0,0,1.49409081484553,1.62863686967359,ATG16L2;RUFY4;ATG7,GO_BP,blue,3
glycosaminoglycan catabolic process (GO:0006027),3/56,0.336198968426852,0.625524042217269,0,0,1.49409081484553,1.62863686967359,TGFB1;LYVE1;CD44,GO_BP,blue,3
Rho protein signal transduction (GO:0007266),3/56,0.336198968426852,0.625524042217269,0,0,1.49409081484553,1.62863686967359,SHTN1;ARHGDIB;ARHGEF1,GO_BP,blue,3
positive regulation of establishment of protein localization to mitochondrion (GO:1903749),3/56,0.336198968426852,0.625524042217269,0,0,1.49409081484553,1.62863686967359,CASP8;RAC2;GZMB,GO_BP,blue,3
cellular response to interleukin-1 (GO:0071347),7/155,0.338844001180193,0.630012628138052,0,0,1.24913207406301,1.35183003092036,IKBKB;CCL24;CCL22;XCL2;CCL17;ST18;PSMB9,GO_BP,blue,7
peptidyl-serine phosphorylation (GO:0018105),7/156,0.344792837878368,0.638444154348939,0,0,1.24068374800697,1.32109433790557,IKBKB;MAP4K1;PRKCH;PRKCB;RPS6KA1;PRKCQ;CAMK1G,GO_BP,blue,7
small GTPase mediated signal transduction (GO:0007264),5/106,0.346050801738479,0.639824827346334,0,0,1.30703979488858,1.38699101248068,SHTN1;ARHGAP30;CDKN2A;CCDC88C;LAT,GO_BP,blue,5
icosanoid metabolic process (GO:0006690),3/57,0.346281753941464,0.639824827346334,0,0,1.46634615384615,1.55506378775556,CYP2S1;DPEP2;CYP4F22,GO_BP,blue,3
positive regulation of proteolysis (GO:0045862),3/57,0.346281753941464,0.639824827346334,0,0,1.46634615384615,1.55506378775556,CASP8;IFNG;ADAM8,GO_BP,blue,3
autophagosome assembly (GO:0000045),3/58,0.356349739766224,0.639824827346334,0,0,1.43961038961039,1.48545134944348,ATG16L2;RUFY4;ATG7,GO_BP,blue,3
negative regulation of neuron projection development (GO:0010977),3/58,0.356349739766224,0.639824827346334,0,0,1.43961038961039,1.48545134944348,GFI1;PTPRO;OMG,GO_BP,blue,3
positive regulation of mitochondrion organization (GO:0010822),3/58,0.356349739766224,0.639824827346334,0,0,1.43961038961039,1.48545134944348,TREM2;BMF;CAMKK2,GO_BP,blue,3
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),6/133,0.359107462657561,0.639824827346334,0,0,1.24737442302471,1.2774780539194,TGFB1;DLX5;TGFB1I1;PDCD4;LPXN;RUNX2,GO_BP,blue,6
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),3/60,0.376416383248265,0.650649641200182,0,0,1.38895315211105,1.35708965850097,OXER1;AKAP5;INSL3,GO_BP,blue,3
positive regulation of protein catabolic process (GO:0045732),4/85,0.377126057363971,0.650649641200182,0,0,1.30337765550971,1.27102231892342,IFNG;ADAM8;WWP2;ATG7,GO_BP,blue,4
positive regulation of protein modification process (GO:0031401),9/214,0.381930724248981,0.650649641200182,0,0,1.1592189716911,1.11576685059522,CD74;CSF1R;CD4;TGFB1;IFNG;TREM2;ATG7;HLA-DRB1;CAMKK2,GO_BP,blue,9
cellular divalent inorganic cation homeostasis (GO:0072503),5/111,0.382504094728614,0.650649641200182,0,0,1.24506211341546,1.19652451312814,EDN1;CXCL12;LCK;SLC8B1;CCR2,GO_BP,blue,5
response to interleukin-1 (GO:0070555),4/86,0.38546518981789,0.653048905076087,0,0,1.28741570771966,1.22729904443356,CCL24;CCL22;XCL2;CCL17,GO_BP,blue,4
negative regulation of response to stimulus (GO:0048585),3/61,0.386403214807451,0.654228943070865,0,0,1.36493463433119,1.29788066000363,CLU;CD34;FOXP3,GO_BP,blue,3
regulation of cytoskeleton organization (GO:0051493),5/112,0.389794272180019,0.659146493967335,0,0,1.2333616539224,1.16199464491818,P2RX7;SYDE1;SH3BP1;RAC2;RHOH,GO_BP,blue,5
phosphatidylinositol metabolic process (GO:0046488),5/112,0.389794272180019,0.659146493967335,0,0,1.2333616539224,1.16199464491818,CSF1R;PLA2G2D;INPP5D;PIK3CD;PIK3CG,GO_BP,blue,5
membrane organization (GO:0061024),10/242,0.391633785484728,0.661703907963358,0,0,1.13808646994117,1.0668742332263,CD4;CTTN;FCHO1;FNBP1;OTOF;CD3G;MITD1;LDLRAP1;IL7R;CD3D,GO_BP,blue,10
negative regulation of angiogenesis (GO:0016525),4/87,0.393790296445589,0.661703907963358,0,0,1.27183838517757,1.18527293616707,CXCL10;STAT1;FASLG;CCR2,GO_BP,blue,4
regulation of neurogenesis (GO:0050767),3/62,0.396351589846338,0.664326628201994,0,0,1.34173030359471,1.24170915108051,CX3CR1;IFNG;RGS14,GO_BP,blue,3
positive regulation of metabolic process (GO:0009893),5/113,0.397078476087277,0.664326628201994,0,0,1.22187786960514,1.12855248143073,SYK;IFNG;UCP2;CXCR4;CCR2,GO_BP,blue,5
protein dephosphorylation (GO:0006470),6/139,0.398423301745283,0.664326628201994,0,0,1.19072854550169,1.09575635423881,PTPRC;PTPRO;DAPP1;PTPN22;PTPN6;PTPN7,GO_BP,blue,6
response to lipid (GO:0033993),5/114,0.404354312647225,0.664326628201994,0,0,1.21060479692673,1.09615878808779,RARG;PAQR7;TGFB1;CD6;PTPN22,GO_BP,blue,5
cellular response to reactive oxygen species (GO:0034614),3/63,0.406256222207745,0.664326628201994,0,0,1.31929945054945,1.18838698782265,RIPK3;MAP3K5;CAMKK2,GO_BP,blue,3
organonitrogen compound catabolic process (GO:1901565),3/63,0.406256222207745,0.664326628201994,0,0,1.31929945054945,1.18838698782265,IL4I1;NAGK;PLA2G7,GO_BP,blue,3
collagen fibril organization (GO:0030199),4/89,0.410384758924599,0.66971826019683,0,0,1.24178331580225,1.10600688071538,LOXL3;COL8A2;COL10A1;COL9A2,GO_BP,blue,4
cellular response to lectin (GO:1990858),5/115,0.411619439017297,0.670924825690648,0,0,1.19953668920611,1.06477599721673,IKBKB;SYK;FYN;CARD11;PSMB9,GO_BP,blue,5
stimulatory C-type lectin receptor signaling pathway (GO:0002223),5/115,0.411619439017297,0.670924825690648,0,0,1.19953668920611,1.06477599721673,IKBKB;SYK;FYN;CARD11;PSMB9,GO_BP,blue,5
protein complex oligomerization (GO:0051259),4/90,0.418647532114012,0.681323286455905,0,0,1.2272799974409,1.06862451127067,PRF1;MS4A1;CARD11;HLA-DRB1,GO_BP,blue,4
ion transport (GO:0006811),5/116,0.418871563918376,0.681323286455905,0,0,1.18866800684983,1.03436812556623,TRPC6;TRPA1;SLC26A11;KCNN4;SLC8B1,GO_BP,blue,5
regulation of cell-matrix adhesion (GO:0001952),3/65,0.425914335495131,0.681722746762089,0,0,1.27660847217299,1.08960708864784,CDKN2A;CD3E;SKAP1,GO_BP,blue,3
"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",3/65,0.425914335495131,0.681722746762089,0,0,1.27660847217299,1.08960708864784,HTR7;XCR1;CNR2,GO_BP,blue,3
negative regulation of MAPK cascade (GO:0043409),4/94,0.451396882563029,0.700363204389029,0,0,1.17248968363136,0.932608050382597,P2RX7;PTPRC;RGS14;CD300A,GO_BP,blue,4
positive regulation of protein localization to nucleus (GO:1900182),3/68,0.454955155057782,0.705479974271053,0,0,1.21749788672866,0.958848283361965,TGFB1;IFNG;PYHIN1,GO_BP,blue,3
regulation of cell cycle phase transition (GO:1901987),4/95,0.459494375755878,0.710485310458147,0,0,1.15954471937966,0.901695110311523,UBD;ANAPC4;XPC;PSMB9,GO_BP,blue,4
positive regulation of protein polymerization (GO:0032273),3/69,0.464499757365371,0.71137891499775,0,0,1.19898851148851,0.91937748813439,FCHSD1;CCL24;CTTN,GO_BP,blue,3
positive regulation of protein transport (GO:0051222),3/69,0.464499757365371,0.71137891499775,0,0,1.19898851148851,0.91937748813439,TGFB1;TREM2;ADAM8,GO_BP,blue,3
regulation of vesicle-mediated transport (GO:0060627),4/96,0.467550524906357,0.71137891499775,0,0,1.14688116739429,0.871913954822457,PTPRC;SYK;SEPTIN1;CD22,GO_BP,blue,4
positive regulation of cell population proliferation (GO:0008284),18/474,0.468117236415778,0.71137891499775,0,0,1.04154056248616,0.790567312816514,CSF1R;CD74;EDN1;PRKCH;TGFB1;STAT1;FLT3;CLEC11A;SIRPG;MATK;TCL1A;ESM1;PTPRC;IFNG;ITGAX;PTPN6;IL7R;IL13RA1,GO_BP,blue,18
regulation of plasma membrane bounded cell projection assembly (GO:0120032),3/70,0.473970240094419,0.717711224379978,0,0,1.18103165491225,0.881770922406904,IFT20;P2RX4;TBC1D10C,GO_BP,blue,3
calcium ion homeostasis (GO:0055074),4/97,0.475562804294156,0.719318613530356,0,0,1.13448994986023,0.843216831091358,EDN1;CXCL12;SLC8B1;CCR2,GO_BP,blue,4
positive regulation of cold-induced thermogenesis (GO:0120162),4/97,0.475562804294156,0.719318613530356,0,0,1.13448994986023,0.843216831091358,SYK;UCP2;CXCR4;CCR2,GO_BP,blue,4
regulation of protein secretion (GO:0050708),5/125,0.483204046239884,0.724011513884071,0,0,1.09900137741047,0.799321569965822,TGFB1;IFNG;ADAM8;TREM2;SLC8B1,GO_BP,blue,5
regulation of glycolytic process (GO:0006110),3/71,0.483363155371966,0.724011513884071,0,0,1.16360294117647,0.845924250225857,P2RX7;NUP210;IFNG,GO_BP,blue,3
regulation of peptidyl-serine phosphorylation (GO:0033135),4/98,0.483528788471259,0.724011513884071,0,0,1.12236237525242,0.815558361727965,TCL1A;TGFB1;CREBL2;CD44,GO_BP,blue,4
regulated exocytosis (GO:0045055),7/180,0.487952098040262,0.724011513884071,0,0,1.06722447545748,0.765774155905742,BLK;TGFB1;SYT12;OTOF;CTSW;CLU;SYT6,GO_BP,blue,7
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",3/73,0.501903526379082,0.732895375633667,0,0,1.13023940345369,0.779127544741963,IKBKB;HLA-B;PSMB9,GO_BP,blue,3
regulation of actin filament polymerization (GO:0030833),3/73,0.501903526379082,0.732895375633667,0,0,1.13023940345369,0.779127544741963,FCHSD1;CCL24;CTTN,GO_BP,blue,3
regulation of actin filament-based process (GO:0032970),3/73,0.501903526379082,0.732895375633667,0,0,1.13023940345369,0.779127544741963,SH3BP1;RAC2;RHOH,GO_BP,blue,3
defense response to Gram-negative bacterium (GO:0050829),3/73,0.501903526379082,0.732895375633667,0,0,1.13023940345369,0.779127544741963,TREM2;TNFRSF14;LYZ,GO_BP,blue,3
positive regulation of JNK cascade (GO:0046330),3/73,0.501903526379082,0.732895375633667,0,0,1.13023940345369,0.779127544741963,CD27;WNT16;MAP3K5,GO_BP,blue,3
regulation of peptide hormone secretion (GO:0090276),3/74,0.511045104148947,0.737964385468816,0,0,1.11426249806532,0.74800154710409,IFNG;PASK;SLC8B1,GO_BP,blue,3
positive regulation of cell growth (GO:0030307),4/102,0.51488472454965,0.742717102665071,0,0,1.07632709204727,0.714479097082771,SHTN1;EDN1;RPS6KA1;CXCL16,GO_BP,blue,4
positive regulation of cellular protein metabolic process (GO:0032270),4/102,0.51488472454965,0.742717102665071,0,0,1.07632709204727,0.714479097082771,TGFB1;CASP8;PASK;ATG7,GO_BP,blue,4
cellular response to metal ion (GO:0071248),5/131,0.524700395647407,0.743475872257167,0,0,1.04634002361275,0.674813826238986,P2RX4;SYT12;CPNE7;RYR3;SYT6,GO_BP,blue,5
chloride transport (GO:0006821),3/76,0.52905779482282,0.746856470127681,0,0,1.08362185759446,0.689896091291839,PACC1;SLC4A10;GABRD,GO_BP,blue,3
cellular metal ion homeostasis (GO:0006875),4/104,0.530229071936124,0.748120081184875,0,0,1.05469050894085,0.669144337703394,EDN1;CXCL12;SLC8B1;CCR2,GO_BP,blue,4
negative regulation of nucleic acid-templated transcription (GO:1903507),17/464,0.531121058781748,0.748988520687015,0,0,1.00255672738894,0.63438310946052,ZMYND15;CIITA;TGFB1;CDKN2A;GFI1;LOXL3;WWP2;IKZF1;FOXP3;NPAS1;RUNX2;FOXS1;SCML4;IFNG;TBX21;MYB;PDCD4,GO_BP,blue,17
cellular response to UV (GO:0034644),3/77,0.537924162669718,0.756983822533882,0,0,1.06892263142263,0.662772319536044,XPC;BMF;CARD16,GO_BP,blue,3
positive regulation of endothelial cell proliferation (GO:0001938),3/77,0.537924162669718,0.756983822533882,0,0,1.06892263142263,0.662772319536044,CCL24;ITGA4;PIK3CD,GO_BP,blue,3
regulation of cell growth (GO:0001558),8/217,0.54056058290767,0.756983822533882,0,0,1.00908627661194,0.620737971384731,TGFB1;NRG3;CDKN2A;RPS6KA1;TMC8;PRKCQ;CXCL16;PAPPA2,GO_BP,blue,8
protein modification process (GO:0036211),3/78,0.546694344196143,0.761437006903523,0,0,1.05461538461538,0.636845760573121,RIPK3;ST8SIA4;WWP2,GO_BP,blue,3
antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),3/78,0.546694344196143,0.761437006903523,0,0,1.05461538461538,0.636845760573121,IKBKB;HLA-B;PSMB9,GO_BP,blue,3
negative regulation of protein serine/threonine kinase activity (GO:0071901),3/78,0.546694344196143,0.761437006903523,0,0,1.05461538461538,0.636845760573121,RGS14;CD300A;CDKN2A,GO_BP,blue,3
response to calcium ion (GO:0051592),4/107,0.552787545349961,0.767555848463887,0,0,1.02381111363363,0.606896325437039,SYT12;CPNE7;RYR3;SYT6,GO_BP,blue,4
cellular calcium ion homeostasis (GO:0006874),5/136,0.558135589292662,0.769625812215738,0,0,1.00614051689694,0.586734217581732,EDN1;CXCL12;TRPC6;SLC8B1;CCR2,GO_BP,blue,5
chemical synaptic transmission (GO:0007268),11/306,0.565568155297052,0.776939215364966,0,0,0.982645951035782,0.560033971368375,FCHSD1;GRIA2;HTR7;RPS6KA1;PNOC;NAAA;SLC1A4;AKAP5;GABRD;GRIN2D;CAMKK2,GO_BP,blue,11
positive regulation of cellular amide metabolic process (GO:0034250),3/81,0.572409206091982,0.780704793755209,0,0,1.01389475908707,0.565653050157236,IFNG;PASK;CLU,GO_BP,blue,3
regulation of cellular component organization (GO:0051128),5/139,0.577624695243836,0.78317582553331,0,0,0.983460795197566,0.539753710118477,NRG3;TMC8;PRKCQ;CD22;PAPPA2,GO_BP,blue,5
cellular protein-containing complex assembly (GO:0034622),6/168,0.58067642794391,0.786662277361805,0,0,0.976091954022989,0.530566104191057,TGFB1;TESPA1;FCHO1;VAMP1;CD3E;CLU,GO_BP,blue,6
regulation of G protein-coupled receptor signaling pathway (GO:0008277),3/82,0.580776875128686,0.786662277361805,0,0,1.0010084851857,0.543936631199256,EDN1;RGS14;PDE6G,GO_BP,blue,3
neuron projection morphogenesis (GO:0048812),5/140,0.584019167647371,0.789869158840104,0,0,0.976124885215794,0.524980925920453,DOCK10;SHTN1;ALCAM;CTTN;PLPPR4,GO_BP,blue,5
protein localization to organelle (GO:0033365),5/142,0.59664954618279,0.798973613746504,0,0,0.96177434598138,0.496684665531613,IFT20;GBP5;LAMP3;TTC21A;OTOF,GO_BP,blue,5
anaphase-promoting complex-dependent catabolic process (GO:0031145),3/84,0.597198166027378,0.799313157988225,0,0,0.976190476190476,0.503232325124583,ANAPC4;SKP2;PSMB9,GO_BP,blue,3
"positive regulation of transcription, DNA-templated (GO:0045893)",42/1183,0.601569353220535,0.801477992166716,0,0,0.968488161913327,0.492198709821783,RARG;RNASEL;CIITA;SP100;AKNA;CDCA4;DLX5;TGFB1I1;TXK;XPC;CREBL2;CAMKK2;SPIB;IKBKB;IL4I1;TBX21;MYB;RPS6KA1;TNNI2;MAP3K5;VENTX;EOMES;CD74;EDN1;TGFB1;BCL11B;STAT1;MACC1;PYHIN1;LILRB1;PBX4;POU2F2;FOXP3;RUNX3;ETV4;ST18;RUNX2;CXCL10;CD4;MZF1;SKAP1;HLA-DRB1,GO_BP,blue,42
nitrogen compound transport (GO:0071705),5/143,0.602883717263746,0.801477992166716,0,0,0.954755060486286,0.483135601882575,ARRDC5;EDN1;SLC1A4;CD3G;SLC25A45,GO_BP,blue,5
positive regulation of cell differentiation (GO:0045597),9/258,0.603965878107586,0.801477992166716,0,0,0.952174348362981,0.480122085197946,MSR1;RIPOR2;PRKCH;TGFB1;TGFB1I1;RPS6KA1;CREBL2;CD34;RUNX2,GO_BP,blue,9
negative regulation of defense response (GO:0031348),3/85,0.605249578961747,0.801477992166716,0,0,0.964235459662289,0.484156488852737,DHX58;NLRC3;AOAH,GO_BP,blue,3
proteolysis (GO:0006508),10/287,0.606212036157106,0.801477992166716,0,0,0.95094558800703,0.475972477361522,FAM111A;ST14;CASP8;UBD;GZMA;CASP1;GZMB;CTSW;NLRP1;PAPPA2,GO_BP,blue,10
positive regulation of protein metabolic process (GO:0051247),4/115,0.609980627844481,0.806067083332048,0,0,0.949626380162831,0.469426985176771,TGFB1;WWP2;CLU;ATG7,GO_BP,blue,4
regulation of autophagy (GO:0010506),8/231,0.611603026981183,0.807612211311525,0,0,0.945040904551911,0.464650015212777,IFNG;DAPL1;IL10RA;LAMP3;BMF;PTPN22;TREM2;ATP6V0D2,GO_BP,blue,8
regulation of Ras protein signal transduction (GO:0046578),3/86,0.613193587206211,0.807948165243981,0,0,0.952568515821528,0.465877056279143,SH3BP1;ARHGDIB;RASAL3,GO_BP,blue,3
glucose homeostasis (GO:0042593),3/86,0.613193587206211,0.807948165243981,0,0,0.952568515821528,0.465877056279143,HKDC1;SLC8B1;HK2,GO_BP,blue,3
negative regulation of phosphorylation (GO:0042326),3/86,0.613193587206211,0.807948165243981,0,0,0.952568515821528,0.465877056279143,TGFB1;CDKN2A;STAP1,GO_BP,blue,3
regulation of gene expression (GO:0010468),38/1079,0.618787586522009,0.808161166627525,0,0,0.960149040840684,0.460865030801224,PRDM8;TXK;NAB2;PIK3CD;CREBL2;TREM2;PTPN22;PRDM1;CD3E;CLU;CASP8;LAMP3;TBX21;MYB;ITGAX;STAP1;ERMAP;CD34;ZNF683;MSR1;CD74;TGFB1;BTN3A1;RHOH;WWP2;BTN3A3;LILRB1;WNT16;FOXP3;RUNX3;PARP15;CLK2;P2RX7;PTPRC;IFNG;ADM2;PRKCQ;MZF1,GO_BP,blue,38
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),19/547,0.623456249860948,0.810044595143074,0,0,0.947179839121553,0.447520390440731,ZMYND15;CIITA;TGFB1;CDKN2A;GFI1;LOXL3;GZMB;WWP2;IKZF1;PASK;FOXP3;NPAS1;RUNX2;FOXS1;SCML4;IFNG;TBX21;MYB;PDCD4,GO_BP,blue,19
regulation of protein binding (GO:0043393),4/118,0.630230971015262,0.813467621159338,0,0,0.924491421125027,0.426808943113981,TMC8;MITD1;CARD16;LDLRAP1,GO_BP,blue,4
negative regulation of response to external stimulus (GO:0032102),4/118,0.630230971015262,0.813467621159338,0,0,0.924491421125027,0.426808943113981,DHX58;NLRC3;CARD16;AOAH,GO_BP,blue,4
glycerophospholipid biosynthetic process (GO:0046474),6/177,0.631448311578433,0.813467621159338,0,0,0.924283121597096,0.424929174368744,PLA2G2D;CPNE7;DGKA;INPP5D;PIK3CD;PIK3CG,GO_BP,blue,6
negative regulation of cell population proliferation (GO:0008285),13/379,0.632121146664442,0.813467621159338,0,0,0.93512260833828,0.428916628724291,RARG;TGFB1;CDKN2A;CD300A;TGFB1I1;SIRPG;TREM2;NLRC3;RUNX3;FOXP3;ST18;IFNG;PTPN6,GO_BP,blue,13
regulation of cell migration (GO:0030334),14/408,0.633717098623217,0.813467621159338,0,0,0.935404852423734,0.42668739366128,LRRC15;CCL24;CSF1R;CD74;CARMIL2;EDN1;TGFB1;PIK3CD;CXCL16;DOCK10;CXCL12;RAP2B;ITGAX;PLXNA3,GO_BP,blue,14
supramolecular fiber organization (GO:0097435),12/351,0.634498738837091,0.813467621159338,0,0,0.931972872844536,0.423973080188553,RIPK3;SH3BP1;CCDC88C;COL8A2;RAC2;LOXL3;COL10A1;RHOH;COL9A2;LYZ;ARHGAP25;MYO1G,GO_BP,blue,12
regulation of type I interferon production (GO:0032479),3/89,0.636374009945465,0.815485900161904,0,0,0.919195629951444,0.415447766546678,ZBP1;DHX58;PTPN22,GO_BP,blue,3
regulation of mitotic cell cycle (GO:0007346),6/178,0.636863280329718,0.815727010124447,0,0,0.918861267040898,0.414590458224453,CUL9;TGFB1;UBD;ANAPC4;XPC;PSMB9,GO_BP,blue,6
cellular amino acid catabolic process (GO:0009063),3/90,0.643881813396637,0.819921951641521,0,0,0.908582796513831,0.399994571464606,IL4I1;HAAO;IDO2,GO_BP,blue,3
negative regulation of protein kinase activity (GO:0006469),3/90,0.643881813396637,0.819921951641521,0,0,0.908582796513831,0.399994571464606,PTPRC;IFNG;PTPRO,GO_BP,blue,3
positive regulation of autophagy (GO:0010508),3/90,0.643881813396637,0.819921951641521,0,0,0.908582796513831,0.399994571464606,IFNG;RUFY4;CAMKK2,GO_BP,blue,3
brain development (GO:0007420),5/150,0.644941692679801,0.819921951641521,0,0,0.908330958487698,0.39838974847731,EOMES;CX3CR1;CXCR4;PBX4;GRIN2D,GO_BP,blue,5
positive regulation of cellular biosynthetic process (GO:0031328),6/180,0.647550928820733,0.819921951641521,0,0,0.90820451843044,0.394667388314693,EDN1;P2RX4;IFNG;PASK;CLU;CD244,GO_BP,blue,6
central nervous system development (GO:0007417),9/268,0.649014498191615,0.821195831667952,0,0,0.914929571439267,0.395524257990552,EOMES;CX3CR1;ATP6AP2;LOXL3;CXCR4;CAPG;PBX4;NPAS1;GRIN2D,GO_BP,blue,9
axonogenesis (GO:0007409),8/240,0.654106241269102,0.826865985813345,0,0,0.907950589020842,0.38541185275964,SHTN1;CXCL12;PLPPR4;PTPRO;CXCR4;PIK3CD;PRKCQ;FYN,GO_BP,blue,8
epithelium development (GO:0060429),4/122,0.656161200068469,0.828501789098082,0,0,0.892966218264052,0.37625023415972,TGFB1;STAT1;LOXL3;CD34,GO_BP,blue,4
regulation of endothelial cell proliferation (GO:0001936),3/92,0.658566821505779,0.828501789098082,0,0,0.888072601555748,0.370938412294748,CCL24;STAT1;PIK3CD,GO_BP,blue,3
Wnt signaling pathway (GO:0016055),3/92,0.658566821505779,0.828501789098082,0,0,0.888072601555748,0.370938412294748,RARG;CCDC88C;WNT16,GO_BP,blue,3
regulation of epithelial cell proliferation (GO:0050678),3/93,0.665743686764509,0.834567166795491,0,0,0.878159340659341,0.357279599516643,TGFB1;NLRC3;RUNX3,GO_BP,blue,3
negative regulation of multicellular organismal process (GO:0051241),7/214,0.66994214939735,0.837875883179186,0,0,0.890343502282008,0.356639478530896,TIFAB;TGFB1;IFNG;PTPRO;ARHGDIB;SLAMF8;FOXP3,GO_BP,blue,7
interleukin-1-mediated signaling pathway (GO:0070498),3/94,0.672810058517107,0.837875883179186,0,0,0.868463953628789,0.344165508348648,IKBKB;ST18;PSMB9,GO_BP,blue,3
inorganic cation transmembrane transport (GO:0098662),9/274,0.674608218581256,0.838919148542307,0,0,0.893931950033973,0.351872331095246,P2RX7;KCNK6;SLC46A1;TRPC6;P2RX4;TRPA1;UCP2;KCNN4;RYR3,GO_BP,blue,9
cellular response to oxidative stress (GO:0034599),4/125,0.674789525534768,0.838919148542307,0,0,0.870690145168075,0.342489843831488,GPX8;PYCR1;WNT16;CAMKK2,GO_BP,blue,4
platelet degranulation (GO:0002576),4/125,0.674789525534768,0.838919148542307,0,0,0.870690145168075,0.342489843831488,BLK;TGFB1;CTSW;CLU,GO_BP,blue,4
regulation of cell population proliferation (GO:0042127),26/764,0.6752627491131,0.83901815061844,0,0,0.926033558207923,0.363610230613124,CSF1R;RARG;CXCL9;FLT3;TGFB1I1;SIRPG;CLU;TCL1A;ESM1;ITGAX;IL13RA1;EDN1;TGFB1;STAT1;CDKN2A;STAT2;TNFRSF9;CLEC11A;MATK;FOXP3;ST18;CXCL10;CXCL11;IFNG;PTPN6;IL7R,GO_BP,blue,26
regulation of cell differentiation (GO:0045595),5/156,0.67868688084732,0.842218396800453,0,0,0.8719646799117,0.337969503504507,TGFB1;PRKCB;RPS6KA1;RUNX3;RUNX2,GO_BP,blue,5
phosphatidylinositol biosynthetic process (GO:0006661),4/126,0.68084124311692,0.843473526892642,0,0,0.863508241820191,0.331955125742428,INPP5D;PIK3CD;SLA2;PIK3CG,GO_BP,blue,4
regulation of mitotic cell cycle phase transition (GO:1901990),6/188,0.688346801516973,0.847220120540427,0,0,0.867919666540356,0.32413544506139,UBD;CNTRL;ANAPC4;XPC;PTPN6;PSMB9,GO_BP,blue,6
cellular response to starvation (GO:0009267),5/158,0.689446703793236,0.848188519789226,0,0,0.860476421973748,0.319981823277329,DAPL1;ATP6V0D2;ATG7;ITFG2;MAP3K5,GO_BP,blue,5
negative regulation of neuron death (GO:1901215),3/98,0.699973086444424,0.85313569252595,0,0,0.831723539618277,0.296686925534501,CD200R1;ADAM8;CD34,GO_BP,blue,3
positive regulation of canonical Wnt signaling pathway (GO:0090263),4/130,0.704255573958068,0.855006095811555,0,0,0.83592061308705,0.293085434321592,TGFB1;PPM1N;ATP6AP2;PSMB9,GO_BP,blue,4
positive regulation of stress-activated MAPK cascade (GO:0032874),3/99,0.706489546470652,0.855006095811555,0,0,0.823016826923077,0.285954623094631,CD27;WNT16;MAP3K5,GO_BP,blue,3
organic acid transport (GO:0015849),3/100,0.712897072090222,0.860239718615773,0,0,0.814489634077263,0.275638138614138,SLC46A1;SLC1A4;SLC25A45,GO_BP,blue,3
cellular response to chemical stress (GO:0062197),3/101,0.7191961735356,0.861318494300592,0,0,0.806136465575241,0.265719601660452,GPX8;PYCR1;ATG7,GO_BP,blue,3
regulation of cell motility (GO:2000145),4/133,0.720983836854903,0.863077867450257,0,0,0.816352643869358,0.267060428061842,DOCK10;CSF1R;TGFB1;PLXNA3,GO_BP,blue,4
protein localization to membrane (GO:0072657),6/195,0.72139692270871,0.863190929159848,0,0,0.835467980295567,0.272835249511409,IKBKB;FYB1;ITGA4;ITGB2;ITGB7;ITGAL,GO_BP,blue,6
protein O-linked glycosylation (GO:0006493),3/102,0.725387422634408,0.864990764423676,0,0,0.797952047952048,0.256182018889032,POFUT2;GALNT5;GALNT13,GO_BP,blue,3
cellular response to organonitrogen compound (GO:0071417),3/103,0.731471449499729,0.866443444116645,0,0,0.789931318681319,0.24700922414533,P2RX7;P2RX4;RYR3,GO_BP,blue,3
regulation of insulin secretion (GO:0050796),3/104,0.737448938913544,0.867659783842211,0,0,0.782069415732782,0.23818583226204,BLK;IFNG;SLC8B1,GO_BP,blue,3
regulation of JNK cascade (GO:0046328),3/105,0.743320627195401,0.872845938046095,0,0,0.774361667744021,0.229697195430273,CD27;WNT16;MAP3K5,GO_BP,blue,3
negative regulation of gene expression (GO:0010629),10/322,0.743690210242899,0.872848339801855,0,0,0.842713112130588,0.24955323638715,MSR1;TGFB1;IFNG;GZMB;WWP2;PTPN22;CD3E;PARP15;CD34;FOXP3,GO_BP,blue,10
peptidyl-lysine modification (GO:0018205),3/106,0.749087299159518,0.873558972631569,0,0,0.76680358476475,0.221529362382385,NUP210;LOXL3;EEF1AKMT3,GO_BP,blue,3
neuron projection development (GO:0031175),5/171,0.753332069007678,0.876954348579785,0,0,0.792550366756281,0.224489220643361,DOCK10;BLK;SHTN1;CTTN;OMG,GO_BP,blue,5
regulation of cell cycle (GO:0051726),9/296,0.75836709197908,0.876954348579785,0,0,0.824452015790439,0.228033303594141,TGFB1;PTPRC;IFNG;CDKN2A;PDCD4;LILRB1;SKP2;EVI2B;RUNX3,GO_BP,blue,9
positive regulation of cellular catabolic process (GO:0031331),4/141,0.762139184664892,0.880700759137096,0,0,0.768361128123776,0.208706923511561,P2RX7;IFNG;ADAM8;ZC3HAV1,GO_BP,blue,4
negative regulation of signal transduction (GO:0009968),8/267,0.764010092931162,0.880700759137096,0,0,0.812145874386538,0.218608780391974,CX3CR1;CYP26B1;PTPRC;RGS14;PRKCB;PRKCQ;WWP2;CARD16,GO_BP,blue,8
"negative regulation of transcription, DNA-templated (GO:0045892)",31/948,0.765601997132668,0.880700759137096,0,0,0.886293815236018,0.236722723554922,ZMYND15;RARG;CIITA;SP100;GFI1;NAB2;LOXL3;FASLG;IKZF1;PRDM1;SLA2;NPAS1;FOXS1;SCML4;TBX21;MYB;EOMES;EDN1;TGFB1;STAT1;CDKN2A;WWP2;FOXP3;RUNX3;PARP15;RUNX2;ETV7;IFNG;PDCD4;MZF1;HOXD9,GO_BP,blue,31
cation transport (GO:0006812),5/174,0.766590029547904,0.880700759137096,0,0,0.778359169967562,0.206890305345207,KCNK6;TRPC6;SLC5A2;KCNN4;SLC8B1,GO_BP,blue,5
neuron differentiation (GO:0030182),5/174,0.766590029547904,0.880700759137096,0,0,0.778359169967562,0.206890305345207,BHLHE22;PBX4;WNT16;RUNX3;RUNX2,GO_BP,blue,5
monocarboxylic acid metabolic process (GO:0032787),4/143,0.771656902114307,0.884531376242203,0,0,0.757226405945395,0.196284635953427,CYP26B1;CYP2S1;NAAA;AOAH,GO_BP,blue,4
regulation of protein serine/threonine kinase activity (GO:0071900),3/111,0.776375895262332,0.885931887222265,0,0,0.731112637362637,0.185058115801995,CSF1R;TCL1A;IFNG,GO_BP,blue,3
anterograde trans-synaptic signaling (GO:0098916),7/244,0.792402725144186,0.897415962548328,0,0,0.776417931323869,0.180661214017612,GRIA2;HTR7;RPS6KA1;PNOC;AKAP5;GABRD;CAMKK2,GO_BP,blue,7
protein transport (GO:0015031),11/369,0.795182501787521,0.898931371587093,0,0,0.807033674736189,0.184958906039966,ARRDC5;CD74;CTTN;PRKCB;IL10RA;TBC1D10C;STX6;RABL2B;CD3G;ATP6V0D2;CLU,GO_BP,blue,11
cellular response to organic cyclic compound (GO:0071407),4/150,0.802623040411214,0.903992279402085,0,0,0.720657232763656,0.158450988171871,P2RX7;TGFB1;P2RX4;RYR3,GO_BP,blue,4
protein polyubiquitination (GO:0000209),9/314,0.814719953346453,0.910237598801888,0,0,0.775060169837882,0.158818230697284,ZNRF2;MARCHF1;NHLRC4;ANAPC4;WWP2;SKP2;RNF166;FBXO41;PSMB9,GO_BP,blue,9
positive regulation of Wnt signaling pathway (GO:0030177),4/153,0.814812173161528,0.910237598801888,0,0,0.706036575796461,0.144594634841627,TGFB1;PPM1N;ATP6AP2;PSMB9,GO_BP,blue,4
cytoskeleton organization (GO:0007010),3/120,0.819324487037239,0.913387765031488,0,0,0.674556213017752,0.134422239621443,CCL24;RAC2;RHOH,GO_BP,blue,3
positive regulation of epithelial cell proliferation (GO:0050679),3/123,0.83199173771326,0.922499538388231,0,0,0.657589285714286,0.120952218083142,CCL24;JAML;PIK3CD,GO_BP,blue,3
cellular response to growth factor stimulus (GO:0071363),4/158,0.833750424204475,0.922642932667452,0,0,0.682934671930545,0.124171983106461,TGFB1;DLX5;RUNX2;CD44,GO_BP,blue,4
skeletal system development (GO:0001501),4/158,0.833750424204475,0.922642932667452,0,0,0.682934671930545,0.124171983106461,DLX5;COL10A1;COL9A2;CD44,GO_BP,blue,4
non-canonical Wnt signaling pathway (GO:0035567),3/124,0.836041307159473,0.924800286278077,0,0,0.652120606666061,0.116779969240337,PDE6G;CCDC88C;PSMB9,GO_BP,blue,3
circulatory system development (GO:0072359),3/126,0.843888579307105,0.9282193931007,0,0,0.641450013401233,0.108876394955999,TGFB1;CASP8;PDLIM2,GO_BP,blue,3
negative regulation of cell growth (GO:0030308),3/126,0.843888579307105,0.9282193931007,0,0,0.641450013401233,0.108876394955999,TGFB1;CDKN2A;TRIM46,GO_BP,blue,3
plasma membrane bounded cell projection organization (GO:0120036),3/128,0.851408321636908,0.933413655732247,0,0,0.631120879120879,0.101524282975322,BLK;CSF1R;CTTN,GO_BP,blue,3
heart development (GO:0007507),4/164,0.854315891728866,0.935540652359791,0,0,0.657118294360385,0.103466072767059,TGFB1;CASP8;PDLIM2;TBX19,GO_BP,blue,4
positive regulation of macromolecule biosynthetic process (GO:0010557),3/129,0.855048488600928,0.935540652359791,0,0,0.626079277864992,0.098042199183254,CIITA;IFNG;PASK,GO_BP,blue,3
DNA repair (GO:0006281),8/298,0.856459851435227,0.93554424900727,0,0,0.724147469833548,0.112205084456628,DCLRE1B;FAM111A;LIG1;TDP1;USP3;APLF;XPC;FANCB,GO_BP,blue,8
regulation of neuron projection development (GO:0010975),4/165,0.857524927354678,0.936330120195011,0,0,0.653002639965142,0.100369790733684,SIPA1L1;GFI1;PTPRO;MBOAT1,GO_BP,blue,4
regulation of macromolecule metabolic process (GO:0060255),5/200,0.859628756655656,0.93749368026577,0,0,0.673659673659674,0.101894165731698,ZNF683;PTPRC;TXK;TREM2;PRDM1,GO_BP,blue,5
cellular response to hypoxia (GO:0071456),3/131,0.862095659100321,0.939049915763076,0,0,0.616232400412088,0.0914421349557237,ADAM8;CARD16;PSMB9,GO_BP,blue,3
generation of neurons (GO:0048699),5/202,0.865289328948481,0.940266523427346,0,0,0.666750569842402,0.0964730358260118,CX3CR1;BHLHE22;WNT16;RUNX3;RUNX2,GO_BP,blue,5
negative regulation of transcription by RNA polymerase II (GO:0000122),20/684,0.875310475381426,0.946215513889977,0,0,0.788173792215275,0.104966326785585,EOMES;RARG;CIITA;EDN1;SP100;STAT1;GFI1;WWP2;FASLG;PRDM1;SLA2;FOXP3;RUNX3;PARP15;ETV7;IFNG;TBX21;MYB;MZF1;HOXD9,GO_BP,blue,20
organic substance transport (GO:0071702),3/136,0.878411538885143,0.948054525434204,0,0,0.592910848549946,0.0768650051309177,ARRDC5;ABCA4;CD3G,GO_BP,blue,3
plasma membrane bounded cell projection assembly (GO:0120031),7/278,0.885905511970828,0.94971034108784,0,0,0.677794540376343,0.0821114058314268,IFT20;P2RX7;SHTN1;RAP2B;NME8;PTPRO;RABL2B,GO_BP,blue,7
positive regulation of transcription by RNA polymerase II (GO:0045944),27/908,0.889641203467997,0.952207830973846,0,0,0.800478536786709,0.0936055904435446,RARG;RNASEL;CIITA;AKNA;DLX5;TXK;SPIB;IKBKB;IL4I1;MYB;RPS6KA1;VENTX;EOMES;EDN1;TGFB1;BCL11B;STAT1;MACC1;LILRB1;POU2F2;FOXP3;ETV4;ST18;RUNX2;CXCL10;MZF1;SKAP1,GO_BP,blue,27
regulation of translation (GO:0006417),4/178,0.894035930288173,0.954648535731439,0,0,0.603804012711663,0.0676316733371816,RPS6KA1;GZMB;PASK;SHFL,GO_BP,blue,4
neuron development (GO:0048666),3/143,0.898369199188362,0.957012253480642,0,0,0.563059262166405,0.0603454035762832,BLK;PBX4;RUNX3,GO_BP,blue,3
negative regulation of cell migration (GO:0030336),3/144,0.900966356572757,0.957519756749941,0,0,0.559036707972878,0.0583004636294549,CD74;RAP2B;ARHGDIB,GO_BP,blue,3
regulation of canonical Wnt signaling pathway (GO:0060828),6/253,0.904194552168729,0.958728957954791,0,0,0.637341895853693,0.0641871670612744,TGFB1;PPM1N;CCDC88C;PTPRO;ATP6AP2;PSMB9,GO_BP,blue,6
negative regulation of protein phosphorylation (GO:0001933),3/152,0.919678435460375,0.968289499285719,0,0,0.528800059001401,0.0442770617611625,TGFB1;PTPRC;PTPN6,GO_BP,blue,3
negative regulation of cell differentiation (GO:0045596),4/191,0.922069065729751,0.970052465655105,0,0,0.561445836306262,0.0455529919381042,TGFB1;IFNG;MYB;PDCD4,GO_BP,blue,4
double-strand break repair (GO:0006302),3/164,0.941753391597559,0.978859575604275,0,0,0.489079243737629,0.0293505409396954,DCLRE1B;TDP1;APLF,GO_BP,blue,3
DNA metabolic process (GO:0006259),6/277,0.94203157475236,0.978859575604275,0,0,0.580165415447258,0.0346454399800929,DCLRE1B;SP100;LIG1;TDP1;USP3;XPC,GO_BP,blue,6
negative regulation of canonical Wnt signaling pathway (GO:0090090),3/165,0.943313170608134,0.978859575604275,0,0,0.486034798534799,0.0283635089977388,CCDC88C;PTPRO;PSMB9,GO_BP,blue,3
cellular response to DNA damage stimulus (GO:0006974),8/350,0.9446466359717,0.97898184815984,0,0,0.612360777462328,0.0348704874217817,BLK;FAM111A;LIG1;TDP1;USP3;APLF;CTLA4;XPC,GO_BP,blue,8
proteasomal protein catabolic process (GO:0010498),4/205,0.944650627940133,0.97898184815984,0,0,0.521956927877805,0.0297202930989651,TBX21;WWP2;SKP2;PSMB9,GO_BP,blue,4
ubiquitin-dependent protein catabolic process (GO:0006511),8/354,0.94883735322891,0.982193500151746,0,0,0.605153542960849,0.0317813827218474,TGFB1I1;UBD;TBX21;ANAPC4;WWP2;SKP2;RNF166;PSMB9,GO_BP,blue,8
regulation of nucleic acid-templated transcription (GO:1903506),10/430,0.954905020955383,0.985582852598644,0,0,0.622448979591837,0.0287219109653386,PRDM8;TBX21;MYB;NAB2;RHOH;PRKCQ;CREBL2;MZF1;FOXP3;RUNX3,GO_BP,blue,10
cellular protein localization (GO:0034613),7/329,0.958772948378957,0.987197231911287,0,0,0.568910641364401,0.0239517017118981,FCN1;CD74;CTTN;SEPTIN1;TBC1D10C;STX6;RABL2B,GO_BP,blue,7
"regulation of transcription, DNA-templated (GO:0006355)",68/2244,0.961219068515983,0.988142614096165,0,0,0.805665535444947,0.0318664382284938,PRDM8;ZMYND15;CIITA;TGFB1I1;GFI1;NAB2;LOXL3;IKZF1;PRDM1;IKZF3;SPIB;IKBKB;ZNF80;SCML4;MYB;RPS6KA1;MAP3K5;VENTX;ZNF683;EOMES;PRKCB;RHOH;PAX5;FOXP3;RUNX3;ETV4;RUNX2;KLF17;ETV7;MYCL;MAF;IFNG;PRKCQ;MZF1;SKAP1;HOXB5;SP100;RGS14;DLX5;SP140;XPC;CREBL2;BHLHE22;NPAS1;CAMKK2;FOXS1;TBX21;ZNF789;TNNI2;ZNF700;ZNF101;CD74;TGFB1;BCL11B;STAT1;CDKN2A;STAT2;PYHIN1;WWP2;PBX4;POU2F2;TBX19;ST18;CD4;ZNF616;PDCD4;HOXD9;HLA-DRB1,GO_BP,blue,68
protein stabilization (GO:0050821),3/179,0.961443665777139,0.988142614096165,0,0,0.447045142357642,0.01757750457165,PYHIN1;CREBL2;CLU,GO_BP,blue,3
"transcription, DNA-templated (GO:0006351)",4/221,0.963039430749216,0.988574162525843,0,0,0.483065942355111,0.0181927089114444,ETV7;MAF;CREBL2;PAX5,GO_BP,blue,4
intracellular protein transport (GO:0006886),7/336,0.964493527697482,0.988574162525843,0,0,0.55660044669096,0.0201223068380503,CD74;TGFB1;SYK;CTTN;TBC1D10C;STX6;RABL2B,GO_BP,blue,7
negative regulation of Wnt signaling pathway (GO:0030178),3/191,0.972495348515736,0.993397397861663,0,0,0.418247311199439,0.0116649118706309,CCDC88C;PTPRO;PSMB9,GO_BP,blue,3
regulation of cellular macromolecule biosynthetic process (GO:2000112),10/468,0.978304479405534,0.9952034677843,0,0,0.569653986154601,0.0124949778143275,PRDM8;TBX21;MYB;NAB2;RHOH;PRKCQ;CREBL2;MZF1;FOXP3;RUNX3,GO_BP,blue,10
modification-dependent protein catabolic process (GO:0019941),3/201,0.979340287295463,0.995571015952034,0,0,0.396915584415584,0.00828605349285804,UBD;ANAPC4;RNF166,GO_BP,blue,3
mitotic cell cycle phase transition (GO:0044772),3/209,0.983614088077462,0.997607848971113,0,0,0.381341352821935,0.00630038674817908,CDKN2A;CNTRL;SKP2,GO_BP,blue,3
post-translational protein modification (GO:0043687),6/345,0.987936012468135,0.999599706831174,0,0,0.462129996948428,0.00560903261266812,CUL9;UBD;TNC;SKP2;FBXO41;PSMB9,GO_BP,blue,6
organelle assembly (GO:0070925),8/425,0.988648113300628,0.999599706831174,0,0,0.500233837826005,0.00571107527048967,IFT20;BIN2;ATG16L2;RUFY4;NME8;RABL2B;ATG7;CD34,GO_BP,blue,8
cilium assembly (GO:0060271),5/314,0.990489031878419,0.999599706831174,0,0,0.422584182513574,0.00403841991822501,IFT20;RPGRIP1;NME8;CNTRL;RABL2B,GO_BP,blue,5
cilium organization (GO:0044782),3/228,0.990636208604174,0.999599706831174,0,0,0.348791208791209,0.00328139535978447,IFT20;NME8;RABL2B,GO_BP,blue,3
regulation of transcription by RNA polymerase II (GO:0006357),62/2206,0.991136470610653,0.999599706831174,0,0,0.740237991656069,0.00659037150837231,RARG;CIITA;GFI1;FASLG;IKZF1;PRDM1;SLA2;IKZF3;SPIB;IKBKB;IL4I1;ZNF80;MYB;RPS6KA1;VENTX;ZNF683;EOMES;EDN1;PRKCB;PAX5;FOXP3;RUNX3;ETV4;RUNX2;KLF17;ETV7;MYCL;MAF;IFNG;MZF1;SKAP1;HOXB5;CSF1R;RNASEL;SP100;AKNA;DLX5;TXK;SP140;BHLHE22;NPAS1;FOXS1;TBX21;ZNF789;ZNF700;ZNF101;TGFB1;BCL11B;STAT1;CDKN2A;STAT2;MACC1;WWP2;LILRB1;PBX4;POU2F2;PARP15;TBX19;ST18;CXCL10;ZNF616;HOXD9,GO_BP,blue,62
transcription by RNA polymerase II (GO:0006366),5/320,0.991871070434608,0.999599706831174,0,0,0.414403778040142,0.00338242557479332,ETV7;RARG;MAF;PAX5;POU2F2,GO_BP,blue,5
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),5/321,0.992081966040464,0.999599706831174,0,0,0.41307057920982,0.00328372441902784,TBX21;ANAPC4;WWP2;SKP2;PSMB9,GO_BP,blue,5
nervous system development (GO:0007399),8/447,0.993135957985067,0.999779007871254,0,0,0.474610661096356,0.00326897960426839,TGFB1;DLX5;AXL;NAB2;ST8SIA4;CXCR4;CAPG;NPAS1,GO_BP,blue,8
protein deubiquitination (GO:0016579),3/267,0.997130567536439,0.99999379930395,0,0,0.296656468531469,0.000852459324303515,USP3;SKP2;PSMB9,GO_BP,blue,3
protein ubiquitination (GO:0016567),9/525,0.997236797454299,0.99999379930395,0,0,0.453029375764994,0.00125354462193832,CUL9;ZNRF2;MARCHF1;UBD;WWP2;SKP2;RNF166;FBXO41;PSMB9,GO_BP,blue,9
protein modification by small protein removal (GO:0070646),3/276,0.997827932489247,0.99999379930395,0,0,0.286740731795677,0.000623497612394996,USP3;SKP2;PSMB9,GO_BP,blue,3
cellular protein metabolic process (GO:0044267),6/417,0.99808714691905,0.99999379930395,0,0,0.379723131135162,0.000727050153265264,RIPK3;TNC;ST8SIA4;WWP2;CSF2RB;PAPPA2,GO_BP,blue,6
protein modification by small protein conjugation (GO:0032446),5/409,0.999298176444343,0.99999379930395,0,0,0.321594659465947,0.000225781946201673,CUL9;NUP210;UBD;WWP2;ATG7,GO_BP,blue,5
cellular macromolecule biosynthetic process (GO:0034645),3/314,0.999341365449367,0.99999379930395,0,0,0.251201370976291,0.000165504411538193,PIF1;FAM111A;CREBL2,GO_BP,blue,3
gene expression (GO:0010467),3/356,0.999827342060515,0.99999379930395,0,0,0.22082308626218,3.81301508961116e-05,RNASEL;NUP210;CREBL2,GO_BP,blue,3
T Memory Cells,93/133,2.57685763208073e-103,4.38065797453724e-101,0,0,70.0743338557994,16552.9376932321,ARHGAP9;ITK;TRAF3IP3;DGKA;GPR65;SIRPG;GIMAP2;PRF1;CD3G;CTSW;IKZF1;CD3E;ITGAL;CD3D;GPR174;SIT1;TRBC2;GPR171;TRBC1;TAGAP;TBC1D10C;ITGB7;UBASH3A;CCR6;CCR5;CD96;GBP5;CD52;CD300A;THEMIS;RHOH;TMC8;ARHGAP45;ZAP70;NCR3;GVINP1;BIN2;JAML;LCK;DPEP2;ARHGEF1;CD48;LCP2;PTPRCAP;LTB;HCST;SKAP1;SP100;SELPLG;KLRB1;CXCR6;RASAL3;CST7;IL2RG;LY9;CYTH4;CXCR3;TBX21;SLAMF6;ICOS;TIGIT;C16ORF54;P2RY10;SEPTIN1;TRAT1;PYHIN1;GZMA;IL10RA;SH2D1A;NKG7;GZMB;ARHGAP25;SNX20;GZMH;CD2;GZMK;CD4;ARHGAP30;PTPRC;CD40LG;PARVG;CD6;CD5;CD7;CD27;TNFSF8;CD247;CD69;IL7R;EVI2B;LAT;CD244;MYO1G,PanglaoDB,blue,93
NK Cells,94/157,1.36644358460958e-94,1.16147704691814e-92,0,0,44.9867683337071,9723.0256580691,ARHGAP9;ITK;TRAF3IP3;TRBV19;GPR65;SIRPG;PRF1;CD3G;CTSW;FASLG;CD3E;ITGAL;CD3D;GPR171;TRBC1;TAGAP;ITGAX;UBASH3A;CCR5;CD96;GBP5;CD52;CD300A;FCRL6;THEMIS;TRGV10;NCR1;ZAP70;NCR3;BIN2;CD8B;JAML;IFNG;CD8A;DPEP2;XCL2;CD48;LCP2;LTB;DOCK2;HCST;SELPLG;KLRB1;TXK;CXCR4;AOAH;RASAL3;CST7;IL2RG;KLRK1;CYTH4;CXCR3;TBX21;SLAMF7;SLAMF6;KLRC1;ICOS;IL12RB1;TIGIT;TRGC2;SAMD3;P2RY10;TGFB1;TRAT1;PYHIN1;GZMA;IL10RA;SH2D1A;STYK1;NKG7;GZMB;LILRB1;ARHGAP25;SNX20;GZMH;CD2;GZMK;GZMM;ARHGAP30;PTPRC;CD40LG;PARVG;CD6;CD5;CD7;IL2RB;CD27;TNFSF8;CD247;CD69;EVI2B;LAT;CD244;MYO1G,PanglaoDB,blue,94
T Cells,93/165,4.48217230259606e-90,2.53989763813777e-88,0,0,38.8653996865204,7995.87780571463,ARHGAP9;ITK;TRAF3IP3;TRBV19;GPR65;SIRPG;GIMAP2;PRF1;CD3G;CTSW;PTPN22;CD3E;ITGAL;CD3D;GPR174;SIT1;TRBC2;GPR171;MYB;TRBC1;TAGAP;TBC1D10C;UBASH3A;CCR5;CCR2;TRBV20-1;CD96;GBP5;CD52;LAG3;THEMIS;RHOH;TRGV10;ZAP70;NCR3;BIN2;CD8B;JAML;IFNG;CD8A;LCK;CD48;LCP2;PTPRCAP;LTB;HCST;SKAP1;SELPLG;KLRB1;TRBV5-1;TXK;CXCR4;CXCR6;RASAL3;CST7;IL2RG;CYTH4;CXCR3;TBX21;SLAMF6;ICOS;TIGIT;P2RY10;SEPTIN1;TRAT1;PYHIN1;GZMA;IL10RA;SH2D1A;TRBV29-1;NKG7;GZMB;SNX20;GZMH;CD2;GZMK;CD4;ARHGAP30;PTPRC;CD40LG;PARVG;CD6;CD5;CD7;IL2RB;TNFSF8;CD247;CD69;IL7R;EVI2B;LAT;CD244;MYO1G,PanglaoDB,blue,93
Natural Killer T Cells,79/118,3.02001088198037e-85,1.28350462484166e-83,0,0,59.7439830108542,11627.0437369026,ARHGAP9;ITK;TRAF3IP3;GPR65;SIRPG;ITGB2;PRF1;CTSW;FASLG;IKZF1;CD3E;ITGAL;CD3D;GPR174;TRBC2;GPR171;TRBC1;TAGAP;UBASH3A;CCR5;CD96;GBP5;CD52;CD300A;THEMIS;ZAP70;NCR3;GVINP1;BIN2;JAML;DPEP2;CD48;LCP2;PTPRCAP;ZNF831;LTB;CD44;SELPLG;KLRB1;CXCR4;AOAH;RASAL3;CST7;IL2RG;CYTH4;CXCR3;TBX21;SLAMF7;SLAMF6;ICOS;IL12RB1;TIGIT;P2RY10;TRAT1;PYHIN1;GZMA;IL10RA;SH2D1A;STYK1;NKG7;GZMB;ARHGAP25;SNX20;GZMH;CD2;GZMK;ARHGAP30;PTPRC;CD40LG;PARVG;CD6;CD5;IL2RB;TNFSF8;CD247;CD69;EVI2B;CD244;MYO1G,PanglaoDB,blue,79
T Cytotoxic Cells,74/102,4.17074034762137e-84,1.41805171819127e-82,0,0,77.3991085018482,14859.781641067,ITK;TRAF3IP3;TRBV19;SIRPG;PRF1;CD3G;CTSW;FASLG;CD3E;ITGAL;CD3D;TRBV6-5;GPR174;SIT1;TRBC2;GPR171;TRBC1;TAGAP;TBC1D10C;CTLA4;UBASH3A;TRBV20-1;CD96;GBP5;CD52;THEMIS;TRGV10;ZAP70;NCR3;BIN2;CD8B;JAML;CD8A;LCK;CD48;PTPRCAP;ZNF831;LTB;KLRB1;TRBV5-1;TRBV3-1;RASAL3;CST7;IL2RG;CXCR3;TBX21;SLAMF6;ICOS;TIGIT;TRAV19;P2RY10;TRAT1;TRBV2;PYHIN1;TRAV12-2;GZMA;SH2D1A;TRBV29-1;NKG7;GZMB;GZMH;CD2;GZMK;GZMM;PTPRC;CD40LG;CD6;CD5;IL2RB;CD27;TNFSF8;TRAV8-6;CD247;CD69,PanglaoDB,blue,74
T Regulatory Cells,74/117,5.30301088114434e-77,1.50251974965756e-75,0,0,50.3601288449966,8844.78857953991,ITK;CD84;TRAF3IP3;TRBV19;GPR65;SIRPG;ITGB2;PRF1;FASLG;CD3E;ITGAL;CD3D;GPR171;TRBC1;TAGAP;CTLA4;UBASH3A;CCR5;CCR4;JAK3;CD96;GBP5;CD52;LAG3;CD300A;TNFRSF18;IZUMO1R;FOXP3;ZAP70;MAF;BIN2;JAML;CD48;LCP2;LTB;HCST;SELPLG;KLRB1;TRBV5-1;SP140;AOAH;RASAL3;IL2RG;CYTH4;CXCR3;TBX21;SLAMF7;SLAMF6;ICOS;TIGIT;P2RY10;TRAT1;PYHIN1;GZMA;IL10RA;SH2D1A;GZMB;SNX20;GZMH;CD2;GZMK;CD4;ARHGAP30;PTPRC;CD40LG;PARVG;CD6;CD5;IL2RB;HLA-DPB1;TNFSF8;CD247;CD69;EVI2B,PanglaoDB,blue,74
T Cells Naive,70/102,9.72165044357459e-77,2.3609722505824e-75,0,0,63.6625378214826,11142.5163770345,ARHGAP9;TRAF3IP3;TRBV19;GPR65;SIRPG;ITGB2;PRF1;IKZF1;CD3E;ITGAL;CD3D;GPR174;SIT1;TRBC2;GPR171;TRBC1;TAGAP;TBC1D10C;CD37;UBASH3A;CCR5;CD96;GBP5;CD52;CD300A;ZAP70;BIN2;JAML;DPEP2;CD48;LCP2;PTPRCAP;LTB;HCST;SELPLG;KLRB1;TRBV5-1;AOAH;RASAL3;CST7;IL2RG;CYTH4;CXCR3;TBX21;SLAMF6;ICOS;P2RY10;TRAT1;PYHIN1;GZMA;IL10RA;SH2D1A;NKG7;GZMB;ARHGAP25;SNX20;GZMH;CD2;GZMK;CD4;ARHGAP30;PTPRC;CD40LG;PARVG;CD6;CD5;TNFSF8;CD247;CD244;MYO1G,PanglaoDB,blue,70
Thymocytes,70/118,5.90763935932522e-70,1.25537336385661e-68,0,0,42.4063918305598,6759.77859993469,ARHGAP9;TRAF3IP3;GPR65;SIRPG;ITGB2;PRF1;IKZF1;CD3E;ITGAL;CD3D;GPR174;SIT1;TRBC1;TAGAP;TBC1D10C;CD37;UBASH3A;CCR5;CCR2;GBP5;CD52;CD300A;TMC8;ZAP70;BIN2;JAML;CD8A;DPEP2;CD48;LCP2;PTPRCAP;LTB;HCST;SELPLG;CXCR4;AOAH;RASAL3;CST7;IL2RG;CD1A;CYTH4;CXCR3;TBX21;UCP2;SLAMF6;ICOS;P2RY10;TRAT1;GZMA;IL10RA;SH2D1A;NKG7;GZMB;ARHGAP25;SNX20;GZMH;CD2;GZMK;CD4;ARHGAP30;PTPRC;PARVG;CD5;CD27;TNFSF8;CD247;CD69;EVI2B;CD244;MYO1G,PanglaoDB,blue,70
Decidual Cells,67/106,1.05442255450779e-69,1.9916870474036e-68,0,0,49.7532437442076,7902.07775142537,TRBV19;SIRPG;PRF1;CTSW;FASLG;CD3E;CD3D;TRBV6-5;TRBC2;GPR171;TRBC1;UBASH3A;ZNF683;TRBV20-1;CD96;GBP5;CD52;FCRL6;TRGV10;ZAP70;NCR3;CD8B;JAML;IFNG;CD8A;LCK;XCL2;CD48;PTPRCAP;LTB;HCST;SKAP1;KLRB1;TRBV5-1;TRBV3-1;CST7;IL2RG;KLRK1;CXCR3;TBX21;SLAMF6;KLRC1;ICOS;TIGIT;TRGC2;P2RY10;TRAT1;TRBV2;PYHIN1;TRAV12-2;GZMA;SH2D1A;TRBV29-1;NKG7;GZMB;GZMH;CD2;GZMK;GZMM;CD40LG;CD5;CD7;IL2RB;TNFSF8;TRAV8-6;CD247;CD244,PanglaoDB,blue,67
B Cells Naive,76/151,1.8675753459282e-68,3.17487808807794e-67,0,0,29.694534351145,4630.89664241406,ARHGAP9;CD84;TRAF3IP3;GPR65;DOCK8;IKZF1;ITGAL;IKZF3;GPR174;SPIB;TCL1A;SIT1;TAGAP;TBC1D10C;CD37;HLA-DOB;FCRL1;MAP4K1;CD52;FCRL2;CD300A;FCRL3;RHOH;TMC8;GVINP1;BIN2;JAML;LINC00926;DPEP2;CD48;LCP2;TLR10;PTPRCAP;LTB;WDFY4;MS4A1;BLK;SP140;CXCR5;CD1C;RASAL3;IL2RG;LY9;ADAM28;CYTH4;CD19;TBX21;BTLA;STAP1;SLAMF6;IL12RB1;C16ORF54;CD74;P2RY10;CD72;NAPSB;PYHIN1;IL10RA;CLEC17A;NKG7;LILRB1;ARHGAP25;SNX20;CD2;ARHGAP30;PTPRC;PARVG;PNOC;TNFSF8;CD69;EVI2B;CD22;GPR18;CD244;GAPT;MYO1G,PanglaoDB,blue,76
B Cells Memory,75/147,3.85023584568105e-68,5.9503644887798e-67,0,0,30.4830411585366,4731.81090237625,ARHGAP9;CD84;TRAF3IP3;TNFRSF13B;GPR65;IKZF1;ITGAL;IKZF3;GPR174;SPIB;TCL1A;SIT1;TAGAP;TBC1D10C;CD37;CCR6;HLA-DOB;FCRL1;MAP4K1;CD52;FCRL2;CD300A;FCRL3;RHOH;TMC8;PAX5;AIM2;BIN2;JAML;BTK;DPEP2;CD48;TLR10;PTPRCAP;LTB;WDFY4;MS4A1;BLK;SP140;CXCR5;CD1C;RASAL3;IL2RG;LY9;ADAM28;CYTH4;CD19;TBX21;BTLA;STAP1;SLAMF6;IL12RB1;P2RY10;CD72;NAPSB;PYHIN1;IL10RA;CLEC17A;NKG7;LILRB1;ARHGAP25;SNX20;TMEM156;ARHGAP30;PTPRC;PARVG;PNOC;CD27;CD69;EVI2B;CD22;GPR18;CD244;GAPT;MYO1G,PanglaoDB,blue,75
T Follicular Helper Cells,66/110,1.9035534378732e-66,2.6967007036537e-65,0,0,43.3646616541353,6562.23954740666,ARHGAP9;CD84;TRAF3IP3;GPR65;SIRPG;ITGB2;GIMAP2;PRF1;IKZF1;CD3E;ITGAL;CD3D;GPR171;TRBC1;TAGAP;TBC1D10C;CD37;UBASH3A;CCR5;GBP5;CD52;CD300A;ZAP70;BIN2;JAML;DPEP2;CD48;LCP2;LTB;HCST;SELPLG;CXCR5;AOAH;RASAL3;CST7;IL2RG;CYTH4;TBX21;SLAMF6;ICOS;P2RY10;TRAT1;PYHIN1;GZMA;IL10RA;SH2D1A;NKG7;GZMB;ARHGAP25;SNX20;GZMH;CD2;GZMK;P2RX7;CD4;ARHGAP30;PTPRC;CD40LG;PARVG;CD6;CD5;TNFSF8;CD247;EVI2B;CD244;MYO1G,PanglaoDB,blue,66
T Helper Cells,73/148,6.45610147365383e-65,8.44259423477809e-64,0,0,28.3923404255319,4196.47324512111,ITK;TRAF3IP3;TRBV19;GPR65;SIRPG;GIMAP2;PRF1;CD3G;FASLG;CD3E;ITGAL;CD3D;TRBV6-5;GPR174;GPR171;TRBC1;TAGAP;CTLA4;UBASH3A;CCR6;CCR5;CCR4;CD96;GBP5;CD52;THEMIS;FOXP3;ZAP70;BIN2;JAML;IFNG;CD48;LCP2;LTB;KLRB1;TRBV5-1;CXCR4;RASAL3;CST7;IL2RG;CYTH4;CXCR3;TBX21;SLAMF6;ICOS;TIGIT;P2RY10;TRAT1;TRBV2;PYHIN1;TRAV12-2;GZMA;IL10RA;SH2D1A;TRBV29-1;NKG7;GZMB;SNX20;GZMH;CD2;GZMK;CD4;ARHGAP30;PTPRC;CD40LG;CD6;CD5;IL2RB;TNFSF8;TRAV8-6;CD247;CD69;MYO1G,PanglaoDB,blue,73
Nuocytes,63/110,1.29183282559307e-61,1.56865414536301e-60,0,0,38.5713466683654,5407.76562280759,ITK;TRAF3IP3;TRBV19;SIRPG;PRF1;CD3G;FASLG;CD3E;CD3D;TRBV6-5;GPR174;TRBC2;GPR171;TRBC1;TAGAP;CTLA4;UBASH3A;CCR4;TRBV20-1;CD96;GBP5;THEMIS;TRGV10;ZAP70;GVINP1;CD8B;JAML;IFNG;CD48;ZNF831;KLRB1;TRBV5-1;TRBV3-1;TRAV29DV5;CXCR3;TBX21;SLAMF6;ICOS;TIGIT;TRAV19;P2RY10;BCL11B;TRAT1;TRBV2;PYHIN1;TRAV12-2;GZMA;SH2D1A;TRBV29-1;GZMB;GZMH;CD2;GZMK;PTPRC;CD40LG;CD6;CD5;IL2RB;TNFSF8;TRAV8-6;CD247;CD69;IL7R,PanglaoDB,blue,63
B Cells,71/182,3.38852257216872e-54,3.84032558179121e-53,0,0,18.5669942669943,2285.95349939689,ARHGAP9;FKBP11;FCMR;TRAF3IP3;TNFRSF13B;GPR65;IKZF1;CD3E;ITGAL;GPR174;SPIB;SIT1;TAGAP;TBC1D10C;BLNK;CD37;ITGB7;CD52;CD300A;IRAG2;RHOH;TMC8;PAX5;BIN2;JAML;CD48;LCP2;TLR10;PTPRCAP;LTB;WDFY4;MS4A1;SP140;CXCR4;CSF2RB;RASAL3;IL2RG;LY9;CYTH4;CD19;BTLA;IL21R;STAP1;SLAMF6;IL12RB1;HLA-DQA1;CD74;NIBAN3;P2RY10;CD72;NAPSB;TNFRSF9;IL10RA;CLEC17A;NKG7;LILRB1;ARHGAP25;SNX20;CD2;ARHGAP30;PTPRC;PARVG;CD5;KLHL6;CD27;HLA-DRA;CD69;EVI2B;CD22;CD244;MYO1G,PanglaoDB,blue,71
Dendritic Cells,67/199,2.95667085809638e-46,3.1414627867274e-45,0,0,14.6287308324206,1533.60080766314,CD84;GPR68;FLT3;GPR65;LST1;ITGB2;LY75;TREM2;CLEC9A;ITGAL;CXCL16;LAMP3;TAGAP;ITGAX;MS4A14;FCER1A;CCR5;CCR2;HLA-DPA1;CD52;CD300A;HLA-B;BIN2;JAML;CD8A;NAAA;TLR8;CD48;LCP2;WDFY4;CX3CR1;IGSF6;CXCR4;CSF2RB;AOAH;CD1C;CD1B;CD1A;HLA-DMA;HLA-DMB;CYTH4;CXCR3;ADGRG5;SLAMF8;BTLA;CD300LB;SLAMF7;CD300LF;CCL17;HLA-DQA1;CD74;P2RY10;XCR1;CCL22;IL10RA;LILRB1;LYZ;SNX20;ARHGAP30;PTPRC;PARVG;AXL;HLA-DPB1;HLA-DRA;EVI2B;CD22;HLA-DRB1,PanglaoDB,blue,67
Plasmacytoid Dendritic Cells,57/150,7.29222265501045e-43,7.29222265501045e-42,0,0,17.4377333205705,1691.88475150811,ARHGAP9;CD84;TRAF3IP3;GPR65;DOCK8;LST1;ITGB2;IKZF1;ITGAL;TNFSF13B;SPIB;TAGAP;BLNK;ITGAX;CD37;CCR5;CCR2;CD52;CD300A;BIN2;JAML;CD8A;BTK;DPEP2;CD48;LCP2;TLR7;WDFY4;MS4A1;CXCR4;CSF2RB;AOAH;RASAL3;IL2RG;LILRA4;CYTH4;CXCR3;SLAMF6;CD300LF;NIBAN3;P2RY10;NAPSB;IL10RA;NKG7;GZMB;LILRB1;ARHGAP25;SNX20;CD4;ARHGAP30;PTPRC;PARVG;HLA-DRA;EVI2B;CD244;GAPT;MYO1G,PanglaoDB,blue,57
Gamma Delta T Cells,50/146,3.92561541740001e-35,3.7075256719889e-34,0,0,14.6636380323054,1161.69673775281,TRBV19;CXORF65;SIRPG;PRF1;CTSW;FASLG;CD3E;CD3D;TRBV6-5;GPR174;TRBC1;UBASH3A;TRGV3;TRBV20-1;CD96;TRGV10;NCR3;CD8B;LCK;XCL2;PTPRCAP;KLRB1;TRBV5-1;TRBV3-1;CST7;IL2RG;TRAV29DV5;TRGC1;CXCR3;TBX21;ICOS;TRGC2;TRAV19;P2RY10;TRAT1;TRBV2;TRAV12-2;GZMA;SH2D1A;TRBV29-1;NKG7;GZMB;GZMH;CD2;GZMK;GZMM;CD7;TRAV8-6;CD247;CD244,PanglaoDB,blue,50
Langerhans Cells,46/123,2.10683200036511e-34,1.88506021085299e-33,0,0,16.7377381742345,1297.88953987837,CSF1R;CD84;CIITA;IGSF6;ITGB2;CSF2RB;AOAH;CD1C;ITGAL;CD1A;HLA-DMA;CYTH4;HLA-DMB;TAGAP;ITGAX;MS4A14;SLAMF7;CCR6;CD300LF;CCR5;HLA-DQA2;HLA-DQA1;HLA-DPA1;CD52;CD74;CD300A;PRKCB;NAPSB;IL10RA;LILRB1;LYZ;SNX20;ARHGAP30;PTPRC;BIN2;JAML;PARVG;HLA-DPB1;HLA-DRA;TLR8;CD48;LCP2;TLR7;WDFY4;HLA-DRB1;HLA-DQB2,PanglaoDB,blue,46
Macrophages,55/204,2.11874498036996e-32,1.80093323331447e-31,0,0,10.4404114213097,761.439031848792,CD84;LST1;ITGB2;TREM2;CD3E;ITGAL;CXCL16;ADGRE5;GPR171;CLEC5A;TAGAP;ITGAX;MS4A14;CCR5;CCR2;SYK;CD300A;RUNX3;CHIT1;CD200R1;MAF;BIN2;JAML;NAAA;TLR8;CD48;ADAM8;LCP2;WDFY4;CX3CR1;CSF1R;IGSF6;MARCHF1;CSF2RB;AOAH;CYTH4;CD19;UCP2;CD300LB;SLAMF7;CD300LF;CCL24;CD74;SLC37A2;CCL22;IL10RA;LILRB1;LYZ;LYVE1;SNX20;PTPRC;PARVG;HLA-DRA;EVI2B;MYO1G,PanglaoDB,blue,55
Eosinophils,41/127,7.68076949270356e-28,6.21776577980764e-27,0,0,13.254179305696,827.506962354971,FCN1;ARHGAP9;TRAF3IP3;SELPLG;GPR65;LST1;ITGB2;CSF2RB;AOAH;RASAL3;ITGAL;CST7;IL2RG;CYTH4;CXCR3;TAGAP;CD300LB;ITGAX;CD300LF;C16ORF54;CCR2;CD300A;IL10RA;NKG7;ARHGAP25;SNX20;ARHGAP30;PTPRC;BIN2;JAML;PARVG;DPEP2;TLR8;CD48;LCP2;CD69;EVI2B;HCST;CD244;GAPT;MYO1G,PanglaoDB,blue,41
Monocytes,40/176,7.05376679854222e-21,5.45063798069172e-20,0,0,8.14378139099344,377.87736225821,FCN1;CX3CR1;CSF1R;IGSF6;LST1;ITGB2;CXCR4;CSF2RB;AOAH;ITGAL;CYTH4;TAGAP;CD300LB;CASP1;ITGAX;MS4A14;S100A12;TNFRSF14;CD300LF;CCR5;CCR2;CD300A;IL10RA;LILRB1;LYZ;SNX20;CXCL10;PTPRC;BIN2;JAML;PARVG;NAAA;CD7;DPEP2;HLA-DRA;TLR8;CD48;LCP2;EVI2B;CD44,PanglaoDB,blue,40
Myeloid-derived Suppressor Cells,31/112,3.80468355514476e-19,2.81215741032439e-18,0,0,10.4907936507937,444.944813597493,FCN1;IGSF6;GPR65;LST1;ITGB2;CSF2RB;AOAH;ITGAL;CYTH4;TAGAP;CD300LB;ITGAX;S100A12;CD300LF;CCR5;CCR2;CD300A;LYZ;SNX20;ARHGAP30;PTPRC;BIN2;JAML;PARVG;DPEP2;TLR8;CD48;LCP2;EVI2B;CD244;GAPT,PanglaoDB,blue,31
Megakaryocytes,33/143,1.15841695322609e-17,8.20545341868479e-17,0,0,8.23452722063037,321.120970368229,FCN1;ARHGAP9;SELPLG;LST1;ITGB2;CXCR4;CSF2RB;AOAH;CST7;CYTH4;TAGAP;CD300LB;ITGAX;IL21R;S100A12;CD300LF;TGFB1;CD300A;MATK;NKG7;CXCR2P1;SNX20;TREML1;BIN2;JAML;PARVG;DPEP2;TLR8;LCP2;HCST;LAT;CD244;GAPT,PanglaoDB,blue,33
Microglia,34/158,3.72822534984253e-17,2.53519323789292e-16,0,0,7.53147128245476,284.90060290566,CX3CR1;CSF1R;CD84;IGSF6;LST1;ITGB2;CSF2RB;TREM2;AOAH;CYTH4;TAGAP;UCP2;CD300LB;ITGAX;IL21R;MS4A14;CD300LF;CCR5;LAG3;CD300A;IL10RA;LILRB1;LYZ;P2RX7;CD4;PTPRC;BIN2;JAML;PARVG;HLA-DRA;TLR8;LCP2;EVI2B;WDFY4,PanglaoDB,blue,34
Plasma Cells,33/166,1.30478878171733e-15,8.53131126507486e-15,0,0,6.80233535127216,233.134638374013,TNFRSF13B;IGHV4-34;CXCR4;PRDM1;RASAL3;ITGAL;IL2RG;IGLV8-61;IGLV1-47;CD19;TAGAP;STAP1;SLAMF6;CD37;ITGB7;HLA-DOB;ZBP1;CD52;FCRL2;CD74;P2RY10;NAPSB;IGHV3-33;GZMB;LILRB1;TMEM156;ARHGAP30;BIN2;PNOC;CD27;CD48;PTPRCAP;MS4A1,PanglaoDB,blue,33
Osteoclast Precursor Cells,26/107,8.91496362588385e-15,5.61312524592687e-14,0,0,8.73632781717888,282.629336302681,CSF1R;CD84;CIITA;SP100;IGSF6;ITGB2;CSF2RB;FPR3;TREM2;CYSLTR1;CYTH4;CLEC5A;CD300LB;SLAMF8;CASP1;ITGAX;MS4A14;SLAMF7;CCR5;LILRB1;LYZ;PTPRC;TLR8;TLR7;EVI2B;WDFY4,PanglaoDB,blue,26
Kupffer Cells,28/137,9.1375186819427e-14,5.54777919975093e-13,0,0,7.00118757096063,210.202272422048,FCN1;CSF1R;IGSF6;LST1;ITGB2;CSF2RB;AOAH;CYTH4;CLEC5A;CD300LB;ITGAX;MS4A14;CD300LF;CCR5;MSR1;CD300A;IL10RA;LILRB1;LYZ;CHIT1;CD4;BIN2;JAML;PARVG;HLA-DRA;TLR8;LCP2;WDFY4,PanglaoDB,blue,28
Platelets,34/214,4.6944742478503e-13,2.75193317977431e-12,0,0,5.17317073170732,146.851936092158,FCN1;CD84;SELPLG;LST1;ITGB2;CXCR4;CSF2RB;AOAH;CYTH4;ADGRE5;ARHGDIB;CD300LB;CASP1;ITGAX;S100A12;CD300LF;CCR4;CCR2;CD300A;LYZ;CXCR2P1;TREML1;CD40LG;BIN2;JAML;DPEP2;TLR8;CD226;LCP2;CD69;CARD16;EVI2B;CD244;GAPT,PanglaoDB,blue,34
Red Pulp Macrophages,22/110,6.5047036535895e-11,3.68599873703405e-10,0,0,6.76339915373766,158.641685014284,FCN1;CSF1R;IGSF6;VCAM1;CD300A;LST1;CSF2RB;LILRB1;AOAH;LYZ;CXCR2P1;CYTH4;JAML;CASP5;CLEC5A;CD300LB;ITGAX;MS4A14;TLR8;CD300LF;CCR5;WDFY4,PanglaoDB,blue,22
Neutrophils,25/151,2.38578527933139e-10,1.30833386285915e-09,0,0,5.37990692027519,119.198953295491,FCN1;IGSF6;DOCK8;LST1;ITGB2;CSF2RB;AOAH;CYTH4;TAGAP;CD300LB;ITGAX;MS4A14;S100A12;CD300LF;CCR2;CD300A;LYZ;SNX20;BIN2;JAML;DPEP2;TLR8;ADAM8;CD244;GAPT,PanglaoDB,blue,25
Basophils,26/169,5.4816557505336e-10,2.91212961747098e-09,0,0,4.93255963894262,105.184090467272,CSF1R;CSF2RB;AOAH;ITGAL;TIFAB;CLEC5A;CD300LB;ITGAX;MS4A14;S100A12;FCER1A;ITGB7;CD300LF;CCR5;CCR2;CD300A;MBOAT1;LYZ;CXCR2P1;CD4;JAML;TLR8;LCP2;CD69;CD44;GAPT,PanglaoDB,blue,26
Alveolar Macrophages,22/123,6.25617206837306e-10,3.22287652007097e-09,0,0,5.88886871761929,124.798569013051,FCN1;CSF1R;IGSF6;CD300A;LST1;ITGB2;CSF2RB;LILRB1;AOAH;LYZ;CYTH4;CLEC5A;CD300LB;SLAMF8;CASP1;ITGAX;MS4A14;TLR8;CD300LF;CCR5;EVI2B;WDFY4,PanglaoDB,blue,22
Trophoblast Progenitor Cells,16/103,9.97721531515325e-07,4.98860765757663e-06,0,0,4.93387991319026,68.175324548702,DENND1C;FCMR;ST14;SYTL1;ARAP1;TMPRSS13;PARP12;DEF6;CXCL16;ARHGAP45;ADGRE5;PSD4;RPS6KA1;S100A12;ADAM8;PTPN6,PanglaoDB,blue,16
Hematopoietic Stem Cells,21/178,2.34682425392148e-06,1.13988606619043e-05,0,0,3.60053826141563,46.6717882755616,CSF1R;TRPC6;ITGA4;FLT3;GFI1;CXCR4;CSF2RB;FPR3;CLEC9A;LYZ;LYVE1;PTPRC;GPR171;FCER1A;TLR8;CD48;CD300LF;WDFY4;CD34;CD44;HOXB5,PanglaoDB,blue,21
Erythroblasts,17/124,2.75446200971901e-06,1.3007181712562e-05,0,0,4.26390743213173,54.5877727091056,GFI1;TMC8;CSF2RB;ZC3HAV1;PIK3CG;ARHGAP45;STK10;ADGRE5;ARHGDIB;BTK;RAC2;RGS10;STAP1;PTPN7;DOCK2;CD44;CD244,PanglaoDB,blue,17
Erythroid-like And Erythroid Precursor Cells,19/153,3.28971146534154e-06,1.51148905164341e-05,0,0,3.81063432835821,48.1081559696256,FCN1;ITGA4;CD300A;NKG7;CSF2RB;CXCR2P1;TREML1;BIN2;UCP2;BTK;DPEP2;S100A12;FCER1A;CD300LF;KCNN4;ERMAP;CD44;CD244;GAPT,PanglaoDB,blue,19
Tuft Cells,16/136,3.7960413462162e-05,0.000169822902330725,0,0,3.57090909090909,36.3481646973569,RIPK3;CD300A;IRAG2;CSF2RB;AOAH;LYZ;CXCR2P1;PTPRC;JAML;IGLV1-47;CASP5;CD300LB;RAC2;TLR8;CD300LF;IL13RA1,PanglaoDB,blue,16
Spermatozoa,12/108,0.000584941941284768,0.00254974692354899,0,0,3.33327538247566,24.8128951516825,CSF1R;MSR1;CD74;ADAM28;HLA-DMB;GPR55;OMG;HLA-DPB1;HLA-DRA;FPR3;FMO3;HLA-DPA1,PanglaoDB,blue,12
Pulmonary Alveolar Type II Cells,13/135,0.00136260821476155,0.00579108491273658,0,0,2.84157952417919,18.7497493556141,ZMYND15;CSF1R;ST14;CXCL9;EGFL6;FPR3;TREM2;LYZ;RUNX3;CXCL16;LAMP3;UBD;SLAMF8,PanglaoDB,blue,13
Osteoclasts,10/144,0.0387883332152504,0.160829674307136,0,0,1.98056182333823,6.43610454165302,ZMYND15;CX3CR1;CSF1R;CLEC5A;COL8A2;SLAMF8;TLR8;FPR3;TREM2;IL13RA1,PanglaoDB,blue,10
Microfold Cells,9/126,0.0416741569395992,0.168681111422187,0,0,2.04048582995951,6.48440702954102,SPIB;ZMYND15;ST14;RAC2;CAPG;SLC8B1;PARP12;CXCL16;IL13RA1,PanglaoDB,blue,9
Chondrocytes,9/146,0.0876054710251411,0.346347211029628,0,0,1.74078492427766,4.23865780276331,CXCL12;STAT1;IL10RA;MGP;TNC;COL10A1;ANGPTL2;RUNX3;RUNX2,PanglaoDB,blue,9
Urothelial Cells,7/106,0.0935608326432228,0.361485035212452,0,0,1.87217478653943,4.43545060983516,DENND1C;ST14;PSD4;SYTL1;ADAM8;PLEKHN1;TMPRSS13,PanglaoDB,blue,7
Osteoblasts,9/154,0.112070591405359,0.423377789753578,0,0,1.64405387334034,3.59821958826776,LRRC15;VCAM1;CXCL12;EGFL6;P2RX4;TNC;ANGPTL2;RUNX2;CD44,PanglaoDB,blue,9
Mast Cells,12/235,0.15382481610879,0.568483016054225,0,0,1.42544765088532,2.66835373257731,VCAM1;CXCL12;BTK;FCER1A;CXCR4;DAPP1;FPR3;CSF2RB;KDELR3;CCR5;CD34;LYVE1,PanglaoDB,blue,12
Pancreatic Stellate Cells,6/111,0.220583749518749,0.79785611528058,0,0,1.51046305418719,2.28303143423403,LRRC15;TGFB1;CXCL12;MGP;TNC;ANGPTL2,PanglaoDB,blue,6
Fibroblasts,11/232,0.230225236428751,0.815381045685161,0,0,1.31679235796883,1.93396919702311,FKBP10;VCAM1;CXCL12;RIPK3;UCP2;MGP;ANGPTL2;ARAP1;ITGAL;CD44;CCR2,PanglaoDB,blue,11
Taste Receptor Cells,6/115,0.244521486153823,0.848339849921426,0,0,1.45472951597596,2.04891683588723,P2RX7;GRIA2;PRKCB;SLC4A10;ST18;TAS2R4,PanglaoDB,blue,6
M?ller Cells,7/147,0.291877580526862,0.992383773791331,0,0,1.3210635359116,1.62678512865123,CXCL12;CNR2;DAPL1;PLPPR4;ANGPTL2;CLU;CD44,PanglaoDB,blue,7
Epithelial Cells,9/218,0.402815212029341,0.99975164513131,0,0,1.13679439091307,1.03366139483096,CD2;P2RX7;CXCL10;ST14;SLC46A2;ITGA4;CDKN2A;DLX5;ITGAL,PanglaoDB,blue,9
Satellite Glial Cells,5/114,0.404354312647225,0.99975164513131,0,0,1.21060479692673,1.09615878808779,P2RX7;CSF1R;GRIA2;MAF;LYVE1,PanglaoDB,blue,5
Adipocyte Progenitor Cells,5/115,0.411619439017297,0.99975164513131,0,0,1.19953668920611,1.06477599721673,SYDE1;FKBP10;CYP26B1;GPX8;HOXD9,PanglaoDB,blue,5
Stromal Cells,5/124,0.476163181078696,0.99975164513131,0,0,1.10829455749242,0.822348650134743,VCAM1;CXCL12;ITGA4;TNC;ANGPTL2,PanglaoDB,blue,5
Osteocytes,4/98,0.483528788471259,0.99975164513131,0,0,1.12236237525242,0.815558361727965,SYDE1;AXL;TNC;GPX8,PanglaoDB,blue,4
Juxtaglomerular Cells,4/103,0.52258629638431,0.99975164513131,0,0,1.06539952482181,0.691407160557123,CXCL12;TGFB1I1;MGP;ANGPTL2,PanglaoDB,blue,4
Paneth Cells,5/132,0.531477179961024,0.99975164513131,0,0,1.03804689703043,0.656144271320652,CCL24;ADAMDEC1;CASP5;KCNN4;LYZ,PanglaoDB,blue,5
Granulosa Cells,4/112,0.589062950031492,0.99975164513131,0,0,0.976157725813847,0.516604363534697,SYDE1;FKBP10;CTTN;GPX8,PanglaoDB,blue,4
Leydig Cells,5/145,0.615186044547056,0.99975164513131,0,0,0.941017316017316,0.457174955932098,CXCL10;CYP26B1;CXCL12;ANGPTL2;INSL3,PanglaoDB,blue,5
Oligodendrocytes,6/178,0.636863280329718,0.99975164513131,0,0,0.918861267040898,0.414590458224453,GRIA2;GJC2;FAM163B;OMG;S1PR5;ST18,PanglaoDB,blue,6
Adipocytes,7/210,0.650688101390344,0.99975164513131,0,0,0.908077729091256,0.390223573649131,ESM1;CXCL12;ADM2;TNFRSF9;ANGPTL2;FMO1;PTGES,PanglaoDB,blue,7
Neural Stem/Precursor Cells,5/152,0.656431913045514,0.99975164513131,0,0,0.89587901276213,0.377107999261076,EOMES;P2RX7;GRIA2;DLX5;PARP12,PanglaoDB,blue,5
Sebocytes,4/124,0.66865879538238,0.99975164513131,0,0,0.877991746905089,0.353375321853566,ZMYND15;ST14;CNR2;CXCL16,PanglaoDB,blue,4
Endothelial Cells,8/246,0.680881426535508,0.99975164513131,0,0,0.884782128619083,0.340081145050493,ESM1;PRKCH;VCAM1;CXCL12;MGP;ANGPTL2;CD34;LYVE1,PanglaoDB,blue,8
Interneurons,10/305,0.681274933228442,0.99975164513131,0,0,0.892075507181645,0.342369065171477,EOMES;GRIA2;CACNA1I;PRKCB;DLX5;PNOC;PTPRO;RGS10;POU2F2;GRIN2D,PanglaoDB,blue,10
Hemangioblasts,3/97,0.693347247083622,0.99975164513131,0,0,0.840615501519757,0.307853846517616,NHLRC4;AQP10;RNF166,PanglaoDB,blue,3
Pyramidal Cells,4/130,0.704255573958068,0.99975164513131,0,0,0.83592061308705,0.293085434321592,GRIA2;KCNN4;CD3E;GRIN2D,PanglaoDB,blue,4
Airway Smooth Muscle Cells,3/99,0.706489546470652,0.99975164513131,0,0,0.823016826923077,0.285954623094631,SYDE1;CXCL12;TGFB1I1,PanglaoDB,blue,3
Myocytes,5/163,0.715261615593616,0.99975164513131,0,0,0.833028210761237,0.279153507382355,EDN1;ANGPTL2;CXCR4;TNNI2;PRKCQ,PanglaoDB,blue,5
Melanocytes,4/133,0.720983836854903,0.99975164513131,0,0,0.816352643869358,0.267060428061842,SYDE1;LRRC15;TNC;ANGPTL2,PanglaoDB,blue,4
Kidney Progenitor Cells,3/105,0.743320627195401,0.99975164513131,0,0,0.774361667744021,0.229697195430273,SYDE1;FKBP10;GPX8,PanglaoDB,blue,3
Satellite Cells,4/139,0.752316147681324,0.99975164513131,0,0,0.779825767996332,0.221937348508155,SYDE1;FKBP10;VCAM1;CXCR4,PanglaoDB,blue,4
Cajal-Retzius Cells,5/174,0.766590029547904,0.99975164513131,0,0,0.778359169967562,0.206890305345207,EOMES;RIPOR2;GRIA2;GALNT13;PNOC,PanglaoDB,blue,5
Embryonic Stem Cells,5/176,0.775124283995305,0.99975164513131,0,0,0.769175003624764,0.19593340706034,FKBP10;SLC46A2;ITGA4;GPX8;HOXB5,PanglaoDB,blue,5
Cardiac Stem And Precursor Cells,3/113,0.786588274877107,0.99975164513131,0,0,0.717744755244755,0.172294861889864,SYDE1;FKBP10;GPX8,PanglaoDB,blue,3
Radial Glia Cells,3/114,0.791547920481858,0.99975164513131,0,0,0.711241461241461,0.166263258915372,GRIA2;VCAM1;PLPPR4,PanglaoDB,blue,3
Peritubular Myoid Cells,3/120,0.819324487037239,0.99975164513131,0,0,0.674556213017752,0.134422239621443,CXCL12;MGP;ANGPTL2,PanglaoDB,blue,3
Neurons,8/289,0.833180913590449,0.99975164513131,0,0,0.747695200405586,0.136457721665689,GRIA2;ZCCHC7;AIM2;CXCR5;MATK;FMO1;MIAT;TMEM130,PanglaoDB,blue,8
Acinar Cells,3/124,0.836041307159473,0.99975164513131,0,0,0.652120606666061,0.116779969240337,OR2I1P;UBD;LYZ,PanglaoDB,blue,3
Oligodendrocyte Progenitor Cells,3/125,0.840006507305266,0.99975164513131,0,0,0.646741578094037,0.112756574594988,GRIA2;PLPPR4;FYN,PanglaoDB,blue,3
Myoblasts,3/126,0.843888579307105,0.99975164513131,0,0,0.641450013401233,0.108876394955999,SYDE1;FKBP10;ANGPTL2,PanglaoDB,blue,3
Gamma (PP) Cells,3/128,0.851408321636908,0.99975164513131,0,0,0.631120879120879,0.101524282975322,GRIA2;PLPPR4;CHN2,PanglaoDB,blue,3
Trophoblast Cells,3/130,0.8586105182648,0.99975164513131,0,0,0.621117071904474,0.0946830074248407,CD4;TNFRSF9;PTGES,PanglaoDB,blue,3
Delta Cells,3/131,0.862095659100321,0.99975164513131,0,0,0.616232400412088,0.0914421349557237,GRIA2;PLPPR4;UCP2,PanglaoDB,blue,3
Pulmonary Alveolar Type I Cells,3/131,0.862095659100321,0.99975164513131,0,0,0.616232400412088,0.0914421349557237,P2RX7;EGFL6;AKAP5,PanglaoDB,blue,3
Bergmann Glia,3/132,0.865505157543214,0.99975164513131,0,0,0.61142346026067,0.0883151940329559,P2RX7;GRIA2;PLPPR4,PanglaoDB,blue,3
Hepatic Stellate Cells,3/132,0.865505157543214,0.99975164513131,0,0,0.61142346026067,0.0883151940329559,CXCL12;MYB;ANGPTL2,PanglaoDB,blue,3
Anterior Pituitary Gland Cells,3/133,0.86884025723562,0.99975164513131,0,0,0.606688503803888,0.0852979734098277,GRIA2;PLPPR4;TMEM130,PanglaoDB,blue,3
Smooth Muscle Cells,4/169,0.869765228830646,0.99975164513131,0,0,0.637038889583594,0.0888872821007342,ADAMDEC1;CXCL12;ANGPTL2;WWP2,PanglaoDB,blue,4
Mammary Epithelial Cells,3/134,0.872102198144795,0.99975164513131,0,0,0.602025836758661,0.0823864303902292,BTN3A1;SERINC2;RUNX2,PanglaoDB,blue,3
Enteroendocrine Cells,3/139,0.887357546910468,0.99975164513131,0,0,0.579741031027796,0.0692832743249798,GRIA2;ALCAM;TRPA1,PanglaoDB,blue,3
Trigeminal Neurons,3/144,0.900966356572757,0.99975164513131,0,0,0.559036707972878,0.0583004636294549,GRIA2;PLPPR4;VAMP1,PanglaoDB,blue,3
Loop Of Henle Cells,3/147,0.908402473468296,0.99975164513131,0,0,0.547304258241758,0.052578286394296,CXCL12;ANGPTL2;PLA2G7,PanglaoDB,blue,3
Endothelial Cells (Aorta),4/185,0.910076430075405,0.99975164513131,0,0,0.580239689331013,0.0546740675977054,CXCL12;MARVELD1;ANGPTL2;PDIA5,PanglaoDB,blue,4
Photoreceptor Cells,3/149,0.913075006445921,0.99975164513131,0,0,0.539750489236791,0.0490834240614475,GRIA2;PDE6G;TMEM130,PanglaoDB,blue,3
Astrocytes,3/154,0.923822899781489,0.99975164513131,0,0,0.521741503529583,0.0413401320044604,GRIA2;PLPPR4;PLA2G7,PanglaoDB,blue,3
Sertoli Cells,3/158,0.9315300567642,0.99975164513131,0,0,0.508170861396668,0.036042944436872,CXCL12;FASLG;CLU,PanglaoDB,blue,3
Proximal Tubule Cells,3/164,0.941753391597559,0.99975164513131,0,0,0.489079243737629,0.0293505409396954,HAAO;AOAH;SLC5A2,PanglaoDB,blue,3
Enteric Neurons,3/166,0.944834137117536,0.99975164513131,0,0,0.483027708487831,0.0274098339141668,GRIA2;PLPPR4;HOXB5,PanglaoDB,blue,3
Podocytes,3/184,0.966479098549629,0.99975164513131,0,0,0.434581992593042,0.0148173366054587,CTTN;PTPRO;ANGPTL2,PanglaoDB,blue,3
Olfactory Epithelial Cells,3/226,0.990062459078213,0.99975164513131,0,0,0.351956339624501,0.00351507520169826,RARG;TTC21A;JAKMIP1,PanglaoDB,blue,3
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),4/6,3.03577567534422e-08,4.1741915535983e-05,0,0,300.939393939394,5209.32524252282,PTEN;TIMP3;THBS1;ATF3,GO_BP,magenta,4
cellular response to copper ion (GO:0071280),4/19,7.32391531466127e-06,0.00503519177882963,0,0,40.0989898989899,474.145112503296,MT1A;MT1M;MT1X;AQP2,GO_BP,magenta,4
response to copper ion (GO:0046688),4/23,1.63825342528572e-05,0.00750866153255957,0,0,31.6507177033493,348.768588220323,MT1A;MT1M;MT1X;AQP2,GO_BP,magenta,4
cellular response to cadmium ion (GO:0071276),4/27,3.17913209503971e-05,0.010928266576699,0,0,26.1409749670619,270.724229500048,JUN;MT1A;MT1M;MT1X,GO_BP,magenta,4
response to cadmium ion (GO:0046686),4/29,4.25730889665773e-05,0.0117075994658088,0,0,24.0472727272727,242.018683601057,JUN;MT1A;MT1M;MT1X,GO_BP,magenta,4
negative regulation of cell-matrix adhesion (GO:0001953),4/32,6.34466465951112e-05,0.0123438333530091,0,0,21.4675324675325,207.490382345615,ADAM15;FAM107A;PTEN;THBS1,GO_BP,magenta,4
regulation of cell population proliferation (GO:0042127),16/764,6.40857280141447e-05,0.0123438333530091,0,0,3.40748663101604,32.9002677455549,BTG3;JUN;BTG2;EDN2;CTBP2;EGR4;NOS3;PTEN;THBS1;FOSL1;ADGRG1;NR4A3;ADAMTS1;CLCF1;NAMPT;HAS2,GO_BP,magenta,16
regulation of sprouting angiogenesis (GO:1903670),4/33,7.18186667811437e-05,0.0123438333530091,0,0,20.7262277951933,197.756527943176,ITGA5;THBS1;ADAMTS9;GLUL,GO_BP,magenta,4
negative regulation of epithelial cell migration (GO:0010633),4/35,9.09343645541762e-05,0.0138927501402214,0,0,19.3870967741935,180.404158734634,PTEN;STC1;THBS1;ADAMTS9,GO_BP,magenta,4
cellular divalent inorganic cation homeostasis (GO:0072503),6/111,0.000111664159672461,0.0141875271012523,0,0,8.68527472527473,79.0361282446276,MT1A;EDN2;MT1M;STC1;MT1X;TMEM165,GO_BP,magenta,6
regulation of vascular associated smooth muscle cell proliferation (GO:1904705),4/37,0.000113500216810018,0.0141875271012523,0,0,18.2102846648301,165.41686862668,JUN;NR4A3;ADAMTS1;PTEN,GO_BP,magenta,4
negative regulation of cell-substrate junction organization (GO:0150118),3/16,0.000161414073182329,0.0167368592921986,0,0,34.4436090225564,300.745667655956,FAM107A;PTEN;THBS1,GO_BP,magenta,3
negative regulation of focal adhesion assembly (GO:0051895),3/16,0.000161414073182329,0.0167368592921986,0,0,34.4436090225564,300.745667655956,FAM107A;PTEN;THBS1,GO_BP,magenta,3
import into cell (GO:0098657),4/41,0.00017041165824784,0.0167368592921986,0,0,16.2383292383292,140.904749220908,SLC22A4;SLC7A5;LRRC8A;GLUL,GO_BP,magenta,4
cellular response to zinc ion (GO:0071294),3/18,0.000232872749686033,0.0213466687212197,0,0,29.8481203007519,249.680075290572,MT1A;MT1M;MT1X,GO_BP,magenta,3
positive regulation of smooth muscle cell proliferation (GO:0048661),4/46,0.000267476423808086,0.0223159877411597,0,0,14.3015873015873,117.651709473954,JUN;NR4A3;ADAMTS1;THBS1,GO_BP,magenta,4
cellular response to metal ion (GO:0071248),6/131,0.000275906757527066,0.0223159877411597,0,0,7.28824615384615,59.730439335855,JUN;MT1A;MT1M;MT1X;AQP2;CACNA1H,GO_BP,magenta,6
positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),3/21,0.000373936129662918,0.0285645654603618,0,0,24.8696741854637,196.257182323057,JUN;NR4A3;ADAMTS1,GO_BP,magenta,3
positive regulation of cell population proliferation (GO:0008284),11/474,0.000402050362244273,0.0290957498992566,0,0,3.68744708423326,28.8319024226965,FOSL1;NR4A3;EDN2;EGR4;CLCF1;NAMPT;PIM1;PTEN;HAS2;CCN1;THBS1,GO_BP,magenta,11
negative regulation of cell junction assembly (GO:1901889),3/25,0.000633926258685575,0.0396203911678484,0,0,20.3438140806562,149.80326020369,FAM107A;PTEN;THBS1,GO_BP,magenta,3
"regulation of DNA-templated transcription, initiation (GO:2000142)",4/61,0.000790643908649887,0.0452973072663998,0,0,10.5300372142477,75.2125058326156,FOSL1;CEBPB;JUN;PTEN,GO_BP,magenta,4
cellular zinc ion homeostasis (GO:0006882),3/28,0.000889580664396354,0.0489269365417995,0,0,17.8998496240602,125.742154265733,MT1A;MT1M;MT1X,GO_BP,magenta,3
response to zinc ion (GO:0010043),3/29,0.000987312846122997,0.0502798208673749,0,0,17.2105263157895,119.105853572367,MT1A;MT1M;MT1X,GO_BP,magenta,3
zinc ion homeostasis (GO:0055069),3/30,0.0010915854315695,0.0536046417288594,0,0,16.5722639933166,113.024897303639,MT1A;MT1M;MT1X,GO_BP,magenta,3
positive regulation of leukocyte cell-cell adhesion (GO:1903039),3/31,0.00120256205883585,0.0537631419083848,0,0,15.9795918367347,107.435604962733,NR4A3;HAS2;CYRIB,GO_BP,magenta,3
regulation of dendritic spine morphogenesis (GO:0061001),3/32,0.00132040218988405,0.0550167579118356,0,0,15.427793621986,102.283477732414,ARC;PTEN;DBN1,GO_BP,magenta,3
response to metal ion (GO:0010038),4/71,0.00139703492524845,0.0564977359475477,0,0,8.95386702849389,58.8573781671074,MT1A;MT1X;THBS1;HAMP,GO_BP,magenta,4
negative regulation of cellular process (GO:0048523),11/566,0.00170205182364476,0.0655659898133018,0,0,3.06160720720721,19.5205650757592,BTG3;ADGRG1;BTG2;ADAM15;CTBP2;ADAMTS1;NOS3;LPCAT3;PTEN;CCN1;RND1,GO_BP,magenta,11
blood vessel diameter maintenance (GO:0097746),3/35,0.00171663682420281,0.0655659898133018,0,0,13.9793233082707,89.0117787954941,EDNRB;EDN2;NOS3,GO_BP,magenta,3
negative regulation of cell cycle (GO:0045786),4/80,0.0021696019011778,0.0768587993993775,0,0,7.88995215311005,48.3907459421731,BTG3;NPPC;BTG2;PTEN,GO_BP,magenta,4
negative regulation of endothelial cell migration (GO:0010596),3/38,0.00217999503750962,0.0768587993993775,0,0,12.7791621911923,78.3162351770632,STC1;THBS1;ADAMTS9,GO_BP,magenta,3
positive regulation of ATPase activity (GO:0032781),3/42,0.00290850862795099,0.0850893481581406,0,0,11.4661654135338,66.9637226536815,VMP1;DNAJB1;ATP1B3,GO_BP,magenta,3
regulation of endothelial cell migration (GO:0010594),4/89,0.00319587964368729,0.0884335007766551,0,0,7.05133689839572,40.5162266919797,STC1;ADAMTS9;GLUL;THBS1,GO_BP,magenta,4
second-messenger-mediated signaling (GO:0019932),4/89,0.00319587964368729,0.0884335007766551,0,0,7.05133689839572,40.5162266919797,EDNRB;EDN2;NOS3;KSR2,GO_BP,magenta,4
cellular amino acid catabolic process (GO:0009063),4/90,0.00332715199467551,0.0884335007766551,0,0,6.96899224806202,39.7625511582056,SDS;NOS3;GLUL;SLC25A44,GO_BP,magenta,4
amino acid transmembrane transport (GO:0003333),3/45,0.00354221610691679,0.0901953175372329,0,0,10.6455424274973,60.0728249679395,SLC22A4;SLC7A5;SLC25A18,GO_BP,magenta,3
cellular transition metal ion homeostasis (GO:0046916),4/96,0.00419259382998,0.0977087545122458,0,0,6.51251646903821,35.652352551267,MT1A;MT1M;MT1X;HAMP,GO_BP,magenta,4
cholesterol transport (GO:0030301),3/51,0.00504689530317849,0.103596150260366,0,0,9.31203007518797,49.2511596020426,STX12;STAR;LDLR,GO_BP,magenta,3
calcium-mediated signaling (GO:0019722),4/102,0.005198643176702,0.103596150260366,0,0,6.11193568336426,32.1448554786895,EDNRB;EDN2;CCL20;KSR2,GO_BP,magenta,4
negative regulation of protein metabolic process (GO:0051248),3/52,0.00532956434209483,0.104687871005434,0,0,9.12152831057235,47.7465102434811,EDNRB;PTX3;LDLR,GO_BP,magenta,3
cellular metal ion homeostasis (GO:0006875),4/104,0.00556691507402527,0.107809975025137,0,0,5.98909090909091,31.0888571956972,EDN2;STC1;ATP1B3;TMEM165,GO_BP,magenta,4
regulation of focal adhesion assembly (GO:0051893),3/54,0.00592302423581456,0.111563812660891,0,0,8.76293675364883,44.9442973821694,FAM107A;PTEN;THBS1,GO_BP,magenta,3
response to endoplasmic reticulum stress (GO:0034976),4/110,0.00677529910847226,0.123870643549386,0,0,5.6483704974271,28.2106269639246,JUN;CEBPB;THBS1;ATF3,GO_BP,magenta,4
regulation of cell migration (GO:0030334),8/408,0.00684666829800243,0.123870643549386,0,0,3.04125,15.1575690910495,ADAM15;FAM107A;PTEN;STC1;HAS2;CCN1;CYRIB;THBS1,GO_BP,magenta,8
negative regulation of transcription by RNA polymerase II (GO:0000122),11/684,0.00707849407407266,0.126401679894155,0,0,2.50937295690936,12.4231378806838,DNAJB1;JUN;CEBPB;EDNRB;NR4A3;CTBP2;NFIL3;ZBTB21;CREM;HAMP;ATF3,GO_BP,magenta,11
fat cell differentiation (GO:0045444),3/58,0.00722460896053743,0.12664428056613,0,0,8.12399179767601,40.0534094258763,NR4A3;CTBP2;FOXO1,GO_BP,magenta,3
anion transmembrane transport (GO:0098656),3/67,0.010731615443145,0.170892718254284,0,0,6.97838345864662,31.6439067292708,SLC7A5;SLC25A18;LRRC8A,GO_BP,magenta,3
negative regulation of growth (GO:0045926),4/126,0.0108128483549983,0.170892718254284,0,0,4.90362642821659,22.1988158420071,MT1A;ADAM15;MT1M;MT1X,GO_BP,magenta,4
phosphatidylinositol biosynthetic process (GO:0006661),4/126,0.0108128483549983,0.170892718254284,0,0,4.90362642821659,22.1988158420071,ITPKC;SOCS1;PIGA;PTEN,GO_BP,magenta,4
regulation of G1/S transition of mitotic cell cycle (GO:2000045),3/71,0.0125553123102657,0.184248398814679,0,0,6.56656346749226,28.7458631684009,ADAMTS1;FAM107A;PTEN,GO_BP,magenta,3
"negative regulation of transcription, DNA-templated (GO:0045892)",13/948,0.012595890537149,0.184248398814679,0,0,2.13970696926221,9.359901356219,JUN;CEBPB;CTBP2;ZBTB21;CREM;FOXO1;DNAJB1;EDNRB;NR4A3;NFIL3;CD38;HAMP;ATF3,GO_BP,magenta,13
regulation of cell adhesion (GO:0030155),4/133,0.0129800569848175,0.186031794528307,0,0,4.63589382194033,20.1399044252389,ADGRG1;GPR4;CYTH1;RND1,GO_BP,magenta,4
regulation of actin filament polymerization (GO:0030833),3/73,0.0135295850566041,0.186031794528307,0,0,6.37830290010741,27.4450496948908,CDC42EP4;CYRIB;DBN1,GO_BP,magenta,3
regulation of actin filament-based process (GO:0032970),3/73,0.0135295850566041,0.186031794528307,0,0,6.37830290010741,27.4450496948908,FAM107A;RND3;RND1,GO_BP,magenta,3
positive regulation of lymphocyte proliferation (GO:0050671),3/75,0.0145458185970549,0.192312505489909,0,0,6.20050125313283,26.2309211187088,PNP;CLCF1;CD38,GO_BP,magenta,3
integrin-mediated signaling pathway (GO:0007229),3/75,0.0145458185970549,0.192312505489909,0,0,6.20050125313283,26.2309211187088,ADAM15;ADAMTS1;ITGA5,GO_BP,magenta,3
negative regulation of cell population proliferation (GO:0008285),7/379,0.0151100666753286,0.197869920748351,0,0,2.84329415687255,11.9202096195315,BTG3;ADGRG1;BTG2;CTBP2;ADAMTS1;NOS3;PTEN,GO_BP,magenta,7
neutrophil migration (GO:1990266),3/77,0.0156042279199624,0.200521620466807,0,0,6.03231050599472,25.095698884998,EDN2;CCL20;CD177,GO_BP,magenta,3
Ras protein signal transduction (GO:0007265),4/142,0.0161488659365747,0.203855195094052,0,0,4.33157663592446,17.8716756597557,ADGRG1;JUN;CDC42EP4;KSR2,GO_BP,magenta,4
extracellular structure organization (GO:0043062),5/216,0.0161601572838194,0.203855195094052,0,0,3.55504504178575,14.6652948893778,ADAM15;ADAMTS1;ITGA5;ADAMTS9;THBS1,GO_BP,magenta,5
external encapsulating structure organization (GO:0045229),5/217,0.0164535964058887,0.204738298131728,0,0,3.53809592395218,14.531707202588,ADAM15;ADAMTS1;ITGA5;ADAMTS9;THBS1,GO_BP,magenta,5
extracellular matrix organization (GO:0030198),6/300,0.0168286862400915,0.205802669674318,0,0,3.07221350078493,12.5489793476821,ADAM15;ADAMTS1;HAS2;ITGA5;ADAMTS9;THBS1,GO_BP,magenta,6
negative regulation of cell migration (GO:0030336),4/144,0.0169132375805076,0.205802669674318,0,0,4.26926406926407,17.4171401955106,ADGRG1;ADAM15;PTEN;STC1,GO_BP,magenta,4
cellular response to cytokine stimulus (GO:0071345),8/482,0.0173609752541658,0.208983001473993,0,0,2.55669831223629,10.3636543146181,SOCS1;EDN2;CCL20;CLCF1;PIM1;HAS2;MT1X;FOXO1,GO_BP,magenta,8
positive regulation of transcription by RNA polymerase II (GO:0045944),12/908,0.0210909897537345,0.229644531839697,0,0,2.04867511520737,7.90565156864019,FOSL1;JUN;CEBPB;NR4A3;CTBP2;EGR4;ELL;NFYB;NAMPT;CCN1;ATF3;FOXO1,GO_BP,magenta,12
negative regulation of angiogenesis (GO:0016525),3/87,0.0215341605003801,0.229644531839697,0,0,5.31149301825994,20.3861196674659,ADAMTS1;ADAMTS9;THBS1,GO_BP,magenta,3
regulation of actin cytoskeleton organization (GO:0032956),3/91,0.0242053378838946,0.229644531839697,0,0,5.06903622693096,18.8628068537987,FAM107A;RND3;RND1,GO_BP,magenta,3
regulation of heart contraction (GO:0008016),3/93,0.0256051135544023,0.229644531839697,0,0,4.95588972431078,18.1631534590153,NPPC;ATP1B3;CACNA1H,GO_BP,magenta,3
negative regulation of cellular protein metabolic process (GO:0032269),3/94,0.0263210313893772,0.229644531839697,0,0,4.90118152524168,17.8274938996935,BTG2;EDNRB;EIF4A3,GO_BP,magenta,3
negative regulation of MAPK cascade (GO:0043409),3/94,0.0263210313893772,0.229644531839697,0,0,4.90118152524168,17.8274938996935,PTEN;TIMP3;FOXO1,GO_BP,magenta,3
positive regulation of cellular process (GO:0048522),9/625,0.027102917949499,0.229644531839697,0,0,2.2143368442581,7.98957951046807,FOSL1;ADGRG1;EDN2;EGR4;CLCF1;NAMPT;PTEN;HAS2;THBS1,GO_BP,magenta,9
calcium ion homeostasis (GO:0055074),3/97,0.028532801380363,0.229644531839697,0,0,4.74404095344745,16.8731348610648,EDN2;STC1;TMEM165,GO_BP,magenta,3
neuron projection development (GO:0031175),4/171,0.0294786265572103,0.229644531839697,0,0,3.5741244783161,12.5955356240928,ARC;BTG2;PTEN;DBN1,GO_BP,magenta,4
organic anion transport (GO:0015711),3/99,0.0300605461386063,0.229644531839697,0,0,4.64473684210526,16.2776740719495,SLCO4A1;SLCO2A1;LRRC8A,GO_BP,magenta,3
"positive regulation of transcription, DNA-templated (GO:0045893)",14/1183,0.0305565330002283,0.229644531839697,0,0,1.83518209482674,6.40143955201394,JUN;CEBPB;CTBP2;EGR4;ELL;NFYB;FOXO1;FOSL1;NR4A3;NFIL3;NAMPT;CD38;CCN1;ATF3,GO_BP,magenta,14
regulation of translation (GO:0006417),4/178,0.0334408707688753,0.229644531839697,0,0,3.42911877394636,11.6520648428053,BTG2;EIF4A3;THBS1;PUM3,GO_BP,magenta,4
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),8/547,0.0335118629931308,0.229644531839697,0,0,2.24083951762523,7.60956783613354,JUN;BTG2;CTBP2;NFIL3;EIF4A3;ZBTB21;CD38;FOXO1,GO_BP,magenta,8
regulation of insulin secretion (GO:0050796),3/104,0.0340653189872392,0.229644531839697,0,0,4.41368272165562,14.9159324051227,MIDN;LRRC8A;TRH,GO_BP,magenta,3
positive regulation of cellular biosynthetic process (GO:0031328),4/180,0.0346273573084693,0.229644531839697,0,0,3.38980716253444,11.4002985551116,STAR;EIF4A3;THBS1;LDLR,GO_BP,magenta,4
regulation of protein phosphorylation (GO:0001932),5/266,0.0354377943942834,0.229644531839697,0,0,2.86669006463689,9.57467713363927,CEBPB;SOCS1;PTEN;CCN1;ATF3,GO_BP,magenta,5
cellular response to peptide hormone stimulus (GO:0071375),3/106,0.035740984967184,0.229644531839697,0,0,4.32754215636178,14.4170215200872,NR4A3;INSIG1;FOXO1,GO_BP,magenta,3
regulation of cytoskeleton organization (GO:0051493),3/112,0.0410183611954423,0.229644531839697,0,0,4.0880871904532,13.0562690993124,FAM107A;RND3;RND1,GO_BP,magenta,3
positive regulation of metabolic process (GO:0009893),3/113,0.0419341419799432,0.229644531839697,0,0,4.05071770334928,12.8474788122241,CEBPB;PIGA;KSR2,GO_BP,magenta,3
negative regulation of cell motility (GO:2000146),3/114,0.0428601884597007,0.229644531839697,0,0,4.01402154033733,12.6434127818825,ADAM15;PTEN;STC1,GO_BP,magenta,3
positive regulation of angiogenesis (GO:0045766),3/116,0.0447429446229018,0.229644531839697,0,0,3.94257768314592,12.2488851459127,NOS3;ITGA5;THBS1,GO_BP,magenta,3
regulation of cellular response to stress (GO:0080135),3/118,0.0466663520132683,0.229644531839697,0,0,3.8736188296829,11.8716031478784,DNAJB1;CEBPB;ATF3,GO_BP,magenta,3
negative regulation of apoptotic process (GO:0043066),7/485,0.0480513794567187,0.229644531839697,0,0,2.20073951542279,6.68031054499824,CLCF1;WNK3;PIM1;CD38;ITGA5;THBS1;FOXO1,GO_BP,magenta,7
cytoskeleton organization (GO:0007010),3/120,0.048630117602977,0.229644531839697,0,0,3.80701754385965,11.5105641274698,ARC;RND3;RND1,GO_BP,magenta,3
regulation of angiogenesis (GO:0045765),4/203,0.0500208594366112,0.229644531839697,0,0,2.9945180447693,8.96952533178862,ADAMTS1;NOS3;GLUL;THBS1,GO_BP,magenta,4
cellular response to oxidative stress (GO:0034599),3/125,0.0537140448739928,0.229644531839697,0,0,3.6500677924319,10.673093035157,JUN;FOXO1;RBM11,GO_BP,magenta,3
platelet degranulation (GO:0002576),3/125,0.0537140448739928,0.229644531839697,0,0,3.6500677924319,10.673093035157,TIMP3;CYRIB;THBS1,GO_BP,magenta,3
cellular response to insulin stimulus (GO:0032869),3/129,0.0579579224637738,0.229644531839697,0,0,3.53347654851414,10.0634755051825,INSIG1;NAMPT;FOXO1,GO_BP,magenta,3
positive regulation of macromolecule biosynthetic process (GO:0010557),3/129,0.0579579224637738,0.229644531839697,0,0,3.53347654851414,10.0634755051825,EIF4A3;NAMPT;THBS1,GO_BP,magenta,3
regulation of primary metabolic process (GO:0080090),3/130,0.0590430697151796,0.229644531839697,0,0,3.50547628914807,9.91870346678334,IDI1;NFYB;LDLR,GO_BP,magenta,3
positive regulation of cell motility (GO:2000147),4/221,0.0643020365963811,0.229644531839697,0,0,2.7436112274822,7.52891909156181,FAM107A;HAS2;CCN1;THBS1,GO_BP,magenta,4
cellular calcium ion homeostasis (GO:0006874),3/136,0.0657534152651723,0.229644531839697,0,0,3.34631692011985,9.1081515137136,EDN2;STC1;TMEM165,GO_BP,magenta,3
organic substance transport (GO:0071702),3/136,0.0657534152651723,0.229644531839697,0,0,3.34631692011985,9.1081515137136,RD3;SLC22A4;SLCO2A1,GO_BP,magenta,3
neuron projection morphogenesis (GO:0048812),3/140,0.0704133026342942,0.230344143550267,0,0,3.24795565556226,8.61803808784479,ARC;PTEN;DBN1,GO_BP,magenta,3
inflammatory response (GO:0006954),4/230,0.0721636178479882,0.230344143550267,0,0,2.6331456154465,6.9220639293624,CEBPB;CCL20;PTX3;THBS1,GO_BP,magenta,4
nitrogen compound transport (GO:0071705),3/143,0.0740036839643598,0.230344143550267,0,0,3.17787325456498,8.27403920347053,SLC22A4;RD3;SLC7A5,GO_BP,magenta,3
positive regulation of cytosolic calcium ion concentration (GO:0007204),3/147,0.0789153721838065,0.230344143550267,0,0,3.08897243107769,7.84407246095291,EDN2;GPR4;CD55,GO_BP,magenta,3
regulation of ERK1 and ERK2 cascade (GO:0070372),4/238,0.0795453036862311,0.230344143550267,0,0,2.54208754208754,6.43511301099389,CCL20;PTEN;TIMP3;CCN1,GO_BP,magenta,4
actin filament organization (GO:0007015),3/152,0.0852500558050567,0.230344143550267,0,0,2.98455871221678,7.34848050301833,RND3;DBN1;RND1,GO_BP,magenta,3
positive regulation of signal transduction (GO:0009967),4/252,0.0933286546851783,0.233120318899858,0,0,2.39687194525904,5.68448884336176,CTBP2;NOS3;PTEN;ITGA5,GO_BP,magenta,4
protein autophosphorylation (GO:0046777),3/159,0.0944697710948896,0.233120318899858,0,0,2.84962406015038,6.72361780719233,WNK3;MKNK2;PIM1,GO_BP,magenta,3
negative regulation of nucleic acid-templated transcription (GO:1903507),6/464,0.0972481479277688,0.233120318899858,0,0,1.95559287873698,4.55748835944612,JUN;CTBP2;NFIL3;ZBTB21;CD38;FOXO1,GO_BP,magenta,6
positive regulation of cell differentiation (GO:0045597),4/258,0.0995623741760834,0.235136311469234,0,0,2.33953710331663,5.39724414568538,TMEM100;CEBPB;LRRC8A;CCN1,GO_BP,magenta,4
regulation of neuron projection development (GO:0010975),3/165,0.102684449433586,0.235136311469234,0,0,2.7432470064049,6.2438896727997,ARC;PTEN;DBN1,GO_BP,magenta,3
neutrophil degranulation (GO:0043312),6/481,0.110425005220326,0.24177449391393,0,0,1.88395141700405,4.1511337335588,PNP;HSPA6;PTX3;S100P;CD55;CD177,GO_BP,magenta,6
positive regulation of cell migration (GO:0030335),4/269,0.111479147117766,0.242366553713443,0,0,2.24116638078902,4.91693465183045,FAM107A;HAS2;CCN1;THBS1,GO_BP,magenta,4
neutrophil activation involved in immune response (GO:0002283),6/485,0.113653271832601,0.242366553713443,0,0,1.86783362775012,4.06179649913146,PNP;HSPA6;PTX3;S100P;CD55;CD177,GO_BP,magenta,6
neutrophil mediated immunity (GO:0002446),6/488,0.116105902530167,0.242366553713443,0,0,1.85592084264283,3.99626628983516,PNP;HSPA6;PTX3;S100P;CD55;CD177,GO_BP,magenta,6
negative regulation of programmed cell death (GO:0043069),5/381,0.118675815217895,0.244884131257418,0,0,1.97823615397109,4.21633290514649,WNK3;PIM1;CD38;THBS1;FOXO1,GO_BP,magenta,5
protein stabilization (GO:0050821),3/179,0.122894133752533,0.247045956008382,0,0,2.52323991797676,5.289800896179,STX12;PTEN;ATP1B3,GO_BP,magenta,3
regulated exocytosis (GO:0045055),3/180,0.124390181633542,0.24819847027231,0,0,2.50885688798267,5.22929076420497,TIMP3;CYRIB;THBS1,GO_BP,magenta,3
positive regulation of programmed cell death (GO:0043068),4/286,0.131074500156807,0.249512543417444,0,0,2.10423382763808,4.2757808622244,JUN;GADD45B;RNF122;FOXO1,GO_BP,magenta,4
cytokine-mediated signaling pathway (GO:0019221),7/621,0.131184789847665,0.249512543417444,0,0,1.70126000555513,3.45551143658608,IL1RL1;SOCS1;EDN2;CCL20;CLCF1;PIM1;FOXO1,GO_BP,magenta,7
regulation of apoptotic process (GO:0042981),8/742,0.133496402148277,0.249512543417444,0,0,1.62891689373297,3.28011859503746,JUN;GADD45B;WNK3;PIM1;CD38;THBS1;RNF122;FOXO1,GO_BP,magenta,8
negative regulation of intracellular signal transduction (GO:1902532),3/198,0.152394753050187,0.266866125321837,0,0,2.27518796992481,4.28026804742388,PTEN;CYRIB;THBS1,GO_BP,magenta,3
positive regulation of apoptotic process (GO:0043065),4/310,0.160950558869935,0.273405379186168,0,0,1.93681917211329,3.53790633004942,JUN;GADD45B;RNF122;FOXO1,GO_BP,magenta,4
cellular response to oxygen-containing compound (GO:1901701),4/323,0.178091986036591,0.286881722425032,0,0,1.85665431746936,3.20357363629513,JUN;NR4A3;INSIG1;FOXO1,GO_BP,magenta,4
negative regulation of multicellular organismal process (GO:0051241),3/214,0.178793269554455,0.286881722425032,0,0,2.10095143070948,3.61684053626313,NOS3;PTEN;STC1,GO_BP,magenta,3
positive regulation of cytokine production (GO:0001819),4/335,0.194439774341665,0.296913315586249,0,0,1.78824498764076,2.92848865935877,SLC7A5;CEBPB;PNP;CYRIB,GO_BP,magenta,4
regulation of cellular macromolecule biosynthetic process (GO:2000112),5/468,0.214010187767665,0.310732849187475,0,0,1.59934380822053,2.46575898228338,CEBPB;NFIL3;NFYB;CREM;PUM3,GO_BP,magenta,5
regulation of transcription by RNA polymerase II (GO:0006357),18/2206,0.24034127373858,0.331131514419386,0,0,1.23233043101044,1.75692781663803,JUN;CEBPB;CTBP2;EGR4;NFYB;ZBTB21;CREM;PTEN;FOXO1;FOSL1;DNAJB1;EDNRB;NR4A3;NFIL3;NAMPT;CCN1;HAMP;ATF3,GO_BP,magenta,18
protein transport (GO:0015031),4/369,0.243024880102296,0.334493376188682,0,0,1.61884599418846,2.29000570812306,RD3;VMP1;STX12;RPGR,GO_BP,magenta,4
cellular component assembly (GO:0022607),3/261,0.262019585611506,0.351489688015435,0,0,1.7141108585417,2.2957704215847,VMP1;FAM107A;HAS2,GO_BP,magenta,3
positive regulation of nucleic acid-templated transcription (GO:1903508),5/511,0.268147681912455,0.356924552400412,0,0,1.46018767160486,1.92192441819692,JUN;CEBPB;NFIL3;CD38;FOXO1,GO_BP,magenta,5
negative regulation of signal transduction (GO:0009968),3/267,0.273037640393564,0.361334702157026,0,0,1.67464114832536,2.17392806574468,SOCS1;PTEN;THBS1,GO_BP,magenta,3
inorganic cation transmembrane transport (GO:0098662),3/274,0.285954622295594,0.371984489741194,0,0,1.63080209749466,2.04163725842125,ATP1B3;CACNA1H;TMEM165,GO_BP,magenta,3
regulation of cell cycle (GO:0051726),3/296,0.326805300305843,0.409377259422221,0,0,1.50665913931587,1.68503356544556,JUN;GADD45B;THBS1,GO_BP,magenta,3
regulation of nucleic acid-templated transcription (GO:1903506),4/430,0.33547432932624,0.417823553282228,0,0,1.38270024185517,1.51019881016475,CEBPB;NFIL3;NFYB;CREM,GO_BP,magenta,4
chemical synaptic transmission (GO:0007268),3/306,0.345405018598554,0.425947892890593,0,0,1.45618997990025,1.5479846774357,PTEN;SYN2;PDLIM4,GO_BP,magenta,3
transcription by RNA polymerase II (GO:0006366),3/320,0.371367845319093,0.449498932494501,0,0,1.39088256919902,1.37775571266174,NR4A3;ELL;ELL2,GO_BP,magenta,3
negative regulation of gene expression (GO:0010629),3/322,0.375064089831916,0.451180122836807,0,0,1.38202088292832,1.35529033446766,SLC7A5;BTG2;EIF4A3,GO_BP,magenta,3
cellular protein localization (GO:0034613),3/329,0.387967015831128,0.460271481249181,0,0,1.35186124821256,1.27998948238314,STX12;CD177;RPGR,GO_BP,magenta,3
supramolecular fiber organization (GO:0097435),3/351,0.42806486677189,0.488487319690451,0,0,1.26497277676951,1.07330478093115,RND3;DBN1;RND1,GO_BP,magenta,3
positive regulation of protein phosphorylation (GO:0001934),3/371,0.463713149164786,0.517536996835699,0,0,1.19499836547891,0.918343255355951,WNK3;ITGA5;CCN1,GO_BP,magenta,3
phosphorylation (GO:0016310),3/400,0.513621904671742,0.560055605807808,0,0,1.10605859737505,0.73693131487428,WNK3;MKNK2;PIM1,GO_BP,magenta,3
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),3/404,0.520316567436289,0.564668729459272,0,0,1.0948005925037,0.715252790193636,NR4A3;NAMPT;FOXO1,GO_BP,magenta,3
organelle organization (GO:0006996),3/420,0.546592999412363,0.587619526342455,0,0,1.05192838210635,0.635418194518603,VMP1;ARC;NOS3,GO_BP,magenta,3
cellular protein modification process (GO:0006464),7/1025,0.550119247580097,0.59048709244546,0,0,1.00456892219126,0.600350690715916,SPSB1;WNK3;MKNK2;PIM1;PTEN;CCN1;THBS1,GO_BP,magenta,7
organelle assembly (GO:0070925),3/425,0.554633575150707,0.594868304081297,0,0,1.03919751986602,0.612552492567577,VMP1;STX12;RPGR,GO_BP,magenta,3
positive regulation of gene expression (GO:0010628),3/482,0.640087976297325,0.670312998788135,0,0,0.912851021080886,0.407268162745871,NOS3;EIF4A3;THBS1,GO_BP,magenta,3
protein phosphorylation (GO:0006468),3/496,0.659251799683135,0.68620077559751,0,0,0.886287727432171,0.369271536893069,WNK3;MKNK2;PIM1,GO_BP,magenta,3
regulation of gene expression (GO:0010468),6/1079,0.748652652067278,0.761952181045527,0,0,0.808272994479891,0.233978989249858,SLC7A5;CEBPB;NFIL3;NFYB;NOS3;CREM,GO_BP,magenta,6
"regulation of transcription, DNA-templated (GO:0006355)",13/2244,0.769426577288387,0.780979387113348,0,0,0.835343077769639,0.218951562258718,JUN;CEBPB;CTBP2;EGR4;NFYB;ZBTB21;CREM;FOXO1;FOSL1;NR4A3;NFIL3;CD38;ATF3,GO_BP,magenta,13
Endothelial Cells,9/246,4.80074639862021e-05,0.00335680409508867,0,0,5.86873318050434,58.3595868806394,TMEM100;SLC7A5;EDNRB;ADAMTS1;NOS3;SLCO2A1;TIMP3;CD55;RND1,PanglaoDB,magenta,9
Loop Of Henle Cells,7/147,6.64713682195777e-05,0.00335680409508867,0,0,7.64496124031008,73.5348887935803,ARC;SPSB1;EDNRB;SLCO2A1;TIMP3;CYP4B1;THBS1,PanglaoDB,magenta,7
Osteocytes,5/98,0.000552721183001719,0.0186082798277245,0,0,8.1141754904375,60.8616461648001,TFPI2;STC1;HAS2;RND3;PDLIM4,PanglaoDB,magenta,5
Mast Cells,7/235,0.00114436795803837,0.0288952909404689,0,0,4.67333061335509,31.6520139782839,SLC7A5;IL1RL1;EDNRB;SOCS1;ST6GALNAC3;ADAMTS9;CD55,PanglaoDB,magenta,7
Trophoblast Cells,5/130,0.00196002529738414,0.0395925110071596,0,0,6.02717557251908,37.5782215964121,PRRG4;STAR;CCL20;S100P;CD55,PanglaoDB,magenta,5
Mesothelial Cells,5/144,0.00305460195915804,0.0514191329791604,0,0,5.41627766489099,31.3662380094178,SLCO2A1;TIMP3;HAS2;RND3;RND1,PanglaoDB,magenta,5
Sertoli Cells,5/158,0.00453417044160667,0.0654216020860391,0,0,4.91717806715562,26.5336491588445,STAR;CDC42EP4;SLCO2A1;TIMP3;CD55,PanglaoDB,magenta,5
Trophoblast Progenitor Cells,4/103,0.00538067061505028,0.0679309665150098,0,0,6.04989286807469,31.6103409326565,CEBPB;ELL;S100P;CD55,PanglaoDB,magenta,4
Satellite Glial Cells,4/114,0.00767047000837344,0.0860797189828575,0,0,5.44187327823692,26.5039765555216,EDNRB;GALNT15;FAM107A;GLUL,PanglaoDB,magenta,4
Luteal Cells,4/125,0.0105238280474716,0.106290663279464,0,0,4.94440270473328,22.5173698957943,ADAMTS1;CDC42EP4;RND3;FKBP5,PanglaoDB,magenta,4
Principal Cells,4/136,0.0139876913089866,0.128432438382513,0,0,4.52984389348026,19.3405196943025,ADGRG1;SLCO2A1;STC1;AQP2,PanglaoDB,magenta,4
Hepatocytes,5/221,0.0176628271150278,0.130590679078766,0,0,3.47186881538027,14.0134798340381,FOSL1;PRRG4;GLUL;HAMP;RND3,PanglaoDB,magenta,5
Chondrocytes,4/146,0.0176999170787487,0.130590679078766,0,0,4.20870678617158,16.9787452378275,TAGLN;GADD45B;TIMP3;HAS2,PanglaoDB,magenta,4
M?ller Cells,4/147,0.0181016782881458,0.130590679078766,0,0,4.17906336088154,16.7653600370049,EDNRB;FAM107A;TIMP3;GLUL,PanglaoDB,magenta,4
Osteoblasts,4/154,0.0210731532658546,0.134379329213747,0,0,3.98262626262626,15.371963246063,TAGLN;TIMP3;ITGA5;FOXO1,PanglaoDB,magenta,4
Fibroblasts,5/232,0.0212878145289105,0.134379329213747,0,0,3.30177892860746,12.7105957107532,TAGLN;CEBPB;TIMP3;PTX3;CD55,PanglaoDB,magenta,5
Airway Smooth Muscle Cells,3/99,0.0300605461386063,0.17859500941172,0,0,4.64473684210526,16.2776740719495,TAGLN;ADAMTS1;TIMP3,PanglaoDB,magenta,3
Juxtaglomerular Cells,3/103,0.0332432483615345,0.186531560250832,0,0,4.45804511278195,15.1747557606378,TAGLN;SLCO2A1;TIMP3,PanglaoDB,magenta,3
Pinealocytes,3/107,0.036594532716972,0.190384161880992,0,0,4.28571428571429,14.1765275530745,RD3;CREM;KSR2,PanglaoDB,magenta,3
Endothelial Cells (Aorta),4/185,0.0376998340358401,0.190384161880992,0,0,3.29532898041185,10.80241656896,NOS3;SLCO2A1;TIMP3;ITGA5,PanglaoDB,magenta,4
Parietal Cells,3/111,0.0401128783086423,0.192323617788096,0,0,4.12614870509607,13.2699328978059,HAMP;CACNA1H;RAI2,PanglaoDB,magenta,3
Adipocyte Progenitor Cells,3/115,0.0437964674170912,0.192323617788096,0,0,3.97798066595059,12.4439275423229,ADAMTS1;TIMP3;RND3,PanglaoDB,magenta,3
Meningeal Cells,3/115,0.0437964674170912,0.192323617788096,0,0,3.97798066595059,12.4439275423229,TMEM100;TIMP3;ADAMTS9,PanglaoDB,magenta,3
Peritubular Myoid Cells,3/120,0.048630117602977,0.204651744912528,0,0,3.80701754385965,11.5105641274698,TAGLN;RASD1;TIMP3,PanglaoDB,magenta,3
Sebocytes,3/124,0.0526774784521224,0.212817012946574,0,0,3.68042005841049,10.8335640187323,PRRG4;CEBPB;S100P,PanglaoDB,magenta,3
Pulmonary Alveolar Type I Cells,3/131,0.0601377954921798,0.229090639939449,0,0,3.47791353383459,9.77682101908712,SLCO2A1;CYP4B1;RND3,PanglaoDB,magenta,3
Hepatic Stellate Cells,3/132,0.0612420522610407,0.229090639939449,0,0,3.45077810806085,9.63775132407819,TAGLN;TIMP3;CCN1,PanglaoDB,magenta,3
Schwann Cells,3/138,0.0680649987212702,0.245520173958867,0,0,3.29640768588137,8.85841055286346,TAGLN;EDNRB;FAM107A,PanglaoDB,magenta,3
Leydig Cells,3/145,0.076441924389198,0.266228771148586,0,0,3.13279678068411,8.055122221897,STAR;SLCO2A1;TIMP3,PanglaoDB,magenta,3
Mesangial Cells,3/148,0.0801651585719332,0.269889367192175,0,0,3.06751361161525,7.74138069658972,TAGLN;RASD1;TIMP3,PanglaoDB,magenta,3
Cardiomyocytes,3/174,0.115516014076857,0.37635862650847,0,0,2.59767840654267,5.6066890801952,NPPC;STC1;HAMP,PanglaoDB,magenta,3
Adipocytes,3/210,0.172076268267963,0.4645207644669,0,0,2.1419853982783,3.76950334641133,TAGLN;SOCS1;TIMP3,PanglaoDB,magenta,3
cilium assembly (GO:0060271),11/314,8.87915906204994e-06,0.00673040256903385,0,0,5.77404813652097,67.1625945110678,CEP135;TTC30B;CENPJ;CEP162;IFT80;PKD1;LZTFL1;CILK1;SEPTIN7;CEP78;CFAP44,GO_BP,black,11
cilium organization (GO:0044782),9/228,2.35839586911487e-05,0.00893832034394536,0,0,6.45928767123288,68.8233470831723,CENPJ;CEP162;IFT80;PKD1;LZTFL1;CILK1;SEPTIN7;CEP78;CFAP44,GO_BP,black,9
plasma membrane bounded cell projection assembly (GO:0120031),8/278,0.000580171469182333,0.0995501747276729,0,0,4.60811287477954,34.3405182221761,CENPJ;CEP162;IFT80;PKD1;LZTFL1;CILK1;SEPTIN7;CFAP44,GO_BP,black,8
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),4/81,0.00215143177583493,0.243038857212778,0,0,7.90769230769231,48.5660548022268,ACER2;APAF1;COL4A3;CASP2,GO_BP,black,4
organelle assembly (GO:0070925),9/425,0.0022896545242685,0.243038857212778,0,0,3.36634615384615,20.4652110853863,CENPJ;CEP162;IFT80;PKD1;BICD1;LZTFL1;CILK1;SEPTIN7;CFAP44,GO_BP,black,9
regulation of cell cycle G2/M phase transition (GO:1902749),4/85,0.00256505390198182,0.243038857212778,0,0,7.51566951566952,44.8367992133796,CEP135;ATAD5;CENPJ;CEP78,GO_BP,black,4
ciliary basal body-plasma membrane docking (GO:0097711),4/95,0.00383132474545276,0.322682684117022,0,0,6.68639053254438,37.2067186593508,CEP135;CENPJ;CEP162;CEP78,GO_BP,black,4
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),4/119,0.00845312579866447,0.344628054782932,0,0,5.28454849498328,25.2243072246183,ACER2;APAF1;COL4A3;CASP2,GO_BP,black,4
mitotic G1 DNA damage checkpoint signaling (GO:0031571),3/65,0.00949224385572028,0.344628054782932,0,0,7.31494705737503,34.0677584607023,PLAGL1;RFWD3;CASP2,GO_BP,black,3
regulation of transcription by RNA polymerase II (GO:0006357),24/2206,0.0113446553606367,0.344628054782932,0,0,1.76825264561287,7.92001869933238,ZNF230;KDM2B;ZBTB14;PRDM5;ZFP69B;ZBTB1;CKAP2;ZNF180;RORA;ZNF99;ZBTB33;PKD1;ZFP14;ZNF816;ZNF704;ZNF429;PLAGL1;RFX5;ZNF549;TBL1X;ZNF665;ZNF169;MAMLD1;ZNF850,GO_BP,black,24
"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",3/74,0.0134883019205102,0.344628054782932,0,0,6.38479733362004,27.492506303845,ACER2;PLAGL1;CASP2,GO_BP,black,3
"regulation of transcription, DNA-templated (GO:0006355)",24/2244,0.0137983210360997,0.344628054782932,0,0,1.73425061425061,7.42815672629553,ZNF230;KDM2B;ZBTB14;PRDM5;ZFP69B;ZBTB1;ZNF180;RORA;ZNF99;ZBTB33;PRICKLE1;POLA1;ZFP14;ZNF816;ZNF704;ZNF429;PLAGL1;RFX5;ZNF549;TBL1X;ZNF665;ZNF169;MAMLD1;ZNF850,GO_BP,black,24
glycerophospholipid biosynthetic process (GO:0046474),4/177,0.0313622047329661,0.344628054782932,0,0,3.50253445975989,12.126305921326,INPP4A;AGPAT5;DGKE;PI4KA,GO_BP,black,4
regulation of mitotic cell cycle phase transition (GO:1901990),4/188,0.037844972749708,0.344628054782932,0,0,3.29130434782609,10.7765767221798,CEP135;CENPJ;PKD1;CEP78,GO_BP,black,4
negative regulation of intracellular signal transduction (GO:1902532),4/198,0.0443583045236104,0.344628054782932,0,0,3.12006344171293,9.72041830459774,SPRED1;SH3BP4;RORA;SH2B3,GO_BP,black,4
phosphorylation (GO:0016310),6/400,0.0526794376579959,0.344628054782932,0,0,2.31662436548223,6.81905349654059,DGKE;NRK;PI4KA;PRKG2;TSSK4;CILK1,GO_BP,black,6
phosphatidylinositol biosynthetic process (GO:0006661),3/126,0.052829962746394,0.344628054782932,0,0,3.67585179668591,10.8094919993804,INPP4A;PI4KA;EFR3B,GO_BP,black,3
G2/M transition of mitotic cell cycle (GO:0000086),3/130,0.0569773153009312,0.344628054782932,0,0,3.55935565306245,10.1979172406929,CEP135;CENPJ;CEP78,GO_BP,black,3
Golgi organization (GO:0007030),3/130,0.0569773153009312,0.344628054782932,0,0,3.55935565306245,10.1979172406929,FBXW8;TBC1D20;ZFP69B,GO_BP,black,3
extracellular structure organization (GO:0043062),4/216,0.0575685905614923,0.344628054782932,0,0,2.85253991291727,8.14336865180832,COL24A1;MMP16;COL4A3;ITGA9,GO_BP,black,4
cell cycle G2/M phase transition (GO:0044839),3/131,0.05803772313365,0.344628054782932,0,0,3.53136927480916,10.0526150085984,CEP135;CENPJ;CEP78,GO_BP,black,3
external encapsulating structure organization (GO:0045229),4/217,0.0583581207030148,0.344628054782932,0,0,2.83900325027086,8.06605326948306,COL24A1;MMP16;COL4A3;ITGA9,GO_BP,black,4
transcription initiation from RNA polymerase II promoter (GO:0006367),3/140,0.067996209367957,0.344628054782932,0,0,3.29787708252076,8.86569390972323,NOTCH2;RORA;TBL1X,GO_BP,black,3
apoptotic process (GO:0006915),4/231,0.0700167172683054,0.344628054782932,0,0,2.66201287699085,7.07834880057578,NOTCH2;APAF1;PLAGL1;CASP2,GO_BP,black,4
regulation of G2/M transition of mitotic cell cycle (GO:0010389),3/149,0.0786765280099057,0.344628054782932,0,0,3.09317159887065,7.86411168656595,CEP135;CENPJ;CEP78,GO_BP,black,3
cellular response to DNA damage stimulus (GO:0006974),5/350,0.0866535353059414,0.345530844624661,0,0,2.19312436804853,5.36402574217883,ACER2;POLA1;RFWD3;ZBTB1;CASP2,GO_BP,black,5
regulation of MAPK cascade (GO:0043408),3/166,0.100683753229982,0.345530844624661,0,0,2.76818245679764,6.35511253811103,SPRED1;NRK;JCAD,GO_BP,black,3
"DNA-templated transcription, initiation (GO:0006352)",3/168,0.103420448549082,0.345530844624661,0,0,2.73435114503817,6.20411307111535,NOTCH2;RORA;TBL1X,GO_BP,black,3
"negative regulation of transcription, DNA-templated (GO:0045892)",10/948,0.104301687136509,0.345530844624661,0,0,1.62734713529129,3.6785657032242,KDM2B;ZBTB14;PRDM5;ZFP69B;ZBTB1;ZNF180;ZBTB33;PRICKLE1;TBL1X;ZNF169,GO_BP,black,10
protein phosphorylation (GO:0006468),6/496,0.116658605284031,0.347054158480889,0,0,1.85357142857143,3.9824047261038,NRK;PRKG2;TSSK4;PKD1;EPHA3;CILK1,GO_BP,black,6
regulation of GTPase activity (GO:0043087),3/189,0.133840130013085,0.357384198048345,0,0,2.42304851021916,4.87301527427454,TBC1D20;SH3BP4;EPHA3,GO_BP,black,3
regulation of cell cycle (GO:0051726),4/296,0.137870810157372,0.357384198048345,0,0,2.06259220231823,4.08689896125489,NOTCH2;FIGNL1;PLAGL1;PKD1,GO_BP,black,4
regulation of programmed cell death (GO:0043067),3/194,0.141499075892579,0.357384198048345,0,0,2.3590184245234,4.61297110517098,ACER2;APAF1;CASP2,GO_BP,black,3
extracellular matrix organization (GO:0030198),4/300,0.142705293685552,0.357384198048345,0,0,2.03430353430353,3.96073539484982,COL24A1;MMP16;COL4A3;ITGA9,GO_BP,black,4
endomembrane system organization (GO:0010256),3/199,0.149302099254804,0.361802014861278,0,0,2.29825517993457,4.37078381190601,FBXW8;TBC1D20;ZFP69B,GO_BP,black,3
mitotic cell cycle phase transition (GO:0044772),3/209,0.16530938895575,0.373573564537631,0,0,2.18557770695916,3.93390103649554,CEP135;CENPJ;CEP78,GO_BP,black,3
transcription by RNA polymerase II (GO:0006366),4/320,0.167844150629937,0.376113059194595,0,0,1.90360272638754,3.3973967251134,NOTCH2;ZBTB1;RORA;TBL1X,GO_BP,black,4
positive regulation of GTPase activity (GO:0043547),3/214,0.173498234670269,0.376824246074681,0,0,2.13324409391845,3.73656444550208,TBC1D8B;TBC1D20;RALGAPA2,GO_BP,black,3
negative regulation of transcription by RNA polymerase II (GO:0000122),7/684,0.175774820426009,0.377352424360997,0,0,1.56227683504111,2.71609878576598,KDM2B;PRDM5;ZFP69B;ZBTB1;ZNF180;TBL1X;ZNF169,GO_BP,black,7
supramolecular fiber organization (GO:0097435),4/351,0.209581767604783,0.397601322945134,0,0,1.73079139880293,2.70460615076899,COL24A1;FIGNL1;CENPJ;COL4A3,GO_BP,black,4
regulation of canonical Wnt signaling pathway (GO:0060828),3/253,0.240680887903599,0.416603526417875,0,0,1.79688549618321,2.55927407518684,TLE4;PRICKLE1;TBL1X,GO_BP,black,3
negative regulation of cell population proliferation (GO:0008285),4/379,0.249543459026651,0.422308078290139,0,0,1.59926153846154,2.21997043632207,KDM2B;COL4A3;SH3BP4;SH2B3,GO_BP,black,4
DNA metabolic process (GO:0006259),3/277,0.283967747480138,0.455993272185767,0,0,1.63748815958099,2.06142502209749,POLA1;TOP3A;ZBTB1,GO_BP,black,3
proteolysis (GO:0006508),3/287,0.302223719016989,0.462799149525006,0,0,1.57902376088593,1.8894404804096,MMP16;CASP2;TBL1X,GO_BP,black,3
organelle organization (GO:0006996),4/420,0.310569470192222,0.467086623820842,0,0,1.43860946745562,1.68223462320578,FBXW8;TBC1D20;ZFP69B;CEP78,GO_BP,black,4
DNA repair (GO:0006281),3/298,0.322372607340007,0.476711473732197,0,0,1.51929098201578,1.71990915806434,POLA1;RFWD3;ZBTB1,GO_BP,black,3
MAPK cascade (GO:0000165),3/303,0.331539250912344,0.484424020588248,0,0,1.49358778625954,1.64893446646624,SPRED1;NRK;PRKG2,GO_BP,black,3
nervous system development (GO:0007399),4/447,0.351580180897897,0.49812668620674,0,0,1.34905365514846,1.41018937134252,NOTCH2;APAF1;NAV2;PKD1,GO_BP,black,4
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),3/321,0.364484625278562,0.508991011464556,0,0,1.40774881175284,1.42079992249964,NHLRC3;EDEM1;TBL1X,GO_BP,black,3
cellular response to oxygen-containing compound (GO:1901701),3/323,0.368133523223214,0.508991011464556,0,0,1.3988072519084,1.39784147590197,SH3BP4;RORA;EPHA3,GO_BP,black,3
negative regulation of nucleic acid-templated transcription (GO:1903507),4/464,0.377468796676736,0.508991011464556,0,0,1.2980602006689,1.2646576997796,ZBTB14;PRDM5;ZBTB33;PRICKLE1,GO_BP,black,4
cellular protein localization (GO:0034613),3/329,0.379058590668395,0.508991011464556,0,0,1.37264084671943,1.33155014711995,TBC1D8B;BICD1;SEPTIN7,GO_BP,black,3
intracellular protein transport (GO:0006886),3/336,0.391755708213738,0.514646147012154,0,0,1.34330513719827,1.25883384758148,TBC1D8B;PRICKLE1;PKD1,GO_BP,black,3
negative regulation of apoptotic process (GO:0043066),4/485,0.409323139802178,0.524986362047464,0,0,1.24004477850632,1.10767044731762,NOTCH2;KDM2B;FIGNL1;CASP2,GO_BP,black,4
negative regulation of programmed cell death (GO:0043069),3/381,0.471438726410142,0.565428092751404,0,0,1.18066157760814,0.887817529095231,NOTCH2;FIGNL1;CASP2,GO_BP,black,3
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),4/547,0.500889063216214,0.583216451486774,0,0,1.09494262643434,0.757011176871085,ZBTB14;PRDM5;ZBTB33;PRICKLE1,GO_BP,black,4
regulation of apoptotic process (GO:0042981),5/742,0.558283864314124,0.632554811883566,0,0,1.0060164294805,0.586394631458678,NOTCH2;ACER2;APAF1;FIGNL1;CASP2,GO_BP,black,5
regulation of intracellular signal transduction (GO:1902531),3/437,0.563521658056269,0.635833816349132,0,0,1.02536321103177,0.588096568652193,SPRED1;NRK;TOP3A,GO_BP,black,3
positive regulation of transcription by RNA polymerase II (GO:0045944),6/908,0.57221412287655,0.640951622501056,0,0,0.985518292682927,0.550157719455403,PLAGL1;RFX5;CKAP2;RORA;TBL1X;PKD1,GO_BP,black,6
protein ubiquitination (GO:0016567),3/525,0.687009445548507,0.72629450449898,0,0,0.848644380100026,0.318587242671832,FBXW8;NHLRC3;RFWD3,GO_BP,black,3
negative regulation of cellular process (GO:0048523),3/566,0.73497337001552,0.766313362409579,0,0,0.785174840345477,0.241771831198266,COL4A3;SH3BP4;SH2B3,GO_BP,black,3
regulation of cell population proliferation (GO:0042127),4/764,0.757706616841546,0.785693044549783,0,0,0.773522267206478,0.214620728106617,ACER2;COL4A3;SH3BP4;SH2B3,GO_BP,black,4
"positive regulation of transcription, DNA-templated (GO:0045893)",6/1183,0.811165442932797,0.834278705214465,0,0,0.744304906542056,0.155770547589876,PLAGL1;RFX5;CKAP2;RORA;TBL1X;PKD1,GO_BP,black,6
cellular protein modification process (GO:0006464),5/1025,0.822721157618735,0.842733293885137,0,0,0.716142270861833,0.139746533099438,FBXW8;NRK;PRKG2;TSSK4;CILK1,GO_BP,black,5
regulation of gene expression (GO:0010468),4/1079,0.935277825347504,0.940239511423618,0,0,0.537846153846154,0.0359881759781007,NOTCH2;MARF1;PRDM5;RORA,GO_BP,black,4
Reticulocytes,3/103,0.0320200569475628,0.741128707802744,0,0,4.52656488549618,15.5776877736104,RFWD3;NCAPD2;NEMP1,PanglaoDB,black,3
Pluripotent Stem Cells,3/112,0.0395339716606564,0.741128707802744,0,0,4.15092093283843,13.4099441397911,ATAD5;RFWD3;PFAS,PanglaoDB,black,3
Embryonic Stem Cells,3/176,0.114656758844464,0.741128707802744,0,0,2.60684816661519,5.64594387415484,PRDM5;SH3BP4;NAV2,PanglaoDB,black,3
Podocytes,3/184,0.126333018278684,0.741128707802744,0,0,2.49061616971026,5.15267105521181,COL4A3;SH3BP4;NAV2,PanglaoDB,black,3
Endothelial Cells (Aorta),3/185,0.127821921962608,0.741128707802744,0,0,2.47680563711098,5.09507952271911,FNDC1;COL4A3;ITGA9,PanglaoDB,black,3
Olfactory Epithelial Cells,3/226,0.19359921786343,0.741128707802744,0,0,2.01721836168829,3.31220223794972,SGPL1;WDFY1;TRIM66,PanglaoDB,black,3
mitotic spindle organization (GO:0007052),22/157,4.55266242066153e-30,2.28998919759275e-27,0,0,68.6386130811663,4637.35103466272,ZWILCH;PLK1;BUB1B;KIF23;TTK;KNL1;CENPA;NDC80;CDC20;SGO1;SGO2;TPX2;CENPF;KIF18A;KIFC1;KIF4A;STMN1;CENPK;BIRC5;KIF2C;BUB1;DLGAP5,GO_BP,tan,22
microtubule cytoskeleton organization involved in mitosis (GO:1902850),20/128,2.511298947659e-28,6.31591685336239e-26,0,0,74.9168556311414,4761.08472944938,ZWILCH;PLK1;BUB1B;TTK;KNL1;CENPA;NDC80;CDC20;SGO1;SGO2;CENPF;KIF18A;KIF4A;STMN1;CENPK;NUSAP1;BIRC5;KIF2C;BUB1;DLGAP5,GO_BP,tan,20
mitotic sister chromatid segregation (GO:0000070),15/102,6.3531497923243e-21,1.06521144851304e-18,0,0,63.3588761174968,2946.52583716798,PLK1;KIF14;NCAPG;KIF23;NDC80;SGO1;SGO2;KIF18A;KIFC1;CENPK;NUSAP1;CDK1;KIF2C;DLGAP5;CEP55,GO_BP,tan,15
sister chromatid segregation (GO:0000819),9/34,1.97145887603316e-15,2.47910953661171e-13,0,0,119.436,4044.10326814728,TOP2A;SGO1;SGO2;KIF18A;KIFC1;PLK1;CENPK;NUSAP1;NDC80,GO_BP,tan,9
mitotic cytokinesis (GO:0000281),9/49,7.41559111950739e-14,7.46008466622443e-12,0,0,74.59125,2255.08791780436,ANLN;KIF4A;STMN1;PLK1;NUSAP1;KIF23;ECT2;CENPA;CEP55,GO_BP,tan,9
spindle assembly checkpoint signaling (GO:0071173),7/21,4.75854226641973e-13,2.99193345001141e-11,0,0,160.620967741935,4557.40550404373,CDC20;CENPF;PLK1;BUB1B;TTK;TRIP13;BUB1,GO_BP,tan,7
mitotic spindle assembly checkpoint signaling (GO:0007094),7/21,4.75854226641973e-13,2.99193345001141e-11,0,0,160.620967741935,4557.40550404373,CDC20;CENPF;PLK1;BUB1B;TTK;TRIP13;BUB1,GO_BP,tan,7
mitotic spindle checkpoint signaling (GO:0071174),7/21,4.75854226641973e-13,2.99193345001141e-11,0,0,160.620967741935,4557.40550404373,CDC20;CENPF;PLK1;BUB1B;TTK;TRIP13;BUB1,GO_BP,tan,7
negative regulation of mitotic metaphase/anaphase transition (GO:0045841),7/22,6.96032816914035e-13,3.89005007675289e-11,0,0,149.905376344086,4196.35810182468,CDC20;CENPF;PLK1;BUB1B;TTK;TRIP13;BUB1,GO_BP,tan,7
cytoskeleton-dependent cytokinesis (GO:0061640),9/72,2.88698769747262e-12,1.45215481182873e-10,0,0,47.3047619047619,1256.92572129832,ANLN;KIF4A;STMN1;PLK1;NUSAP1;KIF23;ECT2;CENPA;CEP55,GO_BP,tan,9
mitotic nuclear division (GO:0140014),9/74,3.72869539258366e-12,1.70503071133598e-10,0,0,45.8446153846154,1206.39934403248,SGO1;SGO2;TPX2;KIF18A;KIFC1;PLK1;CENPK;NUSAP1;NDC80,GO_BP,tan,9
centromere complex assembly (GO:0034508),7/37,4.03442836130231e-11,1.69109788811255e-09,0,0,74.8962365591398,1792.53442537759,HELLS;CENPF;CENPK;OIP5;KNL1;CENPA;DLGAP5,GO_BP,tan,7
"protein localization to chromosome, centromeric region (GO:0071459)",5/17,2.52644119159917e-09,9.77538399518756e-08,0,0,129.680989583333,2567.22376675974,ZWILCH;CDK1;TTK;KNL1;CENPA,GO_BP,tan,5
meiotic sister chromatid cohesion (GO:0051177),4/8,8.98443670423782e-09,3.22797975873688e-07,0,0,306.569230769231,5680.04481345849,SGO1;SGO2;BUB1B;BUB1,GO_BP,tan,4
regulation of mitotic cell cycle phase transition (GO:1901990),9/188,1.64888927028579e-08,5.52927535302501e-07,0,0,16.5519553072626,296.620620242617,CDC20;ANLN;TPX2;CENPF;PLK1;KIF14;E2F1;CDK1;BUB1B,GO_BP,tan,9
mitotic metaphase plate congression (GO:0007080),6/51,2.15185279100198e-08,6.76488721171246e-07,0,0,42.0867724867725,743.014675388604,KIF18A;KIFC1;KIF14;KIF2C;CEP55;NDC80,GO_BP,tan,6
protein localization to condensed chromosome (GO:1903083),4/12,6.28767789387023e-08,1.86041292977455e-06,0,0,153.253846153846,2541.26890359104,ZWILCH;CDK1;TTK;KNL1,GO_BP,tan,4
chromatin remodeling at centromere (GO:0031055),5/32,7.89958170547719e-08,2.20749422103057e-06,0,0,57.5925925925926,941.861826045667,HELLS;CENPK;OIP5;KNL1;CENPA,GO_BP,tan,5
kinetochore organization (GO:0051383),4/13,9.05864697139108e-08,2.39815759295248e-06,0,0,136.218803418803,2209.05501923416,CENPF;CENPA;NDC80;DLGAP5,GO_BP,tan,4
protein localization to kinetochore (GO:0034501),4/14,1.26492097492958e-07,3.1812762519479e-06,0,0,122.590769230769,1947.11973063841,ZWILCH;CDK1;TTK;KNL1,GO_BP,tan,4
DNA replication-independent nucleosome assembly (GO:0006336),5/39,2.21682288092065e-07,5.30981861477662e-06,0,0,45.7192095588235,700.510671354757,CENPK;OIP5;KNL1;CENPA;ASF1B,GO_BP,tan,5
microtubule depolymerization (GO:0007019),4/18,3.82681761732607e-07,8.74949664325006e-06,0,0,87.5472527472527,1293.60364349462,KIF18A;STMN1;KIF14;KIF2C,GO_BP,tan,4
chromosome condensation (GO:0030261),5/45,4.62946569566901e-07,1.01244401953109e-05,0,0,38.849609375,566.646967761217,TOP2A;PLK1;NUSAP1;CDK1;NCAPG,GO_BP,tan,5
centromeric sister chromatid cohesion (GO:0070601),3/6,7.80132137937341e-07,1.63502693909368e-05,0,0,301.939393939394,4246.41601057947,SGO1;BUB1B;BUB1,GO_BP,tan,3
homologous chromosome segregation (GO:0045143),4/22,9.0535107340771e-07,1.82156635969631e-05,0,0,68.0786324786325,947.310293321039,SGO1;SGO2;PTTG1;FANCD2,GO_BP,tan,4
mitotic DNA damage checkpoint signaling (GO:0044773),5/59,1.82752951257412e-06,3.53556671086456e-05,0,0,28.7572337962963,379.956259881344,EME1;FANCD2;PLK1;CDK1;DTL,GO_BP,tan,5
microtubule polymerization or depolymerization (GO:0031109),4/27,2.14406488109834e-06,3.85165941140165e-05,0,0,53.2655518394649,695.264970759125,KIF18A;STMN1;KIF14;KIF2C,GO_BP,tan,4
mitotic chromosome condensation (GO:0007076),4/27,2.14406488109834e-06,3.85165941140165e-05,0,0,53.2655518394649,695.264970759125,PLK1;NUSAP1;CDK1;NCAPG,GO_BP,tan,4
protein depolymerization (GO:0051261),4/28,2.49491883272333e-06,4.32739369951667e-05,0,0,51.0435897435897,658.526334794088,KIF18A;STMN1;KIF14;KIF2C,GO_BP,tan,4
establishment of mitotic spindle localization (GO:0040001),4/29,2.88659700962789e-06,4.83986098614275e-05,0,0,48.9993846153846,625.008330996419,PLK1;NUSAP1;CENPA;NDC80,GO_BP,tan,4
kinetochore assembly (GO:0051382),3/9,3.25235382287786e-06,5.0636059076391e-05,0,0,150.94696969697,1907.38576927039,CENPF;CENPA;DLGAP5,GO_BP,tan,3
CENP-A containing chromatin organization (GO:0061641),4/30,3.32204761336163e-06,5.0636059076391e-05,0,0,47.112426035503,594.319919544091,CENPK;OIP5;KNL1;CENPA,GO_BP,tan,4
CENP-A containing nucleosome assembly (GO:0034080),4/30,3.32204761336163e-06,5.0636059076391e-05,0,0,47.112426035503,594.319919544091,CENPK;OIP5;KNL1;CENPA,GO_BP,tan,4
regulation of cell cycle (GO:0051726),8/296,8.00538614537685e-06,0.000114943898976927,0,0,8.94489981785064,104.971941316103,CCNB2;CENPF;PLK1;BIRC5;FOXM1;PRR11;DTL;DLGAP5,GO_BP,tan,8
DNA repair (GO:0006281),8/298,8.40804280736141e-06,0.000114943898976927,0,0,8.88230638778971,103.801491068239,RAD51AP1;FANCI;EME1;EXO1;FANCD2;CDK1;RAD54L;TRIP13,GO_BP,tan,8
cell cycle checkpoint signaling (GO:0000075),3/12,8.45511781738829e-06,0.000114943898976927,0,0,100.616161616162,1175.27108690604,ZWILCH;BUB1B;BUB1,GO_BP,tan,3
mitotic nuclear membrane disassembly (GO:0007077),3/12,8.45511781738829e-06,0.000114943898976927,0,0,100.616161616162,1175.27108690604,CCNB2;PLK1;CDK1,GO_BP,tan,3
histone exchange (GO:0043486),4/38,8.76388716114227e-06,0.000116006190580383,0,0,36.0126696832579,419.362893244283,CENPK;OIP5;KNL1;CENPA,GO_BP,tan,4
anaphase-promoting complex-dependent catabolic process (GO:0031145),5/84,1.05434507926591e-05,0.000135983480736091,0,0,19.6321202531646,224.984209390879,CDC20;PTTG1;PLK1;CDK1;BUB1B,GO_BP,tan,5
regulation of cell cycle G2/M phase transition (GO:1902749),5/85,1.11726271475655e-05,0.000137069059883548,0,0,19.3857421875,221.037081048236,TPX2;CENPF;PLK1;KIF14;CDK1,GO_BP,tan,5
"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",5/85,1.11726271475655e-05,0.000137069059883548,0,0,19.3857421875,221.037081048236,KIF18A;KIF4A;KIF23;KIF2C;KIF15,GO_BP,tan,5
regulation of G2/M transition of mitotic cell cycle (GO:0010389),6/149,1.25869065523654e-05,0.000150743190377138,0,0,13.1788211788212,148.694707962503,TPX2;CENPF;PLK1;KIF14;CDK1;DTL,GO_BP,tan,6
nuclear membrane disassembly (GO:0051081),3/14,1.39203619560006e-05,0.000162835861950426,0,0,82.3140495867769,920.448699934427,CCNB2;PLK1;CDK1,GO_BP,tan,3
mitotic spindle assembly (GO:0090307),4/44,1.58682752455825e-05,0.000181403237466546,0,0,30.6015384615385,338.183376339778,TPX2;KIFC1;KIF4A;KIF23,GO_BP,tan,4
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),5/98,2.23445170342951e-05,0.000249762045961121,0,0,16.6649865591398,178.464167677651,KIF18A;KIF4A;KIF23;KIF2C;KIF15,GO_BP,tan,5
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),5/100,2.46401341307612e-05,0.000269434510168975,0,0,16.3125,173.094122978528,KIF18A;KIF4A;KIF23;KIF2C;KIF15,GO_BP,tan,5
positive regulation of cell cycle process (GO:0090068),5/101,2.58545778516151e-05,0.000276698992752391,0,0,16.1417643229167,170.505825863036,KIF14;NUSAP1;KIF23;ECT2;NDC80,GO_BP,tan,5
antigen processing and presentation of exogenous peptide antigen (GO:0002478),5/103,2.84227208216135e-05,0.000297846428609824,0,0,15.8107461734694,165.511977319732,KIF18A;KIF4A;KIF23;KIF2C;KIF15,GO_BP,tan,5
regulation of chromosome segregation (GO:0051983),3/18,3.08989779334227e-05,0.000304748743147286,0,0,60.3515151515152,626.737657206113,KIF2C;MKI67;BUB1,GO_BP,tan,3
DNA strand elongation (GO:0022616),3/18,3.08989779334227e-05,0.000304748743147286,0,0,60.3515151515152,626.737657206113,GINS1;GINS2;GINS4,GO_BP,tan,3
DNA strand elongation involved in DNA replication (GO:0006271),3/18,3.08989779334227e-05,0.000304748743147286,0,0,60.3515151515152,626.737657206113,GINS1;GINS2;GINS4,GO_BP,tan,3
regulation of mitotic cell cycle (GO:0007346),6/178,3.44062107093181e-05,0.000332813922822827,0,0,10.9407530454042,112.441110971651,CDC20;PLK1;CDK1;BUB1B;MKI67;DLGAP5,GO_BP,tan,6
interstrand cross-link repair (GO:0036297),4/55,3.87448528885913e-05,0.000367710584961536,0,0,23.9879336349925,243.681727030611,RAD51AP1;FANCI;EME1;FANCD2,GO_BP,tan,4
mitotic cell cycle checkpoint signaling (GO:0007093),3/23,6.62377138534983e-05,0.00061699203830203,0,0,45.2522727272727,435.429159184779,ZWILCH;BUB1B;BUB1,GO_BP,tan,3
establishment of mitotic spindle orientation (GO:0000132),3/24,7.55134210402078e-05,0.000690604559694992,0,0,43.0952380952381,409.025530505884,PLK1;CENPA;NDC80,GO_BP,tan,3
mitotic cell cycle phase transition (GO:0044772),6/209,8.39910822245558e-05,0.000754419899266992,0,0,9.25545390570021,86.8605831547655,CCNB2;MELK;PLK1;E2F1;CDK1;FOXM1,GO_BP,tan,6
G2/M transition of mitotic cell cycle (GO:0000086),5/130,8.64972337157055e-05,0.000763300150157893,0,0,12.37875,115.808134536168,CCNB2;MELK;PLK1;CDK1;FOXM1,GO_BP,tan,5
cell cycle G2/M phase transition (GO:0044839),5/131,8.96909299386186e-05,0.000777836857915951,0,0,12.2798859126984,114.43798717331,CCNB2;MELK;PLK1;CDK1;FOXM1,GO_BP,tan,5
meiosis I (GO:0007127),3/26,9.65252741666454e-05,0.000822918862810553,0,0,39.3438735177866,363.761874677536,SGO1;SGO2;PTTG1,GO_BP,tan,3
establishment of spindle orientation (GO:0051294),3/30,0.000149246182625174,0.0012306693419748,0,0,33.5084175084175,295.206255852885,PLK1;CENPA;NDC80,GO_BP,tan,3
mitotic G2 DNA damage checkpoint signaling (GO:0007095),3/33,0.000199083357299852,0.00159802105116875,0,0,30.1530303030303,256.957699839058,PLK1;CDK1;DTL,GO_BP,tan,3
cellular response to DNA damage stimulus (GO:0006974),7/350,0.000201302167500023,0.00159802105116875,0,0,6.4476629361422,54.8741472457747,TOP2A;RAD51AP1;EXO1;E2F1;CDK1;RAD54L;DTL,GO_BP,tan,7
regulation of cytokinesis (GO:0032465),4/84,0.000203326734144731,0.00159802105116875,0,0,15.27,129.805633188419,PLK1;KIF14;KIF23;ECT2,GO_BP,tan,4
regulation of cell cycle G1/S phase transition (GO:1902806),3/36,0.00025860881855731,0.00200123439591272,0,0,27.4077134986226,226.393030349969,KIF14;E2F1;EZH2,GO_BP,tan,3
positive regulation of cytokinesis (GO:0032467),3/37,0.000280733711515332,0.00213953116503352,0,0,26.6002673796791,217.539752627464,KIF14;KIF23;ECT2,GO_BP,tan,3
negative regulation of G0 to G1 transition (GO:0070317),3/38,0.000304045569209155,0.0022826107658538,0,0,25.838961038961,209.252510068525,RRM2;E2F1;EZH2,GO_BP,tan,3
regulation of cell cycle phase transition (GO:1901987),4/95,0.00032605969416188,0.00232776487562771,0,0,13.4167371090448,107.715335814368,CDC20;PLK1;CDK1;BUB1B,GO_BP,tan,4
regulation of exit from mitosis (GO:0007096),3/39,0.000328571185227769,0.00232776487562771,0,0,25.1199494949495,201.48101189959,CDC20;ANLN;BUB1B,GO_BP,tan,3
double-strand break repair via homologous recombination (GO:0000724),4/97,0.000353038839855756,0.00246636856177007,0,0,13.1268817204301,104.344696457666,RAD51AP1;GINS2;GINS4;RAD54L,GO_BP,tan,4
regulation of G0 to G1 transition (GO:0070316),3/41,0.00038136933762248,0.00262305921220811,0,0,23.7954545454546,187.311685196271,RRM2;E2F1;EZH2,GO_BP,tan,3
DNA metabolic process (GO:0006259),6/277,0.000385897379132008,0.00262305921220811,0,0,6.90915480583377,54.3055358751672,TOP2A;RAD51AP1;HELLS;EXO1;CDK1;RAD54L,GO_BP,tan,6
positive regulation of cell division (GO:0051781),3/44,0.000470322100539523,0.00315429355428507,0,0,22.0509977827051,168.95679085168,KIF14;KIF23;ECT2,GO_BP,tan,3
regulation of cell cycle process (GO:0010564),4/106,0.000494523791550732,0.00327296667302655,0,0,11.963197586727,91.0628466961481,PLK1;MKI67;ECT2;BUB1,GO_BP,tan,4
mitotic G2/M transition checkpoint (GO:0044818),3/45,0.000502675932450775,0.00328371420808753,0,0,21.5248917748918,163.493711687797,PLK1;CDK1;DTL,GO_BP,tan,3
negative regulation of mitotic cell cycle (GO:0045930),3/48,0.000608191891090009,0.00392205796433686,0,0,20.0868686868687,148.743666682608,ZWILCH;BUB1B;BUB1,GO_BP,tan,3
modification-dependent protein catabolic process (GO:0019941),5/201,0.000650801381725185,0.00414371006338947,0,0,7.86631058673469,57.7175283339863,CDC20;PTTG1;PLK1;BUB1B;DTL,GO_BP,tan,5
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),6/321,0.000836548983350852,0.00506968841717444,0,0,5.9307634164777,42.0267268480709,CDC20;PTTG1;PLK1;KIF14;CDK1;BUB1B,GO_BP,tan,6
positive regulation of mitotic cell cycle phase transition (GO:1901992),3/58,0.0010586220505475,0.0063391296598261,0,0,16.4264462809917,112.534087411504,CDK1;DTL;DLGAP5,GO_BP,tan,3
negative regulation of nucleic acid-templated transcription (GO:1903507),7/464,0.00107944858457587,0.00638779574166662,0,0,4.81111032681584,32.8661617331686,CENPF;DEPDC1;E2F1;BIRC5;FOXM1;TNFRSF4;EZH2,GO_BP,tan,7
ubiquitin-dependent protein catabolic process (GO:0006511),6/354,0.00138319878006738,0.00781740434127969,0,0,5.35933223864258,35.2823947587229,CDC20;PTTG1;PLK1;KIF14;BUB1B;DTL,GO_BP,tan,6
negative regulation of cell cycle process (GO:0010948),3/64,0.00140848662495146,0.00787187524833982,0,0,14.806259314456,97.2066380046475,RRM2;E2F1;EZH2,GO_BP,tan,3
positive regulation of protein localization to nucleus (GO:1900182),3/68,0.00167763677273377,0.00927309117236357,0,0,13.8923076923077,88.7769746210765,PLK1;CDK1;ECT2,GO_BP,tan,3
positive regulation of cellular protein localization (GO:1903829),3/71,0.00189921694256607,0.0103837621968558,0,0,13.2774064171123,83.2003925802364,PLK1;CDK1;NDC80,GO_BP,tan,3
response to ionizing radiation (GO:0010212),3/72,0.00197692958961783,0.0106049610932164,0,0,13.0843214756258,81.4657377967379,RAD51AP1;FANCD2;ECT2,GO_BP,tan,3
positive regulation of protein kinase activity (GO:0045860),4/154,0.00198184163571042,0.0106049610932164,0,0,8.11528205128205,50.5073141968192,TPX2;KIF14;ECT2;EZH2,GO_BP,tan,4
"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",3/74,0.00213823906399642,0.0112180716297482,0,0,12.7144686299616,78.1656625786047,E2F1;CDK1;FOXM1,GO_BP,tan,3
cellular protein-containing complex assembly (GO:0034622),4/168,0.00271647000078585,0.013942698065258,0,0,7.4172607879925,43.8243070818362,ANLN;CENPF;CENPA;DLGAP5,GO_BP,tan,4
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),7/547,0.0027470171285507,0.0139570668248586,0,0,4.05427120669056,23.9090088573068,CENPF;DEPDC1;E2F1;BIRC5;FOXM1;TNFRSF4;EZH2,GO_BP,tan,7
regulation of apoptotic process (GO:0042981),8/742,0.00392547456436141,0.0193579775085666,0,0,3.43002635458078,19.0032653438421,TOP2A;MELK;PLK1;KIF14;E2F1;CDK1;BIRC5;ECT2,GO_BP,tan,8
positive regulation of cell population proliferation (GO:0008284),6/474,0.00584137342692434,0.0271511048782947,0,0,3.96072446072446,20.3691715113219,KIF14;E2F1;BIRC5;TTK;FOXM1;EZH2,GO_BP,tan,6
chromosome organization (GO:0051276),3/106,0.00588363902929248,0.0271511048782947,0,0,8.75022065313327,44.937456658997,TOP2A;NDC80;EZH2,GO_BP,tan,3
activation of protein kinase activity (GO:0032147),3/114,0.00719166370989118,0.0318863039226958,0,0,8.11629811629812,40.0525736866796,TPX2;KIF14;ECT2,GO_BP,tan,3
DNA-dependent DNA replication (GO:0006261),3/129,0.0100771909190666,0.0425951851452981,0,0,7.1446608946609,32.8474408130311,GINS1;GINS2;GINS4,GO_BP,tan,3
regulation of small GTPase mediated signal transduction (GO:0051056),3/141,0.0128058657096125,0.0523687028612608,0,0,6.51943346508564,28.410725867805,ARHGAP11A;FOXM1;ECT2,GO_BP,tan,3
positive regulation of hydrolase activity (GO:0051345),3/149,0.0148376507294421,0.0592294955783473,0,0,6.15971357409714,25.9360121188768,ARHGAP11A;ECT2;EZH2,GO_BP,tan,3
"negative regulation of transcription, DNA-templated (GO:0045892)",8/948,0.0160523485802615,0.0624483512787168,0,0,2.64959888385072,10.9478779226139,CENPF;PLK1;DEPDC1;E2F1;BIRC5;FOXM1;TNFRSF4;EZH2,GO_BP,tan,8
regulation of signal transduction by p53 class mediator (GO:1901796),3/156,0.0167568992675724,0.0624483512787168,0,0,5.87581699346405,24.0258937440664,TPX2;EXO1;CDK1,GO_BP,tan,3
peptidyl-serine phosphorylation (GO:0018105),3/156,0.0167568992675724,0.0624483512787168,0,0,5.87581699346405,24.0258937440664,PLK1;CDK1;TTK,GO_BP,tan,3
positive regulation of programmed cell death (GO:0043068),4/286,0.0171213928840866,0.0624483512787168,0,0,4.28783415166394,17.4404504770192,TOP2A;MELK;E2F1;ECT2,GO_BP,tan,4
regulation of intracellular signal transduction (GO:1902531),5/437,0.0174437804749807,0.0631238962511892,0,0,3.52629484953704,14.2771642512716,ARHGAP11A;TPX2;EXO1;CDK1;ECT2,GO_BP,tan,5
double-strand break repair (GO:0006302),3/164,0.0191132479692086,0.0686711694893709,0,0,5.58159232072276,22.0884459475939,RAD51AP1;EME1;TRIP13,GO_BP,tan,3
peptidyl-serine modification (GO:0018209),3/169,0.0206746265765146,0.0717195666757713,0,0,5.41210295728368,20.9927252719491,PLK1;CDK1;TTK,GO_BP,tan,3
positive regulation of apoptotic process (GO:0043065),4/310,0.0222702829545693,0.0761021886213082,0,0,3.94670688788336,15.0152546120751,TOP2A;MELK;E2F1;ECT2,GO_BP,tan,4
regulation of GTPase activity (GO:0043087),3/189,0.027604166776664,0.0831430891536648,0,0,4.8252688172043,17.321694738536,ARHGAP11A;ECT2;EZH2,GO_BP,tan,3
protein phosphorylation (GO:0006468),5/496,0.0282418907598689,0.0845575657869885,0,0,3.09317718940937,11.0332050207343,MELK;PLK1;CDK1;BIRC5;TTK,GO_BP,tan,5
supramolecular fiber organization (GO:0097435),4/351,0.0330640056401991,0.0953028955681177,0,0,3.47311017512747,11.8409093594847,KIF18A;STMN1;KIF14;KIF2C,GO_BP,tan,4
positive regulation of GTPase activity (GO:0043547),3/214,0.0377979110972589,0.099541095716865,0,0,4.24816889271866,13.9148833248721,ARHGAP11A;ECT2;EZH2,GO_BP,tan,3
negative regulation of programmed cell death (GO:0043069),4/381,0.0426091000283851,0.108332284001544,0,0,3.19183840032646,10.0724443275332,PLK1;KIF14;CDK1;BIRC5,GO_BP,tan,4
regulation of cell population proliferation (GO:0042127),6/764,0.047923753402791,0.11758852664197,0,0,2.4089709762533,7.31880072203053,KIF14;BIRC5;TTK;FOXM1;SHCBP1;EZH2,GO_BP,tan,6
phosphorylation (GO:0016310),4/400,0.0493829581081855,0.119903230409232,0,0,3.03574203574204,9.13196707657417,MELK;PLK1;CDK1;BIRC5,GO_BP,tan,4
organelle assembly (GO:0070925),4/425,0.0591539656547134,0.134289064577519,0,0,2.8518180157135,8.06383383569819,ANLN;CENPF;CENPA;DLGAP5,GO_BP,tan,4
positive regulation of cellular process (GO:0048522),5/625,0.0644590136652849,0.139154008041366,0,0,2.43334173387097,6.67155557888657,KIF14;BIRC5;TTK;FOXM1;EZH2,GO_BP,tan,5
negative regulation of apoptotic process (GO:0043066),4/485,0.0864880616122844,0.166680057436701,0,0,2.48840556532864,6.09099196192678,PLK1;KIF14;CDK1;BIRC5,GO_BP,tan,4
cellular macromolecule biosynthetic process (GO:0034645),3/314,0.0944733295247943,0.173285573618184,0,0,2.86758257819351,6.76588247602201,EXO1;E2F1;CDK1,GO_BP,tan,3
organelle organization (GO:0006996),3/420,0.176757279861619,0.254587232538673,0,0,2.12709832134293,3.68621414317897,DIAPH3;KIF4A;CEP55,GO_BP,tan,3
negative regulation of transcription by RNA polymerase II (GO:0000122),4/684,0.210324463993855,0.287481536382905,0,0,1.74217194570136,2.71622702974265,PLK1;E2F1;FOXM1;EZH2,GO_BP,tan,4
cellular protein modification process (GO:0006464),5/1025,0.278848436440961,0.338794114806288,0,0,1.44845281862745,1.84980009579317,MELK;PLK1;CDK1;BIRC5;DTL,GO_BP,tan,5
"regulation of transcription, DNA-templated (GO:0006355)",8/2244,0.51697941954231,0.552103286687435,0,0,1.03786034781079,0.684730660970537,CENPF;RRM2;DEPDC1;E2F1;BIRC5;FOXM1;TNFRSF4;EZH2,GO_BP,tan,8
positive regulation of transcription by RNA polymerase II (GO:0045944),3/908,0.611897817868973,0.638557266365339,0,0,0.955600200904068,0.469381238482717,E2F1;FOXM1;DLGAP5,GO_BP,tan,3
regulation of transcription by RNA polymerase II (GO:0006357),5/2206,0.890392485066943,0.893946946085175,0,0,0.629330417991822,0.0730608052453147,PLK1;E2F1;CDK1;FOXM1;EZH2,GO_BP,tan,5
Pluripotent Stem Cells,9/112,1.67250231124836e-10,2.67600369799738e-09,0,0,28.8757281553398,650.036821651683,SGO1;GINS1;FANCI;HELLS;CENPF;FANCD2;BUB1B;BUB1;NDC80,PanglaoDB,tan,9
Gamma Delta T Cells,8/146,3.81746188280301e-08,3.05396950624241e-07,0,0,18.8101686861487,321.298277743934,TOP2A;ASPM;CENPF;STMN1;NUSAP1;BIRC5;MKI67;CENPA,PanglaoDB,tan,8
Epithelial Cells,7/218,1.00963479529796e-05,5.38471890825578e-05,0,0,10.5519033786883,121.382098322863,ANLN;EXO1;CKAP2L;KIF23;KNL1;ECT2;KIF15,PanglaoDB,tan,7
fatty-acyl-CoA biosynthetic process (GO:0046949),5/30,1.19694521077784e-08,6.4395652339848e-06,0,0,86.6260869565218,1580.138490417,SCD;FASN;ELOVL3;ELOVL6;HACD2,GO_BP,cyan,5
triglyceride biosynthetic process (GO:0019432),4/18,1.11741617436249e-07,2.1957695476748e-05,0,0,121.185410334347,1939.82414820837,DGAT2;PNPLA3;PCK1;PCK2,GO_BP,cyan,4
regulation of lipid metabolic process (GO:0019216),6/92,1.22440681097108e-07,2.1957695476748e-05,0,0,30.7953488372093,490.127659905006,SCD;FASN;ANGPTL8;ELOVL6;PCK1;ACACB,GO_BP,cyan,6
long-chain fatty-acyl-CoA metabolic process (GO:0035336),4/24,3.83680482367119e-07,5.16050248783775e-05,0,0,84.804255319149,1252.85190979855,DGAT2;ELOVL3;ELOVL6;HACD2,GO_BP,cyan,4
regulation of primary metabolic process (GO:0080090),6/130,9.51537560876597e-07,0.000100542108604814,0,0,21.3172043010753,295.567017035334,NQO1;SCD;FASN;ANGPTL8;ELOVL6;ACACB,GO_BP,cyan,6
triglyceride homeostasis (GO:0070328),4/31,1.12128745655926e-06,0.000100542108604814,0,0,62.795902285264,860.368730609174,MLXIPL;DGAT2;ANGPTL8;NR1H3,GO_BP,cyan,4
fatty acid elongation (GO:0030497),3/13,4.387559609331e-06,0.000262278563313342,0,0,124.61875,1537.38879175923,ELOVL3;ELOVL6;HACD2,GO_BP,cyan,3
pentose-phosphate shunt (GO:0006098),3/13,4.387559609331e-06,0.000262278563313342,0,0,124.61875,1537.38879175923,G6PD;PGD;TKT,GO_BP,cyan,3
very long-chain fatty acid biosynthetic process (GO:0042761),3/13,4.387559609331e-06,0.000262278563313342,0,0,124.61875,1537.38879175923,ELOVL3;ELOVL6;HACD2,GO_BP,cyan,3
positive regulation of metabolic process (GO:0009893),5/113,1.00560381111948e-05,0.000541014850382283,0,0,19.9688003220612,229.787720718156,SCD;FASN;ELOVL3;ELOVL6;ACACB,GO_BP,cyan,5
long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),3/18,1.24063265850667e-05,0.000601021670133169,0,0,83.0583333333333,938.335241980765,ELOVL3;ELOVL6;HACD2,GO_BP,cyan,3
dicarboxylic acid metabolic process (GO:0043648),4/57,1.34056878096618e-05,0.000601021670133169,0,0,31.9486150140506,358.458076402251,ALDH1L1;GPT2;SHMT1;PCK1,GO_BP,cyan,4
glucose metabolic process (GO:0006006),4/62,1.87550230061145e-05,0.000776169413637664,0,0,29.1870873074101,317.673686896557,APOD;PCK1;FBP2;PCK2,GO_BP,cyan,4
lipid homeostasis (GO:0055088),4/64,2.12815991364793e-05,0.00081782145253042,0,0,28.2113475177305,303.488303345157,MLXIPL;DGAT2;PNPLA3;NR1H3,GO_BP,cyan,4
fatty-acyl-CoA metabolic process (GO:0035337),3/22,2.32461242149461e-05,0.0008337609885094,0,0,65.5592105263158,699.475614326874,DGAT2;SCD;FASN,GO_BP,cyan,3
glucose 6-phosphate metabolic process (GO:0051156),3/23,2.6685026718527e-05,0.00089728402341047,0,0,62.278125,655.876340544431,G6PD;PGD;TKT,GO_BP,cyan,3
fatty acid biosynthetic process (GO:0006633),4/71,3.21196147568207e-05,0.00101649133759821,0,0,25.2550015878057,261.289349132278,SCD;ELOVL3;ELOVL6;HACD2,GO_BP,cyan,4
acylglycerol homeostasis (GO:0055090),3/25,3.45315047505601e-05,0.00103210830865563,0,0,56.6107954545455,581.598845967846,MLXIPL;ANGPTL8;NR1H3,GO_BP,cyan,3
organonitrogen compound biosynthetic process (GO:1901566),5/158,5.05934410414486e-05,0.00143259322527891,0,0,14.0636544472862,139.113290564069,ARG2;ELOVL3;ELOVL6;MOCS1;HACD2,GO_BP,cyan,5
cellular response to glucose stimulus (GO:0071333),3/32,7.35369537216799e-05,0.00179831277737563,0,0,42.9310344827586,408.605673118268,MLXIPL;PCK1;PCK2,GO_BP,cyan,3
very long-chain fatty acid metabolic process (GO:0000038),3/33,8.07454338821873e-05,0.00188874101863551,0,0,41.4979166666667,391.085045699104,ELOVL3;ELOVL6;HACD2,GO_BP,cyan,3
organophosphate biosynthetic process (GO:0090407),3/39,0.000133801590998895,0.00224953924866893,0,0,34.5711805555556,308.345632153038,G6PD;TKT;MOCS1,GO_BP,cyan,3
fatty acid derivative biosynthetic process (GO:1901570),3/40,0.000144390813622941,0.00232401899149359,0,0,33.6351351351351,297.435061098448,SCD;FASN;AACS,GO_BP,cyan,3
cellular response to peptide hormone stimulus (GO:0071375),4/106,0.000153784216087222,0.00232401899149359,0,0,16.5598664997914,145.394967665705,LHCGR;PRKAR2B;PCK1;PCK2,GO_BP,cyan,4
gluconeogenesis (GO:0006094),3/41,0.00015551056448656,0.00232401899149359,0,0,32.7483552631579,287.163675778706,PCK1;FBP2;PCK2,GO_BP,cyan,3
hexose metabolic process (GO:0019318),3/41,0.00015551056448656,0.00232401899149359,0,0,32.7483552631579,287.163675778706,APOD;PCK1;FBP2,GO_BP,cyan,3
hexose biosynthetic process (GO:0019319),3/44,0.000192168599654951,0.00272070280564115,0,0,30.3475609756098,259.688250481621,PCK1;FBP2;PCK2,GO_BP,cyan,3
regulation of cellular metabolic process (GO:0031323),3/47,0.000234013700124142,0.00322818899145611,0,0,28.2741477272727,236.375575994933,FASN;ANGPTL8;ACACB,GO_BP,cyan,3
protein homotetramerization (GO:0051289),3/52,0.000316096420724349,0.0042514968587425,0,0,25.3826530612245,204.570559840178,SHMT1;CTH;ACACB,GO_BP,cyan,3
membrane lipid biosynthetic process (GO:0046467),3/58,0.000436608807841415,0.00559275091949241,0,0,22.6068181818182,174.897037130885,ELOVL3;ELOVL6;HACD2,GO_BP,cyan,3
protein tetramerization (GO:0051262),3/71,0.000790108685178195,0.009044222821827,0,0,18.2729779411765,130.530095083062,SHMT1;CTH;ACACB,GO_BP,cyan,3
sphingolipid biosynthetic process (GO:0030148),3/74,0.000891321767714833,0.00978634920470572,0,0,17.4982394366197,122.886724538695,ELOVL3;ELOVL6;HACD2,GO_BP,cyan,3
water-soluble vitamin metabolic process (GO:0006767),3/76,0.000963159888173386,0.00996500038148619,0,0,17.0171232876712,118.188875404413,CYB5A;ALDH1L1;SHMT1,GO_BP,cyan,3
long-chain fatty acid metabolic process (GO:0001676),3/83,0.00124315744222435,0.0121603400712128,0,0,15.52265625,103.848135172927,ELOVL3;PNPLA3;ELOVL6,GO_BP,cyan,3
positive regulation of cold-induced thermogenesis (GO:0120162),3/97,0.00194553978831274,0.0177406848493602,0,0,13.2014627659574,82.4063796494225,SCD;ELOVL3;ELOVL6,GO_BP,cyan,3
negative regulation of inflammatory response (GO:0050728),4/212,0.00207699643275359,0.0186237346803572,0,0,8.07733224222586,49.8923279160477,LHCGR;PRKAR2B;TYRO3;NR1H3,GO_BP,cyan,4
positive regulation of cellular metabolic process (GO:0031325),3/105,0.00243851046716356,0.0211511399273627,0,0,12.1611519607843,73.1659641666931,FASN;NR1H3;ACACB,GO_BP,cyan,3
response to lipid (GO:0033993),3/114,0.00307812574033275,0.0250913886105912,0,0,11.170045045045,64.6012226858742,SCD;PCK1;PCK2,GO_BP,cyan,3
sphingolipid metabolic process (GO:0006665),3/116,0.00323292342407859,0.0255781294434453,0,0,10.9712389380531,62.9131266019105,ELOVL3;ELOVL6;HACD2,GO_BP,cyan,3
protein homooligomerization (GO:0051260),3/121,0.00364060662293586,0.0275865684949224,0,0,10.5037076271186,58.9846726131689,SHMT1;CTH;ACACB,GO_BP,cyan,3
negative regulation of immune response (GO:0050777),3/178,0.0105564853490357,0.0682522129459015,0,0,7.06214285714286,32.1399172480161,LHCGR;PRKAR2B;TYRO3,GO_BP,cyan,3
positive regulation of multicellular organismal process (GO:0051240),4/345,0.0115009034853037,0.0682522129459015,0,0,4.89374181069445,21.852170567055,GHR;SCD;ELOVL3;ELOVL6,GO_BP,cyan,4
positive regulation of cellular process (GO:0048522),4/625,0.074624523174994,0.130480833610745,0,0,2.64885051564053,6.87452491602045,MLXIPL;FASN;S100B;ACACB,GO_BP,cyan,4
regulation of intracellular signal transduction (GO:1902531),3/437,0.100240960673621,0.155416820871492,0,0,2.81033986175115,6.46428300367486,PRKAR2B;ARHGEF4;ZNF385A,GO_BP,cyan,3
nervous system development (GO:0007399),3/447,0.10546158328357,0.157606477240446,0,0,2.74563626126126,6.17605763150132,CNTFR;TYRO3;S100B,GO_BP,cyan,3
cellular response to cytokine stimulus (GO:0071345),3/482,0.124554210378297,0.173601464206021,0,0,2.54044885177453,5.29179111676461,GHR;CNTFR;SHMT1,GO_BP,cyan,3
protein phosphorylation (GO:0006468),3/496,0.132526549301496,0.18281867570309,0,0,2.46653144016227,4.98479167211711,GLYCTK;TYRO3;PCK1,GO_BP,cyan,3
Adipocytes,5/210,0.000193023105468105,0.0102302245898096,0,0,10.4687168610817,89.5358015942877,NQO1;SLC36A2;ELOVL3;NR1H3;PCK1,PanglaoDB,cyan,5
Proximal Tubule Cells,4/164,0.000806790967432197,0.0213799606369532,0,0,10.5260638297872,74.9713206675364,GHR;SLC36A2;HGD;PCK1,PanglaoDB,cyan,4
Serotonergic Neurons,3/104,0.00237307442853279,0.0302593106553846,0,0,12.2821782178218,74.2281907593447,SLC22A3;HGD;PCK1,PanglaoDB,cyan,3
Hepatocytes,4/221,0.00241477296564718,0.0302593106553846,0,0,7.73879792136484,46.6351571432125,GHR;SCD;ANGPTL8;PCK1,PanglaoDB,cyan,4
Enteric Glia Cells,3/111,0.00285465194862119,0.0302593106553846,0,0,11.4820601851852,67.2711556732203,CNTFR;APOD;S100B,PanglaoDB,cyan,3
Luteal Cells,3/125,0.00398839876387731,0.0352308557475829,0,0,10.1572745901639,56.1124967200311,LHCGR;GPT2;MOCS1,PanglaoDB,cyan,3
Schwann Cells,3/138,0.00525579131448092,0.039793848523927,0,0,9.17314814814815,48.1445773435009,CNTFR;APOD;S100B,PanglaoDB,cyan,3
Astrocytes,3/154,0.007115201783136,0.047138211813276,0,0,8.19453642384106,40.5262576039216,CNTFR;ALDH1L1;S100B,PanglaoDB,cyan,3
Enterocytes,3/203,0.0150110635729826,0.0883984854853418,0,0,6.1715625,25.9141920787707,DGAT2;PCK1;FBP2,PanglaoDB,cyan,3
epidermis development (GO:0008544),9/83,5.86206650714096e-07,0.000780241052100461,0,0,10.5494701750208,151.380608264385,ALDH3A2;COL17A1;SPRR2F;WNT10A;BNC1;GRHL3;KRT5;EVPL;FGFR2,GO_BP,green,9
O-glycan processing (GO:0016266),6/61,8.17864583351201e-05,0.0544288880220224,0,0,9.34814229249012,87.9790958463303,GALNT12;GALNT14;MUC16;GCNT1;CHST4;GALNT9,GO_BP,green,6
skin development (GO:0043588),6/80,0.000367460021990873,0.163029763089951,0,0,6.94124559341951,54.897589709603,TGM1;SPRR2F;WNT10A;ITGA3;DHCR24;EVPL,GO_BP,green,6
pigment granule transport (GO:0051904),3/18,0.00116116764725753,0.259913636634083,0,0,16.9519313304721,114.566732298191,GPR143;RAB27B;RAB17,GO_BP,green,3
melanosome transport (GO:0032402),3/18,0.00116116764725753,0.259913636634083,0,0,16.9519313304721,114.566732298191,GPR143;RAB27B;RAB17,GO_BP,green,3
protein O-linked glycosylation (GO:0006493),6/102,0.00132856956858919,0.259913636634083,0,0,5.3445652173913,35.4005423780613,GALNT12;GALNT14;MUC16;GCNT1;CHST4;GALNT9,GO_BP,green,6
establishment of melanosome localization (GO:0032401),3/19,0.00136693873511539,0.259913636634083,0,0,15.8916309012876,104.808190749192,GPR143;RAB27B;RAB17,GO_BP,green,3
melanosome localization (GO:0032400),3/21,0.00184384469754176,0.273005477313018,0,0,14.1244635193133,88.9262434566272,GPR143;RAB27B;RAB17,GO_BP,green,3
regulation of BMP signaling pathway (GO:0030510),5/76,0.0020511305583247,0.273005477313018,0,0,6.00359734162551,37.158450133169,CRB2;ITGA3;LRP2;SULF1;GDF5,GO_BP,green,5
regulation of keratinocyte proliferation (GO:0010837),3/24,0.00273382370121012,0.310582498366775,0,0,12.1048436541999,71.4434412305015,TGM1;CDH3;FGFR2,GO_BP,green,3
positive regulation of epithelial cell proliferation (GO:0050679),6/123,0.00341923261676775,0.349464850263763,0,0,4.38060200668896,24.8745438057043,TGM1;EPGN;CDH3;MST1;KDR;FGFR2,GO_BP,green,6
positive regulation of BMP signaling pathway (GO:0030513),3/27,0.00384939728472715,0.349464850263763,0,0,10.5901287553648,58.879407611142,CRB2;SULF1;GDF5,GO_BP,green,3
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),7/170,0.00412799072129703,0.349464850263763,0,0,3.6758110750931,20.1800723056498,NTNG1;CRB2;CDH4;CDH3;MMP24;CLDN15;IGSF9,GO_BP,green,7
external encapsulating structure organization (GO:0045229),8/217,0.0043448374629891,0.349464850263763,0,0,3.28296818601528,17.8552987983764,TGM1;COL17A1;MMP24;ADAMTS3;ITGA3;KDR;SLC39A8;AGRN,GO_BP,green,8
peptide cross-linking (GO:0018149),3/31,0.00571438897143575,0.375553615448858,0,0,9.07541385652974,46.8724062024978,TGM1;EPB42;EVPL,GO_BP,green,3
epithelial cell differentiation (GO:0030855),5/101,0.00694127144911113,0.375553615448858,0,0,4.43452380952381,22.040782053055,UPK1B;WT1;KDR;CCNO;FGFR2,GO_BP,green,5
respiratory system development (GO:0060541),3/35,0.00803819384812064,0.375553615448858,0,0,7.93937768240343,38.2959921016829,ITGA3;WT1;FGFR2,GO_BP,green,3
regulation of signal transduction (GO:0009966),7/198,0.00928406380879725,0.384423804875757,0,0,3.13246759185167,14.6582440094058,KCTD8;ADCYAP1;ITGA3;ALOX15;SULF1;GDF5;FGFR2,GO_BP,green,7
positive regulation of exocytosis (GO:0045921),3/37,0.00937967135979506,0.384423804875757,0,0,7.4715980812926,34.8864646078026,SMPD3;RAB27B;SNCA,GO_BP,green,3
extracellular matrix organization (GO:0030198),9/300,0.00953116871592785,0.384423804875757,0,0,2.65311776193288,12.345455555651,COL17A1;MMP24;ADAMTS3;ITGA3;KDR;HTRA1;SLC39A8;TLL1;AGRN,GO_BP,green,9
ion transport (GO:0006811),5/116,0.0122057876749136,0.415717097941633,0,0,3.83233883233883,16.884691036641,SLC15A1;PDZD3;SLC24A3;PIEZO2;WNK4,GO_BP,green,5
positive regulation of protein kinase B signaling (GO:0051897),6/161,0.0122775935111364,0.415717097941633,0,0,3.30025245441795,14.5210426281567,EPGN;NRG4;IL18;MST1R;LRP2;FGFR2,GO_BP,green,6
keratinocyte differentiation (GO:0030216),3/41,0.0124333000702786,0.415717097941633,0,0,6.68375875310594,29.3241688676072,TGM1;SPRR2F;EVPL,GO_BP,green,3
extracellular structure organization (GO:0043062),7/216,0.0144489001812905,0.415717097941633,0,0,2.86005307034955,12.1184366272581,COL17A1;MMP24;ADAMTS3;ITGA3;KDR;SLC39A8;AGRN,GO_BP,green,7
metal ion homeostasis (GO:0055065),3/44,0.0150545982770323,0.415717097941633,0,0,6.19376112216058,25.9894663874192,KCNA1;SCNN1A;SNCA,GO_BP,green,3
positive regulation of MAPK cascade (GO:0043410),8/274,0.016403757976034,0.415717097941633,0,0,2.57195620630524,10.5713696884341,ADCYAP1;EPGN;WWC1;ALOX15;KDR;MST1R;FGFR2;GSDME,GO_BP,green,8
sensory perception of mechanical stimulus (GO:0050954),4/88,0.0203875670208768,0.415717097941633,0,0,4.03940886699507,15.724732115394,CEMIP;PIEZO2;LRP2;GSDME,GO_BP,green,4
proteolysis (GO:0006508),8/287,0.0210099927054127,0.415717097941633,0,0,2.45048104131296,9.46561306848956,DPP4;MMP24;ADAMTS3;HTRA1;OLR1;CPXM1;CTSE;CPA4,GO_BP,green,8
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),4/89,0.0211552671199522,0.415717097941633,0,0,3.99168356997972,15.3913984295418,DAPK1;NLRP2;DHCR24;SNCA,GO_BP,green,4
epidermal cell differentiation (GO:0009913),3/53,0.0246566768717166,0.415717097941633,0,0,5.07656652360515,18.7970411857121,TGM1;SPRR2F;EVPL,GO_BP,green,3
positive regulation of chemokine production (GO:0032722),3/53,0.0246566768717166,0.415717097941633,0,0,5.07656652360515,18.7970411857121,ADCYAP1;IL7;IL18,GO_BP,green,3
inorganic anion transport (GO:0015698),3/54,0.0258855322987835,0.415717097941633,0,0,4.97677354203484,18.1854841962779,SLC34A2;CLIC3;ANO9,GO_BP,green,3
regulation of protein kinase B signaling (GO:0051896),6/207,0.0365159269552233,0.415717097941633,0,0,2.53900064892927,8.40410930812487,EPGN;NRG4;IL18;MST1R;LRP2;FGFR2,GO_BP,green,6
protein processing (GO:0016485),4/106,0.0369450161755739,0.415717097941633,0,0,3.32352941176471,10.9620785547995,ADAMTS3;MYRF;HP;CPXM1,GO_BP,green,4
positive regulation of protein serine/threonine kinase activity (GO:0071902),4/106,0.0369450161755739,0.415717097941633,0,0,3.32352941176471,10.9620785547995,CEMIP;EPGN;MST1R;SNCA,GO_BP,green,4
diterpenoid metabolic process (GO:0016101),3/64,0.0399406768475028,0.415717097941633,0,0,4.1587982832618,13.3928276583267,ALDH3A2;LRP2;AGRN,GO_BP,green,3
regulation of Wnt signaling pathway (GO:0030111),4/111,0.0425934354243033,0.415717097941633,0,0,3.16741862713503,9.99654782477153,ITGA3;RSPO1;SULF1;FGFR2,GO_BP,green,4
positive regulation of kinase activity (GO:0033674),4/114,0.046203486519762,0.415717097941633,0,0,3.08056426332288,9.47181099572307,ADCYAP1;KDR;MST1R;FGFR2,GO_BP,green,4
gland development (GO:0048732),3/71,0.0516456482091849,0.415717097941633,0,0,3.72936127240596,11.0514002739871,WNT10A;WT1;FGFR2,GO_BP,green,3
response to metal ion (GO:0010038),3/71,0.0516456482091849,0.415717097941633,0,0,3.72936127240596,11.0514002739871,AQP9;CRIP1;SNCA,GO_BP,green,3
negative regulation of epithelial cell proliferation (GO:0050680),3/72,0.05343907474869,0.415717097941633,0,0,3.67512595633514,10.7652269621796,SULF1;GDF5;FGFR2,GO_BP,green,3
cell junction organization (GO:0034330),3/72,0.05343907474869,0.415717097941633,0,0,3.67512595633514,10.7652269621796,AGRN;TJP3;SNCA,GO_BP,green,3
epithelium development (GO:0060429),4/122,0.0566370964680366,0.415717097941633,0,0,2.87054354178843,8.24159199729072,UPK1B;WT1;KDR;FGFR2,GO_BP,green,4
chloride transport (GO:0006821),3/76,0.0609071231560823,0.415717097941633,0,0,3.47304368275619,9.71898331518448,GABRA1;CLIC3;ANO9,GO_BP,green,3
positive regulation of cellular process (GO:0048522),12/625,0.0678063978960072,0.415717097941633,0,0,1.67364833372174,4.50395289570485,TGM1;DPP4;EPGN;CDH3;MYRF;IL7;BNC1;KDR;HP;MST1R;NOX1;FGFR2,GO_BP,green,12
cell-cell junction organization (GO:0045216),3/82,0.0729643971077887,0.415717097941633,0,0,3.20829032433313,8.39861001213669,CDH4;CDH3;TJP3,GO_BP,green,3
vascular transport (GO:0010232),3/84,0.0772028468229535,0.415717097941633,0,0,3.12875536480687,8.01374039542628,SLC13A3;SLC24A3;LRP2,GO_BP,green,3
positive regulation of signal transduction (GO:0009967),6/252,0.0788137629009304,0.415717097941633,0,0,2.06977730646872,5.2586162271712,CDH3;ADAMTS3;IL7;RSPO1;SULF1;FGFR2,GO_BP,green,6
transport across blood-brain barrier (GO:0150104),3/86,0.0815471190480606,0.415717097941633,0,0,3.05305341537825,7.65270516025382,SLC13A3;SLC24A3;LRP2,GO_BP,green,3
potassium ion transmembrane transport (GO:0071805),4/139,0.0826165012457675,0.415717097941633,0,0,2.50689655172414,6.25106148153965,SLC24A3;KCNT2;KCNA1;KCNA4,GO_BP,green,4
sodium ion transmembrane transport (GO:0035725),3/87,0.0837581859845576,0.415717097941633,0,0,3.01655426118945,7.48051572052435,SLC24A3;SCNN1A;ASIC2,GO_BP,green,3
enzyme linked receptor protein signaling pathway (GO:0007167),4/140,0.0843006723294923,0.415717097941633,0,0,2.48833671399594,6.15456602791572,PDZD3;KDR;MST1R;FGFR2,GO_BP,green,4
positive regulation of cell differentiation (GO:0045597),6/258,0.0859329359140901,0.415717097941633,0,0,2.01987577639752,4.95715509774053,CDS1;CRB2;BRINP2;KDR;IL18;GDF5,GO_BP,green,6
collagen fibril organization (GO:0030199),3/89,0.088256643796773,0.415717097941633,0,0,2.94610240542968,7.15168215606675,COL17A1;ADAMTS3;TLL1,GO_BP,green,3
receptor-mediated endocytosis (GO:0006898),4/143,0.0894534291850673,0.415717097941633,0,0,2.43425948896056,5.87639279875105,AP1G2;HP;LRP2;SNCA,GO_BP,green,4
sodium ion transport (GO:0006814),3/90,0.090543409493316,0.415717097941633,0,0,2.91209116471807,6.99462713452781,SLC24A3;SCNN1A;ASIC2,GO_BP,green,3
sensory perception of sound (GO:0007605),3/91,0.0928547777676448,0.415717097941633,0,0,2.8788529067499,6.84222306493055,CEMIP;LRP2;GSDME,GO_BP,green,3
retinoid metabolic process (GO:0001523),3/92,0.0951904285676217,0.415717097941633,0,0,2.84636157592709,6.69428914328452,LRP2;AGRN;ALDH8A1,GO_BP,green,3
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),3/92,0.0951904285676217,0.415717097941633,0,0,2.84636157592709,6.69428914328452,CRB2;SULF1;GDF5,GO_BP,green,3
regulation of epithelial cell proliferation (GO:0050678),3/93,0.0975500392653509,0.415717097941633,0,0,2.81459227467811,6.55065337769608,EPGN;GDF5;FGFR2,GO_BP,green,3
regulation of kinase activity (GO:0043549),3/94,0.0999332847650427,0.415717097941633,0,0,2.78352119983021,6.41115207320802,KDR;MST1R;FGFR2,GO_BP,green,3
inorganic cation transmembrane transport (GO:0098662),6/274,0.106583104747299,0.415717097941633,0,0,1.89772874756652,4.24869256783694,SLC24A3;KCNA1;SCNN1A;KCNA4;SLC39A8;ASIC2,GO_BP,green,6
positive regulation of Wnt signaling pathway (GO:0030177),4/153,0.107682476382179,0.415717097941633,0,0,2.26972922934506,5.05824687281047,CDH3;RSPO1;SULF1;FGFR2,GO_BP,green,4
positive regulation of cell population proliferation (GO:0008284),9/474,0.109889187153916,0.415717097941633,0,0,1.64550234474918,3.63373454247701,DPP4;EPGN;IL7;BNC1;KDR;IL18;MST1R;NOX1;FGFR2,GO_BP,green,9
organic anion transport (GO:0015711),3/99,0.112192506127652,0.415717097941633,0,0,2.63787553648069,5.77045582008665,AQP9;SLC39A8;CA9,GO_BP,green,3
cell-matrix adhesion (GO:0007160),3/100,0.114710618051819,0.415717097941633,0,0,2.6105482058316,5.65273146591317,COL17A1;ITGA3;MSLN,GO_BP,green,3
cellular response to chemical stress (GO:0062197),3/101,0.117250034962933,0.415717097941633,0,0,2.58377857580801,5.53819133490658,ALDH3B1;NOX1;SNCA,GO_BP,green,3
organonitrogen compound biosynthetic process (GO:1901566),4/158,0.117378068724641,0.415717097941633,0,0,2.19547693685625,4.70349142595533,ALDH3A2;ALDH3B1;PAH;GCNT1,GO_BP,green,4
protein autophosphorylation (GO:0046777),4/159,0.119361642641771,0.415717097941633,0,0,2.18120133481646,4.63635584372104,DAPK1;STK26;KDR;FGFR2,GO_BP,green,4
regulation of cell death (GO:0010941),3/102,0.119810418232072,0.415717097941633,0,0,2.55754974639095,5.42672320439651,HP;DHCR24;SNCA,GO_BP,green,3
calcium-mediated signaling (GO:0019722),3/102,0.119810418232072,0.415717097941633,0,0,2.55754974639095,5.42672320439651,GPR143;KDR;MCTP2,GO_BP,green,3
steroid metabolic process (GO:0008202),3/104,0.12499272447956,0.419552902686878,0,0,2.50665023583903,5.21257853259154,HSD3B1;DHCR24;LRP2,GO_BP,green,3
regulation of MAPK cascade (GO:0043408),4/166,0.1336450543637,0.420847982323391,0,0,2.08620689655172,4.19863291065026,WWC1;KDR;FGFR2;GSDME,GO_BP,green,4
inflammatory response (GO:0006954),5/230,0.136906075936279,0.420847982323391,0,0,1.87965367965368,3.73761646669548,ALOX15;IL18;HP;OLR1;NOX1,GO_BP,green,5
regulation of protein serine/threonine kinase activity (GO:0071900),3/111,0.143741092589957,0.420847982323391,0,0,2.34334763948498,4.5454888194662,MST1;CCNO;SNCA,GO_BP,green,3
positive regulation of ERK1 and ERK2 cascade (GO:0070374),4/172,0.146416941301311,0.420847982323391,0,0,2.01108374384236,3.8638890931611,ADCYAP1;ALOX15;KDR;FGFR2,GO_BP,green,4
positive regulation of protein phosphorylation (GO:0001934),7/371,0.150545996397429,0.420847982323391,0,0,1.62915686933154,3.08478673002349,ADCYAP1;CEMIP;KDR;ITLN1;RSPO1;GDF5;SNCA,GO_BP,green,7
cation transport (GO:0006812),4/174,0.150776856299893,0.420847982323391,0,0,1.98722109533469,3.75973151226459,KCNA1;PIEZO2;KCNA4;LRP2,GO_BP,green,4
cellular response to transforming growth factor beta stimulus (GO:0071560),3/114,0.152046168644714,0.420847982323391,0,0,2.27966593202645,4.2939127832645,WNT10A;CGN;GDF5,GO_BP,green,3
axonogenesis (GO:0007409),5/240,0.15511221322518,0.420847982323391,0,0,1.79874735193884,3.3521571988339,NTNG1;SEMA3B;SLIT3;IGSF9;FGFR2,GO_BP,green,5
sphingolipid metabolic process (GO:0006665),3/116,0.157666057687497,0.420847982323391,0,0,2.23908997683163,4.13621726921673,ALDH3A2;SMPD3;ALDH3B1,GO_BP,green,3
negative regulation of programmed cell death (GO:0043069),7/381,0.165387218088188,0.425784114652569,0,0,1.58477920743526,2.85175594973255,KRT18;WT1;IL7;KDR;DHCR24;LRP2;SNCA,GO_BP,green,7
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),3/119,0.166213830486587,0.426263214600477,0,0,2.18084948941838,3.91349119326356,DAPK1;NLRP2;SNCA,GO_BP,green,3
potassium ion transport (GO:0006813),3/122,0.174894997886781,0.434159771593594,0,0,2.12554549716882,3.70603629380294,SLC24A3;KCNA1;KCNA4,GO_BP,green,3
cellular response to organic substance (GO:0071310),3/123,0.177816792298513,0.434159771593594,0,0,2.10772532188841,3.64004482513465,IL18;SLIT3;LRP2,GO_BP,green,3
positive regulation of phosphorylation (GO:0042327),5/253,0.180176911474232,0.434159771593594,0,0,1.70332355816227,2.9191832850951,KDR;ITLN1;MST1R;RSPO1;FGFR2,GO_BP,green,5
cellular response to oxidative stress (GO:0034599),3/125,0.183700484112786,0.435062890309818,0,0,2.07296137339056,3.51252660358743,DAPK1;ALDH3B1;SNCA,GO_BP,green,3
negative regulation of cell growth (GO:0030308),3/126,0.186661717636126,0.43787164135419,0,0,2.05600334973307,3.4509138248846,WT1;SLIT3;OSTN,GO_BP,green,3
circulatory system development (GO:0072359),3/126,0.186661717636126,0.43787164135419,0,0,2.05600334973307,3.4509138248846,CRB2;WT1;CRIP1,GO_BP,green,3
synapse organization (GO:0050808),3/126,0.186661717636126,0.43787164135419,0,0,2.05600334973307,3.4509138248846,NTNG1;AGRN;SNCA,GO_BP,green,3
positive regulation of intracellular signal transduction (GO:1902533),9/546,0.198015418462588,0.438579917169463,0,0,1.41956045578717,2.29885093755977,EPGN;NRG4;WWC1;KDR;IL18;MST1R;LRP2;FGFR2;GSDME,GO_BP,green,9
positive regulation of canonical Wnt signaling pathway (GO:0090263),3/130,0.198628224283278,0.438579917169463,0,0,1.9908418100098,3.2178382729745,CDH3;RSPO1;FGFR2,GO_BP,green,3
cellular response to metal ion (GO:0071248),3/131,0.201648614164673,0.438579917169463,0,0,1.97518776824034,3.16272720445827,KCNA1;ALOX15;SNCA,GO_BP,green,3
regulation of inflammatory response (GO:0050727),4/206,0.22638227780279,0.461605403553238,0,0,1.66968248548993,2.48036377993722,ALOX15;IL18;SMPDL3B;SNCA,GO_BP,green,4
neuron projection morphogenesis (GO:0048812),3/140,0.229282773136259,0.461605403553238,0,0,1.84458506939006,2.71670345141895,NTNG1;LRP2;FGFR2,GO_BP,green,3
positive regulation of cellular catabolic process (GO:0031331),3/141,0.23239758118206,0.465144632411011,0,0,1.83112520992723,2.67217138677501,AADAC;DAPK1;SNCA,GO_BP,green,3
nitrogen compound transport (GO:0071705),3/143,0.23865013676914,0.468705262656982,0,0,1.8047823421214,2.58581392492005,SLC7A4;AQP9;LRP2,GO_BP,green,3
positive regulation of transferase activity (GO:0051347),3/148,0.254401509390114,0.476242468844387,0,0,1.74210448423857,2.38466494044211,KDR;MST1R;FGFR2,GO_BP,green,3
cellular response to organic cyclic compound (GO:0071407),3/150,0.260743949872814,0.482684558109478,0,0,1.71822720504511,2.30966916760273,WT1;AQP9;IL18,GO_BP,green,3
cellular response to growth factor stimulus (GO:0071363),3/158,0.286297024616955,0.49312114616519,0,0,1.62887996677281,2.03728164486019,WNT10A;KDR;LRP2,GO_BP,green,3
skeletal system development (GO:0001501),3/158,0.286297024616955,0.49312114616519,0,0,1.62887996677281,2.03728164486019,TLL1;SULF1;FGFR2,GO_BP,green,3
MAPK cascade (GO:0000165),5/303,0.287733850861011,0.49312114616519,0,0,1.41389929980534,1.76132172388946,EPGN;NRG4;KDR;IL18;FGFR2,GO_BP,green,5
apoptotic process (GO:0006915),4/231,0.290866253054188,0.49312114616519,0,0,1.48389791888197,1.83245326665129,DAPK1;PAEP;DHCR24;NSG1,GO_BP,green,4
regulation of cell population proliferation (GO:0042127),11/764,0.292763357148732,0.494502574067211,0,0,1.23429836210713,1.51620056865131,DPP4;EPGN;WT1;IL7;BNC1;KDR;TNFRSF8;MST1R;NOX1;FGFR2;GSDME,GO_BP,green,11
chemical synaptic transmission (GO:0007268),5/306,0.294579728077838,0.495665391598763,0,0,1.39959154909321,1.71058861362649,GABRA1;KCNA1;NSG1;ASIC2;SNCA,GO_BP,green,5
regulation of ERK1 and ERK2 cascade (GO:0070372),4/238,0.309398212428231,0.502790389792744,0,0,1.43899204244032,1.68811914916045,ADCYAP1;ALOX15;KDR;FGFR2,GO_BP,green,4
anterograde trans-synaptic signaling (GO:0098916),4/244,0.325375472826635,0.510099828424324,0,0,1.40258620689655,1.57478937713601,GABRA1;KCNA1;ASIC2;SNCA,GO_BP,green,4
cellular response to cytokine stimulus (GO:0071345),7/482,0.342713117578692,0.520427411268992,0,0,1.24130544702367,1.32926630442467,GREM2;DAPK1;IL7;IFNE;ALOX15;IL18;GSDME,GO_BP,green,7
positive regulation of developmental process (GO:0051094),3/177,0.34751950102928,0.520427411268992,0,0,1.44960781411869,1.53214050656149,WT1;MST1;KDR,GO_BP,green,3
negative regulation of apoptotic process (GO:0043066),7/485,0.348454631882264,0.520530993305605,0,0,1.23332297966418,1.30022734532729,KRT18;WT1;IL7;KDR;DHCR24;LRP2;SNCA,GO_BP,green,7
regulation of cell migration (GO:0030334),6/408,0.350948292185908,0.52366835975274,0,0,1.25645684620376,1.31565654703397,NTNG1;CEMIP;STK26;SEMA3B;KDR;SULF1,GO_BP,green,6
positive regulation of cytokine production (GO:0001819),5/335,0.361820987122773,0.53082005716263,0,0,1.27469500196773,1.2958622049884,IL7;IL18;PAEP;SULF1;NOX1,GO_BP,green,5
regulation of apoptotic process (GO:0042981),10/742,0.379571208740809,0.542070041667401,0,0,1.15044247787611,1.11444865474549,KRT18;DAPK1;WT1;IL7;STK26;KDR;TNFRSF8;DHCR24;LRP2;SNCA,GO_BP,green,10
positive regulation of multicellular organismal process (GO:0051240),5/345,0.385207169576261,0.546529594828037,0,0,1.23656735421441,1.17965308862934,CRB2;ADCYAP1;MST1;ZBED2;IL18,GO_BP,green,5
negative regulation of signal transduction (GO:0009968),4/267,0.386870942536368,0.547210653045596,0,0,1.27841877540317,1.21406844566595,CHAC1;SULF1;SMPDL3B;SNCA,GO_BP,green,4
negative regulation of macromolecule metabolic process (GO:0010605),3/194,0.401908871585733,0.553571917334838,0,0,1.31943913893445,1.20270823119593,SLC24A3;KDR;UPK3B,GO_BP,green,3
protein localization to membrane (GO:0072657),3/195,0.405074748174186,0.553571917334838,0,0,1.3125,1.18608481098486,DPP6;PDZD3;AGRN,GO_BP,green,3
regulation of macromolecule metabolic process (GO:0060255),3/200,0.420828571813749,0.566733763531449,0,0,1.27886102699288,1.10689222797625,PRDM6;RSPO1;CRIP1,GO_BP,green,3
generation of neurons (GO:0048699),3/202,0.427091931123437,0.571900138062894,0,0,1.26587874997304,1.07695393365371,WNT10A;TAFA3;LHX9,GO_BP,green,3
axon guidance (GO:0007411),3/203,0.430214830143512,0.57433895578838,0,0,1.25948497854077,1.06233853803489,SEMA3B;SLIT3;IGSF9,GO_BP,green,3
positive regulation of protein modification process (GO:0031401),3/214,0.464137570448533,0.599773889579609,0,0,1.19315338771027,0.915833855680002,KDR;ITLN1;RSPO1,GO_BP,green,3
positive regulation of cell motility (GO:2000147),3/221,0.485264528543896,0.614384029780717,0,0,1.15442768830964,0.83472177386697,CEMIP;SEMA3B;KDR,GO_BP,green,3
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),5/404,0.520006700095422,0.643881924627913,0,0,1.05051590013996,0.686946615934155,MST1;KDR;MST1R;SULF1;FGFR2,GO_BP,green,5
negative regulation of gene expression (GO:0010629),4/322,0.528720126062406,0.647998607540574,0,0,1.05432661027977,0.671918183498616,SLC24A3;DAPK1;KDR;UPK3B,GO_BP,green,4
cellular response to oxygen-containing compound (GO:1901701),4/323,0.531163936381791,0.650394847584328,0,0,1.05096746297698,0.664930901572161,BRINP2;DAPK1;WT1;AQP9,GO_BP,green,4
protein phosphorylation (GO:0006468),6/496,0.532975243312396,0.652012912544852,0,0,1.02612244897959,0.645718646341807,DAPK1;STK26;KDR;WNK4;STK32B;FGFR2,GO_BP,green,6
membrane organization (GO:0061024),3/242,0.546096082653206,0.663187852200199,0,0,1.05186129617325,0.636334370693682,REEP1;EPGN;LRP2,GO_BP,green,3
regulation of canonical Wnt signaling pathway (GO:0060828),3/253,0.576250858736412,0.682982985733005,0,0,1.00501287553648,0.553975352582362,CDH3;RSPO1;FGFR2,GO_BP,green,3
supramolecular fiber organization (GO:0097435),4/351,0.596900754672615,0.698132604981766,0,0,0.964771936798171,0.497826583186164,COL17A1;ADAMTS3;TLL1;SNCA,GO_BP,green,4
cytokine-mediated signaling pathway (GO:0019221),7/621,0.601973327437211,0.699761134339675,0,0,0.953373255764334,0.48387710362928,GREM2;IL7;IFNE;ALOX15;IL18;TNFRSF8;IL17RE,GO_BP,green,7
regulation of protein phosphorylation (GO:0001932),3/266,0.610239675403471,0.705672465649018,0,0,0.954698999657305,0.471529166385223,KDR;ITLN1;RSPO1,GO_BP,green,3
central nervous system development (GO:0007417),3/268,0.615305193396141,0.707229026261022,0,0,0.947396550327962,0.460090709411352,ALDH3A2;MYRF;ASIC2,GO_BP,green,3
positive regulation of cell migration (GO:0030335),3/269,0.617821367419585,0.707747454065684,0,0,0.943786504888832,0.454485971840788,CEMIP;SEMA3B;KDR,GO_BP,green,3
protein transport (GO:0015031),4/369,0.636154820455532,0.716983432921922,0,0,0.916343882853094,0.414474541052955,RABL2A;TVP23A;LRP2;RAB17,GO_BP,green,4
plasma membrane bounded cell projection assembly (GO:0120031),3/278,0.639965611562149,0.718193651387484,0,0,0.912477565353102,0.407275999356582,STK26;RAB17;CCNO,GO_BP,green,3
negative regulation of cell population proliferation (GO:0008285),4/379,0.656870653264244,0.728376616853528,0,0,0.891448275862069,0.374647321878497,WT1;TNFRSF8;GDF5;GSDME,GO_BP,green,4
positive regulation of programmed cell death (GO:0043068),3/286,0.658885695486932,0.72959805382122,0,0,0.886319173781829,0.369776977898126,DAPK1;TNFRSF8;SNCA,GO_BP,green,3
positive regulation of macromolecule metabolic process (GO:0010604),4/384,0.666928733523381,0.735445024291317,0,0,0.879491833030853,0.356257590605001,CDH3;SLC24A3;WT1;SNCA,GO_BP,green,4
regulation of cell cycle (GO:0051726),3/296,0.681519021746575,0.744746976966085,0,0,0.855629934523723,0.328075141231903,TGM1;DHCR24;FGFR2,GO_BP,green,3
negative regulation of transcription by RNA polymerase II (GO:0000122),7/684,0.701039671985672,0.761701064010555,0,0,0.861810066243961,0.306107006990476,WT1;PRDM6;WWC1;ZBED2;ID4;FGFR2;SNCA,GO_BP,green,7
positive regulation of apoptotic process (GO:0043065),3/310,0.711312085772759,0.770346937480506,0,0,0.816023821839482,0.277973623893223,DAPK1;TNFRSF8;SNCA,GO_BP,green,3
cellular protein localization (GO:0034613),3/329,0.748268790106427,0.797169177296436,0,0,0.767713736538613,0.222631625334002,REEP1;RABL2A;RAB17,GO_BP,green,3
regulation of nucleic acid-templated transcription (GO:1903506),4/430,0.749943041458704,0.79790102972145,0,0,0.782661486158329,0.225217119632147,WT1;BNC1;WWC1;SLC39A8,GO_BP,green,4
intracellular protein transport (GO:0006886),3/336,0.760900519202712,0.804415084240516,0,0,0.751304953021691,0.20529607196066,RABL2A;AP1S3;RAB17,GO_BP,green,3
nervous system development (GO:0007399),4/447,0.77631993069483,0.814891031352381,0,0,0.751965439402195,0.190390552162063,ALDH3A2;CHAC1;MST1R;ASIC2,GO_BP,green,4
regulation of cellular macromolecule biosynthetic process (GO:2000112),4/468,0.80583253231769,0.839251252359034,0,0,0.717152199762188,0.15481833950855,WT1;BNC1;WWC1;SLC39A8,GO_BP,green,4
neutrophil degranulation (GO:0043312),4/481,0.822472540624055,0.851915137409041,0,0,0.697137280416396,0.136248637074701,SLPI;ALDH3B1;HP;OLR1,GO_BP,green,4
regulation of gene expression (GO:0010468),10/1079,0.824702969285524,0.853561160279185,0,0,0.773818886230618,0.149139657484471,CDH3;SLC24A3;WT1;BNC1;PRDM6;WWC1;KDR;SLC39A8;UPK3B;CRIP1,GO_BP,green,10
neutrophil activation involved in immune response (GO:0002283),4/485,0.827351120619836,0.854972314864132,0,0,0.691196501541329,0.130999779051509,SLPI;ALDH3B1;HP;OLR1,GO_BP,green,4
neutrophil mediated immunity (GO:0002446),4/488,0.830937119117318,0.857346748484612,0,0,0.686805357651753,0.127197146130497,SLPI;ALDH3B1;HP;OLR1,GO_BP,green,4
phosphorylation (GO:0016310),3/400,0.853999198250535,0.876386224264813,0,0,0.62811212851753,0.0991318117646981,DAPK1;STK26;WNK4,GO_BP,green,3
cellular protein modification process (GO:0006464),9/1025,0.859394075936566,0.881243077867156,0,0,0.731607062333067,0.11085873613224,TGM1;EPB42;DAPK1;STK26;WNK4;CHST4;MSLN;FBXL13;EVPL,GO_BP,green,9
cellular protein metabolic process (GO:0044267),3/417,0.87271269170097,0.892836735322053,0,0,0.601791378988617,0.0819332233804151,TGM1;SLC34A2;MSLN,GO_BP,green,3
"negative regulation of transcription, DNA-templated (GO:0045892)",8/948,0.875977705693687,0.89480147834098,0,0,0.702650242627846,0.093041177863157,WT1;PRDM6;WWC1;ZBED2;ID4;FGFR2;LHX9;SNCA,GO_BP,green,8
organelle assembly (GO:0070925),3/425,0.880765006156812,0.897178217323033,0,0,0.590138925614792,0.0749266487564824,CDS1;RAB17;CCNO,GO_BP,green,3
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),4/547,0.889759734116,0.904023058098013,0,0,0.610306725090493,0.0712861534259746,DAPK1;WT1;ID4;LHX9,GO_BP,green,4
regulation of intracellular signal transduction (GO:1902531),3/437,0.891998305092468,0.905606212111423,0,0,0.573465714681276,0.0655419966768343,GPR143;WWC1;ARHGAP18,GO_BP,green,3
negative regulation of cellular process (GO:0048523),4/566,0.904477655778704,0.916877197137438,0,0,0.589090685973739,0.0591433369133507,WT1;TNFRSF8;SLIT3;GSDME,GO_BP,green,4
negative regulation of nucleic acid-templated transcription (GO:1903507),3/464,0.913887153876211,0.925710655866999,0,0,0.539124686955955,0.0485471964117497,WT1;ID4;LHX9,GO_BP,green,3
positive regulation of transcription by RNA polymerase II (GO:0045944),7/908,0.915164556122171,0.926299638173847,0,0,0.639953666232086,0.0567327802039495,ADCYAP1;WT1;WWC1;IL18;GRHL3;AGRN;FGFR2,GO_BP,green,7
positive regulation of gene expression (GO:0010628),3/482,0.92616189044332,0.935183349279626,0,0,0.518381463528273,0.0397630887664857,CDH3;SLC24A3;WT1,GO_BP,green,3
"positive regulation of transcription, DNA-templated (GO:0045893)",8/1183,0.971953915934857,0.977831188291228,0,0,0.555102650242628,0.0157909424954772,ADCYAP1;MYRF;WT1;BNC1;IL18;GRHL3;AGRN;FGFR2,GO_BP,green,8
regulation of transcription by RNA polymerase II (GO:0006357),12/2206,0.999576276955414,0.999992651460414,0,0,0.429010938924339,0.000181820344657481,ADCYAP1;WT1;PRDM6;WWC1;ZBED2;ID4;IL18;GRHL3;AGRN;FGFR2;LHX9;SNCA,GO_BP,green,12
"regulation of transcription, DNA-templated (GO:0006355)",8/2244,0.999992651460414,0.999992651460414,0,0,0.275052568810219,2.02124211680858e-06,MYRF;WT1;BNC1;WWC1;ID4;GRHL3;SLC39A8;LHX9,GO_BP,green,8
Epithelial Cells,19/218,1.38961562717845e-11,2.12611190958303e-09,0,0,8.60836440265845,215.204021156456,COL17A1;MUC16;ALOX15;KRT7;PRG4;KRT5;MST1R;EVPL;SELENBP1;KRT19;CDH3;TMEM125;SLPI;SPINT1;TRIM29;PRR15L;SCNN1A;CTSE;MISP,PanglaoDB,green,19
Urothelial Cells,13/106,3.72592834341863e-10,2.85033518271525e-08,0,0,12.330536670042,267.70254658058,CLIC3;ALOX15;RASSF7;ANO9;UPK3B;EVPL;TGM1;UPK1B;SPINT1;AP1G2;SCNN1A;EPS8L1;TJP3,PanglaoDB,green,13
Mammary Epithelial Cells,14/134,6.73192557453439e-10,3.43328204301254e-08,0,0,10.3234234234234,218.020273042469,COL17A1;KRT80;KRT7;KRT5;MST1R;EVPL;KRT19;TMEM125;KRT18;TRIM29;PRR15L;SCNN1A;PRR15;MISP,PanglaoDB,green,14
Airway Goblet Cells,13/118,1.43769767796268e-09,5.49919361820725e-08,0,0,10.9146700832799,222.225115094541,MUC16;MST1R;MSLN;EVPL;KRT19;TMEM125;SLPI;TRIM29;PRR15L;SCNN1A;PRR15;MISP;TJP3,PanglaoDB,green,13
Sebocytes,13/124,2.66386965601424e-09,8.15144114740359e-08,0,0,10.3215367834202,203.783117120125,COL17A1;IL18;KRT7;KRT5;EVPL;C15ORF48;SLPI;SPINT1;TRIM29;SCNN1A;LIPM;PLEK2;TJP3,PanglaoDB,green,13
Trichocytes,12/103,3.26809105977267e-09,8.33363220242031e-08,0,0,11.5814364207221,226.290378751181,KRT80;KRT19;KRT18;TRIM29;ITGA3;WWC1;KRT7;GRHL3;MST1R;EVPL;MISP;CCNO,PanglaoDB,green,12
Luminal Epithelial Cells,13/140,1.17976132753786e-08,2.45974158203395e-07,0,0,9.01384131916246,164.550995699676,KRT7;MST1R;EVPL;KRT19;TMEM125;KRT18;SLPI;TRIM29;PRR15L;SCNN1A;PRR15;MISP;FGFR2,PanglaoDB,green,13
Basal Cells,13/141,1.2861393892988e-08,2.45974158203395e-07,0,0,8.94296524663677,162.485055135837,COL17A1;KRT80;ITGA3;KRT7;KRT5;MST1R;SERPINB7;KRT19;CDH3;CDCP1;SLPI;TRIM29;PLEK2,PanglaoDB,green,13
Mesothelial Cells,13/144,1.65930113186125e-08,2.82081192416413e-07,0,0,8.73682949371855,156.514046864378,MUC16;LRRN4;HTRA1;KRT7;KRT5;IL17RE;MSLN;SULF1;DPP4;CALB2;WT1;RSPO1;PKHD1L1,PanglaoDB,green,13
Ductal Cells,12/132,5.52075641596252e-08,8.44675731642266e-07,0,0,8.76964285714286,146.559725971832,KRT19;TMEM125;KRT18;SLPI;AADAC;TRIM29;PRR15L;SCNN1A;KRT7;PRR15;RAB17;MISP,PanglaoDB,green,12
Cholangiocytes,12/134,6.5283379852063e-08,8.66616076646178e-07,0,0,8.625,142.696557044075,LGALS2;KRT19;TMEM125;SLPI;PRR15L;SCNN1A;KRT7;PRR15;CGN;RAB17;MISP;TJP3,PanglaoDB,green,12
Gastric Chief Cells,11/109,6.79698883644061e-08,8.66616076646178e-07,0,0,9.8107029478458,161.917813873588,CDS1;PLEKHG3;SELENBP1;PDZD3;TMEM125;SLPI;SPINT1;PRR15L;SCNN1A;FGFR2;TJP3,PanglaoDB,green,11
Clara Cells,11/113,9.88133842250856e-08,1.1629575220337e-06,0,0,9.4240522875817,152.010272257892,SLC34A2;TMEM125;SLPI;MUC16;TRIM29;PRR15L;SCNN1A;KRT5;CTSE;EVPL;KLK11,PanglaoDB,green,11
Goblet Cells,11/122,2.1732558651476e-07,2.37505819548273e-06,0,0,8.65597597597598,132.798851301348,GALNT12;PDZD3;KRT19;PRR15L;SCNN1A;ITLN1;KRT7;PRR15;MST1R;MISP;TJP3,PanglaoDB,green,11
Trophoblast Stem Cells,9/99,2.62170454831784e-06,2.58981361315694e-05,0,0,8.66696035242291,111.385051817112,CDS1;KRT80;KRT19;CDH3;KRT18;TRIM29;WWC1;GRHL3;CCNO,PanglaoDB,green,9
Keratinocytes,10/127,2.70830181768046e-06,2.58981361315694e-05,0,0,7.43022464261402,95.2494521859671,TGM1;COL17A1;KRT80;TRIM29;KRT7;GRHL3;KRT5;MST1R;SERPINB7;EVPL,PanglaoDB,green,10
Trophoblast Cells,9/130,2.43082086349189e-05,0.00021877387771427,0,0,6.43634179196854,68.3841778573347,COL17A1;C15ORF48;KRT80;CDCP1;TRIM29;SCNN1A;IL18;KRT7;PLEK2,PanglaoDB,green,9
Principal Cells,9/136,3.47637581474468e-05,0.000295491944253298,0,0,6.13038953831212,62.9403118119959,CDS1;KRT19;TMEM125;TRIM29;PRR15L;SCNN1A;PRR15;CGN;RAB17,PanglaoDB,green,9
Ionocytes,8/107,3.98650377216303e-05,0.000321018461653128,0,0,6.96969696969697,70.6031060341961,CDS1;SLC34A2;SPAG17;CYP4X1;TMEM125;MUC16;DNAH7;CGN,PanglaoDB,green,8
Foveolar Cells,8/114,6.27195116252365e-05,0.000479804263933059,0,0,6.50711684872559,62.9683153874733,LGALS2;KRT19;AADAC;PRR15L;SCNN1A;PRR15;CTSE;MISP,PanglaoDB,green,8
Myoepithelial Cells,8/115,6.67324879823973e-05,0.000486193841014609,0,0,6.44597474995901,61.9768782267556,COL17A1;CDH3;TRIM29;BNC1;ITGA3;KRT7;KRT5;SERPINB7,PanglaoDB,green,8
Merkel Cells,7/111,0.000349681192104028,0.00243187374508711,0,0,5.7784682566342,45.9878743138311,KRT19;KRT18;PRR15L;PIEZO2;PRR15;CGN;MISP,PanglaoDB,green,7
Salivary Mucous Cells,6/105,0.00154217894470562,0.010045421730657,0,0,5.18181818181818,33.549987355923,COL17A1;TRIM29;KRT7;KRT5;SERPINB7;KLK11,PanglaoDB,green,6
Podocytes,8/184,0.00157575242833835,0.010045421730657,0,0,3.90510366826156,25.1997214007208,DPP4;CRB2;NPHS1;ITGA3;WT1;HTRA1;TDRD5;SULF1,PanglaoDB,green,8
Hepatoblasts,6/114,0.00234162182432987,0.0143307255648988,0,0,4.74782608695652,28.7571624373211,KRT19;KRT18;PAH;DNAJC22;CGN;RAB17,PanglaoDB,green,6
Intercalated Cells,6/118,0.00278307035328344,0.0163772986173987,0,0,4.57732919254658,26.933922801727,SLC34A2;SPAG17;DNAH7;EFHC1;AP1S3;KLK11,PanglaoDB,green,6
Pulmonary Alveolar Type I Cells,6/131,0.00465401201775252,0.0263727347672643,0,0,4.09857391304348,22.0094469671316,KRT19;TRIM29;ITGA3;SCNN1A;SEMA3B;KRT7,PanglaoDB,green,6
Pulmonary Alveolar Type II Cells,6/135,0.00538178267970032,0.0294075982140767,0,0,3.97067745197169,20.745739865599,SLC34A2;SLPI;SPINT1;SCNN1A;CTSE;INMT,PanglaoDB,green,6
Airway Epithelial Cells,5/103,0.00752821497535495,0.0397178238354933,0,0,4.34358158847955,21.2361931049051,SLC34A2;TMEM125;SLPI;TRIM29;KLK11,PanglaoDB,green,5
Kidney Progenitor Cells,5/105,0.00814887915500807,0.0415592836905411,0,0,4.25627705627706,20.4721601301235,ADAMTS3;WT1;ID4;SEZ6L2;CTXN1,PanglaoDB,green,5
Parathyroid Chief Cells,5/106,0.00847214677497517,0.0418141437603613,0,0,4.21392139213921,20.1044982166954,TMEM151A;KIRREL2;WWC1;LRP2;SEZ6L2,PanglaoDB,green,5
Enterocytes,7/203,0.0105555200958634,0.0504685804583469,0,0,3.05177791640674,13.8889657749936,DPP4;KRTCAP3;LGALS2;SLC15A1;PDZD3;CLDN15;PRR15L,PanglaoDB,green,7
Pancreatic Progenitor Cells,5/114,0.0113835878191423,0.0527784526160235,0,0,3.90305413241193,17.4684412629019,WWC1;ID4;CGN;SEZ6L2;CACNG4,PanglaoDB,green,5
Acinar Cells,5/124,0.0158964404643904,0.0715339820897569,0,0,3.57324748081051,14.7991763935731,LGALS2;PDZD3;AADAC;PRR15L;CTSE,PanglaoDB,green,5
Oligodendrocytes,6/178,0.0192261801695488,0.0840458733125992,0,0,2.97148634984833,11.7417759486119,TMEM151A;BRINP2;TMEM125;MYRF;PHYHIP;FGFR2,PanglaoDB,green,6
Ependymal Cells,5/136,0.0227177590823861,0.0965504761001409,0,0,3.24394435081458,12.2770587859735,SPAG17;CCDC153;DNAH7;EFHC1;DRC3,PanglaoDB,green,5
Glycinergic Neurons,4/100,0.0307736027122512,0.12725300581012,0,0,3.5323275862069,12.2963785355382,TMEM151A;ASIC2;CTXN1;PHYHIP,PanglaoDB,green,4
Crypt Cells,4/110,0.0414269093550579,0.166797819245365,0,0,3.19746258945999,10.1801601294475,CDS1;TMEM125;ID4;FGFR2,PanglaoDB,green,4
Endothelial Cells (Blood Brain Barrier),4/113,0.0449817343219318,0.17283033114889,0,0,3.1089844985764,9.64251161560143,SEMA3B;ID4;SEZ6L2;PHYHIP,PanglaoDB,green,4
Proximal Tubule Cells,5/164,0.0452508926744408,0.17283033114889,0,0,2.66887200849465,8.26158105859352,DPP4;SLC13A3;PAH;DPYS;LRP2,PanglaoDB,green,5
Meningeal Cells,4/115,0.0474436203153815,0.17283033114889,0,0,3.05265610438024,9.30514667407797,HTRA1;ID4;SLIT3;SULF1,PanglaoDB,green,4
Taste Receptor Cells,4/115,0.0474436203153815,0.17283033114889,0,0,3.05265610438024,9.30514667407797,GABRA1;DPP6;FAM153B;SEZ6,PanglaoDB,green,4
Transient Cells,4/120,0.0539191837694061,0.191851979458585,0,0,2.92033293697979,8.52815760040168,CDS1;KRT19;TMEM125;AGRN,PanglaoDB,green,4
Pyramidal Cells,4/130,0.068229195998862,0.232120311226541,0,0,2.6871921182266,7.21479566181758,GABRA1;BRINP2;KCNA1;ASIC2,PanglaoDB,green,4
Delta Cells,4/131,0.0697582815038587,0.232120311226541,0,0,2.66589736627749,7.09853592670865,ADCYAP1;KCNT2;PRG4;ASIC2,PanglaoDB,green,4
Hepatic Stellate Cells,4/132,0.071304932206846,0.232120311226541,0,0,2.64493534482759,6.98471822352729,WT1;HTRA1;SLIT3;SULF1,PanglaoDB,green,4
Paneth Cells,4/132,0.071304932206846,0.232120311226541,0,0,2.64493534482759,6.98471822352729,LGALS2;PDZD3;ITLN1;CTSE,PanglaoDB,green,4
Anterior Pituitary Gland Cells,4/133,0.0728690712406538,0.232270164579584,0,0,2.6242983159583,6.87327608177094,ADCYAP1;KCNT2;SEZ6L2;SULF1,PanglaoDB,green,4
Alpha Cells,4/136,0.0776656069040945,0.242506895027071,0,0,2.56426332288401,6.55257171478635,DPP4;ADCYAP1;KCNT2;ID4,PanglaoDB,green,4
Schwann Cells,4/138,0.0809492032169326,0.247704561843814,0,0,2.52573340195574,6.34952566427508,KCNA1;SEMA3B;ID4;PHYHIP,PanglaoDB,green,4
Leydig Cells,4/145,0.092971100399509,0.278796491364132,0,0,2.39948642699927,5.69989982253158,CALB2;HSD3B1;KDR;HTRA1,PanglaoDB,green,4
Chondrocytes,4/146,0.0947543630780058,0.278796491364132,0,0,2.38246721709568,5.6142062995007,HTRA1;PRG4;SLIT3;SULF1,PanglaoDB,green,4
Osteoblasts,4/154,0.109591519052499,0.316367970094949,0,0,2.25448275862069,4.98465075702205,HTRA1;PARD6G;SULF1;FGFR2,PanglaoDB,green,4
Myofibroblasts,3/100,0.114710618051819,0.325013417813487,0,0,2.6105482058316,5.65273146591317,HTRA1;SLIT3;SULF1,PanglaoDB,green,3
Sertoli Cells,4/158,0.117378068724641,0.326524445724911,0,0,2.19547693685625,4.70349142595533,SELENBP1;WT1;SEMA3B;HTRA1,PanglaoDB,green,4
Hepatocytes,5/221,0.121394523367898,0.32852435999692,0,0,1.95887445887446,4.13069720750419,SLPI;AADAC;WT1;PAH;AQP9,PanglaoDB,green,5
Vascular Smooth Muscle Cells,3/103,0.122391428234147,0.32852435999692,0,0,2.53184549356223,5.31821979990203,WT1;SLIT3;SULF1,PanglaoDB,green,3
Retinal Ganglion Cells,4/164,0.12949433844923,0.341597134185037,0,0,2.1125,4.3181995228744,KCTD8;GALNT14;ASIC2;GALNT9,PanglaoDB,green,4
Glutaminergic Neurons,3/107,0.132914915808098,0.343631049472867,0,0,2.43397160779135,4.91186687712651,GABRA1;BRINP2;ASIC2,PanglaoDB,green,3
Undefined Placental Cells,3/108,0.135593939639087,0.343631049472867,0,0,2.41066830165543,4.81673366699201,KRT19;KRT18;AGRN,PanglaoDB,green,3
Fibroblasts,5/232,0.140467830416871,0.343631049472867,0,0,1.86290214924576,3.65646108461433,HTRA1;PRG4;SLIT3;SULF1;INMT,PanglaoDB,green,5
Follicular Cells,3/110,0.141007370961848,0.343631049472867,0,0,2.36536841683045,4.63362217138377,SLC15A1;PAH;HP,PanglaoDB,green,3
Enteric Glia Cells,3/111,0.143741092589957,0.343631049472867,0,0,2.34334763948498,4.5454888194662,KDR;ID4;PHYHIP,PanglaoDB,green,3
Parietal Cells,3/111,0.143741092589957,0.343631049472867,0,0,2.34334763948498,4.5454888194662,TMEM125;CGN;FGFR2,PanglaoDB,green,3
Granulosa Cells,3/112,0.146492361071325,0.344820480675581,0,0,2.32173091309997,4.45953893451914,HSD3B1;HTRA1;SEZ6L2,PanglaoDB,green,3
GABAergic Neurons,3/113,0.149260833829492,0.346013751150187,0,0,2.30050721810378,4.37570262324101,BRINP2;ASIC2;PHYHIP,PanglaoDB,green,3
Neuroendocrine Cells,3/123,0.177816792298513,0.406059242114516,0,0,2.10772532188841,3.64004482513465,GABRA1;BRINP2;ASIC2,PanglaoDB,green,3
Stromal Cells,3/124,0.180752065258847,0.406692146832405,0,0,2.09019969495974,3.57555619717745,CALB2;HTRA1;SULF1,PanglaoDB,green,3
Microfold Cells,3/126,0.186661717636126,0.413902069540974,0,0,2.05600334973307,3.4509138248846,C15ORF48;SLPI;SPINT1,PanglaoDB,green,3
Gamma (PP) Cells,3/128,0.192621310815199,0.421015150781791,0,0,2.02290128755365,3.3317773632617,ADCYAP1;ID4;SERTM1,PanglaoDB,green,3
Distal Tubule Cells,3/137,0.219987858077637,0.474058342054626,0,0,1.88617000832746,2.85600641970773,SLC34A2;SCNN1A;WNK4,PanglaoDB,green,3
Trigeminal Neurons,3/144,0.241787287026054,0.513349144536271,0,0,1.79189115149301,2.54394234621507,PIEZO2;DHCR24;ASIC2,PanglaoDB,green,3
Beta Cells,3/145,0.244931291183972,0.513349144536271,0,0,1.77918152692982,2.50291263286899,ADCYAP1;DPP6;SERTM1,PanglaoDB,green,3
M?ller Cells,3/147,0.251238691807242,0.519452970898756,0,0,1.75429184549356,2.42329424823922,KDR;HTRA1;ID4,PanglaoDB,green,3
Photoreceptor Cells,3/149,0.257570023224435,0.525442847377848,0,0,1.73008407313775,2.34679617567541,NTNG1;GABRA1;KCNA4,PanglaoDB,green,3
Neural Stem/Precursor Cells,3/152,0.267106919990885,0.537728404718493,0,0,1.69499092663537,2.23756811820963,ID4;LHX9;CACNG4,PanglaoDB,green,3
Pericytes,3/155,0.276685026465299,0.542728321143471,0,0,1.66128303591597,2.13454188527485,KDR;HTRA1;SLIT3,PanglaoDB,green,3
Purkinje Neurons,3/155,0.276685026465299,0.542728321143471,0,0,1.66128303591597,2.13454188527485,GABRA1;SLC24A3;ASIC2,PanglaoDB,green,3
Interneurons,5/305,0.292294532212409,0.566089410487323,0,0,1.404329004329,1.72731528474696,NTNG1;CALB2;CDH4;BRINP2;DZANK1,PanglaoDB,green,5
Myocytes,3/163,0.30237311562284,0.578288583628681,0,0,1.57757510729614,1.88692739784507,NPHS1;ITGA3;SULF1,PanglaoDB,green,3
Smooth Muscle Cells,3/169,0.321718320101548,0.607690160191813,0,0,1.52008893944878,1.72390079018821,HTRA1;SLIT3;SULF1,PanglaoDB,green,3
Endothelial Cells,4/246,0.3307146242822,0.617065091648494,0,0,1.39085209461385,1.53897706071169,DPP4;GPR182;KDR;INMT,PanglaoDB,green,4
Cajal-Retzius Cells,3/174,0.337849255502508,0.618877349936273,0,0,1.47526541676079,1.60089234056444,CALB2;CDH4;GDF5,PanglaoDB,green,3
Endothelial Cells (Aorta),3/185,0.373226755895415,0.648721547347638,0,0,1.38532283167476,1.36533140329435,KDR;HTRA1;SULF1,PanglaoDB,green,3
Dendritic Cells,3/199,0.417688407310235,0.672606146157263,0,0,1.28545151966366,1.12222432201418,DPP4;AQP9;AP1S3,PanglaoDB,green,3
Olfactory Epithelial Cells,3/226,0.500109961662766,0.728731658422887,0,0,1.12825497026502,0.781798649287576,CALB2;SEZ6L2;CTXN1,PanglaoDB,green,3
Mast Cells,3/235,0.526274162579629,0.738715108942048,0,0,1.08398697646885,0.69584699051831,KDR;RAB27B;STK32B,PanglaoDB,green,3
Neurons,3/289,0.665794406300132,0.870324089212542,0,0,0.876887061436418,0.356695169128994,CALB2;GABRA1;DZANK1,PanglaoDB,green,3
long-chain fatty acid transport (GO:0015909),3/32,0.00108404510308658,0.190912100117674,0,0,16.5550611790879,113.022325925807,ABCD2;PRKAB2;SLC27A6,GO_BP,purple,3
regulation of postsynaptic membrane potential (GO:0060078),3/35,0.00141076016139819,0.197224270563467,0,0,15.0007560483871,98.4593613939063,MPP2;CHRNA4;GABRA5,GO_BP,purple,3
protein-DNA complex assembly (GO:0065004),4/143,0.0131556034642612,0.386189659188412,0,0,4.61695034216529,19.9955848278422,CUL4A;ORC4;ORC2;ASF1A,GO_BP,purple,4
anterograde trans-synaptic signaling (GO:0098916),5/244,0.0198464005035017,0.386189659188412,0,0,3.36682900061733,13.1970694702141,SLC6A5;GLRB;CHRNA4;GABRA5;LPAR3,GO_BP,purple,5
DNA replication (GO:0006260),3/108,0.031521163938244,0.386189659188412,0,0,4.55483870967742,15.746515083328,ORC4;ORC2;RAD1,GO_BP,purple,3
DNA metabolic process (GO:0006259),5/277,0.0319602123650582,0.386189659188412,0,0,2.95338114754098,10.1692695464682,ORC4;CHRNA4;ORC2;RAD1;ASF1A,GO_BP,purple,5
ion transport (GO:0006811),3/116,0.0377458039540668,0.386189659188412,0,0,4.2306594347702,13.8633673627338,GLRB;CHRNA4;AQP11,GO_BP,purple,3
protein homooligomerization (GO:0051260),3/121,0.041931632213305,0.386189659188412,0,0,4.05036905412794,12.8466154398375,MPP2;AQP11;CBR4,GO_BP,purple,3
fatty acid metabolic process (GO:0006631),3/124,0.0445507104490652,0.386189659188412,0,0,3.94934684084244,12.2869202917479,ABCD2;SLC27A6;CBR4,GO_BP,purple,3
chemical synaptic transmission (GO:0007268),5/306,0.0457649811057847,0.386189659188412,0,0,2.66488753335875,8.21914229284751,SLC6A5;GLRB;CHRNA4;GABRA5;LPAR3,GO_BP,purple,5
protein dephosphorylation (GO:0006470),3/139,0.0588259588073613,0.386189659188412,0,0,3.51108870967742,9.94751838041882,PPP1CC;PTPRU;PPM1L,GO_BP,purple,3
dephosphorylation (GO:0016311),3/153,0.0738471751543455,0.386189659188412,0,0,3.18112903225806,8.2892509038211,PPP1CC;PTPRU;PPM1L,GO_BP,purple,3
heart development (GO:0007507),3/164,0.086724455360148,0.386189659188412,0,0,2.96213183730715,7.24246970752779,LDB3;ALPK2;BMP7,GO_BP,purple,3
regulation of translation (GO:0006417),3/178,0.104376709221766,0.394640450137528,0,0,2.72322580645161,6.15380603085695,GLE1;MTRF1;LARP4B,GO_BP,purple,3
positive regulation of cellular biosynthetic process (GO:0031328),3/180,0.107006868445565,0.394640450137528,0,0,2.69218151995626,6.0166548639058,AGXT2;EGF;LARP4B,GO_BP,purple,3
regulation of signal transduction (GO:0009966),3/198,0.131793621186867,0.413110947128341,0,0,2.44143920595534,4.94762063290068,GRK1;FRMPD1;DLL1,GO_BP,purple,3
cellular macromolecule biosynthetic process (GO:0034645),4/314,0.139748598402721,0.41573240010075,0,0,2.0522423288749,4.03862860430392,ORC4;MRPL42;ORC2;RAD1,GO_BP,purple,4
nervous system development (GO:0007399),5/447,0.155666545664543,0.41573240010075,0,0,1.80170239596469,3.35123688017138,BTBD1;GLRB;GDA;ADAM23;DPF3,GO_BP,purple,5
post-translational protein modification (GO:0043687),4/345,0.176920643179826,0.428555653788555,0,0,1.86271845123143,3.22632892674731,CUL4A;BTBD1;KLHL21;KLHL41,GO_BP,purple,4
cellular response to DNA damage stimulus (GO:0006974),4/350,0.183211533273132,0.428555653788555,0,0,1.83533060764134,3.11476503792798,CUL4A;CHRNA4;RAD1;ASF1A,GO_BP,purple,4
regulation of canonical Wnt signaling pathway (GO:0060828),3/253,0.217342424363503,0.451311112483725,0,0,1.899,2.89840795456283,PTPRU;EGF;WLS,GO_BP,purple,3
organelle organization (GO:0006996),4/420,0.277604893498511,0.476903741802638,0,0,1.52102876797999,1.94928418660728,ABCD2;RHOT1;PTCD2;TMCC1,GO_BP,purple,4
negative regulation of cellular process (GO:0048523),5/566,0.29102816741384,0.484957058401945,0,0,1.41082960755092,1.74143667579432,PTPRU;AQP11;BMP7;DLL1;JAM2,GO_BP,purple,5
DNA repair (GO:0006281),3/298,0.293868895486044,0.487920090130036,0,0,1.60563149261892,1.96629091890648,CHRNA4;RAD1;ASF1A,GO_BP,purple,3
cellular protein modification process (GO:0006464),8/1025,0.326309208150007,0.513171418596478,0,0,1.24644075919453,1.39590129100664,GRK1;CUL4A;PPP1CC;PTPRU;BTBD1;PPM1L;KLHL21;KLHL41,GO_BP,purple,8
negative regulation of cell population proliferation (GO:0008285),3/379,0.433364952862163,0.576022541816842,0,0,1.25452556623198,1.04900298900878,PTPRU;AQP11;DLL1,GO_BP,purple,3
"positive regulation of transcription, DNA-templated (GO:0045893)",8/1183,0.479617879661057,0.605149635168013,0,0,1.06979438583944,0.786048088287085,HLF;EGF;MED21;HSF2;DPF3;BMP7;DLL1;ASF1A,GO_BP,purple,8
protein modification by small protein conjugation (GO:0032446),3/409,0.482869418304378,0.606386533826645,0,0,1.16003893214683,0.844518803091179,CUL4A;KLHL21;KLHL41,GO_BP,purple,3
organelle assembly (GO:0070925),3/425,0.508442226449258,0.620246276244382,0,0,1.11513912245834,0.754284212369668,ABLIM3;TMEM67;KLHL41,GO_BP,purple,3
regulation of intracellular signal transduction (GO:1902531),3/437,0.527191167643805,0.633735716773252,0,0,1.08363683662851,0.693735687100631,PRKAB2;RHOT1;RAD1,GO_BP,purple,3
regulation of cell population proliferation (GO:0042127),5/764,0.536528442583483,0.639988705402482,0,0,1.03209572560962,0.642619647935817,PTPRU;EGF;AQP11;DLL1;KLHL41,GO_BP,purple,5
negative regulation of nucleic acid-templated transcription (GO:1903507),3/464,0.567906337987675,0.659412840952467,0,0,1.01875306136729,0.576409230855652,DPF3;SAMD13;BMP7,GO_BP,purple,3
positive regulation of cell population proliferation (GO:0008284),3/474,0.582439302033609,0.66741815101884,0,0,0.99660982124512,0.538697807144674,EGF;AQP11;DLL1,GO_BP,purple,3
positive regulation of gene expression (GO:0010628),3/482,0.593844239786708,0.672929203653705,0,0,0.979560913192808,0.510486627339775,EGF;LARP4B;BMP7,GO_BP,purple,3
protein ubiquitination (GO:0016567),3/525,0.651655755415689,0.713175976711777,0,0,0.896876158694846,0.384077204907063,CUL4A;KLHL21;KLHL41,GO_BP,purple,3
positive regulation of intracellular signal transduction (GO:1902533),3/546,0.677700792284527,0.73112961776868,0,0,0.861254678310462,0.335070613916573,EGF;GPR61;WLS,GO_BP,purple,3
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),3/547,0.678904892153821,0.731208812966904,0,0,0.859627016129032,0.332911392219831,DPF3;SAMD13;BMP7,GO_BP,purple,3
positive regulation of transcription by RNA polymerase II (GO:0045944),5/908,0.689101061125744,0.737644168035061,0,0,0.860973440081332,0.320598390337946,HLF;MED21;HSF2;DPF3;DLL1,GO_BP,purple,5
positive regulation of cellular process (GO:0048522),3/625,0.762845145068841,0.79231613135679,0,0,0.74879421221865,0.202698760711473,EGF;AQP11;DLL1,GO_BP,purple,3
"negative regulation of transcription, DNA-templated (GO:0045892)",4/948,0.857802014202025,0.87278545549813,0,0,0.652094529419871,0.10001953624516,ORC2;DPF3;SAMD13;BMP7,GO_BP,purple,4
regulation of gene expression (GO:0010468),3/1079,0.970441186889949,0.97602645990802,0,0,0.422645101331095,0.0126812460859597,EGF;ALPK2;BMP7,GO_BP,purple,3
"regulation of transcription, DNA-templated (GO:0006355)",8/2244,0.978813965299074,0.98303299101157,0,0,0.530268636971783,0.0113550027680048,HLF;EGF;TCF24;MED21;HSF2;DPF3;SAMD13;BMP7,GO_BP,purple,8
regulation of transcription by RNA polymerase II (GO:0006357),7/2206,0.989639032448907,0.991056853412301,0,0,0.468841897832348,0.00488299588108769,HLF;TCF24;MED21;HSF2;ORC2;DPF3;DLL1,GO_BP,purple,7
Crypt Cells,3/110,0.0330223340120123,0.731159132911102,0,0,4.46924932167621,15.2426928352724,CAPN9;LRIG1;BMP7,PanglaoDB,purple,3
Myocytes,3/163,0.0855165069261251,0.731159132911102,0,0,2.98079637096774,7.32991497019659,LDB3;DLL1;KLHL41,PanglaoDB,purple,3
Retinal Ganglion Cells,3/164,0.086724455360148,0.731159132911102,0,0,2.96213183730715,7.24246970752779,ABLIM3;CHRNA4;GPHN,PanglaoDB,purple,3
Interneurons,3/305,0.306002063401956,0.731159132911102,0,0,1.5678540910062,1.85659548427393,HLF;GDA;GABRA5,PanglaoDB,purple,3
sarcomere organization (GO:0045214),7/28,1.23857778731479e-06,0.00260863345993976,0,0,16.064039408867,218.495783532525,FHOD3;WDR1;ACTN2;ANKRD1;CASQ1;MYOZ2;LMOD2,GO_BP,yellow,7
myofibril assembly (GO:0030239),8/43,2.3790546830276e-06,0.00260863345993976,0,0,11.0346384479718,142.885407342449,FHOD3;WDR1;ACTN2;MYL2;ANKRD1;CASQ1;MYOZ2;LMOD2,GO_BP,yellow,8
actomyosin structure organization (GO:0031032),9/76,2.62586337033188e-05,0.019195061237126,0,0,6.49032067385843,68.4567593354913,FHOD3;EPB41L4B;WDR1;ACTN2;CUL3;ANKRD1;CASQ1;MYOZ2;LMOD2,GO_BP,yellow,9
magnesium ion transport (GO:0015693),4/12,7.77821619411061e-05,0.0426440702842114,0,0,23.9352078239609,226.465324865406,NIPAL4;MMGT1;TUSC3;SLC41A1,GO_BP,yellow,4
"neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",3/6,0.000166919913947828,0.0732110742575171,0,0,47.7658536585366,415.4672240137,GRIP1;GRIP2;RAB11A,GO_BP,yellow,3
regulation of G2/M transition of mitotic cell cycle (GO:0010389),11/149,0.000275046105463699,0.0788473268315395,0,0,3.85642439974043,31.6171724024176,PSMD12;PSMD11;DCTN1;PSME4;CEP70;FHL1;PSMD1;CEP63;MAPRE1;YWHAG;RAB11A,GO_BP,yellow,11
angiotensin-activated signaling pathway (GO:0038166),3/7,0.000287632747219478,0.0788473268315395,0,0,35.8225609756098,292.090931750188,ACTN2;CA2;CAV1,GO_BP,yellow,3
"neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",3/7,0.000287632747219478,0.0788473268315395,0,0,35.8225609756098,292.090931750188,GRIP1;GRIP2;RAB11A,GO_BP,yellow,3
muscle contraction (GO:0006936),10/129,0.000350433936766957,0.0853890692588817,0,0,4.05946994182288,32.2985163872737,GJC1;ACTA1;ACTN2;MYOT;MYL2;DYSF;CASQ2;MYL12A;LMOD2;TRDN,GO_BP,yellow,10
regulation of mitotic cell cycle phase transition (GO:1901990),12/188,0.000557473817010983,0.122254008070509,0,0,3.30044207662662,24.7272256485206,KLHL18;PSMD12;PSMD11;DCTN1;ZW10;CUL3;PSME4;CEP70;PSMD1;CEP63;MAPRE1;YWHAG,GO_BP,yellow,12
protein modification by small protein removal (GO:0070646),15/276,0.00065993026206542,0.122323747969907,0,0,2.79067752555883,20.4371819085406,USP14;USP7;PSMD12;PSMD11;USP31;USP10;OTUD7B;FOXK2;STAM;RAD23B;UCHL5;COPS2;PSME4;PSMD1;OTUD1,GO_BP,yellow,15
neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),3/9,0.000669350194089777,0.122323747969907,0,0,23.8792682926829,174.538423639819,GRIP1;GRIP2;RAB11A,GO_BP,yellow,3
negative regulation of potassium ion transmembrane transport (GO:1901380),3/11,0.00127493703709283,0.203947881167947,0,0,17.9076219512195,119.351766094567,ACTN2;CAV1;CASQ2,GO_BP,yellow,3
protein deubiquitination (GO:0016579),14/267,0.00138917272334535,0.203947881167947,0,0,2.68136745024617,17.6408421364399,USP14;USP7;PSMD12;PSMD11;USP31;USP10;OTUD7B;FOXK2;STAM;RAD23B;UCHL5;PSME4;PSMD1;OTUD1,GO_BP,yellow,14
regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),4/25,0.00160733917316562,0.203947881167947,0,0,9.11212015368495,58.6198649789176,JPH2;CASQ2;JPH1;TRDN,GO_BP,yellow,4
endoplasmic reticulum membrane organization (GO:0090158),3/12,0.00167399081669998,0.203947881167947,0,0,15.9170731707317,101.750603213735,VAPB;RTN4;TRDN,GO_BP,yellow,3
regulation of sequestering of calcium ion (GO:0051282),3/12,0.00167399081669998,0.203947881167947,0,0,15.9170731707317,101.750603213735,CASQ2;CASQ1;TRDN,GO_BP,yellow,3
positive regulation of actin filament depolymerization (GO:0030836),3/12,0.00167399081669998,0.203947881167947,0,0,15.9170731707317,101.750603213735,WDR1;ACTN2;CFL2,GO_BP,yellow,3
regulation of cellular ketone metabolic process (GO:0010565),6/64,0.00204177022613307,0.213621458699027,0,0,4.96373803270355,30.7450860670716,PSMD12;PSMD11;CAV1;PSME4;PSMD1;AZIN1,GO_BP,yellow,6
regulation of autophagosome maturation (GO:1901096),3/13,0.002143033329402,0.213621458699027,0,0,14.3246341463415,88.0325120014768,RUBCN;CALCOCO2;CLEC16A,GO_BP,yellow,3
regulation of cell communication by electrical coupling (GO:0010649),3/13,0.002143033329402,0.213621458699027,0,0,14.3246341463415,88.0325120014768,CAV1;CASQ2;TRDN,GO_BP,yellow,3
negative regulation of potassium ion transport (GO:0043267),3/13,0.002143033329402,0.213621458699027,0,0,14.3246341463415,88.0325120014768,ACTN2;CAV1;CASQ2,GO_BP,yellow,3
multivesicular body assembly (GO:0036258),4/30,0.00321061157200868,0.241933164250149,0,0,7.35790859507241,42.2439152856387,CHMP1B;VPS37A;STAM;RAB11A,GO_BP,yellow,4
cardiac myofibril assembly (GO:0055003),3/15,0.00330643641680985,0.241933164250149,0,0,11.9359756097561,68.1769114612711,FHOD3;MYL2;NRAP,GO_BP,yellow,3
adherens junction organization (GO:0034332),5/49,0.0033131875743509,0.241933164250149,0,0,5.443126114082,31.0794039208127,CDH2;CADM2;CTNNA1;PVR;CDH17,GO_BP,yellow,5
ciliary basal body-plasma membrane docking (GO:0097711),7/95,0.00354038445676205,0.241933164250149,0,0,3.82033699059561,21.5601480379208,DCTN1;CEP70;RAB3IP;CEP63;MAPRE1;YWHAG;RAB11A,GO_BP,yellow,7
multivesicular body organization (GO:0036257),4/31,0.00362701470104492,0.241933164250149,0,0,7.08503124151046,39.8132374711578,CHMP1B;VPS37A;STAM;RAB11A,GO_BP,yellow,4
proteasomal protein catabolic process (GO:0010498),11/205,0.00368008730862747,0.241933164250149,0,0,2.73533107657588,15.3310350474473,PSMD12;PSMD11;CUL3;CCDC47;PSME4;SPOP;PSMD1;PLAA;ARMC8;UBE2K;RAD23B,GO_BP,yellow,11
translational termination (GO:0006415),7/96,0.00375271001749622,0.241933164250149,0,0,3.77721813250678,21.0968096677609,MRPL30;MRPL3;MRPS27;MRPS10;ETF1;MRRF;GSPT1,GO_BP,yellow,7
regulation of cellular amine metabolic process (GO:0033238),5/51,0.00394683378006588,0.241933164250149,0,0,5.20593563512361,28.8140291002592,PSMD12;PSMD11;PSME4;PSMD1;AZIN1,GO_BP,yellow,5
apoptotic DNA fragmentation (GO:0006309),3/16,0.00400765441869512,0.241933164250149,0,0,11.0172607879925,60.8103123273226,DFFA;CASP3;KPNA1,GO_BP,yellow,3
negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),3/16,0.00400765441869512,0.241933164250149,0,0,11.0172607879925,60.8103123273226,PPP2CA;CAV1;NF2,GO_BP,yellow,3
regulation of release of sequestered calcium ion into cytosol (GO:0051279),5/52,0.00429414649906559,0.246430841733512,0,0,5.09491030454735,27.7698211634551,JPH2;CASQ2;CASQ1;JPH1;TRDN,GO_BP,yellow,5
MAPK cascade (GO:0000165),14/303,0.00438249102946055,0.246430841733512,0,0,2.34298549141019,12.7227345224057,PSMD12;PSMD11;ACTN2;CUL3;FGF1;SPTB;MRAS;LRRC7;PSME4;PSMD1;GRB2;NCAM1;HBEGF;FGFR1,GO_BP,yellow,14
membrane organization (GO:0061024),12/242,0.00465773340171588,0.255360233749073,0,0,2.51852976255015,13.5225563483617,VAPA;VAPB;CHMP1B;COX18;CLTCL1;DYSF;GRB2;STAM;NAPG;HBEGF;DNM2;TRDN,GO_BP,yellow,12
regulation of cellular amino acid metabolic process (GO:0006521),5/54,0.00505319907209229,0.27028452597801,0,0,4.88645458183273,25.8382708426263,PSMD12;PSMD11;PSME4;PSMD1;AZIN1,GO_BP,yellow,5
positive regulation of response to DNA damage stimulus (GO:2001022),5/55,0.00546630460772316,0.273610923334302,0,0,4.78848039215686,24.9439244398828,NACC2;CEBPG;EYA4;ANKRD1;NPAS2,GO_BP,yellow,5
regulation of muscle cell differentiation (GO:0051147),4/35,0.00565754258288347,0.273610923334302,0,0,6.1695717327865,31.9260879007553,CDH2;SRF;CTNNA1;SUPT6H,GO_BP,yellow,4
cellular response to alkaloid (GO:0071312),3/18,0.00566396440558686,0.273610923334302,0,0,9.54731707317073,49.3942975522577,CASP3;CASQ2;TGM2,GO_BP,yellow,3
regulation of protein-containing complex disassembly (GO:0043244),3/18,0.00566396440558686,0.273610923334302,0,0,9.54731707317073,49.3942975522577,CLEC16A;ETF1;GSPT1,GO_BP,yellow,3
mitochondrial translation (GO:0032543),7/105,0.00612527590237994,0.273610923334302,0,0,3.42874736101337,17.4706043596386,MRPL30;MRPL3;MRPS27;FASTKD2;MRPS10;QRSL1;MRRF,GO_BP,yellow,7
membrane fusion (GO:0061025),4/36,0.00626282311711433,0.273610923334302,0,0,5.97646699266504,30.319359440688,VAPA;DYSF;NAPG;DNM2,GO_BP,yellow,4
negative regulation of cell cycle G2/M phase transition (GO:1902750),5/57,0.00636304472870469,0.273610923334302,0,0,4.60383672699849,23.2827453932154,PSMD12;PSMD11;FHL1;PSME4;PSMD1,GO_BP,yellow,5
protein ubiquitination (GO:0016567),20/525,0.00667318443214594,0.276479632938445,0,0,1.92295870808455,9.63336568114616,ARRDC4;KLHL18;USP7;RNF11;PSMD12;PSMD11;CUL3;AKTIP;RNF157;RNF103;NFX1;PSME4;SPOP;ARIH2;PSMD1;TRIM69;FBXL5;UBE2K;TRIM55;MARCHF5,GO_BP,yellow,20
muscle organ development (GO:0007517),5/58,0.0068480067518194,0.276479632938445,0,0,4.51674065852756,22.5105214985463,MRAS;FHL1;SPEG;MEF2D;HBEGF,GO_BP,yellow,5
positive regulation of exocytosis (GO:0045921),4/37,0.0069096017910237,0.276479632938445,0,0,5.79506557012669,28.8295429553329,CADPS2;RAB15;STAM;RAB7A,GO_BP,yellow,4
cell-cell junction organization (GO:0045216),6/82,0.00700164043551675,0.276479632938445,0,0,3.78462433725592,18.7778330214405,GJC1;CDH2;CADM2;CTNNA1;PVR;CDH17,GO_BP,yellow,6
ubiquitin-dependent protein catabolic process (GO:0006511),15/354,0.00710883384958912,0.276479632938445,0,0,2.1399030550985,10.5848529873616,PSMD12;RNF11;PSMD11;CUL3;OTUD7B;VPS37A;ARMC8;RAD23B;NPLOC4;PSME4;ARIH2;SPOP;PSMD1;PLAA;UBE2K,GO_BP,yellow,15
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),14/321,0.00718620112972703,0.276479632938445,0,0,2.20355448882793,10.8758472322264,PSMD12;PSMD11;CUL3;ARMC8;RAD23B;ECPAS;NPLOC4;RNF103;PSME4;SPOP;PSMD1;PLAA;FBXL5;UBE2K,GO_BP,yellow,14
regulation of smooth muscle contraction (GO:0006940),3/20,0.00767523710807279,0.285776669845754,0,0,8.4232424677188,41.0191363251559,CNN1;CAV1;SRF,GO_BP,yellow,3
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),5/60,0.00789437235203047,0.285776669845754,0,0,4.35204991087344,21.0709071913039,CEACAM1;CDH2;MYOT;PVR;CDH17,GO_BP,yellow,5
positive regulation of cation channel activity (GO:2001259),4/40,0.00911022300096312,0.307364908324802,0,0,5.31132844335778,24.9545229568281,JPH2;ACTN2;CASQ1;TRDN,GO_BP,yellow,4
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),6/87,0.00927104602635353,0.308051574784747,0,0,3.55009555009555,16.6174969401866,PSMD12;EGLN3;PSMD11;BAG3;PSME4;PSMD1,GO_BP,yellow,6
metal ion transport (GO:0030001),6/88,0.00978120214179043,0.308868868947235,0,0,3.50662192125607,16.2261666634775,NIPAL4;TUSC3;MMGT1;CAV1;SLC41A1;CACNA1E,GO_BP,yellow,6
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),3/22,0.0100575679108206,0.308868868947235,0,0,7.53581514762516,34.6604535252274,PLAA;VPS37A;STAM,GO_BP,yellow,3
peptidyl-threonine dephosphorylation (GO:0035970),3/22,0.0100575679108206,0.308868868947235,0,0,7.53581514762516,34.6604535252274,PPP2CA;PPM1B;DUSP8,GO_BP,yellow,3
positive regulation of calcium ion transmembrane transporter activity (GO:1901021),3/22,0.0100575679108206,0.308868868947235,0,0,7.53581514762516,34.6604535252274,JPH2;CASQ1;TRDN,GO_BP,yellow,3
regulation of cation channel activity (GO:2001257),6/89,0.0103110349299537,0.308868868947235,0,0,3.46419584973802,15.8471045776488,JPH2;ACTN2;LRRC7;SLMAP;GSG1L;JPH1,GO_BP,yellow,6
protein autoubiquitination (GO:0051865),5/65,0.0109854740528331,0.308868868947235,0,0,3.98835784313726,17.9922057963475,RNF157;RNF11;NFX1;CUL3;MARCHF5,GO_BP,yellow,5
regulation of calcium ion transmembrane transport (GO:1903169),3/23,0.0113918511910558,0.308868868947235,0,0,7.15865853658537,32.0339731698482,CASQ2;CASQ1;TRDN,GO_BP,yellow,3
"DNA catabolic process, endonucleolytic (GO:0000737)",3/23,0.0113918511910558,0.308868868947235,0,0,7.15865853658537,32.0339731698482,DFFA;CASP3;KPNA1,GO_BP,yellow,3
regulation of peptidase activity (GO:0052547),3/23,0.0113918511910558,0.308868868947235,0,0,7.15865853658537,32.0339731698482,CAV1;NRDC;FURIN,GO_BP,yellow,3
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),3/23,0.0113918511910558,0.308868868947235,0,0,7.15865853658537,32.0339731698482,CASQ2;CASQ1;TRDN,GO_BP,yellow,3
positive regulation of supramolecular fiber organization (GO:1902905),6/91,0.0114312708458123,0.308868868947235,0,0,3.38233848822084,15.1237971855529,WDR1;DCTN1;CFL2;CDC42EP3;MAPRE1;LMOD2,GO_BP,yellow,6
cellular response to nutrient levels (GO:0031669),5/66,0.0116899754321115,0.308868868947235,0,0,3.92277402764384,17.452514246524,RALB;RRAGB;CLEC16A;LPL;EIF4G1,GO_BP,yellow,5
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),5/66,0.0116899754321115,0.308868868947235,0,0,3.92277402764384,17.452514246524,PSMD12;PSMD11;FHL1;PSME4;PSMD1,GO_BP,yellow,5
mitotic cell cycle phase transition (GO:0044772),10/209,0.0118455466387096,0.309253378317741,0,0,2.4175467910271,10.7237620168977,PPP6C;WEE1;DCTN1;CUL3;CEP70;CEP63;MAPRE1;GSPT1;YWHAG;DNM2,GO_BP,yellow,10
negative regulation of mitotic cell cycle phase transition (GO:1901991),6/92,0.0120224332306898,0.310178777351798,0,0,3.34283755213988,14.7786210985922,PSMD12;WEE1;PSMD11;FHL1;PSME4;PSMD1,GO_BP,yellow,6
protein stabilization (GO:0050821),9/179,0.0122864633093888,0.312459061302476,0,0,2.54445253348864,11.1937010430211,CCT6A;RAB21;USP7;BAG2;BAG3;CDC37L1;GTPBP4;RTN4;NAPG,GO_BP,yellow,9
negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),4/44,0.0126902969705487,0.312459061302476,0,0,4.77921760391198,20.8704494477014,GRB2;STAM;HBEGF;RAB7A,GO_BP,yellow,4
apoptotic nuclear changes (GO:0030262),3/24,0.0128232172901153,0.312459061302476,0,0,6.81742160278746,29.700082898052,DFFA;CASP3;KPNA1,GO_BP,yellow,3
cardiac muscle cell development (GO:0055013),3/24,0.0128232172901153,0.312459061302476,0,0,6.81742160278746,29.700082898052,FHOD3;MYL2;ALPK3,GO_BP,yellow,3
establishment of mitotic spindle orientation (GO:0000132),3/24,0.0128232172901153,0.312459061302476,0,0,6.81742160278746,29.700082898052,GPSM2;DCTN1;ZW10,GO_BP,yellow,3
regulation of DNA repair (GO:0006282),4/45,0.013706881232091,0.324558784706923,0,0,4.66241278549705,20.0010854886665,CEBPG;EYA4;AXIN2;NPAS2,GO_BP,yellow,4
regulation of vesicle-mediated transport (GO:0060627),6/96,0.0146026766818793,0.337091262772224,0,0,3.19361179361179,13.4979613081538,RAB21;MBTPS1;USP7;RAB4A;RAB15;RAB11A,GO_BP,yellow,6
endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),9/185,0.0149641423026739,0.341837125726706,0,0,2.45695038253825,10.3243474012505,DYNC1LI1;VAPA;DCTN1;VAPB;ZW10;CUL3;BCAP29;SPTB;ERGIC2,GO_BP,yellow,9
regulation of potassium ion transmembrane transporter activity (GO:1901016),3/26,0.0159809737959211,0.361301809633556,0,0,6.22396606574761,25.7445418823999,ACTN2;FHL1;CASQ2,GO_BP,yellow,3
mitotic spindle organization (GO:0007052),8/157,0.0164866146760886,0.368818093028315,0,0,2.5769160659541,10.5787724783957,DYNC1LI1;GPSM2;ZW10;SBDS;CENPN;EFHC2;MAPRE1;RAB11A,GO_BP,yellow,8
microtubule cytoskeleton organization involved in mitosis (GO:1902850),7/128,0.0170741757035594,0.368818093028315,0,0,2.77372470789399,11.2895814367065,DYNC1LI1;GPSM2;ZW10;SBDS;CENPN;EFHC2;MAPRE1,GO_BP,yellow,7
endoplasmic reticulum organization (GO:0007029),5/73,0.0174940499749531,0.372470403835653,0,0,3.51769752018454,14.2322328993638,VAPA;VAPB;CCDC47;RTN4;TRDN,GO_BP,yellow,5
receptor internalization (GO:0031623),4/49,0.0182833838949165,0.377815110480274,0,0,4.24710676446618,16.9959130740192,CEACAM1;CAV1;GRB2;DNM2,GO_BP,yellow,4
response to glucose (GO:0009749),4/49,0.0182833838949165,0.377815110480274,0,0,4.24710676446618,16.9959130740192,ZBTB20;LPL;SELENOT;SLC39A14,GO_BP,yellow,4
G2/M transition of mitotic cell cycle (GO:0000086),7/130,0.0184342073968943,0.377815110480274,0,0,2.72834314550042,10.8957672458338,WEE1;DCTN1;CEP70;CEP63;MAPRE1;YWHAG;DNM2,GO_BP,yellow,7
positive regulation of canonical Wnt signaling pathway (GO:0090263),7/130,0.0184342073968943,0.377815110480274,0,0,2.72834314550042,10.8957672458338,PSMD12;PPM1B;PSMD11;CAV1;PSME4;PSMD1;AXIN2,GO_BP,yellow,7
cell cycle G2/M phase transition (GO:0044839),7/131,0.0191419822364449,0.382531466659137,0,0,2.70620133481646,10.7053842822608,WEE1;DCTN1;CEP70;CEP63;MAPRE1;YWHAG;DNM2,GO_BP,yellow,7
regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),5/75,0.0194478363258481,0.382531466659137,0,0,3.41684173669468,13.4624229274583,PSMD12;EGLN3;PSMD11;PSME4;PSMD1,GO_BP,yellow,5
regulation of muscle contraction (GO:0006937),3/28,0.0195364907732893,0.382531466659137,0,0,5.72546341463415,22.5323966065211,CNN1;CAV1;MYL2,GO_BP,yellow,3
glycogen metabolic process (GO:0005977),3/28,0.0195364907732893,0.382531466659137,0,0,5.72546341463415,22.5323966065211,UGP2;GBE1;STBD1,GO_BP,yellow,3
protein localization to lysosome (GO:0061462),3/28,0.0195364907732893,0.382531466659137,0,0,5.72546341463415,22.5323966065211,NCOA4;RTN4;RAB7A,GO_BP,yellow,3
mitotic metaphase plate congression (GO:0007080),4/51,0.0208871075088424,0.394874368680098,0,0,4.06596264891016,15.7296773361488,CHMP1B;ZW10;CUL3;RAB11A,GO_BP,yellow,4
establishment of mitotic spindle localization (GO:0040001),3/29,0.0214643961187152,0.396698663534899,0,0,5.50497185741088,21.1465771032546,GPSM2;DCTN1;ZW10,GO_BP,yellow,3
transition metal ion homeostasis (GO:0055076),3/29,0.0214643961187152,0.396698663534899,0,0,5.50497185741088,21.1465771032546,HJV;FBXL5;SLC39A14,GO_BP,yellow,3
negative regulation of canonical Wnt signaling pathway (GO:0090090),8/165,0.0215262840677852,0.396698663534899,0,0,2.44460171424078,9.38355619551079,PSMD12;PSMD11;CUL3;CAV1;PSME4;PSMD1;AXIN2;DKK3,GO_BP,yellow,8
establishment of spindle orientation (GO:0051294),3/30,0.0234925984970979,0.416243703622913,0,0,5.30081300813008,19.8837199348597,GPSM2;DCTN1;ZW10,GO_BP,yellow,3
regulation of proteasomal protein catabolic process (GO:0061136),4/54,0.0251994983588652,0.419305822582711,0,0,3.82141809290954,14.0663770522608,USP14;BAG2;RAD23B;UCHL5,GO_BP,yellow,4
protein dephosphorylation (GO:0006470),7/139,0.0255002605298406,0.419305822582711,0,0,2.54114420062696,9.32362733774971,PPP2CA;PPP6C;PPM1B;PPTC7;EYA4;DUSP8;RPAP2,GO_BP,yellow,7
regulation of potassium ion transport (GO:0043266),3/31,0.0256210580146299,0.419305822582711,0,0,5.11123693379791,18.7293134570682,ACTN2;FHL1;CASQ2,GO_BP,yellow,3
negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),3/31,0.0256210580146299,0.419305822582711,0,0,5.11123693379791,18.7293134570682,PPP2CA;CAV1;NF2,GO_BP,yellow,3
negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),3/31,0.0256210580146299,0.419305822582711,0,0,5.11123693379791,18.7293134570682,USP14;USP7;UCHL5,GO_BP,yellow,3
regulation of cardiac conduction (GO:1903779),4/55,0.0267472023356902,0.428793009954233,0,0,3.74629656263483,13.5665588858067,ACE2;CASQ2;CASQ1;TRDN,GO_BP,yellow,4
positive regulation of cytoskeleton organization (GO:0051495),5/82,0.0273928979064986,0.428793009954233,0,0,3.10510567863509,11.1705291823815,GPSM2;WDR1;CFL2;CDC42EP3;LMOD2,GO_BP,yellow,5
post-translational protein modification (GO:0043687),13/345,0.0277981183057418,0.428793009954233,0,0,1.88490210843374,6.75320267126125,MBTPS1;PSMD12;PSMD11;APLP2;CUL3;RAB11A;DCAF6;CDH2;COPS2;ASB8;PSME4;PSMD1;FBXL5,GO_BP,yellow,13
cellular response to glucose stimulus (GO:0071333),3/32,0.0278495932776892,0.428793009954233,0,0,4.93473507148865,17.6709749918657,ZBTB20;SELENOT;SLC39A14,GO_BP,yellow,3
membrane depolarization (GO:0051899),3/32,0.0278495932776892,0.428793009954233,0,0,4.93473507148865,17.6709749918657,SCN10A;CAV1;CACNA1E,GO_BP,yellow,3
protein K63-linked deubiquitination (GO:0070536),3/32,0.0278495932776892,0.428793009954233,0,0,4.93473507148865,17.6709749918657,USP7;OTUD7B;OTUD1,GO_BP,yellow,3
Ras protein signal transduction (GO:0007265),7/142,0.0282176523974197,0.428793009954233,0,0,2.48429118773946,8.86347279474482,GPSM2;MRAS;RALB;CDC42EP3;RRAS2;GRB2;NTN1,GO_BP,yellow,7
anaphase-promoting complex-dependent catabolic process (GO:0031145),5/84,0.0299908871551502,0.442061564809764,0,0,3.02618515760735,10.6124128413311,PSMD12;PSMD11;CUL3;PSME4;PSMD1,GO_BP,yellow,5
muscle cell development (GO:0055001),3/33,0.0301778892868424,0.442061564809764,0,0,4.77,16.698080301762,NRAP;DYSF;ALPK3,GO_BP,yellow,3
protein polyubiquitination (GO:0000209),12/314,0.0307086316796235,0.442061564809764,0,0,1.91095109907351,6.65624684748856,PSMD12;PSMD11;CUL3;AKTIP;PSME4;ARIH2;SPOP;PSMD1;TRIM69;FBXL5;UBE2K;MARCHF5,GO_BP,yellow,12
regulation of cell cycle G2/M phase transition (GO:1902749),5/85,0.0313460569156793,0.442061564809764,0,0,2.98820465686275,10.3471570450551,DCTN1;CEP70;CEP63;MAPRE1;YWHAG,GO_BP,yellow,5
"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",5/85,0.0313460569156793,0.442061564809764,0,0,2.98820465686275,10.3471570450551,PSMD12;PSMD11;RYK;PSME4;PSMD1,GO_BP,yellow,5
organelle assembly (GO:0070925),15/425,0.0315811995918879,0.442061564809764,0,0,1.76280794214977,6.0908421645766,RAB3IP;VPS37A;STAM;TXNDC15;EIF2S1;RAB11A;LMOD2;EHD4;TP53INP2;CHMP1B;CEP63;CEP20;MAPRE1;MAPRE2;RAB7A,GO_BP,yellow,15
positive regulation of mitotic cell cycle phase transition (GO:1901992),4/58,0.0317257821091033,0.442061564809764,0,0,3.53762564520511,12.2070216602545,KLHL18;CUL3;RAB11A;EIF4G1,GO_BP,yellow,4
positive regulation of protein binding (GO:0032092),4/58,0.0317257821091033,0.442061564809764,0,0,3.53762564520511,12.2070216602545,PPP2CA;RALB;AKTIP;CAV1,GO_BP,yellow,4
regulation of myoblast differentiation (GO:0045661),3/34,0.0326055049817107,0.442061564809764,0,0,4.61589299763965,15.801467133654,AKIRIN1;SMYD1;TBX3,GO_BP,yellow,3
positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),3/34,0.0326055049817107,0.442061564809764,0,0,4.61589299763965,15.801467133654,JPH2;CASQ1;TRDN,GO_BP,yellow,3
protein insertion into membrane (GO:0051205),3/34,0.0326055049817107,0.442061564809764,0,0,4.61589299763965,15.801467133654,VAPA;CCDC47;COX18,GO_BP,yellow,3
regulation of neuron death (GO:1901214),5/86,0.0327390142996829,0.442061564809764,0,0,2.95116194625999,10.0905769649877,EGLN3;INPP5A;RRAS2;EIF2S1;EIF4G1,GO_BP,yellow,5
selective autophagy (GO:0061912),4/59,0.0334979698843758,0.447933219246562,0,0,3.47312736163592,11.7956798012016,DYNC1LI1;CALCOCO2;STBD1;RAB7A,GO_BP,yellow,4
translation (GO:0006412),9/214,0.0341994839558307,0.45454223221295,0,0,2.10623037913547,7.10967484389977,MRPL3;FASTKD2;PABPC4;ETF1;QRSL1;MRRF;GSPT1;WARS1;EIF4G1,GO_BP,yellow,9
regulation of lipid biosynthetic process (GO:0046890),3/35,0.0351318805464703,0.457456702912636,0,0,4.47141768292683,14.973196203976,ASAH1;CEACAM1;ZBTB20,GO_BP,yellow,3
regulation of mitotic spindle organization (GO:0060236),3/35,0.0351318805464703,0.457456702912636,0,0,4.47141768292683,14.973196203976,GPSM2;DCTN1;CHMP1B,GO_BP,yellow,3
regulation of TORC1 signaling (GO:1903432),3/35,0.0351318805464703,0.457456702912636,0,0,4.47141768292683,14.973196203976,RRAGB;BMT2;CLEC16A,GO_BP,yellow,3
negative regulation of binding (GO:0051100),5/88,0.035639195666974,0.457456702912636,0,0,2.8797543113631,9.60199142342126,RALB;BAG2;CAV1;XIRP1;GTPBP4,GO_BP,yellow,5
regulation of protein binding (GO:0043393),6/118,0.0357945778722181,0.457456702912636,0,0,2.56339943839944,8.53601465400516,PPP2CA;RALB;BAG2;CAV1;AKTIP;XIRP1,GO_BP,yellow,6
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),5/89,0.0371468260921272,0.457456702912636,0,0,2.8453256302521,9.36930717287001,PSMD12;PSMD11;PSME4;PSMD1;FBXL5,GO_BP,yellow,5
mitochondrial translational termination (GO:0070126),5/89,0.0371468260921272,0.457456702912636,0,0,2.8453256302521,9.36930717287001,MRPL30;MRPL3;MRPS27;MRPS10;MRRF,GO_BP,yellow,5
cellular response to heat (GO:0034605),3/36,0.0377563443808423,0.457456702912636,0,0,4.33569844789357,14.2063571406549,BAG3;FGF1;IER5,GO_BP,yellow,3
negative regulation of cellular protein localization (GO:1903828),3/36,0.0377563443808423,0.457456702912636,0,0,4.33569844789357,14.2063571406549,ACTN2;CTNNA1;OTUD7B,GO_BP,yellow,3
negative regulation of protein phosphorylation (GO:0001933),7/152,0.0386727769678173,0.463682372251028,0,0,2.31177170035672,7.51931339772461,CEACAM1;CAV1;CNKSR3;YWHAG;WARS1;KLHL31;EIF4G1,GO_BP,yellow,7
positive regulation of binding (GO:0051099),5/90,0.0386930570551474,0.463682372251028,0,0,2.81170703575548,9.14393867165061,RALB;AKTIP;CAV1;CEBPG;DPH3,GO_BP,yellow,5
positive regulation of Wnt signaling pathway (GO:0030177),7/153,0.0398406171566664,0.4746979507151,0,0,2.29581955597544,7.39912419690402,PSMD12;PPM1B;PSMD11;CAV1;PSME4;PSMD1;AXIN2,GO_BP,yellow,7
skeletal muscle tissue development (GO:0007519),3/37,0.0404781198284194,0.4746979507151,0,0,4.20796269727403,13.4949098684425,ACTA1;CAV1;MYOZ2,GO_BP,yellow,3
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),3/37,0.0404781198284194,0.4746979507151,0,0,4.20796269727403,13.4949098684425,WEE1;NACC2;FHL1,GO_BP,yellow,3
protein insertion into ER membrane (GO:0045048),3/37,0.0404781198284194,0.4746979507151,0,0,4.20796269727403,13.4949098684425,VAPA;MMGT1;CCDC47,GO_BP,yellow,3
positive regulation of DNA metabolic process (GO:0051054),4/63,0.0411541981456256,0.477688489939071,0,0,3.23699805229787,10.3274135482865,USP7;CEBPG;EYA4;NPAS2,GO_BP,yellow,4
pre-replicative complex assembly (GO:0036388),4/64,0.0432104463640962,0.477688489939071,0,0,3.18288508557457,9.99958413220786,PSMD12;PSMD11;PSME4;PSMD1,GO_BP,yellow,4
actin-myosin filament sliding (GO:0033275),3/38,0.0432963316134021,0.477688489939071,0,0,4.08752613240418,12.8335541634921,ACTA1;ACTN2;MYL2,GO_BP,yellow,3
regulation of axon extension (GO:0030516),3/38,0.0432963316134021,0.477688489939071,0,0,4.08752613240418,12.8335541634921,NTN1;RTN4;DNM2,GO_BP,yellow,3
regulation of cell communication (GO:0010646),3/38,0.0432963316134021,0.477688489939071,0,0,4.08752613240418,12.8335541634921,CASQ2;YWHAG;TRDN,GO_BP,yellow,3
muscle filament sliding (GO:0030049),3/38,0.0432963316134021,0.477688489939071,0,0,4.08752613240418,12.8335541634921,ACTA1;ACTN2;MYL2,GO_BP,yellow,3
regulation of cell differentiation (GO:0045595),7/156,0.0434814333381316,0.477688489939071,0,0,2.24924785929183,7.05233953862091,PPP2CA;CASZ1;SRF;TAF8;SUPT6H;YWHAG;FGFR1,GO_BP,yellow,7
regulation of heart contraction (GO:0008016),5/93,0.0435648417637092,0.477688489939071,0,0,2.71543560606061,8.50883060206337,ACE2;SCN10A;CASQ2;CASQ1;TRDN,GO_BP,yellow,5
negative regulation of Wnt signaling pathway (GO:0030178),8/191,0.0452437538777819,0.491436898754647,0,0,2.09447480267152,6.48384607211727,PSMD12;PSMD11;CUL3;CAV1;PSME4;PSMD1;AXIN2;DKK3,GO_BP,yellow,8
positive regulation of epithelial cell migration (GO:0010634),5/94,0.0452668734831002,0.491436898754647,0,0,2.68478739810531,8.30989967812119,EPB41L4B;FGF1;MAPRE2;RTN4;RAB11A,GO_BP,yellow,5
cell-cell junction assembly (GO:0007043),4/66,0.047493473092337,0.508064324348756,0,0,3.07989589084313,9.38494475920394,GJC1;WDR1;CDH2;CTNNA1,GO_BP,yellow,4
negative regulation of ERBB signaling pathway (GO:1901185),3/40,0.0492181069798942,0.515607753161155,0,0,3.86618325642716,11.6429865009977,GRB2;STAM;HBEGF,GO_BP,yellow,3
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),3/40,0.0492181069798942,0.515607753161155,0,0,3.86618325642716,11.6429865009977,PPM1B;USP10;OTUD7B,GO_BP,yellow,3
regulation of epidermal growth factor receptor signaling pathway (GO:0042058),4/67,0.0497200720199009,0.515607753161155,0,0,3.03085341716149,9.09664148907308,CEACAM1;GRB2;STAM;HBEGF,GO_BP,yellow,4
peptide biosynthetic process (GO:0043043),7/162,0.051390747774422,0.515607753161155,0,0,2.1615127919911,6.41601221068395,MRPL3;PABPC4;FURIN;MRRF;GSPT1;WARS1;EIF4G1,GO_BP,yellow,7
regulation of translational initiation (GO:0006446),4/68,0.0520032144063593,0.515607753161155,0,0,2.9833435207824,8.82010519664737,CTIF;PAIP2B;EIF5;EIF4G1,GO_BP,yellow,4
heart contraction (GO:0060047),3/41,0.0523194814595729,0.515607753161155,0,0,3.76424903722721,11.1059894774154,MYL2;CASQ2;TRDN,GO_BP,yellow,3
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),5/98,0.0524676981719608,0.515607753161155,0,0,2.56878557874763,7.57164338260254,DYNC1LI1;DCTN1;AP1S2;DNM2;RAB7A,GO_BP,yellow,5
regulation of primary metabolic process (GO:0080090),6/130,0.0529883011547038,0.515607753161155,0,0,2.31390187841801,6.79751280977267,PSMD12;PSMD11;OPA3;PSME4;PSMD1;AZIN1,GO_BP,yellow,6
positive regulation of protein polymerization (GO:0032273),4/69,0.0543427209670317,0.515607753161155,0,0,2.93729546736882,8.55471033204098,DCTN1;CDC42EP3;MAPRE1;LMOD2,GO_BP,yellow,4
regulation of DNA recombination (GO:0000018),3/42,0.0555129252481422,0.515607753161155,0,0,3.66754221388368,10.6033757883501,SHLD2;SUPT6H;KPNA1,GO_BP,yellow,3
ceramide biosynthetic process (GO:0046513),3/42,0.0555129252481422,0.515607753161155,0,0,3.66754221388368,10.6033757883501,ASAH1;ST8SIA2;ST6GALNAC5,GO_BP,yellow,3
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),5/100,0.0563042593843601,0.515607753161155,0,0,2.51444788441692,7.23402907696852,DYNC1LI1;DCTN1;AP1S2;DNM2;RAB7A,GO_BP,yellow,5
COPII-coated vesicle budding (GO:0090114),4/70,0.0567383781937255,0.515607753161155,0,0,2.89264280951323,8.29987283680006,PPP6C;VAPA;VAPB;CUL3,GO_BP,yellow,4
establishment of protein localization to membrane (GO:0090150),4/70,0.0567383781937255,0.515607753161155,0,0,2.89264280951323,8.29987283680006,COX18;RAB3IP;VPS37A;RAB11A,GO_BP,yellow,4
wound healing (GO:0042060),4/70,0.0567383781937255,0.515607753161155,0,0,2.89264280951323,8.29987283680006,EPB41L4B;SRF;DYSF;FGF1,GO_BP,yellow,4
regulation of cell-cell adhesion (GO:0022407),3/43,0.0587971580439699,0.515607753161155,0,0,3.57567073170732,10.1322414110352,CEACAM1;NF2;GTPBP4,GO_BP,yellow,3
cellular glucose homeostasis (GO:0001678),3/43,0.0587971580439699,0.515607753161155,0,0,3.57567073170732,10.1322414110352,FOXK2;ZBTB20;SLC39A14,GO_BP,yellow,3
negative regulation of type I interferon production (GO:0032480),3/43,0.0587971580439699,0.515607753161155,0,0,3.57567073170732,10.1322414110352,PPM1B;NPLOC4;TAX1BP1,GO_BP,yellow,3
regulation of hematopoietic stem cell differentiation (GO:1902036),4/71,0.0591899392608456,0.515607753161155,0,0,2.8493230668175,8.05504684228073,PSMD12;PSMD11;PSME4;PSMD1,GO_BP,yellow,4
gland development (GO:0048732),4/71,0.0591899392608456,0.515607753161155,0,0,2.8493230668175,8.05504684228073,CAV1;CEBPG;TBX3;DKK3,GO_BP,yellow,4
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),5/102,0.060298244151492,0.515607753161155,0,0,2.46235091974934,6.91539508974971,USP7;BAG2;ARIH2;RAD23B;UCHL5,GO_BP,yellow,5
metal ion homeostasis (GO:0055065),3/44,0.0621708345172789,0.515607753161155,0,0,3.48828078524688,9.68998806000303,LETM1;JPH2;CAV1,GO_BP,yellow,3
antigen processing and presentation of exogenous peptide antigen (GO:0002478),5/103,0.0623541733881726,0.515607753161155,0,0,2.43709983993597,6.76276847942888,DYNC1LI1;DCTN1;AP1S2;DNM2;RAB7A,GO_BP,yellow,5
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",4/73,0.0642596243506823,0.515607753161155,0,0,2.76645051557351,7.59341913667279,PSMD12;PSMD11;PSME4;PSMD1,GO_BP,yellow,4
cellular metal ion homeostasis (GO:0006875),5/104,0.0644493091792514,0.515607753161155,0,0,2.41235888294712,6.61438957192657,LETM1;VAPB;CAV1;SLC41A1;TRDN,GO_BP,yellow,5
sphingolipid biosynthetic process (GO:0030148),4/74,0.0668770962401506,0.515607753161155,0,0,2.72679008033531,7.37569102148567,ASAH1;VAPA;VAPB;ST6GALNAC5,GO_BP,yellow,4
negative regulation of protein binding (GO:0032091),4/74,0.0668770962401506,0.515607753161155,0,0,2.72679008033531,7.37569102148567,RALB;BAG2;CAV1;XIRP1,GO_BP,yellow,4
NIK/NF-kappaB signaling (GO:0038061),4/74,0.0668770962401506,0.515607753161155,0,0,2.72679008033531,7.37569102148567,PSMD12;PSMD11;PSME4;PSMD1,GO_BP,yellow,4
cellular response to peptide hormone stimulus (GO:0071375),5/106,0.0687568495527394,0.515607753161155,0,0,2.36434672879053,6.32977921607302,CEACAM1;RAB15;CAV1;SLC39A14;RHOQ,GO_BP,yellow,5
small GTPase mediated signal transduction (GO:0007264),5/106,0.0687568495527394,0.515607753161155,0,0,2.36434672879053,6.32977921607302,MRAS;RALB;RRAS2;GRB2;NTN1,GO_BP,yellow,5
erythrocyte differentiation (GO:0030218),3/46,0.0691808406706367,0.515607753161155,0,0,3.32569483834373,8.88303508600158,ALAS1;CASP3;CEBPG,GO_BP,yellow,3
vesicle organization (GO:0016050),3/46,0.0691808406706367,0.515607753161155,0,0,3.32569483834373,8.88303508600158,LAPTM4B;AKTIP;CAV1,GO_BP,yellow,3
regulation of hematopoietic progenitor cell differentiation (GO:1901532),4/75,0.0695491695106954,0.515607753161155,0,0,2.68824684045594,7.166116866508,PSMD12;PSMD11;PSME4;PSMD1,GO_BP,yellow,4
protein localization to cell periphery (GO:1990778),6/140,0.0705816062769167,0.515607753161155,0,0,2.14012248340607,5.67343410564158,EHD4;ACTN2;RAB15;CAV1;SLMAP;RAB11A,GO_BP,yellow,6
water-soluble vitamin metabolic process (GO:0006767),4/76,0.0722754443829383,0.515607753161155,0,0,2.65077424612877,6.96430188716178,PCCA;PNPO;MTHFR;SLC19A2,GO_BP,yellow,4
regulation of wound healing (GO:0061041),3/47,0.0728141968794147,0.515607753161155,0,0,3.24994456762749,8.51434885062718,TNFRSF12A;CAV1;HBEGF,GO_BP,yellow,3
glycosphingolipid metabolic process (GO:0006687),3/47,0.0728141968794147,0.515607753161155,0,0,3.24994456762749,8.51434885062718,B3GALNT1;ASAH1;ST6GALNAC5,GO_BP,yellow,3
positive regulation of developmental process (GO:0051094),7/177,0.0749174651981395,0.515607753161155,0,0,1.96926977687627,5.10310314678114,GRIP1;SRF;SHLD2;MIEF1;RTN4;FGFR1;MARCHF5,GO_BP,yellow,7
protein-DNA complex assembly (GO:0065004),6/143,0.0764432024018926,0.515607753161155,0,0,2.09293566957801,5.38137140123837,PSMD12;PSMD11;H2BC21;PSME4;PSMD1;RAD23B,GO_BP,yellow,6
positive regulation of DNA repair (GO:0045739),3/48,0.0765310584419406,0.515607753161155,0,0,3.17756097560976,8.1665180008449,CEBPG;EYA4;NPAS2,GO_BP,yellow,3
regulation of translation (GO:0006417),7/178,0.076678673697441,0.515607753161155,0,0,1.95765275257108,5.02751000835746,CTIF;PAIP2B;EIF5;PRR16;ETF1;GSPT1;EIF4G1,GO_BP,yellow,7
antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),4/78,0.0778888614579846,0.515607753161155,0,0,2.57886737593339,6.58248759779588,PSMD12;PSMD11;PSME4;PSMD1,GO_BP,yellow,4
cellular divalent inorganic cation homeostasis (GO:0072503),5/111,0.0802040329500057,0.515607753161155,0,0,2.25224287828339,5.68281751717696,VAPB;CAV1;SLC41A1;SLC39A14;TRDN,GO_BP,yellow,5
Fc-epsilon receptor signaling pathway (GO:0038095),5/111,0.0802040329500057,0.515607753161155,0,0,2.25224287828339,5.68281751717696,PSMD12;PSMD11;PSME4;PSMD1;GRB2,GO_BP,yellow,5
regulation of canonical Wnt signaling pathway (GO:0060828),9/253,0.0802833029423515,0.515607753161155,0,0,1.76601809771141,4.45423956670325,PSMD12;PPM1B;PSMD11;CUL3;CAV1;PSME4;PSMD1;AXIN2;DKK3,GO_BP,yellow,9
axon development (GO:0061564),4/79,0.0807750686060288,0.515607753161155,0,0,2.54435207823961,6.40181097865302,RYK;VASH2;MAPK8IP3;RTN4,GO_BP,yellow,4
regulation of cell growth (GO:0001558),8/217,0.0817723222963144,0.515607753161155,0,0,1.8314608068994,4.5856416974297,PPP2CA;URI1;CEACAM1;MYL2;FHL1;PRDM11;RTN4;EIF4G1,GO_BP,yellow,8
regulation of mRNA stability (GO:0043488),6/146,0.0825724132544272,0.515607753161155,0,0,2.04777114777115,5.10730431517794,PSMD12;PSMD11;PSME4;PSMD1;AXIN2;EIF4G1,GO_BP,yellow,6
Fc receptor signaling pathway (GO:0038093),5/112,0.0826084993684064,0.515607753161155,0,0,2.2310793476269,5.56351474132938,PSMD12;PSMD11;PSME4;PSMD1;GRB2,GO_BP,yellow,5
positive regulation of ion transport (GO:0043270),3/50,0.0842088498655286,0.515607753161155,0,0,3.04203425012974,7.52737764514532,ACTN2;FHL1;CNKSR3,GO_BP,yellow,3
"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",5/113,0.0850508659233425,0.515607753161155,0,0,2.21030773420479,5.44731618397944,PPP2CA;CTIF;ETF1;GSPT1;EIF4G1,GO_BP,yellow,5
positive regulation of cell differentiation (GO:0045597),9/258,0.0880596022509467,0.515607753161155,0,0,1.73010855302398,4.20371636992297,CEACAM1;AKIRIN1;CDH2;SRF;CTNNA1;LPL;SMYD1;AXIN2;FGFR1,GO_BP,yellow,9
blood circulation (GO:0008015),3/51,0.0881664619574667,0.515607753161155,0,0,2.97850609756098,7.23338735697439,ACE2;MYL2;TRDN,GO_BP,yellow,3
regulation of epithelial cell migration (GO:0010632),3/51,0.0881664619574667,0.515607753161155,0,0,2.97850609756098,7.23338735697439,CEACAM1;RTN4;RAB11A,GO_BP,yellow,3
negative regulation of protein ubiquitination (GO:0031397),3/51,0.0881664619574667,0.515607753161155,0,0,2.97850609756098,7.23338735697439,BAG2;CAV1;GTPBP4,GO_BP,yellow,3
negative regulation of transport (GO:0051051),3/51,0.0881664619574667,0.515607753161155,0,0,2.97850609756098,7.23338735697439,RUBCN;DYSF;RAB7A,GO_BP,yellow,3
cellular response to organic cyclic compound (GO:0071407),6/150,0.0911571940699327,0.515607753161155,0,0,1.99047911547912,4.76753557511036,GABRB3;URI1;CASP3;NCOA4;CTNNA1;TGM2,GO_BP,yellow,6
regulation of exocytosis (GO:0017157),3/52,0.0922009511118928,0.515607753161155,0,0,2.91757093081135,6.95486133326916,RAB21;CADPS2;RAB15,GO_BP,yellow,3
signal transduction in response to DNA damage (GO:0042770),3/52,0.0922009511118928,0.515607753161155,0,0,2.91757093081135,6.95486133326916,USP10;GRB2;CEP63,GO_BP,yellow,3
positive regulation of developmental growth (GO:0048639),3/52,0.0922009511118928,0.515607753161155,0,0,2.91757093081135,6.95486133326916,RNF157;PLAA;NTN1,GO_BP,yellow,3
cytosolic transport (GO:0016482),5/116,0.0926031179795181,0.515607753161155,0,0,2.15023847376789,5.11634723501106,DCTN1;AKTIP;CLTCL1;RAB6B;RAB7A,GO_BP,yellow,5
sphingolipid metabolic process (GO:0006665),5/116,0.0926031179795181,0.515607753161155,0,0,2.15023847376789,5.11634723501106,PPP2CA;B3GALNT1;ASAH1;VAPA;VAPB,GO_BP,yellow,5
tumor necrosis factor-mediated signaling pathway (GO:0033209),5/116,0.0926031179795181,0.515607753161155,0,0,2.15023847376789,5.11634723501106,PSMD12;PSMD11;TNFRSF12A;PSME4;PSMD1,GO_BP,yellow,5
response to insulin (GO:0032868),4/84,0.0959801661921286,0.515607753161155,0,0,2.38471882640587,5.58885973850375,CEACAM1;RAB15;SLC39A14;RHOQ,GO_BP,yellow,4
spindle assembly (GO:0051225),4/84,0.0959801661921286,0.515607753161155,0,0,2.38471882640587,5.58885973850375,CEP63;MAPRE1;MAPRE2;RAB11A,GO_BP,yellow,4
positive regulation of macroautophagy (GO:0016239),3/53,0.0963105805542684,0.515607753161155,0,0,2.85907317073171,6.6907375483693,RALB;CALCOCO2;BAG3,GO_BP,yellow,3
cytoplasmic microtubule organization (GO:0031122),3/54,0.100493588329993,0.515607753161155,0,0,2.80286944045911,6.44004478588566,DCTN1;RAB11A;TRDN,GO_BP,yellow,3
cellular response to interleukin-1 (GO:0071347),6/155,0.102540923985924,0.515607753161155,0,0,1.92318981580727,4.3800519233734,PSMD12;PSMD11;USP10;PSME4;ANKRD1;PSMD1,GO_BP,yellow,6
triglyceride metabolic process (GO:0006641),3/55,0.104748190387837,0.515607753161155,0,0,2.74882739212008,6.20189335541954,CAV1;LPL;GPAT3,GO_BP,yellow,3
negative regulation of protein modification by small protein conjugation or removal (GO:1903321),3/55,0.104748190387837,0.515607753161155,0,0,2.74882739212008,6.20189335541954,BAG2;CAV1;GTPBP4,GO_BP,yellow,3
protein targeting to membrane (GO:0006612),4/87,0.105701413039322,0.515607753161155,0,0,2.29817067782131,5.16430440335612,ATAD1;ABCD3;RAB3IP;VPS37A,GO_BP,yellow,4
ERAD pathway (GO:0036503),4/87,0.105701413039322,0.515607753161155,0,0,2.29817067782131,5.16430440335612,NPLOC4;RNF103;CCDC47;ECPAS,GO_BP,yellow,4
cellular response to tumor necrosis factor (GO:0071356),7/194,0.108106085863966,0.515607753161155,0,0,1.78867785358658,3.97916833806727,ASAH1;PSMD12;PSMD11;TNFRSF12A;PSME4;ANKRD1;PSMD1,GO_BP,yellow,7
regulation of programmed cell death (GO:0043067),7/194,0.108106085863966,0.515607753161155,0,0,1.78867785358658,3.97916833806727,TOMM70;DFFA;ASAH1;ACTN2;NF2;RTN4;TGM2,GO_BP,yellow,7
regulation of mRNA catabolic process (GO:0061013),5/122,0.108697336406355,0.515607753161155,0,0,2.03934137757667,4.52568189107133,PSMD12;PSMD11;PSME4;PSMD1;EIF4G1,GO_BP,yellow,5
regulation of establishment of planar polarity (GO:0090175),4/88,0.109037710932138,0.515607753161155,0,0,2.27069507509605,5.03199989949323,PSMD12;PSMD11;PSME4;PSMD1,GO_BP,yellow,4
"retrograde transport, endosome to Golgi (GO:0042147)",4/88,0.109037710932138,0.515607753161155,0,0,2.27069507509605,5.03199989949323,DCTN1;CLTCL1;RAB6B;RAB7A,GO_BP,yellow,4
organonitrogen compound biosynthetic process (GO:1901566),6/158,0.109712392938906,0.515607753161155,0,0,1.88494116125695,4.16551817757856,ALAS1;PCYT1A;VAPA;VAPB;TYW1;FURIN,GO_BP,yellow,6
protein localization to membrane (GO:0072657),7/195,0.110269894892597,0.515607753161155,0,0,1.7790719002201,3.92254100756783,EHD4;ACTN2;LRRC7;RAB15;SLMAP;CAV1;RAB11A,GO_BP,yellow,7
regulation of anatomical structure morphogenesis (GO:0022603),5/123,0.111504563233157,0.515607753161155,0,0,2.02195496842805,4.43554191561194,CEACAM1;CDH2;VASH2;WARS1;MARCHF5,GO_BP,yellow,5
mitochondrial translational elongation (GO:0070125),4/89,0.112420813165662,0.515607753161155,0,0,2.2438659571408,4.90398293471367,MRPL30;MRPL3;MRPS27;MRPS10,GO_BP,yellow,4
dicarboxylic acid metabolic process (GO:0043648),3/57,0.113464947930227,0.515607753161155,0,0,2.64674796747968,5.76001522162103,ALDH5A1;ME1;MTHFR,GO_BP,yellow,3
positive regulation of proteolysis (GO:0045862),3/57,0.113464947930227,0.515607753161155,0,0,2.64674796747968,5.76001522162103,BAG2;NRDC;FURIN,GO_BP,yellow,3
protein K48-linked ubiquitination (GO:0070936),3/57,0.113464947930227,0.515607753161155,0,0,2.64674796747968,5.76001522162103,CUL3;ARIH2;UBE2K,GO_BP,yellow,3
non-canonical Wnt signaling pathway (GO:0035567),5/124,0.114346592072114,0.515607753161155,0,0,2.00486076783655,4.34758300103997,PSMD12;PSMD11;RYK;PSME4;PSMD1,GO_BP,yellow,5
negative regulation of protein kinase activity (GO:0006469),4/90,0.115850012858358,0.515607753161155,0,0,2.21766077216126,4.78007668648518,CEACAM1;CAV1;YWHAG;WARS1,GO_BP,yellow,4
platelet degranulation (GO:0002576),5/125,0.117223071595553,0.515607753161155,0,0,1.98805147058824,4.26173934670983,ITIH4;WDR1;ACTN2;APLP2;CDC37L1,GO_BP,yellow,5
cilium assembly (GO:0060271),10/314,0.117302499907382,0.515607753161155,0,0,1.57396826433329,3.3730127493394,EHD4;DCTN1;CEP70;RAB3IP;CEP63;MAPRE1;CEP20;TXNDC15;RAB11A;YWHAG,GO_BP,yellow,10
receptor metabolic process (GO:0043112),3/58,0.117923450481119,0.515607753161155,0,0,2.59849223946785,5.55484776416454,CAV1;GRB2;DNM2,GO_BP,yellow,3
cellular iron ion homeostasis (GO:0006879),3/58,0.117923450481119,0.515607753161155,0,0,2.59849223946785,5.55484776416454,HJV;FBXL5;SLC39A14,GO_BP,yellow,3
regulation of neurotransmitter receptor activity (GO:0099601),3/58,0.117923450481119,0.515607753161155,0,0,2.59849223946785,5.55484776416454,ACTN2;LRRC7;GSG1L,GO_BP,yellow,3
positive regulation of mitochondrion organization (GO:0010822),3/58,0.117923450481119,0.515607753161155,0,0,2.59849223946785,5.55484776416454,MLLT11;MIEF1;MARCHF5,GO_BP,yellow,3
endomembrane system organization (GO:0010256),7/199,0.119153197444287,0.515607753161155,0,0,1.74164870689655,3.70508808696754,LAPTM4B;NPLOC4;VAPA;VAPB;ZW10;AKTIP;DYSF,GO_BP,yellow,7
regulation of stem cell differentiation (GO:2000736),4/91,0.119324587717134,0.515607753161155,0,0,2.19205800522722,4.66011336748725,PSMD12;PSMD11;PSME4;PSMD1,GO_BP,yellow,4
synapse organization (GO:0050808),5/126,0.120133640149479,0.515607753161155,0,0,1.97152001296386,4.17794759748709,CDH2;MYOT;DCTN1;RYK;PPFIA4,GO_BP,yellow,5
negative regulation of cell growth (GO:0030308),5/126,0.120133640149479,0.515607753161155,0,0,1.97152001296386,4.17794759748709,PPP2CA;MYL2;FHL1;PRDM11;RTN4,GO_BP,yellow,5
negative regulation of growth (GO:0045926),5/126,0.120133640149479,0.515607753161155,0,0,1.97152001296386,4.17794759748709,PPP2CA;MYL2;FHL1;PRDM11;RTN4,GO_BP,yellow,5
protein polymerization (GO:0051258),3/59,0.122446246598866,0.515607753161155,0,0,2.55195993031359,5.35932804548827,CASQ2;CASQ1;UBE2K,GO_BP,yellow,3
negative regulation of autophagy (GO:0010507),3/59,0.122446246598866,0.515607753161155,0,0,2.55195993031359,5.35932804548827,RUBCN;FOXK2;EIF4G1,GO_BP,yellow,3
cellular response to insulin stimulus (GO:0032869),5/129,0.129066116213717,0.515607753161155,0,0,1.92352545857053,3.93828464741271,CEACAM1;RAB15;GRB2;SLC39A14;RHOQ,GO_BP,yellow,5
interleukin-1-mediated signaling pathway (GO:0070498),4/94,0.130013126818173,0.515607753161155,0,0,2.11866340668297,4.32232728860336,PSMD12;PSMD11;PSME4;PSMD1,GO_BP,yellow,4
regulation of cell cycle phase transition (GO:1901987),4/95,0.133661700238955,0.515607753161155,0,0,2.0952739192348,4.21661995278839,PSMD12;PSMD11;PSME4;PSMD1,GO_BP,yellow,4
cellular response to hypoxia (GO:0071456),5/131,0.135184481216785,0.515607753161155,0,0,1.89279878618114,3.78770786482262,PSMD12;EGLN3;PSMD11;PSME4;PSMD1,GO_BP,yellow,5
cellular protein-containing complex assembly (GO:0034622),6/168,0.135393309764632,0.515607753161155,0,0,1.76767676767677,3.53459578645142,PSMD11;BBS12;CASQ2;SPAG1;CASQ1;RTN4,GO_BP,yellow,6
negative regulation of kinase activity (GO:0033673),3/62,0.136381833487255,0.515607753161155,0,0,2.42182720132286,4.82499840902555,CEACAM1;YWHAG;WARS1,GO_BP,yellow,3
calcium ion homeostasis (GO:0055074),4/97,0.141082733107772,0.515607753161155,0,0,2.05000394352867,4.01474576519479,JPH2;VAPB;CAV1;TRDN,GO_BP,yellow,4
cell cycle G1/S phase transition (GO:0044843),3/63,0.141143217391005,0.515607753161155,0,0,2.38134146341463,4.66261938224252,PPP6C;CUL3;GSPT1,GO_BP,yellow,3
monocarboxylic acid biosynthetic process (GO:0072330),3/63,0.141143217391005,0.515607753161155,0,0,2.38134146341463,4.66261938224252,ABCD3;OSBPL6;LPL,GO_BP,yellow,3
positive regulation of Ras protein signal transduction (GO:0046579),3/63,0.141143217391005,0.515607753161155,0,0,2.38134146341463,4.66261938224252,GRB2;MAPRE2;ABRA,GO_BP,yellow,3
positive regulation of viral process (GO:0048524),3/63,0.141143217391005,0.515607753161155,0,0,2.38134146341463,4.66261938224252,STAU1;VAPB;RAB7A,GO_BP,yellow,3
protein modification by small protein conjugation (GO:0032446),12/409,0.142273048036896,0.515607753161155,0,0,1.44650967040836,2.82070426382878,RNF157;ARRDC4;KLHL18;USP7;RNF103;NFX1;CUL3;ARIH2;TRIM69;FBXL5;UBE2K;TRIM55,GO_BP,yellow,12
neuron projection development (GO:0031175),6/171,0.143607336302658,0.515607753161155,0,0,1.73526915345097,3.36758918730698,VAPA;RYK;VASH2;MAPK8IP3;RAB11A;DNM2,GO_BP,yellow,6
protein transport (GO:0015031),11/369,0.144028805412494,0.515607753161155,0,0,1.46973929236499,2.84797549975748,ARRDC4;RAB21;TBC1D1;RAB15;CHMP1B;MTTP;RAB28;RAB6B;NAPG;RAB7A;DNM2,GO_BP,yellow,11
RNA splicing (GO:0008380),4/98,0.144853587016969,0.515607753161155,0,0,2.02809134890496,3.9183369619634,PPP2CA;SNRPN;SF3B3;RSRC1,GO_BP,yellow,4
regulation of extrinsic apoptotic signaling pathway (GO:2001236),3/64,0.145959585232821,0.515607753161155,0,0,2.3421831267493,4.50735695602395,TNFRSF12A;CAV1;FGFR1,GO_BP,yellow,3
lipid homeostasis (GO:0055088),3/64,0.145959585232821,0.515607753161155,0,0,2.3421831267493,4.50735695602395,PNPLA8;ZBTB20;ACOX3,GO_BP,yellow,3
chemical homeostasis (GO:0048878),3/65,0.150829072185094,0.515607753161155,0,0,2.30428796223446,4.35880967182141,PNPLA8;ZBTB20;ACOX3,GO_BP,yellow,3
protein localization to plasma membrane (GO:0072659),5/136,0.151027934357637,0.515607753161155,0,0,1.82008681335129,3.44049274607625,EHD4;ACTN2;RAB15;SLMAP;RAB11A,GO_BP,yellow,5
cellular calcium ion homeostasis (GO:0006874),5/136,0.151027934357637,0.515607753161155,0,0,1.82008681335129,3.44049274607625,LETM1;VAPB;CAV1;CCDC47;TRDN,GO_BP,yellow,5
organic substance transport (GO:0071702),5/136,0.151027934357637,0.515607753161155,0,0,1.82008681335129,3.44049274607625,ARRDC4;ABCD3;CHMP1B;SLC19A2;RAB7A,GO_BP,yellow,5
positive regulation of cell death (GO:0010942),3/66,0.155749816861371,0.51673123808924,0,0,2.26759581881533,4.21660416932097,AXIN2;EIF2S1;EIF4G1,GO_BP,yellow,3
positive regulation of cell cycle process (GO:0090068),4/101,0.156397672743417,0.518096822245186,0,0,1.96506440148212,3.64588878319216,DYNC1LI1;GPSM2;CUL3;NUDT16,GO_BP,yellow,4
intracellular protein transport (GO:0006886),10/336,0.159394987690415,0.518708379101815,0,0,1.46607498972431,2.69225606726607,RAB21;TBC1D1;BAG3;COX18;STAM;RAB28;RANBP6;RAB6B;NAPG;RAB7A,GO_BP,yellow,10
regulation of cell death (GO:0010941),4/102,0.160320099569174,0.518708379101815,0,0,1.94491292849658,3.5603242322401,RRAS2;AXIN2;NPAS2;EIF4G1,GO_BP,yellow,4
cell junction assembly (GO:0034329),4/102,0.160320099569174,0.518708379101815,0,0,1.94491292849658,3.5603242322401,GJC1;CDH2;RYK;FLNC,GO_BP,yellow,4
regulation of protein catabolic process (GO:0042176),4/102,0.160320099569174,0.518708379101815,0,0,1.94491292849658,3.5603242322401,SF3B3;FURIN;AZIN1;RAB7A,GO_BP,yellow,4
mitotic sister chromatid segregation (GO:0000070),4/102,0.160320099569174,0.518708379101815,0,0,1.94491292849658,3.5603242322401,ZW10;CUL3;CHMP1B;RAB11A,GO_BP,yellow,4
positive regulation of cell growth (GO:0030307),4/102,0.160320099569174,0.518708379101815,0,0,1.94491292849658,3.5603242322401,RNF157;PLAA;NTN1;EIF4G1,GO_BP,yellow,4
transcription elongation from RNA polymerase II promoter (GO:0006368),3/67,0.160719962905422,0.518708379101815,0,0,2.23205030487805,4.08039283560298,CCNK;SUPT6H;IWS1,GO_BP,yellow,3
RNA processing (GO:0006396),6/179,0.166582074678777,0.518708379101815,0,0,1.65434378151141,2.96502601441543,PPP2CA;SNRPN;SF3B3;FASTKD2;RSRC1;PABPC4,GO_BP,yellow,6
translational elongation (GO:0006414),4/104,0.168271481418168,0.518708379101815,0,0,1.90581907090465,3.39650623398117,MRPL30;MRPL3;MRPS27;MRPS10,GO_BP,yellow,4
"DNA-templated transcription, elongation (GO:0006354)",3/69,0.170801068596496,0.518708379101815,0,0,2.16419068736142,3.8246784173505,CCNK;SUPT6H;IWS1,GO_BP,yellow,3
synapse assembly (GO:0007416),3/69,0.170801068596496,0.518708379101815,0,0,2.16419068736142,3.8246784173505,GABRB3;CDH2;RYK,GO_BP,yellow,3
negative regulation of cellular catabolic process (GO:0031330),3/69,0.170801068596496,0.518708379101815,0,0,2.16419068736142,3.8246784173505,RUBCN;FOXK2;EIF4G1,GO_BP,yellow,3
positive regulation of cellular metabolic process (GO:0031325),4/105,0.172298726549863,0.520923276314841,0,0,1.8868527439541,3.3180787147339,ATAD1;ACE2;GRB2;EIF4G1,GO_BP,yellow,4
snRNA transcription by RNA polymerase II (GO:0042795),3/70,0.175908354730519,0.520923276314841,0,0,2.13178012377139,3.70459072479397,CCNK;TAF8;RPAP2,GO_BP,yellow,3
protein processing (GO:0016485),4/106,0.17635919327055,0.520923276314841,0,0,1.86825830576729,3.24186251717876,ADAM19;HJV;FURIN;METAP2,GO_BP,yellow,4
chromosome organization (GO:0051276),4/106,0.17635919327055,0.520923276314841,0,0,1.86825830576729,3.24186251717876,COPS2;MTHFR;AXIN2;RAD23B,GO_BP,yellow,4
positive regulation of protein serine/threonine kinase activity (GO:0071902),4/106,0.17635919327055,0.520923276314841,0,0,1.86825830576729,3.24186251717876,PPP2CA;RALB;FGF1;FGFR1,GO_BP,yellow,4
regulation of G1/S transition of mitotic cell cycle (GO:2000045),3/71,0.181057697993715,0.520923276314841,0,0,2.10032281205165,3.58932466891668,WEE1;FHL1;EIF4G1,GO_BP,yellow,3
cholesterol homeostasis (GO:0042632),3/71,0.181057697993715,0.520923276314841,0,0,2.10032281205165,3.58932466891668,CAV1;MTTP;LPL,GO_BP,yellow,3
snRNA transcription (GO:0009301),3/71,0.181057697993715,0.520923276314841,0,0,2.10032281205165,3.58932466891668,CCNK;TAF8;RPAP2,GO_BP,yellow,3
cell junction organization (GO:0034330),3/72,0.186247289442509,0.520923276314841,0,0,2.06977730646872,3.47863327201674,MYOT;FLNC;PPFIA4,GO_BP,yellow,3
extrinsic apoptotic signaling pathway (GO:0097191),3/72,0.186247289442509,0.520923276314841,0,0,2.06977730646872,3.47863327201674,MLLT11;BAG3;CASP3,GO_BP,yellow,3
sterol homeostasis (GO:0055092),3/72,0.186247289442509,0.520923276314841,0,0,2.06977730646872,3.47863327201674,CAV1;MTTP;LPL,GO_BP,yellow,3
regulation of protein ubiquitination (GO:0031396),4/109,0.188731248205279,0.521269052032968,0,0,1.81460006985679,3.02572085011098,BAG2;CUL3;CAV1;GTPBP4,GO_BP,yellow,4
insulin receptor signaling pathway (GO:0008286),3/73,0.191475333439896,0.521591779890923,0,0,2.04010452961672,3.37228521001892,GRB2;SLC39A14;RHOQ,GO_BP,yellow,3
ubiquitin-dependent ERAD pathway (GO:0030433),3/73,0.191475333439896,0.521591779890923,0,0,2.04010452961672,3.37228521001892,NPLOC4;RNF103;ECPAS,GO_BP,yellow,3
positive regulation of cell migration (GO:0030335),8/269,0.194180660901735,0.521591779890923,0,0,1.4626365829431,2.39721208540228,PTP4A1;CAV1;PLAA;MAPRE1;FGF1;RAB11A;RTN4;HBEGF,GO_BP,yellow,8
negative regulation of cellular process (GO:0048523),15/566,0.195534220238939,0.521591779890923,0,0,1.30206385831152,2.12499409565987,ZBTB49;FHL1;DYSF;AXIN2;PRDM11;GTPBP4;NPAS2;RTN4;WARS1;PPP2CA;MYL2;NACC2;SPEG;NF2;MARCHF5,GO_BP,yellow,15
cellular response to amino acid starvation (GO:0034198),3/74,0.196740048822492,0.521591779890923,0,0,2.0112676056338,3.27006362565761,RRAGB;BMT2;EIF2S1,GO_BP,yellow,3
regulation of protein serine/threonine kinase activity (GO:0071900),4/111,0.1971294411675,0.521591779890923,0,0,1.78049950871741,2.89134372312728,PPP2CA;CCNK;RALB;GTPBP4,GO_BP,yellow,4
neutrophil degranulation (GO:0043312),13/481,0.197676138296669,0.521591779890923,0,0,1.32770833333333,2.15238150727628,KCMF1;ASAH1;PSMD12;PSMD11;ARMC8;DYNC1LI1;CEACAM1;VAPA;LRRC7;STBD1;PSMD1;MLEC;RAB7A,GO_BP,yellow,13
fibroblast growth factor receptor signaling pathway (GO:0008543),3/75,0.202039669816213,0.521591779890923,0,0,1.98323170731707,3.17176504807745,GRB2;FGF1;FGFR1,GO_BP,yellow,3
response to amino acid starvation (GO:1990928),3/75,0.202039669816213,0.521591779890923,0,0,1.98323170731707,3.17176504807745,RRAGB;BMT2;EIF2S1,GO_BP,yellow,3
integrin-mediated signaling pathway (GO:0007229),3/75,0.202039669816213,0.521591779890923,0,0,1.98323170731707,3.17176504807745,CEACAM1;CUL3;CDH17,GO_BP,yellow,3
regulation of autophagy (GO:0010506),7/231,0.202227276564468,0.521591779890923,0,0,1.49037869458128,2.38216628445231,RUBCN;DHRSX;RRAGB;USP10;CASP3;FOXK2;EIF4G1,GO_BP,yellow,7
neutrophil activation involved in immune response (GO:0002283),13/485,0.205545586493254,0.521591779890923,0,0,1.3161811440678,2.08231365358694,KCMF1;ASAH1;PSMD12;PSMD11;ARMC8;DYNC1LI1;CEACAM1;VAPA;LRRC7;STBD1;PSMD1;MLEC;RAB7A,GO_BP,yellow,13
actin filament organization (GO:0007015),5/152,0.206388662362709,0.521591779890923,0,0,1.62064825930372,2.55737351662729,FHOD3;ACTA1;NRAP;XIRP1;LMOD2,GO_BP,yellow,5
cellular response to hormone stimulus (GO:0032870),3/76,0.207372447181775,0.521591779890923,0,0,1.95596391580354,3.07719840335271,URI1;CAV1;NCOA4,GO_BP,yellow,3
phospholipid metabolic process (GO:0006644),3/76,0.207372447181775,0.521591779890923,0,0,1.95596391580354,3.07719840335271,GDE1;PLAA;LPL,GO_BP,yellow,3
protein import into nucleus (GO:0006606),3/76,0.207372447181775,0.521591779890923,0,0,1.95596391580354,3.07719840335271,KPNA4;RANBP6;KPNA1,GO_BP,yellow,3
neutrophil mediated immunity (GO:0002446),13/488,0.211538422665718,0.531390333225566,0,0,1.30766315789474,2.03125677422245,KCMF1;ASAH1;PSMD12;PSMD11;ARMC8;DYNC1LI1;CEACAM1;VAPA;LRRC7;STBD1;PSMD1;MLEC;RAB7A,GO_BP,yellow,13
cellular response to lectin (GO:1990858),4/115,0.214254665393417,0.532764334482261,0,0,1.71598493358885,2.64362913664831,PSMD12;PSMD11;PSME4;PSMD1,GO_BP,yellow,4
stimulatory C-type lectin receptor signaling pathway (GO:0002223),4/115,0.214254665393417,0.532764334482261,0,0,1.71598493358885,2.64362913664831,PSMD12;PSMD11;PSME4;PSMD1,GO_BP,yellow,4
regulation of cellular response to heat (GO:1900034),3/79,0.22355248917952,0.535208088177606,0,0,1.87846598202824,2.81414687198935,BAG2;BAG3;IER5,GO_BP,yellow,3
regulation of neuron differentiation (GO:0045664),3/79,0.22355248917952,0.535208088177606,0,0,1.87846598202824,2.81414687198935,CASZ1;YWHAG;FGFR1,GO_BP,yellow,3
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),3/79,0.22355248917952,0.535208088177606,0,0,1.87846598202824,2.81414687198935,BAG2;CAV1;ARIH2,GO_BP,yellow,3
negative regulation of intracellular signal transduction (GO:1902532),6/198,0.226602127190514,0.540101361597137,0,0,1.48917383292383,2.21076722486376,RNF157;URI1;PPM1B;USP10;CAV1;OTUD7B,GO_BP,yellow,6
regulation of cellular response to stress (GO:0080135),4/118,0.227358706561391,0.540101361597137,0,0,1.67057006820229,2.47449232701948,BAG2;BAG3;NPAS2;EIF4G1,GO_BP,yellow,4
cellular response to starvation (GO:0009267),5/158,0.228684101224692,0.540101361597137,0,0,1.55661284121492,2.29664790904623,RALB;RRAGB;BMT2;CLEC16A;EIF2S1,GO_BP,yellow,5
regulation of fat cell differentiation (GO:0045598),3/80,0.229000757854645,0.540101361597137,0,0,1.85397529299968,2.73281513815048,BBS12;TAF8;LPL,GO_BP,yellow,3
innate immune response activating cell surface receptor signaling pathway (GO:0002220),4/119,0.231771607262125,0.540101361597137,0,0,1.65595832890401,2.42101578584472,PSMD12;PSMD11;PSME4;PSMD1,GO_BP,yellow,4
macroautophagy (GO:0016236),4/120,0.236205502929243,0.540101361597137,0,0,1.64159851614535,2.36891379113258,TOMM70;PLAA;VPS37A;STAM,GO_BP,yellow,4
modification-dependent protein catabolic process (GO:0019941),6/201,0.236669895285347,0.540101361597137,0,0,1.46603666603667,2.11268924801391,RNF11;NPLOC4;PSMD11;CUL3;ARIH2;UBE2K,GO_BP,yellow,6
regulation of G protein-coupled receptor signaling pathway (GO:0008277),3/82,0.239969719116742,0.543354615240988,0,0,1.80685396727385,2.57881883472449,RNF157;SLC39A14;METAP2,GO_BP,yellow,3
positive regulation of protein ubiquitination (GO:0031398),3/82,0.239969719116742,0.543354615240988,0,0,1.80685396727385,2.57881883472449,ARRDC4;CUL3;CAV1,GO_BP,yellow,3
positive regulation of protein kinase B signaling (GO:0051897),5/161,0.24008692301346,0.543354615240988,0,0,1.52644230769231,2.17785803765065,GRB2;FGF1;RTN4;FGFR1;HBEGF,GO_BP,yellow,5
cellular protein localization (GO:0034613),9/329,0.241553980821311,0.54611121643416,0,0,1.34129795792079,1.90553145234377,RAB21;RIC3;TBC1D1;RRAGB;COX18;AXIN2;RAB28;RAB6B;NAPG,GO_BP,yellow,9
positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),3/83,0.245487165778436,0.550743521660398,0,0,1.78417682926829,2.50589528861183,AKIRIN1;CDC42EP3;RHOQ,GO_BP,yellow,3
cellular protein metabolic process (GO:0044267),11/417,0.245678267310523,0.550743521660398,0,0,1.29274195524839,1.81466383917095,MRPL3;MBTPS1;CDH2;ST8SIA2;PABPC4;APLP2;FURIN;MRRF;GSPT1;WARS1;EIF4G1,GO_BP,yellow,11
G1/S transition of mitotic cell cycle (GO:0000082),3/85,0.256580041289082,0.55600793532308,0,0,1.74048185603807,2.36760289936682,PPP6C;CUL3;GSPT1,GO_BP,yellow,3
"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",3/85,0.256580041289082,0.55600793532308,0,0,1.74048185603807,2.36760289936682,ZW10;ERGIC2;RAB6B,GO_BP,yellow,3
positive regulation of protein catabolic process (GO:0045732),3/85,0.256580041289082,0.55600793532308,0,0,1.74048185603807,2.36760289936682,NRDC;FURIN;RAB7A,GO_BP,yellow,3
regulation of MAPK cascade (GO:0043408),5/166,0.259419597633998,0.559861432194842,0,0,1.47865668006333,1.99516396798149,CEACAM1;RYK;CAV1;PRDM11;FGFR1,GO_BP,yellow,5
positive regulation of phosphorylation (GO:0042327),7/253,0.269292579360882,0.56030230221861,0,0,1.35555088309504,1.77842424603971,RALB;RYK;AKTIP;ZBTB20;AXIN2;FGF1;FGFR1,GO_BP,yellow,7
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),5/170,0.27514237368584,0.568761275421061,0,0,1.44251336898396,1.86151531233202,CEACAM1;CDH2;MYOT;PVR;CDH17,GO_BP,yellow,5
DNA-dependent DNA replication (GO:0006261),4/129,0.27691396848268,0.568761275421061,0,0,1.52269926650367,1.95521956312507,PSMD12;PSMD11;PSME4;PSMD1,GO_BP,yellow,4
regulation of nucleic acid-templated transcription (GO:1903506),11/430,0.27697043911246,0.568761275421061,0,0,1.25178403923105,1.60709604956723,PPP2CA;CASZ1;ASCC1;NFX1;COPS2;FOXK2;ZNF35;SSBP2;YAF2;ZNF146;DNM2,GO_BP,yellow,11
protein import (GO:0017038),3/89,0.278954645286298,0.568761275421061,0,0,1.6591888825865,2.11829652111455,ATAD1;ABCD3;RANBP6,GO_BP,yellow,3
nuclear-transcribed mRNA catabolic process (GO:0000956),5/171,0.279104272235357,0.568761275421061,0,0,1.43374970470116,1.82970811887803,PPP2CA;CTIF;ETF1;GSPT1;EIF4G1,GO_BP,yellow,5
regulation of response to external stimulus (GO:0032101),4/130,0.281510944126522,0.568761275421061,0,0,1.51053673303062,1.91473212511959,ACE2;USP14;CAV1;METAP2,GO_BP,yellow,4
protein glycosylation (GO:0006486),4/130,0.281510944126522,0.568761275421061,0,0,1.51053673303062,1.91473212511959,B3GALNT1;ALG9;TUSC3;ST8SIA2,GO_BP,yellow,4
protein complex oligomerization (GO:0051259),3/90,0.284578942761748,0.569417537843535,0,0,1.64003364171573,2.06110339836904,LETM1;EHD4;NACC2,GO_BP,yellow,3
neuron differentiation (GO:0030182),5/174,0.291056406457777,0.576238619321362,0,0,1.40808098387284,1.73790733049854,RYK;CASP3;SRF;SMARCA1;VXN,GO_BP,yellow,5
cellular protein modification process (GO:0006464),24/1025,0.291319369027197,0.576238619321362,0,0,1.14554853886473,1.41284525099798,B3GALNT1;MBTPS1;EGLN3;PSMD12;PSMD11;RYK;CUL3;ST8SIA2;APLP2;DUSP8;RAB11A;DCAF6;PPP2CA;PPP6C;PPM1B;CDH2;COPS2;ASB8;PSME4;PSMD1;FBXL5;METAP2;TGM2;FGFR1,GO_BP,yellow,24
regulation of cell motility (GO:2000145),4/133,0.295369035784178,0.576238619321362,0,0,1.47518053107409,1.79902652315857,CEACAM1;FGF1;NTN1;HBEGF,GO_BP,yellow,4
cellular response to fibroblast growth factor stimulus (GO:0044344),3/92,0.295854258716742,0.576238619321362,0,0,1.60301452452727,1.95229265837624,GRB2;FGF1;FGFR1,GO_BP,yellow,3
positive regulation of cellular component biogenesis (GO:0044089),3/92,0.295854258716742,0.576238619321362,0,0,1.60301452452727,1.95229265837624,STAM;WARS1;RAB7A,GO_BP,yellow,3
cellular response to lipid (GO:0071396),6/219,0.299549487472117,0.576238619321362,0,0,1.34090043949199,1.61642281741241,URI1;NCOA4;ANKRD1;PLAA;LPL;ZNF35,GO_BP,yellow,6
positive regulation of cell motility (GO:2000147),6/221,0.306741019614219,0.583609000463446,0,0,1.32828981201074,1.56970844022889,PTP4A1;CAV1;MAPRE1;FGF1;NTN1;HBEGF,GO_BP,yellow,6
negative regulation of cell death (GO:0060548),3/94,0.307155998995013,0.583609000463446,0,0,1.56762262128116,1.85042099033705,INPP5A;NPAS2;EIF4G1,GO_BP,yellow,3
regulation of protein phosphorylation (GO:0001932),7/266,0.311442429999352,0.583609000463446,0,0,1.28664625216349,1.5009253138935,PPP2CA;RALB;AKTIP;AXIN2;FGF1;WARS1;KLHL31,GO_BP,yellow,7
regulated exocytosis (GO:0045055),5/180,0.31521274375093,0.586311744737734,0,0,1.3593837535014,1.56941872674299,ITIH4;WDR1;ACTN2;APLP2;CDC37L1,GO_BP,yellow,5
central nervous system development (GO:0007417),7/268,0.318042346831321,0.587591296356211,0,0,1.27665477606025,1.46249835517183,RNF103;ALDH5A1;UGP2;CDH2;SMARCA1;NPAS2;TBX3,GO_BP,yellow,7
cellular transition metal ion homeostasis (GO:0046916),3/96,0.318473471784742,0.587591296356211,0,0,1.53375295043273,1.75494481706609,HJV;FBXL5;SLC39A14,GO_BP,yellow,3
cellular macromolecule biosynthetic process (GO:0034645),8/314,0.323490048813783,0.587591296356211,0,0,1.24463810215444,1.40468229034354,MRPL3;ALAS1;PABPC4;RAD9B;MRRF;GSPT1;WARS1;EIF4G1,GO_BP,yellow,8
protein maturation (GO:0051604),3/97,0.324134877632699,0.587591296356211,0,0,1.5173585884795,1.70944944995951,ADAM19;FURIN;METAP2,GO_BP,yellow,3
regulation of peptidyl-serine phosphorylation (GO:0033135),3/98,0.329796391312333,0.590419394921375,0,0,1.50130937098845,1.66537217525038,CAV1;CNKSR3;EIF4G1,GO_BP,yellow,3
positive regulation of cellular catabolic process (GO:0031331),4/141,0.332677812359526,0.59507540171651,0,0,1.38846751021719,1.52812066624798,DHRSX;NRDC;ZBTB20;FURIN,GO_BP,yellow,4
protein localization to organelle (GO:0033365),4/142,0.337363872745865,0.59533418496734,0,0,1.37833528223663,1.49768973127745,VAPA;CCDC47;RAB11A;MARCHF5,GO_BP,yellow,4
positive regulation of translation (GO:0045727),3/100,0.341114879791268,0.59533418496734,0,0,1.47020367110888,1.58125692790183,MRPS27;FASTKD2;PRR16,GO_BP,yellow,3
receptor-mediated endocytosis (GO:0006898),4/143,0.342052472895051,0.59533418496734,0,0,1.36834884170903,1.46795249215504,CAV1;CLTCL1;GRB2;DNM2,GO_BP,yellow,4
monocarboxylic acid metabolic process (GO:0032787),4/143,0.342052472895051,0.59533418496734,0,0,1.36834884170903,1.46795249215504,PCCA;PNPLA8;ME1;LPL,GO_BP,yellow,4
neuron development (GO:0048666),4/143,0.342052472895051,0.59533418496734,0,0,1.36834884170903,1.46795249215504,VAPA;RYK;SRF;RAB11A,GO_BP,yellow,4
nitrogen compound transport (GO:0071705),4/143,0.342052472895051,0.59533418496734,0,0,1.36834884170903,1.46795249215504,ARRDC4;CHMP1B;SLC19A2;RAB7A,GO_BP,yellow,4
apoptotic process (GO:0006915),6/231,0.343093094099187,0.596671812339031,0,0,1.26859950859951,1.35708871022005,PPP2CA;BCL2L13;EGLN3;FASTKD2;CASP3;RTN4,GO_BP,yellow,6
cellular response to chemical stress (GO:0062197),3/101,0.346769487228669,0.600140108951631,0,0,1.45512692882031,1.54111768627884,CAV1;TXNRD1;EIF2S1,GO_BP,yellow,3
plasma membrane bounded cell projection assembly (GO:0120031),7/278,0.351365675738278,0.600140108951631,0,0,1.22890953047462,1.28535062514685,EHD4;ACTN2;RAB3IP;CEP20;TXNDC15;NTN1;RAB11A,GO_BP,yellow,7
cellular response to organonitrogen compound (GO:0071417),3/103,0.358063700983734,0.604956622694398,0,0,1.42587804878049,1.4644400261584,GABRB3;RRAGB;CTNNA1,GO_BP,yellow,3
positive regulation of cytosolic calcium ion concentration (GO:0007204),4/147,0.360818178157611,0.607236273398727,0,0,1.32979978456751,1.35557277933007,JPH2;CAV1;SELENOT;JPH1,GO_BP,yellow,4
positive regulation of intracellular protein transport (GO:0090316),4/148,0.365508988262857,0.607236273398727,0,0,1.32049714751426,1.32903338037242,BAG3;ARIH2;MIEF1;YWHAG,GO_BP,yellow,4
organelle organization (GO:0006996),10/420,0.368643462611575,0.607389266346495,0,0,1.16062458391333,1.15821666861412,STRIP2;NPLOC4;ALAS1;ABCD3;VAPA;VAPB;ZW10;CHMP1B;CAV1;RAB7A,GO_BP,yellow,10
nucleotide-excision repair (GO:0006289),3/105,0.369330572666314,0.608064523916836,0,0,1.39777618364419,1.3922733835614,USP7;COPS2;RAD23B,GO_BP,yellow,3
response to cytokine (GO:0034097),4/150,0.374885181917465,0.615361679599551,0,0,1.30227417356064,1.2777073982541,ITIH4;CALCOCO2;CASP3;SRF,GO_BP,yellow,4
proteolysis (GO:0006508),7/287,0.381656889870995,0.616328099769582,0,0,1.18885467980296,1.14514437846139,ADAM19;MBTPS1;CASP3;VASH2;ATG4A;FURIN;METAP2,GO_BP,yellow,7
dephosphorylation (GO:0016311),4/153,0.388926222996185,0.621360544141488,0,0,1.27585697641982,1.20487545367037,PPP2CA;PPP6C;PPM1B;DUSP8,GO_BP,yellow,4
lipid transport (GO:0006869),3/109,0.391748864756032,0.621360544141488,0,0,1.34475379659457,1.26021490196591,CEACAM1;ABCD3;MTTP,GO_BP,yellow,3
regulation of protein kinase activity (GO:0045859),3/110,0.397323618931145,0.624162389911175,0,0,1.33211762024162,1.22955011751116,CEACAM1;YWHAG;WARS1,GO_BP,yellow,3
response to endoplasmic reticulum stress (GO:0034976),3/110,0.397323618931145,0.624162389911175,0,0,1.33211762024162,1.22955011751116,MBTPS1;CCDC47;EIF2S1,GO_BP,yellow,3
response to tumor necrosis factor (GO:0034612),3/110,0.397323618931145,0.624162389911175,0,0,1.33211762024162,1.22955011751116,ASAH1;CASP3;ANKRD1,GO_BP,yellow,3
generation of neurons (GO:0048699),5/202,0.405080391117559,0.626692078355912,0,0,1.20620583258684,1.09001170507337,RYK;CASP3;SMARCA1;VXN;FGFR1,GO_BP,yellow,5
regulation of macroautophagy (GO:0016241),3/112,0.408430811278666,0.628994922144743,0,0,1.30754083687626,1.17081488947466,RRAGB;CASP3;CLEC16A,GO_BP,yellow,3
axon guidance (GO:0007411),5/203,0.409161788501499,0.629678457672833,0,0,1.20005199049317,1.07242001732333,RYK;GRB2;NCAM1;SPTB;NTN1,GO_BP,yellow,5
regulation of cell population proliferation (GO:0042127),17/764,0.411153797551441,0.631189141628289,0,0,1.08271469717253,0.96230375577365,EGLN3;CUL3;ZBTB49;AXIN2;FGF1;GTPBP4;TBX3;WARS1;ACE2;NACC2;DNAJA2;STAT4;SPEG;NF2;IER5;HBEGF;FGFR1,GO_BP,yellow,17
skeletal system development (GO:0001501),4/158,0.412224729823258,0.631732237947173,0,0,1.2341155177341,1.09365665639608,GDF11;TBX3;TGM2;FGFR1,GO_BP,yellow,4
T cell receptor signaling pathway (GO:0050852),4/158,0.412224729823258,0.631732237947173,0,0,1.2341155177341,1.09365665639608,PSMD12;PSMD11;PSME4;PSMD1,GO_BP,yellow,4
positive regulation of transcription by RNA polymerase II (GO:0045944),20/908,0.415798708009104,0.632704229406196,0,0,1.07162506017468,0.940408869634651,AKIRIN1;CCNK;CASZ1;SRF;ZBTB49;CEBPG;ECD;FOXK2;FGF1;SMARCA1;SUPT6H;NPAS2;TBX3;ABRA;DCAF6;HJV;SSBP2;IER5;MEF2D;RHOQ,GO_BP,yellow,20
cellular amide metabolic process (GO:0043603),3/115,0.424972712586745,0.641042645752133,0,0,1.27232142857143,1.08876402041167,PPP2CA;PCCA;MTHFR,GO_BP,yellow,3
regulation of protein kinase B signaling (GO:0051896),5/207,0.425445713019232,0.641042645752133,0,0,1.17604591341487,1.0050699159715,GRB2;FGF1;RTN4;HBEGF;FGFR1,GO_BP,yellow,5
heart development (GO:0007507),4/164,0.439923526913834,0.64294077685452,0,0,1.18746943765281,0.975095717547058,MYL2;SRF;ALPK3;MEF2D,GO_BP,yellow,4
nervous system development (GO:0007399),10/447,0.443561343277174,0.643765735146818,0,0,1.0873823895157,0.8839539901031,GDF11;RNF103;ALDH5A1;CDH2;RYK;DCTN1;ST8SIA2;VXN;NPAS2;TBX3,GO_BP,yellow,10
phosphate-containing compound metabolic process (GO:0006796),5/212,0.445677689023915,0.645376200292416,0,0,1.14734299516908,0.927235864294595,INPP5A;GDE1;PLAA;LPL;DUSP8,GO_BP,yellow,5
positive regulation of protein modification process (GO:0031401),5/214,0.453722656975157,0.646345500667514,0,0,1.13624636457454,0.897940454777556,CDCA2;RALB;AKTIP;AXIN2;FGF1,GO_BP,yellow,5
gene expression (GO:0010467),8/356,0.454475495681399,0.646345500667514,0,0,1.09203916560238,0.861194406063735,FYTTD1;MRPL3;FASTKD2;PABPC4;MRRF;GSPT1;WARS1;EIF4G1,GO_BP,yellow,8
protein homooligomerization (GO:0051260),3/121,0.457549025943323,0.650294889108041,0,0,1.20725506407606,0.943918013312816,LETM1;EHD4;NACC2,GO_BP,yellow,3
positive regulation of apoptotic process (GO:0043065),7/310,0.459045375176875,0.651999033525185,0,0,1.09730283373165,0.854366808508998,MLLT11;TNFRSF12A;CASP3;ANKRD1;PRDM11;TGM2;DNM2,GO_BP,yellow,7
regulation of apoptotic process (GO:0042981),16/742,0.465809607883585,0.652728734880959,0,0,1.0470262505985,0.799905329874,TOMM70;DFFA;EGLN3;TNFRSF12A;ACTN2;TBX3;RTN4;DNM2;MLLT11;RNF157;BAG3;CASP3;ANKRD1;TAX1BP1;NF2;TGM2,GO_BP,yellow,16
positive regulation of epithelial cell proliferation (GO:0050679),3/123,0.46823604010454,0.654039258566406,0,0,1.18701219512195,0.900684378900739,VASH2;FGF1;RTN4,GO_BP,yellow,3
fatty acid metabolic process (GO:0006631),3/124,0.473544358057623,0.654418244246642,0,0,1.17714170530135,0.879924830655465,ABCD3;PNPLA8;LPL,GO_BP,yellow,3
protein targeting (GO:0006605),3/125,0.478828403107124,0.65670462039645,0,0,1.16743302678928,0.859712840762655,TOMM70;RAB3IP;VPS37A,GO_BP,yellow,3
regulation of protein secretion (GO:0050708),3/125,0.478828403107124,0.65670462039645,0,0,1.16743302678928,0.859712840762655,DPH3;ANKRD1;CACNA1E,GO_BP,yellow,3
"transcription, DNA-templated (GO:0006351)",5/221,0.481613574752488,0.659289938536033,0,0,1.099026416122,0.802963205235763,CCNK;NFX1;COPS2;SUPT6H;IWS1,GO_BP,yellow,5
circulatory system development (GO:0072359),3/126,0.484087590872243,0.659289938536033,0,0,1.15788221296847,0.840031290208385,MYL2;SRF;ALPK3,GO_BP,yellow,3
mitochondrion organization (GO:0007005),4/175,0.489616242890348,0.661570191410064,0,0,1.11045339510145,0.793011828043647,TOMM70;ALAS1;MIEF1;DNM2,GO_BP,yellow,4
transcription by RNA polymerase II (GO:0006366),7/320,0.492144400158834,0.6634857888556,0,0,1.0616943924204,0.752723391457836,CCNK;NFX1;COPS2;TAF8;RPAP2;SUPT6H;IWS1,GO_BP,yellow,7
plasma membrane bounded cell projection organization (GO:0120036),3/128,0.494529158745764,0.6634857888556,0,0,1.13923902439024,0.802194206095342,VAPA;RYK;RAB11A,GO_BP,yellow,3
positive regulation of protein phosphorylation (GO:0001934),8/371,0.500701902337324,0.66525385902751,0,0,1.04609733700643,0.723631933196854,GDF11;RALB;CAV1;AKTIP;AXIN2;FGF1;UBE2K;EIF4G1,GO_BP,yellow,8
regulation of cellular macromolecule biosynthetic process (GO:2000112),10/468,0.501300430429513,0.665467217876466,0,0,1.0363864899715,0.715676375677925,PPP2CA;CASZ1;ASCC1;NFX1;FOXK2;ZNF35;SSBP2;YAF2;ZNF146;DNM2,GO_BP,yellow,10
regulation of mitotic cell cycle (GO:0007346),4/178,0.502860962582924,0.666388979094396,0,0,1.09113902706349,0.750094318682451,PSMD12;PSMD11;PSME4;PSMD1,GO_BP,yellow,4
cilium organization (GO:0044782),5/228,0.509006376695592,0.66681659742738,0,0,1.06414314604766,0.718610263408911,EHD4;RAB3IP;CEP20;TXNDC15;RAB11A,GO_BP,yellow,5
regulation of cell adhesion (GO:0030155),3/133,0.520161006273786,0.67195468908956,0,0,1.09514071294559,0.715802464588112,PPP2CA;EPB41L4B;TGM2,GO_BP,yellow,3
negative regulation of cytokine production (GO:0001818),4/182,0.520282290047457,0.67195468908956,0,0,1.0663992747452,0.696767956308043,CEACAM1;NPLOC4;TAX1BP1;OTUD7B,GO_BP,yellow,4
negative regulation of cell population proliferation (GO:0008285),8/379,0.524886032702661,0.674628106748249,0,0,1.02311403946624,0.659472832182939,NACC2;ZBTB49;SPEG;NF2;AXIN2;GTPBP4;TBX3;WARS1,GO_BP,yellow,8
positive regulation of cellular process (GO:0048522),13/625,0.529173956073616,0.675089287765817,0,0,1.00765931372549,0.641312740502615,CUL3;SRF;CAV1;AXIN2;FGF1;TBX3;EPB41L4B;DNAJA2;IER5;HBEGF;EIF4G1;TGM2;FGFR1,GO_BP,yellow,13
antigen receptor-mediated signaling pathway (GO:0050851),4/185,0.533157535184339,0.677412789489719,0,0,1.04856205000743,0.659480870178744,PSMD12;PSMD11;PSME4;PSMD1,GO_BP,yellow,4
positive regulation of programmed cell death (GO:0043068),6/286,0.54168220753474,0.683491991440555,0,0,1.01651456651457,0.623200463252599,MLLT11;TNFRSF12A;CASP3;ANKRD1;TGM2;DNM2,GO_BP,yellow,6
regulation of cellular component organization (GO:0051128),3/139,0.549964778870666,0.691409860301696,0,0,1.04650286944046,0.625705155281452,URI1;RAB4A;CEACAM1,GO_BP,yellow,3
regulation of intracellular signal transduction (GO:1902531),9/437,0.550389852087016,0.691409860301696,0,0,0.997218238178958,0.595467360806392,USP7;CEACAM1;RRAGB;GPAT3;NF2;PRDM11;FGF1;RAD9B;RHOQ,GO_BP,yellow,9
negative regulation of cell differentiation (GO:0045596),4/191,0.558381613089774,0.693785199720042,0,0,1.01460455264569,0.591222913584682,PPP2CA;BBS12;CAV1;TBX3,GO_BP,yellow,4
"positive regulation of transcription, DNA-templated (GO:0045893)",24/1183,0.566263660438375,0.699301682761922,0,0,0.980971540486768,0.557874079201371,AKIRIN1;CCNK;CASZ1;SRF;ZBTB49;CEBPG;ECD;FOXK2;PRDM11;FGF1;SMARCA1;NPAS2;TBX3;ABRA;DCAF6;DNM2;MLLT11;HJV;TP53INP2;SSBP2;IER5;MEF2D;YAF2;RHOQ,GO_BP,yellow,24
negative regulation of DNA-binding transcription factor activity (GO:0043433),3/143,0.569218071324234,0.701962029825032,0,0,1.016393728223,0.572729393839246,USP7;CEBPG;TAX1BP1,GO_BP,yellow,3
cellular response to DNA damage stimulus (GO:0006974),7/350,0.586999604072241,0.712785233516292,0,0,0.967326832210717,0.515325119931643,CCNK;USP10;AKTIP;PSME4;GRB2;CEP63;RAD9B,GO_BP,yellow,7
positive regulation of transferase activity (GO:0051347),3/148,0.592558856623018,0.714952904074523,0,0,0.981093355761144,0.513411131955477,ARRDC4;RYK;FGFR1,GO_BP,yellow,3
brain development (GO:0007420),3/150,0.601663470709189,0.719437290766222,0,0,0.967645594823295,0.49161912642448,UGP2;CDH2;SMARCA1,GO_BP,yellow,3
regulation of angiogenesis (GO:0045765),4/203,0.606533172060665,0.723928457014647,0,0,0.95283262277156,0.476412364607215,CEACAM1;VASH2;FGF1;WARS1,GO_BP,yellow,4
regulation of cell migration (GO:0030334),8/408,0.60852910034542,0.723928457014647,0,0,0.947506172839506,0.470636307138138,PTP4A1;CEACAM1;CAV1;NF2;FGF1;MAPRE1;GTPBP4;HBEGF,GO_BP,yellow,8
cellular component assembly (GO:0022607),5/261,0.628815094249991,0.73821814865644,0,0,0.925388710171569,0.429304510465221,ZW10;FLNC;RHOQ;NAPG;RTN4,GO_BP,yellow,5
cellular response to growth factor stimulus (GO:0071363),3/158,0.636724879528969,0.742732798301611,0,0,0.917324940991345,0.414096638853361,URI1;HJV;ANKRD1,GO_BP,yellow,3
regulation of gene expression (GO:0010468),21/1079,0.642434390088455,0.746612939832529,0,0,0.938208884688091,0.415148597319194,CASZ1;ASCC1;CAVIN4;FOXK2;PRDM11;ZNF35;FGF1;NKAPL;WARS1;DNM2;PPP2CA;ADAM19;ACE2;EPB41L4B;ACTA1;NFX1;TDG;ANXA7;SSBP2;YAF2;ZNF146,GO_BP,yellow,21
protein-containing complex assembly (GO:0065003),5/267,0.648613780009137,0.749820779947305,0,0,0.903915955695255,0.391321342683784,PPP6C;ZW10;CUL3;AXIN2;NAPG,GO_BP,yellow,5
cellular response to oxygen-containing compound (GO:1901701),6/323,0.659496525341298,0.757212502656265,0,0,0.896147079112379,0.373046829499508,RRAGB;ANKRD1;PLAA;LPL;ZNF35;TGM2,GO_BP,yellow,6
regulation of neuron projection development (GO:0010975),3/165,0.665593016885891,0.761421745451622,0,0,0.877371273712737,0.35715756157116,CDH2;LRRC7;EFHC2,GO_BP,yellow,3
inorganic cation transmembrane transport (GO:0098662),5/274,0.67085590723016,0.765445892068543,0,0,0.880075078358481,0.351326770735859,SCN10A;SLC1A3;SLC41A1;KCNK1;SLC39A14,GO_BP,yellow,5
DNA metabolic process (GO:0006259),5/277,0.680100459627568,0.773177971987173,0,0,0.870233203575548,0.335487741989973,USP7;TDG;PSME4;AXIN2;RAD9B,GO_BP,yellow,5
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),4/224,0.682662509462325,0.773793473963588,0,0,0.860946877083796,0.32867049195096,PPM1B;VAPA;USP10;OTUD7B,GO_BP,yellow,4
positive regulation of intracellular signal transduction (GO:1902533),10/546,0.694249566869282,0.779987425005303,0,0,0.881958075626829,0.321847471829706,VAPA;RRAGB;RYK;CAV1;GRB2;FGF1;RTN4;HBEGF;TGM2;FGFR1,GO_BP,yellow,10
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),10/547,0.696404641204005,0.779987425005303,0,0,0.880269487225696,0.318502984814196,PAIP2B;NACC2;ANKRD1;FOXK2;PRDM11;YAF2;GTPBP4;ZNF256;TBX3;DKK3,GO_BP,yellow,10
cation transport (GO:0006812),3/174,0.700207914826218,0.783446916945865,0,0,0.830808729139923,0.296081925740824,SLC41A1;KCNK1;SLC36A4,GO_BP,yellow,3
glycerophospholipid biosynthetic process (GO:0046474),3/177,0.711124182576634,0.791220361436102,0,0,0.816358284272498,0.278303237647531,RAB4A;PCYT1A;GPAT3,GO_BP,yellow,3
positive regulation of nucleic acid-templated transcription (GO:1903508),9/511,0.731756621248931,0.808749297171701,0,0,0.846934045994241,0.264503689365294,MLLT11;CASZ1;TP53INP2;FOXK2;PRDM11;SMARCA1;YAF2;NPAS2;DNM2,GO_BP,yellow,9
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),7/404,0.732041657494677,0.808749297171701,0,0,0.833405715278381,0.259954125133184,RYK;CASP3;GRB2;FGF1;SLC39A14;RHOQ;FGFR1,GO_BP,yellow,7
axonogenesis (GO:0007409),4/240,0.733333989264572,0.809361569429898,0,0,0.801914549749285,0.248717032409792,RYK;GRB2;NCAM1;SPTB,GO_BP,yellow,4
DNA repair (GO:0006281),5/298,0.739886192087361,0.812097306930722,0,0,0.806983202837449,0.243110871269353,ASCC1;TDG;PSME4;RAD9B;RAD23B,GO_BP,yellow,5
negative regulation of nucleic acid-templated transcription (GO:1903507),8/464,0.745509366889931,0.816634386408401,0,0,0.828719948018194,0.243384756265102,NACC2;COPS2;FOXK2;PRDM11;YAF2;ZNF256;TBX3;DKK3,GO_BP,yellow,8
positive regulation of DNA-binding transcription factor activity (GO:0051091),4/246,0.750696761852014,0.82108628366158,0,0,0.781789892703429,0.224180978551117,CAV1;SRF;CEBPG;ABRA,GO_BP,yellow,4
negative regulation of transcription by RNA polymerase II (GO:0000122),12/684,0.757466129940294,0.826840827754636,0,0,0.842313858211614,0.233974957993298,URI1;BAG3;NFX1;HJV;NACC2;SRF;CAV1;MXI1;OTUD7B;MYOZ2;TBX3;JAZF1,GO_BP,yellow,12
positive regulation of signal transduction (GO:0009967),4/252,0.767181445632692,0.833493245815043,0,0,0.762639009385598,0.202123696352554,FGF1;TXNDC15;SLC39A14;UCHL5,GO_BP,yellow,4
regulation of signal transduction (GO:0009966),3/198,0.779098997804241,0.840002016806637,0,0,0.72765478424015,0.181635119244773,PPP2CA;NCAM1;YWHAG,GO_BP,yellow,3
regulation of macromolecule metabolic process (GO:0060255),3/200,0.784831030793785,0.844480113479508,0,0,0.720193141017705,0.174493314396227,CAVIN4;PRDM11;NKAPL,GO_BP,yellow,3
negative regulation of programmed cell death (GO:0043069),6/381,0.801846665794576,0.852788427782495,0,0,0.755262899262899,0.166790656894323,RNF157;BAG3;CASP3;TAX1BP1;TBX3;RAB7A,GO_BP,yellow,6
positive regulation of macromolecule metabolic process (GO:0010604),6/384,0.807750997839959,0.857819824824711,0,0,0.749151749151749,0.159944976432534,ATAD1;ADAM19;EPB41L4B;ACTA1;FGF1;WARS1,GO_BP,yellow,6
positive regulation of MAPK cascade (GO:0043410),4/274,0.820409460709111,0.866229151340915,0,0,0.699701168160826,0.138507050441022,RYK;DENND2B;FGF1;FGFR1,GO_BP,yellow,4
negative regulation of multicellular organismal process (GO:0051241),3/214,0.821590660669027,0.866641808007299,0,0,0.671922321118946,0.132041462812244,PPP2CA;SRF;NRDC,GO_BP,yellow,3
positive regulation of GTPase activity (GO:0043547),3/214,0.821590660669027,0.866641808007299,0,0,0.671922321118946,0.132041462812244,TBC1D1;MAPRE2;TGM2,GO_BP,yellow,3
extracellular structure organization (GO:0043062),3/216,0.826380900966952,0.869603318531923,0,0,0.66554448643078,0.12691898253288,ADAM19;ADAMTSL5;FURIN,GO_BP,yellow,3
external encapsulating structure organization (GO:0045229),3/217,0.828734580892527,0.871243976940226,0,0,0.662400273535446,0.124435430530687,ADAM19;ADAMTSL5;FURIN,GO_BP,yellow,3
cytokine-mediated signaling pathway (GO:0019221),10/621,0.829165959769458,0.871279803437672,0,0,0.770652187156068,0.144370089840079,CEACAM1;PSMD12;PSMD11;TNFRSF12A;CASP3;PSME4;STAT4;PSMD1;GRB2;NCAM1,GO_BP,yellow,10
supramolecular fiber organization (GO:0097435),5/351,0.853556729281288,0.887166722845226,0,0,0.681492972911708,0.107909827388274,DCTN1;XIRP1;FURIN;LMOD2;TRDN,GO_BP,yellow,5
regulation of cell cycle (GO:0051726),4/296,0.863206630538386,0.89546458882246,0,0,0.646247111230197,0.0950637150383119,ZBTB49;NF2;PRDM11;TBX3,GO_BP,yellow,4
regulation of ERK1 and ERK2 cascade (GO:0070372),3/238,0.872184031921108,0.903481084824254,0,0,0.602553191489362,0.082402060207525,CEACAM1;DENND2B;CNKSR3,GO_BP,yellow,3
cellular response to cytokine stimulus (GO:0071345),7/482,0.872582278913712,0.903481084824254,0,0,0.693720508166969,0.0945529445798511,ASAH1;USP10;CASP3;STAT4;ANKRD1;GRB2;UBE2K,GO_BP,yellow,7
negative regulation of apoptotic process (GO:0043066),7/485,0.876478034788915,0.905016004028873,0,0,0.689258404270668,0.090874333523663,RNF157;DFFA;BAG3;CAV1;CASP3;TAX1BP1;TBX3,GO_BP,yellow,7
chemical synaptic transmission (GO:0007268),4/306,0.879587660120891,0.907307497010872,0,0,0.624524360821905,0.0801277553728399,GABRB3;RIC3;SLC1A3;CACNA1E,GO_BP,yellow,4
anterograde trans-synaptic signaling (GO:0098916),3/244,0.882668273150397,0.909629475102829,0,0,0.587369699423135,0.0733071631826148,GABRB3;SLC1A3;CACNA1E,GO_BP,yellow,3
"negative regulation of transcription, DNA-templated (GO:0045892)",15/948,0.886024123133622,0.911411720997256,0,0,0.753526474817819,0.0911850689038841,URI1;CAV1;FOXK2;OTUD7B;PRDM11;TBX3;DKK3;NFX1;HJV;NACC2;MXI1;YAF2;MYOZ2;ZNF256;JAZF1,GO_BP,yellow,15
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",3/251,0.893928033713642,0.917782854838023,0,0,0.570584185680566,0.0639796083068555,SF3B3;SNRPN;RSRC1,GO_BP,yellow,3
negative regulation of signal transduction (GO:0009968),3/267,0.91610574782116,0.934427862777584,0,0,0.535559866962306,0.0469276170163478,RNF157;NTN1;DKK3,GO_BP,yellow,3
"mRNA splicing, via spliceosome (GO:0000398)",3/274,0.924411761465179,0.940712293685911,0,0,0.521537215372154,0.0409916137602165,SF3B3;SNRPN;RSRC1,GO_BP,yellow,3
positive regulation of multicellular organismal process (GO:0051240),4/345,0.92825947661589,0.942998976825749,0,0,0.551979292889459,0.0410915337052908,CAV1;SHLD2;AXIN2;RTN4,GO_BP,yellow,4
positive regulation of cell population proliferation (GO:0008284),6/474,0.928896645617195,0.943088122147457,0,0,0.602249102249102,0.0444205686710496,CUL3;DNAJA2;FGF1;TBX3;HBEGF;FGFR1,GO_BP,yellow,6
positive regulation of gene expression (GO:0010628),6/482,0.935388999848741,0.948564736555225,0,0,0.59187950364421,0.0395332855207345,ADAM19;EPB41L4B;ACTA1;PRR16;FGF1;WARS1,GO_BP,yellow,6
extracellular matrix organization (GO:0030198),3/300,0.949088376356446,0.959147838409993,0,0,0.475240206947524,0.0248328971151087,ADAM19;ADAMTSL5;FURIN,GO_BP,yellow,3
mRNA processing (GO:0006397),3/300,0.949088376356446,0.959147838409993,0,0,0.475240206947524,0.0248328971151087,SF3B3;SNRPN;RSRC1,GO_BP,yellow,3
negative regulation of gene expression (GO:0010629),3/322,0.963882939466901,0.972222109549012,0,0,0.441960394525575,0.0162577004301739,PAIP2B;ANXA7;NUDT16,GO_BP,yellow,3
regulation of transcription by RNA polymerase II (GO:0006357),35/2206,0.964209152008142,0.972222109549012,0,0,0.742787928416671,0.0270724252311288,URI1;CCNK;CASZ1;SRF;ZBTB49;CEBPG;ZBTB20;FOXK2;OTUD7B;FGF1;RPAP2;NPAS2;ABRA;DCAF6;HJV;NACC2;MXI1;STAT4;ANKRD1;IER5;MEF2D;MYOZ2;ZNF146;JAZF1;AKIRIN1;CAV1;ECD;ZNF35;SMARCA1;TBX3;TOX4;NFX1;SSBP2;ZNF256;RHOQ,GO_BP,yellow,35
phosphorylation (GO:0016310),3/400,0.989870267112892,0.99167907527573,0,0,0.353689254776679,0.00360104744968787,RYK;COPS2;FGFR1,GO_BP,yellow,3
"regulation of transcription, DNA-templated (GO:0006355)",30/2244,0.997410595679102,0.997865618761073,0,0,0.614638391814728,0.00159361145133073,URI1;CCNK;CASZ1;SRF;ZBTB49;CEBPG;ZBTB20;FOXK2;PRDM11;NPAS2;PPP2CA;NACC2;TP53INP2;MXI1;STAT4;ANKRD1;MEF2D;YAF2;ZNF146;ASCC1;ZNF35;SMARCA1;TBX3;DKK3;DNM2;MLLT11;TOX4;NFX1;SSBP2;ZNF256,GO_BP,yellow,30
protein phosphorylation (GO:0006468),3/496,0.998059820889782,0.998059820889782,0,0,0.283391876515114,0.000550365075043275,RYK;COPS2;FGFR1,GO_BP,yellow,3
Cardiomyocytes,22/174,1.19391727789564e-11,1.4804574245906e-09,0,0,7.19427244582043,180.944558461939,ACTN2;MTTP;SYPL2;SRL;KLHL31;LMOD2;TRDN;ACTA1;JPH2;MYL2;NRAP;ANKRD1;CASQ2;XIRP1;SMYD1;SPEG;XIRP2;ALPK3;CASQ1;FLNC;MYOZ2;TRIM55,PanglaoDB,yellow,22
Myocytes,21/163,2.45380668400494e-11,1.52136014408306e-09,0,0,7.33589034205231,179.221636431559,ACTN2;SYPL2;SRL;LMOD2;TRDN;ACTA1;JPH2;MYL2;NRAP;ANKRD1;CASQ2;XIRP1;SMYD1;SPEG;XIRP2;ALPK3;CASQ1;FLNC;MYOZ2;MEF2D;TRIM55,PanglaoDB,yellow,21
Oxyphil Cells,10/94,2.43983633994853e-05,0.00100846568717873,0,0,5.7612548741581,61.1902563413615,KBTBD12;ACTN2;CADM2;CASQ2;SMYD1;SRL;SPTB;LRRC2;LMOD2;TRDN,PanglaoDB,yellow,10
Kidney Progenitor Cells,7/105,0.00612527590237994,0.189883552973778,0,0,3.42874736101337,17.4706043596386,FHOD3;LAPTM4B;CDH2;TUSC3;EYA4;FLNC;SMARCA1,PanglaoDB,yellow,7
Myoblasts,7/126,0.0157865805980224,0.391507198830956,0,0,2.82063170095624,11.7016586534321,JPH2;TNFRSF12A;CAV1;FLNC;MYOZ2;STK40;TBX3,PanglaoDB,yellow,7
Smooth Muscle Cells,8/169,0.0244171970654145,0.504622072685234,0,0,2.38337550801319,8.84820434539564,GJC1;CNN1;JPH2;ANKRD1;SPEG;NF2;OTUD1;DKK3,PanglaoDB,yellow,8
Cardiac Stem And Precursor Cells,5/113,0.0850508659233425,0.992319875985966,0,0,2.21030773420479,5.44731618397944,LAPTM4B;ANKRD1;FLNC;SMARCA1;TBX3,PanglaoDB,yellow,5
Transient Cells,5/120,0.103188640764367,0.992319875985966,0,0,2.07502131287298,4.71278114759159,CADPS2;EPB41L4B;APLP2;CTNNA1;PTGFRN,PanglaoDB,yellow,5
Airway Smooth Muscle Cells,4/99,0.148663579781044,0.992319875985966,0,0,2.0066400720628,3.82479519733836,CNN1;JPH2;FLNC;DKK3,PanglaoDB,yellow,4
Satellite Cells,5/139,0.160891797508754,0.992319875985966,0,0,1.77906423763535,3.25039164551928,JPH2;TNFRSF12A;CAV1;NCAM1;FLNC,PanglaoDB,yellow,5
Mesothelial Cells,5/144,0.177887450495432,0.992319875985966,0,0,1.71462829736211,2.96048446984087,CAV1;ME1;MIR22HG;FLNC;FGF1,PanglaoDB,yellow,5
Astrocytes,5/154,0.213739912945458,0.992319875985966,0,0,1.59873009606527,2.46683312520061,SYNM;CADM2;SLC1A3;FGF1;DKK3,PanglaoDB,yellow,5
Luteal Cells,4/125,0.258659769065236,0.992319875985966,0,0,1.5733597365071,2.12756266653005,EPB41L4B;ME1;SMARCA1;SLC39A14,PanglaoDB,yellow,4
Embryonic Stem Cells,5/176,0.299074626298924,0.992319875985966,0,0,1.39146886824905,1.6795894043914,GJC1;LAPTM4B;CTNNA1;TAF8;SMARCA1,PanglaoDB,yellow,5
Podocytes,5/184,0.331459302273395,0.992319875985966,0,0,1.32873261036258,1.46725331092956,CADPS2;EHD4;LRRC49;ETF1;SMARCA1,PanglaoDB,yellow,5
Myofibroblasts,3/100,0.341114879791268,0.992319875985966,0,0,1.47020367110888,1.58125692790183,CNN1;FLNC;DKK3,PanglaoDB,yellow,3
Reticulocytes,3/103,0.358063700983734,0.992319875985966,0,0,1.42587804878049,1.4644400261584,SF3B3;PABPC4;EIF4G1,PanglaoDB,yellow,3
Epiblast Cells,3/109,0.391748864756032,0.992319875985966,0,0,1.34475379659457,1.26021490196591,GABRB3;ST8SIA2;VASH2,PanglaoDB,yellow,3
Granulosa Cells,3/112,0.408430811278666,0.992319875985966,0,0,1.30754083687626,1.17081488947466,FHL1;FLNC;SMARCA1,PanglaoDB,yellow,3
Pancreatic Progenitor Cells,3/114,0.419475721799767,0.992319875985966,0,0,1.2838497033619,1.11534395334115,CADPS2;EPB41L4B;JPH1,PanglaoDB,yellow,3
Radial Glia Cells,3/114,0.419475721799767,0.992319875985966,0,0,1.2838497033619,1.11534395334115,SLC1A3;AXIN2;DKK3,PanglaoDB,yellow,3
Myoepithelial Cells,3/115,0.424972712586745,0.992319875985966,0,0,1.27232142857143,1.08876402041167,CNN1;JPH2;CAV1,PanglaoDB,yellow,3
Choroid Plexus Cells,3/117,0.435911752123005,0.992319875985966,0,0,1.24987163029525,1.03778773703341,CADPS2;EPB41L4B;SMARCA1,PanglaoDB,yellow,3
Schwann Cells,3/138,0.545073085694316,0.992319875985966,0,0,1.05430894308943,0.639791979839284,BAG3;NF2;FGF1,PanglaoDB,yellow,3
Osteoclasts,3/144,0.573951582621751,0.992319875985966,0,0,1.00913336792942,0.560281176426682,CA2;DYSF;SLC39A14,PanglaoDB,yellow,3
Trigeminal Neurons,3/144,0.573951582621751,0.992319875985966,0,0,1.00913336792942,0.560281176426682,SCN10A;SYNM;CADM2,PanglaoDB,yellow,3
Beta Cells,3/145,0.578652645671554,0.992319875985966,0,0,1.00197526623154,0.54813347767904,GABRB3;GJD2;CADM2,PanglaoDB,yellow,3
M?ller Cells,3/147,0.58795649748395,0.992319875985966,0,0,0.987957317073171,0.524706420877625,CA2;SLC1A3;DKK3,PanglaoDB,yellow,3
Photoreceptor Cells,3/149,0.597127907936278,0.992319875985966,0,0,0.974323421316405,0.50238447878899,STRIP2;CADM2;NCAM1,PanglaoDB,yellow,3
Enterocytes,4/203,0.606533172060665,0.992319875985966,0,0,0.95283262277156,0.476412364607215,ACE2;CEACAM1;MTTP;CDH17,PanglaoDB,yellow,4
Erythroid-like And Erythroid Precursor Cells,3/153,0.615067614094167,0.992319875985966,0,0,0.948146341463415,0.460821000999045,CEACAM1;NCOA4;PNPO,PanglaoDB,yellow,3
Osteoblasts,3/154,0.619467672240211,0.992319875985966,0,0,0.941818769181069,0.451032076167553,NF2;DKK3;FGFR1,PanglaoDB,yellow,3
Platelets,4/214,0.647751749332551,0.992319875985966,0,0,0.902410059378275,0.391869545906812,GP1BB;CA2;NCOA4;FHL1,PanglaoDB,yellow,4
Enteric Neurons,3/166,0.669578009031034,0.992319875985966,0,0,0.871943737842286,0.349743262022107,CASZ1;CADM2;CACNA1E,PanglaoDB,yellow,3
Hepatocytes,4/221,0.672449757486496,0.992319875985966,0,0,0.87298457516929,0.346424618546457,EPB41L4B;ABCD3;TP53INP2;MTTP,PanglaoDB,yellow,4
Olfactory Epithelial Cells,4/226,0.689346233456608,0.992319875985966,0,0,0.853102491244301,0.317364038330862,EPB41L4B;LRRC49;H2BC21;DUSP8,PanglaoDB,yellow,4
Epithelial Cells,3/218,0.831060922006485,0.992319875985966,0,0,0.659285309132161,0.122002180488384,CEACAM1;DKK3;HBEGF,PanglaoDB,yellow,3
Neurons,4/289,0.850638349844537,0.992319875985966,0,0,0.66236005662077,0.107148801755026,CADM2;KCNK1;SLC36A4;NAPG,PanglaoDB,yellow,4
Interneurons,4/305,0.878029509046805,0.992319875985966,0,0,0.626631684117327,0.0815091642608456,CADM2;RAB15;NRIP3;CACNA1E,PanglaoDB,yellow,4
Endothelial Cells,3/246,0.88598929689068,0.992319875985966,0,0,0.582475158084914,0.0705088559489302,CASZ1;CAV1;CYYR1,PanglaoDB,yellow,3
neutrophil degranulation (GO:0043312),12/481,1.8539568976313e-07,5.31118863457687e-05,0,0,8.02957562418323,124.464632508754,CFD;SERPINA3;CRISPLD2;ANPEP;SLC11A1;TMBIM1;MCEMP1;RNASE2;S100A9;CAMP;S100A8;ELANE,GO_BP,salmon,12
neutrophil activation involved in immune response (GO:0002283),12/485,2.02634547411878e-07,5.31118863457687e-05,0,0,7.96003546341131,122.678966002603,CFD;SERPINA3;CRISPLD2;ANPEP;SLC11A1;TMBIM1;MCEMP1;RNASE2;S100A9;CAMP;S100A8;ELANE,GO_BP,salmon,12
neutrophil mediated immunity (GO:0002446),12/488,2.16488667170253e-07,5.31118863457687e-05,0,0,7.9086473298997,121.363947897836,CFD;SERPINA3;CRISPLD2;ANPEP;SLC11A1;TMBIM1;MCEMP1;RNASE2;S100A9;CAMP;S100A8;ELANE,GO_BP,salmon,12
defense response to bacterium (GO:0042742),7/176,3.97230737454224e-06,0.000730904556915773,0,0,12.2139892254703,151.895166133399,SLC11A1;LBP;RNASE2;S100A9;CAMP;S100A8;ELANE,GO_BP,salmon,7
defense response to Gram-negative bacterium (GO:0050829),5/73,7.46498803790244e-06,0.00109884623917924,0,0,21.1615515771526,249.818184007246,SLC11A1;LBP;RNASE2;CAMP;ELANE,GO_BP,salmon,5
response to lipid (GO:0033993),5/114,6.48645116402179e-05,0.00795671342786673,0,0,13.1744448876479,127.043937365383,SLC11A1;ALPL;LBP;S100A9;S100A8,GO_BP,salmon,5
response to molecule of bacterial origin (GO:0002237),4/73,0.000154924764756758,0.0142530783576218,0,0,16.4447204968944,144.262477271641,SLC11A1;LBP;S100A9;S100A8,GO_BP,salmon,4
innate immune response (GO:0045087),6/302,0.000883362423559185,0.0534104498983438,0,0,5.85155007949126,41.1467835360081,CFD;SRC;SLC11A1;LBP;RNASE2;CAMP,GO_BP,salmon,6
cholesterol transport (GO:0030301),3/51,0.000891321767714833,0.0534104498983438,0,0,17.4982394366197,122.886724538695,SOAT1;AKR1C1;TSKU,GO_BP,salmon,3
regulation of intrinsic apoptotic signaling pathway (GO:2001242),3/52,0.00094339109874792,0.0534104498983438,0,0,17.1402701925841,119.399629898305,SRC;S100A9;S100A8,GO_BP,salmon,3
pattern recognition receptor signaling pathway (GO:0002221),3/61,0.00150016391149846,0.0788657599187763,0,0,14.4740165128703,94.112673752624,LBP;S100A9;S100A8,GO_BP,salmon,3
inflammatory response (GO:0006954),5/230,0.00162833352116294,0.0798968981050616,0,0,6.34492753623188,40.7356921366244,TMIGD3;SERPINA3;SLC11A1;S100A9;S100A8,GO_BP,salmon,5
nitrogen compound transport (GO:0071705),4/143,0.00195677234210455,0.0900115277368093,0,0,8.1344295991778,50.7300360929262,TCN2;SLC11A1;SLC3A2;SLC1A5,GO_BP,salmon,4
defense response to Gram-positive bacterium (GO:0050830),3/70,0.00222808872434221,0.0935397079545773,0,0,12.5240697918856,76.4796240503315,LBP;RNASE2;CAMP,GO_BP,salmon,3
cholesterol homeostasis (GO:0042632),3/71,0.00232025153865281,0.0935397079545773,0,0,12.3392709196355,74.8510005588922,SOAT1;AKR1C1;TSKU,GO_BP,salmon,3
sterol homeostasis (GO:0055092),3/72,0.00241474789556653,0.0935397079545773,0,0,12.159828536436,73.2770770559639,SOAT1;AKR1C1;TSKU,GO_BP,salmon,3
response to lipopolysaccharide (GO:0032496),4/159,0.00287339776386582,0.10070575020025,0,0,7.28884792626728,42.6562335994423,SLC11A1;LBP;S100A9;S100A8,GO_BP,salmon,4
positive regulation of inflammatory response (GO:0050729),3/89,0.00439650259953462,0.118335049656786,0,0,9.74778905994104,52.9007240471218,LBP;S100A9;S100A8,GO_BP,salmon,3
toll-like receptor signaling pathway (GO:0002224),3/91,0.00467845305033688,0.118335049656786,0,0,9.5252880921895,51.1011490483633,LBP;S100A9;S100A8,GO_BP,salmon,3
regulation of lipid metabolic process (GO:0019216),3/92,0.0048234395240538,0.118335049656786,0,0,9.41778762462415,50.2370032623538,SERPINA3;SREBF1;MID1IP1,GO_BP,salmon,3
organic acid transport (GO:0015849),3/100,0.00608144188041602,0.143393885741596,0,0,8.63757804559315,44.0733582371574,AKR1C1;SLC3A2;SLC1A5,GO_BP,salmon,3
negative regulation of inflammatory response (GO:0050728),4/212,0.00792015364025431,0.147191258196531,0,0,5.41703296703297,26.2094726066704,CD163;SRC;GPBAR1;ELANE,GO_BP,salmon,4
positive regulation of cytokine production (GO:0001819),5/335,0.00803104079209489,0.147191258196531,0,0,4.3030303030303,20.7597164484004,SLC11A1;SERPINF2;LBP;ALOX15B;ELANE,GO_BP,salmon,5
positive regulation of cellular process (GO:0048522),7/625,0.00829956245288261,0.147191258196531,0,0,3.26416461382408,15.6404160573169,IL15RA;SLC11A1;TFE3;SERPINF2;LBP;S100A9;S100A8,GO_BP,salmon,7
platelet degranulation (GO:0002576),3/125,0.0111916121084404,0.147191258196531,0,0,6.8589240360194,30.8143383372573,CFD;SERPINA3;SERPINF2,GO_BP,salmon,3
negative regulation of inflammatory response to antigenic stimulus (GO:0002862),3/136,0.0140324424965099,0.147191258196531,0,0,6.28814995234565,26.8276580014001,CD163;SRC;GPBAR1,GO_BP,salmon,3
regulation of inflammatory response to antigenic stimulus (GO:0002861),3/137,0.0143091473369593,0.147191258196531,0,0,6.24090813537944,26.5042398596292,CD163;SRC;GPBAR1,GO_BP,salmon,3
positive regulation of response to external stimulus (GO:0032103),3/139,0.0148718480800554,0.147191258196531,0,0,6.14850869925435,25.8746784303305,SERPINF2;S100A9;S100A8,GO_BP,salmon,3
regulation of cell migration (GO:0030334),5/408,0.0176046379465675,0.147191258196531,0,0,3.51044700974575,14.1807767881779,SEMA6B;TMIGD3;SUN2;SRC;ALOX15B,GO_BP,salmon,5
extracellular matrix organization (GO:0030198),4/300,0.0251593464550974,0.147191258196531,0,0,3.78957528957529,13.9552088622147,VIT;SH3PXD2B;SERPINF2;ELANE,GO_BP,salmon,4
negative regulation of immune response (GO:0050777),3/178,0.0283490059990919,0.147191258196531,0,0,4.76885311871227,16.9922024690185,CD163;SRC;GPBAR1,GO_BP,salmon,3
regulated exocytosis (GO:0045055),3/180,0.0291690697984983,0.147191258196531,0,0,4.71449033182144,16.6640562065545,CFD;SERPINA3;SERPINF2,GO_BP,salmon,3
positive regulation of multicellular organismal process (GO:0051240),4/345,0.0390309976765675,0.149310637567032,0,0,3.28194386258902,10.6446538894008,OLFM1;SLC11A1;LBP;TSKU,GO_BP,salmon,4
regulation of inflammatory response (GO:0050727),3/206,0.0409622952594949,0.152263885409031,0,0,4.10525220287241,13.1167047097064,S100A9;S100A8;ELANE,GO_BP,salmon,3
positive regulation of cell differentiation (GO:0045597),3/258,0.070604467842934,0.16864342438824,0,0,3.25948632974316,8.63979607329216,OLFM1;SERPINF2;ALOX15B,GO_BP,salmon,3
negative regulation of signal transduction (GO:0009968),3/267,0.0765029547210917,0.171122258662595,0,0,3.14692701664533,8.08894275648328,PALM;TMBIM1;TSKU,GO_BP,salmon,3
central nervous system development (GO:0007417),3/268,0.0771715169498614,0.171122258662595,0,0,3.13489237310656,8.03073166748241,VIT;SEMA6B;MARCKSL1,GO_BP,salmon,3
positive regulation of cell migration (GO:0030335),3/269,0.0778426822444135,0.171122258662595,0,0,3.12294821560945,7.97309098300234,SEMA6B;SUN2;SRC,GO_BP,salmon,3
positive regulation of MAPK cascade (GO:0043410),3/274,0.0812372447709395,0.176895302223111,0,0,3.0645496595811,7.69318864109441,MARCO;SERPINF2;ELANE,GO_BP,salmon,3
negative regulation of gene expression (GO:0010629),3/322,0.116896555647123,0.207816098928219,0,0,2.59706830323635,5.57451848803097,OLFM1;SLC11A1;ATOH8,GO_BP,salmon,3
positive regulation of transcription by RNA polymerase II (GO:0045944),6/908,0.119240934403978,0.209454242771666,0,0,1.86096256684492,3.95754006688677,SREBF1;SLC11A1;TFE3;SERPINF2;ATOH8;RGMA,GO_BP,salmon,6
supramolecular fiber organization (GO:0097435),3/351,0.140837172768217,0.231333948411362,0,0,2.37712481787275,4.65952325362053,MARCKSL1;SERPINF2;CDC42EP2,GO_BP,salmon,3
negative regulation of cell population proliferation (GO:0008285),3/379,0.165380347148741,0.251199626723902,0,0,2.1969583458196,3.95344263293078,TMIGD3;IGFBP6;ALOX15B,GO_BP,salmon,3
positive regulation of macromolecule metabolic process (GO:0010604),3/384,0.169893101503344,0.254666645023343,0,0,2.16757236331374,3.84220810960907,OLFM1;C1QTNF1;SLC11A1,GO_BP,salmon,3
cytokine-mediated signaling pathway (GO:0019221),4/621,0.197617961330006,0.274946728806965,0,0,1.78828432507525,2.89955925572974,IL15RA;SRC;IL1R2;LBP,GO_BP,salmon,4
nervous system development (GO:0007399),3/447,0.2294357286827,0.304260714072913,0,0,1.8540159878188,2.72935689086586,SEMA6B;MARCKSL1;PMP22,GO_BP,salmon,3
positive regulation of gene expression (GO:0010628),3/482,0.264090837451177,0.33056268089127,0,0,1.71545767296892,2.28406696794173,OLFM1;C1QTNF1;SLC11A1,GO_BP,salmon,3
"positive regulation of transcription, DNA-templated (GO:0045893)",6/1183,0.272711127368353,0.336573612197237,0,0,1.40554250587236,1.82628067143832,SREBF1;SLC11A1;TFE3;SERPINF2;ATOH8;RGMA,GO_BP,salmon,6
positive regulation of intracellular signal transduction (GO:1902533),3/546,0.328845241610985,0.38295901554697,0,0,1.50828729281768,1.67746890580751,SRC;S100A9;S100A8,GO_BP,salmon,3
negative regulation of cellular process (GO:0048523),3/566,0.34918474880472,0.397217890448646,0,0,1.45320591399194,1.52899660507991,TMIGD3;IGFBP6;ALOX15B,GO_BP,salmon,3
regulation of gene expression (GO:0010468),5/1079,0.369541971295419,0.412720623480165,0,0,1.27196178447089,1.26622645232471,OLFM1;C1QTNF1;SLC11A1;ATOH8;TSKU,GO_BP,salmon,5
regulation of transcription by RNA polymerase II (GO:0006357),9/2206,0.43129847209181,0.466131682025804,0,0,1.11733482721193,0.939628217884145,SREBF1;SLC11A1;KCNIP3;TFE3;SERPINF2;ATOH8;HOXB6;ELANE;RGMA,GO_BP,salmon,9
regulation of cell population proliferation (GO:0042127),3/764,0.541073958591853,0.566472878411955,0,0,1.064111343488,0.653576444724327,TMIGD3;IGFBP6;ALOX15B,GO_BP,salmon,3
"negative regulation of transcription, DNA-templated (GO:0045892)",3/948,0.687807606071417,0.702117056960559,0,0,0.848692152917505,0.317619747420512,KCNIP3;ATOH8;ELANE,GO_BP,salmon,3
"regulation of transcription, DNA-templated (GO:0006355)",4/2244,0.972598350771467,0.973921613833742,0,0,0.451173469387755,0.0125354382804328,SREBF1;TFE3;ATOH8;HOXB6,GO_BP,salmon,4
Neutrophils,9/151,4.56270097531099e-09,4.97334406308898e-07,0,0,19.2910075839653,370.490573136847,SLC11A1;IL1R2;MCEMP1;SLC1A5;RNASE2;S100A9;CAMP;S100A8;ELANE,PanglaoDB,salmon,9
Alveolar Macrophages,5/123,9.30397763334494e-05,0.00507066781017299,0,0,12.1640874478015,112.912940464057,MARCO;SLC11A1;MCEMP1;S100A9;S100A8,PanglaoDB,salmon,5
Kupffer Cells,5/137,0.000154534973858488,0.00531465909277277,0,0,10.8662714097497,95.3525108805413,MARCO;CD163;SLC11A1;S100A9;CLEC4G,PanglaoDB,salmon,5
Osteoclasts,5/144,0.00019503336120267,0.00531465909277277,0,0,10.3153998540298,88.117652076722,TMIGD3;MARCO;CD163;TCN2;ANPEP,PanglaoDB,salmon,5
Adipocytes,5/210,0.00108928187771007,0.0237463449340796,0,0,6.97101449275362,47.5579104043595,CFD;C1QTNF1;TFE3;LBP;SLC1A5,PanglaoDB,salmon,5
Pulmonary Alveolar Type II Cells,4/135,0.00158514495853844,0.0249287032205413,0,0,8.63467829880044,55.6684567528495,MARCO;SOAT1;S100A9;ALOX15B,PanglaoDB,salmon,4
Schwann Cells,4/138,0.00171815700643517,0.0249287032205413,0,0,8.44008528784648,53.7338289005108,CADM3;PALM;PMP22;SEPTIN9,PanglaoDB,salmon,4
Megakaryocytes,4/143,0.00195677234210455,0.0249287032205413,0,0,8.1344295991778,50.7300360929262,SLC11A1;MCEMP1;S100A9;S100A8,PanglaoDB,salmon,4
Leydig Cells,4/145,0.00205833329343919,0.0249287032205413,0,0,8.01823708206687,49.5996816489922,VIT;CFD;SERPINA3;C1QTNF1,PanglaoDB,salmon,4
Erythroid-like And Erythroid Precursor Cells,4/153,0.00250113173193575,0.0259745961894591,0,0,7.58465963566635,45.4397865652938,MCEMP1;RNASE2;S100A9;S100A8,PanglaoDB,salmon,4
Pericytes,4/155,0.00262128952370689,0.0259745961894591,0,0,7.48344370860927,44.4822546646925,C1QTNF1;ANPEP;ALPL;CD248,PanglaoDB,salmon,4
Dendritic Cells,4/199,0.00636140184897939,0.0577827334615628,0,0,5.78197802197802,29.2423914834313,CD163;SLC11A1;S100A9;S100A8,PanglaoDB,salmon,4
Red Pulp Macrophages,3/110,0.00790640738108635,0.0593861810280655,0,0,7.82637883375017,37.8803136540912,MARCO;CD163;SLC11A1,PanglaoDB,salmon,3
Pancreatic Stellate Cells,3/111,0.00810472857138813,0.0593861810280655,0,0,7.75352112676056,37.3355893122564,SRPX;C1QTNF1;CD248,PanglaoDB,salmon,3
Myeloid-derived Suppressor Cells,3/112,0.00830596773997439,0.0593861810280655,0,0,7.68200025843132,36.80278101624,MCEMP1;S100A9;S100A8,PanglaoDB,salmon,3
Satellite Glial Cells,3/114,0.00871723758210136,0.0593861810280655,0,0,7.5428245146555,35.7714898601625,TMIGD3;CADM3;CD163,PanglaoDB,salmon,3
Sebocytes,3/124,0.0109516590148388,0.0692428299131663,0,0,6.91595856128507,31.2204650132438,IL1R2;S100A9;CAMP,PanglaoDB,salmon,3
Microfold Cells,3/126,0.011434595765477,0.0692428299131663,0,0,6.80281690140845,30.4161549399588,MARCKSL1;IL1R2;TMBIM1,PanglaoDB,salmon,3
Hepatic Stellate Cells,3/132,0.0129564887504972,0.0720536698680909,0,0,6.48444153291844,28.1824110395244,SRPX;C1QTNF1;IGFBP6,PanglaoDB,salmon,3
Melanocytes,3/133,0.0132208568565304,0.0720536698680909,0,0,6.43423618634886,27.8342460016192,SRPX;SH3PXD2B;PMP22,PanglaoDB,salmon,3
Microglia,3/158,0.0208402543794977,0.10817084416025,0,0,5.38964107223989,20.8625937708059,CD163;S100A9;S100A8,PanglaoDB,salmon,3
Proximal Tubule Cells,3/164,0.0229606080201315,0.113759376099742,0,0,5.18721021782871,19.576402855013,SERPINF2;ALPL;LBP,PanglaoDB,salmon,3
Basophils,3/169,0.0248142137290292,0.117597795498443,0,0,5.02969624978788,18.5914606747962,RNASE2;S100A9;S100A8,PanglaoDB,salmon,3
Monocytes,3/176,0.0275414927518415,0.12508427958128,0,0,4.82447284865261,17.3298035832085,CD163;S100A9;S100A8,PanglaoDB,salmon,3
Endothelial Cells (Aorta),3/185,0.0312740294608605,0.136354768449352,0,0,4.58381055564154,15.8827534808837,SRPX;C1QTNF1;PMP22,PanglaoDB,salmon,3
Macrophages,3/204,0.0399811750732276,0.167613387806993,0,0,4.14652091654404,13.3490878437319,CD163;SLC11A1;S100A8,PanglaoDB,salmon,3
Fibroblasts,3/232,0.054808422181576,0.202880096924069,0,0,3.63435635647949,10.5538488821097,C1QTNF1;CD248;IGFBP6,PanglaoDB,salmon,3
Endothelial Cells,3/246,0.0630796209377053,0.214864958819059,0,0,3.42253521126761,9.45768843452319,SRPX;C1QTNF1;CLEC4G,PanglaoDB,salmon,3
axonogenesis (GO:0007409),12/240,2.21232938455255e-09,1.2543907610413e-06,0,0,12.0403916768666,239.955612884798,RET;NLGN3;BRSK2;DAB1;EPHA10;NRXN1;CNTN2;SLITRK5;L1CAM;GFRA3;ISL1;NEFH,GO_BP,greenyellow,12
nervous system development (GO:0007399),14/447,3.73636290145061e-08,1.05925888256125e-05,0,0,7.49384141647421,128.163933095455,NLGN3;ADGRV1;NRXN1;CPNE6;POU3F1;L1CAM;GFRA3;SOX10;UGT8;ERBB3;MPZ;PRX;TAGLN3;GPM6B,GO_BP,greenyellow,14
chemical synaptic transmission (GO:0007268),11/306,3.08869752771485e-07,5.83763832738106e-05,0,0,8.40354568478473,125.972058794501,NLGN3;SLC5A7;CNP;NOVA1;MPZ;NRXN1;CPNE6;GRIK3;PLP1;SYN3;HCRTR1,GO_BP,greenyellow,11
galactolipid biosynthetic process (GO:0019375),3/6,2.2573009188482e-06,0.000233360916894055,0,0,209.463157894737,2723.3018887059,FA2H;UGT8;GAL3ST1,GO_BP,greenyellow,3
galactosylceramide biosynthetic process (GO:0006682),3/6,2.2573009188482e-06,0.000233360916894055,0,0,209.463157894737,2723.3018887059,FA2H;UGT8;GAL3ST1,GO_BP,greenyellow,3
axon development (GO:0061564),6/79,2.46942769200058e-06,0.000233360916894055,0,0,17.7150089338892,228.727765451525,BRSK2;PLP1;SLITRK5;L1CAM;NEFH;ISL1,GO_BP,greenyellow,6
myelination (GO:0042552),5/48,3.69248530128354e-06,0.000278980746463484,0,0,24.8299574893723,310.603172470142,GAL3ST1;MPZ;PLP1;SOX10;BCAS1,GO_BP,greenyellow,5
glycosylceramide biosynthetic process (GO:0046476),3/7,3.93623628167173e-06,0.000278980746463484,0,0,157.089473684211,1955.02335684635,FA2H;UGT8;GAL3ST1,GO_BP,greenyellow,3
galactosylceramide metabolic process (GO:0006681),3/8,6.27558964250336e-06,0.00035918903692427,0,0,125.665263157895,1505.3244717991,FA2H;UGT8;GAL3ST1,GO_BP,greenyellow,3
peripheral nervous system development (GO:0007422),4/25,6.33490364945803e-06,0.00035918903692427,0,0,40.2857142857143,482.197276985786,UGT8;ERBB3;GFRA3;SOX10,GO_BP,greenyellow,4
anterograde trans-synaptic signaling (GO:0098916),8/244,2.67591068935938e-05,0.0013793103280607,0,0,7.40715630885122,77.9872503335928,NLGN3;CNP;NOVA1;MPZ;NRXN1;CPNE6;PLP1;HCRTR1,GO_BP,greenyellow,8
neuron cell-cell adhesion (GO:0007158),3/16,6.09936015822626e-05,0.002766635004244,0,0,48.3133603238866,468.868677354869,NLGN3;RET;NRXN1,GO_BP,greenyellow,3
axon guidance (GO:0007411),7/203,6.3432548598187e-05,0.002766635004244,0,0,7.73390894819466,74.7523555872068,RET;DAB1;EPHA10;NRXN1;CNTN2;L1CAM;GFRA3,GO_BP,greenyellow,7
neuropeptide signaling pathway (GO:0007218),4/63,0.000258689079462396,0.010476907718227,0,0,14.3115759105662,118.211952338791,GALR1;SORCS1;SORCS3;HCRTR1,GO_BP,greenyellow,4
glial cell differentiation (GO:0010001),3/29,0.000380010887918222,0.0143644115633088,0,0,24.1408906882591,190.1170136159,SOX2;ERBB3;SOX10,GO_BP,greenyellow,3
neurotransmitter transport (GO:0006836),4/73,0.000455344828021501,0.016136282343012,0,0,12.2312673450509,94.1129430566592,SLC5A7;SLC6A15;NRXN1;SYN3,GO_BP,greenyellow,4
cell morphogenesis involved in neuron differentiation (GO:0048667),4/76,0.000530751494407533,0.0167186720738373,0,0,11.7198581560284,88.3819893649847,BRSK2;SLITRK5;NEFH;ISL1,GO_BP,greenyellow,4
central nervous system neuron differentiation (GO:0021953),3/34,0.00061138323017245,0.0182449627109357,0,0,20.2421052631579,149.787258825716,LMX1A;CEND1;ISL1,GO_BP,greenyellow,3
visual system development (GO:0150063),3/41,0.00106243973303652,0.0286858727919861,0,0,16.5074792243767,113.029803431039,SOX2;MAB21L1;FREM2,GO_BP,greenyellow,3
"regulation of synaptic transmission, glutamatergic (GO:0051966)",3/46,0.0014863872440677,0.0336289774480738,0,0,14.5843329253366,94.9645241708277,NLGN3;NRXN1;GRIK3,GO_BP,greenyellow,3
neuron projection development (GO:0031175),5/171,0.00154206951261009,0.0336289774480738,0,0,6.39201969166991,41.3859619790701,ADGRV1;PLP1;L1CAM;NEFH;GPM6B,GO_BP,greenyellow,5
positive regulation of kinase activity (GO:0033674),4/114,0.00239608372183886,0.0468475679407806,0,0,7.65647969052224,46.1985833080837,RET;EPHA10;ERBB3;MMD2,GO_BP,greenyellow,4
sensory organ development (GO:0007423),3/56,0.00262001357916732,0.0495182566462624,0,0,11.8266137040715,70.3042013649396,SOX2;MAB21L1;FREM2,GO_BP,greenyellow,3
eye development (GO:0001654),3/58,0.00289590181512378,0.0513117602867244,0,0,11.3954066985646,66.5999839180445,SOX2;MAB21L1;FREM2,GO_BP,greenyellow,3
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),3/60,0.00318903585704327,0.0544141544921836,0,0,10.994459833795,63.1965580390657,IGSF11;CNTN2;L1CAM,GO_BP,greenyellow,3
synapse organization (GO:0050808),4/126,0.00343742700823892,0.0544141544921836,0,0,6.89919776770143,39.1393700567126,NLGN3;NRXN1;CNTN2;L1CAM,GO_BP,greenyellow,4
neuron projection morphogenesis (GO:0048812),4/140,0.00499841249043035,0.0745815758440528,0,0,6.1846057571965,32.7699680245652,BRSK2;SLITRK5;ISL1;NEFH,GO_BP,greenyellow,4
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),4/170,0.00980185313909914,0.129247691392307,0,0,5.05921558574725,23.3998020455926,IGSF11;MPZ;CNTN2;L1CAM,GO_BP,greenyellow,4
central nervous system development (GO:0007417),5/268,0.0102887592044429,0.132584692475435,0,0,4.01467762377857,18.3739884057252,UGT8;DLX2;AATK;TAGLN3;SOX10,GO_BP,greenyellow,5
regulation of kinase activity (GO:0043549),3/94,0.0110847852040572,0.139668293571121,0,0,6.87484094852516,30.9517838875931,RET;EPHA10;ERBB3,GO_BP,greenyellow,3
modulation of chemical synaptic transmission (GO:0050804),3/109,0.0164736536291714,0.169781998137231,0,0,5.89751737835154,24.2151646245978,NLGN3;GRIK3;SYN3,GO_BP,greenyellow,3
sphingolipid metabolic process (GO:0006665),3/116,0.0194095678364136,0.169781998137231,0,0,5.53022822543083,21.8000996453348,UGT8;FA2H;GAL3ST1,GO_BP,greenyellow,3
plasma membrane bounded cell projection organization (GO:0120036),3/128,0.0250730174914248,0.169781998137231,0,0,4.99629473684211,18.4161575941192,PLP1;L1CAM;GPM6B,GO_BP,greenyellow,3
enzyme linked receptor protein signaling pathway (GO:0007167),3/140,0.0315327873386332,0.175846397357359,0,0,4.55589704187476,15.7484941662272,RET;EPHA10;ERBB3,GO_BP,greenyellow,3
neuron development (GO:0048666),3/143,0.0332714310047374,0.175846397357359,0,0,4.45759398496241,15.1694427495958,PLP1;L1CAM;GPM6B,GO_BP,greenyellow,3
nitrogen compound transport (GO:0071705),3/143,0.0332714310047374,0.175846397357359,0,0,4.45759398496241,15.1694427495958,SLC5A7;SLC6A15;RHAG,GO_BP,greenyellow,3
positive regulation of transferase activity (GO:0051347),3/148,0.0362782494108652,0.186997885599641,0,0,4.30279491833031,14.2703781502413,RET;EPHA10;ERBB3,GO_BP,greenyellow,3
inorganic cation transmembrane transport (GO:0098662),4/274,0.0458337433544083,0.193883322547426,0,0,3.09408983451537,9.53825811222493,SLC6A15;KCNA2;RHAG;KCNK2,GO_BP,greenyellow,4
regulation of MAPK cascade (GO:0043408),3/166,0.0482143712154974,0.193883322547426,0,0,3.82415240555376,11.5952054126599,SOX2;RET;GPR37L1,GO_BP,greenyellow,3
positive regulation of developmental process (GO:0051094),3/177,0.0563428932685008,0.198478239268005,0,0,3.58039927404719,10.2982994392078,DLX2;NRXN1;ISL1,GO_BP,greenyellow,3
generation of neurons (GO:0048699),3/202,0.0770424552972922,0.216252832443389,0,0,3.12663316582915,8.01480721000028,BRSK2;TUBB2B;LMX1A,GO_BP,greenyellow,3
positive regulation of phosphorylation (GO:0042327),3/253,0.127726517759805,0.258525718307028,0,0,2.48235789473684,5.1083546508162,RET;EPHA10;ERBB3,GO_BP,greenyellow,3
positive regulation of intracellular signal transduction (GO:1902533),5/546,0.130245734198944,0.259137987701124,0,0,1.92405541311391,3.92186439127478,SOX2;RET;ADGRV1;ERBB3;GPR37L1,GO_BP,greenyellow,5
positive regulation of cell differentiation (GO:0045597),3/258,0.133221663412748,0.259137987701124,0,0,2.43306501547988,4.90442865400404,DLX2;MMD2;ISL1,GO_BP,greenyellow,3
phosphorylation (GO:0016310),4/400,0.133398563689585,0.259137987701124,0,0,2.09606705351386,4.22234663413795,RET;NIM1K;BRSK2;AATK,GO_BP,greenyellow,4
cellular component assembly (GO:0022607),3/261,0.136558254817346,0.259137987701124,0,0,2.40440636474908,4.78718264218823,NLGN3;NEFH;GPM6B,GO_BP,greenyellow,3
positive regulation of MAPK cascade (GO:0043410),3/274,0.151341619245045,0.274155585022174,0,0,2.28755098077297,4.3193894897525,SOX2;RET;GPR37L1,GO_BP,greenyellow,3
MAPK cascade (GO:0000165),3/303,0.186002013759508,0.300766817403848,0,0,2.06336842105263,3.47058110077499,RET;ERBB3;GFRA3,GO_BP,greenyellow,3
positive regulation of cellular process (GO:0048522),5/625,0.192347310092157,0.30379087694221,0,0,1.67204301075269,2.75628370578134,DLX2;ERBB3;GLP2R;NCMAP;ISL1,GO_BP,greenyellow,5
protein phosphorylation (GO:0006468),4/496,0.22581478628262,0.331702030627579,0,0,1.67877529839128,2.49808503916387,RET;NIM1K;BRSK2;AATK,GO_BP,greenyellow,4
positive regulation of nucleic acid-templated transcription (GO:1903508),4/511,0.241583261055365,0.346779010173144,0,0,1.62784841999245,2.31242558359511,SOX2;RET;POU3F1;SOX10,GO_BP,greenyellow,4
negative regulation of transcription by RNA polymerase II (GO:0000122),5/684,0.244432901274949,0.348324766885573,0,0,1.52208339271858,2.14433306276526,SOX2;DLX2;ZNF536;ISL1;SOX10,GO_BP,greenyellow,5
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),3/404,0.317707294829594,0.40848080763805,0,0,1.53571334820843,1.76088697480021,RET;EPHA10;ERBB3,GO_BP,greenyellow,3
"positive regulation of transcription, DNA-templated (GO:0045893)",7/1183,0.359914014040175,0.437485838868818,0,0,1.22488226059655,1.25169508755439,SOX2;RET;LMX1A;GALR1;POU3F1;ISL1;SOX10,GO_BP,greenyellow,7
cellular protein modification process (GO:0006464),6/1025,0.38803793551596,0.460297698032129,0,0,1.20853778213935,1.14406491663576,RET;NIM1K;BRSK2;ST6GALNAC2;AATK;PPEF1,GO_BP,greenyellow,6
"negative regulation of transcription, DNA-templated (GO:0045892)",5/948,0.49841540351503,0.549868546814546,0,0,1.08091312329673,0.752662945839917,SOX2;DLX2;ZNF536;ISL1;SOX10,GO_BP,greenyellow,5
regulation of gene expression (GO:0010468),5/1079,0.614764871748732,0.660173640684717,0,0,0.942512164353938,0.458546688903079,SOX2;NOVA1;PRX;ZNF536;POU3F1,GO_BP,greenyellow,5
positive regulation of transcription by RNA polymerase II (GO:0045944),4/908,0.655445964756722,0.695107519038528,0,0,0.894276030879307,0.377777441369712,SOX2;LMX1A;GALR1;ISL1,GO_BP,greenyellow,4
regulation of transcription by RNA polymerase II (GO:0006357),8/2206,0.859810148664771,0.87055777552308,0,0,0.715964007683753,0.108141832362092,SOX2;DLX2;LMX1A;GALR1;ZNF536;POU3F1;ISL1;SOX10,GO_BP,greenyellow,8
"regulation of transcription, DNA-templated (GO:0006355)",8/2244,0.872185056602991,0.879944710131487,0,0,0.702285827867223,0.096040155019144,SOX2;RET;DLX2;LMX1A;ZNF536;POU3F1;ISL1;SOX10,GO_BP,greenyellow,8
Enteric Glia Cells,14/111,2.5012290007377e-16,1.51399625636357e-14,0,0,34.0292096219931,1222.48503878299,NRXN1;GRIK3;PHYHIPL;SORCS1;L1CAM;GFRA3;SOX10;MPZ;PLP1;CNTN2;ZNF536;PMP2;GPM6B;PRIMA1,PanglaoDB,greenyellow,14
Oligodendrocytes,16/178,3.93245780873656e-16,1.51399625636357e-14,0,0,23.7759710930443,843.383549573889,DDC;TTYH1;NRXN1;CPNE6;PHYHIPL;MMD2;POU3F1;SOX10;FA2H;MPPED1;PLP1;CNTN2;PMP2;ENPP6;GPM6B;BCAS1,PanglaoDB,greenyellow,16
Neural Stem/Precursor Cells,14/152,2.20110868959586e-14,5.64951230329603e-13,0,0,23.8695652173913,750.631710224052,DLX2;BRSK2;GRIK3;PHYHIPL;SLC35F1;ELAVL3;SOX2;TUBB2B;PLP1;CNTN2;ZNF536;TAGLN3;SULT4A1;GPM6B,PanglaoDB,greenyellow,14
Schwann Cells,13/138,1.47383590656274e-13,2.83713412013328e-12,0,0,24.1977411764706,714.940114860474,CNP;PHYHIPL;GPR37L1;POU3F1;GFRA3;SOX10;MPZ;PRX;PLP1;CNTN2;PMP2;PRIMA1;BCAS1,PanglaoDB,greenyellow,13
Retinal Progenitor Cells,12/112,2.82530028162829e-13,4.35096243370756e-12,0,0,27.6306976744186,798.388775977423,SOX2;BRSK2;TUBB2B;GRIK3;PHYHIPL;ZNF536;MMD2;SLC35F1;TAGLN3;NEFH;SULT4A1;ELAVL3,PanglaoDB,greenyellow,12
Oligodendrocyte Progenitor Cells,12/125,1.06990130344006e-12,1.37304000608141e-11,0,0,24.4358921588804,673.537606856026,CNP;PLP1;PHYHIPL;CNTN2;ZNF536;MMD2;SLC35F1;PMP2;GPR37L1;TAGLN3;SOX10;ELAVL3,PanglaoDB,greenyellow,12
Purkinje Fiber Cells,11/102,2.70981259813388e-12,2.83764649234823e-11,0,0,27.5257041808766,733.123503767814,RAB3C;NOVA1;TMEM132B;NRXN1;DENND2A;PLP1;CNTN2;SLC35F1;SULT4A1;GPM6B;ELAVL3,PanglaoDB,greenyellow,11
Immature Neurons,12/136,2.94820414789426e-12,2.83764649234823e-11,0,0,22.2558139534884,590.887963346886,RAB3C;NOVA1;NRXN1;GRIK3;PHYHIPL;CNTN2;ZNF536;MMD2;SLC35F1;SULT4A1;GPM6B;ELAVL3,PanglaoDB,greenyellow,12
Trigeminal Neurons,12/144,5.83412901516005e-12,4.99142149074804e-11,0,0,20.8985200845666,540.588207713976,RAB3C;NOVA1;NRXN1;PLP1;PHYHIPL;CNTN2;ZNF536;MMD2;TAGLN3;NEFH;SULT4A1;ELAVL3,PanglaoDB,greenyellow,12
Interneurons,15/305,2.33066659003942e-11,1.79461327433036e-10,0,0,12.2218529289572,299.218846377586,RAB3C;DLX2;NRXN1;KCNA2;PHYHIPL;MMD2;SLC35F1;SHISA9;L1CAM;ISL1;ELAVL3;SLC5A7;CNTN2;TAGLN3;SULT4A1,PanglaoDB,greenyellow,15
Neuroblasts,11/146,1.39540598324365e-10,9.76784188270556e-10,0,0,18.5131545338442,420.112823734187,SOX2;DLX2;BRSK2;TUBB2B;DAB1;SLC35F1;TAGLN3;ISL1;SULT4A1;B4GALNT4;ELAVL3,PanglaoDB,greenyellow,11
Neuroendocrine Cells,10/123,4.7409910540518e-10,3.04213592634991e-09,0,0,19.9004424778761,427.254634010908,RAB3C;NRXN1;PLP1;PHYHIPL;CNTN2;ZNF536;MMD2;TAGLN3;SULT4A1;ELAVL3,PanglaoDB,greenyellow,10
Enteric Neurons,11/166,5.54446496039808e-10,3.28402924577425e-09,0,0,16.1080459770115,343.311602265303,RET;SLC5A7;TAFA5;NOVA1;NRXN1;PHYHIPL;CNTN2;ZNF536;TAGLN3;SULT4A1;ELAVL3,PanglaoDB,greenyellow,11
Bergmann Glia,10/132,9.51203560415718e-10,5.23161958228645e-09,0,0,18.4239940387481,382.727026903479,NRXN1;KCNA2;PLP1;PHYHIPL;CNTN2;MMD2;PMP2;GPR37L1;GPM6B;ELAVL3,PanglaoDB,greenyellow,10
Cajal-Retzius Cells,10/174,1.38711745542354e-08,7.12053627117415e-08,0,0,13.6765521064302,247.456051688444,TUBB2B;NOVA1;CNTN2;ZNF536;SLITRK5;SLC35F1;TAGLN3;SULT4A1;GPM6B;ELAVL3,PanglaoDB,greenyellow,10
Pyramidal Cells,9/130,1.51301967758706e-08,7.28140719838772e-08,0,0,16.5316185346829,297.677800971179,RAB3C;DAB1;NRXN1;CNTN2;MMD2;TAGLN3;POU3F1;SORCS3;ELAVL3,PanglaoDB,greenyellow,9
Enteroendocrine Cells,9/139,2.71597266300097e-08,1.23017585324162e-07,0,0,15.3801210025929,267.945248670309,RAB3C;NRXN1;GLP2R;PHYHIPL;TAGLN3;GFRA3;ISL1;SULT4A1;ELAVL3,PanglaoDB,greenyellow,9
Astrocytes,9/154,6.60268984760946e-08,2.82448399036627e-07,0,0,13.7786129407207,227.804613422838,ENTPD2;NRXN1;PLP1;PHYHIPL;CNTN2;MMD2;PMP2;GPR37L1;GPM6B,PanglaoDB,greenyellow,9
Purkinje Neurons,9/155,6.98161419740608e-08,2.82939101684351e-07,0,0,13.6835462521164,225.469273136372,RAB3C;NRXN1;KCNA2;GRIK3;PLP1;CNTN2;MMD2;SULT4A1;ELAVL3,PanglaoDB,greenyellow,9
Retinal Ganglion Cells,9/164,1.13399321747763e-07,4.36587388728886e-07,0,0,12.8831460674157,206.031786508873,BRSK2;NKAIN3;CNTN2;MMD2;SLC35F1;TAGLN3;ISL1;SULT4A1;ELAVL3,PanglaoDB,greenyellow,9
Dopaminergic Neurons,8/119,1.24732343571093e-07,4.57351926427342e-07,0,0,15.8486486486487,251.947483440602,BRSK2;DDC;NRXN1;GRIK3;PHYHIPL;CNTN2;SULT4A1;ELAVL3,PanglaoDB,greenyellow,8
Neurons,11/289,1.74443469330644e-07,6.10552142657252e-07,0,0,8.92516331762177,138.890402563224,RAB3C;NRXN1;CPNE6;PHYHIPL;CNTN2;MMD2;TAGLN3;ISL1;NEFH;SULT4A1;ELAVL3,PanglaoDB,greenyellow,11
Beta Cells,8/145,5.70664463302258e-07,1.91048537714234e-06,0,0,12.8240064882401,184.363873127709,RAB3C;LMX1A;NOVA1;NRXN1;PHYHIPL;ISL1;SULT4A1;ELAVL3,PanglaoDB,greenyellow,8
Glycinergic Neurons,7/100,6.02413828081765e-07,1.93274436509566e-06,0,0,16.3846153846154,234.66572437099,TUBB2B;CNTN2;MMD2;TAGLN3;SULT4A1;B4GALNT4;ELAVL3,PanglaoDB,greenyellow,7
Radial Glia Cells,7/114,1.46453913756963e-06,4.33728898434084e-06,0,0,14.2307692307692,191.175726166715,NOVA1;PLP1;PHYHIPL;CNTN2;ZNF536;SLC35F1;GPM6B,PanglaoDB,greenyellow,7
Satellite Glial Cells,7/114,1.46453913756963e-06,4.33728898434084e-06,0,0,14.2307692307692,191.175726166715,SOX2;NRXN1;CPNE6;KCNA2;PLP1;MMD2;PMP2,PanglaoDB,greenyellow,7
Photoreceptor Cells,7/149,8.68239089374928e-06,2.47608925488405e-05,0,0,10.7042253521127,124.749328875502,RAB3C;NRXN1;CNTN2;ZNF536;MMD2;ISL1;ELAVL3,PanglaoDB,greenyellow,7
Glutaminergic Neurons,6/107,1.43798954727297e-05,3.95447125500066e-05,0,0,12.7858372793801,142.557987479886,TMEM132B;NRXN1;PHYHIPL;CNTN2;MMD2;ELAVL3,PanglaoDB,greenyellow,6
GABAergic Neurons,6/113,1.9634413617738e-05,5.21327533988216e-05,0,0,12.0652173913043,130.765561688155,PHYHIPL;CNTN2;ZNF536;MMD2;SULT4A1;ELAVL3,PanglaoDB,greenyellow,6
Taste Receptor Cells,6/115,2.16947256403007e-05,5.56831291434384e-05,0,0,11.8426406063024,127.17150199454,NRXN1;CPNE6;KCNA2;CNTN2;PMP2;XKR4,PanglaoDB,greenyellow,6
Chromaffin Cells,6/122,3.03198017714311e-05,7.53104753677482e-05,0,0,11.1240629685157,115.731519974523,RAB3C;NRXN1;PHYHIPL;CNTN2;TAGLN3;SULT4A1,PanglaoDB,greenyellow,6
Peri-islet Schwann Cells,5/114,0.000245351785123168,0.000590377732952622,0,0,9.76275032060767,81.1559619049389,MPZ;INSC;DENND2A;PLP1;GFRA3,PanglaoDB,greenyellow,5
Gamma (PP) Cells,5/128,0.00041896904729768,0.000977594443694587,0,0,8.6454235510097,67.2416275832138,ENTPD2;NOVA1;NRXN1;PHYHIPL;ISL1,PanglaoDB,greenyellow,5
Delta Cells,5/131,0.000465877690277737,0.00105507594562899,0,0,8.43830005120328,64.7351565654436,RAB3C;NRXN1;PHYHIPL;POU3F1;ISL1,PanglaoDB,greenyellow,5
Anterior Pituitary Gland Cells,5/133,0.000499278722355823,0.00109841318918281,0,0,8.30561155913978,63.1421332819109,RAB3C;NOVA1;NRXN1;MAB21L1;ZNF536,PanglaoDB,greenyellow,5
Gastric Chief Cells,4/109,0.00203511998009629,0.00435289551298372,0,0,8.02310030395137,49.7207612436577,FA2H;ENTPD2;ERBB3;AATK,PanglaoDB,greenyellow,4
Enterocytes,5/203,0.00324695099653951,0.00675716829009575,0,0,5.35027696318019,30.657295006524,DDC;DAB1;SLC35F1;L1CAM;SOX10,PanglaoDB,greenyellow,5
Cholinergic Neurons,3/102,0.0138068662760688,0.02797707113835,0,0,6.31674641148325,27.0520303040963,SLC5A7;TUBB2B;SULT4A1,PanglaoDB,greenyellow,3
Adrenergic Neurons,3/106,0.0152979333906273,0.0302036120789308,0,0,6.07020950434338,25.3737035565628,DDC;GAL3ST1;PHYHIPL,PanglaoDB,greenyellow,3
Enterochromaffin Cells,3/109,0.0164736536291714,0.031711783236155,0,0,5.89751737835154,24.2151646245978,LMX1A;DENND2A;PHYHIPL,PanglaoDB,greenyellow,3
Motor Neurons,3/111,0.0172849269810209,0.032461936037527,0,0,5.78771929824561,23.4861043836326,DLX2;TUBB2B;ISL1,PanglaoDB,greenyellow,3
Pancreatic Progenitor Cells,3/114,0.0185431512028613,0.0339957772052458,0,0,5.63044096728307,22.4522547550271,TUBB2B;ISL1;PRIMA1,PanglaoDB,greenyellow,3
Principal Cells,3/136,0.029291359521112,0.0524519693750145,0,0,4.69386624455877,16.5715197108819,FA2H;ERBB3;L1CAM,PanglaoDB,greenyellow,3
Plasma Cells,54/166,3.02003422935573e-103,6.04006845871145e-102,0,0,682.576530612245,161129.695944346,IGHM;IGHV3-21;IGHV1-2;IGHV3-23;IGHV4-39;IGHV1-46;JCHAIN;IGHG3;IGHG1;IGHG2;IGKV1-16;IGKV1-17;IGLV7-46;IGLC3;IGKV1-12;IGKV2-24;IGLC1;IGLC2;IGHV3-7;IGHV5-51;IGHV3-74;AMPD1;IGLV4-69;MZB1;IGKV4-1;IGHD;IGLV3-19;IGKV2-30;IGHV2-5;IGHV4-59;IGLV3-1;IGHV3-49;IGLV2-11;CD79A;IGLV3-25;IGLV1-40;IGKC;IGLV6-57;IGLV3-21;IGLV2-14;IGLV1-44;IGKV3-15;TNFRSF17;IGHA1;IGHA2;IGLC7;IGHV3-11;IGKV1-5;IGHV3-15;IGLV7-43;IGLL5;IGLV2-23;SDC1;IGKV3-20,PanglaoDB,midnightblue,54
Tuft Cells,36/136,1.26387966157312e-61,1.26387966157312e-60,0,0,223.11,31285.2661081593,IGHM;IGHV2-5;IGHV3-21;IGHV3-23;IGHV4-59;IGLV3-1;JCHAIN;IGLV2-11;IGLV3-25;IGHG1;IGHG2;IGLV1-40;IGKV1-16;IGKC;IGKV1-17;IGLV3-21;IGLV2-14;IGLV1-44;IGLC3;IGKV3-15;IGKV2-24;IGLC1;IGLC2;IGHV3-7;IGHA1;IGHA2;IGHV5-51;IGHV3-74;IGKV1-5;IGHV3-15;IGLL5;IGLV2-23;IGKV4-1;IGLV3-19;IGKV2-30;IGKV3-20,PanglaoDB,midnightblue,36
Paneth Cells,18/132,1.63878481331839e-24,1.09252320887893e-23,0,0,62.5831578947368,3427.55985084311,IGHV3-72;IGHV3-74;IGHV3-21;IGHV3-23;IGKV1-5;IGHV3-15;IGLV2-11;IGKV1-16;IGKV1-17;IGKV1-12;IGKV4-1;IGKV2-24;IGHV3-7;IGHA1;IGHA2;IGLV3-19;IGKV2-30;IGKV3-20,PanglaoDB,midnightblue,18
B Cells,17/182,2.82276681034554e-20,1.41138340517277e-19,0,0,39.9333333333333,1797.55844041265,IGHM;JCHAIN;IGHG3;CD79A;IGLL5;IGHG1;IGKC;POU2AF1;IGLC3;MZB1;IGKV4-1;IGHD;TNFRSF17;SDC1;IGLC1;IGLC2;IGHA1,PanglaoDB,midnightblue,17
B Cells Memory,6/147,1.07040649966293e-05,4.28162599865172e-05,0,0,13.5833905284832,155.460369436503,IGHM;CD79A;IGLL5;IGKC;IGHD;TNFRSF17,PanglaoDB,midnightblue,6
Plasmacytoid Dendritic Cells,4/150,0.00170584885471354,0.00499379045768258,0,0,8.47003424657534,53.9853931603963,IGHM;IGKC;MZB1;JCHAIN,PanglaoDB,midnightblue,4
B Cells Naive,4/151,0.0017478266601889,0.00499379045768258,0,0,8.41198979591837,53.4109380355096,IGHM;CD79A;IGKC;IGHD,PanglaoDB,midnightblue,4
